UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O00141	SGK1	V219I	O00141/V219I	SGK1/V219I	VARIANT	V -> I (in dbSNP:rs34133418)	ECO:0000269|PubMed:17344846	17344846
O00141	SGK1	A342V	O00141/A342V	SGK1/A342V	VARIANT	A -> V (in dbSNP:rs55932330)	ECO:0000269|PubMed:17344846	17344846
O00141	SGK1	K127M	O00141/K127M	SGK1/K127M	MUTAGEN	K->M: Abolishes enzymatic activity.	ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:15040001	11696533,12911626,15040001
O00141	SGK1	T256A	O00141/T256A	SGK1/T256A	MUTAGEN	T->A: Low activity.	ECO:0000269|PubMed:10191262	10191262
O00141	SGK1	T256D	O00141/T256D	SGK1/T256D	MUTAGEN	T->D: Low activity.	ECO:0000269|PubMed:10191262	10191262
O00141	SGK1	T256E	O00141/T256E	SGK1/T256E	MUTAGEN	T->E: Low activity.	ECO:0000269|PubMed:10191262	10191262
O00141	SGK1	Y298A	O00141/Y298A	SGK1/Y298A	MUTAGEN	Y->A: Abolishes interaction with NEDD4 and NEDD4L.	ECO:0000269|PubMed:11696533	11696533
O00141	SGK1	S422A	O00141/S422A	SGK1/S422A	MUTAGEN	S->A: Low activity.	ECO:0000269|PubMed:10191262, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:15040001	10191262,11696533,12911626,15040001
O00141	SGK1	S422D	O00141/S422D	SGK1/S422D	MUTAGEN	S->D: 10-fold activation.	ECO:0000269|PubMed:10191262, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:15040001	10191262,11696533,12911626,15040001

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O00238	BMPR1B	R31C	O00238/R31C	BMPR1B/R31C	VARIANT	R -> C (in AMD3; unknown pathological significance; mouse BMPR1B construct containing this mutation shows reduced GDF5-dependent receptor activation, mouse BMPR1B construct containing this mutation shows no loss of cell membrane localization; dbSNP:rs745854387)	ECO:0000269|PubMed:26105076	26105076
O00238	BMPR1B	R31H	O00238/R31H	BMPR1B/R31H	VARIANT	R -> H (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs200035802)	ECO:0000269|PubMed:17344846	17344846
O00238	BMPR1B	C53R	O00238/C53R	BMPR1B/C53R	VARIANT	C -> R (in AMD3; mouse BMPR1B construct containing this mutation shows loss of GDF5-dependent receptor activation, chicken BMPR1B construct containing this mutation does not show reduced chondrocyte differentiation, mouse BMPR1B construct containing this mutation shows no loss of cell membrane localization; dbSNP:rs863225041)	ECO:0000269|PubMed:24129431	24129431
O00238	BMPR1B	R149W	O00238/R149W	BMPR1B/R149W	VARIANT	R -> W (in dbSNP:rs34231464)	ECO:0000269|PubMed:17344846	17344846
O00238	BMPR1B	I200K	O00238/I200K	BMPR1B/I200K	VARIANT	I -> K (in BDA2; in animal models loss of kinase activity and loss of positive regulation of chondrocyte differentiation; dbSNP:rs121434417)	ECO:0000269|PubMed:14523231	14523231
O00238	BMPR1B	R224H	O00238/R224H	BMPR1B/R224H	VARIANT	R -> H (in dbSNP:rs35973133)	ECO:0000269|PubMed:17344846	17344846
O00238	BMPR1B	D297N	O00238/D297N	BMPR1B/D297N	VARIANT	D -> N (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O00238	BMPR1B	K325N	O00238/K325N	BMPR1B/K325N	VARIANT	K -> N (in BDA1D; acts in a dominant-negative manner; dbSNP:rs869025614)	ECO:0000269|PubMed:25758993	25758993
O00238	BMPR1B	R371Q	O00238/R371Q	BMPR1B/R371Q	VARIANT	R -> Q (in dbSNP:rs34970181)	ECO:0000269|PubMed:17344846	17344846
O00238	BMPR1B	R486Q	O00238/R486Q	BMPR1B/R486Q	VARIANT	R -> Q (in brachydactyly type C and BDA2; with also additional features of symphalangism-1; dbSNP:rs121434419)	ECO:0000269|PubMed:16957682	16957682
O00238	BMPR1B	R486W	O00238/R486W	BMPR1B/R486W	VARIANT	R -> W (in BDA2; in animal models no effect on kinase activity but strongly decreased positive regulation of chondrocyte differentiation; dbSNP:rs121434418)	ECO:0000269|PubMed:14523231	14523231

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O00311	CDC7	Q23P	O00311/Q23P	CDC7/Q23P	VARIANT	Q -> P (in dbSNP:rs13447459)	ECO:0000269|Ref.4	
O00311	CDC7	I99V	O00311/I99V	CDC7/I99V	VARIANT	I -> V (in dbSNP:rs13447492)	ECO:0000269|Ref.4	
O00311	CDC7	G112W	O00311/G112W	CDC7/G112W	VARIANT	G -> W (in dbSNP:rs13447493)	ECO:0000269|Ref.4	
O00311	CDC7	F162L	O00311/F162L	CDC7/F162L	VARIANT	F -> L (in dbSNP:rs13447503)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
O00311	CDC7	I208M	O00311/I208M	CDC7/I208M	VARIANT	I -> M (in dbSNP:rs34979509)	ECO:0000269|PubMed:17344846	17344846
O00311	CDC7	E209D	O00311/E209D	CDC7/E209D	VARIANT	E -> D (in dbSNP:rs56327502)	ECO:0000269|PubMed:17344846	17344846
O00311	CDC7	K441R	O00311/K441R	CDC7/K441R	VARIANT	K -> R (in dbSNP:rs13447539)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
O00311	CDC7	T472I	O00311/T472I	CDC7/T472I	VARIANT	T -> I (in dbSNP:rs56381770)	ECO:0000269|PubMed:17344846	17344846
O00311	CDC7	S498A	O00311/S498A	CDC7/S498A	VARIANT	S -> A (in dbSNP:rs35055915)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O00418	EEF2K	H23R	O00418/H23R	EEF2K/H23R	VARIANT	H -> R (in dbSNP:rs9935059)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
O00418	EEF2K	P75A	O00418/P75A	EEF2K/P75A	VARIANT	P -> A (in dbSNP:rs17841292)	ECO:0000269|PubMed:17344846	17344846
O00418	EEF2K	T291M	O00418/T291M	EEF2K/T291M	VARIANT	T -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs147978363)	ECO:0000269|PubMed:17344846	17344846
O00418	EEF2K	Q361R	O00418/Q361R	EEF2K/Q361R	VARIANT	Q -> R (in dbSNP:rs4783453)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9144159	15489334,9144159
O00418	EEF2K	R433W	O00418/R433W	EEF2K/R433W	VARIANT	R -> W (in dbSNP:rs56137739)	ECO:0000269|PubMed:17344846	17344846
O00418	EEF2K	D609H	O00418/D609H	EEF2K/D609H	VARIANT	D -> H	ECO:0000269|PubMed:17344846	17344846
O00418	EEF2K	S78A	O00418/S78A	EEF2K/S78A	MUTAGEN	S->A: Decreased kinase activity.	ECO:0000269|PubMed:22216903	22216903
O00418	EEF2K	T348A	O00418/T348A	EEF2K/T348A	MUTAGEN	T->A: Decreased kinase activity.	ECO:0000269|PubMed:22216903	22216903
O00418	EEF2K	S366A	O00418/S366A	EEF2K/S366A	MUTAGEN	S->A: Decreased kinase activity.	ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:22216903	11500364,22216903

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O00444	PLK4	Y86C	O00444/Y86C	PLK4/Y86C	VARIANT	Y -> C (in dbSNP:rs34156294)	ECO:0000269|PubMed:17344846	17344846
O00444	PLK4	R146H	O00444/R146H	PLK4/R146H	VARIANT	R -> H (in dbSNP:rs35232579)	ECO:0000269|PubMed:17344846	17344846
O00444	PLK4	A226T	O00444/A226T	PLK4/A226T	VARIANT	A -> T (in dbSNP:rs35448573)	ECO:0000269|PubMed:17344846	17344846
O00444	PLK4	S232T	O00444/S232T	PLK4/S232T	VARIANT	S -> T (in dbSNP:rs3811740)	ECO:0000269|PubMed:11489907, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.1	11489907,14702039,17344846
O00444	PLK4	P317L	O00444/P317L	PLK4/P317L	VARIANT	P -> L (in dbSNP:rs35049837)	ECO:0000269|PubMed:17344846	17344846
O00444	PLK4	N449D	O00444/N449D	PLK4/N449D	VARIANT	N -> D (in dbSNP:rs34906574)	ECO:0000269|PubMed:17344846	17344846
O00444	PLK4	W519S	O00444/W519S	PLK4/W519S	VARIANT	W -> S (in dbSNP:rs56043017)	ECO:0000269|PubMed:17344846	17344846
O00444	PLK4	E830D	O00444/E830D	PLK4/E830D	VARIANT	E -> D (in dbSNP:rs17012739)	ECO:0000269|PubMed:11489907, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.1	11489907,14702039,17344846
O00444	PLK4	K41M	O00444/K41M	PLK4/K41M	MUTAGEN	K->M: Abolishes ability to phosphorylate CDC25C and CHEK2.	ECO:0000269|PubMed:18239451, ECO:0000269|PubMed:19164942	18239451,19164942
O00444	PLK4	D154A	O00444/D154A	PLK4/D154A	MUTAGEN	D->A: Catalytically inactive mutant that causes some centrosome amplification above background levels when overexpressed.	ECO:0000269|PubMed:16244668	16244668
O00444	PLK4	T170D	O00444/T170D	PLK4/T170D	MUTAGEN	T->D: Activating mutant.	ECO:0000269|PubMed:18239451, ECO:0000269|PubMed:19164942	18239451,19164942
O00444	PLK4	N669R	O00444/N669R	PLK4/N669R	MUTAGEN	N->R: Does not affect the interaction with TENT5C.	ECO:0000269|PubMed:32433990	32433990
O00444	PLK4	I670P	O00444/I670P	PLK4/I670P	MUTAGEN	I->P: Decreases substantially the interaction with TENT5C. Does not affect localization to the centrosome. Loss of TENT5C recruitment to the centrosome.	ECO:0000269|PubMed:32433990	32433990

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O00506	STK25	Q64H	O00506/Q64H	STK25/Q64H	VARIANT	Q -> H (in dbSNP:rs34341643)		
O00506	STK25	K49R	O00506/K49R	STK25/K49R	MUTAGEN	K->R: Loss of kinase activity and autophosphorylation.	ECO:0000269|PubMed:15037601	15037601
O00506	STK25	D158A	O00506/D158A	STK25/D158A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:15037601	15037601

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O14578	CIT	G7E	O14578/G7E	CIT/G7E	VARIANT	G -> E (in dbSNP:rs36054900)	ECO:0000269|PubMed:17344846	17344846
O14578	CIT	R9Q	O14578/R9Q	CIT/R9Q	VARIANT	R -> Q (in dbSNP:rs56193743)	ECO:0000269|PubMed:17344846	17344846
O14578	CIT	G106V	O14578/G106V	CIT/G106V	VARIANT	G -> V (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037892)	ECO:0000269|PubMed:27453578	27453578
O14578	CIT	K126Q	O14578/K126Q	CIT/K126Q	VARIANT	K -> Q (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037893)	ECO:0000269|PubMed:27453578	27453578
O14578	CIT	L183F	O14578/L183F	CIT/L183F	VARIANT	L -> F	ECO:0000269|PubMed:17344846	17344846
O14578	CIT	D230V	O14578/D230V	CIT/D230V	VARIANT	D -> V (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037894)	ECO:0000269|PubMed:27453578	27453578

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O14730	RIOK3	L336V	O14730/L336V	RIOK3/L336V	VARIANT	L -> V (in dbSNP:rs35401850)	ECO:0000269|PubMed:17344846	17344846
O14730	RIOK3	R441Q	O14730/R441Q	RIOK3/R441Q	VARIANT	R -> Q (in dbSNP:rs33969048)	ECO:0000269|PubMed:17344846	17344846
O14730	RIOK3	S447L	O14730/S447L	RIOK3/S447L	VARIANT	S -> L (in dbSNP:rs56282762)	ECO:0000269|PubMed:17344846	17344846
O14730	RIOK3	K290A	O14730/K290A	RIOK3/K290A	MUTAGEN	K->A: Decreases autophosphorylation (in vitro); abolishes inhibition of TNF-alpha-induced NF-kappaB activation; no effect on interaction with IRF3; fails to activate IFN-beta promoter and IRF3 phosphorylation.	ECO:0000269|PubMed:19557502, ECO:0000269|PubMed:24807708	19557502,24807708

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O14733	MAP2K7	N118S	O14733/N118S	MAP2K7/N118S	VARIANT	N -> S (in dbSNP:rs56316660)	ECO:0000269|PubMed:17344846	17344846
O14733	MAP2K7	R138C	O14733/R138C	MAP2K7/R138C	VARIANT	R -> C (in dbSNP:rs56106612)	ECO:0000269|PubMed:17344846	17344846
O14733	MAP2K7	R162C	O14733/R162C	MAP2K7/R162C	VARIANT	R -> C (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O14733	MAP2K7	R162H	O14733/R162H	MAP2K7/R162H	VARIANT	R -> H (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O14733	MAP2K7	A195T	O14733/A195T	MAP2K7/A195T	VARIANT	A -> T (in dbSNP:rs55800262)	ECO:0000269|PubMed:17344846	17344846
O14733	MAP2K7	L259F	O14733/L259F	MAP2K7/L259F	VARIANT	L -> F (in dbSNP:rs1053566)	ECO:0000269|PubMed:9535930	9535930

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O14757	CHEK1	R156Q	O14757/R156Q	CHEK1/R156Q	VARIANT	R -> Q (in dbSNP:rs3731410)	ECO:0000269|Ref.6	
O14757	CHEK1	E223V	O14757/E223V	CHEK1/E223V	VARIANT	E -> V (in dbSNP:rs35817404)	ECO:0000269|PubMed:17344846	17344846
O14757	CHEK1	V312M	O14757/V312M	CHEK1/V312M	VARIANT	V -> M (in dbSNP:rs34097480)	ECO:0000269|PubMed:17344846	17344846
O14757	CHEK1	I471V	O14757/I471V	CHEK1/I471V	VARIANT	I -> V (in dbSNP:rs506504)	ECO:0000269|PubMed:10717241, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:19054851, ECO:0000269|PubMed:9278511, ECO:0000269|PubMed:9382850, ECO:0000269|Ref.6, ECO:0000269|Ref.9	10717241,14702039,15489334,19054851,9278511,9382850
O14757	CHEK1	K38R	O14757/K38R	CHEK1/K38R	MUTAGEN	K->R: Abolishes kinase activity.	ECO:0000269|PubMed:12446774, ECO:0000269|PubMed:14681223	12446774,14681223
O14757	CHEK1	D130A	O14757/D130A	CHEK1/D130A	MUTAGEN	D->A: Abolishes kinase activity.	ECO:0000269|PubMed:10673501, ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:11535615, ECO:0000269|PubMed:11821419, ECO:0000269|PubMed:12588868, ECO:0000269|PubMed:14681206, ECO:0000269|PubMed:15311285, ECO:0000269|PubMed:9278511	10673501,11390642,11535615,11821419,12588868,14681206,15311285,9278511
O14757	CHEK1	K132R	O14757/K132R	CHEK1/K132R	MUTAGEN	K->R: Strong reduction of chromatin-associated CHK1 ubiquitination.	ECO:0000269|PubMed:32357935	32357935
O14757	CHEK1	S317A	O14757/S317A	CHEK1/S317A	MUTAGEN	S->A: Abrogates interaction with RAD51; when associated with A-345. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Abrogates nuclear retention upon checkpoint activation. Impairs interaction with FBXO6.	ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12588868, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:15665856	11390642,12588868,12676583,12676962,15665856
O14757	CHEK1	S317E	O14757/S317E	CHEK1/S317E	MUTAGEN	S->E: Enhances interaction with RAD51; when associated with E-345.	ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12588868, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:15665856	11390642,12588868,12676583,12676962,15665856
O14757	CHEK1	F344A	O14757/F344A	CHEK1/F344A	MUTAGEN	F->A: Impairs nuclear export.	ECO:0000269|PubMed:12676962	12676962
O14757	CHEK1	S345A	O14757/S345A	CHEK1/S345A	MUTAGEN	S->A: Abrogates interaction with RAD51; when associated with A-317. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Impairs interaction with YWHAZ which is required for nuclear retention after checkpoint activation.	ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12588868, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:15665856, ECO:0000269|PubMed:19716789	11390642,12588868,12676583,12676962,15665856,19716789
O14757	CHEK1	S345E	O14757/S345E	CHEK1/S345E	MUTAGEN	S->E: Enhances interaction with RAD51; when associated with E-317.	ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12588868, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:15665856, ECO:0000269|PubMed:19716789	11390642,12588868,12676583,12676962,15665856,19716789
O14757	CHEK1	M353A	O14757/M353A	CHEK1/M353A	MUTAGEN	M->A: Impairs nuclear export.	ECO:0000269|PubMed:12676962	12676962
O14757	CHEK1	S357A	O14757/S357A	CHEK1/S357A	MUTAGEN	S->A: No effect on phosphorylation induced by hydroxyurea.	ECO:0000269|PubMed:11390642	11390642
O14757	CHEK1	S366A	O14757/S366A	CHEK1/S366A	MUTAGEN	S->A: No effect on phosphorylation induced by hydroxyurea.	ECO:0000269|PubMed:11390642	11390642
O14757	CHEK1	R372E	O14757/R372E	CHEK1/R372E	MUTAGEN	R->E: In 3RE mutant. Disrupts the folding and/or conformation, allowing increased accessibility to FBXO6 component of SCF-type E3 ubiquitin ligase complex; when associated with E-376 and E-379.	ECO:0000269|PubMed:19716789	19716789
O14757	CHEK1	R376E	O14757/R376E	CHEK1/R376E	MUTAGEN	R->E: In 3RE mutant. Disrupts the folding and/or conformation, allowing increased accessibility to FBXO6 component of SCF-type E3 ubiquitin ligase complex; when associated with E-372 and E-379.	ECO:0000269|PubMed:19716789	19716789
O14757	CHEK1	R379E	O14757/R379E	CHEK1/R379E	MUTAGEN	R->E: In 3RE mutant. Disrupts the folding and/or conformation, allowing increased accessibility to FBXO6 component of SCF-type E3 ubiquitin ligase complex; when associated with E-372 and E-376.	ECO:0000269|PubMed:19716789	19716789
O14757	CHEK1	K436R	O14757/K436R	CHEK1/K436R	MUTAGEN	K->R: Enhances stability of the protein, probably by preventing ubiquitination at this site.	ECO:0000269|PubMed:19716789	19716789
O14757	CHEK1	S468A	O14757/S468A	CHEK1/S468A	MUTAGEN	S->A: No effect on phosphorylation induced by hydroxyurea.	ECO:0000269|PubMed:11390642	11390642

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O14874	BCKDK	R174G	O14874/R174G	BCKDK/R174G	VARIANT	R -> G (in BCKDKD; partial loss of kinase activity)	ECO:0000269|PubMed:24449431	24449431
O14874	BCKDK	R224P	O14874/R224P	BCKDK/R224P	VARIANT	R -> P (in BCKDKD; dbSNP:rs147210405)	ECO:0000269|PubMed:22956686	22956686
O14874	BCKDK	L389P	O14874/L389P	BCKDK/L389P	VARIANT	L -> P (in BCKDKD; complete loss of kinase activity)	ECO:0000269|PubMed:24449431	24449431

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O14920	IKBKB	V203I	O14920/V203I	IKBKB/V203I	VARIANT	V -> I (in IMD15A; gain-of-function mutation resulting in increased activation of NF-kappa-B signaling pathway; dbSNP:rs1563340753)	ECO:0000269|PubMed:30337470	30337470
O14920	IKBKB	A360S	O14920/A360S	IKBKB/A360S	VARIANT	A -> S (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17344846	16959974,17344846
O14920	IKBKB	Q369R	O14920/Q369R	IKBKB/Q369R	VARIANT	Q -> R (in dbSNP:rs56411242)	ECO:0000269|PubMed:17344846	17344846
O14920	IKBKB	R526Q	O14920/R526Q	IKBKB/R526Q	VARIANT	R -> Q (in dbSNP:rs2272736)	ECO:0000269|PubMed:17344846	17344846
O14920	IKBKB	R554W	O14920/R554W	IKBKB/R554W	VARIANT	R -> W (in dbSNP:rs17875749)	ECO:0000269|Ref.6	
O14920	IKBKB	A710T	O14920/A710T	IKBKB/A710T	VARIANT	A -> T (in dbSNP:rs34309584)	ECO:0000269|PubMed:17344846	17344846
O14920	IKBKB	F734L	O14920/F734L	IKBKB/F734L	VARIANT	F -> L (in dbSNP:rs56301637)	ECO:0000269|PubMed:17344846	17344846
O14920	IKBKB	A736T	O14920/A736T	IKBKB/A736T	VARIANT	A -> T (in dbSNP:rs17611716)		
O14920	IKBKB	K44A	O14920/K44A	IKBKB/K44A	MUTAGEN	K->A: Loss of kinase activity and no effect on binding to NIK.	ECO:0000269|PubMed:9346484, ECO:0000269|PubMed:9346485	9346484,9346485
O14920	IKBKB	K163R	O14920/K163R	IKBKB/K163R	MUTAGEN	K->R: Monoubiquitinated; when associated with E-177 and E-181.	ECO:0000269|PubMed:19675099	19675099
O14920	IKBKB	D166A	O14920/D166A	IKBKB/D166A	MUTAGEN	D->A: Loss of protein kinase activity.	ECO:0000269|PubMed:25326418	25326418
O14920	IKBKB	K171E	O14920/K171E	IKBKB/K171E	MUTAGEN	K->E: Increased activation of NF-kappa-B signaling.	ECO:0000269|PubMed:30337470	30337470
O14920	IKBKB	S177A	O14920/S177A	IKBKB/S177A	MUTAGEN	S->A: Decrease of activity.	ECO:0000269|PubMed:19675099, ECO:0000269|PubMed:9346484	19675099,9346484
O14920	IKBKB	S177E	O14920/S177E	IKBKB/S177E	MUTAGEN	S->E: Full activation. Interaction with TRIM21 is enhanced; when associated with E-181. Monoubiquitinated; when associated with R-163 and E-181. Strongly promoted NF-kappa-B gene expression; when associated with E-181.	ECO:0000269|PubMed:19675099, ECO:0000269|PubMed:9346484	19675099,9346484
O14920	IKBKB	S181A	O14920/S181A	IKBKB/S181A	MUTAGEN	S->A: Decrease of activity.	ECO:0000269|PubMed:19675099, ECO:0000269|PubMed:9346484	19675099,9346484
O14920	IKBKB	S181E	O14920/S181E	IKBKB/S181E	MUTAGEN	S->E: Full activation. Interaction with TRIM21 is enhanced; when associated with E-177. Monoubiquitinated; when associated with R-163 and E-177. Strongly promoted NF-kappa-B gene expression; when associated with E-177.	ECO:0000269|PubMed:19675099, ECO:0000269|PubMed:9346484	19675099,9346484
O14920	IKBKB	P191A	O14920/P191A	IKBKB/P191A	MUTAGEN	P->A: Loss of hypoxic inducibility.	ECO:0000269|PubMed:17114296	17114296

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O14936	CASK	R28L	O14936/R28L	CASK/R28L	VARIANT	R -> L (in FGS4; does not reveal significant alterations induced by the mutation substitution; causes a partial skipping of exon 2 of the protein; dbSNP:rs137852816)	ECO:0000269|PubMed:19200522	19200522
O14936	CASK	G96V	O14936/G96V	CASK/G96V	VARIANT	G -> V (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O14936	CASK	Y268H	O14936/Y268H	CASK/Y268H	VARIANT	Y -> H (in MICPCH; dbSNP:rs137852817)	ECO:0000269|PubMed:19377476	19377476
O14936	CASK	P396S	O14936/P396S	CASK/P396S	VARIANT	P -> S (in MICPCH; dbSNP:rs137852820)	ECO:0000269|PubMed:19377476	19377476
O14936	CASK	D710G	O14936/D710G	CASK/D710G	VARIANT	D -> G (in MICPCH; dbSNP:rs137852818)	ECO:0000269|PubMed:19377476	19377476

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O14965	AURKA	G11R	O14965/G11R	AURKA/G11R	VARIANT	G -> R (in dbSNP:rs6069717)		
O14965	AURKA	F31I	O14965/F31I	AURKA/F31I	VARIANT	F -> I (in dbSNP:rs2273535)	ECO:0000269|PubMed:15867347, ECO:0000269|PubMed:16011022, ECO:0000269|PubMed:16762494, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9771714	15867347,16011022,16762494,17344846,9771714
O14965	AURKA	P50L	O14965/P50L	AURKA/P50L	VARIANT	P -> L (in dbSNP:rs34572020)	ECO:0000269|PubMed:17344846	17344846
O14965	AURKA	I57V	O14965/I57V	AURKA/I57V	VARIANT	I -> V (increased kinase activity; dbSNP:rs1047972)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:15867347, ECO:0000269|PubMed:16011022, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9153231, ECO:0000269|PubMed:9514916, ECO:0000269|PubMed:9771714	15489334,15867347,16011022,17344846,9153231,9514916,9771714
O14965	AURKA	S104L	O14965/S104L	AURKA/S104L	VARIANT	S -> L (in dbSNP:rs2230743)		
O14965	AURKA	S155R	O14965/S155R	AURKA/S155R	VARIANT	S -> R (in a colorectal adenocarcinoma sample; somatic mutation; reduces interaction with TPX2)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19801554	17344846,19801554
O14965	AURKA	V174M	O14965/V174M	AURKA/V174M	VARIANT	V -> M (in a metastatic melanoma sample; somatic mutation; constitutively enhanced kinase activity)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19801554	17344846,19801554
O14965	AURKA	M373V	O14965/M373V	AURKA/M373V	VARIANT	M -> V (in dbSNP:rs33923703)	ECO:0000269|PubMed:17344846	17344846
O14965	AURKA	K162R	O14965/K162R	AURKA/K162R	MUTAGEN	K->R: Loss of kinase activity.	ECO:0000269|PubMed:14702041	14702041
O14965	AURKA	F165A	O14965/F165A	AURKA/F165A	MUTAGEN	F->A: Decreases the interaction with phosphatase type 1 isoforms.	ECO:0000269|PubMed:11551964	11551964
O14965	AURKA	G198N	O14965/G198N	AURKA/G198N	MUTAGEN	G->N: Reduces interaction with TPX2. Reduces kinase activity tenfold. Promotes interaction with the AURKB binding partners INCENP and BIRC5 that are normally not bound by AURKA.	ECO:0000269|PubMed:19357306	19357306
O14965	AURKA	R205A	O14965/R205A	AURKA/R205A	MUTAGEN	R->A: Reduces ubiquitination and proteasomal degradation.	ECO:0000269|PubMed:10851084	10851084
O14965	AURKA	D274N	O14965/D274N	AURKA/D274N	MUTAGEN	D->N: Abolishes cilia disassembly and kinase activity.	ECO:0000269|PubMed:14580337, ECO:0000269|PubMed:17604723	14580337,17604723
O14965	AURKA	T287A	O14965/T287A	AURKA/T287A	MUTAGEN	T->A: No direct effect on catalytic activity.	ECO:0000269|PubMed:19668197	19668197
O14965	AURKA	T287E	O14965/T287E	AURKA/T287E	MUTAGEN	T->E: Enhances interaction with TPX2.	ECO:0000269|PubMed:19668197	19668197
O14965	AURKA	T288A	O14965/T288A	AURKA/T288A	MUTAGEN	T->A: Reduces cilia disassembly and kinase activity.	ECO:0000269|PubMed:17604723	17604723
O14965	AURKA	T288D	O14965/T288D	AURKA/T288D	MUTAGEN	T->D: Mimics phosphorylation state and increases kinase activity.	ECO:0000269|PubMed:11039908	11039908
O14965	AURKA	C290A	O14965/C290A	AURKA/C290A	MUTAGEN	C->A: Enhances stability; when associated with A-393.	ECO:0000269|PubMed:27837025	27837025
O14965	AURKA	Y334A	O14965/Y334A	AURKA/Y334A	MUTAGEN	Y->A: Reduces binding to MYCN.	ECO:0000269|PubMed:27837025	27837025
O14965	AURKA	Q335A	O14965/Q335A	AURKA/Q335A	MUTAGEN	Q->A: Reduces binding to MYCN.	ECO:0000269|PubMed:27837025	27837025
O14965	AURKA	F346A	O14965/F346A	AURKA/F346A	MUTAGEN	F->A: Decreases the interaction with phosphatase type 1 isoforms.	ECO:0000269|PubMed:11551964	11551964
O14965	AURKA	C393A	O14965/C393A	AURKA/C393A	MUTAGEN	C->A: Enhances stability; when associated with A-290.	ECO:0000269|PubMed:27837025	27837025

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O14976	GAK	S144L	O14976/S144L	GAK/S144L	VARIANT	S -> L (in dbSNP:rs768962219)	ECO:0000269|PubMed:17344846	17344846
O14976	GAK	V580M	O14976/V580M	GAK/V580M	VARIANT	V -> M (in dbSNP:rs34255232)	ECO:0000269|PubMed:17344846	17344846
O14976	GAK	D787Y	O14976/D787Y	GAK/D787Y	VARIANT	D -> Y (in dbSNP:rs34585705)	ECO:0000269|PubMed:17344846	17344846
O14976	GAK	Q877R	O14976/Q877R	GAK/Q877R	VARIANT	Q -> R (in dbSNP:rs149842313)	ECO:0000269|PubMed:17344846	17344846
O14976	GAK	G962D	O14976/G962D	GAK/G962D	VARIANT	G -> D (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs773153935)	ECO:0000269|PubMed:17344846	17344846
O14976	GAK	T1051M	O14976/T1051M	GAK/T1051M	VARIANT	T -> M (in dbSNP:rs35227944)	ECO:0000269|PubMed:17344846	17344846
O14976	GAK	Q1120H	O14976/Q1120H	GAK/Q1120H	VARIANT	Q -> H (in dbSNP:rs55801437)	ECO:0000269|PubMed:17344846	17344846
O14976	GAK	P1137L	O14976/P1137L	GAK/P1137L	VARIANT	P -> L (in dbSNP:rs56169884)	ECO:0000269|PubMed:17344846	17344846
O14976	GAK	S1168N	O14976/S1168N	GAK/S1168N	VARIANT	S -> N (in dbSNP:rs56326341)	ECO:0000269|PubMed:17344846	17344846
O14976	GAK	K1265R	O14976/K1265R	GAK/K1265R	VARIANT	K -> R (in dbSNP:rs2306242)	ECO:0000269|PubMed:17344846	17344846
O14976	GAK	D1297N	O14976/D1297N	GAK/D1297N	VARIANT	D -> N (in dbSNP:rs1134921)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O15021	MAST4	A77P	O15021/A77P	MAST4/A77P	VARIANT	A -> P (in dbSNP:rs6867856)		
O15021	MAST4	Q920R	O15021/Q920R	MAST4/Q920R	VARIANT	Q -> R	ECO:0000269|PubMed:17344846	17344846
O15021	MAST4	R1954W	O15021/R1954W	MAST4/R1954W	VARIANT	R -> W	ECO:0000269|PubMed:17344846	17344846
O15021	MAST4	P2198L	O15021/P2198L	MAST4/P2198L	VARIANT	P -> L (in dbSNP:rs752429440)	ECO:0000269|PubMed:17344846	17344846
O15021	MAST4	S2290C	O15021/S2290C	MAST4/S2290C	VARIANT	S -> C	ECO:0000269|PubMed:17344846	17344846
O15021	MAST4	E2467D	O15021/E2467D	MAST4/E2467D	VARIANT	E -> D (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O15075	DCLK1	G29C	O15075/G29C	DCLK1/G29C	VARIANT	G -> C (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O15075	DCLK1	T46M	O15075/T46M	DCLK1/T46M	VARIANT	T -> M (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O15075	DCLK1	R93Q	O15075/R93Q	DCLK1/R93Q	VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1366698690)	ECO:0000269|PubMed:17344846	17344846
O15075	DCLK1	S291F	O15075/S291F	DCLK1/S291F	VARIANT	S -> F (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O15075	DCLK1	R292H	O15075/R292H	DCLK1/R292H	VARIANT	R -> H (in dbSNP:rs56185003)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O15111	CHUK	S126C	O15111/S126C	CHUK/S126C	VARIANT	S -> C (in dbSNP:rs34427437)	ECO:0000269|PubMed:17344846	17344846
O15111	CHUK	V155A	O15111/V155A	CHUK/V155A	VARIANT	V -> A (in dbSNP:rs2230803)	ECO:0000269|PubMed:17344846	17344846
O15111	CHUK	V268I	O15111/V268I	CHUK/V268I	VARIANT	V -> I (in dbSNP:rs2230804)	ECO:0000269|PubMed:15164054, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8777433, ECO:0000269|PubMed:9244310, ECO:0000269|PubMed:9252186, ECO:0000269|PubMed:9813230	15164054,17344846,8777433,9244310,9252186,9813230
O15111	CHUK	T23A	O15111/T23A	CHUK/T23A	MUTAGEN	T->A: Loss of phosphorylation and decrease of kinase activity.	ECO:0000269|PubMed:10485710	10485710
O15111	CHUK	K44A	O15111/K44A	CHUK/K44A	MUTAGEN	K->A: Loss of kinase activity.	ECO:0000269|PubMed:9244310, ECO:0000269|PubMed:9346484	9244310,9346484
O15111	CHUK	K44M	O15111/K44M	CHUK/K44M	MUTAGEN	K->M: Loss of autophosphorylation.	ECO:0000269|PubMed:9244310, ECO:0000269|PubMed:9346484	9244310,9346484
O15111	CHUK	S176A	O15111/S176A	CHUK/S176A	MUTAGEN	S->A: Loss of phosphorylation and of activity.	ECO:0000269|PubMed:9346484, ECO:0000269|PubMed:9520446	9346484,9520446
O15111	CHUK	S176E	O15111/S176E	CHUK/S176E	MUTAGEN	S->E: Full activation.	ECO:0000269|PubMed:9346484, ECO:0000269|PubMed:9520446	9346484,9520446
O15111	CHUK	T179A	O15111/T179A	CHUK/T179A	MUTAGEN	T->A: No change in phosphorylation.	ECO:0000269|PubMed:9520446	9520446
O15111	CHUK	S180A	O15111/S180A	CHUK/S180A	MUTAGEN	S->A: No change in phosphorylation.	ECO:0000269|PubMed:9520446	9520446

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O15146	MUSK	A27G	O15146/A27G	MUSK/A27G	VARIANT	A -> G (in dbSNP:rs56054734)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	D38E	O15146/D38E	MUSK/D38E	VARIANT	D -> E (in CMS9; dbSNP:rs775587809)	ECO:0000269|PubMed:24183479	24183479
O15146	MUSK	T100M	O15146/T100M	MUSK/T100M	VARIANT	T -> M (in dbSNP:rs35142681)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	G107E	O15146/G107E	MUSK/G107E	VARIANT	G -> E (in dbSNP:rs55786136)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	S159G	O15146/S159G	MUSK/S159G	VARIANT	S -> G (in dbSNP:rs35176182)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	N222S	O15146/N222S	MUSK/N222S	VARIANT	N -> S (in dbSNP:rs55826142)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	P344R	O15146/P344R	MUSK/P344R	VARIANT	P -> R (in CMS9; dbSNP:rs387906803)	ECO:0000269|PubMed:19949040	19949040
O15146	MUSK	M413I	O15146/M413I	MUSK/M413I	VARIANT	M -> I (in dbSNP:rs2274419)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	I575T	O15146/I575T	MUSK/I575T	VARIANT	I -> T (in FADS1; reduces agrin-dependent AChR aggregation and tyrosine kinase activity in developing neuromuscular junction; dbSNP:rs751889864)	ECO:0000269|PubMed:25537362	25537362
O15146	MUSK	M605I	O15146/M605I	MUSK/M605I	VARIANT	M -> I (in CMS9; affects interaction with DOK7 and impairs MUSK phosphorylation; altered AChR clustering; dbSNP:rs766640370)	ECO:0000269|PubMed:20371544	20371544
O15146	MUSK	L629F	O15146/L629F	MUSK/L629F	VARIANT	L -> F (in dbSNP:rs34267283)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	V644A	O15146/V644A	MUSK/V644A	VARIANT	V -> A (in dbSNP:rs41279055)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	N664S	O15146/N664S	MUSK/N664S	VARIANT	N -> S (in dbSNP:rs55963442)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	P696L	O15146/P696L	MUSK/P696L	VARIANT	P -> L (in dbSNP:rs56126328)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	A727V	O15146/A727V	MUSK/A727V	VARIANT	A -> V (in CMS9; affects interaction with DOK7 and impairs MUSK phosphorylation; altered AChR clustering; dbSNP:rs397515450)	ECO:0000269|PubMed:20371544	20371544
O15146	MUSK	E782D	O15146/E782D	MUSK/E782D	VARIANT	E -> D (in dbSNP:rs34614566)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	V790M	O15146/V790M	MUSK/V790M	VARIANT	V -> M (in CMS9; does not affect catalytic kinase activity; reduces protein expression and stability; dbSNP:rs199476083)	ECO:0000269|PubMed:15496425	15496425
O15146	MUSK	N819S	O15146/N819S	MUSK/N819S	VARIANT	N -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs757577755)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	V829L	O15146/V829L	MUSK/V829L	VARIANT	V -> L (in dbSNP:rs578430)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	M835V	O15146/M835V	MUSK/M835V	VARIANT	M -> V (in CMS9; reduces AChR aggregation in developing neuromuscular junction)	ECO:0000269|PubMed:23326516	23326516
O15146	MUSK	R858H	O15146/R858H	MUSK/R858H	VARIANT	R -> H (in dbSNP:rs34115159)	ECO:0000269|PubMed:17344846	17344846
O15146	MUSK	G584C	O15146/G584C	MUSK/G584C	MUTAGEN	G->C,D: Mild decrease in kinase activity.		
O15146	MUSK	G584D	O15146/G584D	MUSK/G584D	MUTAGEN	G->C,D: Mild decrease in kinase activity.	ECO:0000269|PubMed:25029443	25029443
O15146	MUSK	K609R	O15146/K609R	MUSK/K609R	MUTAGEN	K->R: Severe loss of kinase activity.	ECO:0000269|PubMed:25029443	25029443
O15146	MUSK	D743N	O15146/D743N	MUSK/D743N	MUTAGEN	D->N: Severe loss of kinase activity.	ECO:0000269|PubMed:25029443	25029443

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O15164	TRIM24	I320T	O15164/I320T	TRIM24/I320T	VARIANT	I -> T (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O15164	TRIM24	T403N	O15164/T403N	TRIM24/T403N	VARIANT	T -> N (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O15164	TRIM24	S762N	O15164/S762N	TRIM24/S762N	VARIANT	S -> N	ECO:0000269|PubMed:17344846	17344846
O15164	TRIM24	N796S	O15164/N796S	TRIM24/N796S	VARIANT	N -> S (in dbSNP:rs35356723)		
O15164	TRIM24	R1009S	O15164/R1009S	TRIM24/R1009S	VARIANT	R -> S (in dbSNP:rs34585297)	ECO:0000269|PubMed:17344846	17344846
O15164	TRIM24	S768A	O15164/S768A	TRIM24/S768A	MUTAGEN	S->A: Ubiquitination is significantly lower than wild-type.	ECO:0000269|PubMed:24820418	24820418
O15164	TRIM24	D827A	O15164/D827A	TRIM24/D827A	MUTAGEN	D->A: Strongly reduced affinity for histone H3 that is not methylated at 'Lys-4' (H3K4me0).	ECO:0000269|PubMed:21164480	21164480
O15164	TRIM24	C840W	O15164/C840W	TRIM24/C840W	MUTAGEN	C->W: Abolishes interaction with histone H3.	ECO:0000269|PubMed:21164480	21164480

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O15197	EPHB6	G122S	O15197/G122S	EPHB6/G122S	VARIANT	G -> S (in dbSNP:rs8177173)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.2	17344846
O15197	EPHB6	S170T	O15197/S170T	EPHB6/S170T	VARIANT	S -> T	ECO:0000269|PubMed:17344846	17344846
O15197	EPHB6	A221V	O15197/A221V	EPHB6/A221V	VARIANT	A -> V	ECO:0000269|PubMed:17344846	17344846
O15197	EPHB6	P282H	O15197/P282H	EPHB6/P282H	VARIANT	P -> H	ECO:0000269|PubMed:17344846	17344846
O15197	EPHB6	P282R	O15197/P282R	EPHB6/P282R	VARIANT	P -> R (in dbSNP:rs8177143)	ECO:0000269|Ref.2	
O15197	EPHB6	R309Q	O15197/R309Q	EPHB6/R309Q	VARIANT	R -> Q (in dbSNP:rs55728646)	ECO:0000269|PubMed:17344846	17344846
O15197	EPHB6	S324A	O15197/S324A	EPHB6/S324A	VARIANT	S -> A (in dbSNP:rs8177146)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.2	17344846
O15197	EPHB6	S332L	O15197/S332L	EPHB6/S332L	VARIANT	S -> L (in dbSNP:rs35189999)	ECO:0000269|PubMed:17344846	17344846
O15197	EPHB6	D360N	O15197/D360N	EPHB6/D360N	VARIANT	D -> N (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
O15197	EPHB6	R499Q	O15197/R499Q	EPHB6/R499Q	VARIANT	R -> Q (in dbSNP:rs8177175)	ECO:0000269|Ref.2	
O15197	EPHB6	A603P	O15197/A603P	EPHB6/A603P	VARIANT	A -> P (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
O15197	EPHB6	A662V	O15197/A662V	EPHB6/A662V	VARIANT	A -> V (in dbSNP:rs35984674)	ECO:0000269|PubMed:17344846	17344846
O15197	EPHB6	R719Q	O15197/R719Q	EPHB6/R719Q	VARIANT	R -> Q (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
O15197	EPHB6	P743S	O15197/P743S	EPHB6/P743S	VARIANT	P -> S (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O15197	EPHB6	R813H	O15197/R813H	EPHB6/R813H	VARIANT	R -> H	ECO:0000269|PubMed:17344846	17344846
O15197	EPHB6	E875K	O15197/E875K	EPHB6/E875K	VARIANT	E -> K (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O15197	EPHB6	D930G	O15197/D930G	EPHB6/D930G	VARIANT	D -> G (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
O15197	EPHB6	I993V	O15197/I993V	EPHB6/I993V	VARIANT	I -> V	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O15264	MAPK13	S41L	O15264/S41L	MAPK13/S41L	VARIANT	S -> L (in dbSNP:rs55776345)	ECO:0000269|PubMed:17344846	17344846
O15264	MAPK13	A282V	O15264/A282V	MAPK13/A282V	VARIANT	A -> V (in dbSNP:rs55990045)	ECO:0000269|PubMed:17344846	17344846
O15264	MAPK13	A300T	O15264/A300T	MAPK13/A300T	VARIANT	A -> T (in dbSNP:rs41270090)	ECO:0000269|PubMed:17344846	17344846
O15264	MAPK13	T180A	O15264/T180A	MAPK13/T180A	MUTAGEN	T->A: Loss of kinase activity.	ECO:0000269|PubMed:9374491	9374491
O15264	MAPK13	Y182A	O15264/Y182A	MAPK13/Y182A	MUTAGEN	Y->A: Loss of kinase activity.	ECO:0000269|PubMed:9374491	9374491

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O15530	PDPK1	Y9F	O15530/Y9F	PDPK1/Y9F	MUTAGEN	Y->F: Slight reduction in pervanadate-stimulated tyrosine phosphorylation.	ECO:0000269|PubMed:11481331	11481331
O15530	PDPK1	S25A	O15530/S25A	PDPK1/S25A	MUTAGEN	S->A: No effect.	ECO:0000269|PubMed:10455013	10455013
O15530	PDPK1	S241A	O15530/S241A	PDPK1/S241A	MUTAGEN	S->A: No activation.	ECO:0000269|PubMed:10455013	10455013
O15530	PDPK1	A277V	O15530/A277V	PDPK1/A277V	MUTAGEN	A->V: 3-fold increase in kinase activity.	ECO:0000269|PubMed:10364160	10364160
O15530	PDPK1	T354A	O15530/T354A	PDPK1/T354A	MUTAGEN	T->A: Abolishes phosphorylation by MELK.	ECO:0000269|PubMed:22544756	22544756
O15530	PDPK1	Y373F	O15530/Y373F	PDPK1/Y373F	MUTAGEN	Y->F: Reduction in basal activity.	ECO:0000269|PubMed:11481331	11481331
O15530	PDPK1	Y376F	O15530/Y376F	PDPK1/Y376F	MUTAGEN	Y->F: Reduction in basal activity.	ECO:0000269|PubMed:11481331	11481331
O15530	PDPK1	S393A	O15530/S393A	PDPK1/S393A	MUTAGEN	S->A: No effect.	ECO:0000269|PubMed:10455013	10455013
O15530	PDPK1	S394A	O15530/S394A	PDPK1/S394A	MUTAGEN	S->A: Abolishes phosphorylation by MAP3K5; when associated with A-398.	ECO:0000269|PubMed:22544756	22544756
O15530	PDPK1	S396A	O15530/S396A	PDPK1/S396A	MUTAGEN	S->A: No effect.	ECO:0000269|PubMed:10455013	10455013
O15530	PDPK1	S398A	O15530/S398A	PDPK1/S398A	MUTAGEN	S->A: Abolishes phosphorylation by MAP3K5; when associated with A-394.	ECO:0000269|PubMed:22544756	22544756
O15530	PDPK1	S410A	O15530/S410A	PDPK1/S410A	MUTAGEN	S->A: No effect.	ECO:0000269|PubMed:10455013	10455013
O15530	PDPK1	R474A	O15530/R474A	PDPK1/R474A	MUTAGEN	R->A: No PDGF-dependent translocation to the membrane.	ECO:0000269|PubMed:9637919	9637919
O15530	PDPK1	T513E	O15530/T513E	PDPK1/T513E	MUTAGEN	T->E: Enhanced kinase activity towards PKB.	ECO:0000269|PubMed:20978239	20978239

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O43187	IRAK2	R43Q	O43187/R43Q	IRAK2/R43Q	VARIANT	R -> Q (in dbSNP:rs34945585)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	S47Y	O43187/S47Y	IRAK2/S47Y	VARIANT	S -> Y (in dbSNP:rs11465864)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	I99V	O43187/I99V	IRAK2/I99V	VARIANT	I -> V (in dbSNP:rs55898544)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	R147T	O43187/R147T	IRAK2/R147T	VARIANT	R -> T (in dbSNP:rs56053222)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	R214G	O43187/R214G	IRAK2/R214G	VARIANT	R -> G (in dbSNP:rs35060588)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	S249L	O43187/S249L	IRAK2/S249L	VARIANT	S -> L (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	L392V	O43187/L392V	IRAK2/L392V	VARIANT	L -> V (in dbSNP:rs3844283)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	P421T	O43187/P421T	IRAK2/P421T	VARIANT	P -> T (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	D431E	O43187/D431E	IRAK2/D431E	VARIANT	D -> E (in dbSNP:rs708035)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9374458, ECO:0000269|Ref.1	17344846,9374458
O43187	IRAK2	L439V	O43187/L439V	IRAK2/L439V	VARIANT	L -> V (in dbSNP:rs11465927)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	D469N	O43187/D469N	IRAK2/D469N	VARIANT	D -> N (in dbSNP:rs56242986)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	L503I	O43187/L503I	IRAK2/L503I	VARIANT	L -> I (in dbSNP:rs9854688)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	R566W	O43187/R566W	IRAK2/R566W	VARIANT	R -> W (in dbSNP:rs55740652)	ECO:0000269|PubMed:17344846	17344846
O43187	IRAK2	D574H	O43187/D574H	IRAK2/D574H	VARIANT	D -> H (in dbSNP:rs11465930)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O43283	MAP3K13	E44K	O43283/E44K	MAP3K13/E44K	VARIANT	E -> K (in dbSNP:rs35266179)		
O43283	MAP3K13	R517G	O43283/R517G	MAP3K13/R517G	VARIANT	R -> G (in dbSNP:rs56408536)	ECO:0000269|PubMed:17344846	17344846
O43283	MAP3K13	E712K	O43283/E712K	MAP3K13/E712K	VARIANT	E -> K (in dbSNP:rs56309231)	ECO:0000269|PubMed:17344846	17344846
O43283	MAP3K13	P746L	O43283/P746L	MAP3K13/P746L	VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O43283	MAP3K13	R915H	O43283/R915H	MAP3K13/R915H	VARIANT	R -> H (in dbSNP:rs3732576)		
O43283	MAP3K13	K195A	O43283/K195A	MAP3K13/K195A	MUTAGEN	K->A: Kinase inactive. Fails to activate NF-kappa-B.	ECO:0000269|PubMed:12492477	12492477

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O43293	DAPK3	T112M	O43293/T112M	DAPK3/T112M	VARIANT	T -> M (in a colorectal adenocarcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation and cell survival)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21487036	17344846,21487036
O43293	DAPK3	D161N	O43293/D161N	DAPK3/D161N	VARIANT	D -> N (in an ovarian mucinous carcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation and cell survival)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21487036	17344846,21487036
O43293	DAPK3	P216S	O43293/P216S	DAPK3/P216S	VARIANT	P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation, cell adhesion and cell survival)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21487036	17344846,21487036
O43293	DAPK3	K42A	O43293/K42A	DAPK3/K42A	MUTAGEN	K->A: Loss of kinase activity at low concentrations of ATP.	ECO:0000269|PubMed:17158456	17158456
O43293	DAPK3	D161A	O43293/D161A	DAPK3/D161A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:17158456	17158456
O43293	DAPK3	T180A	O43293/T180A	DAPK3/T180A	MUTAGEN	T->A: Greatly reduced kinase activity.	ECO:0000269|PubMed:21487036	21487036
O43293	DAPK3	T225A	O43293/T225A	DAPK3/T225A	MUTAGEN	T->A: Loss of kinase activity.	ECO:0000269|PubMed:17158456	17158456
O43293	DAPK3	T265A	O43293/T265A	DAPK3/T265A	MUTAGEN	T->A: Loss of phosphorylation by ROCK1, catalytically inactive.	ECO:0000269|PubMed:17158456	17158456
O43293	DAPK3	T299A	O43293/T299A	DAPK3/T299A	MUTAGEN	T->A: Loss of phosphorylation by ROCK1.	ECO:0000269|PubMed:17158456	17158456
O43293	DAPK3	T299D	O43293/T299D	DAPK3/T299D	MUTAGEN	T->D: Predominantly cytoplasmic localization; phosphomimetic.	ECO:0000269|PubMed:15611134	15611134
O43293	DAPK3	V427A	O43293/V427A	DAPK3/V427A	MUTAGEN	V->A: Predominantly nuclear localization; when associated with A-434 and A-441.	ECO:0000269|PubMed:15611134	15611134
O43293	DAPK3	V434A	O43293/V434A	DAPK3/V434A	MUTAGEN	V->A: Predominantly nuclear localization; when associated with A-427 and A-441.	ECO:0000269|PubMed:15611134	15611134
O43293	DAPK3	L441A	O43293/L441A	DAPK3/L441A	MUTAGEN	L->A: Predominantly nuclear localization; when associated with A-427 and A-434.	ECO:0000269|PubMed:15611134	15611134

Error: O43318 MAP3K7 'NoneType' object has no attribute 'group' FT                   /note="Missing (in CSCF; dbSNP:rs886039236)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O43318	MAP3K7	E70Q	O43318/E70Q	MAP3K7/E70Q	VARIANT	E -> Q (in FMD2; dbSNP:rs886039231)	ECO:0000269|PubMed:27426733	27426733
O43318	MAP3K7	V100E	O43318/V100E	MAP3K7/V100E	VARIANT	V -> E (in FMD2; dbSNP:rs886039232)	ECO:0000269|PubMed:27426733	27426733
O43318	MAP3K7	G110C	O43318/G110C	MAP3K7/G110C	VARIANT	G -> C (in CSCF; dbSNP:rs886039235)	ECO:0000269|PubMed:27426734	27426734
O43318	MAP3K7	G168R	O43318/G168R	MAP3K7/G168R	VARIANT	G -> R (in FMD2; increases autophosphorylation; no effect on MAPK signaling; no effect on NF-kappa-B signaling; dbSNP:rs886039233)	ECO:0000269|PubMed:27426733	27426733
O43318	MAP3K7	W241R	O43318/W241R	MAP3K7/W241R	VARIANT	W -> R (in CSCF; dbSNP:rs886039237)	ECO:0000269|PubMed:27426734	27426734
O43318	MAP3K7	R410Q	O43318/R410Q	MAP3K7/R410Q	VARIANT	R -> Q (found in a consanguineous family with intellectual disability; unknown pathological significance; dbSNP:rs201721045)	ECO:0000269|PubMed:28397838	28397838
O43318	MAP3K7	P512L	O43318/P512L	MAP3K7/P512L	VARIANT	P -> L (in FMD2; does not affect interaction with TAB2; does not affect homodimerization; increases autophosphorylation; increases MAPK signaling; increases NF-kappa-B signaling; dbSNP:rs886039230)	ECO:0000269|PubMed:27426733	27426733
O43318	MAP3K7	K34R	O43318/K34R	MAP3K7/K34R	MUTAGEN	K->R: No effect on ubiquitination.	ECO:0000269|PubMed:29291351	29291351
O43318	MAP3K7	K63W	O43318/K63W	MAP3K7/K63W	MUTAGEN	K->W: Loss of kinase activity. Loss of autophosphorylation.	ECO:0000269|PubMed:12589052, ECO:0000269|PubMed:22802624	12589052,22802624
O43318	MAP3K7	K158R	O43318/K158R	MAP3K7/K158R	MUTAGEN	K->R: Abolishes ubiquitination.	ECO:0000269|PubMed:29291351	29291351
O43318	MAP3K7	K209R	O43318/K209R	MAP3K7/K209R	MUTAGEN	K->R: Strongly decreases ubiquitination.	ECO:0000269|PubMed:29291351	29291351
O43318	MAP3K7	P512R	O43318/P512R	MAP3K7/P512R	MUTAGEN			
O43318	MAP3K7	P512A	O43318/P512A	MAP3K7/P512A	MUTAGEN	P->R,A: Enhances autophosphorylation; Alters MAPK signaling.	ECO:0000269|PubMed:27426733	27426733

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O43353	RIPK2	I259T	O43353/I259T	RIPK2/I259T	VARIANT	I -> T (in dbSNP:rs2230801)	ECO:0000269|PubMed:17344846	17344846
O43353	RIPK2	L268V	O43353/L268V	RIPK2/L268V	VARIANT	L -> V (in dbSNP:rs35004667)	ECO:0000269|PubMed:17344846	17344846
O43353	RIPK2	K313N	O43353/K313N	RIPK2/K313N	VARIANT	K -> N (in dbSNP:rs35395048)	ECO:0000269|PubMed:17344846	17344846
O43353	RIPK2	K47A	O43353/K47A	RIPK2/K47A	MUTAGEN	K->A: Abolishes kinase activity.	ECO:0000269|PubMed:9575181, ECO:0000269|PubMed:9642260	9575181,9642260
O43353	RIPK2	K47M	O43353/K47M	RIPK2/K47M	MUTAGEN	K->M: Reduces FAS-mediated apoptosis.	ECO:0000269|PubMed:9575181, ECO:0000269|PubMed:9642260	9575181,9642260
O43353	RIPK2	D146N	O43353/D146N	RIPK2/D146N	MUTAGEN	D->N: Abolishes kinase activity.	ECO:0000269|PubMed:9705938	9705938
O43353	RIPK2	K209R	O43353/K209R	RIPK2/K209R	MUTAGEN	K->R: Complete loss of polyubiquitination.	ECO:0000269|PubMed:18079694	18079694
O43353	RIPK2	Y381A	O43353/Y381A	RIPK2/Y381A	MUTAGEN	Y->A: Prevents phosphorylation. Reduces serine and threonine phosphorylation of ARHGEF2.	ECO:0000269|PubMed:21887730	21887730
O43353	RIPK2	Q437E	O43353/Q437E	RIPK2/Q437E	MUTAGEN	Q->E: Decreased interaction with NGFR.	ECO:0000269|PubMed:26646181	26646181
O43353	RIPK2	R444E	O43353/R444E	RIPK2/R444E	MUTAGEN	R->E: Abolishes interaction with NOD1.	ECO:0000269|PubMed:17054981	17054981
O43353	RIPK2	D467R	O43353/D467R	RIPK2/D467R	MUTAGEN	D->R: Decreased interaction with NGFR.	ECO:0000269|PubMed:26646181	26646181
O43353	RIPK2	K471E	O43353/K471E	RIPK2/K471E	MUTAGEN	K->E: Decreased interaction with NGFR.	ECO:0000269|PubMed:26646181	26646181
O43353	RIPK2	Y474F	O43353/Y474F	RIPK2/Y474F	MUTAGEN	Y->F: Decreases interaction with NOD2.	ECO:0000269|PubMed:21123652	21123652
O43353	RIPK2	R483E	O43353/R483E	RIPK2/R483E	MUTAGEN	R->E: Abolishes interaction with NOD1.	ECO:0000269|PubMed:17054981	17054981
O43353	RIPK2	R488E	O43353/R488E	RIPK2/R488E	MUTAGEN	R->E: Abolishes interaction with NOD1.	ECO:0000269|PubMed:17054981	17054981
O43353	RIPK2	I496A	O43353/I496A	RIPK2/I496A	MUTAGEN	I->A: Decreased interaction with NGFR.	ECO:0000269|PubMed:26646181	26646181
O43353	RIPK2	E500R	O43353/E500R	RIPK2/E500R	MUTAGEN	E->R: Decreased interaction with NGFR.	ECO:0000269|PubMed:26646181	26646181
O43353	RIPK2	K503R	O43353/K503R	RIPK2/K503R	MUTAGEN	K->R: Abolished ubiquitination by ZNRF4.	ECO:0000269|PubMed:28656966	28656966
O43353	RIPK2	R528E	O43353/R528E	RIPK2/R528E	MUTAGEN	R->E: Decreased interaction with NGFR.	ECO:0000269|PubMed:26646181	26646181

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O43683	BUB1	G20D	O43683/G20D	BUB1/G20D	VARIANT	G -> D (in dbSNP:rs35890336)	ECO:0000269|PubMed:17344846	17344846
O43683	BUB1	E36D	O43683/E36D	BUB1/E36D	VARIANT	E -> D (in colorectal cancer; dbSNP:rs1801328)	ECO:0000269|PubMed:10366450	10366450
O43683	BUB1	Y259C	O43683/Y259C	BUB1/Y259C	VARIANT	Y -> C (in pancreatic cancer; associated with N-265; failure to rescue the spindle-assembly checkpoint activity as a result of a deficient recruitment of MAD2L1 and BUBR1 to kinetochores; efficient restoration of chromosome congression; reduced binding to BUB3; rescue of the ability of kinetochores to bind SGO1 and CENPF but not MCAK)	ECO:0000269|PubMed:12655561, ECO:0000269|PubMed:19487456	12655561,19487456
O43683	BUB1	H265N	O43683/H265N	BUB1/H265N	VARIANT	H -> N (in pancreatic cancer; associated with C-259; complete rescue of the spindle-assembly checkpoint activity; increased rate of chromosome congression errors)	ECO:0000269|PubMed:12655561, ECO:0000269|PubMed:19487456	12655561,19487456
O43683	BUB1	S492Y	O43683/S492Y	BUB1/S492Y	VARIANT	S -> Y (in colorectal cancer; dbSNP:rs121909055)	ECO:0000269|PubMed:9521327	9521327
O43683	BUB1	N534D	O43683/N534D	BUB1/N534D	VARIANT	N -> D (in dbSNP:rs36109304)	ECO:0000269|PubMed:17344846	17344846
O43683	BUB1	P648R	O43683/P648R	BUB1/P648R	VARIANT	P -> R (in colorectal cancer; dbSNP:rs376649190)	ECO:0000269|PubMed:10366450	10366450
O43683	BUB1	A106D	O43683/A106D	BUB1/A106D	MUTAGEN	A->D,W: Loss of interaction with KNL1.		
O43683	BUB1	A106W	O43683/A106W	BUB1/A106W	MUTAGEN	A->D,W: Loss of interaction with KNL1.	ECO:0000269|PubMed:17981135	17981135
O43683	BUB1	L122G	O43683/L122G	BUB1/L122G	MUTAGEN	L->G: Loss of interaction with KNL1.	ECO:0000269|PubMed:17981135	17981135
O43683	BUB1	A130S	O43683/A130S	BUB1/A130S	MUTAGEN	A->S: Partial rescue of the spindle-assembly checkpoint activity. Increased rate of chromosome congression errors. Impaired localization to kinetochores and loss of kinetochore binding of CENPF, SGO1 and BUBR1 but not of MCAK, MAD1L1 or MAD2L1.	ECO:0000269|PubMed:19487456	19487456
O43683	BUB1	K535A	O43683/K535A	BUB1/K535A	MUTAGEN	K->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-536 and A-537.	ECO:0000269|PubMed:17158872	17158872
O43683	BUB1	E536A	O43683/E536A	BUB1/E536A	MUTAGEN	E->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-535 and A-537.	ECO:0000269|PubMed:17158872	17158872
O43683	BUB1	N537A	O43683/N537A	BUB1/N537A	MUTAGEN	N->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-535 and A-536.	ECO:0000269|PubMed:17158872	17158872
O43683	BUB1	T609A	O43683/T609A	BUB1/T609A	MUTAGEN	T->A: Diminished interaction with PLK1.	ECO:0000269|PubMed:16760428	16760428
O43683	BUB1	K625A	O43683/K625A	BUB1/K625A	MUTAGEN	K->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-626 and A-627.	ECO:0000269|PubMed:17158872	17158872
O43683	BUB1	E626A	O43683/E626A	BUB1/E626A	MUTAGEN	E->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-625 and A-627.	ECO:0000269|PubMed:17158872	17158872
O43683	BUB1	N627A	O43683/N627A	BUB1/N627A	MUTAGEN	N->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-625 and A-626.	ECO:0000269|PubMed:17158872	17158872
O43683	BUB1	K821A	O43683/K821A	BUB1/K821A	MUTAGEN	K->A: Loss of activity.	ECO:0000269|PubMed:10198256	10198256

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O43781	DYRK3	M239L	O43781/M239L	DYRK3/M239L	VARIANT	M -> L	ECO:0000269|PubMed:17344846	17344846
O43781	DYRK3	K238M	O43781/K238M	DYRK3/K238M	MUTAGEN	K->M: Kinase dead; Induces formation of stress granules-like in absence of stress. Impaired dissolution of membraneless organelles during mitosis, such as stress granules, nuclear speckles and pericentriolar material.	ECO:0000269|PubMed:23415227, ECO:0000269|PubMed:29634919, ECO:0000269|PubMed:29973724	23415227,29634919,29973724
O43781	DYRK3	S350A	O43781/S350A	DYRK3/S350A	MUTAGEN	S->A: Decreased stability of the protein.	ECO:0000269|PubMed:29634919	29634919
O43781	DYRK3	S350E	O43781/S350E	DYRK3/S350E	MUTAGEN			
O43781	DYRK3	S350D	O43781/S350D	DYRK3/S350D	MUTAGEN	S->E,D: Phosphomimetic mutant; increased stability of the protein.	ECO:0000269|PubMed:29634919	29634919

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O60229	KALRN	S196L	O60229/S196L	KALRN/S196L	VARIANT	S -> L	ECO:0000269|PubMed:17344846	17344846
O60229	KALRN	R213W	O60229/R213W	KALRN/R213W	VARIANT	R -> W (in a colorectal cancer sample; somatic mutation; dbSNP:rs1187034389)	ECO:0000269|PubMed:16959974	16959974
O60229	KALRN	E1326D	O60229/E1326D	KALRN/E1326D	VARIANT	E -> D (in dbSNP:rs2289838)		
O60229	KALRN	S1897C	O60229/S1897C	KALRN/S1897C	VARIANT	S -> C (in a breast cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
O60229	KALRN	R1930M	O60229/R1930M	KALRN/R1930M	VARIANT	R -> M (in dbSNP:rs35298864)		
O60229	KALRN	K2713A	O60229/K2713A	KALRN/K2713A	MUTAGEN	K->A: Loss of autophosphorylation.	ECO:0000269|PubMed:10023074	10023074

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O60285	NUAK1	G419D	O60285/G419D	NUAK1/G419D	VARIANT	G -> D (in dbSNP:rs55774704)	ECO:0000269|PubMed:17344846	17344846
O60285	NUAK1	P543R	O60285/P543R	NUAK1/P543R	VARIANT	P -> R (in dbSNP:rs3741883)	ECO:0000269|PubMed:17344846	17344846
O60285	NUAK1	K84A	O60285/K84A	NUAK1/K84A	MUTAGEN	K->A: Abolishes kinase activity and ability to induce senescence.	ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:21317932	19927127,21317932
O60285	NUAK1	T211A	O60285/T211A	NUAK1/T211A	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. Abolishes ability to induce senescence.	ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:21317932	14976552,19927127,21317932
O60285	NUAK1	S600A	O60285/S600A	NUAK1/S600A	MUTAGEN	S->A: Abrogates phosphorylation by PKB/AKT1. Does not affect ability to induce senescence.	ECO:0000269|PubMed:12409306, ECO:0000269|PubMed:19927127	12409306,19927127

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O60307	MAST3	S101F	O60307/S101F	MAST3/S101F	VARIANT	S -> F (in DEE108; unknown pathological significance)	ECO:0000269|PubMed:35095415	35095415
O60307	MAST3	S104L	O60307/S104L	MAST3/S104L	VARIANT	S -> L (in DEE108)	ECO:0000269|PubMed:35095415	35095415
O60307	MAST3	R203Q	O60307/R203Q	MAST3/R203Q	VARIANT	R -> Q (in dbSNP:rs35945810)		
O60307	MAST3	R406P	O60307/R406P	MAST3/R406P	VARIANT	R -> P (in DEE108)	ECO:0000269|PubMed:34185323	34185323
O60307	MAST3	G510S	O60307/G510S	MAST3/G510S	VARIANT	G -> S (in DEE108)	ECO:0000269|PubMed:34185323	34185323
O60307	MAST3	G515S	O60307/G515S	MAST3/G515S	VARIANT	G -> S (in DEE108)	ECO:0000269|PubMed:34185323, ECO:0000269|PubMed:35095415	34185323,35095415
O60307	MAST3	L516P	O60307/L516P	MAST3/L516P	VARIANT	L -> P (in DEE108)	ECO:0000269|PubMed:34185323, ECO:0000269|PubMed:35095415	34185323,35095415
O60307	MAST3	V551L	O60307/V551L	MAST3/V551L	VARIANT	V -> L (in DEE108; unknown pathological significance)	ECO:0000269|PubMed:34185323	34185323
O60307	MAST3	F655L	O60307/F655L	MAST3/F655L	VARIANT	F -> L (found in a patient with autism spectrum disorder without history of seizures; unknown pathological significance)	ECO:0000269|PubMed:34185323	34185323
O60307	MAST3	G861S	O60307/G861S	MAST3/G861S	VARIANT	G -> S (in dbSNP:rs8108738)		
O60307	MAST3	G883S	O60307/G883S	MAST3/G883S	VARIANT	G -> S (in dbSNP:rs369960905)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O60566	BUB1B	M15T	O60566/M15T	BUB1B/M15T	VARIANT	M -> T (in a colorectal cancer cell line; dbSNP:rs1392369693)	ECO:0000269|PubMed:9521327	9521327
O60566	BUB1B	R36Q	O60566/R36Q	BUB1B/R36Q	VARIANT	R -> Q (in PCS; dbSNP:rs534297115)	ECO:0000269|PubMed:16411201	16411201
O60566	BUB1B	T40M	O60566/T40M	BUB1B/T40M	VARIANT	T -> M (in dbSNP:rs56079734)	ECO:0000269|PubMed:17344846	17344846
O60566	BUB1B	R349Q	O60566/R349Q	BUB1B/R349Q	VARIANT	R -> Q (in dbSNP:rs1801376)	ECO:0000269|PubMed:10366450, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9521327, ECO:0000269|PubMed:9618306, ECO:0000269|PubMed:9660858, ECO:0000269|PubMed:9763420, ECO:0000269|Ref.6	10366450,14702039,15489334,17344846,9521327,9618306,9660858,9763420
O60566	BUB1B	P378S	O60566/P378S	BUB1B/P378S	VARIANT	P -> S (in dbSNP:rs17851677)	ECO:0000269|PubMed:15489334	15489334
O60566	BUB1B	E390D	O60566/E390D	BUB1B/E390D	VARIANT	E -> D (in dbSNP:rs1017842)	ECO:0000269|PubMed:17344846	17344846
O60566	BUB1B	R550Q	O60566/R550Q	BUB1B/R550Q	VARIANT	R -> Q (in MVA1; heterozygous compound with nonsense mutation; dbSNP:rs28989187)	ECO:0000269|PubMed:15475955	15475955
O60566	BUB1B	V618A	O60566/V618A	BUB1B/V618A	VARIANT	V -> A (in dbSNP:rs1801528)	ECO:0000269|PubMed:10366450, ECO:0000269|PubMed:17344846	10366450,17344846
O60566	BUB1B	R814H	O60566/R814H	BUB1B/R814H	VARIANT	R -> H (in MVA1; heterozygous compound with nonsense mutation; dbSNP:rs28989182)	ECO:0000269|PubMed:15475955	15475955
O60566	BUB1B	L844F	O60566/L844F	BUB1B/L844F	VARIANT	L -> F (in MVA1; associated with H-921; heterozygous compound with nonsense mutation; dbSNP:rs28989181)	ECO:0000269|PubMed:15475955	15475955
O60566	BUB1B	I909T	O60566/I909T	BUB1B/I909T	VARIANT	I -> T (in MVA1; heterozygous compound with nonsense mutation; dbSNP:rs28989184)	ECO:0000269|PubMed:15475955	15475955
O60566	BUB1B	Q921H	O60566/Q921H	BUB1B/Q921H	VARIANT	Q -> H (in MVA1; associated with F-844; heterozygous compound with nonsense mutation; dbSNP:rs28989183)	ECO:0000269|PubMed:15475955	15475955
O60566	BUB1B	L1012P	O60566/L1012P	BUB1B/L1012P	VARIANT	L -> P (in MVA1; heterozygous compound with nonsense mutation; dbSNP:rs28989185)	ECO:0000269|PubMed:15475955	15475955
O60566	BUB1B	A159W	O60566/A159W	BUB1B/A159W	MUTAGEN	A->W: Loss of interaction with KNL1.	ECO:0000269|PubMed:17981135	17981135
O60566	BUB1B	F175A	O60566/F175A	BUB1B/F175A	MUTAGEN	F->A: Loss of interaction with KNL1.	ECO:0000269|PubMed:17981135	17981135
O60566	BUB1B	D579E	O60566/D579E	BUB1B/D579E	MUTAGEN	D->E: Abolishes the cleavage by caspase-3.	ECO:0000269|PubMed:16227576	16227576
O60566	BUB1B	D610E	O60566/D610E	BUB1B/D610E	MUTAGEN	D->E: Abolishes the cleavage by caspase-3.	ECO:0000269|PubMed:16227576	16227576
O60566	BUB1B	T620A	O60566/T620A	BUB1B/T620A	MUTAGEN	T->A: Induces chromosome congression defects and mitotic delay.	ECO:0000269|PubMed:17785528	17785528
O60566	BUB1B	K795A	O60566/K795A	BUB1B/K795A	MUTAGEN	K->A: Does not abolish the capacity to inhibit APC/CDC20.	ECO:0000269|PubMed:11702782, ECO:0000269|PubMed:12925705	11702782,12925705
O60566	BUB1B	K795R	O60566/K795R	BUB1B/K795R	MUTAGEN	K->R: Inhibits kinase activity.	ECO:0000269|PubMed:11702782, ECO:0000269|PubMed:12925705	11702782,12925705

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O60674	JAK2	G127D	O60674/G127D	JAK2/G127D	VARIANT	G -> D (in dbSNP:rs56118985)	ECO:0000269|PubMed:17344846	17344846
O60674	JAK2	K191Q	O60674/K191Q	JAK2/K191Q	VARIANT	K -> Q (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O60674	JAK2	K346R	O60674/K346R	JAK2/K346R	VARIANT	K -> R (in dbSNP:rs55667734)	ECO:0000269|PubMed:17344846	17344846
O60674	JAK2	A377E	O60674/A377E	JAK2/A377E	VARIANT	A -> E (in dbSNP:rs55953208)	ECO:0000269|PubMed:17344846	17344846
O60674	JAK2	L393V	O60674/L393V	JAK2/L393V	VARIANT	L -> V (in dbSNP:rs2230723)	ECO:0000269|PubMed:17344846	17344846
O60674	JAK2	K539L	O60674/K539L	JAK2/K539L	VARIANT	K -> L (in myeloproliferative disorder with erythrocytosis; requires 2 nucleotide substitutions; dbSNP:rs121912473)	ECO:0000269|PubMed:17267906	17267906
O60674	JAK2	D584E	O60674/D584E	JAK2/D584E	VARIANT	D -> E (in dbSNP:rs17490221)		
O60674	JAK2	K607N	O60674/K607N	JAK2/K607N	VARIANT	K -> N (in AML; dbSNP:rs121912472)	ECO:0000269|PubMed:16247455	16247455
O60674	JAK2	V617F	O60674/V617F	JAK2/V617F	VARIANT	V -> F (in PV, THCYT3 and AML; associated with susceptibility to Budd-Chiari syndrome; somatic mutation in a high percentage of patients with essential thrombocythemia or myelofibrosis; leads to constitutive tyrosine phosphorylation activity that promotes cytokine hypersensitivity; dbSNP:rs77375493)	ECO:0000269|PubMed:15781101, ECO:0000269|PubMed:15793561, ECO:0000269|PubMed:15858187, ECO:0000269|PubMed:16247455, ECO:0000269|PubMed:16325696, ECO:0000269|PubMed:16603627	15781101,15793561,15858187,16247455,16325696,16603627
O60674	JAK2	V617I	O60674/V617I	JAK2/V617I	VARIANT	V -> I (in THCYT3; dbSNP:rs77375493)	ECO:0000269|PubMed:22397670	22397670
O60674	JAK2	R1063H	O60674/R1063H	JAK2/R1063H	VARIANT	R -> H (in dbSNP:rs41316003)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O60885	BRD4	P37S	O60885/P37S	BRD4/P37S	VARIANT	P -> S (in dbSNP:rs35177876)	ECO:0000269|PubMed:17344846	17344846
O60885	BRD4	A371G	O60885/A371G	BRD4/A371G	VARIANT	A -> G (in dbSNP:rs55805532)	ECO:0000269|PubMed:17344846	17344846
O60885	BRD4	S563N	O60885/S563N	BRD4/S563N	VARIANT	S -> N (in dbSNP:rs55970906)	ECO:0000269|PubMed:17344846	17344846
O60885	BRD4	T598S	O60885/T598S	BRD4/T598S	VARIANT	T -> S (in dbSNP:rs34362023)	ECO:0000269|PubMed:17344846	17344846
O60885	BRD4	R669H	O60885/R669H	BRD4/R669H	VARIANT	R -> H (in dbSNP:rs35824241)	ECO:0000269|PubMed:17344846	17344846
O60885	BRD4	R1097H	O60885/R1097H	BRD4/R1097H	VARIANT	R -> H (in dbSNP:rs35676845)		
O60885	BRD4	N140A	O60885/N140A	BRD4/N140A	MUTAGEN	N->A: Abolishes binding to acetylated histones.	ECO:0000269|PubMed:22464331, ECO:0000269|PubMed:23728299	22464331,23728299
O60885	BRD4	N433A	O60885/N433A	BRD4/N433A	MUTAGEN	N->A: Abolishes binding to acetylated histones.	ECO:0000269|PubMed:22464331	22464331
O60885	BRD4	S503A	O60885/S503A	BRD4/S503A	MUTAGEN	S->A: Impaired phosphorylation by CK2 and binding to acetylated histones.	ECO:0000269|PubMed:23317504	23317504

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O75116	ROCK2	T431N	O75116/T431N	ROCK2/T431N	VARIANT	T -> N (in dbSNP:rs2230774)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9734811, ECO:0000269|PubMed:9933571	17344846,9734811,9933571
O75116	ROCK2	D601V	O75116/D601V	ROCK2/D601V	VARIANT	D -> V (in dbSNP:rs35768389)	ECO:0000269|PubMed:17344846	17344846
O75116	ROCK2	K1083M	O75116/K1083M	ROCK2/K1083M	VARIANT	K -> M (in dbSNP:rs34945852)		
O75116	ROCK2	S1194P	O75116/S1194P	ROCK2/S1194P	VARIANT	S -> P (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O75116	ROCK2	D1131A	O75116/D1131A	ROCK2/D1131A	MUTAGEN	D->A: Abolishes cleavage by granzyme B.	ECO:0000269|PubMed:15699075	15699075

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O75385	ULK1	V290M	O75385/V290M	ULK1/V290M	VARIANT	V -> M (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs370624303)	ECO:0000269|PubMed:17344846	17344846
O75385	ULK1	S298L	O75385/S298L	ULK1/S298L	VARIANT	S -> L (in dbSNP:rs56364352)	ECO:0000269|PubMed:17344846	17344846
O75385	ULK1	P478L	O75385/P478L	ULK1/P478L	VARIANT	P -> L (in dbSNP:rs12827141)	ECO:0000269|PubMed:17344846	17344846
O75385	ULK1	T503M	O75385/T503M	ULK1/T503M	VARIANT	T -> M (in dbSNP:rs55824543)	ECO:0000269|PubMed:17344846	17344846
O75385	ULK1	S665L	O75385/S665L	ULK1/S665L	VARIANT	S -> L (in dbSNP:rs55815560)	ECO:0000269|PubMed:17344846	17344846
O75385	ULK1	P714L	O75385/P714L	ULK1/P714L	VARIANT	P -> L (in dbSNP:rs11546871)	ECO:0000269|PubMed:17344846	17344846
O75385	ULK1	S784C	O75385/S784C	ULK1/S784C	VARIANT	S -> C (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O75385	ULK1	T816A	O75385/T816A	ULK1/T816A	VARIANT	T -> A (in dbSNP:rs11609348)	ECO:0000269|PubMed:9693035, ECO:0000269|PubMed:9872452	9693035,9872452
O75385	ULK1	K46I	O75385/K46I	ULK1/K46I	MUTAGEN	K->I: Abolished serine/threonine-protein kinase activity.	ECO:0000269|PubMed:20921139, ECO:0000269|PubMed:28821708	20921139,28821708

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O75460	ERN1	N244S	O75460/N244S	ERN1/N244S	VARIANT	N -> S (in a renal clear cell carcinoma sample; somatic mutation; dbSNP:rs1397145500)	ECO:0000269|PubMed:17344846	17344846
O75460	ERN1	V418M	O75460/V418M	ERN1/V418M	VARIANT	V -> M (in dbSNP:rs55869215)	ECO:0000269|PubMed:17344846	17344846
O75460	ERN1	L474R	O75460/L474R	ERN1/L474R	VARIANT	L -> R (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs186305118)	ECO:0000269|PubMed:17344846	17344846
O75460	ERN1	R635W	O75460/R635W	ERN1/R635W	VARIANT	R -> W (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs146710304)	ECO:0000269|PubMed:17344846	17344846
O75460	ERN1	N700S	O75460/N700S	ERN1/N700S	VARIANT	N -> S (in dbSNP:rs918253870)	ECO:0000269|PubMed:17344846	17344846
O75460	ERN1	S769F	O75460/S769F	ERN1/S769F	VARIANT	S -> F (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O75460	ERN1	P830L	O75460/P830L	ERN1/P830L	VARIANT	P -> L (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs1279653488)	ECO:0000269|PubMed:17344846	17344846
O75460	ERN1	Q105E	O75460/Q105E	ERN1/Q105E	MUTAGEN	Q->E: Impaired ability to homodimerize.	ECO:0000269|PubMed:16973740	16973740
O75460	ERN1	C109S	O75460/C109S	ERN1/C109S	MUTAGEN	C->S: No effect on dimerization. No effect on interaction with P4HB; when associated with S-148 and S-332.	ECO:0000269|PubMed:12637535, ECO:0000269|PubMed:32149426	12637535,32149426
O75460	ERN1	D123P	O75460/D123P	ERN1/D123P	MUTAGEN	D->P: Abolishes ability to homodimerize.	ECO:0000269|PubMed:16973740	16973740
O75460	ERN1	W125A	O75460/W125A	ERN1/W125A	MUTAGEN	W->A: Abolishes ability to homodimerize.	ECO:0000269|PubMed:16973740	16973740
O75460	ERN1	C148S	O75460/C148S	ERN1/C148S	MUTAGEN	C->S: No effect on dimerization. Weakens dimer; when associated with S-332. Abolishes interaction with PDIA6. Prolonged splicing of XBP1, probably due to prolonged activation of PDIA6. Inhibits formation of oxidized multimeric forms of ERN1 in response to ER stress. No effect on interaction with P4HB; when associated with S-109 and S-332.	ECO:0000269|PubMed:12637535, ECO:0000269|PubMed:24508390, ECO:0000269|PubMed:32149426	12637535,24508390,32149426
O75460	ERN1	C332S	O75460/C332S	ERN1/C332S	MUTAGEN	C->S: No effect on dimerization. Weakens dimer; when associated with S-148. No effect on interaction with P4HB; when associated with S-109 and S-148.	ECO:0000269|PubMed:12637535, ECO:0000269|PubMed:32149426	12637535,32149426
O75460	ERN1	K599A	O75460/K599A	ERN1/K599A	MUTAGEN	K->A: Loss of autophosphorylation and of endoribonuclease activity. Inhibition of growth arrest.	ECO:0000269|PubMed:11175748, ECO:0000269|PubMed:9637683	11175748,9637683

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O75582	RPS6KA5	H190R	O75582/H190R	RPS6KA5/H190R	VARIANT	H -> R (in dbSNP:rs34699345)		
O75582	RPS6KA5	D554N	O75582/D554N	RPS6KA5/D554N	VARIANT	D -> N (in dbSNP:rs55911249)	ECO:0000269|PubMed:17344846	17344846
O75582	RPS6KA5	P574L	O75582/P574L	RPS6KA5/P574L	VARIANT	P -> L (in dbSNP:rs34604933)	ECO:0000269|PubMed:17344846	17344846
O75582	RPS6KA5	Y599C	O75582/Y599C	RPS6KA5/Y599C	VARIANT	Y -> C (in dbSNP:rs55968863)	ECO:0000269|PubMed:17344846	17344846
O75582	RPS6KA5	D195A	O75582/D195A	RPS6KA5/D195A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:9687510	9687510
O75582	RPS6KA5	S212A	O75582/S212A	RPS6KA5/S212A	MUTAGEN	S->A: Inactivates the N-terminal kinase domain.	ECO:0000269|PubMed:15568999	15568999
O75582	RPS6KA5	S360A	O75582/S360A	RPS6KA5/S360A	MUTAGEN	S->A: Decreases kinase activity by 60% in response to PMA and UV-C.	ECO:0000269|PubMed:15568999	15568999
O75582	RPS6KA5	S376A	O75582/S376A	RPS6KA5/S376A	MUTAGEN	S->A: Loss of kinase activity, and decreases the phosphorylation of S-360 and T-581.	ECO:0000269|PubMed:15568999	15568999
O75582	RPS6KA5	D565A	O75582/D565A	RPS6KA5/D565A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:9687510	9687510
O75582	RPS6KA5	T581A	O75582/T581A	RPS6KA5/T581A	MUTAGEN	T->A: Loss of kinase activity, and blocks phosphorylation of S-212; S-376 and S-381 in response to PMA and UV-C.	ECO:0000269|PubMed:15568999	15568999
O75582	RPS6KA5	T700A	O75582/T700A	RPS6KA5/T700A	MUTAGEN			
O75582	RPS6KA5	T700D	O75582/T700D	RPS6KA5/T700D	MUTAGEN	T->A,D: Strongly reduces phosphorylation of T-581 in response to PMA and UV-C.	ECO:0000269|PubMed:17117922	17117922

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O75676	RPS6KA4	S236L	O75676/S236L	RPS6KA4/S236L	VARIANT	S -> L (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs746466314)	ECO:0000269|PubMed:17344846	17344846
O75676	RPS6KA4	S758A	O75676/S758A	RPS6KA4/S758A	VARIANT	S -> A (in dbSNP:rs17857342)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
O75676	RPS6KA4	F709A	O75676/F709A	RPS6KA4/F709A	MUTAGEN	F->A: Strongly elevates basal activity.	ECO:0000269|PubMed:11035004	11035004

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O75716	STK16	H41R	O75716/H41R	STK16/H41R	VARIANT	H -> R (in dbSNP:rs34799131)	ECO:0000269|PubMed:17344846	17344846
O75716	STK16	E55K	O75716/E55K	STK16/E55K	VARIANT	E -> K (in dbSNP:rs35947471)	ECO:0000269|PubMed:17344846	17344846
O75716	STK16	I77V	O75716/I77V	STK16/I77V	VARIANT	I -> V (in dbSNP:rs34282267)	ECO:0000269|PubMed:17344846	17344846
O75716	STK16	R266W	O75716/R266W	STK16/R266W	VARIANT	R -> W (in dbSNP:rs17849638)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.8	15489334,17344846
O75716	STK16	P277L	O75716/P277L	STK16/P277L	VARIANT	P -> L (in dbSNP:rs35454203)	ECO:0000269|PubMed:17344846	17344846
O75716	STK16	G2A	O75716/G2A	STK16/G2A	MUTAGEN	G->A: Loss of myristoylation.	ECO:0000269|PubMed:10364453	10364453
O75716	STK16	C6S	O75716/C6S	STK16/C6S	MUTAGEN	C->S: Loss of palmitoylation.	ECO:0000269|PubMed:10364453	10364453
O75716	STK16	C8S	O75716/C8S	STK16/C8S	MUTAGEN	C->S: Loss of palmitoylation.	ECO:0000269|PubMed:10364453	10364453

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O75914	PAK3	R67C	O75914/R67C	PAK3/R67C	VARIANT	R -> C (in XLID30; dbSNP:rs121434612)	ECO:0000269|PubMed:10946356	10946356
O75914	PAK3	A380E	O75914/A380E	PAK3/A380E	VARIANT	A -> E (in XLID30; dbSNP:rs121434613)	ECO:0000269|PubMed:12884430	12884430
O75914	PAK3	T440S	O75914/T440S	PAK3/T440S	VARIANT	T -> S (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O75962	TRIO	S291T	O75962/S291T	TRIO/S291T	VARIANT	S -> T (in dbSNP:rs55772118)	ECO:0000269|PubMed:17344846	17344846
O75962	TRIO	D348E	O75962/D348E	TRIO/D348E	VARIANT	D -> E (in dbSNP:rs16903367)		
O75962	TRIO	R924S	O75962/R924S	TRIO/R924S	VARIANT	R -> S (in MRD44; unknown pathological significance; dbSNP:rs772072746)	ECO:0000269|PubMed:26721934	26721934
O75962	TRIO	T1075I	O75962/T1075I	TRIO/T1075I	VARIANT	T -> I (in MRD63; slightly increased occipitofrontal circumference; increased activation of RAC1-mediated signaling; increased lamellipodia formation)	ECO:0000269|PubMed:32109419	32109419
O75962	TRIO	R1078G	O75962/R1078G	TRIO/R1078G	VARIANT	R -> G (in MRD63; increased activation of RAC1-mediated signaling; increased neurite outgrowth)	ECO:0000269|PubMed:32109419	32109419
O75962	TRIO	R1078Q	O75962/R1078Q	TRIO/R1078Q	VARIANT	R -> Q (in MRD63; increased activation of RAC1-mediated signaling; increased neurite outgrowth)	ECO:0000269|PubMed:32109419	32109419
O75962	TRIO	R1078W	O75962/R1078W	TRIO/R1078W	VARIANT	R -> W (in MRD63; increased activation of RAC1-mediated signaling; increased neurite outgrowth; dbSNP:rs1554065887)	ECO:0000269|PubMed:32109419	32109419
O75962	TRIO	N1080I	O75962/N1080I	TRIO/N1080I	VARIANT	N -> I (in MRD63; slightly increased occipitofrontal circumference; increased activation of RAC1-mediated signaling; increased neurite outgrowth; dbSNP:rs879255628)	ECO:0000269|PubMed:27418539, ECO:0000269|PubMed:32109419	27418539,32109419
O75962	TRIO	Y1238H	O75962/Y1238H	TRIO/Y1238H	VARIANT	Y -> H (in MRD44; unknown pathological significance; dbSNP:rs756004023)	ECO:0000269|PubMed:26721934	26721934
O75962	TRIO	E1299K	O75962/E1299K	TRIO/E1299K	VARIANT	E -> K (in MRD44; severely decreased activation of RAC1-mediated signaling; severely decreased neurite outgrowth)	ECO:0000269|PubMed:32109419	32109419
O75962	TRIO	D1368V	O75962/D1368V	TRIO/D1368V	VARIANT	D -> V (found in patient with severe intellectual disability; unknown pathological significance)	ECO:0000269|PubMed:23033978	23033978
O75962	TRIO	R1428Q	O75962/R1428Q	TRIO/R1428Q	VARIANT	R -> Q (in MRD44; severely decreased activation of RAC1-mediated signaling; severely decreased neurite outgrowth; dbSNP:rs879255626)	ECO:0000269|PubMed:27418539, ECO:0000269|PubMed:32109419	27418539,32109419
O75962	TRIO	P1461L	O75962/P1461L	TRIO/P1461L	VARIANT	P -> L (in MRD63; slightly increased occipitofrontal circumference; slightly increased RAC1-mediated signaling; slightly increased neurite outgrowth)	ECO:0000269|PubMed:32109419	32109419
O75962	TRIO	P1461T	O75962/P1461T	TRIO/P1461T	VARIANT	P -> T (in MRD44; no effect on RAC1-mediated signaling; no effect on neurite outgrowth; dbSNP:rs879255627)	ECO:0000269|PubMed:27418539, ECO:0000269|PubMed:32109419	27418539,32109419
O75962	TRIO	H1469R	O75962/H1469R	TRIO/H1469R	VARIANT	H -> R (in MRD44; decreased activation of RAC1-mediated signaling; severely decreased neurite outgrowth; dbSNP:rs1554070777)	ECO:0000269|PubMed:32109419	32109419
O75962	TRIO	A1613T	O75962/A1613T	TRIO/A1613T	VARIANT	A -> T (in dbSNP:rs16903474)		
O75962	TRIO	T1644M	O75962/T1644M	TRIO/T1644M	VARIANT	T -> M (in dbSNP:rs55687522)	ECO:0000269|PubMed:17344846	17344846
O75962	TRIO	H1690R	O75962/H1690R	TRIO/H1690R	VARIANT	H -> R (in dbSNP:rs56292586)	ECO:0000269|PubMed:17344846	17344846
O75962	TRIO	A1922T	O75962/A1922T	TRIO/A1922T	VARIANT	A -> T (in MRD44; unknown pathological significance)	ECO:0000269|PubMed:26721934	26721934
O75962	TRIO	S1939N	O75962/S1939N	TRIO/S1939N	VARIANT	S -> N (in MRD44; unknown pathological significance)	ECO:0000269|PubMed:26721934	26721934
O75962	TRIO	V1978M	O75962/V1978M	TRIO/V1978M	VARIANT	V -> M (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O75962	TRIO	L2201V	O75962/L2201V	TRIO/L2201V	VARIANT	L -> V (in MRD44; unknown pathological significance; dbSNP:rs771342869)	ECO:0000269|PubMed:26721934	26721934
O75962	TRIO	T2242M	O75962/T2242M	TRIO/T2242M	VARIANT	T -> M (in dbSNP:rs55916212)	ECO:0000269|PubMed:17344846	17344846
O75962	TRIO	E2247D	O75962/E2247D	TRIO/E2247D	VARIANT	E -> D (in MRD44; unknown pathological significance; dbSNP:rs1258664728)	ECO:0000269|PubMed:26721934	26721934
O75962	TRIO	T2563M	O75962/T2563M	TRIO/T2563M	VARIANT	T -> M (found in patient with severe intellectual disability; unknown pathological significance; dbSNP:rs751663099)	ECO:0000269|PubMed:23033978	23033978
O75962	TRIO	R2707Q	O75962/R2707Q	TRIO/R2707Q	VARIANT	R -> Q (in MRD44; unknown pathological significance; dbSNP:rs768858988)	ECO:0000269|PubMed:26721934	26721934
O75962	TRIO	E1299A	O75962/E1299A	TRIO/E1299A	MUTAGEN	E->A: 50% decrease in nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	T1303A	O75962/T1303A	TRIO/T1303A	MUTAGEN	T->A: 40% decrease in nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	N1389A	O75962/N1389A	TRIO/N1389A	MUTAGEN	N->A: No change in nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	V1426A	O75962/V1426A	TRIO/V1426A	MUTAGEN	V->A: 90% decrease in nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	Q1427A	O75962/Q1427A	TRIO/Q1427A	MUTAGEN	Q->A: 80% decrease in nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	R1428A	O75962/R1428A	TRIO/R1428A	MUTAGEN	R->A: 80% decrease in nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	T1430A	O75962/T1430A	TRIO/T1430A	MUTAGEN	T->A: 80% decrease in nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	K1431A	O75962/K1431A	TRIO/K1431A	MUTAGEN	K->A: Loss of nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	L1434A	O75962/L1434A	TRIO/L1434A	MUTAGEN	L->A: 40% decrease in nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	K1437A	O75962/K1437A	TRIO/K1437A	MUTAGEN	K->A: No change in nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	E1438A	O75962/E1438A	TRIO/E1438A	MUTAGEN	E->A: 30% decrease in nucleotide exchange activity.	ECO:0000269|PubMed:9790533	9790533
O75962	TRIO	K2917A	O75962/K2917A	TRIO/K2917A	MUTAGEN	K->A: Expected to disrupt kinase activity. Causes reorganization of the actin cytoskeleton in the absence of NGF.	ECO:0000269|PubMed:22155786	22155786

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O76039-1	CDKL5	R923C	O76039-1/R923C	CDKL5/R923C	VARIANT	R -> C (in dbSNP:rs267608664)	ECO:0000269|PubMed:19241098	19241098
O76039-1	CDKL5	G994R	O76039-1/G994R	CDKL5/G994R	VARIANT	G -> R (in DEE2; unknown pathological significance; dbSNP:rs866859766)	ECO:0000269|PubMed:27864847	27864847
O76039-1	CDKL5	V999M	O76039-1/V999M	CDKL5/V999M	VARIANT	V -> M (in dbSNP:rs35693326)		
O76039-1	CDKL5	E1023G	O76039-1/E1023G	CDKL5/E1023G	VARIANT	E -> G (in dbSNP:rs34166184)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O76039	CDKL5	A40V	O76039/A40V	CDKL5/A40V	VARIANT	A -> V (in DEE2; causes mislocalization of the protein in the cytoplasm; dbSNP:rs122460159)	ECO:0000269|PubMed:17993579, ECO:0000269|PubMed:18790821	17993579,18790821
O76039	CDKL5	I72N	O76039/I72N	CDKL5/I72N	VARIANT	I -> N (in DEE2; dbSNP:rs62641235)	ECO:0000269|PubMed:16015284	16015284
O76039	CDKL5	I72T	O76039/I72T	CDKL5/I72T	VARIANT	I -> T (in DEE2; dbSNP:rs62641235)	ECO:0000269|PubMed:19241098	19241098
O76039	CDKL5	H127R	O76039/H127R	CDKL5/H127R	VARIANT	H -> R (in DEE2; dbSNP:rs267608468)	ECO:0000269|PubMed:19241098	19241098
O76039	CDKL5	H145Y	O76039/H145Y	CDKL5/H145Y	VARIANT	H -> Y (in DEE2; unknown pathological significance)	ECO:0000269|PubMed:23708187	23708187
O76039	CDKL5	C152F	O76039/C152F	CDKL5/C152F	VARIANT	C -> F (in DEE2; affect activity; causes mislocalization of the protein in the cytoplasm; dbSNP:rs122460157)	ECO:0000269|PubMed:15499549, ECO:0000269|PubMed:16935860	15499549,16935860
O76039	CDKL5	R175S	O76039/R175S	CDKL5/R175S	VARIANT	R -> S (in DEE2; affect activity; does not affect the cellular distribution of the protein; dbSNP:rs61749700)	ECO:0000269|PubMed:15499549, ECO:0000269|PubMed:16935860	15499549,16935860
O76039	CDKL5	R178P	O76039/R178P	CDKL5/R178P	VARIANT	R -> P (in DEE2; dbSNP:rs267606715)	ECO:0000269|PubMed:18809835	18809835
O76039	CDKL5	R178Q	O76039/R178Q	CDKL5/R178Q	VARIANT	R -> Q (in DEE2; dbSNP:rs267606715)	ECO:0000269|PubMed:23662938, ECO:0000269|PubMed:23708187, ECO:0000269|PubMed:24564546	23662938,23708187,24564546
O76039	CDKL5	R178W	O76039/R178W	CDKL5/R178W	VARIANT	R -> W (in DEE2; dbSNP:rs267608493)	ECO:0000269|PubMed:26993267	26993267
O76039	CDKL5	P180L	O76039/P180L	CDKL5/P180L	VARIANT	P -> L (in DEE2; dbSNP:rs61749704)	ECO:0000269|PubMed:16611748	16611748
O76039	CDKL5	L182P	O76039/L182P	CDKL5/L182P	VARIANT	L -> P (in DEE2)	ECO:0000269|PubMed:23708187	23708187
O76039	CDKL5	S196L	O76039/S196L	CDKL5/S196L	VARIANT	S -> L (in DEE2; dbSNP:rs267608501)	ECO:0000269|PubMed:27864847	27864847
O76039	CDKL5	G207E	O76039/G207E	CDKL5/G207E	VARIANT	G -> E (in DEE2)	ECO:0000269|PubMed:23708187	23708187
O76039	CDKL5	L220P	O76039/L220P	CDKL5/L220P	VARIANT	L -> P (in DEE2; causes mislocalization of the protein in the cytoplasm; dbSNP:rs267608511)	ECO:0000269|PubMed:17993579, ECO:0000269|PubMed:18790821	17993579,18790821
O76039	CDKL5	T288I	O76039/T288I	CDKL5/T288I	VARIANT	T -> I (in DEE2; dbSNP:rs267606713)	ECO:0000269|PubMed:18809835	18809835
O76039	CDKL5	C291Y	O76039/C291Y	CDKL5/C291Y	VARIANT	C -> Y (in DEE2; dbSNP:rs267606714)	ECO:0000269|PubMed:18809835	18809835
O76039	CDKL5	N368H	O76039/N368H	CDKL5/N368H	VARIANT	N -> H (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
O76039	CDKL5	A374T	O76039/A374T	CDKL5/A374T	VARIANT	A -> T (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O76039	CDKL5	N399T	O76039/N399T	CDKL5/N399T	VARIANT	N -> T (in DEE2; dbSNP:rs267608611)	ECO:0000269|PubMed:19253388	19253388
O76039	CDKL5	R444C	O76039/R444C	CDKL5/R444C	VARIANT	R -> C (in dbSNP:rs61753977)	ECO:0000269|PubMed:16015284	16015284
O76039	CDKL5	P574Q	O76039/P574Q	CDKL5/P574Q	VARIANT	P -> Q (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs199897804)	ECO:0000269|PubMed:17344846	17344846
O76039	CDKL5	H581Y	O76039/H581Y	CDKL5/H581Y	VARIANT	H -> Y (in DEE2; unknown pathological significance)	ECO:0000269|PubMed:23708187	23708187
O76039	CDKL5	P647L	O76039/P647L	CDKL5/P647L	VARIANT	P -> L (probable disease-associated variant found in a patient with autism spectrum disorder)	ECO:0000269|PubMed:25969726	25969726
O76039	CDKL5	V718M	O76039/V718M	CDKL5/V718M	VARIANT	V -> M (in DEE2; dbSNP:rs267608653)	ECO:0000269|PubMed:18790821, ECO:0000269|PubMed:26993267	18790821,26993267
O76039	CDKL5	T734A	O76039/T734A	CDKL5/T734A	VARIANT	T -> A (in dbSNP:rs55803460)	ECO:0000269|PubMed:17344846	17344846
O76039	CDKL5	Q791P	O76039/Q791P	CDKL5/Q791P	VARIANT	Q -> P (in dbSNP:rs35478150)	ECO:0000269|PubMed:12736870, ECO:0000269|PubMed:15499549, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19241098	12736870,15499549,17344846,19241098
O76039	CDKL5	V793A	O76039/V793A	CDKL5/V793A	VARIANT	V -> A (in DEE2; unknown pathological significance; dbSNP:rs62643617)	ECO:0000269|PubMed:16611748	16611748
O76039	CDKL5	R858C	O76039/R858C	CDKL5/R858C	VARIANT	R -> C (in DEE2; unknown pathological significance; dbSNP:rs773760466)	ECO:0000269|PubMed:23708187	23708187

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O94768	STK17B	S320F	O94768/S320F	STK17B/S320F	VARIANT	S -> F (in dbSNP:rs34740616)	ECO:0000269|PubMed:17344846	17344846
O94768	STK17B	K62A	O94768/K62A	STK17B/K62A	MUTAGEN	K->A: Loss of activity and of apoptotic function.	ECO:0000269|PubMed:9786912	9786912

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O94804	STK10	R268C	O94804/R268C	STK10/R268C	VARIANT	R -> C (in dbSNP:rs35826078)	ECO:0000269|PubMed:17344846	17344846
O94804	STK10	K277E	O94804/K277E	STK10/K277E	VARIANT	K -> E (in TGCT; somatic mutation; dbSNP:rs757545210)	ECO:0000269|PubMed:16175573, ECO:0000269|PubMed:17344846	16175573,17344846
O94804	STK10	R322W	O94804/R322W	STK10/R322W	VARIANT	R -> W (in dbSNP:rs56214442)	ECO:0000269|PubMed:17344846	17344846
O94804	STK10	T336I	O94804/T336I	STK10/T336I	VARIANT	T -> I (in dbSNP:rs55972616)	ECO:0000269|PubMed:17344846	17344846
O94804	STK10	N467S	O94804/N467S	STK10/N467S	VARIANT	N -> S (in dbSNP:rs56063773)	ECO:0000269|PubMed:17344846	17344846
O94804	STK10	P480L	O94804/P480L	STK10/P480L	VARIANT	P -> L (in dbSNP:rs34505340)		
O94804	STK10	P520L	O94804/P520L	STK10/P520L	VARIANT	P -> L (in dbSNP:rs17074311)		
O94804	STK10	M710T	O94804/M710T	STK10/M710T	VARIANT	M -> T (in dbSNP:rs34936670)	ECO:0000269|PubMed:17344846	17344846
O94804	STK10	S853L	O94804/S853L	STK10/S853L	VARIANT	S -> L (in dbSNP:rs56066852)	ECO:0000269|PubMed:17344846	17344846
O94804	STK10	S905T	O94804/S905T	STK10/S905T	VARIANT	S -> T (in dbSNP:rs55791916)	ECO:0000269|PubMed:17344846	17344846
O94804	STK10	S942N	O94804/S942N	STK10/S942N	VARIANT	S -> N (in dbSNP:rs1128204)		
O94804	STK10	C947Y	O94804/C947Y	STK10/C947Y	VARIANT	C -> Y (in dbSNP:rs56355550)	ECO:0000269|PubMed:17344846	17344846
O94804	STK10	K65I	O94804/K65I	STK10/K65I	MUTAGEN	K->I: Loss of kinase activity.	ECO:0000269|PubMed:12639966	12639966

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O94806	PRKD3	N42D	O94806/N42D	PRKD3/N42D	VARIANT	N -> D (in dbSNP:rs11896614)		
O94806	PRKD3	A128T	O94806/A128T	PRKD3/A128T	VARIANT	A -> T (in dbSNP:rs17852819)	ECO:0000269|PubMed:15489334	15489334
O94806	PRKD3	P225S	O94806/P225S	PRKD3/P225S	VARIANT	P -> S (in dbSNP:rs34280934)		
O94806	PRKD3	L445I	O94806/L445I	PRKD3/L445I	VARIANT	L -> I (in dbSNP:rs55912911)		
O94806	PRKD3	Q546R	O94806/Q546R	PRKD3/Q546R	VARIANT	Q -> R (in dbSNP:rs17856887)	ECO:0000269|PubMed:15489334	15489334
O94806	PRKD3	V716M	O94806/V716M	PRKD3/V716M	VARIANT	V -> M (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O94806	PRKD3	T156A	O94806/T156A	PRKD3/T156A	MUTAGEN	T->A: Slight loss in ability to bind DAG and phorbol-ester; when associated with F-158.	ECO:0000269|PubMed:18076381	18076381
O94806	PRKD3	Y158F	O94806/Y158F	PRKD3/Y158F	MUTAGEN	Y->F: Slight loss in ability to bind DAG and phorbol-ester; when associated with A-156.	ECO:0000269|PubMed:18076381	18076381
O94806	PRKD3	P165G	O94806/P165G	PRKD3/P165G	MUTAGEN	P->G: No effect on ability to bind phorbol ester, loss of ability to bind DAG, reduced DAG-induced membrane translocation.	ECO:0000269|PubMed:18076381	18076381
O94806	PRKD3	T166A	O94806/T166A	PRKD3/T166A	MUTAGEN	T->A: Slight loss in ability to bind DAG and phorbol-ester.	ECO:0000269|PubMed:18076381	18076381
O94806	PRKD3	Y170F	O94806/Y170F	PRKD3/Y170F	MUTAGEN	Y->F: Slight loss in ability to bind DAG and phorbol-ester.	ECO:0000269|PubMed:18076381	18076381
O94806	PRKD3	P282G	O94806/P282G	PRKD3/P282G	MUTAGEN	P->G: No effect on ability to bind phorbol ester, increase in ability to bind DAG.	ECO:0000269|PubMed:18076381	18076381
O94806	PRKD3	I284V	O94806/I284V	PRKD3/I284V	MUTAGEN	I->V: Slight increase in ability to bind DAG, no effect on phorbol-ester binding.		
O94806	PRKD3	K293W	O94806/K293W	PRKD3/K293W	MUTAGEN	K->W: Increased ability to bind DAG, no effect on phorbol-ester binding.	ECO:0000269|PubMed:18076381	18076381

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O94921	CDK14	M432I	O94921/M432I	CDK14/M432I	VARIANT	M -> I (in an ovarian mucinous carcinoma; somatic mutation; dbSNP:rs773301216)	ECO:0000269|PubMed:17344846	17344846
O94921	CDK14	S463R	O94921/S463R	CDK14/S463R	VARIANT	S -> R (in dbSNP:rs35643773)	ECO:0000269|PubMed:17344846	17344846
O94921	CDK14	K164R	O94921/K164R	CDK14/K164R	MUTAGEN	K->R: Abolishes protein kinase activity.	ECO:0000269|PubMed:17517622, ECO:0000269|PubMed:19524571	17517622,19524571

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O95382	MAP3K6	T455I	O95382/T455I	MAP3K6/T455I	VARIANT	T -> I (in dbSNP:rs1138294)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17210579	15489334,17210579
O95382	MAP3K6	R499C	O95382/R499C	MAP3K6/R499C	VARIANT	R -> C (in dbSNP:rs11247641)		
O95382	MAP3K6	R544W	O95382/R544W	MAP3K6/R544W	VARIANT	R -> W (in dbSNP:rs55671988)	ECO:0000269|PubMed:17344846	17344846
O95382	MAP3K6	N622K	O95382/N622K	MAP3K6/N622K	VARIANT	N -> K (in dbSNP:rs35659744)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
O95382	MAP3K6	R668G	O95382/R668G	MAP3K6/R668G	VARIANT	R -> G (in dbSNP:rs55869163)	ECO:0000269|PubMed:17344846	17344846
O95382	MAP3K6	R673L	O95382/R673L	MAP3K6/R673L	VARIANT	R -> L (in dbSNP:rs56359841)	ECO:0000269|PubMed:17344846	17344846
O95382	MAP3K6	P869T	O95382/P869T	MAP3K6/P869T	VARIANT	P -> T (in a breast cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
O95382	MAP3K6	S925L	O95382/S925L	MAP3K6/S925L	VARIANT	S -> L (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O95382	MAP3K6	T968I	O95382/T968I	MAP3K6/T968I	VARIANT	T -> I (in an ovarian endometrioid cancer sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O95382	MAP3K6	S969N	O95382/S969N	MAP3K6/S969N	VARIANT	S -> N (in dbSNP:rs17856498)	ECO:0000269|PubMed:15489334	15489334
O95382	MAP3K6	A1061T	O95382/A1061T	MAP3K6/A1061T	VARIANT	A -> T (in dbSNP:rs55990440)	ECO:0000269|PubMed:17344846	17344846
O95382	MAP3K6	G1233A	O95382/G1233A	MAP3K6/G1233A	VARIANT	G -> A (in dbSNP:rs17162549)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O95747	OXSR1	T304I	O95747/T304I	OXSR1/T304I	VARIANT	T -> I (in dbSNP:rs6599079)	ECO:0000269|PubMed:10083736, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	10083736,17344846
O95747	OXSR1	S425T	O95747/S425T	OXSR1/S425T	VARIANT	S -> T (in dbSNP:rs35295772)	ECO:0000269|Ref.3	
O95747	OXSR1	P433S	O95747/P433S	OXSR1/P433S	VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O95747	OXSR1	K46A	O95747/K46A	OXSR1/K46A	MUTAGEN	K->A: Loss of autophosphorylation and kinase activity.	ECO:0000269|PubMed:14707132, ECO:0000269|PubMed:16389068	14707132,16389068
O95747	OXSR1	K46M	O95747/K46M	OXSR1/K46M	MUTAGEN	K->M: Loss of RELT, RELL1 and RELL2 phosphorylation. Retention of some autophosphorylation activity may be due to complex formation with other endogenous kinases in the assay.	ECO:0000269|PubMed:14707132, ECO:0000269|PubMed:16389068	14707132,16389068

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O95819	MAP4K4	S712T	O95819/S712T	MAP4K4/S712T	VARIANT	S -> T	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O95835	LATS1	R96W	O95835/R96W	LATS1/R96W	VARIANT	R -> W (in dbSNP:rs55945045)	ECO:0000269|PubMed:17344846	17344846
O95835	LATS1	S204G	O95835/S204G	LATS1/S204G	VARIANT	S -> G (in dbSNP:rs34793526)	ECO:0000269|PubMed:17344846	17344846
O95835	LATS1	P237Q	O95835/P237Q	LATS1/P237Q	VARIANT	P -> Q (in dbSNP:rs56149740)	ECO:0000269|PubMed:17344846	17344846
O95835	LATS1	R370W	O95835/R370W	LATS1/R370W	VARIANT	R -> W (in dbSNP:rs56348064)	ECO:0000269|PubMed:17344846	17344846
O95835	LATS1	P531S	O95835/P531S	LATS1/P531S	VARIANT	P -> S (in dbSNP:rs55874734)	ECO:0000269|PubMed:17344846	17344846
O95835	LATS1	F641L	O95835/F641L	LATS1/F641L	VARIANT	F -> L (in dbSNP:rs35163691)	ECO:0000269|PubMed:17344846	17344846
O95835	LATS1	M669I	O95835/M669I	LATS1/M669I	VARIANT	M -> I (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1390558952)	ECO:0000269|PubMed:17344846	17344846
O95835	LATS1	R806P	O95835/R806P	LATS1/R806P	VARIANT	R -> P (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
O95835	LATS1	G1000S	O95835/G1000S	LATS1/G1000S	VARIANT	G -> S (in dbSNP:rs56412005)	ECO:0000269|PubMed:17344846	17344846
O95835	LATS1	S464A	O95835/S464A	LATS1/S464A	MUTAGEN	S->A: Abolishes phosphorylation by NUAK1 and NUAK2.	ECO:0000269|PubMed:19927127	19927127
O95835	LATS1	Y559F	O95835/Y559F	LATS1/Y559F	MUTAGEN	Y->F: Loss of interaction with YAP1.	ECO:0000269|PubMed:18158288	18158288
O95835	LATS1	K734A	O95835/K734A	LATS1/K734A	MUTAGEN	K->A: Loss of kinase activity, autophosphorylation, increased ploidy, prolonged duration of mitosis and lack of p53 expression.	ECO:0000269|PubMed:15122335	15122335

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O96013	PAK4	R135Q	O96013/R135Q	PAK4/R135Q	VARIANT	R -> Q (in dbSNP:rs56099436)	ECO:0000269|PubMed:17344846	17344846
O96013	PAK4	A139T	O96013/A139T	PAK4/A139T	VARIANT	A -> T (in dbSNP:rs35655056)	ECO:0000269|PubMed:17344846	17344846
O96013	PAK4	S445N	O96013/S445N	PAK4/S445N	MUTAGEN	S->N: Approximately 30-fold increased autophosphorylation (constitutively active mutant).	ECO:0000269|PubMed:11313478	11313478
O96013	PAK4	S474E	O96013/S474E	PAK4/S474E	MUTAGEN	S->E: Approximately 3-fold increased autophosphorylation.	ECO:0000269|PubMed:11313478	11313478

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
O96017	CHEK2	A17S	O96017/A17S	CHEK2/A17S	VARIANT	A -> S (in an osteogenic sarcoma sample; somatic mutation; might influence susceptibility to breast cancer; does not cause protein abrogation in familial colorectal cancer; dbSNP:rs137853008)	ECO:0000269|PubMed:11746983	11746983
O96017	CHEK2	T59K	O96017/T59K	CHEK2/T59K	VARIANT	T -> K (in multiple cancers; dbSNP:rs149991239)	ECO:0000269|PubMed:12052256	12052256
O96017	CHEK2	E64K	O96017/E64K	CHEK2/E64K	VARIANT	E -> K (in prostate cancer; somatic mutation; dbSNP:rs141568342)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	P85L	O96017/P85L	CHEK2/P85L	VARIANT	P -> L (in an osteogenic sarcoma sample; neutral allele among Ashkenazi Jewish women; dbSNP:rs17883862)	ECO:0000269|PubMed:11746983, ECO:0000269|PubMed:15649950, ECO:0000269|Ref.10	11746983,15649950
O96017	CHEK2	R117G	O96017/R117G	CHEK2/R117G	VARIANT	R -> G (in BC; dbSNP:rs28909982)	ECO:0000269|PubMed:12454775, ECO:0000269|PubMed:12610780, ECO:0000269|PubMed:15818573	12454775,12610780,15818573
O96017	CHEK2	R137Q	O96017/R137Q	CHEK2/R137Q	VARIANT	R -> Q (might influence susceptibility to breast cancer; does not cause protein abrogation in familial colorectal cancer; dbSNP:rs368570187)	ECO:0000269|PubMed:12454775, ECO:0000269|PubMed:15818573	12454775,15818573
O96017	CHEK2	R145P	O96017/R145P	CHEK2/R145P	VARIANT	R -> P (in prostate cancer; somatic mutation; dbSNP:rs587781667)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	R145W	O96017/R145W	CHEK2/R145W	VARIANT	R -> W (in colon cancer and LFS2; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs137853007)	ECO:0000269|PubMed:10617473, ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:11719428, ECO:0000269|PubMed:12610780, ECO:0000269|PubMed:15535844, ECO:0000269|PubMed:15818573	10617473,11298456,11719428,12610780,15535844,15818573
O96017	CHEK2	I157T	O96017/I157T	CHEK2/I157T	VARIANT	I -> T (might influence susceptibility to different types of cancer; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs17879961)	ECO:0000269|PubMed:10617473, ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:11461078, ECO:0000269|PubMed:12533788, ECO:0000269|PubMed:12610780, ECO:0000269|PubMed:14612911, ECO:0000269|PubMed:15087378, ECO:0000269|PubMed:15095295, ECO:0000269|PubMed:15239132, ECO:0000269|PubMed:15492928, ECO:0000269|PubMed:15535844, ECO:0000269|PubMed:15810020, ECO:0000269|PubMed:15818573, ECO:0000269|Ref.10	10617473,11298456,11461078,12533788,12610780,14612911,15087378,15095295,15239132,15492928,15535844,15810020,15818573
O96017	CHEK2	G167R	O96017/G167R	CHEK2/G167R	VARIANT	G -> R (in prostate cancer; somatic mutation; dbSNP:rs72552322)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	R180C	O96017/R180C	CHEK2/R180C	VARIANT	R -> C (in prostate cancer; somatic mutation; dbSNP:rs77130927)	ECO:0000269|PubMed:12533788, ECO:0000269|PubMed:21618645	12533788,21618645
O96017	CHEK2	R180H	O96017/R180H	CHEK2/R180H	VARIANT	R -> H (in prostate cancer; somatic mutation; dbSNP:rs137853009)	ECO:0000269|PubMed:12454775, ECO:0000269|PubMed:12533788, ECO:0000269|PubMed:15818573	12454775,12533788,15818573
O96017	CHEK2	R181C	O96017/R181C	CHEK2/R181C	VARIANT	R -> C (in prostate cancer; somatic mutation; dbSNP:rs137853010)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	R181H	O96017/R181H	CHEK2/R181H	VARIANT	R -> H (in prostate cancer; somatic mutation; dbSNP:rs121908701)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	E239K	O96017/E239K	CHEK2/E239K	VARIANT	E -> K (in prostate cancer; germline mutation; dbSNP:rs121908702)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	I251F	O96017/I251F	CHEK2/I251F	VARIANT	I -> F (in prostate cancer; unknown pathological significance; dbSNP:rs587780189)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	R318H	O96017/R318H	CHEK2/R318H	VARIANT	R -> H (in prostate cancer; unknown pathological significance; somatic mutation; dbSNP:rs143611747)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	T323P	O96017/T323P	CHEK2/T323P	VARIANT	T -> P (in prostate cancer; somatic mutation; dbSNP:rs750984976)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	Y327C	O96017/Y327C	CHEK2/Y327C	VARIANT	Y -> C (in prostate cancer; unknown pathological significance; somatic mutation; dbSNP:rs587780194)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	D347N	O96017/D347N	CHEK2/D347N	VARIANT	D -> N (in dbSNP:rs28909980)		
O96017	CHEK2	H371Y	O96017/H371Y	CHEK2/H371Y	VARIANT	H -> Y (confers a moderate risk of breast cancer; partially reduces kinase activity; dbSNP:rs531398630)	ECO:0000269|PubMed:21618645	21618645
O96017	CHEK2	Y390C	O96017/Y390C	CHEK2/Y390C	VARIANT	Y -> C (in BC; does not phosphorylate p53/TP53; dbSNP:rs200928781)	ECO:0000269|PubMed:25619829	25619829
O96017	CHEK2	R406H	O96017/R406H	CHEK2/R406H	VARIANT	R -> H (in dbSNP:rs200649225)		
O96017	CHEK2	S428F	O96017/S428F	CHEK2/S428F	VARIANT	S -> F (may increase breast cancer risk; dbSNP:rs137853011)	ECO:0000269|PubMed:15649950	15649950
O96017	CHEK2	L436M	O96017/L436M	CHEK2/L436M	VARIANT	L -> M (in dbSNP:rs17882922)	ECO:0000269|Ref.10	
O96017	CHEK2	N446K	O96017/N446K	CHEK2/N446K	VARIANT	N -> K (in dbSNP:rs17880867)	ECO:0000269|Ref.10	
O96017	CHEK2	F447I	O96017/F447I	CHEK2/F447I	VARIANT	F -> I (in dbSNP:rs17881473)	ECO:0000269|Ref.10	
O96017	CHEK2	I448S	O96017/I448S	CHEK2/I448S	VARIANT	I -> S (in dbSNP:rs17886163)	ECO:0000269|Ref.10	
O96017	CHEK2	T476K	O96017/T476K	CHEK2/T476K	VARIANT	T -> K (in prostate cancer; somatic mutation)	ECO:0000269|PubMed:12533788	12533788
O96017	CHEK2	S500C	O96017/S500C	CHEK2/S500C	VARIANT	S -> C (in dbSNP:rs28909981)		
O96017	CHEK2	E501K	O96017/E501K	CHEK2/E501K	VARIANT	E -> K (in dbSNP:rs17883172)	ECO:0000269|Ref.10	
O96017	CHEK2	L512V	O96017/L512V	CHEK2/L512V	VARIANT	L -> V (in dbSNP:rs17882942)	ECO:0000269|Ref.10	
O96017	CHEK2	T68A	O96017/T68A	CHEK2/T68A	MUTAGEN	T->A: Loss of activation and phosphorylation.	ECO:0000269|PubMed:11901158, ECO:0000269|PubMed:15342622	11901158,15342622
O96017	CHEK2	S73A	O96017/S73A	CHEK2/S73A	MUTAGEN	S->A: Impaired activation, phosphorylation by ATM and G2/M transition checkpoint.	ECO:0000269|PubMed:16481012	16481012
O96017	CHEK2	D347A	O96017/D347A	CHEK2/D347A	MUTAGEN	D->A: Loss of kinase activity and of the ability to phosphorylate CDC25A.	ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:9836640	11298456,9836640
O96017	CHEK2	D368N	O96017/D368N	CHEK2/D368N	MUTAGEN	D->N: Loss of autophosphorylation activity.	ECO:0000269|PubMed:15342622	15342622
O96017	CHEK2	S379A	O96017/S379A	CHEK2/S379A	MUTAGEN	S->A: Abrogates autophosphorylation at Ser-379 and prevents ubiquitination.	ECO:0000269|PubMed:18644861	18644861
O96017	CHEK2	T383A	O96017/T383A	CHEK2/T383A	MUTAGEN	T->A: Loss of phosphorylation in response to ionizing radiation.	ECO:0000269|PubMed:11390408	11390408
O96017	CHEK2	T387A	O96017/T387A	CHEK2/T387A	MUTAGEN	T->A: Loss of phosphorylation in response to ionizing radiation.	ECO:0000269|PubMed:11390408	11390408
O96017	CHEK2	S456A	O96017/S456A	CHEK2/S456A	MUTAGEN	S->A: Increased ubiquitination and degradation by the proteasome.	ECO:0000269|PubMed:17715138	17715138

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P00519	ABL1	R47G	P00519/R47G	ABL1/R47G	VARIANT	R -> G (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P00519	ABL1	L140P	P00519/L140P	ABL1/L140P	VARIANT	L -> P (in dbSNP:rs1064152)	ECO:0000269|PubMed:3021337	3021337
P00519	ABL1	R166K	P00519/R166K	ABL1/R166K	VARIANT	R -> K (in a melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P00519	ABL1	Y226C	P00519/Y226C	ABL1/Y226C	VARIANT	Y -> C (in CHDSKM; increases kinase activity; no effect on protein levels; dbSNP:rs1060499547)	ECO:0000269|PubMed:28288113	28288113
P00519	ABL1	K247R	P00519/K247R	ABL1/K247R	VARIANT	K -> R (in dbSNP:rs34549764)		
P00519	ABL1	A337T	P00519/A337T	ABL1/A337T	VARIANT	A -> T (in CHDSKM; increases kinase activity; no effect on protein levels; dbSNP:rs1060499548)	ECO:0000269|PubMed:28288113	28288113
P00519	ABL1	G706V	P00519/G706V	ABL1/G706V	VARIANT	G -> V (in dbSNP:rs34634745)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
P00519	ABL1	P810L	P00519/P810L	ABL1/P810L	VARIANT	P -> L (in dbSNP:rs2229071)	ECO:0000269|PubMed:17344846	17344846
P00519	ABL1	T852P	P00519/T852P	ABL1/T852P	VARIANT	T -> P (in dbSNP:rs1588283506)	ECO:0000269|Ref.4	
P00519	ABL1	P900S	P00519/P900S	ABL1/P900S	VARIANT	P -> S (in dbSNP:rs35266696)	ECO:0000269|Ref.4	
P00519	ABL1	S968P	P00519/S968P	ABL1/S968P	VARIANT	S -> P (in dbSNP:rs1064165)		
P00519	ABL1	S972L	P00519/S972L	ABL1/S972L	VARIANT	S -> L (in dbSNP:rs2229067)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
P00519	ABL1	T735A	P00519/T735A	ABL1/T735A	MUTAGEN	T->A: Abolishes phosphorylation. Loss of binding YWHAS and YWHAZ. Localizes to the nucleus. No effect on kinase activity.	ECO:0000269|PubMed:15696159	15696159

Error: P00533 EGFR 'NoneType' object has no attribute 'group' FT                   /note="Missing (found in a lung cancer sample)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P00533	EGFR	R98Q	P00533/R98Q	EGFR/R98Q	VARIANT	R -> Q (in dbSNP:rs17289589)	ECO:0000269|Ref.7	
P00533	EGFR	P266R	P00533/P266R	EGFR/P266R	VARIANT	P -> R (in dbSNP:rs17336639)	ECO:0000269|Ref.7	
P00533	EGFR	G428D	P00533/G428D	EGFR/G428D	VARIANT	G -> D (in NISBD2; loss of function; the mutant does not localize to the cell membrane; has diffuse cytoplasmic localization; dbSNP:rs606231253)	ECO:0000269|PubMed:24691054	24691054
P00533	EGFR	R521K	P00533/R521K	EGFR/R521K	VARIANT	R -> K (in dbSNP:rs2227983)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.7	17344846
P00533	EGFR	V674I	P00533/V674I	EGFR/V674I	VARIANT	V -> I (in dbSNP:rs17337079)	ECO:0000269|Ref.7	
P00533	EGFR	E709A	P00533/E709A	EGFR/E709A	VARIANT	E -> A (found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517085)	ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628, ECO:0000269|PubMed:16533793	15623594,16205628,16533793
P00533	EGFR	E709G	P00533/E709G	EGFR/E709G	VARIANT	E -> G (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs397517085)	ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628	15623594,16205628
P00533	EGFR	E709K	P00533/E709K	EGFR/E709K	VARIANT	E -> K (found in a lung cancer sample; dbSNP:rs727504256)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	G719A	P00533/G719A	EGFR/G719A	VARIANT	G -> A (found in a lung cancer sample; dbSNP:rs121913428)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	G719C	P00533/G719C	EGFR/G719C	VARIANT	G -> C (found in a lung cancer sample; dbSNP:rs28929495)	ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16533793	15623594,16533793
P00533	EGFR	G719D	P00533/G719D	EGFR/G719D	VARIANT	G -> D (found in a lung cancer sample; dbSNP:rs121913428)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	G719S	P00533/G719S	EGFR/G719S	VARIANT	G -> S (found in a lung cancer sample; somatic mutation; strongly increased kinase activity; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs28929495)	ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:17349580	15118125,15623594,16205628,16533793,17349580
P00533	EGFR	G724S	P00533/G724S	EGFR/G724S	VARIANT	G -> S (found in a lung cancer sample; dbSNP:rs1051753269)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	E734K	P00533/E734K	EGFR/E734K	VARIANT	E -> K (found in a lung cancer sample; dbSNP:rs121913420)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	L747F	P00533/L747F	EGFR/L747F	VARIANT	L -> F (found in a lung cancer sample)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	R748P	P00533/R748P	EGFR/R748P	VARIANT	R -> P (found in a lung cancer sample)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	S768I	P00533/S768I	EGFR/S768I	VARIANT	S -> I (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913465)	ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628	15623594,16205628
P00533	EGFR	V769M	P00533/V769M	EGFR/V769M	VARIANT	V -> M (found in a lung cancer sample; dbSNP:rs147149347)	ECO:0000269|PubMed:15623594	15623594
P00533	EGFR	Q787R	P00533/Q787R	EGFR/Q787R	VARIANT	Q -> R (found in a lung cancer sample)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	T790M	P00533/T790M	EGFR/T790M	VARIANT	T -> M (found in a lung cancer sample; increased kinase activity; dbSNP:rs121434569)	ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:18227510	16533793,18227510
P00533	EGFR	L833V	P00533/L833V	EGFR/L833V	VARIANT	L -> V (found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517126)	ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628, ECO:0000269|PubMed:16533793	15623594,16205628,16533793
P00533	EGFR	V834L	P00533/V834L	EGFR/V834L	VARIANT	V -> L (found in a lung cancer sample; dbSNP:rs397517127)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	H835L	P00533/H835L	EGFR/H835L	VARIANT	H -> L (found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517128)	ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628	15623594,16205628
P00533	EGFR	L838V	P00533/L838V	EGFR/L838V	VARIANT	L -> V (found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs864621996)	ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628	15623594,16205628
P00533	EGFR	L858M	P00533/L858M	EGFR/L858M	VARIANT	L -> M (found in a lung cancer sample; dbSNP:rs121913443)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	L858R	P00533/L858R	EGFR/L858R	VARIANT	L -> R (found in a lung cancer sample; somatic mutation; constitutively activated enzyme with strongly increased kinase activity; more sensitive to gefitinib than wild-type; dbSNP:rs121434568)	ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:17349580	15118125,15623594,16205628,16533793,17349580
P00533	EGFR	L861Q	P00533/L861Q	EGFR/L861Q	VARIANT	L -> Q (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913444)	ECO:0000269|PubMed:15623594, ECO:0000269|PubMed:16205628, ECO:0000269|PubMed:16533793	15623594,16205628,16533793
P00533	EGFR	G873E	P00533/G873E	EGFR/G873E	VARIANT	G -> E (found in a lung cancer sample)	ECO:0000269|PubMed:16533793	16533793
P00533	EGFR	R962G	P00533/R962G	EGFR/R962G	VARIANT	R -> G (in dbSNP:rs17337451)	ECO:0000269|Ref.7	
P00533	EGFR	H988P	P00533/H988P	EGFR/H988P	VARIANT	H -> P (in dbSNP:rs17290699)	ECO:0000269|Ref.7	
P00533	EGFR	L1034R	P00533/L1034R	EGFR/L1034R	VARIANT	L -> R (in dbSNP:rs34352568)	ECO:0000269|PubMed:17344846	17344846
P00533	EGFR	A1210V	P00533/A1210V	EGFR/A1210V	VARIANT	A -> V (in dbSNP:rs35918369)	ECO:0000269|PubMed:17344846	17344846
P00533	EGFR	Y275A	P00533/Y275A	EGFR/Y275A	MUTAGEN	Y->A: Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-309.	ECO:0000269|PubMed:12297050	12297050
P00533	EGFR	F287A	P00533/F287A	EGFR/F287A	MUTAGEN	F->A: Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-309.	ECO:0000269|PubMed:12297050	12297050
P00533	EGFR	R309S	P00533/R309S	EGFR/R309S	MUTAGEN	R->S: Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-275. Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-287.	ECO:0000269|PubMed:12297050	12297050
P00533	EGFR	R429E	P00533/R429E	EGFR/R429E	MUTAGEN	R->E: Abolishes autophosphorylation and activation of downstream kinases.	ECO:0000269|PubMed:12297050	12297050
P00533	EGFR	D587A	P00533/D587A	EGFR/D587A	MUTAGEN	D->A: Increased EGF binding; when associated with A-590 and A-609.	ECO:0000269|PubMed:19718021	19718021
P00533	EGFR	H590A	P00533/H590A	EGFR/H590A	MUTAGEN	H->A: Increased EGF binding; when associated with A-587; A-590 and A-609.	ECO:0000269|PubMed:19718021	19718021
P00533	EGFR	K609A	P00533/K609A	EGFR/K609A	MUTAGEN	K->A: Decreases intramolecular interactions and facilitates EGF binding. Increased EGF binding; when associated with A-587; A-590 and A-609.	ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:19718021	12620237,19718021
P00533	EGFR	L688A	P00533/L688A	EGFR/L688A	MUTAGEN	L->A: Strongly reduced phosphorylation.	ECO:0000269|PubMed:19560417, ECO:0000269|PubMed:19563760	19560417,19563760
P00533	EGFR	V689A	P00533/V689A	EGFR/V689A	MUTAGEN	V->A: Reduced autophosphorylation.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	V689M	P00533/V689M	EGFR/V689M	MUTAGEN	V->M: Constitutively activated kinase.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	E690A	P00533/E690A	EGFR/E690A	MUTAGEN	E->A: Reduced phosphorylation.	ECO:0000269|PubMed:19560417, ECO:0000269|PubMed:19563760	19560417,19563760
P00533	EGFR	L692A	P00533/L692A	EGFR/L692A	MUTAGEN	L->A,P: Strongly reduced phosphorylation.		
P00533	EGFR	L692P	P00533/L692P	EGFR/L692P	MUTAGEN	L->A,P: Strongly reduced phosphorylation.	ECO:0000269|PubMed:19560417, ECO:0000269|PubMed:19563760	19560417,19563760
P00533	EGFR	T693A	P00533/T693A	EGFR/T693A	MUTAGEN	T->A: Increased phosphorylation.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	T693D	P00533/T693D	EGFR/T693D	MUTAGEN	T->D: Strongly reduced phosphorylation.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	P694A	P00533/P694A	EGFR/P694A	MUTAGEN	P->A: Strongly reduced phosphorylation.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	P699A	P00533/P699A	EGFR/P699A	MUTAGEN	P->A: Reduced phosphorylation.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	N700A	P00533/N700A	EGFR/N700A	MUTAGEN	N->A: Abolishes phosphorylation.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	L704A	P00533/L704A	EGFR/L704A	MUTAGEN	L->A: Abolishes phosphorylation.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	R705A	P00533/R705A	EGFR/R705A	MUTAGEN	R->A: Abolishes phosphorylation.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	I706A	P00533/I706A	EGFR/I706A	MUTAGEN	I->A: Abolishes phosphorylation.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	K745A	P00533/K745A	EGFR/K745A	MUTAGEN	K->A,M: Abolishes kinase activity.		
P00533	EGFR	K745M	P00533/K745M	EGFR/K745M	MUTAGEN	K->A,M: Abolishes kinase activity.	ECO:0000269|PubMed:19560417	19560417
P00533	EGFR	D974A	P00533/D974A	EGFR/D974A	MUTAGEN	D->A: Strongly reduced phosphorylation.		
P00533	EGFR	R977A	P00533/R977A	EGFR/R977A	MUTAGEN	R->A: Reduced phosphorylation.	ECO:0000269|PubMed:19563760	19563760
P00533	EGFR	Y1016F	P00533/Y1016F	EGFR/Y1016F	MUTAGEN	Y->F: 50% decrease in interaction with PIK3C2B. 65% decrease in interaction with PIK3C2B; when associated with F-1197. Abolishes interaction with PIK3C2B; when associated with F-1197 and F-1092.	ECO:0000269|PubMed:10805725	10805725
P00533	EGFR	C1049A	P00533/C1049A	EGFR/C1049A	MUTAGEN	C->A: Decreased palmitoylation.	ECO:0000269|PubMed:27153536	27153536
P00533	EGFR	Q1067G	P00533/Q1067G	EGFR/Q1067G	MUTAGEN	Q->G: No effect on interaction with CBLC.	ECO:0000269|PubMed:22888118	22888118
P00533	EGFR	R1068G	P00533/R1068G	EGFR/R1068G	MUTAGEN	R->G: Strongly decreases interaction with CBLC.	ECO:0000269|PubMed:22888118	22888118
P00533	EGFR	Y1069F	P00533/Y1069F	EGFR/Y1069F	MUTAGEN	Y->F: Abolishes interaction with CBLC.	ECO:0000269|PubMed:22888118	22888118
P00533	EGFR	Y1092F	P00533/Y1092F	EGFR/Y1092F	MUTAGEN	Y->F: No change in interaction with PIK3C2B. Abolishes interaction with PIK3C2B; when associated with F-1197 and F-1016.	ECO:0000269|PubMed:10805725	10805725
P00533	EGFR	Y1110F	P00533/Y1110F	EGFR/Y1110F	MUTAGEN	Y->F: No change in interaction with PIK3C2B.	ECO:0000269|PubMed:10805725	10805725
P00533	EGFR	C1146A	P00533/C1146A	EGFR/C1146A	MUTAGEN	C->A: Decreased palmitoylation.	ECO:0000269|PubMed:27153536	27153536
P00533	EGFR	Y1172F	P00533/Y1172F	EGFR/Y1172F	MUTAGEN	Y->F: No change in interaction with PIK3C2B.	ECO:0000269|PubMed:10805725	10805725
P00533	EGFR	Y1197F	P00533/Y1197F	EGFR/Y1197F	MUTAGEN	Y->F: No change in interaction with PIK3C2B. 65% decrease in interaction with PIK3C2B; when associated with F-1016. Abolishes interaction with PIK3C2B; when associated with F-1092 and F-1016.	ECO:0000269|PubMed:10805725	10805725

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P00540	MOS	R96L	P00540/R96L	MOS/R96L	VARIANT	R -> L (in dbSNP:rs34532635)	ECO:0000269|PubMed:17344846	17344846
P00540	MOS	A105S	P00540/A105S	MOS/A105S	VARIANT	A -> S (in dbSNP:rs35392772)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
P00540	MOS	A123T	P00540/A123T	MOS/A123T	VARIANT	A -> T (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P00540	MOS	S300P	P00540/S300P	MOS/S300P	VARIANT	S -> P (in dbSNP:rs56300224)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P04049	RAF1	A237T	P04049/A237T	RAF1/A237T	VARIANT	A -> T (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs587777588)	ECO:0000269|PubMed:24777450	24777450
P04049	RAF1	R256S	P04049/R256S	RAF1/R256S	VARIANT	R -> S (in NS5; dbSNP:rs397516826)	ECO:0000269|PubMed:17603483	17603483
P04049	RAF1	S257L	P04049/S257L	RAF1/S257L	VARIANT	S -> L (in NS5 and LPRD2; shows in vitro greater kinase activity and enhanced ERK activation than wild-type; dbSNP:rs80338796)	ECO:0000269|PubMed:17603482, ECO:0000269|PubMed:17603483	17603482,17603483
P04049	RAF1	S259A	P04049/S259A	RAF1/S259A	VARIANT	S -> A (in an ovarian serous carcinoma sample; somatic mutation; increased ERK activation; dbSNP:rs3730271)	ECO:0000269|PubMed:16630891, ECO:0000269|PubMed:17344846	16630891,17344846
P04049	RAF1	S259F	P04049/S259F	RAF1/S259F	VARIANT	S -> F (in NS5; dbSNP:rs397516827)	ECO:0000269|PubMed:17603483	17603483
P04049	RAF1	T260I	P04049/T260I	RAF1/T260I	VARIANT	T -> I (in hypertrophic cardiomyopathy; unknown pathological significance; dbSNP:rs869025501)	ECO:0000269|PubMed:17603483	17603483
P04049	RAF1	T260R	P04049/T260R	RAF1/T260R	VARIANT	T -> R (in NS5)	ECO:0000269|PubMed:17603483	17603483
P04049	RAF1	P261A	P04049/P261A	RAF1/P261A	VARIANT	P -> A (in NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs121434594)	ECO:0000269|PubMed:17603482	17603482
P04049	RAF1	P261L	P04049/P261L	RAF1/P261L	VARIANT	P -> L (in NS5; shows greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs397516828)	ECO:0000269|PubMed:17603483	17603483
P04049	RAF1	P261S	P04049/P261S	RAF1/P261S	VARIANT	P -> S (in NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs121434594)	ECO:0000269|PubMed:17603482, ECO:0000269|PubMed:17603483, ECO:0000269|PubMed:20683980	17603482,17603483,20683980
P04049	RAF1	V263A	P04049/V263A	RAF1/V263A	VARIANT	V -> A (in NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs397516830)	ECO:0000269|PubMed:17603482	17603482
P04049	RAF1	P308L	P04049/P308L	RAF1/P308L	VARIANT	P -> L (in dbSNP:rs5746220)	ECO:0000269|PubMed:14702039, ECO:0000269|Ref.3	14702039
P04049	RAF1	T310A	P04049/T310A	RAF1/T310A	VARIANT	T -> A (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs778155315)	ECO:0000269|PubMed:24777450	24777450
P04049	RAF1	P332A	P04049/P332A	RAF1/P332A	VARIANT	P -> A (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs1057403865)	ECO:0000269|PubMed:24777450	24777450
P04049	RAF1	Q335H	P04049/Q335H	RAF1/Q335H	VARIANT	Q -> H (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P04049	RAF1	D486G	P04049/D486G	RAF1/D486G	VARIANT	D -> G (in NS5; dbSNP:rs397516815)	ECO:0000269|PubMed:17603483	17603483
P04049	RAF1	D486N	P04049/D486N	RAF1/D486N	VARIANT	D -> N (in NS5; has reduced or absent kinase activity; dbSNP:rs80338798)	ECO:0000269|PubMed:17603483	17603483
P04049	RAF1	T491I	P04049/T491I	RAF1/T491I	VARIANT	T -> I (in NS5; has reduced or absent kinase activity; dbSNP:rs80338799)	ECO:0000269|PubMed:17603483	17603483
P04049	RAF1	T491R	P04049/T491R	RAF1/T491R	VARIANT	T -> R (in NS5; dbSNP:rs80338799)	ECO:0000269|PubMed:17603483	17603483
P04049	RAF1	L603P	P04049/L603P	RAF1/L603P	VARIANT	L -> P (in CMD1NN; shows impaired kinase activity and reduced MAPK3 activation with this mutation; dbSNP:rs587777586)	ECO:0000269|PubMed:24777450	24777450
P04049	RAF1	S612T	P04049/S612T	RAF1/S612T	VARIANT	S -> T (in NS5; dbSNP:rs1448392469)	ECO:0000269|PubMed:17603483	17603483
P04049	RAF1	L613V	P04049/L613V	RAF1/L613V	VARIANT	L -> V (in NS5 and LPRD2; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs80338797)	ECO:0000269|PubMed:17603482, ECO:0000269|PubMed:17603483	17603482,17603483
P04049	RAF1	H626R	P04049/H626R	RAF1/H626R	VARIANT	H -> R (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs1553609795)	ECO:0000269|PubMed:24777450	24777450
P04049	RAF1	T641M	P04049/T641M	RAF1/T641M	VARIANT	T -> M (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs587777587)	ECO:0000269|PubMed:24777450	24777450
P04049	RAF1	K375W	P04049/K375W	RAF1/K375W	MUTAGEN	K->W: Catalytically inactive.	ECO:0000269|PubMed:20956560	20956560
P04049	RAF1	T491D	P04049/T491D	RAF1/T491D	MUTAGEN	T->D: Increased kinase activity but can still be inhibited by PPP5C; when associated with D-494.	ECO:0000269|PubMed:16892053	16892053
P04049	RAF1	S494D	P04049/S494D	RAF1/S494D	MUTAGEN	S->D: Increased kinase activity but can still be inhibited by PPP5C; when associated with D-491.	ECO:0000269|PubMed:16892053	16892053
P04049	RAF1	R563K	P04049/R563K	RAF1/R563K	MUTAGEN	R->K: Loss of methylation. Increased stability and catalytic activity in response to EGF treatment.	ECO:0000269|PubMed:21917714	21917714

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P04626	ERBB2	W452C	P04626/W452C	ERBB2/W452C	VARIANT	W -> C (in dbSNP:rs4252633)	ECO:0000269|Ref.3	
P04626	ERBB2	I654V	P04626/I654V	ERBB2/I654V	VARIANT	I -> V (in allele B3; dbSNP:rs1801201)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8095488	17344846,8095488
P04626	ERBB2	I655V	P04626/I655V	ERBB2/I655V	VARIANT	I -> V (in allele B2 and allele B3; dbSNP:rs1136201)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8095488, ECO:0000269|Ref.3	17344846,8095488
P04626	ERBB2	A710V	P04626/A710V	ERBB2/A710V	VARIANT	A -> V (in VSCN2; almost complete loss of ERBB2 and ERBB3 phosphorylation in the presence or in the absence of NRG1 stimulation, suggesting alteration of downstream signaling; does not affect the subcellular localization at the cell membrane)	ECO:0000269|PubMed:33497358	33497358
P04626	ERBB2	L755P	P04626/L755P	ERBB2/L755P	VARIANT	L -> P (in LNCR; somatic mutation; unknown pathological significance; dbSNP:rs121913469)	ECO:0000269|PubMed:15457249	15457249
P04626	ERBB2	L768S	P04626/L768S	ERBB2/L768S	VARIANT	L -> S (in dbSNP:rs56366519)	ECO:0000269|PubMed:17344846	17344846
P04626	ERBB2	M774MAYVM	P04626/M774MAYVM	ERBB2/M774MAYVM	VARIANT	M -> MAYVM (in LNCR; somatic mutation; unknown pathological significance)	ECO:0000269|PubMed:15457249	15457249
P04626	ERBB2	G776S	P04626/G776S	ERBB2/G776S	VARIANT	G -> S (in GASC; somatic mutation; unknown pathological significance; dbSNP:rs28933369)	ECO:0000269|PubMed:15457249, ECO:0000269|PubMed:17344846	15457249,17344846
P04626	ERBB2	S779SVGS	P04626/S779SVGS	ERBB2/S779SVGS	VARIANT	S -> SVGS (in LNCR; somatic mutation; unknown pathological significance)	ECO:0000269|PubMed:15457249	15457249
P04626	ERBB2	N857S	P04626/N857S	ERBB2/N857S	VARIANT	N -> S (in OC; somatic mutation; unknown pathological significance; dbSNP:rs28933370)	ECO:0000269|PubMed:15457249, ECO:0000269|PubMed:17344846	15457249,17344846
P04626	ERBB2	E914K	P04626/E914K	ERBB2/E914K	VARIANT	E -> K (in GLM; somatic mutation; unknown pathological significance; dbSNP:rs28933368)	ECO:0000269|PubMed:15457249	15457249
P04626	ERBB2	P1170A	P04626/P1170A	ERBB2/P1170A	VARIANT	P -> A (in dbSNP:rs1058808)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2999974, ECO:0000269|PubMed:8104414, ECO:0000269|Ref.3	17344846,2999974,8104414
P04626	ERBB2	A1216D	P04626/A1216D	ERBB2/A1216D	VARIANT	A -> D (in dbSNP:rs55943169)	ECO:0000269|PubMed:17344846	17344846
P04626	ERBB2	M611A	P04626/M611A	ERBB2/M611A	MUTAGEN	M->A: Prevents synthesis of isoform 2.	ECO:0000269|PubMed:16794579	16794579
P04626	ERBB2	M687A	P04626/M687A	ERBB2/M687A	MUTAGEN	M->A: Prevents synthesis of isoform 3.	ECO:0000269|PubMed:16794579	16794579
P04626	ERBB2	M706A	P04626/M706A	ERBB2/M706A	MUTAGEN	M->A: No effect on isoform production.	ECO:0000269|PubMed:16794579	16794579
P04626	ERBB2	M712A	P04626/M712A	ERBB2/M712A	MUTAGEN	M->A: No effect on isoform production.	ECO:0000269|PubMed:16794579	16794579

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P04629	NTRK1	R6W	P04629/R6W	NTRK1/R6W	VARIANT	R -> W (in dbSNP:rs201472270)	ECO:0000269|PubMed:22302274	22302274
P04629	NTRK1	G18E	P04629/G18E	NTRK1/G18E	VARIANT	G -> E (in dbSNP:rs1007211)		
P04629	NTRK1	Q80R	P04629/Q80R	NTRK1/Q80R	VARIANT	Q -> R (in dbSNP:rs55891455)	ECO:0000269|PubMed:17344846	17344846
P04629	NTRK1	R85S	P04629/R85S	NTRK1/R85S	VARIANT	R -> S (in dbSNP:rs543320028)	ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:11159935	10330344,11159935
P04629	NTRK1	L93P	P04629/L93P	NTRK1/L93P	VARIANT	L -> P (in CIPA; aberrantly processed; shows diminished autophosphorylation in neuronal cells)	ECO:0000269|PubMed:10982191, ECO:0000269|PubMed:11159935	10982191,11159935
P04629	NTRK1	A107V	P04629/A107V	NTRK1/A107V	VARIANT	A -> V (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs540521894)	ECO:0000269|PubMed:17344846	17344846
P04629	NTRK1	A110D	P04629/A110D	NTRK1/A110D	VARIANT	A -> D (in CIPA)	ECO:0000269|PubMed:28328124	28328124
P04629	NTRK1	L213P	P04629/L213P	NTRK1/L213P	VARIANT	L -> P (in CIPA; aberrantly processed; shows diminished autophosphorylation in neuronal cells; dbSNP:rs747711259)	ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:11159935	10330344,11159935
P04629	NTRK1	T237M	P04629/T237M	NTRK1/T237M	VARIANT	T -> M (in dbSNP:rs55909005)	ECO:0000269|PubMed:17344846	17344846
P04629	NTRK1	V238G	P04629/V238G	NTRK1/V238G	VARIANT	V -> G (in dbSNP:rs56000394)	ECO:0000269|PubMed:17344846	17344846
P04629	NTRK1	R260G	P04629/R260G	NTRK1/R260G	VARIANT	R -> G (in dbSNP:rs35116695)	ECO:0000269|PubMed:17344846	17344846
P04629	NTRK1	Y359C	P04629/Y359C	NTRK1/Y359C	VARIANT	Y -> C (in CIPA; dbSNP:rs121964869)	ECO:0000269|PubMed:11310631	11310631
P04629	NTRK1	R444Q	P04629/R444Q	NTRK1/R444Q	VARIANT	R -> Q (in dbSNP:rs56320207)	ECO:0000269|PubMed:17344846	17344846
P04629	NTRK1	R452C	P04629/R452C	NTRK1/R452C	VARIANT	R -> C (in dbSNP:rs34900547)	ECO:0000269|PubMed:17344846	17344846
P04629	NTRK1	E492K	P04629/E492K	NTRK1/E492K	VARIANT	E -> K (in CIPA; dbSNP:rs144901788)	ECO:0000269|PubMed:22302274	22302274
P04629	NTRK1	G517E	P04629/G517E	NTRK1/G517E	VARIANT	G -> E (in CIPA; following transfection in neuroblastoma cells and NGF treatment, small decrease in the percentage of cells differentiated into neuronal phenotype, but in differentiated cells, the average neurite length is comparable to wild-type; no effect on N-glycosylation, subcellular location, nor on basal and NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux; dbSNP:rs606231467)	ECO:0000269|PubMed:27676246	27676246
P04629	NTRK1	G522E	P04629/G522E	NTRK1/G522E	VARIANT	G -> E (in CIPA; no effect on N-glycosylation, nor on subcellular location; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux)	ECO:0000269|PubMed:27676246	27676246
P04629	NTRK1	G522R	P04629/G522R	NTRK1/G522R	VARIANT	G -> R (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs1571699266)	ECO:0000269|PubMed:10982191, ECO:0000269|PubMed:11159935	10982191,11159935
P04629	NTRK1	M566T	P04629/M566T	NTRK1/M566T	VARIANT	M -> T (in dbSNP:rs55892037)	ECO:0000269|PubMed:17344846	17344846
P04629	NTRK1	I572S	P04629/I572S	NTRK1/I572S	VARIANT	I -> S (in CIPA)	ECO:0000269|PubMed:18077166	18077166
P04629	NTRK1	G577R	P04629/G577R	NTRK1/G577R	VARIANT	G -> R (in CIPA; loss of function; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs121964866)	ECO:0000269|PubMed:10567924, ECO:0000269|PubMed:10982191, ECO:0000269|PubMed:11159935, ECO:0000269|PubMed:8696348	10567924,10982191,11159935,8696348
P04629	NTRK1	M587V	P04629/M587V	NTRK1/M587V	VARIANT	M -> V (in CIPA; dbSNP:rs121964870)	ECO:0000269|PubMed:10233776	10233776
P04629	NTRK1	D596N	P04629/D596N	NTRK1/D596N	VARIANT	D -> N (in CIPA; abolishes autophosphorylation)	ECO:0000269|PubMed:28177573	28177573
P04629	NTRK1	H604Y	P04629/H604Y	NTRK1/H604Y	VARIANT	H -> Y (in dbSNP:rs6336)	ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:10391209, ECO:0000269|PubMed:10443680, ECO:0000269|PubMed:11159935, ECO:0000269|PubMed:11310631, ECO:0000269|PubMed:17344846	10330344,10391209,10443680,11159935,11310631,17344846
P04629	NTRK1	G613V	P04629/G613V	NTRK1/G613V	VARIANT	G -> V (in dbSNP:rs6339)	ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:10391209, ECO:0000269|PubMed:10443680, ECO:0000269|PubMed:10861667, ECO:0000269|PubMed:11159935, ECO:0000269|PubMed:11310631, ECO:0000269|PubMed:17344846	10330344,10391209,10443680,10861667,11159935,11310631,17344846
P04629	NTRK1	R649Q	P04629/R649Q	NTRK1/R649Q	VARIANT	R -> Q (in CIPA; dbSNP:rs786205449)	ECO:0000269|PubMed:28328124	28328124
P04629	NTRK1	R649W	P04629/R649W	NTRK1/R649W	VARIANT	R -> W (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs369353892)	ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:11159935	10330344,11159935
P04629	NTRK1	R654C	P04629/R654C	NTRK1/R654C	VARIANT	R -> C (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs764992664)	ECO:0000269|PubMed:10982191, ECO:0000269|PubMed:11159935, ECO:0000269|PubMed:22302274	10982191,11159935,22302274
P04629	NTRK1	L657P	P04629/L657P	NTRK1/L657P	VARIANT	L -> P (in CIPA; following transfection in neuroblastoma cells and NGF treatment, loss of differentiation into neuronal phenotype; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux)	ECO:0000269|PubMed:27676246	27676246
P04629	NTRK1	D674Y	P04629/D674Y	NTRK1/D674Y	VARIANT	D -> Y (in CIPA; might impair the function of the enzyme without compromising autophosphorylation; dbSNP:rs80356677)	ECO:0000269|PubMed:10982191, ECO:0000269|PubMed:11159935, ECO:0000269|PubMed:28177573	10982191,11159935,28177573
P04629	NTRK1	P695L	P04629/P695L	NTRK1/P695L	VARIANT	P -> L (in CIPA; dbSNP:rs121964868)	ECO:0000269|PubMed:10861667	10861667
P04629	NTRK1	I699T	P04629/I699T	NTRK1/I699T	VARIANT	I -> T (in CIPA; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux)	ECO:0000269|PubMed:27676246	27676246
P04629	NTRK1	L700P	P04629/L700P	NTRK1/L700P	VARIANT	L -> P (in CIPA)	ECO:0000269|PubMed:28328124	28328124
P04629	NTRK1	G714S	P04629/G714S	NTRK1/G714S	VARIANT	G -> S (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs770727871)	ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:11159935	10330344,11159935
P04629	NTRK1	L717R	P04629/L717R	NTRK1/L717R	VARIANT	L -> R (in CIPA)	ECO:0000269|PubMed:18077166	18077166
P04629	NTRK1	C752S	P04629/C752S	NTRK1/C752S	VARIANT	C -> S (in CIPA; unknown pathological significance; following transfection in neuroblastoma cells and NGF treatment, no effect on neurite outgrowth, nor neurite length; no effect on N-glycosylation, subcellular location, basal and NGF-induced autophosphorylation, nor on NGF-stimulated calcium flux)	ECO:0000269|PubMed:27676246	27676246
P04629	NTRK1	C763S	P04629/C763S	NTRK1/C763S	VARIANT	C -> S (in CIPA; following transfection in neuroblastoma cells and NGF treatment, decreased percentage of cells differentiated into neuronal phenotype and reduced neurite length compared with wild-type; slightly decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal and NGF-induced autophosphorylation; small reduction in NGF-stimulated calcium flux)	ECO:0000269|PubMed:27676246	27676246
P04629	NTRK1	R771C	P04629/R771C	NTRK1/R771C	VARIANT	R -> C (in CIPA; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux; dbSNP:rs1324983370)	ECO:0000269|PubMed:27676246	27676246
P04629	NTRK1	R780P	P04629/R780P	NTRK1/R780P	VARIANT	R -> P (in CIPA; loss of function; dbSNP:rs35669708)	ECO:0000269|PubMed:10090906	10090906
P04629	NTRK1	R780Q	P04629/R780Q	NTRK1/R780Q	VARIANT	R -> Q (in dbSNP:rs35669708)	ECO:0000269|PubMed:10443680, ECO:0000269|PubMed:17344846	10443680,17344846
P04629	NTRK1	V790I	P04629/V790I	NTRK1/V790I	VARIANT	V -> I (in dbSNP:rs55948542)	ECO:0000269|PubMed:17344846	17344846
P04629	NTRK1	Y496F	P04629/Y496F	NTRK1/Y496F	MUTAGEN	Y->F: Loss of interaction with SHC1 and altered phosphorylation of SHC1. Altered neurite outgrowth and altered activation of the MAPK pathway; when associated with F-791.	ECO:0000269|PubMed:8155326	8155326
P04629	NTRK1	K544A	P04629/K544A	NTRK1/K544A	MUTAGEN	K->A: No effect on interaction with GGA3.	ECO:0000269|PubMed:26446845	26446845
P04629	NTRK1	K544N	P04629/K544N	NTRK1/K544N	MUTAGEN	K->N: Loss of kinase activity.	ECO:0000269|PubMed:1281417, ECO:0000269|PubMed:8155326	1281417,8155326
P04629	NTRK1	Y791F	P04629/Y791F	NTRK1/Y791F	MUTAGEN	Y->F: Loss of interaction with PLCG1 and altered phosphorylation of PLCG1. Altered neurite outgrowth and altered activation of the MAPK pathway; when associated with F-496.	ECO:0000269|PubMed:7510697, ECO:0000269|PubMed:8155326	7510697,8155326

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P05129	PRKCG	G63R	P05129/G63R	PRKCG/G63R	VARIANT	G -> R (in SCA14)	ECO:0000269|PubMed:29053796	29053796
P05129	PRKCG	G63V	P05129/G63V	PRKCG/G63V	VARIANT	G -> V (in SCA14; dbSNP:rs386134159)	ECO:0000269|PubMed:29053796	29053796
P05129	PRKCG	H101Y	P05129/H101Y	PRKCG/H101Y	VARIANT	H -> Y (in SCA14; dbSNP:rs121918511)	ECO:0000269|PubMed:12644968	12644968
P05129	PRKCG	S119P	P05129/S119P	PRKCG/S119P	VARIANT	S -> P (in SCA14; dbSNP:rs121918512)	ECO:0000269|PubMed:12644968	12644968
P05129	PRKCG	G128D	P05129/G128D	PRKCG/G128D	VARIANT	G -> D (in SCA14; dbSNP:rs121918513)	ECO:0000269|PubMed:12644968	12644968
P05129	PRKCG	R141C	P05129/R141C	PRKCG/R141C	VARIANT	R -> C	ECO:0000269|PubMed:9545390	9545390
P05129	PRKCG	H415Q	P05129/H415Q	PRKCG/H415Q	VARIANT	H -> Q	ECO:0000269|PubMed:9545390	9545390
P05129	PRKCG	A523D	P05129/A523D	PRKCG/A523D	VARIANT	A -> D	ECO:0000269|PubMed:9545390	9545390
P05129	PRKCG	R659S	P05129/R659S	PRKCG/R659S	VARIANT	R -> S (in dbSNP:rs752933837)	ECO:0000269|PubMed:9545390	9545390

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P05771	PRKCB	V144M	P05771/V144M	PRKCB/V144M	VARIANT	V -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs764534677)	ECO:0000269|PubMed:17344846	17344846
P05771	PRKCB	V496M	P05771/V496M	PRKCB/V496M	VARIANT	V -> M (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs1466858740)	ECO:0000269|PubMed:17344846	17344846
P05771	PRKCB	P588H	P05771/P588H	PRKCB/P588H	VARIANT	P -> H (in dbSNP:rs35631544)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

Error: P06213 INSR 'NoneType' object has no attribute 'group' FT                   /note="Missing (in LEPRCH; abolishes insulin binding)"

Error: P06213 INSR 'NoneType' object has no attribute 'group' FT                   /note="Missing (in LEPRCH)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P06213	INSR	A2G	P06213/A2G	INSR/A2G	VARIANT	A -> G (in dbSNP:rs7508518)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2210055, ECO:0000269|PubMed:2280779, ECO:0000269|PubMed:2777789, ECO:0000269|PubMed:2806055, ECO:0000269|PubMed:2859121, ECO:0000269|PubMed:2983222, ECO:0000269|PubMed:3680248	15489334,2210055,2280779,2777789,2806055,2859121,2983222,3680248
P06213	INSR	N42K	P06213/N42K	INSR/N42K	VARIANT	N -> K (in RMS; impairs transport to the plasma membrane and reduces the affinity to bind insulin; dbSNP:rs121913143)	ECO:0000269|PubMed:2121734, ECO:0000269|PubMed:2365819	2121734,2365819
P06213	INSR	V55A	P06213/V55A	INSR/V55A	VARIANT	V -> A (in LEPRCH; Verona-1; dbSNP:rs121913152)	ECO:0000269|PubMed:1607067	1607067
P06213	INSR	I56T	P06213/I56T	INSR/I56T	VARIANT	I -> T (in LEPRCH; abolishes post-translational processing; dbSNP:rs1555689937)	ECO:0000269|PubMed:24498630	24498630
P06213	INSR	G58R	P06213/G58R	INSR/G58R	VARIANT	G -> R (in LEPRCH; Helmond; inhibits processing and transport; dbSNP:rs52836744)	ECO:0000269|PubMed:1730625	1730625
P06213	INSR	D86G	P06213/D86G	INSR/D86G	VARIANT	D -> G (in IRAN type A)	ECO:0000269|PubMed:9175790	9175790
P06213	INSR	L89P	P06213/L89P	INSR/L89P	VARIANT	L -> P (in IRAN type A)	ECO:0000269|PubMed:9175790	9175790
P06213	INSR	R113P	P06213/R113P	INSR/R113P	VARIANT	R -> P (in LEPRCH; Atlanta-1; abolishes insulin binding; dbSNP:rs121913153)	ECO:0000269|PubMed:12023989, ECO:0000269|PubMed:8419945	12023989,8419945
P06213	INSR	A119V	P06213/A119V	INSR/A119V	VARIANT	A -> V (in LEPRCH; markedly impairs insulin binding; dbSNP:rs1347473020)	ECO:0000269|PubMed:12023989	12023989
P06213	INSR	L120Q	P06213/L120Q	INSR/L120Q	VARIANT	L -> Q (in LEPRCH; inhibits receptor processing)	ECO:0000269|PubMed:12970295	12970295
P06213	INSR	I146M	P06213/I146M	INSR/I146M	VARIANT	I -> M (in LEPRCH; mild; dbSNP:rs121913159)	ECO:0000269|PubMed:7815442, ECO:0000269|PubMed:8326490	7815442,8326490
P06213	INSR	V167L	P06213/V167L	INSR/V167L	VARIANT	V -> L (in IRAN type A; dbSNP:rs938519025)	ECO:0000269|PubMed:10733238	10733238
P06213	INSR	Y171H	P06213/Y171H	INSR/Y171H	VARIANT	Y -> H (in dbSNP:rs1051692)	ECO:0000269|PubMed:2859121	2859121
P06213	INSR	P220L	P06213/P220L	INSR/P220L	VARIANT	P -> L (in Ins resistance; severe; dbSNP:rs749094324)	ECO:0000269|PubMed:8242067	8242067
P06213	INSR	C228R	P06213/C228R	INSR/C228R	VARIANT	C -> R (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P06213	INSR	H236R	P06213/H236R	INSR/H236R	VARIANT	H -> R (in RMS and LEPRCH; Winnipeg; may impair receptor processing; dbSNP:rs121913145)	ECO:0000269|PubMed:17201797, ECO:0000269|PubMed:2365819	17201797,2365819
P06213	INSR	R256C	P06213/R256C	INSR/R256C	VARIANT	R -> C (in RMS; dbSNP:rs781007453)	ECO:0000269|PubMed:28765322	28765322
P06213	INSR	L260P	P06213/L260P	INSR/L260P	VARIANT	L -> P (in LEPRCH; Geldeimalsen; dbSNP:rs121913141)	ECO:0000269|PubMed:2479553	2479553
P06213	INSR	R279C	P06213/R279C	INSR/R279C	VARIANT	R -> C (in IRAN type A; inhibits receptor internalization; dbSNP:rs1568470274)	ECO:0000269|PubMed:12107746	12107746
P06213	INSR	R279H	P06213/R279H	INSR/R279H	VARIANT	R -> H (in IRAN type A; interferes with receptor processing; dbSNP:rs1329693158)	ECO:0000269|PubMed:12970295	12970295
P06213	INSR	C280Y	P06213/C280Y	INSR/C280Y	VARIANT	C -> Y (in IRAN type A)	ECO:0000269|PubMed:11260230	11260230
P06213	INSR	C286Y	P06213/C286Y	INSR/C286Y	VARIANT	C -> Y (in LEPRCH; abolishes post-translational processing)	ECO:0000269|PubMed:24498630	24498630
P06213	INSR	C301Y	P06213/C301Y	INSR/C301Y	VARIANT	C -> Y (in LEPRCH)	ECO:0000269|PubMed:9703342	9703342
P06213	INSR	S350L	P06213/S350L	INSR/S350L	VARIANT	S -> L (in RMS and LEPRCH)	ECO:0000269|PubMed:12970295, ECO:0000269|PubMed:8314008	12970295,8314008
P06213	INSR	G386S	P06213/G386S	INSR/G386S	VARIANT	G -> S (in RMS; may impair receptor processing; dbSNP:rs764221583)	ECO:0000269|PubMed:17201797	17201797
P06213	INSR	G393R	P06213/G393R	INSR/G393R	VARIANT	G -> R (in LEPRCH; Verona-1; dbSNP:rs267607184)	ECO:0000269|PubMed:1607067	1607067
P06213	INSR	F409V	P06213/F409V	INSR/F409V	VARIANT	F -> V (in IRAN type A; dbSNP:rs121913142)	ECO:0000269|PubMed:8388389	8388389
P06213	INSR	W439S	P06213/W439S	INSR/W439S	VARIANT	W -> S (in LEPRCH; impairs transport of the receptor to the cell surface; dbSNP:rs121913158)	ECO:0000269|PubMed:8188715	8188715
P06213	INSR	I448T	P06213/I448T	INSR/I448T	VARIANT	I -> T (in dbSNP:rs1051691)	ECO:0000269|PubMed:2859121	2859121
P06213	INSR	N458D	P06213/N458D	INSR/N458D	VARIANT	N -> D (in LEPRCH; partially inhibits receptor processing and autophosphorylation; strongly impairs ERK phosphorylation; induces wild-type levels of IRS-1 phosphorylation; dbSNP:rs121913160)	ECO:0000269|PubMed:12970295	12970295
P06213	INSR	K487E	P06213/K487E	INSR/K487E	VARIANT	K -> E (in LEPRCH; ARK-1; dbSNP:rs121913136)	ECO:0000269|PubMed:2834824	2834824
P06213	INSR	N489D	P06213/N489D	INSR/N489D	VARIANT	N -> D (in IRAN type A; unknown pathological significance; dbSNP:rs1135401742)	ECO:0000269|PubMed:28765322	28765322
P06213	INSR	N489S	P06213/N489S	INSR/N489S	VARIANT	N -> S (in IRAN type A; dbSNP:rs121913147)	ECO:0000269|PubMed:2365819	2365819
P06213	INSR	Q492K	P06213/Q492K	INSR/Q492K	VARIANT	Q -> K	ECO:0000269|PubMed:2859121	2859121
P06213	INSR	S635L	P06213/S635L	INSR/S635L	VARIANT	S -> L (in RMS; decreases post-translational processing)	ECO:0000269|PubMed:28765322	28765322
P06213	INSR	V657F	P06213/V657F	INSR/V657F	VARIANT	V -> F (in LEPRCH; impairs post-translational processing; dbSNP:rs1135401737)	ECO:0000269|PubMed:28765322	28765322
P06213	INSR	W659R	P06213/W659R	INSR/W659R	VARIANT	W -> R (in LEPRCH; impairs post-translational processing)	ECO:0000269|PubMed:28765322	28765322
P06213	INSR	Q695R	P06213/Q695R	INSR/Q695R	VARIANT	Q -> R (in dbSNP:rs55906835)	ECO:0000269|PubMed:17344846	17344846
P06213	INSR	R762S	P06213/R762S	INSR/R762S	VARIANT	R -> S (in IRAN type A; dbSNP:rs121913138)	ECO:0000269|PubMed:3283938	3283938
P06213	INSR	G811S	P06213/G811S	INSR/G811S	VARIANT	G -> S (in dbSNP:rs35045353)	ECO:0000269|PubMed:17344846	17344846
P06213	INSR	Y818C	P06213/Y818C	INSR/Y818C	VARIANT	Y -> C (in LEPRCH; abolishes post-translational processing)	ECO:0000269|PubMed:22768670, ECO:0000269|PubMed:28765322	22768670,28765322
P06213	INSR	P830L	P06213/P830L	INSR/P830L	VARIANT	P -> L (in dbSNP:rs2162771)		
P06213	INSR	S835I	P06213/S835I	INSR/S835I	VARIANT	S -> I (in RMS; impairs post-translational processing; dbSNP:rs1135401739)	ECO:0000269|PubMed:28765322	28765322
P06213	INSR	A842V	P06213/A842V	INSR/A842V	VARIANT	A -> V (in RMS; decreases post-translational processing; dbSNP:rs1135401738)	ECO:0000269|PubMed:28765322	28765322
P06213	INSR	T858A	P06213/T858A	INSR/T858A	VARIANT	T -> A (in T2D; dbSNP:rs182552223)	ECO:0000269|PubMed:7657032	7657032
P06213	INSR	P874L	P06213/P874L	INSR/P874L	VARIANT	P -> L (in RMS; impairs post-translational processing)	ECO:0000269|PubMed:28765322	28765322
P06213	INSR	N878S	P06213/N878S	INSR/N878S	VARIANT	N -> S (in RMS; impairs post-translational processing; dbSNP:rs887190835)	ECO:0000269|PubMed:28765322	28765322
P06213	INSR	I925T	P06213/I925T	INSR/I925T	VARIANT	I -> T (in LEPRCH; abolishes post-translational processing; abolishes insulin binding; dbSNP:rs1599881881)	ECO:0000269|PubMed:12023989, ECO:0000269|PubMed:28765322	12023989,28765322
P06213	INSR	R926W	P06213/R926W	INSR/R926W	VARIANT	R -> W (in LEPRCH; markedly impairs insulin binding;impairs post-translational processing; dbSNP:rs911929963)	ECO:0000269|PubMed:12023989, ECO:0000269|PubMed:28765322	12023989,28765322
P06213	INSR	T937M	P06213/T937M	INSR/T937M	VARIANT	T -> M (in LEPRCH; impaired receptor processing; impairs post-translational processing)	ECO:0000269|PubMed:28765322, ECO:0000269|PubMed:9299395	28765322,9299395
P06213	INSR	P997T	P06213/P997T	INSR/P997T	VARIANT	P -> T (in RMS; reduces insulin binding)	ECO:0000269|PubMed:12023989	12023989
P06213	INSR	V1012M	P06213/V1012M	INSR/V1012M	VARIANT	V -> M (in dbSNP:rs1799816)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8314008, ECO:0000269|PubMed:8432414, ECO:0000269|PubMed:8458533, ECO:0000269|PubMed:9199575	17344846,8314008,8432414,8458533,9199575
P06213	INSR	R1020Q	P06213/R1020Q	INSR/R1020Q	VARIANT	R -> Q (in IRAN type A; dbSNP:rs121913148)	ECO:0000269|PubMed:2002058	2002058
P06213	INSR	I1023F	P06213/I1023F	INSR/I1023F	VARIANT	I -> F	ECO:0000269|PubMed:8890729	8890729
P06213	INSR	G1035V	P06213/G1035V	INSR/G1035V	VARIANT	G -> V (in IRAN type A; dbSNP:rs121913135)	ECO:0000269|PubMed:2544998	2544998
P06213	INSR	V1054M	P06213/V1054M	INSR/V1054M	VARIANT	V -> M (in IRAN type A; unknown pathological significance; dbSNP:rs1135401741)	ECO:0000269|PubMed:28765322	28765322
P06213	INSR	A1055V	P06213/A1055V	INSR/A1055V	VARIANT	A -> V (in IRAN type A; dbSNP:rs1599874183)	ECO:0000269|PubMed:10733238	10733238
P06213	INSR	L1065V	P06213/L1065V	INSR/L1065V	VARIANT	L -> V (in dbSNP:rs56395521)	ECO:0000269|PubMed:17344846	17344846
P06213	INSR	A1075D	P06213/A1075D	INSR/A1075D	VARIANT	A -> D (in IRAN type A)	ECO:0000269|PubMed:8243830	8243830
P06213	INSR	K1095E	P06213/K1095E	INSR/K1095E	VARIANT	K -> E (in a subject with non-insulin dependent diabetes mellitus; dbSNP:rs909008899)	ECO:0000269|PubMed:2040394	2040394
P06213	INSR	R1119W	P06213/R1119W	INSR/R1119W	VARIANT	R -> W (in LEPRCH; dbSNP:rs1229730671)	ECO:0000269|PubMed:12970295, ECO:0000269|PubMed:9249867	12970295,9249867
P06213	INSR	I1143T	P06213/I1143T	INSR/I1143T	VARIANT	I -> T (in RMS; reduces insulin binding)	ECO:0000269|PubMed:10443650, ECO:0000269|PubMed:12023989	10443650,12023989
P06213	INSR	R1158Q	P06213/R1158Q	INSR/R1158Q	VARIANT	R -> Q (in T2D)	ECO:0000269|PubMed:1470163	1470163
P06213	INSR	R1158W	P06213/R1158W	INSR/R1158W	VARIANT	R -> W (in RMS; abolishes insulin binding; dbSNP:rs111993466)	ECO:0000269|PubMed:10443650, ECO:0000269|PubMed:12023989	10443650,12023989
P06213	INSR	A1161T	P06213/A1161T	INSR/A1161T	VARIANT	A -> T (in IRAN type A; dbSNP:rs121913139)	ECO:0000269|PubMed:2168397	2168397
P06213	INSR	A1162E	P06213/A1162E	INSR/A1162E	VARIANT	A -> E (in IRAN type A; impairs proteolytic processing; dbSNP:rs121913154)	ECO:0000269|PubMed:8096518	8096518
P06213	INSR	M1180I	P06213/M1180I	INSR/M1180I	VARIANT	M -> I (in a patient with insulin resistance; dbSNP:rs121913157)	ECO:0000269|PubMed:1890161	1890161
P06213	INSR	R1191Q	P06213/R1191Q	INSR/R1191Q	VARIANT	R -> Q (in T2D; dbSNP:rs121913150)	ECO:0000269|PubMed:1607076	1607076
P06213	INSR	R1201Q	P06213/R1201Q	INSR/R1201Q	VARIANT	R -> Q (in HHF5 and IRAN type A; interferes with kinase activation by insulin; dbSNP:rs121913156)	ECO:0000269|PubMed:15161766, ECO:0000269|PubMed:8082780, ECO:0000269|PubMed:8288049	15161766,8082780,8288049
P06213	INSR	R1201W	P06213/R1201W	INSR/R1201W	VARIANT	R -> W (in LEPRCH and RMS; reduces insulin binding possibly due to reduced receptor levels on the cell surface; dbSNP:rs1568426700)	ECO:0000269|PubMed:12023989, ECO:0000269|PubMed:9703342	12023989,9703342
P06213	INSR	P1205L	P06213/P1205L	INSR/P1205L	VARIANT	P -> L (in IRAN type A; moderate; dbSNP:rs1295645322)	ECO:0000269|PubMed:1563582, ECO:0000269|PubMed:8314008	1563582,8314008
P06213	INSR	E1206D	P06213/E1206D	INSR/E1206D	VARIANT	E -> D (in IRAN type A; accelerates degradation of the protein and impairs kinase activity)	ECO:0000269|PubMed:7983039	7983039
P06213	INSR	E1206K	P06213/E1206K	INSR/E1206K	VARIANT	E -> K (in LEPRCH)	ECO:0000269|PubMed:9249867	9249867
P06213	INSR	W1220L	P06213/W1220L	INSR/W1220L	VARIANT	W -> L (in IRAN type A; accelerates degradation of the protein and impairs kinase activity; dbSNP:rs52800171)	ECO:0000269|PubMed:7983039, ECO:0000269|PubMed:8390949	7983039,8390949
P06213	INSR	W1227S	P06213/W1227S	INSR/W1227S	VARIANT	W -> S (in IRAN type A; dbSNP:rs121913140)	ECO:0000269|PubMed:1963473	1963473
P06213	INSR	T1282A	P06213/T1282A	INSR/T1282A	VARIANT	T -> A (in dbSNP:rs55875349)	ECO:0000269|PubMed:17344846	17344846
P06213	INSR	Y1361C	P06213/Y1361C	INSR/Y1361C	VARIANT	Y -> C (in dbSNP:rs13306449)	ECO:0000269|PubMed:7657032	7657032
P06213	INSR	R1378Q	P06213/R1378Q	INSR/R1378Q	VARIANT	R -> Q (in IRAN type A; dbSNP:rs52826008)	ECO:0000269|PubMed:8314008	8314008
P06213	INSR	L991A	P06213/L991A	INSR/L991A	MUTAGEN	L->A: Reduces interaction with IRS1 but has no effect on interaction with SHC1.	ECO:0000269|PubMed:7559478	7559478
P06213	INSR	Y992A	P06213/Y992A	INSR/Y992A	MUTAGEN	Y->A: Reduces interaction with IRS1 but has no effect on interaction with SHC1.	ECO:0000269|PubMed:7559478	7559478
P06213	INSR	N996A	P06213/N996A	INSR/N996A	MUTAGEN	N->A: Abolishes interaction with IRS1 and significantly reduces interaction with SHC1. Has no effect on interaction with PIK3R1.	ECO:0000269|PubMed:7537849, ECO:0000269|PubMed:7559478	7537849,7559478
P06213	INSR	P997A	P06213/P997A	INSR/P997A	MUTAGEN	P->A: Abolishes interaction with IRS1 and significantly reduces interaction with SHC1. Has no effect on interaction with PIK3R1.	ECO:0000269|PubMed:7537849, ECO:0000269|PubMed:7559478	7537849,7559478
P06213	INSR	E998A	P06213/E998A	INSR/E998A	MUTAGEN	E->A: Does not affect interaction with IRS1, SHC1 or PIK3R1.	ECO:0000269|PubMed:7537849	7537849
P06213	INSR	Y999E	P06213/Y999E	INSR/Y999E	MUTAGEN	Y->E: Abolishes interaction with IRS1 and SHC1.	ECO:0000269|PubMed:2842060, ECO:0000269|PubMed:7537849, ECO:0000269|PubMed:7559478, ECO:0000269|PubMed:9428692	2842060,7537849,7559478,9428692
P06213	INSR	Y999F	P06213/Y999F	INSR/Y999F	MUTAGEN	Y->F: Has no effect on insulin-stimulated autophosphorylation, but inhibits the biological activity of the receptor. Abolishes interaction with IRS1 and almost completely prevents interaction with SHC1. Has no effect on interaction with PIK3R1. Abolishes interaction with STAT5B.	ECO:0000269|PubMed:2842060, ECO:0000269|PubMed:7537849, ECO:0000269|PubMed:7559478, ECO:0000269|PubMed:9428692	2842060,7537849,7559478,9428692
P06213	INSR	L1000A	P06213/L1000A	INSR/L1000A	MUTAGEN			
P06213	INSR	L1000R	P06213/L1000R	INSR/L1000R	MUTAGEN	L->A,R: Severely reduces interaction with SHC1. Has no effect on interaction with IRS1.	ECO:0000269|PubMed:7559478	7559478
P06213	INSR	A1002D	P06213/A1002D	INSR/A1002D	MUTAGEN	A->D: Reduces interaction with IRS1 but has no effect on interaction with SHC1.	ECO:0000269|PubMed:7559478	7559478
P06213	INSR	Y1011A	P06213/Y1011A	INSR/Y1011A	MUTAGEN	Y->A: Increases kinase activity.	ECO:0000269|PubMed:12707268	12707268
P06213	INSR	K1057A	P06213/K1057A	INSR/K1057A	MUTAGEN	K->A: Abolishes the kinase activity and abolishes interaction with IRS1, SHC1, GRB7 and PIK3R1.	ECO:0000269|PubMed:10803466, ECO:0000269|PubMed:3101064, ECO:0000269|PubMed:7537849	10803466,3101064,7537849
P06213	INSR	K1057M	P06213/K1057M	INSR/K1057M	MUTAGEN	K->M,R: Abolishes the kinase activity.		
P06213	INSR	K1057R	P06213/K1057R	INSR/K1057R	MUTAGEN	K->M,R: Abolishes the kinase activity.	ECO:0000269|PubMed:10803466, ECO:0000269|PubMed:3101064, ECO:0000269|PubMed:7537849	10803466,3101064,7537849
P06213	INSR	D1159N	P06213/D1159N	INSR/D1159N	MUTAGEN	D->N: Loss of kinase activity.	ECO:0000269|PubMed:11598120	11598120
P06213	INSR	R1163Q	P06213/R1163Q	INSR/R1163Q	MUTAGEN	R->Q: Loss of kinase activity.	ECO:0000269|PubMed:11598120	11598120
P06213	INSR	Y1189F	P06213/Y1189F	INSR/Y1189F	MUTAGEN	Y->F: Reduced interaction with GRB7.	ECO:0000269|PubMed:10803466	10803466
P06213	INSR	Y1190F	P06213/Y1190F	INSR/Y1190F	MUTAGEN	Y->F: Strongly reduced interaction with GRB7.	ECO:0000269|PubMed:10803466	10803466

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P06239	LCK	V28L	P06239/V28L	LCK/V28L	VARIANT	V -> L (found in leukemia)	ECO:0000269|PubMed:8139546	8139546
P06239	LCK	G201S	P06239/G201S	LCK/G201S	VARIANT	G -> S (in dbSNP:rs11567841)		
P06239	LCK	P232PQKP	P06239/P232PQKP	LCK/P232PQKP	VARIANT	P -> PQKP (in leukemia)		
P06239	LCK	L341P	P06239/L341P	LCK/L341P	VARIANT	L -> P (in IMD22; dbSNP:rs587777335)	ECO:0000269|PubMed:22985903	22985903
P06239	LCK	A353V	P06239/A353V	LCK/A353V	VARIANT	A -> V (found in leukemia)	ECO:0000269|PubMed:8139546	8139546
P06239	LCK	P447L	P06239/P447L	LCK/P447L	VARIANT	P -> L (found in leukemia)	ECO:0000269|PubMed:8139546	8139546
P06239	LCK	S59E	P06239/S59E	LCK/S59E	MUTAGEN	S->E: Allows interaction with SQSTM1.	ECO:0000269|PubMed:8618896	8618896
P06239	LCK	R154K	P06239/R154K	LCK/R154K	MUTAGEN	R->K: No effect on interaction with SQSTM1.	ECO:0000269|PubMed:8618896	8618896

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P06241	FYN	V243L	P06241/V243L	FYN/V243L	VARIANT	V -> L (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P06241	FYN	G410R	P06241/G410R	FYN/G410R	VARIANT	G -> R (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P06241	FYN	I445F	P06241/I445F	FYN/I445F	VARIANT	I -> F (in dbSNP:rs1801121)		
P06241	FYN	D506E	P06241/D506E	FYN/D506E	VARIANT	D -> E (in dbSNP:rs28763975)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P06493	CDK1	Y4D	P06493/Y4D	CDK1/Y4D	MUTAGEN	Y->D,E: Constitutive polyubiquitination.		
P06493	CDK1	Y4E	P06493/Y4E	CDK1/Y4E	MUTAGEN	Y->D,E: Constitutive polyubiquitination.	ECO:0000269|PubMed:20395957	20395957

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P07332	FES	R85C	P07332/R85C	FES/R85C	VARIANT	R -> C (in dbSNP:rs56041861)	ECO:0000269|PubMed:17344846	17344846
P07332	FES	R246Q	P07332/R246Q	FES/R246Q	VARIANT	R -> Q (in dbSNP:rs34573430)	ECO:0000269|PubMed:17344846	17344846
P07332	FES	M323V	P07332/M323V	FES/M323V	VARIANT	M -> V (in dbSNP:rs56296062)	ECO:0000269|PubMed:17344846	17344846
P07332	FES	L145P	P07332/L145P	FES/L145P	MUTAGEN	L->P: Constitutively activated kinase that can act as oncogene. Promotes myeloid cell survival and proliferation.	ECO:0000269|PubMed:11509660, ECO:0000269|PubMed:15485904	11509660,15485904
P07332	FES	L334P	P07332/L334P	FES/L334P	MUTAGEN	L->P: Abolishes autophosphorylation.	ECO:0000269|PubMed:11509660	11509660
P07332	FES	G463V	P07332/G463V	FES/G463V	MUTAGEN	G->V: Abolishes kinase activity.	ECO:0000269|PubMed:18775312	18775312
P07332	FES	R483M	P07332/R483M	FES/R483M	MUTAGEN	R->M: Abolishes pTyr binding. Abolishes association with microtubules. Abolishes autophosphorylation. Reduced kinase activity.	ECO:0000269|PubMed:15485904, ECO:0000269|PubMed:18775312	15485904,18775312
P07332	FES	K590E	P07332/K590E	FES/K590E	MUTAGEN	K->E: Abolishes kinase activity. Fails to inhibit proliferation of melanoma cells.	ECO:0000269|PubMed:15485904, ECO:0000269|PubMed:28463229	15485904,28463229
P07332	FES	M704V	P07332/M704V	FES/M704V	MUTAGEN	M->V: Reduced autophosphorylation and strongly reduced kinase activity.	ECO:0000269|PubMed:15867340, ECO:0000269|PubMed:16455651	15867340,16455651
P07332	FES	R706Q	P07332/R706Q	FES/R706Q	MUTAGEN	R->Q: Negligible effect on autophosphorylation and kinase activity.	ECO:0000269|PubMed:15867340, ECO:0000269|PubMed:16455651	15867340,16455651
P07332	FES	Y713F	P07332/Y713F	FES/Y713F	MUTAGEN	Y->F: Reduces kinase activity by over 90%.	ECO:0000269|PubMed:7687763	7687763
P07332	FES	V743M	P07332/V743M	FES/V743M	MUTAGEN	V->M: Strongly reduced autophosphorylation and kinase activity.	ECO:0000269|PubMed:15867340, ECO:0000269|PubMed:16455651	15867340,16455651
P07332	FES	S759F	P07332/S759F	FES/S759F	MUTAGEN	S->F: Reduced autophosphorylation and strongly reduced kinase activity.	ECO:0000269|PubMed:15867340, ECO:0000269|PubMed:16455651	15867340,16455651

Error: P07333 CSF1R 'NoneType' object has no attribute 'group' FT                   /note="Missing (in BANDDOS; impairs phosphorylation of JNK

Error: P07333 CSF1R 'NoneType' object has no attribute 'group' FT                   /note="Missing (in HDLS1)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P07333	CSF1R	V32G	P07333/V32G	CSF1R/V32G	VARIANT	V -> G (in dbSNP:rs56048668)	ECO:0000269|PubMed:17344846	17344846
P07333	CSF1R	P132L	P07333/P132L	CSF1R/P132L	VARIANT	P -> L (in BANDDOS; impairs phosphorylation of JNK kinases upon stimulation with CSF1; dbSNP:rs1351319114)	ECO:0000269|PubMed:30982609	30982609
P07333	CSF1R	A245S	P07333/A245S	CSF1R/A245S	VARIANT	A -> S (in dbSNP:rs41338945)		
P07333	CSF1R	V279M	P07333/V279M	CSF1R/V279M	VARIANT	V -> M (in dbSNP:rs3829986)		
P07333	CSF1R	H362R	P07333/H362R	CSF1R/H362R	VARIANT	H -> R (in dbSNP:rs10079250)	ECO:0000269|PubMed:17344846	17344846
P07333	CSF1R	G413S	P07333/G413S	CSF1R/G413S	VARIANT	G -> S (in dbSNP:rs34951517)	ECO:0000269|PubMed:17344846	17344846
P07333	CSF1R	L536V	P07333/L536V	CSF1R/L536V	VARIANT	L -> V (in dbSNP:rs55942044)	ECO:0000269|PubMed:17344846	17344846
P07333	CSF1R	G589E	P07333/G589E	CSF1R/G589E	VARIANT	G -> E (in HDLS1; dbSNP:rs281860268)	ECO:0000269|PubMed:22197934	22197934
P07333	CSF1R	E633K	P07333/E633K	CSF1R/E633K	VARIANT	E -> K (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860269)	ECO:0000269|PubMed:22197934	22197934
P07333	CSF1R	H643Q	P07333/H643Q	CSF1R/H643Q	VARIANT	H -> Q (in BANDDOS; dbSNP:rs184499252)	ECO:0000269|PubMed:30982608	30982608
P07333	CSF1R	C653R	P07333/C653R	CSF1R/C653R	VARIANT	C -> R (in HDLS1; dbSNP:rs690016559)	ECO:0000269|PubMed:24532199	24532199
P07333	CSF1R	P693H	P07333/P693H	CSF1R/P693H	VARIANT	P -> H (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P07333	CSF1R	R710H	P07333/R710H	CSF1R/R710H	VARIANT	R -> H (in dbSNP:rs201569135)	ECO:0000269|PubMed:22197934	22197934
P07333	CSF1R	G747R	P07333/G747R	CSF1R/G747R	VARIANT	G -> R (in dbSNP:rs41355444)	ECO:0000269|PubMed:22197934	22197934
P07333	CSF1R	G765D	P07333/G765D	CSF1R/G765D	VARIANT	G -> D (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs690016566)	ECO:0000269|PubMed:24336230	24336230
P07333	CSF1R	M766T	P07333/M766T	CSF1R/M766T	VARIANT	M -> T (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860270)	ECO:0000269|PubMed:22197934, ECO:0000269|PubMed:23408870	22197934,23408870
P07333	CSF1R	A770P	P07333/A770P	CSF1R/A770P	VARIANT	A -> P (in HDLS1; dbSNP:rs281860271)	ECO:0000269|PubMed:22197934	22197934
P07333	CSF1R	I775N	P07333/I775N	CSF1R/I775N	VARIANT	I -> N (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860273)	ECO:0000269|PubMed:22197934	22197934
P07333	CSF1R	A781E	P07333/A781E	CSF1R/A781E	VARIANT	A -> E (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs587777247)	ECO:0000269|PubMed:24336230	24336230
P07333	CSF1R	R782H	P07333/R782H	CSF1R/R782H	VARIANT	R -> H (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860281)	ECO:0000269|PubMed:23408870	23408870
P07333	CSF1R	I794T	P07333/I794T	CSF1R/I794T	VARIANT	I -> T (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860274)	ECO:0000269|PubMed:22197934, ECO:0000269|PubMed:24336230	22197934,24336230
P07333	CSF1R	P824S	P07333/P824S	CSF1R/P824S	VARIANT	P -> S (in HDLS1; impairs autophosphorylation upon stimulation with CSF1)	ECO:0000269|PubMed:24336230	24336230
P07333	CSF1R	D837Y	P07333/D837Y	CSF1R/D837Y	VARIANT	D -> Y (in HDLS1; dbSNP:rs387906662)	ECO:0000269|PubMed:22197934	22197934
P07333	CSF1R	I843F	P07333/I843F	CSF1R/I843F	VARIANT	I -> F (in HDLS1; dbSNP:rs690016558)	ECO:0000269|PubMed:24532199	24532199
P07333	CSF1R	F849S	P07333/F849S	CSF1R/F849S	VARIANT	F -> S (in HDLS1; dbSNP:rs281860277)	ECO:0000269|PubMed:22197934	22197934
P07333	CSF1R	L868P	P07333/L868P	CSF1R/L868P	VARIANT	L -> P (in HDLS1; dbSNP:rs281860278)	ECO:0000269|PubMed:22197934	22197934
P07333	CSF1R	M875T	P07333/M875T	CSF1R/M875T	VARIANT	M -> T (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860279)	ECO:0000269|PubMed:22197934, ECO:0000269|PubMed:23408870	22197934,23408870
P07333	CSF1R	P878T	P07333/P878T	CSF1R/P878T	VARIANT	P -> T (in HDLS1; dbSNP:rs281860280)	ECO:0000269|PubMed:22197934	22197934
P07333	CSF1R	I906T	P07333/I906T	CSF1R/I906T	VARIANT	I -> T (in HDLS1; dbSNP:rs690016560)	ECO:0000269|PubMed:24532199	24532199
P07333	CSF1R	E920D	P07333/E920D	CSF1R/E920D	VARIANT	E -> D (in dbSNP:rs34030164)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:22197934	17344846,22197934
P07333	CSF1R	R921Q	P07333/R921Q	CSF1R/R921Q	VARIANT	R -> Q (in dbSNP:rs56059682)	ECO:0000269|PubMed:17344846	17344846
P07333	CSF1R	Y969C	P07333/Y969C	CSF1R/Y969C	VARIANT	Y -> C (in dbSNP:rs1801271)		
P07333	CSF1R	L301S	P07333/L301S	CSF1R/L301S	MUTAGEN	L->S: Constitutive kinase activity.	ECO:0000269|PubMed:15117969	15117969
P07333	CSF1R	Y708F	P07333/Y708F	CSF1R/Y708F	MUTAGEN	Y->F: Impairs degradation of activated CSF1R.	ECO:0000269|PubMed:10340379	10340379
P07333	CSF1R	D802V	P07333/D802V	CSF1R/D802V	MUTAGEN	D->V: Constitutive kinase activity. Loss of inhibition by imatinib.	ECO:0000269|PubMed:10340379, ECO:0000269|PubMed:16170366	10340379,16170366
P07333	CSF1R	Y809F	P07333/Y809F	CSF1R/Y809F	MUTAGEN	Y->F: Reduced kinase activity. Reduced interaction with SRC, FYN and YES1.	ECO:0000269|PubMed:7681396	7681396
P07333	CSF1R	Y969F	P07333/Y969F	CSF1R/Y969F	MUTAGEN	Y->F: Abolishes down-regulation of activated CSF1R.	ECO:0000269|PubMed:15117969	15117969

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P07947	YES1	I198V	P07947/I198V	YES1/I198V	VARIANT	I -> V (in dbSNP:rs34580680)	ECO:0000269|PubMed:17344846	17344846
P07947	YES1	K282R	P07947/K282R	YES1/K282R	VARIANT	K -> R (in dbSNP:rs35126906)	ECO:0000269|PubMed:17344846	17344846
P07947	YES1	Y426F	P07947/Y426F	YES1/Y426F	MUTAGEN	Y->F: About 50% loss of CSK-mediated inhibition.	ECO:0000269|PubMed:9794236	9794236

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P07948	LYN	D385Y	P07948/D385Y	LYN/D385Y	VARIANT	D -> Y (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P07948	LYN	G2A	P07948/G2A	LYN/G2A	MUTAGEN	G->A: Loss of localization to the cell membrane; when associated with A-3.	ECO:0000269|PubMed:18817770	18817770
P07948	LYN	C3A	P07948/C3A	LYN/C3A	MUTAGEN	C->A: Loss of localization to the cell membrane; when associated with A-2.	ECO:0000269|PubMed:18817770	18817770
P07948	LYN	K275A	P07948/K275A	LYN/K275A	MUTAGEN	K->A: Loss of activity and no effect on localization to the cell membrane. Abundant localization in the nucleus; when associated with A-2 and A-3.	ECO:0000269|PubMed:11435302, ECO:0000269|PubMed:11517336, ECO:0000269|PubMed:15173188, ECO:0000269|PubMed:18817770	11435302,11517336,15173188,18817770
P07948	LYN	K275L	P07948/K275L	LYN/K275L	MUTAGEN	K->L,R: Loss of kinase activity.		
P07948	LYN	K275R	P07948/K275R	LYN/K275R	MUTAGEN	K->L,R: Loss of kinase activity.	ECO:0000269|PubMed:11435302, ECO:0000269|PubMed:11517336, ECO:0000269|PubMed:15173188, ECO:0000269|PubMed:18817770	11435302,11517336,15173188,18817770
P07948	LYN	D346A	P07948/D346A	LYN/D346A	MUTAGEN	D->A: Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-353; A-498 and A-499.	ECO:0000269|PubMed:15173188	15173188
P07948	LYN	E353A	P07948/E353A	LYN/E353A	MUTAGEN	E->A: Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-346; A-498 and A-499.	ECO:0000269|PubMed:15173188	15173188
P07948	LYN	Y397F	P07948/Y397F	LYN/Y397F	MUTAGEN	Y->F: Strongly reduced kinase activity.	ECO:0000269|PubMed:16920712	16920712
P07948	LYN	D498A	P07948/D498A	LYN/D498A	MUTAGEN	D->A: Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-346; A-353 and A-499.	ECO:0000269|PubMed:15173188	15173188
P07948	LYN	D499A	P07948/D499A	LYN/D499A	MUTAGEN	D->A: Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-346; A-353 and A-498.	ECO:0000269|PubMed:15173188	15173188
P07948	LYN	Y508F	P07948/Y508F	LYN/Y508F	MUTAGEN	Y->F: Abolishes autoinhibition and thereby increases kinase activity.	ECO:0000269|PubMed:16920712	16920712

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

Error: P07949 RET 'NoneType' object has no attribute 'group' FT                   /note="Missing (in HSCR1)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P07949	RET	P20L	P07949/P20L	RET/P20L	VARIANT	P -> L (in HSCR1; sporadic form)	ECO:0000269|PubMed:7633441	7633441
P07949	RET	S32L	P07949/S32L	RET/S32L	VARIANT	S -> L (in HSCR1; familial form; dbSNP:rs76764689)	ECO:0000269|PubMed:10618407, ECO:0000269|PubMed:8114939	10618407,8114939
P07949	RET	L40P	P07949/L40P	RET/L40P	VARIANT	L -> P (in HSCR1)	ECO:0000269|PubMed:7704557, ECO:0000269|PubMed:9043870	7704557,9043870
P07949	RET	P64L	P07949/P64L	RET/P64L	VARIANT	P -> L (in HSCR1; familial form; dbSNP:rs77596424)	ECO:0000269|PubMed:8114939	8114939
P07949	RET	R67H	P07949/R67H	RET/R67H	VARIANT	R -> H (in dbSNP:rs192489011)	ECO:0000269|PubMed:14566559	14566559
P07949	RET	R77C	P07949/R77C	RET/R77C	VARIANT	R -> C (in HSCR1)	ECO:0000269|PubMed:10618407	10618407
P07949	RET	G93S	P07949/G93S	RET/G93S	VARIANT	G -> S (in HSCR1; unknown pathological significance; dbSNP:rs1477699803)	ECO:0000269|PubMed:7633441	7633441
P07949	RET	R114C	P07949/R114C	RET/R114C	VARIANT	R -> C (in HSCR1; unknown pathological significance; dbSNP:rs747483905)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	R114H	P07949/R114H	RET/R114H	VARIANT	R -> H (in dbSNP:rs76397662)	ECO:0000269|PubMed:12086152, ECO:0000269|PubMed:14566559, ECO:0000269|PubMed:22174939	12086152,14566559,22174939
P07949	RET	C142S	P07949/C142S	RET/C142S	VARIANT	C -> S (in HSCR1; sporadic form)		
P07949	RET	V145G	P07949/V145G	RET/V145G	VARIANT	V -> G (in HSCR1; also in a colorectal cancer sample; somatic mutation; dbSNP:rs1588863999)	ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:22174939	16959974,22174939
P07949	RET	P155L	P07949/P155L	RET/P155L	VARIANT	P -> L (in HSCR1)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	C157Y	P07949/C157Y	RET/C157Y	VARIANT	C -> Y (in HSCR1; unknown pathological significance)	ECO:0000269|Ref.63	
P07949	RET	R163Q	P07949/R163Q	RET/R163Q	VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs149403911)	ECO:0000269|PubMed:17344846	17344846
P07949	RET	F174S	P07949/F174S	RET/F174S	VARIANT	F -> S (in HSCR1; sporadic form)	ECO:0000269|PubMed:9094028	9094028
P07949	RET	R175P	P07949/R175P	RET/R175P	VARIANT	R -> P (in HSCR1)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	R180P	P07949/R180P	RET/R180P	VARIANT	R -> P (in HSCR1; sporadic form)	ECO:0000269|PubMed:9090527	9090527
P07949	RET	C197Y	P07949/C197Y	RET/C197Y	VARIANT	C -> Y (in HSCR1; sporadic form)	ECO:0000269|PubMed:9094028	9094028
P07949	RET	P198T	P07949/P198T	RET/P198T	VARIANT	P -> T (in a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF; dbSNP:rs76736111)	ECO:0000269|PubMed:18252215	18252215
P07949	RET	R231H	P07949/R231H	RET/R231H	VARIANT	R -> H (in HSCR1; familial form; dbSNP:rs79661516)		
P07949	RET	E251K	P07949/E251K	RET/E251K	VARIANT	E -> K (in HSCR1; familial form; dbSNP:rs562449603)		
P07949	RET	T278A	P07949/T278A	RET/T278A	VARIANT	T -> A (in HSCR1; dbSNP:rs541929171)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	T278N	P07949/T278N	RET/T278N	VARIANT	T -> N (found in two patients with Hirschsprung disease; dbSNP:rs35118262)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:22174939	17344846,22174939
P07949	RET	T278P	P07949/T278P	RET/T278P	VARIANT	T -> P (in HSCR1)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	R287Q	P07949/R287Q	RET/R287Q	VARIANT	R -> Q (in HSCR1; sporadic form; dbSNP:rs1564491460)		
P07949	RET	V292M	P07949/V292M	RET/V292M	VARIANT	V -> M (found in patients with Hirschsprung disease; unknown pathological significance; dbSNP:rs34682185)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:22174939	17344846,22174939
P07949	RET	D300N	P07949/D300N	RET/D300N	VARIANT	D -> N (in HSCR1)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	R313Q	P07949/R313Q	RET/R313Q	VARIANT	R -> Q (in HSCR1; dbSNP:rs77702891)	ECO:0000269|PubMed:22174939, ECO:0000269|PubMed:9090527	22174939,9090527
P07949	RET	S316I	P07949/S316I	RET/S316I	VARIANT	S -> I (in HSCR1; dbSNP:rs1060499894)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	R330Q	P07949/R330Q	RET/R330Q	VARIANT	R -> Q (in HSCR1; dbSNP:rs80236571)	ECO:0000269|PubMed:7633441, ECO:0000269|PubMed:8114939	7633441,8114939
P07949	RET	S339L	P07949/S339L	RET/S339L	VARIANT	S -> L (in HSCR1; dbSNP:rs774829203)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	D353Y	P07949/D353Y	RET/D353Y	VARIANT	D -> Y (in HSCR1; dbSNP:rs1837785429)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	N359K	P07949/N359K	RET/N359K	VARIANT	N -> K (in HSCR1; unknown pathological significance)	ECO:0000269|Ref.63	
P07949	RET	R360Q	P07949/R360Q	RET/R360Q	VARIANT	R -> Q (in HSCR1; dbSNP:rs762472027)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	R360W	P07949/R360W	RET/R360W	VARIANT	R -> W (in HSCR1)	ECO:0000269|PubMed:10618407, ECO:0000269|PubMed:16959974	10618407,16959974
P07949	RET	V376A	P07949/V376A	RET/V376A	VARIANT	V -> A (in a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; expressed only the immature intracellular form)	ECO:0000269|PubMed:18252215	18252215
P07949	RET	F393L	P07949/F393L	RET/F393L	VARIANT	F -> L (in HSCR1; familial form; dbSNP:rs78098482)	ECO:0000269|PubMed:8114939	8114939
P07949	RET	N394H	P07949/N394H	RET/N394H	VARIANT	N -> H (in a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF)	ECO:0000269|PubMed:18252215	18252215
P07949	RET	N394K	P07949/N394K	RET/N394K	VARIANT	N -> K (in HSCR1)	ECO:0000269|PubMed:10618407	10618407
P07949	RET	V397M	P07949/V397M	RET/V397M	VARIANT	V -> M (in HSCR1; dbSNP:rs183729115)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	P399L	P07949/P399L	RET/P399L	VARIANT	P -> L (in HSCR1; sporadic form; dbSNP:rs1554818362)	ECO:0000269|PubMed:7704557	7704557
P07949	RET	V412M	P07949/V412M	RET/V412M	VARIANT	V -> M (in HSCR1; dbSNP:rs746970700)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	G423R	P07949/G423R	RET/G423R	VARIANT	G -> R (in HSCR1; dbSNP:rs767601598)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	A432E	P07949/A432E	RET/A432E	VARIANT	A -> E (found in a patient with congenital central hypoventilation syndrome; unknown pathological significance; dbSNP:rs552057730)	ECO:0000269|PubMed:14566559	14566559
P07949	RET	R475Q	P07949/R475Q	RET/R475Q	VARIANT	R -> Q (in HSCR1; sporadic form; dbSNP:rs138624658)		
P07949	RET	E480K	P07949/E480K	RET/E480K	VARIANT	E -> K (in HSCR1; dbSNP:rs537874538)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	D489N	P07949/D489N	RET/D489N	VARIANT	D -> N (in dbSNP:rs9282834)	ECO:0000269|PubMed:14566559, ECO:0000269|PubMed:17344846	14566559,17344846
P07949	RET	C531CEEC	P07949/C531CEEC	RET/C531CEEC	VARIANT	C -> CEEC (in MTC; familial form)	ECO:0000269|PubMed:10323403	10323403
P07949	RET	G593E	P07949/G593E	RET/G593E	VARIANT	G -> E (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
P07949	RET	E595Q	P07949/E595Q	RET/E595Q	VARIANT	E -> Q (in HSCR1; dbSNP:rs1483605155)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	R600Q	P07949/R600Q	RET/R600Q	VARIANT	R -> Q (in dbSNP:rs377767393)	ECO:0000269|PubMed:10612852	10612852
P07949	RET	C609G	P07949/C609G	RET/C609G	VARIANT	C -> G (in MEN2A; dbSNP:rs77558292)		
P07949	RET	C609R	P07949/C609R	RET/C609R	VARIANT	C -> R (in MEN2A; dbSNP:rs77558292)		
P07949	RET	C609W	P07949/C609W	RET/C609W	VARIANT	C -> W (in HSCR1; familial form; dbSNP:rs377767396)	ECO:0000269|PubMed:7881414	7881414
P07949	RET	C609Y	P07949/C609Y	RET/C609Y	VARIANT	C -> Y (in MTC, MEN2A and HSCR1; familial and sporadic forms; dbSNP:rs77939446)	ECO:0000269|PubMed:7633441, ECO:0000269|PubMed:7849720, ECO:0000269|PubMed:9384613, ECO:0000269|Ref.63	7633441,7849720,9384613
P07949	RET	C611G	P07949/C611G	RET/C611G	VARIANT	C -> G (in MTC; familial form; dbSNP:rs377767391)	ECO:0000269|PubMed:9677065	9677065
P07949	RET	C611R	P07949/C611R	RET/C611R	VARIANT	C -> R (in MEN2A; dbSNP:rs377767391)		
P07949	RET	C611S	P07949/C611S	RET/C611S	VARIANT	C -> S (in MEN2A; dbSNP:rs377767391)		
P07949	RET	C611W	P07949/C611W	RET/C611W	VARIANT	C -> W (in MEN2A and MTC; familial form; dbSNP:rs80069458)	ECO:0000269|PubMed:8103403	8103403
P07949	RET	C611Y	P07949/C611Y	RET/C611Y	VARIANT	C -> Y (in MEN2A; dbSNP:rs377767397)		
P07949	RET	C618F	P07949/C618F	RET/C618F	VARIANT	C -> F (in MEN2A and MTC; familial form; dbSNP:rs79781594)		
P07949	RET	C618G	P07949/C618G	RET/C618G	VARIANT	C -> G (in MEN2A; dbSNP:rs76262710)	ECO:0000269|PubMed:8099202	8099202
P07949	RET	C618R	P07949/C618R	RET/C618R	VARIANT	C -> R (in MEN2A, MTC and HSCR1; dbSNP:rs76262710)	ECO:0000269|PubMed:7849720, ECO:0000269|PubMed:7881414, ECO:0000269|PubMed:7915165, ECO:0000269|PubMed:9259198	7849720,7881414,7915165,9259198
P07949	RET	C618S	P07949/C618S	RET/C618S	VARIANT	C -> S (in MEN2A, HSCR1 and MTC; familial and sporadic forms; dbSNP:rs79781594)	ECO:0000269|PubMed:7849720, ECO:0000269|PubMed:7860065, ECO:0000269|PubMed:7915165, ECO:0000269|PubMed:8103403, ECO:0000269|PubMed:9384613	7849720,7860065,7915165,8103403,9384613
P07949	RET	C618Y	P07949/C618Y	RET/C618Y	VARIANT	C -> Y (in MEN2A and MTC; familial form; dbSNP:rs79781594)		
P07949	RET	C620F	P07949/C620F	RET/C620F	VARIANT	C -> F (in MEN2A and MTC; familial form; dbSNP:rs77503355)	ECO:0000269|PubMed:7915165	7915165
P07949	RET	C620G	P07949/C620G	RET/C620G	VARIANT	C -> G (in MEN2A and MTC; familial and sporadic forms; dbSNP:rs77316810)		
P07949	RET	C620R	P07949/C620R	RET/C620R	VARIANT	C -> R (in MEN2A, MTC and HSCR1; familial and sporadic forms; dbSNP:rs77316810)	ECO:0000269|PubMed:7633441, ECO:0000269|PubMed:7881414, ECO:0000269|PubMed:7915165, ECO:0000269|PubMed:8103403, ECO:0000269|PubMed:9090527, ECO:0000269|PubMed:9384613, ECO:0000269|Ref.63	7633441,7881414,7915165,8103403,9090527,9384613
P07949	RET	C620S	P07949/C620S	RET/C620S	VARIANT	C -> S (in MEN2A and MTC; familial form; dbSNP:rs77503355)	ECO:0000269|PubMed:7849720, ECO:0000269|PubMed:7860065	7849720,7860065
P07949	RET	C620W	P07949/C620W	RET/C620W	VARIANT	C -> W (in MEN2A and HSCR1; dbSNP:rs79890926)	ECO:0000269|PubMed:9384613	9384613
P07949	RET	C620Y	P07949/C620Y	RET/C620Y	VARIANT	C -> Y (in MEN2A; dbSNP:rs77503355)	ECO:0000269|PubMed:8103403	8103403
P07949	RET	Q626K	P07949/Q626K	RET/Q626K	VARIANT	Q -> K (in HSCR1; sporadic form; dbSNP:rs1255575160)	ECO:0000269|PubMed:10090908	10090908
P07949	RET	C630F	P07949/C630F	RET/C630F	VARIANT	C -> F (in MEN2A and MTC; familial form; dbSNP:rs377767405)		
P07949	RET	C630S	P07949/C630S	RET/C630S	VARIANT	C -> S (in MTC; sporadic form; dbSNP:rs377767405)		
P07949	RET	C630Y	P07949/C630Y	RET/C630Y	VARIANT	C -> Y (in MTC; familial and sporadic forms; dbSNP:rs377767405)		
P07949	RET	D631G	P07949/D631G	RET/D631G	VARIANT	D -> G (in thyroid carcinoma; somatic mutation; dbSNP:rs121913308)		
P07949	RET	C634CHELC	P07949/C634CHELC	RET/C634CHELC	VARIANT	C -> CHELC (in MEN2A)	ECO:0000269|PubMed:9097963	9097963
P07949	RET	C634F	P07949/C634F	RET/C634F	VARIANT	C -> F (in MEN2A and pheochromocytoma; dbSNP:rs75996173)	ECO:0000269|PubMed:12000816, ECO:0000269|PubMed:7915165, ECO:0000269|PubMed:8099202	12000816,7915165,8099202
P07949	RET	C634G	P07949/C634G	RET/C634G	VARIANT	C -> G (in MEN2A and pheochromocytoma; dbSNP:rs75076352)	ECO:0000269|PubMed:12000816, ECO:0000269|PubMed:7915165, ECO:0000269|PubMed:8099202	12000816,7915165,8099202
P07949	RET	C634R	P07949/C634R	RET/C634R	VARIANT	C -> R (in MEN2A, pheochromocytoma and MTC; familial form; also found as somatic mutation in a sporadic thyroid carcinoma; dbSNP:rs75076352)	ECO:0000269|PubMed:12000816, ECO:0000269|PubMed:7860065, ECO:0000269|PubMed:8103403	12000816,7860065,8103403
P07949	RET	C634S	P07949/C634S	RET/C634S	VARIANT	C -> S (in MEN2A, pheochromocytoma and MTC; familial form; dbSNP:rs75076352)	ECO:0000269|PubMed:12000816, ECO:0000269|PubMed:8099202	12000816,8099202
P07949	RET	C634W	P07949/C634W	RET/C634W	VARIANT	C -> W (in MEN2A, pheochromocytoma and MTC; familial form; dbSNP:rs77709286)	ECO:0000269|PubMed:12000816	12000816
P07949	RET	C634Y	P07949/C634Y	RET/C634Y	VARIANT	C -> Y (in MEN2A, pheochromocytoma and MTC; familial form; dbSNP:rs75996173)	ECO:0000269|PubMed:12000816, ECO:0000269|PubMed:7860065, ECO:0000269|PubMed:7915165, ECO:0000269|PubMed:8099202	12000816,7860065,7915165,8099202
P07949	RET	T636TCRT	P07949/T636TCRT	RET/T636TCRT	VARIANT	T -> TCRT (in MEN2A)	ECO:0000269|PubMed:9452064	9452064
P07949	RET	A639G	P07949/A639G	RET/A639G	VARIANT	A -> G (in MTC; sporadic form)	ECO:0000269|PubMed:11692159	11692159
P07949	RET	A640G	P07949/A640G	RET/A640G	VARIANT	A -> G (in MEN2A; dbSNP:rs78935588)	ECO:0000269|PubMed:10522989	10522989
P07949	RET	A641G	P07949/A641G	RET/A641G	VARIANT	A -> G (in MTC; sporadic form)	ECO:0000269|PubMed:11692159	11692159
P07949	RET	P679L	P07949/P679L	RET/P679L	VARIANT	P -> L (in HSCR1)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	S690P	P07949/S690P	RET/S690P	VARIANT	S -> P (in HSCR1; sporadic form)		
P07949	RET	G691S	P07949/G691S	RET/G691S	VARIANT	G -> S (in dbSNP:rs1799939)	ECO:0000269|PubMed:14566559, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9223675, ECO:0000269|PubMed:9497256	14566559,17344846,9223675,9497256
P07949	RET	R694Q	P07949/R694Q	RET/R694Q	VARIANT	R -> Q (in HSCR1; dbSNP:rs141185224)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	R749T	P07949/R749T	RET/R749T	VARIANT	R -> T (in dbSNP:rs34288963)	ECO:0000269|PubMed:17344846	17344846
P07949	RET	E762Q	P07949/E762Q	RET/E762Q	VARIANT	E -> Q (in HSCR1; sporadic form)	ECO:0000269|PubMed:7704557	7704557
P07949	RET	S765P	P07949/S765P	RET/S765P	VARIANT	S -> P (in HSCR1; dbSNP:rs75075748)	ECO:0000269|PubMed:7704557, ECO:0000269|PubMed:8114938, ECO:0000269|PubMed:9043870	7704557,8114938,9043870
P07949	RET	S767R	P07949/S767R	RET/S767R	VARIANT	S -> R (in HSCR1; sporadic form)		
P07949	RET	E768D	P07949/E768D	RET/E768D	VARIANT	E -> D (in MTC; familial and sporadic forms; dbSNP:rs78014899)	ECO:0000269|PubMed:7784092, ECO:0000269|PubMed:7845675, ECO:0000269|PubMed:8807338	7784092,7845675,8807338
P07949	RET	V778I	P07949/V778I	RET/V778I	VARIANT	V -> I (in a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; dbSNP:rs75686697)	ECO:0000269|PubMed:18252215	18252215
P07949	RET	N783S	P07949/N783S	RET/N783S	VARIANT	N -> S (in HSCR1; dbSNP:rs587778656)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	L790F	P07949/L790F	RET/L790F	VARIANT	L -> F (in MEN2A and MTC; familial form; dbSNP:rs75030001)	ECO:0000269|PubMed:9506724	9506724
P07949	RET	Y791F	P07949/Y791F	RET/Y791F	VARIANT	Y -> F (in HSCR1, pheochromocytoma, MTC and MEN2A; familial form; dbSNP:rs77724903)	ECO:0000269|PubMed:12000816, ECO:0000269|PubMed:9090527, ECO:0000269|PubMed:9506724	12000816,9090527,9506724
P07949	RET	V804L	P07949/V804L	RET/V804L	VARIANT	V -> L (in MTC; familial form; dbSNP:rs79658334)	ECO:0000269|PubMed:7784092	7784092
P07949	RET	V804M	P07949/V804M	RET/V804M	VARIANT	V -> M (in MTC; familial form; dbSNP:rs79658334)	ECO:0000269|PubMed:10826520, ECO:0000269|PubMed:9452077	10826520,9452077
P07949	RET	R813Q	P07949/R813Q	RET/R813Q	VARIANT	R -> Q (in HSCR1; sporadic form; dbSNP:rs1318733775)	ECO:0000269|PubMed:10090908	10090908
P07949	RET	Y826S	P07949/Y826S	RET/Y826S	VARIANT	Y -> S (in dbSNP:rs34617196)	ECO:0000269|PubMed:17344846	17344846
P07949	RET	G830R	P07949/G830R	RET/G830R	VARIANT	G -> R (in HSCR1; dbSNP:rs200127630)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	R844L	P07949/R844L	RET/R844L	VARIANT	R -> L (in MTC; familial form; dbSNP:rs55947360)	ECO:0000269|PubMed:10826520, ECO:0000269|PubMed:17344846	10826520,17344846
P07949	RET	R873Q	P07949/R873Q	RET/R873Q	VARIANT	R -> Q (in HSCR1; sporadic form; dbSNP:rs1451004715)		
P07949	RET	A883F	P07949/A883F	RET/A883F	VARIANT	A -> F (in MEN2B; somatic mutation in sporadic medullary thyroid carcinoma; requires 2 nucleotide substitutions; dbSNP:rs377767429)	ECO:0000269|PubMed:9294615, ECO:0000269|PubMed:9360560	9294615,9360560
P07949	RET	S891A	P07949/S891A	RET/S891A	VARIANT	S -> A (in MTC; familial form; dbSNP:rs75234356)	ECO:0000269|PubMed:9398735	9398735
P07949	RET	F893L	P07949/F893L	RET/F893L	VARIANT	F -> L (in HSCR1; sporadic form)		
P07949	RET	G894S	P07949/G894S	RET/G894S	VARIANT	G -> S (in a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; expressed only the immature intracellular form)	ECO:0000269|PubMed:18252215	18252215
P07949	RET	R897Q	P07949/R897Q	RET/R897Q	VARIANT	R -> Q (in HSCR1; sporadic form; dbSNP:rs76087194)	ECO:0000269|PubMed:7704557, ECO:0000269|PubMed:8114938	7704557,8114938
P07949	RET	K907E	P07949/K907E	RET/K907E	VARIANT	K -> E (in HSCR1; sporadic form; dbSNP:rs377767430)		
P07949	RET	K907T	P07949/K907T	RET/K907T	VARIANT	K -> T (in HSCR1)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	M918T	P07949/M918T	RET/M918T	VARIANT	M -> T (in MEN2B and MTC; sporadic form; somatic mutation; also found in a patient with renal agenesis; dbSNP:rs74799832)	ECO:0000269|PubMed:18252215, ECO:0000269|PubMed:7906417, ECO:0000269|PubMed:7906866, ECO:0000269|PubMed:7911697, ECO:0000269|PubMed:8595427, ECO:0000269|PubMed:8807338	18252215,7906417,7906866,7911697,8595427,8807338
P07949	RET	E921K	P07949/E921K	RET/E921K	VARIANT	E -> K (in HSCR1; sporadic form)		
P07949	RET	S922F	P07949/S922F	RET/S922F	VARIANT	S -> F (in MTC; sporadic form; dbSNP:rs377767432)	ECO:0000269|PubMed:11692159	11692159
P07949	RET	S922Y	P07949/S922Y	RET/S922Y	VARIANT	S -> Y (in dbSNP:rs377767432)	ECO:0000269|PubMed:8595427	8595427
P07949	RET	T946M	P07949/T946M	RET/T946M	VARIANT	T -> M (in MEN2B and MTC; familial form)		
P07949	RET	F961L	P07949/F961L	RET/F961L	VARIANT	F -> L (in HSCR1)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	R972G	P07949/R972G	RET/R972G	VARIANT	R -> G (in HSCR1; familial form; dbSNP:rs76534745)	ECO:0000269|PubMed:7704557, ECO:0000269|PubMed:8114938	7704557,8114938
P07949	RET	P973L	P07949/P973L	RET/P973L	VARIANT	P -> L (in HSCR1; familial form)	ECO:0000269|PubMed:7704557	7704557
P07949	RET	M980T	P07949/M980T	RET/M980T	VARIANT	M -> T (in HSCR1; sporadic form)		
P07949	RET	R982C	P07949/R982C	RET/R982C	VARIANT	R -> C (in dbSNP:rs17158558)	ECO:0000269|PubMed:14566559, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7633441, ECO:0000269|PubMed:9760196	14566559,15489334,17344846,7633441,9760196
P07949	RET	P1039L	P07949/P1039L	RET/P1039L	VARIANT	P -> L (in HSCR1; dbSNP:rs79853121)	ECO:0000269|PubMed:9497256	9497256
P07949	RET	P1039Q	P07949/P1039Q	RET/P1039Q	VARIANT	P -> Q (in dbSNP:rs79853121)		
P07949	RET	P1049L	P07949/P1049L	RET/P1049L	VARIANT	P -> L (in a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF; dbSNP:rs1490712863)	ECO:0000269|PubMed:18252215	18252215
P07949	RET	L1052V	P07949/L1052V	RET/L1052V	VARIANT	L -> V (in HSCR1; dbSNP:rs1564501947)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	L1061P	P07949/L1061P	RET/L1061P	VARIANT	L -> P (in HSCR1; dbSNP:rs536486113)	ECO:0000269|PubMed:10484767, ECO:0000269|Ref.63	10484767
P07949	RET	Y1062C	P07949/Y1062C	RET/Y1062C	VARIANT	Y -> C (in HSCR1; dbSNP:rs587778659)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	M1064T	P07949/M1064T	RET/M1064T	VARIANT	M -> T (in HSCR1; familial form; dbSNP:rs149513065)	ECO:0000269|PubMed:22174939	22174939
P07949	RET	P1067S	P07949/P1067S	RET/P1067S	VARIANT	P -> S (in a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF; dbSNP:rs775583354)	ECO:0000269|PubMed:18252215	18252215
P07949	RET	F1112Y	P07949/F1112Y	RET/F1112Y	VARIANT	F -> Y (in a bladder transitional cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P07949	RET	D707N	P07949/D707N	RET/D707N	MUTAGEN	D->N: Impaired cleavage by caspase-3 and loss of induced cell death.	ECO:0000269|PubMed:21357690	21357690
P07949	RET	K758R	P07949/K758R	RET/K758R	MUTAGEN	K->R: Loss of kinase activity. No effect on interaction with and dissociation from CBLC and CD2AP.	ECO:0000269|PubMed:18753381, ECO:0000269|PubMed:21357690	18753381,21357690
P07949	RET	Y1062F	P07949/Y1062F	RET/Y1062F	MUTAGEN	Y->F: Abolishes GFRAL-mediated MAPK1/MAPK2 phosphorylation.	ECO:0000269|PubMed:28953886	28953886

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P08069	IGF1R	V105L	P08069/V105L	IGF1R/V105L	VARIANT	V -> L (in a renal chromophobe sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P08069	IGF1R	R138Q	P08069/R138Q	IGF1R/R138Q	VARIANT	R -> Q (in IGF1RES; has decreased IGF1R function; dbSNP:rs121912426)	ECO:0000269|PubMed:14657428	14657428
P08069	IGF1R	K145N	P08069/K145N	IGF1R/K145N	VARIANT	K -> N (in IGF1RES; has decreased IGF1R function; dbSNP:rs121912427)	ECO:0000269|PubMed:14657428	14657428
P08069	IGF1R	N359Y	P08069/N359Y	IGF1R/N359Y	VARIANT	N -> Y (in IGF1RES; significant decrease in IGF1-induced DNA synthesis and AKT1 phosphorylation in patient fibroblasts)	ECO:0000269|PubMed:25040157	25040157
P08069	IGF1R	V388M	P08069/V388M	IGF1R/V388M	VARIANT	V -> M (in dbSNP:rs45445894)	ECO:0000269|Ref.4	
P08069	IGF1R	R437H	P08069/R437H	IGF1R/R437H	VARIANT	R -> H (in dbSNP:rs34516635)	ECO:0000269|PubMed:17344846	17344846
P08069	IGF1R	R511Q	P08069/R511Q	IGF1R/R511Q	VARIANT	R -> Q (in dbSNP:rs33958176)		
P08069	IGF1R	R595H	P08069/R595H	IGF1R/R595H	VARIANT	R -> H (in dbSNP:rs56248469)	ECO:0000269|PubMed:17344846	17344846
P08069	IGF1R	R605H	P08069/R605H	IGF1R/R605H	VARIANT	R -> H (in dbSNP:rs45553041)	ECO:0000269|Ref.4	
P08069	IGF1R	R739Q	P08069/R739Q	IGF1R/R739Q	VARIANT	R -> Q (in IGF1RES; leads to failure of processing of the IGF1R proreceptor to mature IGF1R; dbSNP:rs121912429)	ECO:0000269|PubMed:15928254	15928254
P08069	IGF1R	H808R	P08069/H808R	IGF1R/H808R	VARIANT	H -> R (in dbSNP:rs34061581)		
P08069	IGF1R	A828T	P08069/A828T	IGF1R/A828T	VARIANT	A -> T (in dbSNP:rs35224135)		
P08069	IGF1R	N857S	P08069/N857S	IGF1R/N857S	VARIANT	N -> S (in dbSNP:rs45611935)	ECO:0000269|PubMed:17344846	17344846
P08069	IGF1R	Y865C	P08069/Y865C	IGF1R/Y865C	VARIANT	Y -> C (in IGF1RES; significant decrease in IGF1-induced DNA synthesis and AKT1 phosphorylation in patient fibroblasts)	ECO:0000269|PubMed:25040157	25040157
P08069	IGF1R	R1256S	P08069/R1256S	IGF1R/R1256S	VARIANT	R -> S (in IGF1RES; significant decrease in IGF1-induced DNA synthesis and AKT1 phosphorylation in patient fibroblasts)	ECO:0000269|PubMed:25040157	25040157
P08069	IGF1R	R1337C	P08069/R1337C	IGF1R/R1337C	VARIANT	R -> C (in IGF1RES; unknown pathological significance; significant decrease in IGF1-induced DNA synthesis; significant increase in IGF1-induced AKT1 phosphorylation in patient fibroblasts; dbSNP:rs141802822)	ECO:0000269|PubMed:25040157	25040157
P08069	IGF1R	A1338T	P08069/A1338T	IGF1R/A1338T	VARIANT	A -> T (in dbSNP:rs34102392)	ECO:0000269|PubMed:17344846	17344846
P08069	IGF1R	A1347V	P08069/A1347V	IGF1R/A1347V	VARIANT	A -> V (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P08069	IGF1R	Y980F	P08069/Y980F	IGF1R/Y980F	MUTAGEN	Y->F: Reduces tyrosine phosphorylation. Abolishes interaction with IRS1 and SHC1. Does not abolish interaction with PIK3R1, nor with GRB10.	ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:7541045	10454568,7541045
P08069	IGF1R	K1033A	P08069/K1033A	IGF1R/K1033A	MUTAGEN	K->A: Kinase inactive. Abolishes tyrosine phosphorylation and abolishes interaction with IRS1, SHC1 and PIK3R1.	ECO:0000269|PubMed:7541045	7541045
P08069	IGF1R	Y1280F	P08069/Y1280F	IGF1R/Y1280F	MUTAGEN	Y->F: No effect on GRB10-binding.	ECO:0000269|PubMed:10454568	10454568
P08069	IGF1R	Y1281F	P08069/Y1281F	IGF1R/Y1281F	MUTAGEN	Y->F: No effect on GRB10-binding.	ECO:0000269|PubMed:10454568	10454568
P08069	IGF1R	Y1346F	P08069/Y1346F	IGF1R/Y1346F	MUTAGEN	Y->F: Loss of GRB10-binding.	ECO:0000269|PubMed:10454568	10454568

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P08581	MET	R143Q	P08581/R143Q	MET/R143Q	VARIANT	R -> Q (in dbSNP:rs35469582)	ECO:0000269|PubMed:17344846	17344846
P08581	MET	H150Y	P08581/H150Y	MET/H150Y	VARIANT	H -> Y (found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs1436957498)	ECO:0000269|PubMed:20949619	20949619
P08581	MET	S156L	P08581/S156L	MET/S156L	VARIANT	S -> L (in dbSNP:rs56311081)	ECO:0000269|PubMed:17344846	17344846
P08581	MET	E168D	P08581/E168D	MET/E168D	VARIANT	E -> D (found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs55985569)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:20949619	17344846,20949619
P08581	MET	L238S	P08581/L238S	MET/L238S	VARIANT	L -> S (in dbSNP:rs34349517)		
P08581	MET	I316M	P08581/I316M	MET/I316M	VARIANT	I -> M (in dbSNP:rs35225896)		
P08581	MET	A320V	P08581/A320V	MET/A320V	VARIANT	A -> V (in dbSNP:rs35776110)	ECO:0000269|PubMed:9140397	9140397
P08581	MET	N375K	P08581/N375K	MET/N375K	VARIANT	N -> K (found in lung cancer also including cases carrying EGFR mutations; unknown pathological significance; decreased hepatocyte growth factor-activated receptor activity; decreased interaction with HGF; dbSNP:rs776693512)	ECO:0000269|PubMed:28294470	28294470
P08581	MET	N375S	P08581/N375S	MET/N375S	VARIANT	N -> S (in dbSNP:rs33917957)	ECO:0000269|PubMed:17344846	17344846
P08581	MET	C385Y	P08581/C385Y	MET/C385Y	VARIANT	C -> Y (found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs752055485)	ECO:0000269|PubMed:20949619	20949619
P08581	MET	P773L	P08581/P773L	MET/P773L	VARIANT	P -> L (in gastric cancer; dbSNP:rs771333219)	ECO:0000269|PubMed:12920089	12920089
P08581	MET	F841V	P08581/F841V	MET/F841V	VARIANT	F -> V (in DFNB97; dbSNP:rs794728016)	ECO:0000269|PubMed:25941349	25941349
P08581	MET	R970C	P08581/R970C	MET/R970C	VARIANT	R -> C (in dbSNP:rs34589476)	ECO:0000269|PubMed:17053076, ECO:0000269|PubMed:17344846	17053076,17344846
P08581	MET	P991S	P08581/P991S	MET/P991S	VARIANT	P -> S (in gastric cancer; prolonged tyrosine phosphorylation in response to HGF/SF; transforming activity in athymic nude mice; dbSNP:rs768678989)	ECO:0000269|PubMed:11042681	11042681
P08581	MET	T992I	P08581/T992I	MET/T992I	VARIANT	T -> I (found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs56391007)	ECO:0000269|PubMed:11042681, ECO:0000269|PubMed:17053076, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:20949619	11042681,17053076,17344846,20949619
P08581	MET	Y1003S	P08581/Y1003S	MET/Y1003S	VARIANT	Y -> S (probable disease-associated variant found in lesional sample from a patient with sporadically occurring, unilateral osteofibrous dysplasia; somatic mutation; complete loss of ligand-induced CBL-mediated ubiquitination, resulting in protein stabilization)	ECO:0000269|PubMed:12244174	12244174
P08581	MET	V1092I	P08581/V1092I	MET/V1092I	VARIANT	V -> I (in RCCP; constitutive autophosphorylation; dbSNP:rs786202724)	ECO:0000269|PubMed:10327054, ECO:0000269|PubMed:10417759, ECO:0000269|PubMed:10433944	10327054,10417759,10433944
P08581	MET	H1094L	P08581/H1094L	MET/H1094L	VARIANT	H -> L (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines)	ECO:0000269|PubMed:10327054	10327054
P08581	MET	H1094R	P08581/H1094R	MET/H1094R	VARIANT	H -> R (in RCCP; causes malignant transformation in cell lines; dbSNP:rs121913243)	ECO:0000269|PubMed:10433944, ECO:0000269|PubMed:9563489	10433944,9563489
P08581	MET	H1094Y	P08581/H1094Y	MET/H1094Y	VARIANT	H -> Y (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines; dbSNP:rs121913244)	ECO:0000269|PubMed:10327054	10327054
P08581	MET	H1106D	P08581/H1106D	MET/H1106D	VARIANT	H -> D (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines)	ECO:0000269|PubMed:10327054, ECO:0000269|PubMed:10433944	10327054,10433944
P08581	MET	M1131T	P08581/M1131T	MET/M1131T	VARIANT	M -> T (in RCCP; germline mutation; dbSNP:rs121913668)	ECO:0000269|PubMed:10433944, ECO:0000269|PubMed:9140397	10433944,9140397
P08581	MET	T1173I	P08581/T1173I	MET/T1173I	VARIANT	T -> I (in HCC; dbSNP:rs121913675)	ECO:0000269|PubMed:9927037	9927037
P08581	MET	V1188L	P08581/V1188L	MET/V1188L	VARIANT	V -> L (in RCCP; germline mutation; dbSNP:rs121913669)	ECO:0000269|PubMed:10433944, ECO:0000269|PubMed:9140397	10433944,9140397
P08581	MET	L1195V	P08581/L1195V	MET/L1195V	VARIANT	L -> V (in RCCP; somatic mutation; dbSNP:rs121913673)	ECO:0000269|PubMed:9140397	9140397
P08581	MET	V1220I	P08581/V1220I	MET/V1220I	VARIANT	V -> I (in RCCP; germline mutation; dbSNP:rs121913670)	ECO:0000269|PubMed:9140397	9140397
P08581	MET	D1228H	P08581/D1228H	MET/D1228H	VARIANT	D -> H (in RCCP; somatic mutation; dbSNP:rs121913671)	ECO:0000269|PubMed:9140397	9140397
P08581	MET	D1228N	P08581/D1228N	MET/D1228N	VARIANT	D -> N (in RCCP; germline mutation; dbSNP:rs121913671)	ECO:0000269|PubMed:9140397	9140397
P08581	MET	Y1230C	P08581/Y1230C	MET/Y1230C	VARIANT	Y -> C (in RCCP; germline mutation; dbSNP:rs121913246)	ECO:0000269|PubMed:10433944, ECO:0000269|PubMed:9140397	10433944,9140397
P08581	MET	Y1230D	P08581/Y1230D	MET/Y1230D	VARIANT	Y -> D (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines)	ECO:0000269|PubMed:10327054, ECO:0000269|PubMed:10433944	10327054,10433944
P08581	MET	Y1230H	P08581/Y1230H	MET/Y1230H	VARIANT	Y -> H (in RCCP; somatic mutation; dbSNP:rs121913247)	ECO:0000269|PubMed:9140397	9140397
P08581	MET	Y1234C	P08581/Y1234C	MET/Y1234C	VARIANT	Y -> C (in DA11; not phosphorylated in reponse to HGF; severely decreased tyrosin kinase activity; dbSNP:rs1554400286)	ECO:0000269|PubMed:30777867	30777867
P08581	MET	K1244R	P08581/K1244R	MET/K1244R	VARIANT	K -> R (in HCC; dbSNP:rs121913677)	ECO:0000269|PubMed:9927037	9927037
P08581	MET	M1250I	P08581/M1250I	MET/M1250I	VARIANT	M -> I (in HCC; dbSNP:rs121913676)	ECO:0000269|PubMed:9927037	9927037
P08581	MET	M1250T	P08581/M1250T	MET/M1250T	VARIANT	M -> T (in RCCP; somatic mutation; dbSNP:rs121913245)	ECO:0000269|PubMed:10433944, ECO:0000269|PubMed:9140397	10433944,9140397
P08581	MET	V1294I	P08581/V1294I	MET/V1294I	VARIANT	V -> I (found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs1263785859)	ECO:0000269|PubMed:20949619	20949619
P08581	MET	Y1234F	P08581/Y1234F	MET/Y1234F	MUTAGEN	Y->F: Complete loss of kinase activity and of ligand-induced ubiquitination. Alters interaction with PTPN1 and PTPN2. Loss of interaction with PTPN1 and PTPN2; when associated with F-1235.	ECO:0000269|PubMed:12244174, ECO:0000269|PubMed:18819921	12244174,18819921
P08581	MET	Y1235F	P08581/Y1235F	MET/Y1235F	MUTAGEN	Y->F: Complete loss of kinase activity. Alters interaction with PTPN1 and PTPN2. Loss of interaction with PTPN1 and PTPN2; when associated with F-1234.	ECO:0000269|PubMed:12244174, ECO:0000269|PubMed:18819921	12244174,18819921
P08581	MET	Y1313F	P08581/Y1313F	MET/Y1313F	MUTAGEN	Y->F: No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1349, F-1356 and F-1365.	ECO:0000269|PubMed:12244174	12244174
P08581	MET	Y1349F	P08581/Y1349F	MET/Y1349F	MUTAGEN	Y->F: No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1313, F-1356 and F-1365.	ECO:0000269|PubMed:12244174	12244174
P08581	MET	Y1356F	P08581/Y1356F	MET/Y1356F	MUTAGEN	Y->F: No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1313, F-1349 and F-1365.	ECO:0000269|PubMed:12244174	12244174
P08581	MET	Y1365F	P08581/Y1365F	MET/Y1365F	MUTAGEN	Y->F: No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1313, F-1349 and F-1356.	ECO:0000269|PubMed:12244174	12244174

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P08631	HCK	A44T	P08631/A44T	HCK/A44T	VARIANT	A -> T (in dbSNP:rs56029200)	ECO:0000269|PubMed:17344846	17344846
P08631	HCK	M105L	P08631/M105L	HCK/M105L	VARIANT	M -> L (in dbSNP:rs55722810)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
P08631	HCK	D399G	P08631/D399G	HCK/D399G	VARIANT	D -> G (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P08631	HCK	P502Q	P08631/P502Q	HCK/P502Q	VARIANT	P -> Q (in dbSNP:rs17093828)		
P08631	HCK	G3C	P08631/G3C	HCK/G3C	MUTAGEN	G->C: Slight palmitoylation, cytoplasmic and caveolar localization; in isoform 1;.	ECO:0000269|PubMed:11904303, ECO:0000269|PubMed:7791757	11904303,7791757
P08631	HCK	G3S	P08631/G3S	HCK/G3S	MUTAGEN	G->S: Abolishes palmitoylation and localization at the cell membrane.	ECO:0000269|PubMed:11904303, ECO:0000269|PubMed:7791757	11904303,7791757
P08631	HCK	G23A	P08631/G23A	HCK/G23A	MUTAGEN	G->A: Myristoylation and palmitoylation are abolished, leading to entirely cytoplasmic localization; in isoform 2.	ECO:0000269|PubMed:7791757	7791757
P08631	HCK	C24S	P08631/C24S	HCK/C24S	MUTAGEN	C->S: Palmitoylation is abolished, some cytoplasmic and no calveolar localization; in isoform 2.	ECO:0000269|PubMed:7791757	7791757
P08631	HCK	K290E	P08631/K290E	HCK/K290E	MUTAGEN	K->E: Loss of kinase activity.	ECO:0000269|PubMed:11896602	11896602
P08631	HCK	E305A	P08631/E305A	HCK/E305A	MUTAGEN	E->A: Loss of kinase activity.	ECO:0000269|PubMed:10644735	10644735
P08631	HCK	D381E	P08631/D381E	HCK/D381E	MUTAGEN	D->E: Loss of kinase activity.	ECO:0000269|PubMed:15998323	15998323
P08631	HCK	Y411A	P08631/Y411A	HCK/Y411A	MUTAGEN	Y->A: Reduced catalytic activity and higher affinity for target peptides.	ECO:0000269|PubMed:10644735	10644735
P08631	HCK	Y522F	P08631/Y522F	HCK/Y522F	MUTAGEN	Y->F: Constitutively activated kinase, leading to cellular transformation.	ECO:0000269|PubMed:10092522, ECO:0000269|PubMed:11896602	10092522,11896602

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P08922	ROS1	N13S	P08922/N13S	ROS1/N13S	VARIANT	N -> S (in dbSNP:rs45606237)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	G126V	P08922/G126V	ROS1/G126V	VARIANT	G -> V (in dbSNP:rs34245787)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	T145P	P08922/T145P	ROS1/T145P	VARIANT	T -> P (in dbSNP:rs1998206)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	R167Q	P08922/R167Q	ROS1/R167Q	VARIANT	R -> Q (in dbSNP:rs2243380)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	P224S	P08922/P224S	ROS1/P224S	VARIANT	P -> S (in dbSNP:rs55959124)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	Y338C	P08922/Y338C	ROS1/Y338C	VARIANT	Y -> C (in dbSNP:rs55707658)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	S370P	P08922/S370P	ROS1/S370P	VARIANT	S -> P (in dbSNP:rs56274823)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	Y419H	P08922/Y419H	ROS1/Y419H	VARIANT	Y -> H (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1444274116)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	I537M	P08922/I537M	ROS1/I537M	VARIANT	I -> M (in dbSNP:rs28639589)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	S653F	P08922/S653F	ROS1/S653F	VARIANT	S -> F (in dbSNP:rs34203286)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	N790S	P08922/N790S	ROS1/N790S	VARIANT	N -> S (in dbSNP:rs34582164)		
P08922	ROS1	Q865H	P08922/Q865H	ROS1/Q865H	VARIANT	Q -> H (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	S1109L	P08922/S1109L	ROS1/S1109L	VARIANT	S -> L (in dbSNP:rs2229079)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	Y1239F	P08922/Y1239F	ROS1/Y1239F	VARIANT	Y -> F (in dbSNP:rs56192249)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	Y1353S	P08922/Y1353S	ROS1/Y1353S	VARIANT	Y -> S (in dbSNP:rs35269727)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	C1370R	P08922/C1370R	ROS1/C1370R	VARIANT	C -> R (in dbSNP:rs36106063)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	F1439S	P08922/F1439S	ROS1/F1439S	VARIANT	F -> S (in dbSNP:rs17079086)		
P08922	ROS1	R1506G	P08922/R1506G	ROS1/R1506G	VARIANT	R -> G (in dbSNP:rs35841892)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	D1776H	P08922/D1776H	ROS1/D1776H	VARIANT	D -> H (in dbSNP:rs12664076)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	E1902K	P08922/E1902K	ROS1/E1902K	VARIANT	E -> K (in dbSNP:rs9489124)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	H1999N	P08922/H1999N	ROS1/H1999N	VARIANT	H -> N (in dbSNP:rs45569132)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	K2003R	P08922/K2003R	ROS1/K2003R	VARIANT	K -> R (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	R2039H	P08922/R2039H	ROS1/R2039H	VARIANT	R -> H (in dbSNP:rs3752566)		
P08922	ROS1	F2138S	P08922/F2138S	ROS1/F2138S	VARIANT	F -> S (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	D2203N	P08922/D2203N	ROS1/D2203N	VARIANT	D -> N (in dbSNP:rs556427413)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	D2213E	P08922/D2213E	ROS1/D2213E	VARIANT	D -> E (in dbSNP:rs75510639)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	D2213N	P08922/D2213N	ROS1/D2213N	VARIANT	D -> N (in dbSNP:rs529038)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2352949	17344846,2352949
P08922	ROS1	K2228Q	P08922/K2228Q	ROS1/K2228Q	VARIANT	K -> Q (in dbSNP:rs529156)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2352949	17344846,2352949
P08922	ROS1	S2229C	P08922/S2229C	ROS1/S2229C	VARIANT	S -> C (in dbSNP:rs619203)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2352949	17344846,2352949
P08922	ROS1	N2240K	P08922/N2240K	ROS1/N2240K	VARIANT	N -> K (in dbSNP:rs210968)	ECO:0000269|PubMed:17344846	17344846
P08922	ROS1	K2328R	P08922/K2328R	ROS1/K2328R	VARIANT	K -> R (in dbSNP:rs35932630)		
P08922	ROS1	K1980M	P08922/K1980M	ROS1/K1980M	MUTAGEN	K->M: Loss of kinase activity.	ECO:0000269|PubMed:12661006	12661006
P08922	ROS1	Y2274F	P08922/Y2274F	ROS1/Y2274F	MUTAGEN	Y->F: Loss of phosphorylation at Y-2274 and loss of interaction with PTPN11.	ECO:0000269|PubMed:12538861	12538861
P08922	ROS1	Y2334F	P08922/Y2334F	ROS1/Y2334F	MUTAGEN	Y->F: Loss of phosphorylation at Y-2334 and loss of interaction with PTPN11.	ECO:0000269|PubMed:12538861	12538861

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P09619	PDGFRB	I29F	P09619/I29F	PDGFRB/I29F	VARIANT	I -> F (in dbSNP:rs17110944)	ECO:0000269|PubMed:17344846	17344846
P09619	PDGFRB	S180F	P09619/S180F	PDGFRB/S180F	VARIANT	S -> F (in dbSNP:rs17853027)	ECO:0000269|PubMed:15489334	15489334
P09619	PDGFRB	E282K	P09619/E282K	PDGFRB/E282K	VARIANT	E -> K (in dbSNP:rs34586048)	ECO:0000269|PubMed:17344846	17344846
P09619	PDGFRB	P345S	P09619/P345S	PDGFRB/P345S	VARIANT	P -> S (in dbSNP:rs2229558)		
P09619	PDGFRB	E485K	P09619/E485K	PDGFRB/E485K	VARIANT	E -> K (in dbSNP:rs41287110)	ECO:0000269|PubMed:17344846	17344846
P09619	PDGFRB	R561C	P09619/R561C	PDGFRB/R561C	VARIANT	R -> C (in IMF1; dbSNP:rs367543286)	ECO:0000269|PubMed:23731537	23731537
P09619	PDGFRB	P584R	P09619/P584R	PDGFRB/P584R	VARIANT	P -> R (in KOGS; dbSNP:rs863224946)	ECO:0000269|PubMed:25454926	25454926
P09619	PDGFRB	Y589H	P09619/Y589H	PDGFRB/Y589H	VARIANT	Y -> H (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P09619	PDGFRB	L658P	P09619/L658P	PDGFRB/L658P	VARIANT	L -> P (in IBGC4; no effect on protein abundance; loss of PDGF beta receptor activity; dbSNP:rs397509381)	ECO:0000269|PubMed:23255827, ECO:0000269|PubMed:24065723, ECO:0000269|PubMed:26599395	23255827,24065723,26599395
P09619	PDGFRB	P660T	P09619/P660T	PDGFRB/P660T	VARIANT	P -> T (in IMF1; dbSNP:rs144050370)	ECO:0000269|PubMed:23731542	23731542
P09619	PDGFRB	V665A	P09619/V665A	PDGFRB/V665A	VARIANT	V -> A (in PENTT; gain of function in protein tyrosine kinase activity; shows ligand-independent constitutive signaling; dbSNP:rs1554108211)	ECO:0000269|PubMed:26279204	26279204
P09619	PDGFRB	N718Y	P09619/N718Y	PDGFRB/N718Y	VARIANT	N -> Y (in dbSNP:rs35322465)	ECO:0000269|PubMed:17344846	17344846
P09619	PDGFRB	T882I	P09619/T882I	PDGFRB/T882I	VARIANT	T -> I (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P09619	PDGFRB	R987W	P09619/R987W	PDGFRB/R987W	VARIANT	R -> W (in IBGC4; decreased protein abundance; no effect on receptor activity; decreased PDGF signaling pathway; dbSNP:rs397509382)	ECO:0000269|PubMed:23255827, ECO:0000269|PubMed:24065723, ECO:0000269|PubMed:26599395	23255827,24065723,26599395
P09619	PDGFRB	E1071V	P09619/E1071V	PDGFRB/E1071V	VARIANT	E -> V (in IBGC4; no effect on protein abundance; no effect on receptor activity; decreased PDGF signaling pathway)	ECO:0000269|PubMed:24065723, ECO:0000269|PubMed:26599395	24065723,26599395
P09619	PDGFRB	Y579F	P09619/Y579F	PDGFRB/Y579F	MUTAGEN	Y->F: Loss of kinase activity; when associated with F-581. Strongly reduces interaction with SRC family kinases. No effect on interaction with GRB10.	ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:7685273	10454568,7685273
P09619	PDGFRB	Y581F	P09619/Y581F	PDGFRB/Y581F	MUTAGEN	Y->F: Loss of kinase activity; when associated with F-579. No effect on interaction with GRB10.	ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:7685273	10454568,7685273
P09619	PDGFRB	K634A	P09619/K634A	PDGFRB/K634A	MUTAGEN			
P09619	PDGFRB	K634R	P09619/K634R	PDGFRB/K634R	MUTAGEN	K->A,R: Loss of kinase activity. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity.	ECO:0000269|PubMed:1314164, ECO:0000269|PubMed:1846866, ECO:0000269|PubMed:20494825	1314164,1846866,20494825
P09619	PDGFRB	Y716F	P09619/Y716F	PDGFRB/Y716F	MUTAGEN	Y->F: No effect neither on interaction with GRB10 and RASA1 nor on phosphatidylinositol 3-kinase activity.	ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:1314164	10454568,1314164
P09619	PDGFRB	Y740F	P09619/Y740F	PDGFRB/Y740F	MUTAGEN	Y->F: Strongly reduces up-regulation of cell proliferation; when associated with F-751. Strongly decreases phosphatidylinositol 3-kinase activity. No effect on interaction with GRB10 and RASA1.	ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:1314164, ECO:0000269|PubMed:1375321, ECO:0000269|PubMed:21679854	10454568,1314164,1375321,21679854
P09619	PDGFRB	Y751F	P09619/Y751F	PDGFRB/Y751F	MUTAGEN	Y->F: Strongly reduces up-regulation of cell proliferation; when associated with F-740. Abolishes phosphatidylinositol 3-kinase activity and interaction with NCK1, and slightly reduces interaction with RASA1. No effect on interaction with GRB10.	ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:1314164, ECO:0000269|PubMed:1375321, ECO:0000269|PubMed:1653029, ECO:0000269|PubMed:21679854, ECO:0000269|PubMed:7692233	10454568,1314164,1375321,1653029,21679854,7692233
P09619	PDGFRB	Y763F	P09619/Y763F	PDGFRB/Y763F	MUTAGEN	Y->F: No effect on interaction with RASA1 and on phosphatidylinositol 3-kinase activity.	ECO:0000269|PubMed:1314164	1314164
P09619	PDGFRB	Y771F	P09619/Y771F	PDGFRB/Y771F	MUTAGEN	Y->F: Loss of interaction with GRB10. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity.	ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:1314164, ECO:0000269|PubMed:1375321	10454568,1314164,1375321
P09619	PDGFRB	Y775F	P09619/Y775F	PDGFRB/Y775F	MUTAGEN	Y->F: No effect on interaction with RASA1 and on phosphatidylinositol 3-kinase activity.	ECO:0000269|PubMed:1314164	1314164
P09619	PDGFRB	Y778F	P09619/Y778F	PDGFRB/Y778F	MUTAGEN	Y->F: Strongly reduces expression levels.	ECO:0000269|PubMed:1314164	1314164
P09619	PDGFRB	Y857F	P09619/Y857F	PDGFRB/Y857F	MUTAGEN	Y->F: Reduces kinase activity. No effect on interaction with GRB10. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity.	ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:1314164, ECO:0000269|PubMed:1653029, ECO:0000269|PubMed:20494825	10454568,1314164,1653029,20494825
P09619	PDGFRB	Y1009F	P09619/Y1009F	PDGFRB/Y1009F	MUTAGEN	Y->F: No effect on interaction with GRB10. Abolishes interaction with PLCG1; when associated with F-1021.	ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:1396585, ECO:0000269|PubMed:7691811	10454568,1396585,7691811
P09619	PDGFRB	Y1021F	P09619/Y1021F	PDGFRB/Y1021F	MUTAGEN	Y->F: Strongly reduces up-regulation of cell proliferation. Abolishes interaction with PLCG1; when associated with F-1009. No effect on interaction with GRB10.	ECO:0000269|PubMed:10454568, ECO:0000269|PubMed:1396585, ECO:0000269|PubMed:17620338, ECO:0000269|PubMed:21679854	10454568,1396585,17620338,21679854

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P09769	FGR	T110I	P09769/T110I	FGR/T110I	VARIANT	T -> I (in dbSNP:rs34597831)	ECO:0000269|PubMed:17344846	17344846
P09769	FGR	S130R	P09769/S130R	FGR/S130R	VARIANT	S -> R (in dbSNP:rs35334091)	ECO:0000269|PubMed:17344846	17344846
P09769	FGR	Y523F	P09769/Y523F	FGR/Y523F	MUTAGEN	Y->F: Strongly increased catalytic activity. Functions as oncogene.	ECO:0000269|PubMed:1737799	1737799

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P0C1S8	WEE2	K8T	P0C1S8/K8T	WEE2/K8T	VARIANT	K -> T (in dbSNP:rs35672788)	ECO:0000269|PubMed:17344846	17344846
P0C1S8	WEE2	D234H	P0C1S8/D234H	WEE2/D234H	VARIANT			
P0C1S8	WEE2	N332K	P0C1S8/N332K	WEE2/N332K	VARIANT	N -> K (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P0C1S8	WEE2	R398H	P0C1S8/R398H	WEE2/R398H	VARIANT	R -> H (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs200610853)	ECO:0000269|PubMed:17344846	17344846
P0C1S8	WEE2	D470E	P0C1S8/D470E	WEE2/D470E	VARIANT	D -> E (in dbSNP:rs55901099)	ECO:0000269|PubMed:17344846	17344846
P0C1S8	WEE2	Y526D	P0C1S8/Y526D	WEE2/Y526D	VARIANT	Y -> D (in dbSNP:rs35683659)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P10398	ARAF	M98T	P10398/M98T	ARAF/M98T	VARIANT	M -> T (in dbSNP:rs56197559)	ECO:0000269|PubMed:17344846	17344846
P10398	ARAF	G331C	P10398/G331C	ARAF/G331C	VARIANT	G -> C (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P10398	ARAF	E578D	P10398/E578D	ARAF/E578D	VARIANT	E -> D (in dbSNP:rs55852926)	ECO:0000269|PubMed:17344846	17344846

Error: P10721 KIT 'NoneType' object has no attribute 'group' FT                   /note="Missing (in GIST; dbSNP:rs121913685)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P10721	KIT	S451C	P10721/S451C	KIT/S451C	VARIANT	S -> C (in MASTC; unknown pathological significance)	ECO:0000269|PubMed:24289326	24289326
P10721	KIT	V532I	P10721/V532I	KIT/V532I	VARIANT	V -> I (in dbSNP:rs55792975)	ECO:0000269|PubMed:17344846	17344846
P10721	KIT	A533D	P10721/A533D	KIT/A533D	VARIANT	A -> D (in MASTC; unknown pathological significance; dbSNP:rs753212327)	ECO:0000269|PubMed:15173254	15173254
P10721	KIT	M541L	P10721/M541L	KIT/M541L	VARIANT	M -> L (in dbSNP:rs3822214)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19865100	17344846,19865100
P10721	KIT	M541V	P10721/M541V	KIT/M541V	VARIANT	M -> V (in dbSNP:rs3822214)		
P10721	KIT	K550I	P10721/K550I	KIT/K550I	VARIANT	K -> I (in GIST; somatic mutation)	ECO:0000269|PubMed:9438854	9438854
P10721	KIT	V559A	P10721/V559A	KIT/V559A	VARIANT	V -> A (in GIST; dbSNP:rs121913517)	ECO:0000269|PubMed:11505412	11505412
P10721	KIT	V559D	P10721/V559D	KIT/V559D	VARIANT	V -> D (in GIST; somatic mutation; dbSNP:rs121913517)	ECO:0000269|PubMed:9438854	9438854
P10721	KIT	E583K	P10721/E583K	KIT/E583K	VARIANT	E -> K (in PBT; dbSNP:rs121913680)	ECO:0000269|PubMed:1376329	1376329
P10721	KIT	F584C	P10721/F584C	KIT/F584C	VARIANT	F -> C (in PBT; dbSNP:rs28933371)	ECO:0000269|PubMed:11074500	11074500
P10721	KIT	F584L	P10721/F584L	KIT/F584L	VARIANT	F -> L (in PBT; dbSNP:rs794726671)	ECO:0000269|PubMed:1370874	1370874
P10721	KIT	G601R	P10721/G601R	KIT/G601R	VARIANT	G -> R (in PBT)	ECO:0000269|PubMed:11074500	11074500
P10721	KIT	L656P	P10721/L656P	KIT/L656P	VARIANT	L -> P (in PBT)	ECO:0000269|PubMed:11074500	11074500
P10721	KIT	G664R	P10721/G664R	KIT/G664R	VARIANT	G -> R (in PBT; dbSNP:rs121913679)	ECO:0000269|PubMed:1717985	1717985
P10721	KIT	C691S	P10721/C691S	KIT/C691S	VARIANT	C -> S (in dbSNP:rs35200131)	ECO:0000269|PubMed:17344846	17344846
P10721	KIT	S715N	P10721/S715N	KIT/S715N	VARIANT	S -> N (in dbSNP:rs56094246)	ECO:0000269|PubMed:17344846	17344846
P10721	KIT	D737N	P10721/D737N	KIT/D737N	VARIANT	D -> N (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs751005114)	ECO:0000269|PubMed:17344846	17344846
P10721	KIT	R791G	P10721/R791G	KIT/R791G	VARIANT	R -> G (in PBT; dbSNP:rs1722708855)	ECO:0000269|PubMed:7687267	7687267
P10721	KIT	R796G	P10721/R796G	KIT/R796G	VARIANT	R -> G (in PBT; with sensorineural deafness; dbSNP:rs121913684)	ECO:0000269|PubMed:9450866	9450866
P10721	KIT	R804W	P10721/R804W	KIT/R804W	VARIANT	R -> W (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs145602440)	ECO:0000269|PubMed:17344846	17344846
P10721	KIT	G812V	P10721/G812V	KIT/G812V	VARIANT	G -> V (in PBT)	ECO:0000269|PubMed:7687267	7687267
P10721	KIT	D816F	P10721/D816F	KIT/D816F	VARIANT	D -> F (in MASTC; sporadic case; somatic mutation; requires 2 nucleotide substitutions; constitutively activated and is much more rapidly autophosphorylated than wild type)	ECO:0000269|PubMed:9990072	9990072
P10721	KIT	D816H	P10721/D816H	KIT/D816H	VARIANT	D -> H (in a testicular tumor; seminoma; somatic mutation; constitutively activated; dbSNP:rs121913506)	ECO:0000269|PubMed:10362788, ECO:0000269|PubMed:19164557, ECO:0000269|PubMed:20147452	10362788,19164557,20147452
P10721	KIT	D816I	P10721/D816I	KIT/D816I	VARIANT	D -> I (in MASTC; somatic mutation; constitutively activated; requires 2 nucleotide substitutions; dbSNP:rs1057519709)	ECO:0000269|PubMed:19865100	19865100
P10721	KIT	D816V	P10721/D816V	KIT/D816V	VARIANT	D -> V (in MASTSYS, MASTC and mast cell leukemia; somatic mutation; constitutively activated; loss of interaction with MPDZ; dbSNP:rs121913507)	ECO:0000269|PubMed:11018522, ECO:0000269|PubMed:17595334, ECO:0000269|PubMed:19164557, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19865100, ECO:0000269|PubMed:21640708, ECO:0000269|PubMed:7691885, ECO:0000269|PubMed:9990072	11018522,17595334,19164557,19265199,19865100,21640708,7691885,9990072
P10721	KIT	D816Y	P10721/D816Y	KIT/D816Y	VARIANT	D -> Y (in MASTSYS and MASTC; also found in acute myeloid leukemia and a germ cell tumor of the testis; somatic mutation; constitutively activated; dbSNP:rs121913506)	ECO:0000269|PubMed:16175573, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19865100, ECO:0000269|PubMed:9657776, ECO:0000269|PubMed:9990072	16175573,17344846,19865100,9657776,9990072
P10721	KIT	D820G	P10721/D820G	KIT/D820G	VARIANT	D -> G (in mast cell disease; systemic; dbSNP:rs121913682)	ECO:0000269|PubMed:9029028	9029028
P10721	KIT	N822I	P10721/N822I	KIT/N822I	VARIANT	N -> I (in MASTC; constitutively activated; dbSNP:rs993022333)	ECO:0000269|PubMed:21689725	21689725
P10721	KIT	N822K	P10721/N822K	KIT/N822K	VARIANT	N -> K (in a germ cell tumor of the testis; somatic mutation; dbSNP:rs121913514)	ECO:0000269|PubMed:16175573, ECO:0000269|PubMed:17344846	16175573,17344846
P10721	KIT	A829P	P10721/A829P	KIT/A829P	VARIANT	A -> P (in a germ cell tumor of the testis; somatic mutation; dbSNP:rs1057519713)	ECO:0000269|PubMed:16175573, ECO:0000269|PubMed:17344846	16175573,17344846
P10721	KIT	E839K	P10721/E839K	KIT/E839K	VARIANT	E -> K (in MASTC; sporadic case; somatic mutation; dominant negative mutation; loss of autophosphorylation; dbSNP:rs121913509)	ECO:0000269|PubMed:9990072	9990072
P10721	KIT	T847P	P10721/T847P	KIT/T847P	VARIANT	T -> P (in PBT; dbSNP:rs121913687)	ECO:0000269|PubMed:9699740	9699740
P10721	KIT	R381A	P10721/R381A	KIT/R381A	MUTAGEN	R->A: Reduces autophosphorylation in response to KITLG/SCF.	ECO:0000269|PubMed:17662946	17662946
P10721	KIT	E386A	P10721/E386A	KIT/E386A	MUTAGEN	E->A: Reduces autophosphorylation in response to KITLG/SCF.	ECO:0000269|PubMed:17662946	17662946
P10721	KIT	I571A	P10721/I571A	KIT/I571A	MUTAGEN	I->A: Reduction in SH2B2/APS binding. Abolishes SH2B2/APS binding; when associated with A-939.	ECO:0000269|PubMed:12444928	12444928
P10721	KIT	K623M	P10721/K623M	KIT/K623M	MUTAGEN	K->M: Stronger interaction with MPDZ.	ECO:0000269|PubMed:11018522	11018522
P10721	KIT	S741A	P10721/S741A	KIT/S741A	MUTAGEN	S->A: Abolishes down-regulation of kinase activity by PKC/PRKCA-mediated phosphorylation; when associated with A-746.	ECO:0000269|PubMed:7539802	7539802
P10721	KIT	S746A	P10721/S746A	KIT/S746A	MUTAGEN	S->A: Abolishes down-regulation of kinase activity by PKC/PRKCA-mediated phosphorylation; when associated with A-741.	ECO:0000269|PubMed:7539802	7539802
P10721	KIT	Y823F	P10721/Y823F	KIT/Y823F	MUTAGEN	Y->F: No decrease in activity. Leads to autophosphorylation at Tyr-900.	ECO:0000269|PubMed:20147452	20147452
P10721	KIT	L939A	P10721/L939A	KIT/L939A	MUTAGEN	L->A: Reduction in SH2B2/APS binding. Abolishes SH2B2/APS binding; when associated with A-571.	ECO:0000269|PubMed:12444928	12444928

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P11274	BCR	S400P	P11274/S400P	BCR/S400P	VARIANT	S -> P (in a bladder transitional cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	I413M	P11274/I413M	BCR/I413M	VARIANT	I -> M (in dbSNP:rs56321828)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	K558T	P11274/K558T	BCR/K558T	VARIANT	K -> T (in dbSNP:rs4437065)		
P11274	BCR	D752E	P11274/D752E	BCR/D752E	VARIANT	D -> E (in dbSNP:rs12484731)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	N796S	P11274/N796S	BCR/N796S	VARIANT	N -> S (in dbSNP:rs140504)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2407300, ECO:0000269|PubMed:3107980, ECO:0000269|PubMed:3285291, ECO:0000269|Ref.3	17344846,2407300,3107980,3285291
P11274	BCR	Y910C	P11274/Y910C	BCR/Y910C	VARIANT	Y -> C (in dbSNP:rs35537221)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	V949I	P11274/V949I	BCR/V949I	VARIANT	V -> I (in dbSNP:rs2229038)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	E1037K	P11274/E1037K	BCR/E1037K	VARIANT	E -> K (in dbSNP:rs776552570)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	V1091M	P11274/V1091M	BCR/V1091M	VARIANT	V -> M (in dbSNP:rs778229520)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	T1096A	P11274/T1096A	BCR/T1096A	VARIANT	T -> A (in dbSNP:rs745459086)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	A1104G	P11274/A1104G	BCR/A1104G	VARIANT	A -> G (in dbSNP:rs11558696)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	D1106N	P11274/D1106N	BCR/D1106N	VARIANT	D -> N (in dbSNP:rs879255379)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	T1127M	P11274/T1127M	BCR/T1127M	VARIANT	T -> M (in dbSNP:rs35812689)		
P11274	BCR	A1149T	P11274/A1149T	BCR/A1149T	VARIANT	A -> T (in dbSNP:rs200099830)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	E1161K	P11274/E1161K	BCR/E1161K	VARIANT	E -> K	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	K1187E	P11274/K1187E	BCR/K1187E	VARIANT	K -> E (in dbSNP:rs1195127922)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	V1189M	P11274/V1189M	BCR/V1189M	VARIANT	V -> M (in dbSNP:rs55816482)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	A1204G	P11274/A1204G	BCR/A1204G	VARIANT	A -> G (in dbSNP:rs56265970)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	W1235R	P11274/W1235R	BCR/W1235R	VARIANT	W -> R (in dbSNP:rs55719322)	ECO:0000269|PubMed:17344846	17344846
P11274	BCR	Y177F	P11274/Y177F	BCR/Y177F	MUTAGEN	Y->F: Abolishes interaction with FES and GRB2.	ECO:0000269|PubMed:15302586, ECO:0000269|PubMed:9407116	15302586,9407116
P11274	BCR	R1090A	P11274/R1090A	BCR/R1090A	MUTAGEN	R->A: Loss of GAP activity. Loss of GAP activity; when associated with A-1202.	ECO:0000269|PubMed:17116687	17116687
P11274	BCR	N1202A	P11274/N1202A	BCR/N1202A	MUTAGEN	N->A: Loss of GAP activity; when associated with A-1090.	ECO:0000269|PubMed:17116687	17116687
P11274	BCR	V1271A	P11274/V1271A	BCR/V1271A	MUTAGEN	V->A: Reduces interaction with PDZK1. Abolishes interaction with DLG4. No effect on synaptic localization.	ECO:0000269|PubMed:15494376, ECO:0000269|PubMed:20962234	15494376,20962234

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P11309	PIM1	Y53H	P11309/Y53H	PIM1/Y53H	VARIANT	Y -> H (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P11309	PIM1	E124Q	P11309/E124Q	PIM1/E124Q	VARIANT	E -> Q (in dbSNP:rs35760989)	ECO:0000269|PubMed:17344846	17344846
P11309	PIM1	E135K	P11309/E135K	PIM1/E135K	VARIANT	E -> K (in dbSNP:rs200523275)	ECO:0000269|PubMed:17344846	17344846
P11309	PIM1	E142D	P11309/E142D	PIM1/E142D	VARIANT	E -> D (in dbSNP:rs33989191)	ECO:0000269|PubMed:17344846	17344846
P11309	PIM1	H68Y	P11309/H68Y	PIM1/H68Y	MUTAGEN	H->Y: Increased kinase activity.	ECO:0000269|PubMed:15808862	15808862
P11309	PIM1	P81S	P11309/P81S	PIM1/P81S	MUTAGEN	P->S: Decreased kinase activity.	ECO:0000269|PubMed:15808862	15808862
P11309	PIM1	N82K	P11309/N82K	PIM1/N82K	MUTAGEN	N->K: Decreased kinase activity.	ECO:0000269|PubMed:15808862	15808862
P11309	PIM1	L193F	P11309/L193F	PIM1/L193F	MUTAGEN	L->F: Decreased kinase activity.	ECO:0000269|PubMed:15808862	15808862

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P11362	FGFR1	W4C	P11362/W4C	FGFR1/W4C	VARIANT	W -> C (in HH2; unknown pathological significance; dbSNP:rs760884357)	ECO:0000269|PubMed:26277103	26277103
P11362	FGFR1	R22S	P11362/R22S	FGFR1/R22S	VARIANT	R -> S (in dbSNP:rs17175750)	ECO:0000269|Ref.13	
P11362	FGFR1	G48S	P11362/G48S	FGFR1/G48S	VARIANT	G -> S (in HH2; phenotype consistent with normosmic idiopathic hypogonadotropic hypogonadism; dbSNP:rs121909640)	ECO:0000269|PubMed:16882753	16882753
P11362	FGFR1	G70R	P11362/G70R	FGFR1/G70R	VARIANT	G -> R (in HH2; dbSNP:rs140254426)	ECO:0000269|PubMed:25077900	25077900
P11362	FGFR1	N77K	P11362/N77K	FGFR1/N77K	VARIANT	N -> K (in dbSNP:rs767195580)	ECO:0000269|PubMed:17154279	17154279
P11362	FGFR1	R78C	P11362/R78C	FGFR1/R78C	VARIANT	R -> C (in HH2; dbSNP:rs1554570706)	ECO:0000269|PubMed:16764984	16764984
P11362	FGFR1	S96C	P11362/S96C	FGFR1/S96C	VARIANT	S -> C (in HH2; unknown pathological significance)	ECO:0000269|PubMed:26277103	26277103
P11362	FGFR1	G97D	P11362/G97D	FGFR1/G97D	VARIANT	G -> D (in HH2)	ECO:0000269|PubMed:12627230	12627230
P11362	FGFR1	Y99C	P11362/Y99C	FGFR1/Y99C	VARIANT	Y -> C (in HH2; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression; dbSNP:rs727505373)	ECO:0000269|PubMed:12627230, ECO:0000269|PubMed:19820032	12627230,19820032
P11362	FGFR1	C101F	P11362/C101F	FGFR1/C101F	VARIANT	C -> F (in HH2)	ECO:0000269|PubMed:17154279	17154279
P11362	FGFR1	V102I	P11362/V102I	FGFR1/V102I	VARIANT	V -> I (in HH2; dbSNP:rs55642501)	ECO:0000269|PubMed:15605412, ECO:0000269|PubMed:16764984	15605412,16764984
P11362	FGFR1	V116I	P11362/V116I	FGFR1/V116I	VARIANT	V -> I (in HH2; dbSNP:rs747842199)	ECO:0000269|PubMed:25077900	25077900
P11362	FGFR1	N117S	P11362/N117S	FGFR1/N117S	VARIANT	N -> S (in HH2; some patients also carry GNRHR mutations; dbSNP:rs780765366)	ECO:0000269|PubMed:19820032, ECO:0000269|PubMed:23643382	19820032,23643382
P11362	FGFR1	S125L	P11362/S125L	FGFR1/S125L	VARIANT	S -> L (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs121913473)	ECO:0000269|PubMed:17344846	17344846
P11362	FGFR1	D129A	P11362/D129A	FGFR1/D129A	VARIANT	D -> A (in HH2; dbSNP:rs765615419)	ECO:0000269|PubMed:15605412	15605412
P11362	FGFR1	L165S	P11362/L165S	FGFR1/L165S	VARIANT	L -> S (in HRTFDS; dbSNP:rs397515481)	ECO:0000269|PubMed:23812909	23812909
P11362	FGFR1	A167S	P11362/A167S	FGFR1/A167S	VARIANT	A -> S (in HH2; with cleft palate, corpus callosum agenesis, unilateral deafness and fusion of fourth and fifth metacarpal bones; dbSNP:rs121909630)	ECO:0000269|PubMed:12627230	12627230
P11362	FGFR1	V174A	P11362/V174A	FGFR1/V174A	VARIANT	V -> A (in HH2)	ECO:0000269|PubMed:25077900	25077900
P11362	FGFR1	C178S	P11362/C178S	FGFR1/C178S	VARIANT	C -> S (in HH2; with severe ear anomalies)	ECO:0000269|PubMed:16757108	16757108
P11362	FGFR1	L191S	P11362/L191S	FGFR1/L191S	VARIANT	L -> S (in HRTFDS; dbSNP:rs869025669)	ECO:0000269|PubMed:23812909	23812909
P11362	FGFR1	W213G	P11362/W213G	FGFR1/W213G	VARIANT	W -> G (in dbSNP:rs17851623)	ECO:0000269|PubMed:15489334	15489334
P11362	FGFR1	D224H	P11362/D224H	FGFR1/D224H	VARIANT	D -> H (in HH2)	ECO:0000269|PubMed:16764984	16764984
P11362	FGFR1	Y228D	P11362/Y228D	FGFR1/Y228D	VARIANT	Y -> D (in HH2; some patients also carry KISS1R mutations; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression)	ECO:0000269|PubMed:19820032, ECO:0000269|PubMed:23643382	19820032,23643382
P11362	FGFR1	G237D	P11362/G237D	FGFR1/G237D	VARIANT	G -> D (in HH2)	ECO:0000269|PubMed:16764984	16764984
P11362	FGFR1	G237S	P11362/G237S	FGFR1/G237S	VARIANT	G -> S (in HH2; with or without anosmia; also found in a family member with isolated anosmia; may impair proper folding; dbSNP:rs121909635)	ECO:0000269|PubMed:16606836	16606836
P11362	FGFR1	I239T	P11362/I239T	FGFR1/I239T	VARIANT	I -> T (in HH2; some patients also carry PROKR2 and GNRH1 mutations; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression)	ECO:0000269|PubMed:19820032, ECO:0000269|PubMed:23643382	19820032,23643382
P11362	FGFR1	L245P	P11362/L245P	FGFR1/L245P	VARIANT	L -> P (in HH2)	ECO:0000269|PubMed:16882753	16882753
P11362	FGFR1	R250Q	P11362/R250Q	FGFR1/R250Q	VARIANT	R -> Q (in HH2; with or without anosmia; results in Kallmann syndrome in the presence of HS6ST1 mutation TRP-306; reduces receptor affinity for fibroblast growth factor; dbSNP:rs121909645)	ECO:0000269|PubMed:19820032, ECO:0000269|PubMed:21700882, ECO:0000269|PubMed:23643382, ECO:0000269|PubMed:25077900	19820032,21700882,23643382,25077900
P11362	FGFR1	R250W	P11362/R250W	FGFR1/R250W	VARIANT	R -> W (in HH2)	ECO:0000269|PubMed:16882753, ECO:0000269|PubMed:17154279	16882753,17154279
P11362	FGFR1	P252R	P11362/P252R	FGFR1/P252R	VARIANT	P -> R (in PS and JWS; dbSNP:rs121909627)	ECO:0000269|PubMed:10861678, ECO:0000269|PubMed:7874169	10861678,7874169
P11362	FGFR1	P252T	P11362/P252T	FGFR1/P252T	VARIANT	P -> T (in a lung bronchoalveolar carcinoma sample; somatic mutation; dbSNP:rs121913472)	ECO:0000269|PubMed:17344846	17344846
P11362	FGFR1	R254Q	P11362/R254Q	FGFR1/R254Q	VARIANT	R -> Q (in HH2)	ECO:0000269|PubMed:16764984	16764984
P11362	FGFR1	G270D	P11362/G270D	FGFR1/G270D	VARIANT	G -> D (in HH2)	ECO:0000269|PubMed:17154279	17154279
P11362	FGFR1	V273M	P11362/V273M	FGFR1/V273M	VARIANT	V -> M (in HH2; dbSNP:rs1131691929)	ECO:0000269|PubMed:15605412, ECO:0000269|PubMed:16764984	15605412,16764984
P11362	FGFR1	E274G	P11362/E274G	FGFR1/E274G	VARIANT	E -> G (in HH2; also found in a family member with isolated anosmia; dbSNP:rs727505369)		
P11362	FGFR1	C277Y	P11362/C277Y	FGFR1/C277Y	VARIANT	C -> Y (in HH2)	ECO:0000269|PubMed:12627230	12627230
P11362	FGFR1	P283R	P11362/P283R	FGFR1/P283R	VARIANT	P -> R (in HH2)	ECO:0000269|PubMed:17154279	17154279
P11362	FGFR1	I300T	P11362/I300T	FGFR1/I300T	VARIANT	I -> T (in TRIGNO1; dbSNP:rs121909633)	ECO:0000269|PubMed:11173846	11173846
P11362	FGFR1	N330I	P11362/N330I	FGFR1/N330I	VARIANT	N -> I (in OGD; dbSNP:rs121909632)	ECO:0000269|PubMed:15625620, ECO:0000269|PubMed:16470795	15625620,16470795
P11362	FGFR1	S332C	P11362/S332C	FGFR1/S332C	VARIANT	S -> C (in HH2)	ECO:0000269|PubMed:17154279	17154279
P11362	FGFR1	Y339C	P11362/Y339C	FGFR1/Y339C	VARIANT	Y -> C (in HH2)	ECO:0000269|PubMed:16764984	16764984
P11362	FGFR1	L342S	P11362/L342S	FGFR1/L342S	VARIANT	L -> S (in HH2; phenotype consistent with Kallmann syndrome; the patient also carries a splice site mutation in NSMF; dbSNP:rs121909638)	ECO:0000269|PubMed:23643382	23643382
P11362	FGFR1	A343V	P11362/A343V	FGFR1/A343V	VARIANT	A -> V (in HH2)	ECO:0000269|PubMed:16882753	16882753
P11362	FGFR1	S346C	P11362/S346C	FGFR1/S346C	VARIANT	S -> C (in HH2; also found in a family member with isolated anosmia)	ECO:0000269|PubMed:16764984	16764984
P11362	FGFR1	G348R	P11362/G348R	FGFR1/G348R	VARIANT	G -> R (in HH2; phenotype consistent with Kallmann syndrome; the patient also carries a mutation in IL17RD; dbSNP:rs886037634)	ECO:0000269|PubMed:23643382, ECO:0000269|PubMed:25077900	23643382,25077900
P11362	FGFR1	P366L	P11362/P366L	FGFR1/P366L	VARIANT	P -> L (in HH2; with or without anosmia; dbSNP:rs121909641)	ECO:0000269|PubMed:16882753	16882753
P11362	FGFR1	Y374C	P11362/Y374C	FGFR1/Y374C	VARIANT	Y -> C (in OGD; elevated basal activity and increased FGF2-mediated activity; dbSNP:rs121909631)	ECO:0000269|PubMed:15625620	15625620
P11362	FGFR1	C381R	P11362/C381R	FGFR1/C381R	VARIANT	C -> R (in OGD; dbSNP:rs121909634)	ECO:0000269|PubMed:15625620, ECO:0000269|PubMed:16470795	15625620,16470795
P11362	FGFR1	R470L	P11362/R470L	FGFR1/R470L	VARIANT	R -> L (in HH2; some patients also carry GNRHR mutations; dbSNP:rs121909637)	ECO:0000269|PubMed:19820032, ECO:0000269|PubMed:23643382	19820032,23643382
P11362	FGFR1	P483T	P11362/P483T	FGFR1/P483T	VARIANT	P -> T (in HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in SPRY4; dbSNP:rs397515444)	ECO:0000269|PubMed:23643382	23643382
P11362	FGFR1	G490R	P11362/G490R	FGFR1/G490R	VARIANT	G -> R (in HRTFDS; dbSNP:rs869025670)	ECO:0000269|PubMed:23812909	23812909
P11362	FGFR1	A520T	P11362/A520T	FGFR1/A520T	VARIANT	A -> T (in HH2; dbSNP:rs749758370)	ECO:0000269|PubMed:15605412	15605412
P11362	FGFR1	I538V	P11362/I538V	FGFR1/I538V	VARIANT	I -> V (in HH2)	ECO:0000269|PubMed:16764984	16764984
P11362	FGFR1	N546K	P11362/N546K	FGFR1/N546K	VARIANT	N -> K (in ECCL; somatic mutation; activating mutation; strongly increased speed of the first autophosphorylation and loss of the normal sequential order of autophosphorylation; dbSNP:rs779707422)	ECO:0000269|PubMed:19224897, ECO:0000269|PubMed:26942290	19224897,26942290
P11362	FGFR1	V561M	P11362/V561M	FGFR1/V561M	VARIANT	V -> M	ECO:0000269|PubMed:26942290	26942290
P11362	FGFR1	V607M	P11362/V607M	FGFR1/V607M	VARIANT	V -> M (in HH2; with bimanual synkinesis; dbSNP:rs121909629)	ECO:0000269|PubMed:12627230	12627230
P11362	FGFR1	K618N	P11362/K618N	FGFR1/K618N	VARIANT	K -> N (in HH2; some patients also carry GNRHR mutations; impairs tyrosine kinase activity)	ECO:0000269|PubMed:19820032, ECO:0000269|PubMed:23643382	19820032,23643382
P11362	FGFR1	H621R	P11362/H621R	FGFR1/H621R	VARIANT	H -> R (in HH2)	ECO:0000269|PubMed:17154279	17154279
P11362	FGFR1	R622G	P11362/R622G	FGFR1/R622G	VARIANT	R -> G (in HH2; with severe ear anomalies; dbSNP:rs121909628)	ECO:0000269|PubMed:16757108	16757108
P11362	FGFR1	R622Q	P11362/R622Q	FGFR1/R622Q	VARIANT	R -> Q (in HH2)	ECO:0000269|PubMed:16757108	16757108
P11362	FGFR1	D623Y	P11362/D623Y	FGFR1/D623Y	VARIANT	D -> Y (in HRTFDS; dbSNP:rs398122946)	ECO:0000269|PubMed:23812909	23812909
P11362	FGFR1	R627T	P11362/R627T	FGFR1/R627T	VARIANT	R -> T (in HRTFDS; dbSNP:rs869025671)	ECO:0000269|PubMed:24888332	24888332
P11362	FGFR1	N628K	P11362/N628K	FGFR1/N628K	VARIANT	N -> K (in HRTFDS; dbSNP:rs869025672)	ECO:0000269|PubMed:23812909	23812909
P11362	FGFR1	K656E	P11362/K656E	FGFR1/K656E	VARIANT	K -> E (in ECCL; somatic mutation; dbSNP:rs869320694)	ECO:0000269|PubMed:26942290	26942290
P11362	FGFR1	V664L	P11362/V664L	FGFR1/V664L	VARIANT	V -> L (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P11362	FGFR1	W666R	P11362/W666R	FGFR1/W666R	VARIANT	W -> R (in HH2; with cleft palate; dbSNP:rs1563433902)	ECO:0000269|PubMed:12627230	12627230
P11362	FGFR1	E670K	P11362/E670K	FGFR1/E670K	VARIANT	E -> K (in HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in FLRT3; dbSNP:rs397515446)	ECO:0000269|PubMed:23643382	23643382
P11362	FGFR1	A671P	P11362/A671P	FGFR1/A671P	VARIANT	A -> P (in HH2)	ECO:0000269|PubMed:19820032	19820032
P11362	FGFR1	S685F	P11362/S685F	FGFR1/S685F	VARIANT	S -> F (in HH2)	ECO:0000269|PubMed:17154279	17154279
P11362	FGFR1	G687R	P11362/G687R	FGFR1/G687R	VARIANT	G -> R (in HH2; dbSNP:rs727505376)	ECO:0000269|PubMed:15845591, ECO:0000269|PubMed:22927827	15845591,22927827
P11362	FGFR1	E692G	P11362/E692G	FGFR1/E692G	VARIANT	E -> G (in HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in DUSP6; dbSNP:rs397515445)	ECO:0000269|PubMed:23643382	23643382
P11362	FGFR1	I693F	P11362/I693F	FGFR1/I693F	VARIANT	I -> F (in HH2)	ECO:0000269|PubMed:17154279	17154279
P11362	FGFR1	G703R	P11362/G703R	FGFR1/G703R	VARIANT	G -> R (in HH2)	ECO:0000269|PubMed:16764984	16764984
P11362	FGFR1	G703S	P11362/G703S	FGFR1/G703S	VARIANT	G -> S (in HH2; dbSNP:rs768957161)	ECO:0000269|PubMed:16764984	16764984
P11362	FGFR1	M719R	P11362/M719R	FGFR1/M719R	VARIANT	M -> R (in HH2)	ECO:0000269|PubMed:12627230	12627230
P11362	FGFR1	M719V	P11362/M719V	FGFR1/M719V	VARIANT	M -> V (in HH2; unknown pathological significance; dbSNP:rs1085307879)	ECO:0000269|PubMed:26277103	26277103
P11362	FGFR1	P722H	P11362/P722H	FGFR1/P722H	VARIANT	P -> H (in HH2; associated with K-724; also found in a family member with isolated anosmia; reduced tyrosine kinase activity; dbSNP:rs267606805)	ECO:0000269|PubMed:16606836, ECO:0000269|PubMed:23643382	16606836,23643382
P11362	FGFR1	P722S	P11362/P722S	FGFR1/P722S	VARIANT	P -> S (in HH2; dbSNP:rs121909642)	ECO:0000269|PubMed:16882753	16882753
P11362	FGFR1	N724K	P11362/N724K	FGFR1/N724K	VARIANT	N -> K (in HH2; associated with H-722; also found in a family member with isolated anosmia; reduced tyrosine kinase activity; dbSNP:rs267606806)	ECO:0000269|PubMed:16606836, ECO:0000269|PubMed:23643382	16606836,23643382
P11362	FGFR1	C725Y	P11362/C725Y	FGFR1/C725Y	VARIANT	C -> Y (in HRTFDS; dbSNP:rs398122945)	ECO:0000269|PubMed:23812909	23812909
P11362	FGFR1	P745S	P11362/P745S	FGFR1/P745S	VARIANT	P -> S (in HH2)	ECO:0000269|PubMed:15001591, ECO:0000269|PubMed:15845591	15001591,15845591
P11362	FGFR1	D768Y	P11362/D768Y	FGFR1/D768Y	VARIANT	D -> Y (in HH2; the patient also carries a rare variant in FGF8; dbSNP:rs121909644)	ECO:0000269|PubMed:23643382	23643382
P11362	FGFR1	L769V	P11362/L769V	FGFR1/L769V	VARIANT	L -> V (in dbSNP:rs2956723)	ECO:0000269|PubMed:16764984	16764984
P11362	FGFR1	P772S	P11362/P772S	FGFR1/P772S	VARIANT	P -> S (in dbSNP:rs56234888)	ECO:0000269|PubMed:12627230, ECO:0000269|PubMed:17154279	12627230,17154279
P11362	FGFR1	V795I	P11362/V795I	FGFR1/V795I	VARIANT	V -> I (in HH2; also found in a family member with isolated anosmia; dbSNP:rs781328162)	ECO:0000269|PubMed:16882753	16882753
P11362	FGFR1	G818R	P11362/G818R	FGFR1/G818R	VARIANT	G -> R (in dbSNP:rs17182456)	ECO:0000269|Ref.13	
P11362	FGFR1	R822C	P11362/R822C	FGFR1/R822C	VARIANT	R -> C (in dbSNP:rs17182463)	ECO:0000269|PubMed:17154279, ECO:0000269|Ref.13	17154279
P11362	FGFR1	K514A	P11362/K514A	FGFR1/K514A	MUTAGEN	K->A: Loss of kinase activity.	ECO:0000269|PubMed:15117958	15117958
P11362	FGFR1	R577E	P11362/R577E	FGFR1/R577E	MUTAGEN	R->E: Strongly reduced autophosphorylation in response to FGF signaling. No effect on in vitro kinase activity.	ECO:0000269|PubMed:20133753	20133753
P11362	FGFR1	R609V	P11362/R609V	FGFR1/R609V	MUTAGEN	R->V: Abolishes interaction with PLCG1.		
P11362	FGFR1	D623A	P11362/D623A	FGFR1/D623A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:19224897	19224897
P11362	FGFR1	Y653F	P11362/Y653F	FGFR1/Y653F	MUTAGEN	Y->F: No effect on kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-654.	ECO:0000269|PubMed:8622701	8622701
P11362	FGFR1	Y654F	P11362/Y654F	FGFR1/Y654F	MUTAGEN	Y->F: Reduced kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-653.	ECO:0000269|PubMed:8622701	8622701
P11362	FGFR1	D755V	P11362/D755V	FGFR1/D755V	MUTAGEN	D->V: Abolishes interaction with PLCG1.		
P11362	FGFR1	Y766F	P11362/Y766F	FGFR1/Y766F	MUTAGEN	Y->F: Abolishes interaction with PLCG1 and SHB. Decreases phosphorylation of FRS2, activation of RAS and MAP kinase signaling and stimulation of cell proliferation.	ECO:0000269|PubMed:12181353, ECO:0000269|PubMed:1379697, ECO:0000269|PubMed:1379698, ECO:0000269|PubMed:7516330	12181353,1379697,1379698,7516330

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P11801	PSKH1	N301S	P11801/N301S	PSKH1/N301S	VARIANT	N -> S (in dbSNP:rs35552721)	ECO:0000269|PubMed:17344846	17344846
P11801	PSKH1	D218A	P11801/D218A	PSKH1/D218A	MUTAGEN	D->A: Loss of autophosphorylation.	ECO:0000269|PubMed:11087665	11087665

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P11802	CDK4	R24C	P11802/R24C	CDK4/R24C	VARIANT	R -> C (in CMM3; somatic and familial; generates a dominant oncogene resistant to inhibition by p16(INK4a); dbSNP:rs11547328)	ECO:0000269|PubMed:7652577, ECO:0000269|PubMed:8528263	7652577,8528263
P11802	CDK4	R24H	P11802/R24H	CDK4/R24H	VARIANT	R -> H (in CMM3; dbSNP:rs104894340)	ECO:0000269|PubMed:9425228	9425228
P11802	CDK4	N41S	P11802/N41S	CDK4/N41S	VARIANT	N -> S (in CMM3; sporadic; dbSNP:rs144890720)	ECO:0000269|PubMed:9311594	9311594
P11802	CDK4	R82Q	P11802/R82Q	CDK4/R82Q	VARIANT	R -> Q (in dbSNP:rs3211612)	ECO:0000269|Ref.5	
P11802	CDK4	R122H	P11802/R122H	CDK4/R122H	VARIANT	R -> H (in dbSNP:rs34386532)	ECO:0000269|PubMed:17344846	17344846
P11802	CDK4	T172A	P11802/T172A	CDK4/T172A	MUTAGEN	T->A: Weak enzyme activity towards RB1, but no effect on binding of CCDN1 nor CCDN3.	ECO:0000269|PubMed:16782892	16782892
P11802	CDK4	T172E	P11802/T172E	CDK4/T172E	MUTAGEN	T->E: Retains moderate enzyme activity.	ECO:0000269|PubMed:16782892	16782892
P11802	CDK4	P173S	P11802/P173S	CDK4/P173S	MUTAGEN	P->S: No effect on in vitro phosphorylation by CDK7. Greatly reduced T-172 phosphorylation and enzyme activity.	ECO:0000269|PubMed:19487459	19487459

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P12931	SRC	L176F	P12931/L176F	SRC/L176F	VARIANT	L -> F (in dbSNP:rs6018260)		
P12931	SRC	A237T	P12931/A237T	SRC/A237T	VARIANT	A -> T (in dbSNP:rs34881773)	ECO:0000269|PubMed:17344846	17344846
P12931	SRC	E527K	P12931/E527K	SRC/E527K	VARIANT	E -> K (in THC6; increased protein tyrosine kinase activity; increased autophosphorylation at Y-419; causes defective megakaryopoiesis associated with increased overall tyrosine phosphorylation in megakaryocytes; dbSNP:rs879255268)	ECO:0000269|PubMed:26936507	26936507
P12931	SRC	K298M	P12931/K298M	SRC/K298M	MUTAGEN	K->M: Kinase inactive. Abolishes ubiquitination promoted by CBLC.	ECO:0000269|PubMed:14661060	14661060
P12931	SRC	P302E	P12931/P302E	SRC/P302E	MUTAGEN	P->E: Kinase active. Interacts with PDLIM4; when associated with E-307 and F-419.	ECO:0000269|PubMed:19307596	19307596
P12931	SRC	P307E	P12931/P307E	SRC/P307E	MUTAGEN	P->E: Kinase active. Interacts with PDLIM4; when associated with E-302 and F-419.	ECO:0000269|PubMed:19307596	19307596
P12931	SRC	Y419F	P12931/Y419F	SRC/Y419F	MUTAGEN	Y->F: Loss of kinase activity. Loss of interaction with PDLIM4.	ECO:0000269|PubMed:19307596	19307596

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P14616	INSRR	A127E	P14616/A127E	INSRR/A127E	VARIANT	A -> E (in dbSNP:rs55757706)	ECO:0000269|PubMed:17344846	17344846
P14616	INSRR	A161V	P14616/A161V	INSRR/A161V	VARIANT	A -> V (in dbSNP:rs55971900)	ECO:0000269|PubMed:17344846	17344846
P14616	INSRR	R244H	P14616/R244H	INSRR/R244H	VARIANT	R -> H (in dbSNP:rs55951840)	ECO:0000269|PubMed:17344846	17344846
P14616	INSRR	C246R	P14616/C246R	INSRR/C246R	VARIANT	C -> R (in dbSNP:rs56377825)	ECO:0000269|PubMed:17344846	17344846
P14616	INSRR	E278Q	P14616/E278Q	INSRR/E278Q	VARIANT	E -> Q (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P14616	INSRR	R554C	P14616/R554C	INSRR/R554C	VARIANT	R -> C (in dbSNP:rs56068937)	ECO:0000269|PubMed:17344846	17344846
P14616	INSRR	P928L	P14616/P928L	INSRR/P928L	VARIANT	P -> L (in dbSNP:rs56252149)	ECO:0000269|PubMed:17344846	17344846
P14616	INSRR	G1065E	P14616/G1065E	INSRR/G1065E	VARIANT	G -> E (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P15056	BRAF	T241M	P15056/T241M	BRAF/T241M	VARIANT	T -> M (in NS7; dbSNP:rs387906660)	ECO:0000269|PubMed:19206169	19206169
P15056	BRAF	T241P	P15056/T241P	BRAF/T241P	VARIANT	T -> P (in CFC1 and LPRD3; dbSNP:rs387906661)	ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:19206169	18042262,19206169
P15056	BRAF	T241R	P15056/T241R	BRAF/T241R	VARIANT	T -> R (in NS7; dbSNP:rs387906660)	ECO:0000269|PubMed:19206169	19206169
P15056	BRAF	T244P	P15056/T244P	BRAF/T244P	VARIANT	T -> P (in CFC1; dbSNP:rs397507465)	ECO:0000269|PubMed:18042262	18042262
P15056	BRAF	L245F	P15056/L245F	BRAF/L245F	VARIANT	L -> F (in CFC1; dbSNP:rs397507466)	ECO:0000269|PubMed:19206169	19206169
P15056	BRAF	A246P	P15056/A246P	BRAF/A246P	VARIANT	A -> P (in CFC1; dbSNP:rs180177034)	ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:19206169	16474404,18042262,19206169
P15056	BRAF	Q257R	P15056/Q257R	BRAF/Q257R	VARIANT	Q -> R (in CFC1; dbSNP:rs180177035)	ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:19206169	16439621,16474404,18042262,19206169
P15056	BRAF	Q262K	P15056/Q262K	BRAF/Q262K	VARIANT	Q -> K (in CFC1; dbSNP:rs397507470)	ECO:0000269|PubMed:18042262	18042262
P15056	BRAF	E275K	P15056/E275K	BRAF/E275K	VARIANT	E -> K (in CFC1)	ECO:0000269|PubMed:19206169	19206169
P15056	BRAF	P301S	P15056/P301S	BRAF/P301S	VARIANT	P -> S (in dbSNP:rs34776339)	ECO:0000269|PubMed:17344846	17344846
P15056	BRAF	R462I	P15056/R462I	BRAF/R462I	VARIANT	R -> I (in CRC; dbSNP:rs180177032)	ECO:0000269|PubMed:12198537	12198537
P15056	BRAF	I463S	P15056/I463S	BRAF/I463S	VARIANT	I -> S (in CRC; dbSNP:rs180177033)	ECO:0000269|PubMed:12198537	12198537
P15056	BRAF	G464E	P15056/G464E	BRAF/G464E	VARIANT	G -> E (in CRC; dbSNP:rs121913348)	ECO:0000269|PubMed:12068308, ECO:0000269|PubMed:12198537	12068308,12198537
P15056	BRAF	G464V	P15056/G464V	BRAF/G464V	VARIANT	G -> V (in a colorectal cancer cell line; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913348)	ECO:0000269|PubMed:12068308	12068308
P15056	BRAF	G466A	P15056/G466A	BRAF/G466A	VARIANT	G -> A (in melanoma; dbSNP:rs121913351)	ECO:0000269|PubMed:12068308	12068308
P15056	BRAF	G466E	P15056/G466E	BRAF/G466E	VARIANT	G -> E (in melanoma; dbSNP:rs121913351)	ECO:0000269|PubMed:12068308	12068308
P15056	BRAF	G466V	P15056/G466V	BRAF/G466V	VARIANT	G -> V (in LNCR; dbSNP:rs121913351)	ECO:0000269|PubMed:12068308, ECO:0000269|PubMed:12460919	12068308,12460919
P15056	BRAF	S467A	P15056/S467A	BRAF/S467A	VARIANT	S -> A (in CFC1; dbSNP:rs869025606)	ECO:0000269|PubMed:16439621	16439621
P15056	BRAF	F468S	P15056/F468S	BRAF/F468S	VARIANT	F -> S (in CFC1; dbSNP:rs397507473)	ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:18042262	16439621,18042262
P15056	BRAF	G469A	P15056/G469A	BRAF/G469A	VARIANT	G -> A (in NHL; also in a lung adenocarcinoma sample; somatic mutation; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913355)	ECO:0000269|PubMed:12068308, ECO:0000269|PubMed:14612909, ECO:0000269|PubMed:17344846	12068308,14612909,17344846
P15056	BRAF	G469E	P15056/G469E	BRAF/G469E	VARIANT	G -> E (in CFC1 and colon cancer; dbSNP:rs121913355)	ECO:0000269|PubMed:12068308, ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:19206169	12068308,16439621,16474404,18042262,19206169
P15056	BRAF	G469R	P15056/G469R	BRAF/G469R	VARIANT	G -> R (in NHL; dbSNP:rs121913357)	ECO:0000269|PubMed:14612909	14612909
P15056	BRAF	G469V	P15056/G469V	BRAF/G469V	VARIANT	G -> V (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs121913355)	ECO:0000269|PubMed:17344846	17344846
P15056	BRAF	L485F	P15056/L485F	BRAF/L485F	VARIANT	L -> F (in CFC1; dbSNP:rs180177036)	ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:19206169	16439621,16474404,19206169
P15056	BRAF	K499E	P15056/K499E	BRAF/K499E	VARIANT	K -> E (in CFC1; dbSNP:rs180177037)	ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:18042262	16439621,16474404,18042262
P15056	BRAF	K499N	P15056/K499N	BRAF/K499N	VARIANT	K -> N (in CFC1; dbSNP:rs397507476)	ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:19206169	18042262,19206169
P15056	BRAF	E501G	P15056/E501G	BRAF/E501G	VARIANT	E -> G (in CFC1; dbSNP:rs180177039)	ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:16474404	16439621,16474404
P15056	BRAF	E501K	P15056/E501K	BRAF/E501K	VARIANT	E -> K (in CFC1; dbSNP:rs180177038)	ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:19206169	16439621,16474404,19206169
P15056	BRAF	L525P	P15056/L525P	BRAF/L525P	VARIANT	L -> P (in CFC1; dbSNP:rs869025340)	ECO:0000269|PubMed:19206169	19206169
P15056	BRAF	W531C	P15056/W531C	BRAF/W531C	VARIANT	W -> C (in NS7; dbSNP:rs606231228)	ECO:0000269|PubMed:19206169	19206169
P15056	BRAF	N580D	P15056/N580D	BRAF/N580D	VARIANT	N -> D (in CFC1)	ECO:0000269|PubMed:18042262	18042262
P15056	BRAF	N581D	P15056/N581D	BRAF/N581D	VARIANT	N -> D (in CFC1; dbSNP:rs180177040)	ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:18042262	16439621,16474404,18042262
P15056	BRAF	N581S	P15056/N581S	BRAF/N581S	VARIANT	N -> S (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs121913370)	ECO:0000269|PubMed:17344846	17344846
P15056	BRAF	E586K	P15056/E586K	BRAF/E586K	VARIANT	E -> K (in ovarian cancer; dbSNP:rs121913340)	ECO:0000269|PubMed:12068308	12068308
P15056	BRAF	D594G	P15056/D594G	BRAF/D594G	VARIANT	D -> G (in NHL; dbSNP:rs121913338)	ECO:0000269|PubMed:14612909	14612909
P15056	BRAF	F595L	P15056/F595L	BRAF/F595L	VARIANT	F -> L (in CFC1; also found in colon cancer; dbSNP:rs121913341)	ECO:0000269|PubMed:12068308, ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:19206169	12068308,16439621,18042262,19206169
P15056	BRAF	G596R	P15056/G596R	BRAF/G596R	VARIANT	G -> R (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs121913361)	ECO:0000269|PubMed:12068308, ECO:0000269|PubMed:17344846	12068308,17344846
P15056	BRAF	G596V	P15056/G596V	BRAF/G596V	VARIANT	G -> V (in CFC1; dbSNP:rs397507483)	ECO:0000269|PubMed:16439621	16439621
P15056	BRAF	L597R	P15056/L597R	BRAF/L597R	VARIANT	L -> R (in LNCR; also found in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs121913366)	ECO:0000269|PubMed:12068308, ECO:0000269|PubMed:12460919, ECO:0000269|PubMed:17344846	12068308,12460919,17344846
P15056	BRAF	L597V	P15056/L597V	BRAF/L597V	VARIANT	L -> V (in NS7; also in a lung adenocarcinoma sample; somatic mutation; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913369)	ECO:0000269|PubMed:12068308, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19206169	12068308,17344846,19206169
P15056	BRAF	T599R	P15056/T599R	BRAF/T599R	VARIANT	T -> R (in CFC1; dbSNP:rs121913375)	ECO:0000269|PubMed:19206169	19206169
P15056	BRAF	V600D	P15056/V600D	BRAF/V600D	VARIANT	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions; dbSNP:rs121913377)	ECO:0000269|PubMed:12068308	12068308
P15056	BRAF	V600E	P15056/V600E	BRAF/V600E	VARIANT			
P15056	BRAF	K601E	P15056/K601E	BRAF/K601E	VARIANT	K -> E (in CRC; dbSNP:rs121913364)	ECO:0000269|PubMed:12198537	12198537
P15056	BRAF	K601Q	P15056/K601Q	BRAF/K601Q	VARIANT	K -> Q (in CFC1; dbSNP:rs121913364)	ECO:0000269|PubMed:19206169	19206169
P15056	BRAF	D638E	P15056/D638E	BRAF/D638E	VARIANT	D -> E (in CFC1; dbSNP:rs180177042)	ECO:0000269|PubMed:19206169	19206169
P15056	BRAF	Q709R	P15056/Q709R	BRAF/Q709R	VARIANT	Q -> R (in CFC1; dbSNP:rs397507486)	ECO:0000269|PubMed:19206169	19206169
P15056	BRAF	M53D	P15056/M53D	BRAF/M53D	MUTAGEN	M->D: Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1.	ECO:0000269|PubMed:29433126	29433126
P15056	BRAF	K88E	P15056/K88E	BRAF/K88E	MUTAGEN	K->E: Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1.	ECO:0000269|PubMed:29433126	29433126
P15056	BRAF	K483S	P15056/K483S	BRAF/K483S	MUTAGEN	K->S: Reduces kinase activity with MAP2K1.	ECO:0000269|PubMed:21441910	21441910
P15056	BRAF	R509H	P15056/R509H	BRAF/R509H	MUTAGEN	R->H: Loss of MAP2K1-mediated-BRAF-KSR1 dimerization.	ECO:0000269|PubMed:29433126	29433126
P15056	BRAF	K578R	P15056/K578R	BRAF/K578R	MUTAGEN	K->R: Blocks EGF-induced ubiquitination and ERK activation.	ECO:0000269|PubMed:23907581	23907581
P15056	BRAF	I666R	P15056/I666R	BRAF/I666R	MUTAGEN	I->R: No effect on MAP2K1-mediated-BRAF-KSR1 dimerization, however loss of BRAF-mediated phosphorylation of MAP2K1.	ECO:0000269|PubMed:29433126	29433126
P15056	BRAF	R671K	P15056/R671K	BRAF/R671K	MUTAGEN	R->K: Increased kinase activity and stability in response to EGF treatment.	ECO:0000269|PubMed:21917714	21917714

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P15735	PHKG2	V106E	P15735/V106E	PHKG2/V106E	VARIANT	V -> E (in GSD9C; dbSNP:rs137853589)	ECO:0000269|PubMed:8896567	8896567
P15735	PHKG2	E157K	P15735/E157K	PHKG2/E157K	VARIANT	E -> K (in GSD9C; dbSNP:rs752961445)	ECO:0000269|PubMed:12930917	12930917
P15735	PHKG2	G189E	P15735/G189E	PHKG2/G189E	VARIANT	G -> E (in GSD9C; dbSNP:rs137853588)	ECO:0000269|PubMed:8896567	8896567
P15735	PHKG2	D215N	P15735/D215N	PHKG2/D215N	VARIANT	D -> N (in GSD9C; dbSNP:rs767427889)	ECO:0000269|PubMed:12930917	12930917
P15735	PHKG2	E247G	P15735/E247G	PHKG2/E247G	VARIANT	E -> G (in dbSNP:rs34006569)		
P15735	PHKG2	A317T	P15735/A317T	PHKG2/A317T	VARIANT	A -> T (in dbSNP:rs759992249)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P16066	NPR1	A182V	P16066/A182V	NPR1/A182V	VARIANT	A -> V (in dbSNP:rs56019647)	ECO:0000269|PubMed:17344846	17344846
P16066	NPR1	F270C	P16066/F270C	NPR1/F270C	VARIANT	F -> C (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P16066	NPR1	V755M	P16066/V755M	NPR1/V755M	VARIANT	V -> M (in dbSNP:rs55837780)	ECO:0000269|PubMed:17344846	17344846
P16066	NPR1	R939Q	P16066/R939Q	NPR1/R939Q	VARIANT	R -> Q (in dbSNP:rs35240348)	ECO:0000269|PubMed:17344846	17344846
P16066	NPR1	E967K	P16066/E967K	NPR1/E967K	VARIANT	E -> K (in dbSNP:rs35479618)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P16234	PDGFRA	G79D	P16234/G79D	PDGFRA/G79D	VARIANT	G -> D (in dbSNP:rs36035373)	ECO:0000269|PubMed:17344846	17344846
P16234	PDGFRA	G426D	P16234/G426D	PDGFRA/G426D	VARIANT	G -> D (in dbSNP:rs55865821)	ECO:0000269|PubMed:17344846	17344846
P16234	PDGFRA	S478P	P16234/S478P	PDGFRA/S478P	VARIANT	S -> P (in dbSNP:rs35597368)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	14702039,15489334,17344846
P16234	PDGFRA	R481G	P16234/R481G	PDGFRA/R481G	VARIANT	R -> G (in a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation)	ECO:0000269|PubMed:21224473	21224473
P16234	PDGFRA	L507P	P16234/L507P	PDGFRA/L507P	VARIANT	L -> P (in a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation)	ECO:0000269|PubMed:21224473	21224473
P16234	PDGFRA	Y555C	P16234/Y555C	PDGFRA/Y555C	VARIANT	Y -> C (in GISTPS; increased platelet-derived growth factor alpha-receptor activity; constitutively activated kinase; dbSNP:rs121908589)	ECO:0000269|PubMed:17087943	17087943
P16234	PDGFRA	V561D	P16234/V561D	PDGFRA/V561D	VARIANT	V -> D (in a GIST sample; constitutively activated kinase; dbSNP:rs121908586)	ECO:0000269|PubMed:12522257, ECO:0000269|PubMed:15928335	12522257,15928335
P16234	PDGFRA	I562M	P16234/I562M	PDGFRA/I562M	VARIANT	I -> M (in a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation)	ECO:0000269|PubMed:21224473	21224473
P16234	PDGFRA	H570R	P16234/H570R	PDGFRA/H570R	VARIANT	H -> R (in a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation)	ECO:0000269|PubMed:21224473	21224473
P16234	PDGFRA	H650Q	P16234/H650Q	PDGFRA/H650Q	VARIANT	H -> Q (in a hypereosinophilic syndrome sample; constitutively activated kinase)	ECO:0000269|PubMed:21224473	21224473
P16234	PDGFRA	P653L	P16234/P653L	PDGFRA/P653L	VARIANT	P -> L (in GISTPS; unknown pathological significance)	ECO:0000269|PubMed:25975287	25975287
P16234	PDGFRA	N659K	P16234/N659K	PDGFRA/N659K	VARIANT	N -> K (in GIST sample; constitutively activated kinase; dbSNP:rs1057519700)	ECO:0000269|PubMed:15928335	15928335
P16234	PDGFRA	N659S	P16234/N659S	PDGFRA/N659S	VARIANT	N -> S (in a hypereosinophilic syndrome sample; constitutively activated kinase)	ECO:0000269|PubMed:21224473	21224473
P16234	PDGFRA	L705P	P16234/L705P	PDGFRA/L705P	VARIANT	L -> P (in a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation)	ECO:0000269|PubMed:21224473	21224473
P16234	PDGFRA	R748G	P16234/R748G	PDGFRA/R748G	VARIANT	R -> G (in a hypereosinophilic syndrome sample; constitutively activated kinase)	ECO:0000269|PubMed:21224473	21224473
P16234	PDGFRA	R764C	P16234/R764C	PDGFRA/R764C	VARIANT	R -> C (in dbSNP:rs34392012)	ECO:0000269|PubMed:17344846	17344846
P16234	PDGFRA	G829R	P16234/G829R	PDGFRA/G829R	VARIANT	G -> R (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P16234	PDGFRA	D842V	P16234/D842V	PDGFRA/D842V	VARIANT	D -> V (in a GIST sample; imatinib resistant, constitutively activated kinase; dbSNP:rs121908585)	ECO:0000269|PubMed:12522257, ECO:0000269|PubMed:15928335, ECO:0000269|PubMed:20972453	12522257,15928335,20972453
P16234	PDGFRA	D842Y	P16234/D842Y	PDGFRA/D842Y	VARIANT	D -> Y (in a GIST sample; imatinib sensitive, constitutively activated kinase; dbSNP:rs121913265)	ECO:0000269|PubMed:15928335	15928335
P16234	PDGFRA	D846Y	P16234/D846Y	PDGFRA/D846Y	VARIANT	D -> Y (in GISTPS; unknown pathological significance; dbSNP:rs121908588)	ECO:0000269|PubMed:14699510	14699510
P16234	PDGFRA	Y849C	P16234/Y849C	PDGFRA/Y849C	VARIANT	Y -> C (in GIST)	ECO:0000269|PubMed:15928335	15928335
P16234	PDGFRA	Y849S	P16234/Y849S	PDGFRA/Y849S	VARIANT	Y -> S (in a hypereosinophilic syndrome sample; constitutively activated kinase)	ECO:0000269|PubMed:21224473	21224473
P16234	PDGFRA	E996K	P16234/E996K	PDGFRA/E996K	VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs779173667)	ECO:0000269|PubMed:17344846	17344846
P16234	PDGFRA	D1071N	P16234/D1071N	PDGFRA/D1071N	VARIANT	D -> N (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs376544204)	ECO:0000269|PubMed:17344846	17344846
P16234	PDGFRA	Y572F	P16234/Y572F	PDGFRA/Y572F	MUTAGEN	Y->F: Abolishes interaction with SRC-family members and impairs internalization of the activated receptor; when associated with F-574.	ECO:0000269|PubMed:10734113, ECO:0000269|PubMed:14644164	10734113,14644164
P16234	PDGFRA	Y574F	P16234/Y574F	PDGFRA/Y574F	MUTAGEN	Y->F: Abolishes interaction with SRC-family members and impairs internalization of the activated receptor; when associated with F-572.	ECO:0000269|PubMed:10734113, ECO:0000269|PubMed:14644164	10734113,14644164
P16234	PDGFRA	Y720F	P16234/Y720F	PDGFRA/Y720F	MUTAGEN	Y->F: Strongly reduced interaction with PTPN11 and GRB2.	ECO:0000269|PubMed:8943348	8943348
P16234	PDGFRA	Y731F	P16234/Y731F	PDGFRA/Y731F	MUTAGEN	Y->F: No effect on autophosphorylation and phosphorylation of PLCG1. Abolishes activation of phosphatidylinositol 3-kinase.	ECO:0000269|PubMed:1646396	1646396
P16234	PDGFRA	Y742F	P16234/Y742F	PDGFRA/Y742F	MUTAGEN	Y->F: No effect on autophosphorylation and phosphorylation of PLCG1. Abolishes activation of phosphatidylinositol 3-kinase.	ECO:0000269|PubMed:1646396	1646396
P16234	PDGFRA	Y762F	P16234/Y762F	PDGFRA/Y762F	MUTAGEN	Y->F: Abolishes interaction with CRK.	ECO:0000269|PubMed:10733900	10733900

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P16591	FER	V128F	P16591/V128F	FER/V128F	VARIANT	V -> F (in dbSNP:rs35150210)	ECO:0000269|PubMed:17344846	17344846
P16591	FER	E404Q	P16591/E404Q	FER/E404Q	VARIANT	E -> Q (in an ovarian Endometrioid carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P16591	FER	M412V	P16591/M412V	FER/M412V	VARIANT	M -> V (in dbSNP:rs33940843)	ECO:0000269|PubMed:17344846	17344846
P16591	FER	L439V	P16591/L439V	FER/L439V	VARIANT	L -> V (in dbSNP:rs2229086)	ECO:0000269|PubMed:1651563, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2725517	1651563,17344846,2725517
P16591	FER	A443P	P16591/A443P	FER/A443P	VARIANT	A -> P (in dbSNP:rs34259824)	ECO:0000269|PubMed:17344846	17344846
P16591	FER	W460C	P16591/W460C	FER/W460C	VARIANT	W -> C (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P16591	FER	I507T	P16591/I507T	FER/I507T	VARIANT	I -> T (in dbSNP:rs34204308)		
P16591	FER	E813Q	P16591/E813Q	FER/E813Q	VARIANT	E -> Q (in dbSNP:rs56097357)	ECO:0000269|PubMed:17344846	17344846
P16591	FER	R483Q	P16591/R483Q	FER/R483Q	MUTAGEN	R->Q: Abolishes kinase activity. Abolishes location at microtubules.	ECO:0000269|PubMed:12972546	12972546
P16591	FER	K591R	P16591/K591R	FER/K591R	MUTAGEN	K->R: Abolishes kinase activity.	ECO:0000269|PubMed:9722593	9722593

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P17252	PRKCA	P98S	P17252/P98S	PRKCA/P98S	VARIANT	P -> S (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P17252	PRKCA	D467N	P17252/D467N	PRKCA/D467N	VARIANT	D -> N (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P17252	PRKCA	M489V	P17252/M489V	PRKCA/M489V	VARIANT	M -> V (in dbSNP:rs34406842)	ECO:0000269|PubMed:17344846	17344846
P17252	PRKCA	V568I	P17252/V568I	PRKCA/V568I	VARIANT	V -> I (in dbSNP:rs6504459)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:19054851, ECO:0000269|PubMed:2336401, ECO:0000269|Ref.4	15489334,19054851,2336401

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P17612	PRKACA	L41V	P17612/L41V	PRKACA/L41V	VARIANT	L -> V (in dbSNP:rs56029020)	ECO:0000269|PubMed:17344846	17344846
P17612	PRKACA	R46Q	P17612/R46Q	PRKACA/R46Q	VARIANT	R -> Q (in dbSNP:rs56085217)	ECO:0000269|PubMed:17344846	17344846
P17612	PRKACA	G137R	P17612/G137R	PRKACA/G137R	VARIANT	G -> R (in CAFD1; decreased interaction with regulatory subunit PRKAR2B)	ECO:0000269|PubMed:33058759	33058759
P17612	PRKACA	L206R	P17612/L206R	PRKACA/L206R	VARIANT	L -> R (in PPNAD4; somatic mutation; the mutation results in cAMP-independent basal protein kinase activity and constitutive activation of protein kinase A; dbSNP:rs386352352)	ECO:0000269|PubMed:24571724, ECO:0000269|PubMed:24700472, ECO:0000269|PubMed:24747643, ECO:0000269|PubMed:24855271	24571724,24700472,24747643,24855271
P17612	PRKACA	S264C	P17612/S264C	PRKACA/S264C	VARIANT	S -> C (in dbSNP:rs35635531)	ECO:0000269|PubMed:17344846	17344846
P17612	PRKACA	K48R	P17612/K48R	PRKACA/K48R	MUTAGEN	K->R: Enhanced basal kinase activity; when associated with Q-96, L-121, A-124, K-182 and A-184.	ECO:0000269|PubMed:21774789	21774789
P17612	PRKACA	L96Q	P17612/L96Q	PRKACA/L96Q	MUTAGEN	L->Q: Enhanced basal kinase activity; when associated with R-48, L-121, A-124, K-182 and A-184.	ECO:0000269|PubMed:21774789	21774789
P17612	PRKACA	M121L	P17612/M121L	PRKACA/M121L	MUTAGEN	M->L: Enhanced basal kinase activity; when associated with R-48, Q-96, A-124, K-182 and A-184.	ECO:0000269|PubMed:21774789	21774789
P17612	PRKACA	V124A	P17612/V124A	PRKACA/V124A	MUTAGEN	V->A: Enhanced basal kinase activity; when associated with R-48, Q-96, L-121, K-182 and A-184.	ECO:0000269|PubMed:21774789	21774789
P17612	PRKACA	Q182K	P17612/Q182K	PRKACA/Q182K	MUTAGEN	Q->K: Enhanced basal kinase activity; when associated with R-48, Q-96, L-121, A-124 and A-184.	ECO:0000269|PubMed:21774789	21774789
P17612	PRKACA	T184A	P17612/T184A	PRKACA/T184A	MUTAGEN	T->A: Enhanced basal kinase activity; when associated with R-48, Q-96, L-121, A-124 and K-182.	ECO:0000269|PubMed:21774789	21774789
P17612	PRKACA	R195A	P17612/R195A	PRKACA/R195A	MUTAGEN	R->A: No phosphorylation.	ECO:0000269|PubMed:12372837	12372837
P17612	PRKACA	G201A	P17612/G201A	PRKACA/G201A	MUTAGEN	G->A: No phosphorylation.	ECO:0000269|PubMed:12372837	12372837
P17612	PRKACA	T202A	P17612/T202A	PRKACA/T202A	MUTAGEN	T->A: No phosphorylation.	ECO:0000269|PubMed:12372837	12372837
P17612	PRKACA	Y205A	P17612/Y205A	PRKACA/Y205A	MUTAGEN	Y->A: Loss of allosteric regulation.	ECO:0000269|PubMed:18178622	18178622

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P17948	FLT1	K60T	P17948/K60T	FLT1/K60T	VARIANT	K -> T (in dbSNP:rs56409818)	ECO:0000269|PubMed:17344846	17344846
P17948	FLT1	I128L	P17948/I128L	FLT1/I128L	VARIANT	I -> L (in dbSNP:rs35073261)		
P17948	FLT1	E144K	P17948/E144K	FLT1/E144K	VARIANT	E -> K (in dbSNP:rs55974987)	ECO:0000269|PubMed:17344846	17344846
P17948	FLT1	R281Q	P17948/R281Q	FLT1/R281Q	VARIANT	R -> Q (in dbSNP:rs55687105)	ECO:0000269|PubMed:17344846	17344846
P17948	FLT1	L422I	P17948/L422I	FLT1/L422I	VARIANT	L -> I (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P17948	FLT1	R781Q	P17948/R781Q	FLT1/R781Q	VARIANT	R -> Q (in a glioma low grade oligodendroglioma sample; somatic mutation; dbSNP:rs553261958)	ECO:0000269|PubMed:17344846	17344846
P17948	FLT1	M938V	P17948/M938V	FLT1/M938V	VARIANT	M -> V (in dbSNP:rs35549791)	ECO:0000269|PubMed:17344846	17344846
P17948	FLT1	E982A	P17948/E982A	FLT1/E982A	VARIANT	E -> A (in dbSNP:rs35832528)	ECO:0000269|PubMed:17344846	17344846
P17948	FLT1	L1061V	P17948/L1061V	FLT1/L1061V	VARIANT	L -> V (in a bladder transitional cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P17948	FLT1	V767A	P17948/V767A	FLT1/V767A	MUTAGEN	V->A: Abolishes proteolytic cleavage by PSEN1.	ECO:0000269|PubMed:22016384	22016384
P17948	FLT1	K861M	P17948/K861M	FLT1/K861M	MUTAGEN	K->M: Abolishes enzyme activity. Abolishes interaction with PLCG.	ECO:0000269|PubMed:9299537	9299537
P17948	FLT1	Y914F	P17948/Y914F	FLT1/Y914F	MUTAGEN	Y->F: Reduces phosphorylation at other tyrosine residues.	ECO:0000269|PubMed:9722576	9722576
P17948	FLT1	N1050D	P17948/N1050D	FLT1/N1050D	MUTAGEN	N->D: Strongly increases kinase activity. Increases activity in promoting proliferation of endothelial cells.	ECO:0000269|PubMed:16286478	16286478
P17948	FLT1	Y1169F	P17948/Y1169F	FLT1/Y1169F	MUTAGEN	Y->F: Loss of phosphorylation site. Abolishes interaction with PLCG.	ECO:0000269|PubMed:9299537	9299537
P17948	FLT1	Y1213F	P17948/Y1213F	FLT1/Y1213F	MUTAGEN	Y->F: Loss of phosphorylation site. Abolishes interaction with PIK3R1.	ECO:0000269|PubMed:9722576	9722576
P17948	FLT1	Y1242F	P17948/Y1242F	FLT1/Y1242F	MUTAGEN	Y->F: Loss of phosphorylation site.	ECO:0000269|PubMed:9722576	9722576
P17948	FLT1	Y1327F	P17948/Y1327F	FLT1/Y1327F	MUTAGEN	Y->F: Loss of phosphorylation site.	ECO:0000269|PubMed:9722576	9722576
P17948	FLT1	Y1333F	P17948/Y1333F	FLT1/Y1333F	MUTAGEN	Y->F: Loss of phosphorylation site. Abolishes interaction with CBL.	ECO:0000269|PubMed:15001553, ECO:0000269|PubMed:9722576	15001553,9722576

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P19525	EIF2AK2	M11L	P19525/M11L	EIF2AK2/M11L	VARIANT	M -> L (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells)	ECO:0000269|PubMed:32197074	32197074
P19525	EIF2AK2	N32S	P19525/N32S	EIF2AK2/N32S	VARIANT	N -> S (in LEUDEN; unknown pathological significance)	ECO:0000269|PubMed:32197074	32197074
P19525	EIF2AK2	N32T	P19525/N32T	EIF2AK2/N32T	VARIANT	N -> T (in DYT33; unknown pathological significance; gain-of-function variant resulting in increased levels of phosphorylated EIF2AK2 and EIF2A in patient cells compared to controls)	ECO:0000269|PubMed:33236446	33236446
P19525	EIF2AK2	S97F	P19525/S97F	EIF2AK2/S97F	VARIANT	S -> F (in LEUDEN; unknown pathological significance)	ECO:0000269|PubMed:32197074	32197074
P19525	EIF2AK2	A109S	P19525/A109S	EIF2AK2/A109S	VARIANT	A -> S (in LEUDEN; unknown pathological significance)	ECO:0000269|PubMed:32197074	32197074
P19525	EIF2AK2	A109V	P19525/A109V	EIF2AK2/A109V	VARIANT	A -> V (in LEUDEN; unknown pathological significance)	ECO:0000269|PubMed:32197074	32197074
P19525	EIF2AK2	L114Q	P19525/L114Q	EIF2AK2/L114Q	VARIANT	L -> Q (found in a patient with dysmorphic facies, syndactyly, congenital microcephaly and global developmental delay; unknown pathological significance)	ECO:0000269|PubMed:32197074	32197074
P19525	EIF2AK2	G130R	P19525/G130R	EIF2AK2/G130R	VARIANT	G -> R (in DYT33; gain-of-function variant resulting in increased levels of phosphorylated EIF2AK2 and EIF2A in patient cells compared to controls)	ECO:0000269|PubMed:33236446, ECO:0000269|PubMed:33866603, ECO:0000269|PubMed:35146068	33236446,33866603,35146068
P19525	EIF2AK2	Y133F	P19525/Y133F	EIF2AK2/Y133F	VARIANT	Y -> F (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells)	ECO:0000269|PubMed:32197074	32197074
P19525	EIF2AK2	G138A	P19525/G138A	EIF2AK2/G138A	VARIANT	G -> A (in DYT33; unknown pathological significance)	ECO:0000269|PubMed:33236446	33236446
P19525	EIF2AK2	G325S	P19525/G325S	EIF2AK2/G325S	VARIANT	G -> S (in LEUDEN; unknown pathological significance)	ECO:0000269|PubMed:32197074	32197074
P19525	EIF2AK2	V428E	P19525/V428E	EIF2AK2/V428E	VARIANT	V -> E (in dbSNP:rs56219559)	ECO:0000269|PubMed:17344846	17344846
P19525	EIF2AK2	L439V	P19525/L439V	EIF2AK2/L439V	VARIANT	L -> V (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P19525	EIF2AK2	S461C	P19525/S461C	EIF2AK2/S461C	VARIANT	S -> C (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells)	ECO:0000269|PubMed:32197074	32197074
P19525	EIF2AK2	I506V	P19525/I506V	EIF2AK2/I506V	VARIANT	I -> V (in dbSNP:rs34821155)	ECO:0000269|PubMed:17344846	17344846
P19525	EIF2AK2	K60A	P19525/K60A	EIF2AK2/K60A	MUTAGEN	K->A: Impairs dsRNA binding but not dimerization or activity.	ECO:0000269|PubMed:11337501	11337501
P19525	EIF2AK2	A67E	P19525/A67E	EIF2AK2/A67E	MUTAGEN	A->E: Significant loss of activity; loss of dsRNA binding and dimerization.	ECO:0000269|PubMed:11337501	11337501
P19525	EIF2AK2	S83A	P19525/S83A	EIF2AK2/S83A	MUTAGEN	S->A: No effect on enzymatic activity; when associated with A-88; A-89 and A-90.	ECO:0000269|PubMed:11152499	11152499
P19525	EIF2AK2	T88A	P19525/T88A	EIF2AK2/T88A	MUTAGEN	T->A: No effect on enzymatic activity; when associated with A-83; A-89 and A-90.	ECO:0000269|PubMed:11152499	11152499
P19525	EIF2AK2	T89A	P19525/T89A	EIF2AK2/T89A	MUTAGEN	T->A: No effect on enzymatic activity; when associated with A-83; A-88 and A-90.	ECO:0000269|PubMed:11152499	11152499
P19525	EIF2AK2	T90A	P19525/T90A	EIF2AK2/T90A	MUTAGEN	T->A: No effect on enzymatic activity; when associated with A-83; A-88 and A-89.	ECO:0000269|PubMed:11152499	11152499
P19525	EIF2AK2	S242A	P19525/S242A	EIF2AK2/S242A	MUTAGEN	S->A: Moderate loss of activity; when associated with A-255 and A-258.	ECO:0000269|PubMed:11152499	11152499
P19525	EIF2AK2	T255A	P19525/T255A	EIF2AK2/T255A	MUTAGEN	T->A: Moderate loss of activity; when associated with A-242 and A-255.	ECO:0000269|PubMed:11152499	11152499
P19525	EIF2AK2	T258A	P19525/T258A	EIF2AK2/T258A	MUTAGEN	T->A: Moderate loss of activity.	ECO:0000269|PubMed:11152499	11152499
P19525	EIF2AK2	K296R	P19525/K296R	EIF2AK2/K296R	MUTAGEN	K->R: Loss of activity.	ECO:0000269|PubMed:11152499	11152499
P19525	EIF2AK2	T446A	P19525/T446A	EIF2AK2/T446A	MUTAGEN	T->A: Significant loss of activity and impairs autophosphorylation of T-451.	ECO:0000269|PubMed:11337501	11337501
P19525	EIF2AK2	T451A	P19525/T451A	EIF2AK2/T451A	MUTAGEN	T->A: Loss of activity.	ECO:0000269|PubMed:11337501	11337501

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P19784	CSNK2A2	E188A	P19784/E188A	CSNK2A2/E188A	VARIANT	E -> A (in dbSNP:rs55911801)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P20594	NPR2	P32T	P20594/P32T	NPR2/P32T	VARIANT	P -> T (in AMD1; dbSNP:rs28931581)	ECO:0000269|PubMed:15146390	15146390
P20594	NPR2	S76P	P20594/S76P	NPR2/S76P	VARIANT	S -> P (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; loss of localization to the plasma membrane; dbSNP:rs796065355)	ECO:0000269|PubMed:24001744	24001744
P20594	NPR2	R110C	P20594/R110C	NPR2/R110C	VARIANT	R -> C (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; retained in the endoplasmic reticulum; dbSNP:rs758478717)	ECO:0000269|PubMed:24471569	24471569
P20594	NPR2	W115G	P20594/W115G	NPR2/W115G	VARIANT	W -> G (in AMD1; markedly deficient activity; dbSNP:rs28931582)	ECO:0000269|PubMed:15146390	15146390
P20594	NPR2	D176E	P20594/D176E	NPR2/D176E	VARIANT	D -> E (in AMD1; dbSNP:rs28929479)	ECO:0000269|PubMed:15146390	15146390
P20594	NPR2	V187I	P20594/V187I	NPR2/V187I	VARIANT	V -> I (does not affect C-type natriuretic peptide-induced signaling; dbSNP:rs768423636)	ECO:0000269|PubMed:24471569	24471569
P20594	NPR2	M232I	P20594/M232I	NPR2/M232I	VARIANT	M -> I (in dbSNP:rs55747238)	ECO:0000269|PubMed:17344846	17344846
P20594	NPR2	R263P	P20594/R263P	NPR2/R263P	VARIANT	R -> P (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; loss of localization to the plasma membrane; dbSNP:rs139036657)	ECO:0000269|PubMed:24001744	24001744
P20594	NPR2	T297M	P20594/T297M	NPR2/T297M	VARIANT	T -> M (in AMD1; markedly deficient activity; dbSNP:rs1313765432)	ECO:0000269|PubMed:15146390	15146390
P20594	NPR2	Y338C	P20594/Y338C	NPR2/Y338C	VARIANT	Y -> C (in AMD1; dbSNP:rs1828087195)	ECO:0000269|PubMed:15146390	15146390
P20594	NPR2	A409T	P20594/A409T	NPR2/A409T	VARIANT	A -> T (in AMD1)	ECO:0000269|PubMed:15146390	15146390
P20594	NPR2	G413E	P20594/G413E	NPR2/G413E	VARIANT	G -> E (in AMD1; markedly deficient activity)	ECO:0000269|PubMed:15146390	15146390
P20594	NPR2	Q417E	P20594/Q417E	NPR2/Q417E	VARIANT	Q -> E (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; no effect on cell surface expression; dbSNP:rs796065356)	ECO:0000269|PubMed:24471569	24471569
P20594	NPR2	A488P	P20594/A488P	NPR2/A488P	VARIANT	A -> P (in ECDM; mutant and wild-type alleles have similar expression levels; the mutation results in increased guanylate cyclase activity; dbSNP:rs587777597)	ECO:0000269|PubMed:24259409	24259409
P20594	NPR2	R655C	P20594/R655C	NPR2/R655C	VARIANT	R -> C (in ECDM; the mutation results in increased guanylate cyclase activity; dbSNP:rs587777596)	ECO:0000269|PubMed:24057292	24057292
P20594	NPR2	L658F	P20594/L658F	NPR2/L658F	VARIANT	L -> F (in AMD1; no effect on subcellular location; changed glycosylation; no effect on C-type natriuretic peptide binding; decreased guanylate cyclase activity; loss of natriuretic peptide receptor activity; dominant negative effect; dbSNP:rs1314542724)	ECO:0000269|PubMed:17652215, ECO:0000269|PubMed:26980729	17652215,26980729
P20594	NPR2	Y708C	P20594/Y708C	NPR2/Y708C	VARIANT	Y -> C (in AMD1; no effect on subcellular location; changed glycosylation; no effect on C-type natriuretic peptide binding; decreased guanylate cyclase activity; dbSNP:rs1305337032)	ECO:0000269|PubMed:15146390, ECO:0000269|PubMed:26980729	15146390,26980729
P20594	NPR2	Q771E	P20594/Q771E	NPR2/Q771E	VARIANT	Q -> E (in dbSNP:rs5816)		
P20594	NPR2	R776W	P20594/R776W	NPR2/R776W	VARIANT	R -> W (in AMD1; no effect on subcellular location; changed glycosylation; no effect on C-type natriuretic peptide binding; decreased guanylate cyclase activity; dbSNP:rs1303913631)	ECO:0000269|PubMed:15146390, ECO:0000269|PubMed:26980729	15146390,26980729
P20594	NPR2	R819C	P20594/R819C	NPR2/R819C	VARIANT	R -> C (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; no effect on cell surface expression; dbSNP:rs766256429)	ECO:0000269|PubMed:24001744	24001744
P20594	NPR2	V882I	P20594/V882I	NPR2/V882I	VARIANT	V -> I (in dbSNP:rs55700371)	ECO:0000269|PubMed:17344846	17344846
P20594	NPR2	V882M	P20594/V882M	NPR2/V882M	VARIANT	V -> M (in ECDM; the mutation results in higher guanylate cyclase activity; causes a 15-fold increase in basal Vmax; has higher affinity for GTP than wild-type in the presence of NPPC; might lead to a structural change that locks the enzyme in a conformation mimicking the ATP-bound state)	ECO:0000269|PubMed:22870295, ECO:0000269|PubMed:23827346	22870295,23827346
P20594	NPR2	R957C	P20594/R957C	NPR2/R957C	VARIANT	R -> C (in AMD1; dbSNP:rs370158184)	ECO:0000269|PubMed:15146390	15146390
P20594	NPR2	G959A	P20594/G959A	NPR2/G959A	VARIANT	G -> A (in AMD1; no effect on subcellular location; changed glycosylation; no effect on C-type natriuretic peptide binding; decreased guanylate cyclase activity)	ECO:0000269|PubMed:15146390, ECO:0000269|PubMed:26980729	15146390,26980729
P20594	NPR2	N24D	P20594/N24D	NPR2/N24D	MUTAGEN			
P20594	NPR2	N24Q	P20594/N24Q	NPR2/N24Q	MUTAGEN	N->D,Q: Decreased glycosylation. Decreased guanylate cyclase activity.	ECO:0000269|PubMed:26980729	26980729

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P20794	MAK	G13S	P20794/G13S	MAK/G13S	VARIANT	G -> S (in RP62; results in a complete loss of kinase activity compared to wild-type; dbSNP:rs387906647)	ECO:0000269|PubMed:21835304	21835304
P20794	MAK	G27R	P20794/G27R	MAK/G27R	VARIANT	G -> R (in RP62; dbSNP:rs754916169)	ECO:0000269|PubMed:21835304	21835304
P20794	MAK	N130H	P20794/N130H	MAK/N130H	VARIANT	N -> H (in RP62; results in a complete loss of kinase activity compared to wild-type; dbSNP:rs387906646)	ECO:0000269|PubMed:21835304	21835304
P20794	MAK	R166H	P20794/R166H	MAK/R166H	VARIANT	R -> H (in RP62; dbSNP:rs387906648)	ECO:0000269|PubMed:21835304	21835304
P20794	MAK	I181T	P20794/I181T	MAK/I181T	VARIANT	I -> T (in RP62; dbSNP:rs750559316)	ECO:0000269|PubMed:21835304	21835304
P20794	MAK	I189V	P20794/I189V	MAK/I189V	VARIANT	I -> V (in dbSNP:rs56215624)	ECO:0000269|PubMed:17344846	17344846
P20794	MAK	R272P	P20794/R272P	MAK/R272P	VARIANT	R -> P (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P20794	MAK	P325L	P20794/P325L	MAK/P325L	VARIANT	P -> L (in dbSNP:rs371971492)	ECO:0000269|PubMed:21835304	21835304
P20794	MAK	D329E	P20794/D329E	MAK/D329E	VARIANT	D -> E (in dbSNP:rs17579447)		
P20794	MAK	N384S	P20794/N384S	MAK/N384S	VARIANT	N -> S (in dbSNP:rs55773478)	ECO:0000269|PubMed:17344846	17344846
P20794	MAK	P520S	P20794/P520S	MAK/P520S	VARIANT	P -> S (in dbSNP:rs567083)	ECO:0000269|PubMed:17344846	17344846
P20794	MAK	F550L	P20794/F550L	MAK/F550L	VARIANT	F -> L (in dbSNP:rs56217305)	ECO:0000269|PubMed:17344846	17344846
P20794	MAK	K33R	P20794/K33R	MAK/K33R	MUTAGEN	K->R: Abolishes autophosphorylation.	ECO:0000269|PubMed:12084720	12084720
P20794	MAK	T157A	P20794/T157A	MAK/T157A	MUTAGEN	T->A: Abolishes autophosphorylation and impairs kinase activity.	ECO:0000269|PubMed:21986944	21986944
P20794	MAK	Y159F	P20794/Y159F	MAK/Y159F	MUTAGEN	Y->F: Abolishes autophosphorylation and impairs kinase activity.	ECO:0000269|PubMed:21986944	21986944

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P21127	CDK11B	R57C	P21127/R57C	CDK11B/R57C	VARIANT	R -> C (in dbSNP:rs752740049)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8195233	17344846,8195233
P21127	CDK11B	R93W	P21127/R93W	CDK11B/R93W	VARIANT	R -> W (in dbSNP:rs1059831)		
P21127	CDK11B	R109C	P21127/R109C	CDK11B/R109C	VARIANT	R -> C (in dbSNP:rs1059830)		
P21127	CDK11B	R201W	P21127/R201W	CDK11B/R201W	VARIANT	R -> W (in dbSNP:rs1557687207)	ECO:0000269|PubMed:17344846	17344846
P21127	CDK11B	S414L	P21127/S414L	CDK11B/S414L	VARIANT	S -> L (in dbSNP:rs1241694892)	ECO:0000269|PubMed:17344846	17344846
P21127	CDK11B	V452A	P21127/V452A	CDK11B/V452A	VARIANT	V -> A	ECO:0000269|PubMed:17344846	17344846
P21127	CDK11B	I463V	P21127/I463V	CDK11B/I463V	VARIANT	I -> V	ECO:0000269|PubMed:17344846	17344846
P21127	CDK11B	G506S	P21127/G506S	CDK11B/G506S	VARIANT	G -> S	ECO:0000269|PubMed:17344846	17344846
P21127	CDK11B	L601Q	P21127/L601Q	CDK11B/L601Q	VARIANT	L -> Q (in dbSNP:rs200190129)	ECO:0000269|PubMed:1639388, ECO:0000269|PubMed:17344846	1639388,17344846
P21127	CDK11B	K641N	P21127/K641N	CDK11B/K641N	VARIANT	K -> N (in dbSNP:rs1059815)	ECO:0000269|PubMed:17344846	17344846
P21127	CDK11B	A670V	P21127/A670V	CDK11B/A670V	VARIANT	A -> V (in dbSNP:rs1059811)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P21675	TAF1	L269V	P21675/L269V	TAF1/L269V	VARIANT	L -> V (in dbSNP:rs28382158)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5	17344846
P21675	TAF1	A297G	P21675/A297G	TAF1/A297G	VARIANT	A -> G (in dbSNP:rs35317750)	ECO:0000269|PubMed:17344846	17344846
P21675	TAF1	G453D	P21675/G453D	TAF1/G453D	VARIANT	G -> D (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P21675	TAF1	N472D	P21675/N472D	TAF1/N472D	VARIANT	N -> D (found in a patient with X-linked intellectual disability; unknown pathological significance; dbSNP:rs200177996)	ECO:0000269|PubMed:25644381	25644381
P21675	TAF1	P575S	P21675/P575S	TAF1/P575S	VARIANT	P -> S (in MRXS33; dbSNP:rs864321630)	ECO:0000269|PubMed:26637982	26637982
P21675	TAF1	E651K	P21675/E651K	TAF1/E651K	VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P21675	TAF1	M691I	P21675/M691I	TAF1/M691I	VARIANT	M -> I (in a lung bronchoalveolar carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P21675	TAF1	C786R	P21675/C786R	TAF1/C786R	VARIANT	C -> R (in MRXS33; dbSNP:rs864321628)	ECO:0000269|PubMed:26637982	26637982
P21675	TAF1	D955H	P21675/D955H	TAF1/D955H	VARIANT	D -> H (in MRXS33; dbSNP:rs864321631)	ECO:0000269|PubMed:26637982	26637982
P21675	TAF1	R1169C	P21675/R1169C	TAF1/R1169C	VARIANT	R -> C (found in a patient with X-linked intellectual disability; unknown pathological significance; dbSNP:rs1569301036)	ECO:0000269|PubMed:25644381	25644381
P21675	TAF1	R1225W	P21675/R1225W	TAF1/R1225W	VARIANT	R -> W (in MRXS33; dbSNP:rs864321629)	ECO:0000269|PubMed:26637982	26637982
P21675	TAF1	I1316T	P21675/I1316T	TAF1/I1316T	VARIANT	I -> T (in MRXS33; dbSNP:rs864321627)	ECO:0000269|PubMed:26637982	26637982
P21675	TAF1	V1383I	P21675/V1383I	TAF1/V1383I	VARIANT	V -> I (in dbSNP:rs7050748)		
P21675	TAF1	R1431H	P21675/R1431H	TAF1/R1431H	VARIANT	R -> H (in MRXS33; unknown pathological significance)	ECO:0000269|PubMed:26637982	26637982
P21675	TAF1	N1496H	P21675/N1496H	TAF1/N1496H	VARIANT	N -> H (in MRXS33; unknown pathological significance)	ECO:0000269|PubMed:26637982	26637982
P21675	TAF1	S137A	P21675/S137A	TAF1/S137A	MUTAGEN	S->A: No decrease in kinase activity.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	D145A	P21675/D145A	TAF1/D145A	MUTAGEN	D->A: Reduces kinase activity; when associated with A-147; A-149; A-150; A-152 and A-154.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	D147A	P21675/D147A	TAF1/D147A	MUTAGEN	D->A: Reduces kinase activity; when associated with A-145; A-149; A-150; A-152 and A-154.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	E149A	P21675/E149A	TAF1/E149A	MUTAGEN	E->A: Reduces kinase activity; when associated with A-145; A-147; A-150; A-152 and A-154.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	D150A	P21675/D150A	TAF1/D150A	MUTAGEN	D->A: Reduces kinase activity; when associated with A-145; A-147; A-149; A-152 and A-154.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	D152A	P21675/D152A	TAF1/D152A	MUTAGEN	D->A: Reduces kinase activity; when associated with A-145; A-147; A-149; A-150 and A-154.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	K154A	P21675/K154A	TAF1/K154A	MUTAGEN	K->A: Reduces kinase activity; when associated with A-145; A-147; A-149; A-150 and A-152.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	C305A	P21675/C305A	TAF1/C305A	MUTAGEN	C->A: Reduces kinase activity; when associated with A-307; A-308; A-309 and A-310.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	S307A	P21675/S307A	TAF1/S307A	MUTAGEN	S->A: Reduces kinase activity; when associated with A-305; A-308; A-309 and A-310.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	D308A	P21675/D308A	TAF1/D308A	MUTAGEN	D->A: Reduces kinase activity; when associated with A-305; A-307; A-309 and A-310.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	D309A	P21675/D309A	TAF1/D309A	MUTAGEN	D->A: Reduces kinase activity; when associated with A-305; A-307; A-308 and A-310.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	E310A	P21675/E310A	TAF1/E310A	MUTAGEN	E->A: Reduces kinase activity; when associated with A-305; A-307; A-308 and A-309.	ECO:0000269|PubMed:9660973	9660973
P21675	TAF1	E721Q	P21675/E721Q	TAF1/E721Q	MUTAGEN	E->Q: 25% decrease in histone acetylation.	ECO:0000269|PubMed:15870300	15870300

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P21709	EPHA1	V160A	P21709/V160A	EPHA1/V160A	VARIANT	V -> A (in dbSNP:rs4725617)	ECO:0000269|PubMed:10369740, ECO:0000269|PubMed:12690205, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2825356, ECO:0000269|Ref.6	10369740,12690205,15489334,17344846,2825356
P21709	EPHA1	R351C	P21709/R351C	EPHA1/R351C	VARIANT	R -> C (in dbSNP:rs56006153)	ECO:0000269|PubMed:17344846	17344846
P21709	EPHA1	R492Q	P21709/R492Q	EPHA1/R492Q	VARIANT	R -> Q (in dbSNP:rs11768549)	ECO:0000269|PubMed:17344846	17344846
P21709	EPHA1	R575Q	P21709/R575Q	EPHA1/R575Q	VARIANT	R -> Q (in dbSNP:rs35719334)	ECO:0000269|PubMed:17344846	17344846
P21709	EPHA1	A585T	P21709/A585T	EPHA1/A585T	VARIANT	A -> T (in dbSNP:rs34178823)	ECO:0000269|PubMed:17344846	17344846
P21709	EPHA1	P697L	P21709/P697L	EPHA1/P697L	VARIANT	P -> L (in dbSNP:rs34372369)	ECO:0000269|PubMed:17344846	17344846
P21709	EPHA1	E703K	P21709/E703K	EPHA1/E703K	VARIANT	E -> K (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P21709	EPHA1	S807R	P21709/S807R	EPHA1/S807R	VARIANT	S -> R (in dbSNP:rs56244405)	ECO:0000269|PubMed:17344846	17344846
P21709	EPHA1	M900V	P21709/M900V	EPHA1/M900V	VARIANT	M -> V (in dbSNP:rs6967117)	ECO:0000269|PubMed:10369740, ECO:0000269|PubMed:12690205, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2825356, ECO:0000269|Ref.6, ECO:0000269|Ref.8, ECO:0007744|PubMed:19369195	10369740,12690205,15489334,17344846,2825356,19369195

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

Error: P21802 FGFR2 'NoneType' object has no attribute 'group' FT                   /note="Missing (in PS; type 2; dbSNP:rs121918503)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P21802	FGFR2	R6P	P21802/R6P	FGFR2/R6P	VARIANT	R -> P (in dbSNP:rs3750819)	ECO:0000269|Ref.15	
P21802	FGFR2	S57L	P21802/S57L	FGFR2/S57L	VARIANT	S -> L (in dbSNP:rs56226109)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:26429889	17344846,26429889
P21802	FGFR2	Y105C	P21802/Y105C	FGFR2/Y105C	VARIANT	Y -> C (in CS; dbSNP:rs1434545235)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:8946174	11781872,8946174
P21802	FGFR2	A172F	P21802/A172F	FGFR2/A172F	VARIANT	A -> F (in PS; requires 2 nucleotide substitutions)	ECO:0000269|PubMed:11781872	11781872
P21802	FGFR2	M186T	P21802/M186T	FGFR2/M186T	VARIANT	M -> T (in dbSNP:rs755793)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.15	11781872,17344846
P21802	FGFR2	R203C	P21802/R203C	FGFR2/R203C	VARIANT	R -> C (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17344846	16959974,17344846
P21802	FGFR2	S252F	P21802/S252F	FGFR2/S252F	VARIANT	S -> F (in APRS; requires 2 nucleotide substitutions; dbSNP:rs121918498)	ECO:0000269|PubMed:9002682	9002682
P21802	FGFR2	S252L	P21802/S252L	FGFR2/S252L	VARIANT	S -> L (in dbSNP:rs79184941)	ECO:0000269|PubMed:9002682	9002682
P21802	FGFR2	S252W	P21802/S252W	FGFR2/S252W	VARIANT	S -> W (in APRS and PS; common mutation; dbSNP:rs79184941)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:15190072, ECO:0000269|PubMed:7668257, ECO:0000269|PubMed:7719344, ECO:0000269|PubMed:9452027, ECO:0000269|PubMed:9677057, ECO:0000269|PubMed:9719378	11781872,15190072,7668257,7719344,9452027,9677057,9719378
P21802	FGFR2	P253R	P21802/P253R	FGFR2/P253R	VARIANT	P -> R (in APRS; common mutation; dbSNP:rs77543610)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7668257, ECO:0000269|PubMed:7719344, ECO:0000269|PubMed:9452027, ECO:0000269|PubMed:9677057	11781872,7668257,7719344,9452027,9677057
P21802	FGFR2	P263L	P21802/P263L	FGFR2/P263L	VARIANT	P -> L (in CS; dbSNP:rs779326224)	ECO:0000269|PubMed:11173845	11173845
P21802	FGFR2	S267P	P21802/S267P	FGFR2/S267P	VARIANT	S -> P (in CS; dbSNP:rs121918505)	ECO:0000269|PubMed:11781872	11781872
P21802	FGFR2	T268TG	P21802/T268TG	FGFR2/T268TG	VARIANT	T -> TG (in CS)	ECO:0000269|PubMed:8644708	8644708
P21802	FGFR2	G272V	P21802/G272V	FGFR2/G272V	VARIANT	G -> V (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P21802	FGFR2	F276V	P21802/F276V	FGFR2/F276V	VARIANT	F -> V (in CS; dbSNP:rs1057519036)	ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:9521581	11173845,11781872,9521581
P21802	FGFR2	C278F	P21802/C278F	FGFR2/C278F	VARIANT	C -> F (in CS, JWS and PS; forms disulfide-linked dimers with constitutive kinase activity, is retained in an intracellular compartment and not detected at the cell surface; dbSNP:rs776587763)	ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:16844695, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9677057	11173845,11781872,16844695,8644708,9677057
P21802	FGFR2	C278Y	P21802/C278Y	FGFR2/C278Y	VARIANT	C -> Y (in CS; dbSNP:rs776587763)	ECO:0000269|PubMed:11173845	11173845
P21802	FGFR2	Y281C	P21802/Y281C	FGFR2/Y281C	VARIANT	Y -> C (in CS; dbSNP:rs1057519038)	ECO:0000269|PubMed:11380921, ECO:0000269|PubMed:11781872	11380921,11781872
P21802	FGFR2	D283N	P21802/D283N	FGFR2/D283N	VARIANT	D -> N (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P21802	FGFR2	I288S	P21802/I288S	FGFR2/I288S	VARIANT	I -> S (in CS)	ECO:0000269|PubMed:11173845	11173845
P21802	FGFR2	Q289P	P21802/Q289P	FGFR2/Q289P	VARIANT	Q -> P (in CS and JWS; dbSNP:rs121918497)	ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11380921, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7581378, ECO:0000269|PubMed:8644708	11173845,11380921,11781872,7581378,8644708
P21802	FGFR2	W290C	P21802/W290C	FGFR2/W290C	VARIANT	W -> C (in PS; severe; also in a lung squamous cell carcinoma sample; somatic mutation; dbSNP:rs121918499)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9150725	11781872,17344846,9150725
P21802	FGFR2	W290G	P21802/W290G	FGFR2/W290G	VARIANT	W -> G (in CS; dbSNP:rs121918501)	ECO:0000269|PubMed:8528214	8528214
P21802	FGFR2	W290R	P21802/W290R	FGFR2/W290R	VARIANT	W -> R (in CS; dbSNP:rs121918501)		
P21802	FGFR2	K292E	P21802/K292E	FGFR2/K292E	VARIANT	K -> E (in CS; dbSNP:rs121918500)	ECO:0000269|PubMed:9152842	9152842
P21802	FGFR2	Y301C	P21802/Y301C	FGFR2/Y301C	VARIANT	Y -> C (in CS; dbSNP:rs1554930684)	ECO:0000269|PubMed:9521581	9521581
P21802	FGFR2	A314S	P21802/A314S	FGFR2/A314S	VARIANT	A -> S (in craniosynostosis; dbSNP:rs1358919643)	ECO:0000269|PubMed:9521581	9521581
P21802	FGFR2	A315S	P21802/A315S	FGFR2/A315S	VARIANT	A -> S (in a non-syndromic craniosynostosis patient with abnormal intrauterine history; confers predisposition to craniosynostosis; dbSNP:rs121918504)	ECO:0000269|PubMed:10951518, ECO:0000269|PubMed:11781872	10951518,11781872
P21802	FGFR2	D321A	P21802/D321A	FGFR2/D321A	VARIANT	D -> A (in PS; dbSNP:rs121918510)	ECO:0000269|PubMed:7719333	7719333
P21802	FGFR2	Y328C	P21802/Y328C	FGFR2/Y328C	VARIANT	Y -> C (in CS; dbSNP:rs121918493)	ECO:0000269|PubMed:7874170	7874170
P21802	FGFR2	N331I	P21802/N331I	FGFR2/N331I	VARIANT	N -> I (in CS)	ECO:0000269|PubMed:8956050	8956050
P21802	FGFR2	A337ANA	P21802/A337ANA	FGFR2/A337ANA	VARIANT	A -> ANA (in CS)		
P21802	FGFR2	A337P	P21802/A337P	FGFR2/A337P	VARIANT	A -> P (in CS; dbSNP:rs387906676)	ECO:0000269|PubMed:9677057	9677057
P21802	FGFR2	G338E	P21802/G338E	FGFR2/G338E	VARIANT	G -> E (in CS; dbSNP:rs1057519044)	ECO:0000269|PubMed:8946174	8946174
P21802	FGFR2	G338R	P21802/G338R	FGFR2/G338R	VARIANT	G -> R (in CS; dbSNP:rs1057519043)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7581378, ECO:0000269|PubMed:9677057	11781872,7581378,9677057
P21802	FGFR2	Y340C	P21802/Y340C	FGFR2/Y340C	VARIANT	Y -> C (in PS; dbSNP:rs1554928884)	ECO:0000269|PubMed:10394936, ECO:0000269|PubMed:11781872	10394936,11781872
P21802	FGFR2	Y340H	P21802/Y340H	FGFR2/Y340H	VARIANT	Y -> H (in CS; dbSNP:rs121918489)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7987400	11781872,7987400
P21802	FGFR2	T341P	P21802/T341P	FGFR2/T341P	VARIANT	T -> P (in PS and CS; dbSNP:rs121918495)	ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7719345	11173845,11781872,7719345
P21802	FGFR2	C342F	P21802/C342F	FGFR2/C342F	VARIANT	C -> F (in CS; dbSNP:rs121918487)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9677057	11781872,8644708,9677057
P21802	FGFR2	C342G	P21802/C342G	FGFR2/C342G	VARIANT	C -> G (in PS; dbSNP:rs121918488)	ECO:0000269|PubMed:10394936	10394936
P21802	FGFR2	C342R	P21802/C342R	FGFR2/C342R	VARIANT	C -> R (in CS, JWS, PS and ABS2; dbSNP:rs121918488)	ECO:0000269|PubMed:10633130, ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11380921, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7719345, ECO:0000269|PubMed:7987400, ECO:0000269|PubMed:8528214, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9677057	10633130,11173845,11380921,11781872,7719345,7987400,8528214,8644708,9677057
P21802	FGFR2	C342S	P21802/C342S	FGFR2/C342S	VARIANT	C -> S (in CS, JWS, PS and ABS2; dbSNP:rs121918488)	ECO:0000269|PubMed:10633130, ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7581378, ECO:0000269|PubMed:7987400, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9385368, ECO:0000269|Ref.10	10633130,11173845,11781872,7581378,7987400,8644708,9385368
P21802	FGFR2	C342W	P21802/C342W	FGFR2/C342W	VARIANT	C -> W (in CS; dbSNP:rs121918496)	ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:8528214	11173845,11781872,8528214
P21802	FGFR2	C342Y	P21802/C342Y	FGFR2/C342Y	VARIANT	C -> Y (in CS and PS; dbSNP:rs121918487)	ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11380921, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7581378, ECO:0000269|PubMed:7719345, ECO:0000269|PubMed:7987400, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9677057	11173845,11380921,11781872,7581378,7719345,7987400,8644708,9677057
P21802	FGFR2	A344G	P21802/A344G	FGFR2/A344G	VARIANT	A -> G (in CS and JWS; dbSNP:rs121918492)	ECO:0000269|PubMed:7581378, ECO:0000269|PubMed:7874170	7581378,7874170
P21802	FGFR2	A344P	P21802/A344P	FGFR2/A344P	VARIANT	A -> P (in CS and PS)	ECO:0000269|PubMed:8644708	8644708
P21802	FGFR2	S347C	P21802/S347C	FGFR2/S347C	VARIANT	S -> C (in CS; dbSNP:rs121918494)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7874170	11781872,7874170
P21802	FGFR2	S351C	P21802/S351C	FGFR2/S351C	VARIANT	S -> C (in CS, PS and ABS2; dbSNP:rs121918502)	ECO:0000269|PubMed:10633130, ECO:0000269|PubMed:8946174, ECO:0000269|PubMed:9693549	10633130,8946174,9693549
P21802	FGFR2	S354C	P21802/S354C	FGFR2/S354C	VARIANT	S -> C (in CS; dbSNP:rs121918490)	ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7581378, ECO:0000269|PubMed:7987400, ECO:0000269|PubMed:8528214	11173845,11781872,7581378,7987400,8528214
P21802	FGFR2	S354Y	P21802/S354Y	FGFR2/S354Y	VARIANT	S -> Y (in CS)	ECO:0000269|PubMed:11173845	11173845
P21802	FGFR2	V359F	P21802/V359F	FGFR2/V359F	VARIANT	V -> F (in CS and PS)	ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:8644708	11173845,8644708
P21802	FGFR2	A362S	P21802/A362S	FGFR2/A362S	VARIANT	A -> S (in CS)	ECO:0000269|PubMed:10574673	10574673
P21802	FGFR2	S372C	P21802/S372C	FGFR2/S372C	VARIANT	S -> C (in BSTVS; dbSNP:rs121913477)	ECO:0000269|PubMed:8696350	8696350
P21802	FGFR2	Y375C	P21802/Y375C	FGFR2/Y375C	VARIANT	Y -> C (in PS and BSTVS; dbSNP:rs121913478)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:12000365, ECO:0000269|PubMed:8696350	11781872,12000365,8696350
P21802	FGFR2	Y381D	P21802/Y381D	FGFR2/Y381D	VARIANT	Y -> D (in BBDS1; dbSNP:rs387906678)	ECO:0000269|PubMed:22387015	22387015
P21802	FGFR2	G384R	P21802/G384R	FGFR2/G384R	VARIANT	G -> R (in CS; dbSNP:rs1554927408)	ECO:0000269|PubMed:8946174	8946174
P21802	FGFR2	M391R	P21802/M391R	FGFR2/M391R	VARIANT			
P21802	FGFR2	K526E	P21802/K526E	FGFR2/K526E	VARIANT	K -> E (in FSPC; constitutive kinase activity; dbSNP:rs121918507)	ECO:0000269|PubMed:16061565, ECO:0000269|PubMed:17803937	16061565,17803937
P21802	FGFR2	N549H	P21802/N549H	FGFR2/N549H	VARIANT	N -> H (in CS; constitutive kinase activity; dbSNP:rs1057519045)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:17803937	11781872,17803937
P21802	FGFR2	E565G	P21802/E565G	FGFR2/E565G	VARIANT	E -> G (in PS; constitutive kinase activity; dbSNP:rs121918506)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:17803937	11781872,17803937
P21802	FGFR2	R612T	P21802/R612T	FGFR2/R612T	VARIANT	R -> T (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P21802	FGFR2	G613R	P21802/G613R	FGFR2/G613R	VARIANT	G -> R	ECO:0000269|PubMed:10626794, ECO:0000269|PubMed:1309608	10626794,1309608
P21802	FGFR2	A628T	P21802/A628T	FGFR2/A628T	VARIANT	A -> T (in LADD1; strongly reduced kinase activity; dbSNP:rs121918509)	ECO:0000269|PubMed:16501574	16501574
P21802	FGFR2	K641R	P21802/K641R	FGFR2/K641R	VARIANT	K -> R (in PS; constitutive kinase activity; dbSNP:rs1057519047)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:17803937	11781872,17803937
P21802	FGFR2	A648T	P21802/A648T	FGFR2/A648T	VARIANT	A -> T (in LADD1; dbSNP:rs121918508)	ECO:0000269|PubMed:16501574	16501574
P21802	FGFR2	K659N	P21802/K659N	FGFR2/K659N	VARIANT	K -> N (in craniosynostosis; constitutive kinase activity; dbSNP:rs1589722765)	ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:17803937	11781872,17803937
P21802	FGFR2	G663E	P21802/G663E	FGFR2/G663E	VARIANT	G -> E (in PS)	ECO:0000269|PubMed:11781872	11781872
P21802	FGFR2	R678G	P21802/R678G	FGFR2/R678G	VARIANT	R -> G (in CS; dbSNP:rs1845559552)	ECO:0000269|PubMed:11781872	11781872
P21802	FGFR2	N265Q	P21802/N265Q	FGFR2/N265Q	MUTAGEN	N->Q: Reduced N-glycosylation. Reduced expression at the cell surface.	ECO:0000269|PubMed:16844695	16844695
P21802	FGFR2	N549T	P21802/N549T	FGFR2/N549T	MUTAGEN	N->T: Constitutive kinase activity.	ECO:0000269|PubMed:17803937	17803937
P21802	FGFR2	E565A	P21802/E565A	FGFR2/E565A	MUTAGEN	E->A: Constitutive kinase activity.	ECO:0000269|PubMed:17803937	17803937
P21802	FGFR2	Y769F	P21802/Y769F	FGFR2/Y769F	MUTAGEN			

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P21860	ERBB3	S20Y	P21860/S20Y	ERBB3/S20Y	VARIANT	S -> Y (in dbSNP:rs34379766)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	P30L	P21860/P30L	ERBB3/P30L	VARIANT	P -> L (in dbSNP:rs56017157)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	V104M	P21860/V104M	ERBB3/V104M	VARIANT	V -> M (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs1057519893)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	T204I	P21860/T204I	ERBB3/T204I	VARIANT	T -> I (in dbSNP:rs56107455)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	N385S	P21860/N385S	ERBB3/N385S	VARIANT	N -> S (in dbSNP:rs12320176)		
P21860	ERBB3	R683W	P21860/R683W	ERBB3/R683W	VARIANT	R -> W (in dbSNP:rs56387488)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	S717L	P21860/S717L	ERBB3/S717L	VARIANT	S -> L (in dbSNP:rs35961836)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	I744T	P21860/I744T	ERBB3/I744T	VARIANT	I -> T (in dbSNP:rs55787439)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	T787P	P21860/T787P	ERBB3/T787P	VARIANT	T -> P (in VSCN1; almost complete loss of ERBB2 and ERBB3 phosphorylation in the presence or in the absence of NRG1 stimulation, suggesting alteration of downstream signaling; does not affect the subcellular localization at the cell membrane)	ECO:0000269|PubMed:33497358	33497358
P21860	ERBB3	T873S	P21860/T873S	ERBB3/T873S	VARIANT	T -> S (in VSCN1; unknown pathological significance; some decrease in ERBB2 phosphorylation upon NG1 treatment, compared to wild-type; does not affect the subcellular localization at the cell membrane)	ECO:0000269|PubMed:33497358	33497358
P21860	ERBB3	V899M	P21860/V899M	ERBB3/V899M	VARIANT	V -> M (in VSCN1; almost complete loss of ERBB2 and ERBB3 phosphorylation in the presence or in the absence of NRG1 stimulation, suggesting alteration of downstream signaling; does not affect the subcellular localization at the cell membrane)	ECO:0000269|PubMed:33497358	33497358
P21860	ERBB3	Q932R	P21860/Q932R	ERBB3/Q932R	VARIANT	Q -> R (in VSCN1; unknown pathological significance; some decrease in ERBB2 phosphorylation upon NG1 treatment, compared to wild-type; does not affect the subcellular localization at the cell membrane)	ECO:0000269|PubMed:33497358	33497358
P21860	ERBB3	K998R	P21860/K998R	ERBB3/K998R	VARIANT	K -> R (in dbSNP:rs56259600)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	S1119C	P21860/S1119C	ERBB3/S1119C	VARIANT	S -> C (in dbSNP:rs773123)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	R1127H	P21860/R1127H	ERBB3/R1127H	VARIANT	R -> H (in dbSNP:rs2271188)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	L1177I	P21860/L1177I	ERBB3/L1177I	VARIANT	L -> I (in dbSNP:rs55699040)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	T1254K	P21860/T1254K	ERBB3/T1254K	VARIANT	T -> K (in dbSNP:rs55709407)	ECO:0000269|PubMed:17344846	17344846
P21860	ERBB3	G1271S	P21860/G1271S	ERBB3/G1271S	VARIANT	G -> S (in dbSNP:rs11171743)		
P21860	ERBB3	A1337T	P21860/A1337T	ERBB3/A1337T	VARIANT	A -> T (in FERLK; risk factor for erythroleukemia; results in increased ERBB-mediated signaling; results in a block of erythroid differentiation and increased cell proliferation; dbSNP:rs755855285)	ECO:0000269|PubMed:27416908	27416908
P21860	ERBB3	K742M	P21860/K742M	ERBB3/K742M	MUTAGEN	K->M: Strongly reduced autophosphorylation.	ECO:0000269|PubMed:20351256	20351256
P21860	ERBB3	Y868E	P21860/Y868E	ERBB3/Y868E	MUTAGEN	Y->E: Strongly reduced tyrosine phosphorylation.	ECO:0000269|PubMed:20351256	20351256

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P22455	FGFR4	V10I	P22455/V10I	FGFR4/V10I	VARIANT	V -> I (in dbSNP:rs1966265)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21882254, ECO:0000269|Ref.7	17344846,21882254
P22455	FGFR4	P136L	P22455/P136L	FGFR4/P136L	VARIANT	P -> L (in dbSNP:rs376618)	ECO:0000269|PubMed:10631118, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21882254, ECO:0000269|Ref.6, ECO:0000269|Ref.7, ECO:0000269|Ref.9	10631118,17344846,21882254
P22455	FGFR4	T179A	P22455/T179A	FGFR4/T179A	VARIANT	T -> A (in dbSNP:rs55675160)	ECO:0000269|PubMed:17344846	17344846
P22455	FGFR4	G388R	P22455/G388R	FGFR4/G388R	VARIANT	G -> R (in cancer cells, may be associated with accelerated disease progression and increased tumor cell motility, possibly due to increased stability of the protease MMP14; leads to phosphorylation at residue Y-390, resulting in prolonged FGFR4 activity; increases interaction with STAT3, resulting in STAT3 phosphorylation and signaling activation.; dbSNP:rs351855)	ECO:0000269|PubMed:18670643, ECO:0000269|PubMed:18756523, ECO:0000269|PubMed:20876804, ECO:0000269|PubMed:21349172, ECO:0000269|PubMed:21882254, ECO:0000269|PubMed:26675719, ECO:0000269|Ref.7	18670643,18756523,20876804,21349172,21882254,26675719
P22455	FGFR4	G426S	P22455/G426S	FGFR4/G426S	VARIANT	G -> S (in dbSNP:rs55879131)	ECO:0000269|PubMed:17344846	17344846
P22455	FGFR4	D516N	P22455/D516N	FGFR4/D516N	VARIANT	D -> N (in dbSNP:rs34158682)	ECO:0000269|PubMed:17344846	17344846
P22455	FGFR4	R529Q	P22455/R529Q	FGFR4/R529Q	VARIANT	R -> Q (in dbSNP:rs34284947)		
P22455	FGFR4	V550M	P22455/V550M	FGFR4/V550M	VARIANT	V -> M (in breast pleomorphic lobular sample; somatic mutation; dbSNP:rs774571806)	ECO:0000269|PubMed:17344846	17344846
P22455	FGFR4	P712T	P22455/P712T	FGFR4/P712T	VARIANT	P -> T (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P22455	FGFR4	S772N	P22455/S772N	FGFR4/S772N	VARIANT	S -> N (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P22455	FGFR4	K503R	P22455/K503R	FGFR4/K503R	MUTAGEN	K->R: Loss of kinase activity.	ECO:0000269|PubMed:11433297, ECO:0000269|PubMed:17311277	11433297,17311277
P22455	FGFR4	Y754F	P22455/Y754F	FGFR4/Y754F	MUTAGEN	Y->F: Loss of interaction with PLCG1.	ECO:0000269|PubMed:7518429	7518429

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P22607	FGFR3	G65R	P22607/G65R	FGFR3/G65R	VARIANT	G -> R (in dbSNP:rs2305178)	ECO:0000269|Ref.4	
P22607	FGFR3	T79S	P22607/T79S	FGFR3/T79S	VARIANT	T -> S (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P22607	FGFR3	C228R	P22607/C228R	FGFR3/C228R	VARIANT	C -> R (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P22607	FGFR3	R248C	P22607/R248C	FGFR3/R248C	VARIANT	R -> C (in KERSEB, BLC, keratinocytic non-epidermolytic nevus and TD1; severe and lethal; also found as somatic mutation in one patient with multiple myeloma; constitutive dimerization and kinase activation; dbSNP:rs121913482)	ECO:0000269|PubMed:10360402, ECO:0000269|PubMed:10471491, ECO:0000269|PubMed:11529856, ECO:0000269|PubMed:15772091, ECO:0000269|PubMed:16841094, ECO:0000269|PubMed:17509076, ECO:0000269|PubMed:7773297, ECO:0000269|PubMed:8845844	10360402,10471491,11529856,15772091,16841094,17509076,7773297,8845844
P22607	FGFR3	S249C	P22607/S249C	FGFR3/S249C	VARIANT	S -> C (in KERSEB, BLC, cervical cancer and TD1; dbSNP:rs121913483)	ECO:0000269|PubMed:10360402, ECO:0000269|PubMed:10471491, ECO:0000269|PubMed:15772091, ECO:0000269|PubMed:8589699, ECO:0000269|PubMed:8845844	10360402,10471491,15772091,8589699,8845844
P22607	FGFR3	P250R	P22607/P250R	FGFR3/P250R	VARIANT	P -> R (in MNKS; also some individuals with autosomal dominant congenital sensorineural deafness without craniosynostosis; dbSNP:rs4647924)	ECO:0000269|PubMed:11746040, ECO:0000269|PubMed:9042914, ECO:0000269|PubMed:9525367, ECO:0000269|PubMed:9950359	11746040,9042914,9525367,9950359
P22607	FGFR3	E322K	P22607/E322K	FGFR3/E322K	VARIANT	E -> K (in colorectal cancer; dbSNP:rs121913111)	ECO:0000269|PubMed:11325814	11325814
P22607	FGFR3	T338M	P22607/T338M	FGFR3/T338M	VARIANT	T -> M	ECO:0000269|PubMed:17344846	17344846
P22607	FGFR3	G370C	P22607/G370C	FGFR3/G370C	VARIANT	G -> C (in KERSEB, BLC, keratinocytic non-epidermolytic nevus and TD1; dbSNP:rs121913479)	ECO:0000269|PubMed:10471491, ECO:0000269|PubMed:15772091, ECO:0000269|PubMed:16841094, ECO:0000269|PubMed:8845844, ECO:0000269|PubMed:9790257	10471491,15772091,16841094,8845844,9790257
P22607	FGFR3	S371C	P22607/S371C	FGFR3/S371C	VARIANT	S -> C (in KERSEB and TD1; dbSNP:rs121913484)	ECO:0000269|PubMed:15772091, ECO:0000269|PubMed:7773297	15772091,7773297
P22607	FGFR3	Y373C	P22607/Y373C	FGFR3/Y373C	VARIANT	Y -> C (in KERSEB and TD1; disulfide-linked dimer with constitutive kinase activation; dbSNP:rs121913485)	ECO:0000269|PubMed:10360402, ECO:0000269|PubMed:15772091, ECO:0000269|PubMed:17509076, ECO:0000269|PubMed:8845844, ECO:0000269|PubMed:9207791	10360402,15772091,17509076,8845844,9207791
P22607	FGFR3	G375C	P22607/G375C	FGFR3/G375C	VARIANT	G -> C (in ACH; dbSNP:rs75790268)	ECO:0000269|PubMed:7758520	7758520
P22607	FGFR3	G380R	P22607/G380R	FGFR3/G380R	VARIANT	G -> R (in keratinocytic non-epidermolytic nevus and ACH; very common mutation; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs28931614)	ECO:0000269|PubMed:10611230, ECO:0000269|PubMed:12297284, ECO:0000269|PubMed:16841094, ECO:0000269|PubMed:17561467, ECO:0000269|PubMed:7847369, ECO:0000269|PubMed:8078586, ECO:0000269|PubMed:8599935	10611230,12297284,16841094,17561467,7847369,8078586,8599935
P22607	FGFR3	F384L	P22607/F384L	FGFR3/F384L	VARIANT	F -> L (in dbSNP:rs17881656)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
P22607	FGFR3	A391E	P22607/A391E	FGFR3/A391E	VARIANT	A -> E (in CAN; dbSNP:rs28931615)	ECO:0000269|PubMed:17935505, ECO:0000269|PubMed:7493034	17935505,7493034
P22607	FGFR3	A441T	P22607/A441T	FGFR3/A441T	VARIANT	A -> T (in dbSNP:rs17884368)	ECO:0000269|Ref.4	
P22607	FGFR3	D513N	P22607/D513N	FGFR3/D513N	VARIANT	D -> N (in LADD2; unknown pathological significance; dbSNP:rs121913112)	ECO:0000269|PubMed:16501574	16501574
P22607	FGFR3	I538V	P22607/I538V	FGFR3/I538V	VARIANT	I -> V (in hypochondroplasia; dbSNP:rs80053154)	ECO:0000269|PubMed:10215410	10215410
P22607	FGFR3	N540K	P22607/N540K	FGFR3/N540K	VARIANT	N -> K (in hypochondroplasia; dbSNP:rs28933068)	ECO:0000269|PubMed:7670477	7670477
P22607	FGFR3	N540S	P22607/N540S	FGFR3/N540S	VARIANT	N -> S (in hypochondroplasia; mild; dbSNP:rs77722678)	ECO:0000269|PubMed:10777366, ECO:0000269|PubMed:12707965	10777366,12707965
P22607	FGFR3	N540T	P22607/N540T	FGFR3/N540T	VARIANT	N -> T (in hypochondroplasia; dbSNP:rs77722678)	ECO:0000269|PubMed:9452043	9452043
P22607	FGFR3	R621H	P22607/R621H	FGFR3/R621H	VARIANT	R -> H (in CATSHLS; dbSNP:rs121913113)	ECO:0000269|PubMed:17033969	17033969
P22607	FGFR3	D646N	P22607/D646N	FGFR3/D646N	VARIANT	D -> N	ECO:0000269|PubMed:17344846	17344846
P22607	FGFR3	K650E	P22607/K650E	FGFR3/K650E	VARIANT	K -> E (in KERSEB, TD2, TGCT and BLC; bladder transitional cell carcinoma; somatic mutation; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs78311289)	ECO:0000269|PubMed:10471491, ECO:0000269|PubMed:11294897, ECO:0000269|PubMed:12297284, ECO:0000269|PubMed:14534538, ECO:0000269|PubMed:15772091, ECO:0000269|PubMed:17145761, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17561467, ECO:0000269|PubMed:19855393, ECO:0000269|PubMed:7773297, ECO:0000269|PubMed:8754806, ECO:0000269|PubMed:9207791	10471491,11294897,12297284,14534538,15772091,17145761,17344846,17561467,19855393,7773297,8754806,9207791
P22607	FGFR3	K650M	P22607/K650M	FGFR3/K650M	VARIANT	K -> M (in KERSEB, ACH, TD1 and SADDAN; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs121913105)	ECO:0000269|PubMed:10053006, ECO:0000269|PubMed:10671061, ECO:0000269|PubMed:15772091, ECO:0000269|PubMed:17509076, ECO:0000269|PubMed:17561467, ECO:0000269|PubMed:9207791	10053006,10671061,15772091,17509076,17561467,9207791
P22607	FGFR3	K650Q	P22607/K650Q	FGFR3/K650Q	VARIANT	K -> Q (in hypochondroplasia and BLC; in hypochondroplasia the form is milder than that seen in individuals with the K-540 or M-650 mutations; constitutively activated kinase; dbSNP:rs78311289)	ECO:0000269|PubMed:11055896, ECO:0000269|PubMed:11314002, ECO:0000269|PubMed:8754806	11055896,11314002,8754806
P22607	FGFR3	A717T	P22607/A717T	FGFR3/A717T	VARIANT	A -> T (in dbSNP:rs17882190)	ECO:0000269|Ref.4	
P22607	FGFR3	I726F	P22607/I726F	FGFR3/I726F	VARIANT	I -> F (in dbSNP:rs17880763)	ECO:0000269|Ref.4	
P22607	FGFR3	K508A	P22607/K508A	FGFR3/K508A	MUTAGEN	K->A: Loss of kinase activity. Abolishes ubiquitination.	ECO:0000269|PubMed:12297284, ECO:0000269|PubMed:16410555	12297284,16410555
P22607	FGFR3	Y577F	P22607/Y577F	FGFR3/Y577F	MUTAGEN	Y->F: Minor effect on kinase activity.	ECO:0000269|PubMed:11294897	11294897
P22607	FGFR3	K650D	P22607/K650D	FGFR3/K650D	MUTAGEN	K->D: Constitutively activated kinase.		
P22607	FGFR3	K650L	P22607/K650L	FGFR3/K650L	MUTAGEN	K->L: Constitutively activated kinase.		
P22607	FGFR3	Y724F	P22607/Y724F	FGFR3/Y724F	MUTAGEN	Y->F: Strongly reduced kinase activity. Strongly reduced mitogen activity.	ECO:0000269|PubMed:11294897	11294897
P22607	FGFR3	Y760F	P22607/Y760F	FGFR3/Y760F	MUTAGEN	Y->F: Minor effect on kinase activity.	ECO:0000269|PubMed:11294897	11294897
P22607	FGFR3	Y770F	P22607/Y770F	FGFR3/Y770F	MUTAGEN	Y->F: Minor effect on kinase activity. Increased mitogen activity.	ECO:0000269|PubMed:11294897	11294897

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P22612	PRKACG	I74M	P22612/I74M	PRKACG/I74M	VARIANT	I -> M (in BDPLT19; patient platelets show impaired activation; dbSNP:rs724159972)	ECO:0000269|PubMed:25061177	25061177
P22612	PRKACG	I251N	P22612/I251N	PRKACG/I251N	VARIANT	I -> N (in dbSNP:rs56287972)	ECO:0000269|PubMed:17344846	17344846
P22612	PRKACG	H268D	P22612/H268D	PRKACG/H268D	VARIANT	H -> D (in dbSNP:rs3730386)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2342480, ECO:0000269|Ref.3	17344846,2342480

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P22694	PRKACB	S54L	P22694/S54L	PRKACB/S54L	VARIANT	S -> L (in CAFD2; dbSNP:rs1663748771)	ECO:0000269|PubMed:33058759	33058759
P22694	PRKACB	H88N	P22694/H88N	PRKACB/H88N	VARIANT	H -> N (in CAFD2)	ECO:0000269|PubMed:33058759	33058759
P22694	PRKACB	H88R	P22694/H88R	PRKACB/H88R	VARIANT	H -> R (in CAFD2; increased sensitivity to cAMP activation; dbSNP:rs768056300)	ECO:0000269|PubMed:33058759	33058759
P22694	PRKACB	R106Q	P22694/R106Q	PRKACB/R106Q	VARIANT	R -> Q (in dbSNP:rs36117118)	ECO:0000269|PubMed:17344846	17344846
P22694	PRKACB	G235R	P22694/G235R	PRKACB/G235R	VARIANT	G -> R (in CAFD2; increased sensitivity to cAMP activation; decreased interaction with regulatory subunits PRKAR1A and PRKAR2B)	ECO:0000269|PubMed:33058759	33058759

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P23443	RPS6KB1	M225I	P23443/M225I	RPS6KB1/M225I	VARIANT	M -> I	ECO:0000269|PubMed:17344846	17344846
P23443	RPS6KB1	R272C	P23443/R272C	RPS6KB1/R272C	VARIANT	R -> C (in dbSNP:rs766645749)	ECO:0000269|PubMed:17344846	17344846
P23443	RPS6KB1	W276C	P23443/W276C	RPS6KB1/W276C	VARIANT	W -> C	ECO:0000269|PubMed:17344846	17344846
P23443	RPS6KB1	G289E	P23443/G289E	RPS6KB1/G289E	VARIANT	G -> E (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
P23443	RPS6KB1	S398A	P23443/S398A	RPS6KB1/S398A	VARIANT	S -> A	ECO:0000269|PubMed:17344846	17344846
P23443	RPS6KB1	K167N	P23443/K167N	RPS6KB1/K167N	MUTAGEN	K->N: Greatly reduces activity. Greatly reduces phosphorylation at T-412 and moderately reduces phosphorylation at T-252.	ECO:0000269|PubMed:17446865	17446865
P23443	RPS6KB1	S394A	P23443/S394A	RPS6KB1/S394A	MUTAGEN	S->A: Loss of activity. Loss of phosphorylation at T-412.	ECO:0000269|PubMed:17446865	17446865
P23443	RPS6KB1	T412E	P23443/T412E	RPS6KB1/T412E	MUTAGEN	T->E: Mimics phosphorylation. Facilitates phosphorylation of T-252 by PDPK1; when associated with E-434; E-441; E-444 and E-447. Mimics phosphorylation. No effect on interaction with PDPK1 and phosphorylation of T-252. Impairs association with the eIF3 complex.	ECO:0000269|PubMed:16286006, ECO:0000269|PubMed:19570988, ECO:0000269|PubMed:9445476	16286006,19570988,9445476
P23443	RPS6KB1	S434E	P23443/S434E	RPS6KB1/S434E	MUTAGEN	S->E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-441; E-444 and E-447.	ECO:0000269|PubMed:9445476	9445476
P23443	RPS6KB1	S441E	P23443/S441E	RPS6KB1/S441E	MUTAGEN	S->E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-434; E-444 and E-447.	ECO:0000269|PubMed:9445476	9445476
P23443	RPS6KB1	T444E	P23443/T444E	RPS6KB1/T444E	MUTAGEN	T->E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-434; E-441 and E-447.	ECO:0000269|PubMed:9445476	9445476
P23443	RPS6KB1	S447E	P23443/S447E	RPS6KB1/S447E	MUTAGEN	S->E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-434; E-441 and E-444.	ECO:0000269|PubMed:9445476	9445476

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P23458	JAK1	A634D	P23458/A634D	JAK1/A634D	VARIANT	A -> D (in AIIDE; constitutive gain of function resulting in increased receptor signaling pathway via JAK-STAT; no effect on protein abundance)	ECO:0000269|PubMed:28111307	28111307
P23458	JAK1	S703I	P23458/S703I	JAK1/S703I	VARIANT	S -> I (in AIIDE; increased activation of protein kinase activity; constitutive gain of function through the transactivation of associated JAK kinases; increased receptor signaling pathway via JAK-STAT)	ECO:0000269|PubMed:32750333	32750333
P23458	JAK1	N973K	P23458/N973K	JAK1/N973K	VARIANT	N -> K (in dbSNP:rs34680086)	ECO:0000269|PubMed:17344846	17344846
P23458	JAK1	V658F	P23458/V658F	JAK1/V658F	MUTAGEN	V->F: Constitutively active. Increased receptor signaling pathway via JAK-STAT.	ECO:0000269|PubMed:16239216	16239216
P23458	JAK1	K908A	P23458/K908A	JAK1/K908A	MUTAGEN	K->A: Loss of protein tyrosine kinase activity.	ECO:0000269|PubMed:32750333	32750333

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P24723	PRKCH	A19V	P24723/A19V	PRKCH/A19V	VARIANT	A -> V (in dbSNP:rs55645551)	ECO:0000269|PubMed:17344846	17344846
P24723	PRKCH	K65R	P24723/K65R	PRKCH/K65R	VARIANT	K -> R (in dbSNP:rs55737090)	ECO:0000269|PubMed:17344846	17344846
P24723	PRKCH	R149Q	P24723/R149Q	PRKCH/R149Q	VARIANT	R -> Q (in dbSNP:rs55848048)	ECO:0000269|PubMed:17344846	17344846
P24723	PRKCH	R359Q	P24723/R359Q	PRKCH/R359Q	VARIANT	R -> Q (in dbSNP:rs55818778)	ECO:0000269|PubMed:17344846	17344846
P24723	PRKCH	V374I	P24723/V374I	PRKCH/V374I	VARIANT	V -> I (associated with susceptibility to ischemic stroke; increases autophosphorylation and kinase activity; dbSNP:rs2230500)	ECO:0000269|PubMed:17206144, ECO:0000269|PubMed:17344846	17206144,17344846
P24723	PRKCH	D497Y	P24723/D497Y	PRKCH/D497Y	VARIANT	D -> Y (in dbSNP:rs11846991)		
P24723	PRKCH	T575A	P24723/T575A	PRKCH/T575A	VARIANT	T -> A (in a aLLTEL/AML1+ sample; somatic mutation; dbSNP:rs1378993559)	ECO:0000269|PubMed:17344846	17344846
P24723	PRKCH	T594I	P24723/T594I	PRKCH/T594I	VARIANT	T -> I (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P24723	PRKCH	P612S	P24723/P612S	PRKCH/P612S	VARIANT	P -> S (in dbSNP:rs34159231)	ECO:0000269|PubMed:17344846	17344846
P24723	PRKCH	D645V	P24723/D645V	PRKCH/D645V	VARIANT	D -> V (in dbSNP:rs35561533)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P24941	CDK2	Y15S	P24941/Y15S	CDK2/Y15S	VARIANT	Y -> S (in dbSNP:rs3087335)		
P24941	CDK2	V18L	P24941/V18L	CDK2/V18L	VARIANT	V -> L (in dbSNP:rs11554376)		
P24941	CDK2	P45L	P24941/P45L	CDK2/P45L	VARIANT	P -> L (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P24941	CDK2	T290S	P24941/T290S	CDK2/T290S	VARIANT	T -> S (in dbSNP:rs2069413)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.6	17344846
P24941	CDK2	K9F	P24941/K9F	CDK2/K9F	MUTAGEN	K->F: Reduced phosphorylation by CAK.	ECO:0000269|PubMed:17373709	17373709
P24941	CDK2	T14A	P24941/T14A	CDK2/T14A	MUTAGEN	T->A: 2-fold increase in activity.	ECO:0000269|PubMed:1396589	1396589
P24941	CDK2	Y15F	P24941/Y15F	CDK2/Y15F	MUTAGEN	Y->F: 2-fold increase in activity.	ECO:0000269|PubMed:1396589	1396589
P24941	CDK2	T160A	P24941/T160A	CDK2/T160A	MUTAGEN	T->A: Abolishes activity.	ECO:0000269|PubMed:1396589	1396589
P24941	CDK2	L166R	P24941/L166R	CDK2/L166R	MUTAGEN	L->R: Reduced phosphorylation by CAK and reduced kinase activity.	ECO:0000269|PubMed:17373709	17373709

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P25092	GUCY2C	C30R	P25092/C30R	GUCY2C/C30R	VARIANT	C -> R (in dbSNP:rs56142849)	ECO:0000269|PubMed:17344846	17344846
P25092	GUCY2C	G61R	P25092/G61R	GUCY2C/G61R	VARIANT	G -> R (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P25092	GUCY2C	R114Q	P25092/R114Q	GUCY2C/R114Q	VARIANT	R -> Q (in dbSNP:rs56275235)	ECO:0000269|PubMed:17344846	17344846
P25092	GUCY2C	F281L	P25092/F281L	GUCY2C/F281L	VARIANT	F -> L (in dbSNP:rs1420635)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:1680854, ECO:0000269|PubMed:1718270, ECO:0000269|PubMed:8381596, ECO:0000269|Ref.4	15489334,1680854,1718270,8381596
P25092	GUCY2C	D387G	P25092/D387G	GUCY2C/D387G	VARIANT	D -> G (in MECIL; activation of guanylate cyclase activity is 60% lower than in wild-type; dbSNP:rs587776905)	ECO:0000269|PubMed:22521417	22521417
P25092	GUCY2C	R464L	P25092/R464L	GUCY2C/R464L	VARIANT	R -> L (in dbSNP:rs55684775)	ECO:0000269|PubMed:17344846	17344846
P25092	GUCY2C	E610K	P25092/E610K	GUCY2C/E610K	VARIANT	E -> K (in dbSNP:rs55897626)	ECO:0000269|PubMed:17344846	17344846
P25092	GUCY2C	S840I	P25092/S840I	GUCY2C/S840I	VARIANT	S -> I (in DIAR6; activating mutation; exposure of the mutant receptor to its ligands results in markedly increased production of cyclic guanosine monophosphate; dbSNP:rs587776871)	ECO:0000269|PubMed:22436048	22436048
P25092	GUCY2C	I859V	P25092/I859V	GUCY2C/I859V	VARIANT	I -> V (in dbSNP:rs34890806)	ECO:0000269|PubMed:17344846	17344846
P25092	GUCY2C	Q1045R	P25092/Q1045R	GUCY2C/Q1045R	VARIANT	Q -> R (in dbSNP:rs35617837)	ECO:0000269|PubMed:17344846	17344846
P25092	GUCY2C	Y1072C	P25092/Y1072C	GUCY2C/Y1072C	VARIANT	Y -> C (in dbSNP:rs35179392)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P25098	GRK2	I184T	P25098/I184T	GRK2/I184T	VARIANT	I -> T (in dbSNP:rs55696045)	ECO:0000269|PubMed:17344846	17344846
P25098	GRK2	R578Q	P25098/R578Q	GRK2/R578Q	VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P25098	GRK2	D3A	P25098/D3A	GRK2/D3A	MUTAGEN	D->A: 85% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	ECO:0000269|PubMed:19715378	19715378
P25098	GRK2	D3K	P25098/D3K	GRK2/D3K	MUTAGEN	D->K: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin. 60% reduction in phosphorylation of beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin.	ECO:0000269|PubMed:19715378	19715378
P25098	GRK2	D3N	P25098/D3N	GRK2/D3N	MUTAGEN	D->N: 60% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	ECO:0000269|PubMed:19715378	19715378
P25098	GRK2	L4A	P25098/L4A	GRK2/L4A	MUTAGEN	L->A: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin. 90% reduction in phosphorylation of beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin.	ECO:0000269|PubMed:19715378	19715378
P25098	GRK2	L4K	P25098/L4K	GRK2/L4K	MUTAGEN	L->K: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	ECO:0000269|PubMed:19715378	19715378
P25098	GRK2	E5A	P25098/E5A	GRK2/E5A	MUTAGEN	E->A: 50% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	ECO:0000269|PubMed:19715378	19715378
P25098	GRK2	D10A	P25098/D10A	GRK2/D10A	MUTAGEN	D->A: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin and beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin.	ECO:0000269|PubMed:19715378	19715378

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P25440	BRD2	G30E	P25440/G30E	BRD2/G30E	VARIANT	G -> E (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P25440	BRD2	A49G	P25440/A49G	BRD2/A49G	VARIANT	A -> G (in dbSNP:rs3918144)	ECO:0000269|PubMed:17344846	17344846
P25440	BRD2	A49S	P25440/A49S	BRD2/A49S	VARIANT	A -> S (in dbSNP:rs55669504)	ECO:0000269|PubMed:17344846	17344846
P25440	BRD2	A212P	P25440/A212P	BRD2/A212P	VARIANT	A -> P (in dbSNP:rs35952031)	ECO:0000269|PubMed:17344846	17344846
P25440	BRD2	L238F	P25440/L238F	BRD2/L238F	VARIANT	L -> F (in dbSNP:rs176250)	ECO:0000269|PubMed:14574404, ECO:0000269|PubMed:17344846	14574404,17344846
P25440	BRD2	P260Q	P25440/P260Q	BRD2/P260Q	VARIANT	P -> Q (in dbSNP:rs35294809)	ECO:0000269|PubMed:17344846	17344846
P25440	BRD2	A474V	P25440/A474V	BRD2/A474V	VARIANT	A -> V (in dbSNP:rs3918143)	ECO:0000269|PubMed:17344846	17344846
P25440	BRD2	R547K	P25440/R547K	BRD2/R547K	VARIANT	R -> K (in dbSNP:rs1049369)		
P25440	BRD2	R558G	P25440/R558G	BRD2/R558G	VARIANT	R -> G (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P25440	BRD2	A569T	P25440/A569T	BRD2/A569T	VARIANT	A -> T (in dbSNP:rs34530779)	ECO:0000269|PubMed:17344846	17344846
P25440	BRD2	A599P	P25440/A599P	BRD2/A599P	VARIANT	A -> P (in dbSNP:rs55952113)	ECO:0000269|PubMed:17344846	17344846
P25440	BRD2	P714L	P25440/P714L	BRD2/P714L	VARIANT	P -> L (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P25440	BRD2	Q78A	P25440/Q78A	BRD2/Q78A	MUTAGEN	Q->A: Loss of homodimerization.	ECO:0000269|PubMed:17148447	17148447
P25440	BRD2	Y153K	P25440/Y153K	BRD2/Y153K	MUTAGEN	Y->K: Loss of homodimerization.	ECO:0000269|PubMed:17148447	17148447
P25440	BRD2	I154A	P25440/I154A	BRD2/I154A	MUTAGEN	I->A: Partial loss of homodimerization; when associated with A-182.	ECO:0000269|PubMed:17148447	17148447
P25440	BRD2	E170A	P25440/E170A	BRD2/E170A	MUTAGEN	E->A: Loss of homodimerization.	ECO:0000269|PubMed:17148447	17148447
P25440	BRD2	L174E	P25440/L174E	BRD2/L174E	MUTAGEN	L->E: Loss of homodimerization.	ECO:0000269|PubMed:17148447	17148447
P25440	BRD2	V177E	P25440/V177E	BRD2/V177E	MUTAGEN	V->E: Loss of homodimerization.	ECO:0000269|PubMed:17148447	17148447
P25440	BRD2	Q182A	P25440/Q182A	BRD2/Q182A	MUTAGEN	Q->A: Partial loss of homodimerization; when associated with A-154.	ECO:0000269|PubMed:17148447	17148447

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P27037	ACVR2A	S258R	P27037/S258R	ACVR2A/S258R	VARIANT	S -> R (in dbSNP:rs34917571)	ECO:0000269|PubMed:17344846	17344846
P27037	ACVR2A	D306N	P27037/D306N	ACVR2A/D306N	VARIANT	D -> N (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs764255410)	ECO:0000269|PubMed:17344846	17344846
P27037	ACVR2A	A367T	P27037/A367T	ACVR2A/A367T	VARIANT	A -> T (found in a clear cell renal carcinoma case; somatic mutation)	ECO:0000269|PubMed:21248752	21248752

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P27361	MAPK3	E323K	P27361/E323K	MAPK3/E323K	VARIANT	E -> K (in dbSNP:rs55859133)	ECO:0000269|PubMed:17344846	17344846
P27361	MAPK3	K168R	P27361/K168R	MAPK3/K168R	MUTAGEN	K->R: Complete loss of ubiquitination by TRIM15; when associated with R-302.	ECO:0000269|PubMed:34497368	34497368
P27361	MAPK3	K302R	P27361/K302R	MAPK3/K302R	MUTAGEN	K->R: Complete loss of ubiquitination by TRIM15; when associated with R-168.	ECO:0000269|PubMed:34497368	34497368

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P27448	MARK3	S410F	P27448/S410F	MARK3/S410F	VARIANT	S -> F (in dbSNP:rs10137161)	ECO:0000269|Ref.6	
P27448	MARK3	V429A	P27448/V429A	MARK3/V429A	VARIANT	V -> A	ECO:0000269|PubMed:17344846	17344846
P27448	MARK3	S443G	P27448/S443G	MARK3/S443G	VARIANT	S -> G (in dbSNP:rs56305318)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9543386, ECO:0000269|Ref.2	17344846,9543386
P27448	MARK3	R570G	P27448/R570G	MARK3/R570G	VARIANT	R -> G (in VIPB; dbSNP:rs376395495)	ECO:0000269|PubMed:29771303	29771303
P27448	MARK3	T211A	P27448/T211A	MARK3/T211A	MUTAGEN			

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P28482	MAPK1	I74N	P28482/I74N	MAPK1/I74N	VARIANT	I -> N (in NS13; results in increased MAPK signaling; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	ECO:0000269|PubMed:32721402	32721402
P28482	MAPK1	H80Y	P28482/H80Y	MAPK1/H80Y	VARIANT	H -> Y (in NS13; results in increased MAPK signaling; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	ECO:0000269|PubMed:32721402	32721402
P28482	MAPK1	A174V	P28482/A174V	MAPK1/A174V	VARIANT	A -> V (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	ECO:0000269|PubMed:32721402	32721402
P28482	MAPK1	D318G	P28482/D318G	MAPK1/D318G	VARIANT	D -> G (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	ECO:0000269|PubMed:32721402	32721402
P28482	MAPK1	D318N	P28482/D318N	MAPK1/D318N	VARIANT	D->N: Inhibits interaction with MAP2K1 but not with TPR; when associated with N-321.	ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19494114	18794356,19494114
P28482	MAPK1	E322Q	P28482/E322Q	MAPK1/E322Q	VARIANT	E -> Q (in NS13)	ECO:0000269|PubMed:32721402	32721402
P28482	MAPK1	P323R	P28482/P323R	MAPK1/P323R	VARIANT	P -> R (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	ECO:0000269|PubMed:32721402	32721402
P28482	MAPK1	K54R	P28482/K54R	MAPK1/K54R	MUTAGEN	K->R: Does not inhibit interaction with MAP2K1.	ECO:0000269|PubMed:18794356	18794356
P28482	MAPK1	T185A	P28482/T185A	MAPK1/T185A	MUTAGEN	T->A: Inhibits interaction with TPR; when associated with A-187.	ECO:0000269|PubMed:18794356	18794356
P28482	MAPK1	Y187A	P28482/Y187A	MAPK1/Y187A	MUTAGEN	Y->A: Inhibits interaction with TPR; when associated with A-185.	ECO:0000269|PubMed:18794356	18794356
P28482	MAPK1	L234A	P28482/L234A	MAPK1/L234A	MUTAGEN	L->A: Inhibits interaction with TPR.	ECO:0000269|PubMed:18794356	18794356
P28482	MAPK1	D318A	P28482/D318A	MAPK1/D318A	MUTAGEN	D->A: Loss of dephosphorylation by PTPRJ.	ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19494114	18794356,19494114
P28482	MAPK1	D321N	P28482/D321N	MAPK1/D321N	MUTAGEN	D->N: Inhibits interaction with MAP2K1 but not with TPR; when associated with N-318.	ECO:0000269|PubMed:18794356	18794356

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P29317	EPHA2	K99N	P29317/K99N	EPHA2/K99N	VARIANT	K -> N (in dbSNP:rs1058372)		
P29317	EPHA2	G391R	P29317/G391R	EPHA2/G391R	VARIANT	G -> R (in dbSNP:rs34192549)	ECO:0000269|PubMed:17344846	17344846
P29317	EPHA2	T511M	P29317/T511M	EPHA2/T511M	VARIANT	T -> M (in dbSNP:rs55747232)	ECO:0000269|PubMed:17344846	17344846
P29317	EPHA2	R568H	P29317/R568H	EPHA2/R568H	VARIANT	R -> H (in dbSNP:rs56198600)	ECO:0000269|PubMed:17344846	17344846
P29317	EPHA2	M631T	P29317/M631T	EPHA2/M631T	VARIANT	M -> T (in dbSNP:rs34021505)		
P29317	EPHA2	R721Q	P29317/R721Q	EPHA2/R721Q	VARIANT	R -> Q (in CTRCT6; retained in the cytoplasm and constitutively active it alters EPHA2 signaling; dbSNP:rs116506614)	ECO:0000269|PubMed:19649315	19649315
P29317	EPHA2	G777S	P29317/G777S	EPHA2/G777S	VARIANT	G -> S (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs922655349)	ECO:0000269|PubMed:17344846	17344846
P29317	EPHA2	R876H	P29317/R876H	EPHA2/R876H	VARIANT	R -> H (in dbSNP:rs35903225)	ECO:0000269|PubMed:17344846	17344846
P29317	EPHA2	T940I	P29317/T940I	EPHA2/T940I	VARIANT	T -> I (in CTRCT6; reduced protein stability and reduced ability to stimulate cell migration in absence of its ephrin ligand; dbSNP:rs137853200)	ECO:0000269|PubMed:19306328, ECO:0000269|PubMed:22570727	19306328,22570727
P29317	EPHA2	G948W	P29317/G948W	EPHA2/G948W	VARIANT	G -> W (in CTRCT6; reduced protein stability and reduced ability to stimulate cell migration in absence of its ephrin ligand; dbSNP:rs137853199)	ECO:0000269|PubMed:19005574, ECO:0000269|PubMed:22570727	19005574,22570727
P29317	EPHA2	R103E	P29317/R103E	EPHA2/R103E	MUTAGEN	R->E: Significantly reduced response to EFNA1.	ECO:0000269|PubMed:19525919	19525919
P29317	EPHA2	K646M	P29317/K646M	EPHA2/K646M	MUTAGEN	K->M: Loss of kinase activity.	ECO:0000269|PubMed:16236711	16236711
P29317	EPHA2	D739N	P29317/D739N	EPHA2/D739N	MUTAGEN	D->N: Increases serum-induced chemotaxis. Loss of EFNA1-dependent regulation of cell migration.	ECO:0000269|PubMed:19573808	19573808
P29317	EPHA2	S897A	P29317/S897A	EPHA2/S897A	MUTAGEN			
P29317	EPHA2	S897D	P29317/S897D	EPHA2/S897D	MUTAGEN	S->A,D: Loss of serum-induced phosphorylation by PKB. Loss of serum-induced chemotaxis.	ECO:0000269|PubMed:19573808	19573808

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P29320	EPHA3	T37K	P29320/T37K	EPHA3/T37K	VARIANT	T -> K (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
P29320	EPHA3	N85S	P29320/N85S	EPHA3/N85S	VARIANT	N -> S (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
P29320	EPHA3	K207N	P29320/K207N	EPHA3/K207N	VARIANT	K -> N (in a pancreatic ductal adenocarcinoma sample; somatic mutation; dbSNP:rs200567888)	ECO:0000269|PubMed:20838624	20838624
P29320	EPHA3	S229Y	P29320/S229Y	EPHA3/S229Y	VARIANT	S -> Y (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P29320	EPHA3	S449F	P29320/S449F	EPHA3/S449F	VARIANT	S -> F (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P29320	EPHA3	G518L	P29320/G518L	EPHA3/G518L	VARIANT	G -> L (in a lung squamous cell carcinoma sample; somatic mutation; requires 2 nucleotide substitutions)	ECO:0000269|PubMed:17344846	17344846
P29320	EPHA3	I564V	P29320/I564V	EPHA3/I564V	VARIANT	I -> V (in dbSNP:rs55712516)	ECO:0000269|PubMed:17344846	17344846
P29320	EPHA3	C568S	P29320/C568S	EPHA3/C568S	VARIANT	C -> S (in dbSNP:rs56077781)	ECO:0000269|PubMed:17344846	17344846
P29320	EPHA3	L590P	P29320/L590P	EPHA3/L590P	VARIANT	L -> P (in dbSNP:rs56081642)	ECO:0000269|PubMed:17344846	17344846
P29320	EPHA3	I621L	P29320/I621L	EPHA3/I621L	VARIANT	I -> L (in a colorectal cancer sample; somatic mutation; dbSNP:rs1414714315)	ECO:0000269|PubMed:16959974	16959974
P29320	EPHA3	T660K	P29320/T660K	EPHA3/T660K	VARIANT	T -> K (in a lung carcinoma sample; somatic mutation)	ECO:0000269|PubMed:16941478	16941478
P29320	EPHA3	G766E	P29320/G766E	EPHA3/G766E	VARIANT	G -> E (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P29320	EPHA3	A777G	P29320/A777G	EPHA3/A777G	VARIANT	A -> G (in dbSNP:rs34437982)	ECO:0000269|PubMed:17344846	17344846
P29320	EPHA3	D806N	P29320/D806N	EPHA3/D806N	VARIANT	D -> N (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
P29320	EPHA3	R914H	P29320/R914H	EPHA3/R914H	VARIANT	R -> H (in dbSNP:rs17801309)	ECO:0000269|PubMed:17344846	17344846
P29320	EPHA3	W924R	P29320/W924R	EPHA3/W924R	VARIANT	W -> R (in dbSNP:rs35124509)	ECO:0000269|PubMed:1311845, ECO:0000269|PubMed:17344846	1311845,17344846
P29320	EPHA3	T933M	P29320/T933M	EPHA3/T933M	VARIANT	T -> M (in a lung carcinoma sample; somatic mutation; dbSNP:rs372594677)	ECO:0000269|PubMed:16941478	16941478
P29320	EPHA3	V133E	P29320/V133E	EPHA3/V133E	MUTAGEN	V->E: Loss of EFNA5-binding ability and function.	ECO:0000269|PubMed:14660665	14660665
P29320	EPHA3	F152L	P29320/F152L	EPHA3/F152L	MUTAGEN	F->L: Loss of EFNA5-binding ability and function.	ECO:0000269|PubMed:14660665	14660665
P29320	EPHA3	Y596F	P29320/Y596F	EPHA3/Y596F	MUTAGEN	Y->F: 10-fold suppression of kinase activity; when associated with F-602. Full kinase activity; when associated with F-602 and F-742. Full kinase activity; when associated with F-602 and A-768.	ECO:0000269|PubMed:18547520	18547520
P29320	EPHA3	Y602F	P29320/Y602F	EPHA3/Y602F	MUTAGEN	Y->F: 10-fold suppression of kinase activity; when associated with F-596. Full kinase activity; when associated with F-596 and F-742. Full kinase activity; when associated with F-596 and A-768.	ECO:0000269|PubMed:18547520	18547520
P29320	EPHA3	Y742F	P29320/Y742F	EPHA3/Y742F	MUTAGEN	Y->F: Full kinase activity; when associated with F-596 and F-602.	ECO:0000269|PubMed:18547520	18547520
P29320	EPHA3	S768A	P29320/S768A	EPHA3/S768A	MUTAGEN	S->A: Full kinase activity; when associated with F-596 and F-602.	ECO:0000269|PubMed:18547520	18547520

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P29322	EPHA8	G45S	P29322/G45S	EPHA8/G45S	VARIANT	G -> S (in dbSNP:rs45498698)	ECO:0000269|PubMed:17344846	17344846
P29322	EPHA8	V60L	P29322/V60L	EPHA8/V60L	VARIANT	V -> L (in dbSNP:rs56402644)	ECO:0000269|PubMed:17344846	17344846
P29322	EPHA8	N123K	P29322/N123K	EPHA8/N123K	VARIANT	N -> K (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P29322	EPHA8	R179C	P29322/R179C	EPHA8/R179C	VARIANT	R -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1557556639)	ECO:0000269|PubMed:17344846	17344846
P29322	EPHA8	R198L	P29322/R198L	EPHA8/R198L	VARIANT	R -> L (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P29322	EPHA8	P321L	P29322/P321L	EPHA8/P321L	VARIANT	P -> L (in dbSNP:rs56656925)		
P29322	EPHA8	V444M	P29322/V444M	EPHA8/V444M	VARIANT	V -> M (in dbSNP:rs2295021)		
P29322	EPHA8	E612Q	P29322/E612Q	EPHA8/E612Q	VARIANT	E -> Q (in dbSNP:rs999765)	ECO:0000269|PubMed:10819331	10819331
P29322	EPHA8	P860L	P29322/P860L	EPHA8/P860L	VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P29323	EPHB2	R199H	P29323/R199H	EPHB2/R199H	VARIANT	R -> H (in prostate cancer; dbSNP:rs201754821)	ECO:0000269|PubMed:15300251	15300251
P29323	EPHB2	A279S	P29323/A279S	EPHB2/A279S	VARIANT	A -> S (in prostate cancer; dbSNP:rs35882952)	ECO:0000269|PubMed:15300251, ECO:0000269|PubMed:16155194, ECO:0000269|PubMed:17344846	15300251,16155194,17344846
P29323	EPHB2	C289G	P29323/C289G	EPHB2/C289G	VARIANT	C -> G	ECO:0000269|PubMed:17344846	17344846
P29323	EPHB2	I361V	P29323/I361V	EPHB2/I361V	VARIANT	I -> V (in dbSNP:rs56180036)	ECO:0000269|PubMed:17344846	17344846
P29323	EPHB2	V650A	P29323/V650A	EPHB2/V650A	VARIANT	V -> A (in prostate cancer; dbSNP:rs142173175)	ECO:0000269|PubMed:16155194	16155194
P29323	EPHB2	D678N	P29323/D678N	EPHB2/D678N	VARIANT	D -> N (in dbSNP:rs28936395)	ECO:0000269|PubMed:17344846	17344846
P29323	EPHB2	H679N	P29323/H679N	EPHB2/H679N	VARIANT	H -> N (in prostate cancer)	ECO:0000269|PubMed:15300251	15300251
P29323	EPHB2	R745C	P29323/R745C	EPHB2/R745C	VARIANT	R -> C (in BDPLT22; dbSNP:rs761749948)	ECO:0000269|PubMed:30213874	30213874
P29323	EPHB2	R844W	P29323/R844W	EPHB2/R844W	VARIANT	R -> W (in dbSNP:rs55826626)	ECO:0000269|PubMed:17344846	17344846
P29323	EPHB2	M883V	P29323/M883V	EPHB2/M883V	VARIANT	M -> V (in prostate cancer; dbSNP:rs372653137)	ECO:0000269|PubMed:16155194	16155194
P29323	EPHB2	I909M	P29323/I909M	EPHB2/I909M	VARIANT	I -> M (in prostate cancer)	ECO:0000269|PubMed:15300251	15300251
P29323	EPHB2	K787R	P29323/K787R	EPHB2/K787R	MUTAGEN	K->R: No loss of ubiquitination by RNF186.	ECO:0000269|PubMed:33280498	33280498
P29323	EPHB2	K891R	P29323/K891R	EPHB2/K891R	MUTAGEN	K->R: Complete loss of ubiquitination by RNF186.	ECO:0000269|PubMed:33280498	33280498

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P29376	LTK	R42Q	P29376/R42Q	LTK/R42Q	VARIANT	R -> Q (in dbSNP:rs2305030)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7685902	17344846,7685902
P29376	LTK	C384R	P29376/C384R	LTK/C384R	VARIANT	C -> R (in dbSNP:rs55683312)	ECO:0000269|PubMed:17344846	17344846
P29376	LTK	D535N	P29376/D535N	LTK/D535N	VARIANT	D -> N (in dbSNP:rs35932273)	ECO:0000269|PubMed:17344846	17344846
P29376	LTK	R569S	P29376/R569S	LTK/R569S	VARIANT	R -> S (in dbSNP:rs148513655)	ECO:0000269|PubMed:17344846	17344846
P29376	LTK	R673Q	P29376/R673Q	LTK/R673Q	VARIANT	R -> Q (in dbSNP:rs55876255)	ECO:0000269|PubMed:17344846	17344846
P29376	LTK	P745S	P29376/P745S	LTK/P745S	VARIANT	P -> S (in dbSNP:rs55900837)	ECO:0000269|PubMed:17344846	17344846
P29376	LTK	E763K	P29376/E763K	LTK/E763K	VARIANT	E -> K (may possibly contribute to susceptibility to systemic lupus erythematosus; increases autophosphorylation and interaction with PI3-kinase subunit p85; dbSNP:rs76282169)	ECO:0000269|PubMed:14695357	14695357
P29376	LTK	P838S	P29376/P838S	LTK/P838S	VARIANT	P -> S (in dbSNP:rs56367146)	ECO:0000269|PubMed:17344846	17344846
P29376	LTK	R241A	P29376/R241A	LTK/R241A	MUTAGEN	R->A: Abolished homodimerization following interaction with ALKAL1.	ECO:0000269|PubMed:34646012	34646012
P29376	LTK	K544M	P29376/K544M	LTK/K544M	MUTAGEN	K->M: Loss of interaction with PLCG1, PI3-kinase subunit p85, Ras GTPase-activating protein and RAF1.	ECO:0000269|PubMed:8084603	8084603
P29376	LTK	G750E	P29376/G750E	LTK/G750E	MUTAGEN	G->E: Increases autophosphorylation and interaction with PI3-kinase subunit p85 (demonstrated with chimeric EGFR-LTK).	ECO:0000269|PubMed:14695357	14695357
P29376	LTK	Y753F	P29376/Y753F	LTK/Y753F	MUTAGEN	Y->F: Abolishes interaction with PI3-kinase subunit p85, impairs PI3 kinase activity and leads to apoptosis (demonstrated with chimeric EGFR-LTK).	ECO:0000269|PubMed:9223670	9223670
P29376	LTK	Y862F	P29376/Y862F	LTK/Y862F	MUTAGEN	Y->F: Impairs phosphorylation of CBLC (demonstrated with chimeric EGFR-LTK).	ECO:0000269|PubMed:9223670	9223670

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P29597	TYK2	R4H	P29597/R4H	TYK2/R4H	VARIANT	R -> H (in dbSNP:rs12720343)	ECO:0000269|Ref.2	
P29597	TYK2	A81V	P29597/A81V	TYK2/A81V	VARIANT	A -> V (in dbSNP:rs1049619)		
P29597	TYK2	R197H	P29597/R197H	TYK2/R197H	VARIANT	R -> H (in dbSNP:rs12720263)	ECO:0000269|Ref.2	
P29597	TYK2	V362F	P29597/V362F	TYK2/V362F	VARIANT	V -> F (in dbSNP:rs2304256)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2216457, ECO:0000269|Ref.2	17344846,2216457
P29597	TYK2	G363S	P29597/G363S	TYK2/G363S	VARIANT	G -> S (in dbSNP:rs2304255)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.2	17344846
P29597	TYK2	V386M	P29597/V386M	TYK2/V386M	VARIANT	V -> M (in dbSNP:rs55956017)	ECO:0000269|PubMed:17344846	17344846
P29597	TYK2	R442Q	P29597/R442Q	TYK2/R442Q	VARIANT	R -> Q (in dbSNP:rs2304254)		
P29597	TYK2	I684S	P29597/I684S	TYK2/I684S	VARIANT	I -> S (in dbSNP:rs12720356)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:2216457, ECO:0000269|Ref.2	17344846,2216457
P29597	TYK2	R703W	P29597/R703W	TYK2/R703W	VARIANT	R -> W (in dbSNP:rs55882956)	ECO:0000269|PubMed:17344846	17344846
P29597	TYK2	H732R	P29597/H732R	TYK2/H732R	VARIANT	H -> R (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P29597	TYK2	P820H	P29597/P820H	TYK2/P820H	VARIANT	P -> H (in dbSNP:rs34046749)		
P29597	TYK2	A928V	P29597/A928V	TYK2/A928V	VARIANT	A -> V (in dbSNP:rs35018800)	ECO:0000269|PubMed:17344846	17344846
P29597	TYK2	P1104A	P29597/P1104A	TYK2/P1104A	VARIANT	P -> A (in dbSNP:rs34536443)	ECO:0000269|PubMed:17344846	17344846
P29597	TYK2	E1163G	P29597/E1163G	TYK2/E1163G	VARIANT	E -> G (in dbSNP:rs55886939)	ECO:0000269|PubMed:17344846	17344846
P29597	TYK2	K930R	P29597/K930R	TYK2/K930R	MUTAGEN	K->R: Complete loss of catalytic activity.	ECO:0000269|PubMed:8702790	8702790
P29597	TYK2	D1023N	P29597/D1023N	TYK2/D1023N	MUTAGEN	D->N: Complete loss of catalytic activity.	ECO:0000269|PubMed:24843152	24843152
P29597	TYK2	Y1054F	P29597/Y1054F	TYK2/Y1054F	MUTAGEN	Y->F: Reduces basal catalytic activity and abolishes IFN-dependent activation.	ECO:0000269|PubMed:8702790	8702790
P29597	TYK2	Y1055F	P29597/Y1055F	TYK2/Y1055F	MUTAGEN	Y->F: Reduces basal catalytic activity and abolishes IFN-dependent activation.	ECO:0000269|PubMed:8702790	8702790
P29597	TYK2	Y1145F	P29597/Y1145F	TYK2/Y1145F	MUTAGEN	Y->F: Does not affect phosphorylation state and enzymatic activity.	ECO:0000269|PubMed:8702790	8702790
P29597	TYK2	Y1176F	P29597/Y1176F	TYK2/Y1176F	MUTAGEN	Y->F: Does not affect phosphorylation state and enzymatic activity.	ECO:0000269|PubMed:8702790	8702790

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P30291	WEE1	G210C	P30291/G210C	WEE1/G210C	VARIANT	G -> C (in dbSNP:rs34412975)	ECO:0000269|PubMed:17344846	17344846
P30291	WEE1	S472I	P30291/S472I	WEE1/S472I	VARIANT	S -> I (in dbSNP:rs56411856)	ECO:0000269|PubMed:17344846	17344846
P30291	WEE1	S53A	P30291/S53A	WEE1/S53A	MUTAGEN	S->A: Abolishes phosphorylation by PLK1 and CDK1 and binding of the SCF(BTRC) complex, leading to stabilization of the protein; when associated with A-123.	ECO:0000269|PubMed:15070733	15070733
P30291	WEE1	S123A	P30291/S123A	WEE1/S123A	MUTAGEN	S->A: Abolishes phosphorylation by PLK1 and CDK1 and binding of the SCF(BTRC) complex, leading to stabilization of the protein; when associated with A-53.	ECO:0000269|PubMed:15070733	15070733
P30291	WEE1	K328R	P30291/K328R	WEE1/K328R	MUTAGEN	K->R: Abolishes activity.	ECO:0000269|PubMed:8428596	8428596
P30291	WEE1	S642A	P30291/S642A	WEE1/S642A	MUTAGEN	S->A: Abolishes phosphorylation by BRSK1 and BRSK2.	ECO:0000269|PubMed:20026642	20026642

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P30530	AXL	T112M	P30530/T112M	AXL/T112M	VARIANT	T -> M (in dbSNP:rs35202236)	ECO:0000269|PubMed:17344846	17344846
P30530	AXL	D266N	P30530/D266N	AXL/D266N	VARIANT	D -> N (in dbSNP:rs7249222)		
P30530	AXL	R295W	P30530/R295W	AXL/R295W	VARIANT	R -> W (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs751738506)	ECO:0000269|PubMed:17344846	17344846
P30530	AXL	R499C	P30530/R499C	AXL/R499C	VARIANT	R -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs747576071)	ECO:0000269|PubMed:17344846	17344846
P30530	AXL	S515G	P30530/S515G	AXL/S515G	VARIANT	S -> G (in dbSNP:rs1240393707)	ECO:0000269|PubMed:17344846	17344846
P30530	AXL	E63R	P30530/E63R	AXL/E63R	MUTAGEN	E->R: Slightly reduced affinity for GAS6.	ECO:0000269|PubMed:16362042	16362042
P30530	AXL	E66R	P30530/E66R	AXL/E66R	MUTAGEN	E->R: Reduced affinity for GAS6.	ECO:0000269|PubMed:16362042	16362042
P30530	AXL	T84R	P30530/T84R	AXL/T84R	MUTAGEN	T->R: Reduced affinity for GAS6.	ECO:0000269|PubMed:16362042	16362042
P30530	AXL	K567M	P30530/K567M	AXL/K567M	MUTAGEN	K->M: Catalytically inactive mutant.	ECO:0000269|PubMed:28076778	28076778

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P31152	MAPK4	V38M	P31152/V38M	MAPK4/V38M	VARIANT	V -> M (in dbSNP:rs3752087)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
P31152	MAPK4	R371P	P31152/R371P	MAPK4/R371P	VARIANT	R -> P (in dbSNP:rs3752089)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P31749	AKT1	E17K	P31749/E17K	AKT1/E17K	VARIANT	E->K: No effect on membrane localization. Loss of membrane localization; when associated with Q-20.	ECO:0000269|PubMed:21775285	21775285
P31749	AKT1	R25C	P31749/R25C	AKT1/R25C	VARIANT	R->A,C: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	ECO:0000269|PubMed:12176338	12176338
P31749	AKT1	V167A	P31749/V167A	AKT1/V167A	VARIANT	V -> A (in dbSNP:rs11555433)		
P31749	AKT1	T435P	P31749/T435P	AKT1/T435P	VARIANT	T -> P (in CWS6; dbSNP:rs397514645)	ECO:0000269|PubMed:23246288	23246288
P31749	AKT1	K8R	P31749/K8R	AKT1/K8R	MUTAGEN	K->R: Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation as well as IGF1-induced membrane recruitment. Decrease in ubiquitination and phosphorylation at T-308 as well as impaired association with the membrane; when associated with K-17.	ECO:0000269|PubMed:19713527	19713527
P31749	AKT1	K14A	P31749/K14A	AKT1/K14A	MUTAGEN	K->A: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:19713527, ECO:0000269|PubMed:21775285	12176338,19713527,21775285
P31749	AKT1	K14Q	P31749/K14Q	AKT1/K14Q	MUTAGEN	K->Q: Substantial reduction of phosphorylation at T-308 and S-473, loss of AKT activation, and loss of binding to PIP3 as well as IGF1-induced membrane recruitment.	ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:19713527, ECO:0000269|PubMed:21775285	12176338,19713527,21775285
P31749	AKT1	K14R	P31749/K14R	AKT1/K14R	MUTAGEN	K->R: Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation, loss of binding to PIP3 as well as IGF1-induced membrane recruitment.	ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:19713527, ECO:0000269|PubMed:21775285	12176338,19713527,21775285
P31749	AKT1	K20Q	P31749/K20Q	AKT1/K20Q	MUTAGEN	K->Q: Substantial reduction of phosphorylation at T-308 and S-473, reduced AKT activation, and reduced binding to PIP3 as well as IGF1-induced membrane recruitment. Loss of membrane localization; when associated with K-17.	ECO:0000269|PubMed:21775285	21775285
P31749	AKT1	K20R	P31749/K20R	AKT1/K20R	MUTAGEN	K->R: Slight increase of phosphorylation at T-308 and S-473.	ECO:0000269|PubMed:21775285	21775285
P31749	AKT1	R25A	P31749/R25A	AKT1/R25A	MUTAGEN			
P31749	AKT1	R86A	P31749/R86A	AKT1/R86A	MUTAGEN	R->A: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	ECO:0000269|PubMed:12176338	12176338
P31749	AKT1	Y176F	P31749/Y176F	AKT1/Y176F	MUTAGEN	Y->F: Significant loss of interaction with TNK2. Loss of membrane localization. Significant reduction in phosphorylation on Ser-473.	ECO:0000269|PubMed:20333297	20333297
P31749	AKT1	K179M	P31749/K179M	AKT1/K179M	MUTAGEN	K->M: Abolished serine/threonine-protein kinase activity.	ECO:0000269|PubMed:33594058	33594058
P31749	AKT1	T305A	P31749/T305A	AKT1/T305A	MUTAGEN	T->A: Reduces O-GlcNAc levels; Reduces O-GlcNAc levels even more; when associated with A-312.	ECO:0000269|PubMed:22629392	22629392
P31749	AKT1	T305Y	P31749/T305Y	AKT1/T305Y	MUTAGEN	T->Y: Abolishes phosphorylation at Thr-308.	ECO:0000269|PubMed:22629392	22629392
P31749	AKT1	T308D	P31749/T308D	AKT1/T308D	MUTAGEN	T->D: 5-fold activation and 18-fold activation; when associated with D-473.	ECO:0000269|PubMed:12244301, ECO:0000269|PubMed:8978681	12244301,8978681
P31749	AKT1	T312A	P31749/T312A	AKT1/T312A	MUTAGEN	T->A: Reduces O-GlcNAc levels; Reduces O-GlcNAc levels even more; when associated with A-305.	ECO:0000269|PubMed:22629392	22629392
P31749	AKT1	T312Y	P31749/T312Y	AKT1/T312Y	MUTAGEN	T->Y: Abolishes phosphorylation at Thr-308.	ECO:0000269|PubMed:22629392	22629392
P31749	AKT1	S473D	P31749/S473D	AKT1/S473D	MUTAGEN	S->D: 7-fold activation and 25-fold activation; when associated with D-308.	ECO:0000269|PubMed:12244301, ECO:0000269|PubMed:8978681	12244301,8978681
P31749	AKT1	Y474F	P31749/Y474F	AKT1/Y474F	MUTAGEN	Y->F: 55% inhibition of activation.	ECO:0000269|PubMed:12149249	12149249

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P31751	AKT2	E17K	P31751/E17K	AKT2/E17K	VARIANT	E -> K (in HIHGHH; exhibits plasma membrane localization in serum-starved cells and produced inappropriate tonic nuclear exclusion of FOXO1 in preadipocytes; dbSNP:rs387906659)	ECO:0000269|PubMed:21979934	21979934
P31751	AKT2	I188V	P31751/I188V	AKT2/I188V	VARIANT	I -> V (in dbSNP:rs55859611)	ECO:0000269|PubMed:17344846	17344846
P31751	AKT2	R208K	P31751/R208K	AKT2/R208K	VARIANT	R -> K (in dbSNP:rs35817154)	ECO:0000269|PubMed:17344846	17344846
P31751	AKT2	R274H	P31751/R274H	AKT2/R274H	VARIANT	R -> H (in T2D; associated with typical metabolic dyslipidemia with elevated fastin triglyceride, high VLDL triglyceride/cholesterol ratios, low HDL cholesterol levels and high small dense LDL levels; de novo lipogenesis and liver fat are also significantly elevated in this subject; dbSNP:rs121434593)	ECO:0000269|PubMed:15166380, ECO:0000269|PubMed:19164855	15166380,19164855
P31751	AKT2	T309A	P31751/T309A	AKT2/T309A	MUTAGEN	T->A: Impairs interaction with TTC3; when associated with A-474.	ECO:0000269|PubMed:15890450, ECO:0000269|PubMed:20059950	15890450,20059950
P31751	AKT2	T309E	P31751/T309E	AKT2/T309E	MUTAGEN	T->E: Constitutively active; when associated with D-474.	ECO:0000269|PubMed:15890450, ECO:0000269|PubMed:20059950	15890450,20059950
P31751	AKT2	S474A	P31751/S474A	AKT2/S474A	MUTAGEN	S->A: Impairs interaction with TTC3; when associated with A-309.	ECO:0000269|PubMed:15890450, ECO:0000269|PubMed:20059950	15890450,20059950
P31751	AKT2	S474D	P31751/S474D	AKT2/S474D	MUTAGEN	S->D: Constitutively active; when associated with E-309.	ECO:0000269|PubMed:15890450, ECO:0000269|PubMed:20059950	15890450,20059950

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P32298	GRK4	R65L	P32298/R65L	GRK4/R65L	VARIANT	R -> L (in dbSNP:rs2960306)	ECO:0000269|PubMed:17344846	17344846
P32298	GRK4	D95H	P32298/D95H	GRK4/D95H	VARIANT	D -> H (in dbSNP:rs13305979)		
P32298	GRK4	A116T	P32298/A116T	GRK4/A116T	VARIANT	A -> T (in dbSNP:rs34857805)	ECO:0000269|PubMed:17344846	17344846
P32298	GRK4	A142V	P32298/A142V	GRK4/A142V	VARIANT	A -> V (in dbSNP:rs1024323)	ECO:0000269|PubMed:17344846	17344846
P32298	GRK4	T183R	P32298/T183R	GRK4/T183R	VARIANT	T -> R (in dbSNP:rs45538934)		
P32298	GRK4	V247I	P32298/V247I	GRK4/V247I	VARIANT	V -> I (in dbSNP:rs1140085)	ECO:0000269|PubMed:17344846	17344846
P32298	GRK4	H383Q	P32298/H383Q	GRK4/H383Q	VARIANT	H -> Q (in dbSNP:rs55852353)	ECO:0000269|PubMed:17344846	17344846
P32298	GRK4	L425P	P32298/L425P	GRK4/L425P	VARIANT	L -> P	ECO:0000269|PubMed:17344846	17344846
P32298	GRK4	A440V	P32298/A440V	GRK4/A440V	VARIANT	A -> V (in dbSNP:rs747003103)		
P32298	GRK4	V473I	P32298/V473I	GRK4/V473I	VARIANT	V -> I (in dbSNP:rs35024854)	ECO:0000269|PubMed:17344846	17344846
P32298	GRK4	V486A	P32298/V486A	GRK4/V486A	VARIANT	V -> A (in dbSNP:rs1801058)	ECO:0000269|PubMed:1338872, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8135832, ECO:0000269|PubMed:8626439, ECO:0000269|PubMed:9092566	1338872,15489334,17344846,8135832,8626439,9092566
P32298	GRK4	A495T	P32298/A495T	GRK4/A495T	VARIANT	A -> T (in dbSNP:rs35463176)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P33981	TTK	A97V	P33981/A97V	TTK/A97V	VARIANT	A -> V (in dbSNP:rs2230513)		
P33981	TTK	D758N	P33981/D758N	TTK/D758N	VARIANT	D -> N (in dbSNP:rs2230512)		
P33981	TTK	D664A	P33981/D664A	TTK/D664A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:18243099, ECO:0000269|PubMed:18480048	18243099,18480048
P33981	TTK	T686A	P33981/T686A	TTK/T686A	MUTAGEN	T->A: Loss of kinase activity.	ECO:0000269|PubMed:18480048	18480048

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P34925	RYK	S99N	P34925/S99N	RYK/S99N	VARIANT	S -> N (in dbSNP:rs1131262)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8386829, ECO:0000269|PubMed:8390040, ECO:0000269|PubMed:8726462	17344846,8386829,8390040,8726462
P34925	RYK	R227C	P34925/R227C	RYK/R227C	VARIANT	R -> C (in dbSNP:rs55740278)	ECO:0000269|PubMed:17344846	17344846
P34925	RYK	V243I	P34925/V243I	RYK/V243I	VARIANT	V -> I (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs746238409)	ECO:0000269|PubMed:17344846	17344846
P34925	RYK	K364A	P34925/K364A	RYK/K364A	MUTAGEN	K->A: No induction of the MAPK pathway.	ECO:0000269|PubMed:10454588	10454588
P34925	RYK	N484F	P34925/N484F	RYK/N484F	MUTAGEN	N->F: Gain of an autophosphorylation activity. Gain of an autophosphorylation activity; when associated with A-359. Gain of an autophosphorylation activity; when associated with G-334 and G-482.	ECO:0000269|PubMed:10454588	10454588
P34925	RYK	A485G	P34925/A485G	RYK/A485G	MUTAGEN	A->G: Gain of an autophosphorylation activity. Gain of an autophosphorylation activity; when associated with G-334 and F-481.	ECO:0000269|PubMed:10454588	10454588

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P34947	GRK5	Q41L	P34947/Q41L	GRK5/Q41L	VARIANT	Q -> L (exerts a protective effect in heart failure and ischemia; dbSNP:rs2230345)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:18425130	17344846,18425130
P34947	GRK5	A119V	P34947/A119V	GRK5/A119V	VARIANT	A -> V (in dbSNP:rs55980792)	ECO:0000269|PubMed:17344846	17344846
P34947	GRK5	G122S	P34947/G122S	GRK5/G122S	VARIANT	G -> S (in dbSNP:rs55902633)	ECO:0000269|PubMed:17344846	17344846
P34947	GRK5	T129M	P34947/T129M	GRK5/T129M	VARIANT	T -> M (in dbSNP:rs34679178)	ECO:0000269|PubMed:17344846	17344846
P34947	GRK5	L141I	P34947/L141I	GRK5/L141I	VARIANT	L -> I (in dbSNP:rs56254855)	ECO:0000269|PubMed:17344846	17344846
P34947	GRK5	D163E	P34947/D163E	GRK5/D163E	VARIANT	D -> E (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P34947	GRK5	R304H	P34947/R304H	GRK5/R304H	VARIANT	R -> H (in dbSNP:rs2230349)	ECO:0000269|PubMed:17344846	17344846
P34947	GRK5	K215R	P34947/K215R	GRK5/K215R	MUTAGEN	K->R: Failed to phosphorylate p53/TP53.	ECO:0000269|PubMed:20124405	20124405
P34947	GRK5	R388A	P34947/R388A	GRK5/R388A	MUTAGEN	R->A: Nuclear exclusion; when associated with A-389; A-391; A-393 and A-394.	ECO:0000269|PubMed:15542828	15542828
P34947	GRK5	K389A	P34947/K389A	GRK5/K389A	MUTAGEN	K->A: Nuclear exclusion; when associated with A-388; A-391; A-393 and A-394.	ECO:0000269|PubMed:15542828	15542828
P34947	GRK5	K391A	P34947/K391A	GRK5/K391A	MUTAGEN	K->A: Nuclear exclusion; when associated with A-388; A-389; A-393 and A-394.	ECO:0000269|PubMed:15542828	15542828
P34947	GRK5	K393A	P34947/K393A	GRK5/K393A	MUTAGEN	K->A: Nuclear exclusion; when associated with A-388; A-389; A-391 and A-394.	ECO:0000269|PubMed:15542828	15542828
P34947	GRK5	R394A	P34947/R394A	GRK5/R394A	MUTAGEN	R->A: Nuclear exclusion; when associated with A-388; A-389; A-391 and A-393.	ECO:0000269|PubMed:15542828	15542828
P34947	GRK5	S484A	P34947/S484A	GRK5/S484A	MUTAGEN	S->A: 15-20 fold defects in kinase activity; when associated with A-485.	ECO:0000269|PubMed:8144599	8144599
P34947	GRK5	T485A	P34947/T485A	GRK5/T485A	MUTAGEN	T->A: 15-20 fold defects in kinase activity; when associated with A-484.	ECO:0000269|PubMed:8144599	8144599
P34947	GRK5	L550A	P34947/L550A	GRK5/L550A	MUTAGEN	L->A: No detectable plasma membrane localization; when associated with A-551; A-554; and A-555.	ECO:0000269|PubMed:14976207	14976207
P34947	GRK5	L551A	P34947/L551A	GRK5/L551A	MUTAGEN	L->A: No detectable plasma membrane localization; when associated with A-550; A-554; and A-555.	ECO:0000269|PubMed:14976207	14976207
P34947	GRK5	L554A	P34947/L554A	GRK5/L554A	MUTAGEN	L->A: No detectable plasma membrane localization; when associated with A-550; A-551; and A-555.	ECO:0000269|PubMed:14976207	14976207
P34947	GRK5	F555A	P34947/F555A	GRK5/F555A	MUTAGEN	F->A: No detectable plasma membrane localization; when associated with A-550; A-551; and A-554.	ECO:0000269|PubMed:14976207	14976207

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P35590	TIE1	V448M	P35590/V448M	TIE1/V448M	VARIANT	V -> M (in dbSNP:rs56302794)	ECO:0000269|PubMed:17344846	17344846
P35590	TIE1	R481C	P35590/R481C	TIE1/R481C	VARIANT	R -> C (in LMPHM11; unknown pathological significance; dbSNP:rs139244400)	ECO:0000269|PubMed:32947856	32947856
P35590	TIE1	E1061K	P35590/E1061K	TIE1/E1061K	VARIANT	E -> K (in LMPHM11; unknown pathological significance; dbSNP:rs760492428)	ECO:0000269|PubMed:32947856	32947856
P35590	TIE1	A1104V	P35590/A1104V	TIE1/A1104V	VARIANT	A -> V (in dbSNP:rs35573981)	ECO:0000269|PubMed:17344846	17344846
P35590	TIE1	R1109H	P35590/R1109H	TIE1/R1109H	VARIANT	R -> H (in LMPHM11; unknown pathological significance; dbSNP:rs34993202)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:32947856	17344846,32947856

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P35626	GRK3	R50S	P35626/R50S	GRK3/R50S	VARIANT	R -> S (in dbSNP:rs55700971)	ECO:0000269|PubMed:17344846	17344846
P35626	GRK3	N60S	P35626/N60S	GRK3/N60S	VARIANT	N -> S (in dbSNP:rs55740593)	ECO:0000269|PubMed:17344846	17344846
P35626	GRK3	R104K	P35626/R104K	GRK3/R104K	VARIANT	R -> K (in a lung bronchoalveolar carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P35626	GRK3	V409M	P35626/V409M	GRK3/V409M	VARIANT	V -> M (in dbSNP:rs2272859)		

Error: P35916 FLT4 'NoneType' object has no attribute 'group' FT                   /note="Missing (in CHTD7; unknown pathological

Error: P35916 FLT4 'NoneType' object has no attribute 'group' FT                   /note="Missing (in LMPHM1)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P35916	FLT4	N149D	P35916/N149D	FLT4/N149D	VARIANT	N -> D (in dbSNP:rs34221241)	ECO:0000269|PubMed:17344846	17344846
P35916	FLT4	R378C	P35916/R378C	FLT4/R378C	VARIANT	R -> C (in a renal clear cell carcinoma sample; somatic mutation; dbSNP:rs372947534)	ECO:0000269|PubMed:17344846	17344846
P35916	FLT4	T494A	P35916/T494A	FLT4/T494A	VARIANT	T -> A (in dbSNP:rs307826)	ECO:0000269|PubMed:11807987, ECO:0000269|PubMed:17344846	11807987,17344846
P35916	FLT4	N527S	P35916/N527S	FLT4/N527S	VARIANT	N -> S (in dbSNP:rs35874891)	ECO:0000269|PubMed:17344846	17344846
P35916	FLT4	P641S	P35916/P641S	FLT4/P641S	VARIANT	P -> S (in dbSNP:rs55667289)	ECO:0000269|PubMed:10835628, ECO:0000269|PubMed:17344846	10835628,17344846
P35916	FLT4	A855T	P35916/A855T	FLT4/A855T	VARIANT	A -> T (in LMPHM1; recessive form; results in reduced autophosphorylation; results in impaired ligand-induced receptor internalization and downstream signaling; dbSNP:rs121909657)	ECO:0000269|PubMed:19289394	19289394
P35916	FLT4	G857R	P35916/G857R	FLT4/G857R	VARIANT	G -> R (in LMPHM1; loss of kinase activity; dbSNP:rs267606818)	ECO:0000269|PubMed:10835628, ECO:0000269|PubMed:15102829	10835628,15102829
P35916	FLT4	H868Y	P35916/H868Y	FLT4/H868Y	VARIANT	H -> Y (in dbSNP:rs35171798)	ECO:0000269|PubMed:17344846	17344846
P35916	FLT4	V878M	P35916/V878M	FLT4/V878M	VARIANT	V -> M (in LMPHM1; dbSNP:rs121909654)	ECO:0000269|PubMed:16965327	16965327
P35916	FLT4	H890Q	P35916/H890Q	FLT4/H890Q	VARIANT	H -> Q (in dbSNP:rs448012)	ECO:0000269|PubMed:11807987, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:8386825, ECO:0000269|Ref.7	11807987,14702039,8386825
P35916	FLT4	P954S	P35916/P954S	FLT4/P954S	VARIANT	P -> S (in HCI; dbSNP:rs34255532)	ECO:0000269|PubMed:11807987	11807987
P35916	FLT4	T1010I	P35916/T1010I	FLT4/T1010I	VARIANT	T -> I (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P35916	FLT4	Q1020L	P35916/Q1020L	FLT4/Q1020L	VARIANT	Q -> L (in LMPHM1)	ECO:0000269|PubMed:17458866	17458866
P35916	FLT4	R1031Q	P35916/R1031Q	FLT4/R1031Q	VARIANT	R -> Q (in dbSNP:rs56082504)	ECO:0000269|PubMed:17344846	17344846
P35916	FLT4	H1035Q	P35916/H1035Q	FLT4/H1035Q	VARIANT	H -> Q (probable disease-associated variant found in sporadic congenital lymphedema; de novo mutation)	ECO:0000269|PubMed:16965327	16965327
P35916	FLT4	H1035R	P35916/H1035R	FLT4/H1035R	VARIANT	H -> R (in LMPHM1; loss of kinase activity; dbSNP:rs121909653)	ECO:0000269|PubMed:10856194	10856194
P35916	FLT4	R1041P	P35916/R1041P	FLT4/R1041P	VARIANT	R -> P (in LMPHM1; loss of kinase activity; dbSNP:rs121909650)	ECO:0000269|PubMed:10835628, ECO:0000269|PubMed:12881528	10835628,12881528
P35916	FLT4	L1044P	P35916/L1044P	FLT4/L1044P	VARIANT	L -> P (in LMPHM1; loss of kinase activity; dbSNP:rs121909651)	ECO:0000269|PubMed:10835628	10835628
P35916	FLT4	D1049N	P35916/D1049N	FLT4/D1049N	VARIANT	D -> N (in dbSNP:rs56310180)	ECO:0000269|PubMed:17344846	17344846
P35916	FLT4	R1075Q	P35916/R1075Q	FLT4/R1075Q	VARIANT	R -> Q (in dbSNP:rs1400220848)	ECO:0000269|PubMed:17344846	17344846
P35916	FLT4	I1086T	P35916/I1086T	FLT4/I1086T	VARIANT	I -> T (in LMPHM1; dbSNP:rs121909655)	ECO:0000269|PubMed:16965327	16965327
P35916	FLT4	E1106K	P35916/E1106K	FLT4/E1106K	VARIANT	E -> K (in LMPHM1; dbSNP:rs121909656)	ECO:0000269|PubMed:16924388	16924388
P35916	FLT4	P1114L	P35916/P1114L	FLT4/P1114L	VARIANT	P -> L (in LMPHM1; loss of kinase activity; dbSNP:rs121909652)	ECO:0000269|PubMed:10835628, ECO:0000269|PubMed:9817924	10835628,9817924
P35916	FLT4	P1137S	P35916/P1137S	FLT4/P1137S	VARIANT	P -> S (in HCI)	ECO:0000269|PubMed:11807987	11807987
P35916	FLT4	R1146H	P35916/R1146H	FLT4/R1146H	VARIANT	R -> H (in dbSNP:rs1130379)	ECO:0000269|PubMed:11807987, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8386825, ECO:0000269|Ref.7	11807987,17344846,8386825
P35916	FLT4	L1173V	P35916/L1173V	FLT4/L1173V	VARIANT	L -> V (in CHTD7; unknown pathological significance)	ECO:0000269|PubMed:30232381	30232381
P35916	FLT4	S1235C	P35916/S1235C	FLT4/S1235C	VARIANT	S -> C (in LMPHM1; recessive form)	ECO:0000269|PubMed:26091405	26091405
P35916	FLT4	T446E	P35916/T446E	FLT4/T446E	MUTAGEN	T->E: Decreases autophosphorylation on tyrosine residues upon ligand binding; when associated with A-516. Abolishes autophosphorylation on tyrosine residues upon ligand binding; when associated with A-516 and A-737.	ECO:0000269|PubMed:23878260	23878260
P35916	FLT4	K516A	P35916/K516A	FLT4/K516A	MUTAGEN	K->A: Decreases autophosphorylation on tyrosine residues upon ligand binding; when associated with E-446. Abolishes autophosphorylation on tyrosine residues upon ligand binding; when associated with E-446 and A-737.	ECO:0000269|PubMed:23878260	23878260
P35916	FLT4	R737A	P35916/R737A	FLT4/R737A	MUTAGEN	R->A: Decreases autophosphorylation on tyrosine residues upon ligand binding. Abolishes autophosphorylation on tyrosine residues upon ligand binding; when associated with E-446 and A-516.	ECO:0000269|PubMed:23878260	23878260
P35916	FLT4	K879G	P35916/K879G	FLT4/K879G	MUTAGEN	K->G: Abolishes enzyme activity.	ECO:0000269|PubMed:12881528	12881528
P35916	FLT4	Y1063F	P35916/Y1063F	FLT4/Y1063F	MUTAGEN	Y->F: Loss of phosphorylation site. No effect on stimulation of cell proliferation and cell migration.	ECO:0000269|PubMed:16076871, ECO:0000269|PubMed:20431062	16076871,20431062
P35916	FLT4	Y1068F	P35916/Y1068F	FLT4/Y1068F	MUTAGEN	Y->F: Global loss of autophosphorylation. Abolishes stimulation of cell proliferation and cell migration.	ECO:0000269|PubMed:16076871, ECO:0000269|PubMed:20431062	16076871,20431062
P35916	FLT4	Y1230F	P35916/Y1230F	FLT4/Y1230F	MUTAGEN	Y->F: Loss of phosphorylation site. Strongly reduces stimulation of cell proliferation and cell migration.	ECO:0000269|PubMed:12881528, ECO:0000269|PubMed:16076871	12881528,16076871
P35916	FLT4	Y1231F	P35916/Y1231F	FLT4/Y1231F	MUTAGEN	Y->F: Loss of phosphorylation site. Strongly reduces stimulation of cell proliferation and cell migration.	ECO:0000269|PubMed:12881528, ECO:0000269|PubMed:16076871	12881528,16076871
P35916	FLT4	Y1265F	P35916/Y1265F	FLT4/Y1265F	MUTAGEN	Y->F: Loss of phosphorylation site. No effect on stimulation of cell proliferation and cell migration.	ECO:0000269|PubMed:12881528	12881528
P35916	FLT4	Y1333F	P35916/Y1333F	FLT4/Y1333F	MUTAGEN	Y->F: Loss of phosphorylation site. Reduced autophosphorylation.	ECO:0000269|PubMed:12881528, ECO:0000269|PubMed:7675451	12881528,7675451
P35916	FLT4	Y1337F	P35916/Y1337F	FLT4/Y1337F	MUTAGEN	Y->F: Reduced autophosphorylation. Strongly reduces stimulation of cell proliferation and cell migration.	ECO:0000269|PubMed:12881528, ECO:0000269|PubMed:20431062, ECO:0000269|PubMed:7675451	12881528,20431062,7675451
P35916	FLT4	Y1363F	P35916/Y1363F	FLT4/Y1363F	MUTAGEN	Y->F: Loss of phosphorylation site. Slightly reduced autophosphorylation.	ECO:0000269|PubMed:12881528, ECO:0000269|PubMed:7675451	12881528,7675451

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P35968	KDR	Q2R	P35968/Q2R	KDR/Q2R	VARIANT	Q -> R (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P35968	KDR	V136M	P35968/V136M	KDR/V136M	VARIANT	V -> M (in dbSNP:rs35636987)	ECO:0000269|PubMed:17344846	17344846
P35968	KDR	A248G	P35968/A248G	KDR/A248G	VARIANT	A -> G (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P35968	KDR	R275L	P35968/R275L	KDR/R275L	VARIANT	R -> L (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
P35968	KDR	V297I	P35968/V297I	KDR/V297I	VARIANT	V -> I (in dbSNP:rs2305948)	ECO:0000269|PubMed:17344846	17344846
P35968	KDR	L462V	P35968/L462V	KDR/L462V	VARIANT	L -> V (in dbSNP:rs56286620)	ECO:0000269|PubMed:17344846	17344846
P35968	KDR	Q472H	P35968/Q472H	KDR/Q472H	VARIANT	Q -> H (in dbSNP:rs1870377)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
P35968	KDR	C482R	P35968/C482R	KDR/C482R	VARIANT	C -> R (in HCI; associated with disease susceptibility; expression of FLT1 in hemangioma endothelial cells is markedly reduced and KDR activity is increased compared to controls; low FLT1 expression in hemangioma cells is caused by reduced activity of a pathway involving ITGB1, ANTXR1, KDR and NFATC2IP; the mutation predicts to result in loss-of-function and disruption of the normal association of these molecules; dbSNP:rs34231037)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:18931684	17344846,18931684
P35968	KDR	G539R	P35968/G539R	KDR/G539R	VARIANT	G -> R (in dbSNP:rs55716939)	ECO:0000269|PubMed:17344846	17344846
P35968	KDR	T689M	P35968/T689M	KDR/T689M	VARIANT	T -> M (in dbSNP:rs34038364)	ECO:0000269|PubMed:17344846	17344846
P35968	KDR	D814N	P35968/D814N	KDR/D814N	VARIANT	D -> N (in dbSNP:rs35603373)	ECO:0000269|PubMed:17344846	17344846
P35968	KDR	V848E	P35968/V848E	KDR/V848E	VARIANT	V -> E (strongly reduced autophosphorylation and kinase activity; dbSNP:rs1139776)	ECO:0000269|PubMed:10037737, ECO:0000269|PubMed:1656371	10037737,1656371
P35968	KDR	G873R	P35968/G873R	KDR/G873R	VARIANT	G -> R (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
P35968	KDR	V952I	P35968/V952I	KDR/V952I	VARIANT	V -> I (in dbSNP:rs13129474)		
P35968	KDR	A1065T	P35968/A1065T	KDR/A1065T	VARIANT	A -> T (in dbSNP:rs56302315)	ECO:0000269|PubMed:17344846	17344846
P35968	KDR	P1147S	P35968/P1147S	KDR/P1147S	VARIANT	P -> S (in HCI; somatic mutation; dbSNP:rs121917766)	ECO:0000269|PubMed:11807987	11807987
P35968	KDR	R726A	P35968/R726A	KDR/R726A	MUTAGEN	R->A: Strongly reduced autophosphorylation and activation of MAP kinases.	ECO:0000269|PubMed:20080685	20080685
P35968	KDR	D731A	P35968/D731A	KDR/D731A	MUTAGEN	D->A: Strongly reduced autophosphorylation and activation of MAP kinases.	ECO:0000269|PubMed:20080685	20080685
P35968	KDR	Y801F	P35968/Y801F	KDR/Y801F	MUTAGEN	Y->F: Abolishes stimulation of nitric oxide synthesis.	ECO:0000269|PubMed:17303569	17303569
P35968	KDR	K868M	P35968/K868M	KDR/K868M	MUTAGEN	K->M: Loss of enzyme activity.	ECO:0000269|PubMed:11387210	11387210
P35968	KDR	Y951F	P35968/Y951F	KDR/Y951F	MUTAGEN	Y->F: Abolishes reorganization of the actin cytoskeleton and cell migration in response to VEGFA.	ECO:0000269|PubMed:15962004	15962004
P35968	KDR	Y996F	P35968/Y996F	KDR/Y996F	MUTAGEN	Y->F: Strongly reduced autophosphorylation. Reduces phosphorylation of PLCG1.	ECO:0000269|PubMed:10102632	10102632
P35968	KDR	C1045A	P35968/C1045A	KDR/C1045A	MUTAGEN	C->A: Significantly higher kinase activity.	ECO:0000269|PubMed:23199280	23199280
P35968	KDR	Y1054F	P35968/Y1054F	KDR/Y1054F	MUTAGEN	Y->F: Strongly reduced autophosphorylation. Abolishes phosphorylation of downstream signaling proteins; when associated with F-1059.	ECO:0000269|PubMed:10102632	10102632
P35968	KDR	Y1059F	P35968/Y1059F	KDR/Y1059F	MUTAGEN	Y->F: Strongly reduced autophosphorylation. Abolishes phosphorylation of downstream signaling proteins; when associated with F-1054.	ECO:0000269|PubMed:10102632	10102632
P35968	KDR	Y1175F	P35968/Y1175F	KDR/Y1175F	MUTAGEN	Y->F: Abolishes phosphorylation of PLCG1 and MAP kinases in response to VEGFA.	ECO:0000269|PubMed:11387210	11387210
P35968	KDR	Y1214F	P35968/Y1214F	KDR/Y1214F	MUTAGEN	Y->F: Loss of phosphorylation site. Abolishes reorganization of the actin cytoskeleton in response to VEGFA.	ECO:0000269|PubMed:16966330	16966330

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P36507	MAP2K2	F57C	P36507/F57C	MAP2K2/F57C	VARIANT	F -> C (in CFC4; dbSNP:rs121434497)	ECO:0000269|PubMed:16439621	16439621
P36507	MAP2K2	F57V	P36507/F57V	MAP2K2/F57V	VARIANT	F -> V (in CFC4; dbSNP:rs121434498)	ECO:0000269|PubMed:18042262	18042262
P36507	MAP2K2	P128Q	P36507/P128Q	MAP2K2/P128Q	VARIANT	P -> Q (in CFC4; results in increased kinase activity; dbSNP:rs267607230)	ECO:0000269|PubMed:20358587	20358587
P36507	MAP2K2	Y134H	P36507/Y134H	MAP2K2/Y134H	VARIANT	Y -> H (in CFC4; dbSNP:rs121434499)	ECO:0000269|PubMed:18042262	18042262

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P36888	FLT3	D7G	P36888/D7G	FLT3/D7G	VARIANT	D -> G (in dbSNP:rs12872889)		
P36888	FLT3	V158A	P36888/V158A	FLT3/V158A	VARIANT	V -> A (in dbSNP:rs56321896)	ECO:0000269|PubMed:17344846	17344846
P36888	FLT3	V194M	P36888/V194M	FLT3/V194M	VARIANT	V -> M (in dbSNP:rs146030737)	ECO:0000269|PubMed:18987736	18987736
P36888	FLT3	T227M	P36888/T227M	FLT3/T227M	VARIANT	T -> M (in dbSNP:rs1933437)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8394751, ECO:0000269|Ref.4	15489334,17344846,8394751
P36888	FLT3	D324N	P36888/D324N	FLT3/D324N	VARIANT	D -> N (in dbSNP:rs35602083)	ECO:0000269|PubMed:17344846	17344846
P36888	FLT3	D358V	P36888/D358V	FLT3/D358V	VARIANT	D -> V (in dbSNP:rs34172843)	ECO:0000269|PubMed:17344846	17344846
P36888	FLT3	I417L	P36888/I417L	FLT3/I417L	VARIANT	I -> L (in dbSNP:rs56090538)		
P36888	FLT3	V557I	P36888/V557I	FLT3/V557I	VARIANT	V -> I (in dbSNP:rs35958982)	ECO:0000269|PubMed:17344846	17344846
P36888	FLT3	D835E	P36888/D835E	FLT3/D835E	VARIANT	D -> E (in acute lymphoblastic leukemia patients and acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913487)	ECO:0000269|PubMed:11290608, ECO:0000269|PubMed:14504097	11290608,14504097
P36888	FLT3	D835H	P36888/D835H	FLT3/D835H	VARIANT	D -> H (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913488)	ECO:0000269|PubMed:11290608, ECO:0000269|PubMed:11442493, ECO:0000269|PubMed:14504097	11290608,11442493,14504097
P36888	FLT3	D835N	P36888/D835N	FLT3/D835N	VARIANT	D -> N (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913488)	ECO:0000269|PubMed:11290608	11290608
P36888	FLT3	D835V	P36888/D835V	FLT3/D835V	VARIANT	D -> V (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121909646)	ECO:0000269|PubMed:11290608	11290608
P36888	FLT3	D835Y	P36888/D835Y	FLT3/D835Y	VARIANT	D -> Y (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913488)	ECO:0000269|PubMed:11290608, ECO:0000269|PubMed:11442493, ECO:0000269|PubMed:14504097	11290608,11442493,14504097
P36888	FLT3	I836M	P36888/I836M	FLT3/I836M	VARIANT	I -> M (in acute lymphoblastic leukemia patients; somatic mutation; dbSNP:rs121913232)	ECO:0000269|PubMed:14504097	14504097
P36888	FLT3	Y589F	P36888/Y589F	FLT3/Y589F	MUTAGEN	Y->F: Reduced phosphorylation of the wild-type kinase in response to ligand binding. No effect on the phosphorylation of the constitutively activated mutant kinase variants. Abolishes activation of STAT5A.	ECO:0000269|PubMed:16627759, ECO:0000269|PubMed:16684964, ECO:0000269|PubMed:9737679	16627759,16684964,9737679
P36888	FLT3	Y591F	P36888/Y591F	FLT3/Y591F	MUTAGEN	Y->F: No significant effect on tyrosine phosphorylation. Abolishes activation of STAT5A.	ECO:0000269|PubMed:16627759, ECO:0000269|PubMed:9737679	16627759,9737679
P36888	FLT3	Y599F	P36888/Y599F	FLT3/Y599F	MUTAGEN	Y->F: Abolishes interaction with PTPN11/SHP2 and phosphorylation of PTPN11/SHP2.	ECO:0000269|PubMed:16684964	16684964
P36888	FLT3	K644A	P36888/K644A	FLT3/K644A	MUTAGEN	K->A: Abolishes kinase activity.	ECO:0000269|PubMed:15831474	15831474

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P36894	BMPR1A	P2T	P36894/P2T	BMPR1A/P2T	VARIANT	P -> T (in dbSNP:rs11528010)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8397373	14702039,17344846,8397373
P36894	BMPR1A	F58Y	P36894/F58Y	BMPR1A/F58Y	VARIANT	F -> Y (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P36894	BMPR1A	Y62D	P36894/Y62D	BMPR1A/Y62D	VARIANT	Y -> D (in JPS)	ECO:0000269|PubMed:12417513	12417513
P36894	BMPR1A	C82Y	P36894/C82Y	BMPR1A/C82Y	VARIANT	C -> Y (in JPS)	ECO:0000269|PubMed:12417513	12417513
P36894	BMPR1A	C124R	P36894/C124R	BMPR1A/C124R	VARIANT	C -> R (in JPS; dbSNP:rs199476087)	ECO:0000269|PubMed:11536076	11536076
P36894	BMPR1A	C130R	P36894/C130R	BMPR1A/C130R	VARIANT	C -> R (in JPS; dbSNP:rs1131691168)	ECO:0000269|PubMed:12136244	12136244
P36894	BMPR1A	A338D	P36894/A338D	BMPR1A/A338D	VARIANT	A -> D (in JPS; dbSNP:rs199476086)	ECO:0000269|PubMed:11536076	11536076
P36894	BMPR1A	C376Y	P36894/C376Y	BMPR1A/C376Y	VARIANT	C -> Y (in JPS; dbSNP:rs199476088)	ECO:0000269|PubMed:11536076	11536076
P36894	BMPR1A	R443C	P36894/R443C	BMPR1A/R443C	VARIANT	R -> C (in JPS; dbSNP:rs35619497)	ECO:0000269|PubMed:12417513, ECO:0000269|PubMed:17344846	12417513,17344846
P36894	BMPR1A	V450M	P36894/V450M	BMPR1A/V450M	VARIANT	V -> M (in dbSNP:rs55932635)	ECO:0000269|PubMed:17344846	17344846
P36894	BMPR1A	M460T	P36894/M460T	BMPR1A/M460T	VARIANT	M -> T (found in a patient with tubular adenoma and rectal neuroendocrine tumor; unknown pathological significance; dbSNP:rs758309022)	ECO:0000269|PubMed:25860647	25860647
P36894	BMPR1A	M470T	P36894/M470T	BMPR1A/M470T	VARIANT	M -> T (in JPS; dbSNP:rs199476089)	ECO:0000269|PubMed:12630959	12630959
P36894	BMPR1A	R486Q	P36894/R486Q	BMPR1A/R486Q	VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs752802257)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P36896	ACVR1B	F146L	P36896/F146L	ACVR1B/F146L	VARIANT	F -> L (in dbSNP:rs34488074)	ECO:0000269|PubMed:17344846	17344846
P36896	ACVR1B	L408V	P36896/L408V	ACVR1B/L408V	VARIANT	L -> V (in dbSNP:rs928906)		
P36896	ACVR1B	L40A	P36896/L40A	ACVR1B/L40A	MUTAGEN	L->A: Increases binding to activin.	ECO:0000269|PubMed:12665502	12665502
P36896	ACVR1B	I70A	P36896/I70A	ACVR1B/I70A	MUTAGEN	I->A: Decreases binding to activin.	ECO:0000269|PubMed:12665502	12665502
P36896	ACVR1B	V73A	P36896/V73A	ACVR1B/V73A	MUTAGEN	V->A: Increases binding to activin.	ECO:0000269|PubMed:12665502	12665502
P36896	ACVR1B	L75A	P36896/L75A	ACVR1B/L75A	MUTAGEN	L->A: Decreases binding to activin.	ECO:0000269|PubMed:12665502	12665502
P36896	ACVR1B	P77A	P36896/P77A	ACVR1B/P77A	MUTAGEN	P->A: Decreases binding to activin.	ECO:0000269|PubMed:12665502	12665502
P36896	ACVR1B	T206V	P36896/T206V	ACVR1B/T206V	MUTAGEN	T->V: Leads to constitutive activation.	ECO:0000269|PubMed:8622651	8622651

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P36897	TGFBR1	A26AA	P36897/A26AA	TGFBR1/A26AA	VARIANT	A -> AA (in allele TGFBR1*10A)	ECO:0000269|PubMed:9661882	9661882
P36897	TGFBR1	C41Y	P36897/C41Y	TGFBR1/C41Y	VARIANT	C -> Y (in MSSE; hypomorphic variant)	ECO:0000269|PubMed:21358634	21358634
P36897	TGFBR1	N45S	P36897/N45S	TGFBR1/N45S	VARIANT	N -> S (in MSSE; hypomorphic variant; dbSNP:rs387906696)	ECO:0000269|PubMed:21358634	21358634
P36897	TGFBR1	G52R	P36897/G52R	TGFBR1/G52R	VARIANT	G -> R (in MSSE; hypomorphic variant; dbSNP:rs587776865)	ECO:0000269|PubMed:21358634	21358634
P36897	TGFBR1	P83L	P36897/P83L	TGFBR1/P83L	VARIANT	P -> L (in MSSE; hypomorphic variant; dbSNP:rs757374917)	ECO:0000269|PubMed:21358634	21358634
P36897	TGFBR1	I139V	P36897/I139V	TGFBR1/I139V	VARIANT	I -> V (in dbSNP:rs148176750)	ECO:0000269|PubMed:18987736	18987736
P36897	TGFBR1	V153I	P36897/V153I	TGFBR1/V153I	VARIANT	V -> I (in dbSNP:rs56014374)	ECO:0000269|PubMed:17344846	17344846
P36897	TGFBR1	T200I	P36897/T200I	TGFBR1/T200I	VARIANT	T -> I (in LDS1; dbSNP:rs121918712)	ECO:0000269|PubMed:15731757	15731757
P36897	TGFBR1	K232E	P36897/K232E	TGFBR1/K232E	VARIANT	K -> E (in LDS1)	ECO:0000269|PubMed:16928994	16928994
P36897	TGFBR1	S241L	P36897/S241L	TGFBR1/S241L	VARIANT	S -> L (in LDS1; dbSNP:rs111854391)	ECO:0000269|PubMed:16596670, ECO:0000269|PubMed:16791849	16596670,16791849
P36897	TGFBR1	D266Y	P36897/D266Y	TGFBR1/D266Y	VARIANT	D -> Y (in LDS1)	ECO:0000269|PubMed:22113417	22113417
P36897	TGFBR1	N267H	P36897/N267H	TGFBR1/N267H	VARIANT	N -> H (in a patient with Marfan syndrome)	ECO:0000269|PubMed:16791849	16791849
P36897	TGFBR1	Y291C	P36897/Y291C	TGFBR1/Y291C	VARIANT	Y -> C (in dbSNP:rs35974499)	ECO:0000269|PubMed:17344846	17344846
P36897	TGFBR1	M318R	P36897/M318R	TGFBR1/M318R	VARIANT	M -> R (in LDS1; dbSNP:rs121918710)	ECO:0000269|PubMed:15731757	15731757
P36897	TGFBR1	D351G	P36897/D351G	TGFBR1/D351G	VARIANT	D -> G (in LDS1)	ECO:0000269|PubMed:19883511	19883511
P36897	TGFBR1	T375R	P36897/T375R	TGFBR1/T375R	VARIANT	T -> R (in LDS1; dbSNP:rs1827743139)	ECO:0000269|PubMed:22113417	22113417
P36897	TGFBR1	D400G	P36897/D400G	TGFBR1/D400G	VARIANT	D -> G (in LDS1; dbSNP:rs121918711)	ECO:0000269|PubMed:15731757	15731757
P36897	TGFBR1	R487P	P36897/R487P	TGFBR1/R487P	VARIANT	R -> P (in LDS1; dbSNP:rs113605875)	ECO:0000269|PubMed:15731757, ECO:0000269|PubMed:16928994	15731757,16928994
P36897	TGFBR1	R487Q	P36897/R487Q	TGFBR1/R487Q	VARIANT	R -> Q (in LDS1; dbSNP:rs113605875)	ECO:0000269|PubMed:16791849, ECO:0000269|PubMed:16928994, ECO:0000269|PubMed:22113417	16791849,16928994,22113417
P36897	TGFBR1	R487W	P36897/R487W	TGFBR1/R487W	VARIANT	R -> W (in LDS1; dbSNP:rs111426349)	ECO:0000269|PubMed:16928994	16928994
P36897	TGFBR1	S187A	P36897/S187A	TGFBR1/S187A	MUTAGEN	S->A: Loss of threonine phosphorylation, reduced phosphorylation on serine residues and loss of response to TGF-beta; when associated with 185-VV-186; A-189 and A-191.	ECO:0000269|PubMed:7774578	7774578
P36897	TGFBR1	S189A	P36897/S189A	TGFBR1/S189A	MUTAGEN	S->A: Loss of threonine phosphorylation, reduced phosphorylation on serine residues and loss of response to TGF-beta; when associated with 185-VV-186; A-187 and A-191.	ECO:0000269|PubMed:7774578	7774578
P36897	TGFBR1	S191A	P36897/S191A	TGFBR1/S191A	MUTAGEN	S->A: Loss of threonine phosphorylation, reduced phosphorylation on serine residues and loss of response to TGF-beta; when associated with 185-VV-186; A-187 and A-189.	ECO:0000269|PubMed:7774578	7774578
P36897	TGFBR1	L193G	P36897/L193G	TGFBR1/L193G	MUTAGEN	L->G: Loss of interaction with FKBP1A.	ECO:0000269|PubMed:9233797	9233797
P36897	TGFBR1	P194K	P36897/P194K	TGFBR1/P194K	MUTAGEN	P->K: Loss of interaction with FKBP1A.	ECO:0000269|PubMed:9233797	9233797
P36897	TGFBR1	T200D	P36897/T200D	TGFBR1/T200D	MUTAGEN	T->D: Loss of response to TGF-beta.	ECO:0000269|PubMed:7774578	7774578
P36897	TGFBR1	T200V	P36897/T200V	TGFBR1/T200V	MUTAGEN	T->V: Loss of phosphorylation. Loss of response to TGF-beta.	ECO:0000269|PubMed:7774578	7774578
P36897	TGFBR1	T204D	P36897/T204D	TGFBR1/T204D	MUTAGEN	T->D: Constitutive activation.	ECO:0000269|PubMed:7774578	7774578
P36897	TGFBR1	T204V	P36897/T204V	TGFBR1/T204V	MUTAGEN	T->V: Reduced phosphorylation. Reduced response to TGF-beta.	ECO:0000269|PubMed:7774578	7774578

Error: P37023 ACVRL1 'NoneType' object has no attribute 'group' FT                   /note="Missing (in HHT2; mutant protein is capable of

Error: P37023 ACVRL1 'NoneType' object has no attribute 'group' FT                   /note="Missing (in HHT2)"

Error: P37023 ACVRL1 'NoneType' object has no attribute 'group' FT                   /note="Missing (in HHT2; retained in the endoplasmic

Error: P37023 ACVRL1 'NoneType' object has no attribute 'group' FT                   /note="Missing (in HHT2)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P37023	ACVRL1	K8N	P37023/K8N	ACVRL1/K8N	VARIANT	K -> N	ECO:0000269|PubMed:24936649	24936649
P37023	ACVRL1	P30S	P37023/P30S	ACVRL1/P30S	VARIANT	P -> S (found in a patient with hereditary hemorrhagic talagiectasia; unknown pathological significance; dbSNP:rs149664056)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	C34Y	P37023/C34Y	ACVRL1/C34Y	VARIANT	C -> Y (in HHT2)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	S38C	P37023/S38C	ACVRL1/S38C	VARIANT	S -> C	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	C41G	P37023/C41G	ACVRL1/C41G	VARIANT	C -> G (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	C41Y	P37023/C41Y	ACVRL1/C41Y	VARIANT	C -> Y (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum; dbSNP:rs1184716348)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	C46G	P37023/C46G	ACVRL1/C46G	VARIANT	C -> G (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	R47P	P37023/R47P	ACVRL1/R47P	VARIANT	R -> P (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs774389618)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	G48R	P37023/G48R	ACVRL1/G48R	VARIANT	G -> R (in HHT2)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	W50C	P37023/W50C	ACVRL1/W50C	VARIANT	W -> C (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs121909285)	ECO:0000269|PubMed:10767348, ECO:0000269|PubMed:14684682, ECO:0000269|PubMed:9245985	10767348,14684682,9245985
P37023	ACVRL1	W50G	P37023/W50G	ACVRL1/W50G	VARIANT	W -> G (in HHT2)	ECO:0000269|PubMed:16525724	16525724
P37023	ACVRL1	C51Y	P37023/C51Y	ACVRL1/C51Y	VARIANT	C -> Y (in HHT2; dbSNP:rs863223409)	ECO:0000269|PubMed:10694922	10694922
P37023	ACVRL1	T52A	P37023/T52A	ACVRL1/T52A	VARIANT	T -> A (in HHT2; dbSNP:rs1131691346)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	E59V	P37023/E59V	ACVRL1/E59V	VARIANT	E -> V (found in a patient with pulmonary arterial hypertension; unknown pathological significance; dbSNP:rs1466116430)	ECO:0000269|PubMed:24936649	24936649
P37023	ACVRL1	H66P	P37023/H66P	ACVRL1/H66P	VARIANT	H -> P (in HHT2)	ECO:0000269|PubMed:16525724	16525724
P37023	ACVRL1	H66Y	P37023/H66Y	ACVRL1/H66Y	VARIANT	H -> Y (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1480110873)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	R67Q	P37023/R67Q	ACVRL1/R67Q	VARIANT	R -> Q (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs863223414)	ECO:0000269|PubMed:14684682, ECO:0000269|PubMed:9245985	14684682,9245985
P37023	ACVRL1	R67W	P37023/R67W	ACVRL1/R67W	VARIANT	R -> W (in HHT2; dbSNP:rs1085307405)	ECO:0000269|PubMed:15712270	15712270
P37023	ACVRL1	C69R	P37023/C69R	ACVRL1/C69R	VARIANT	C -> R (in HHT2)	ECO:0000269|PubMed:16525724	16525724
P37023	ACVRL1	C77F	P37023/C77F	ACVRL1/C77F	VARIANT	C -> F (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1330837892)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	C77W	P37023/C77W	ACVRL1/C77W	VARIANT	C -> W (in HHT2; retained in the endoplasmic reticulum)	ECO:0000269|PubMed:10694922, ECO:0000269|PubMed:14684682	10694922,14684682
P37023	ACVRL1	N96D	P37023/N96D	ACVRL1/N96D	VARIANT	N -> D (in HHT2)	ECO:0000269|PubMed:10694922	10694922
P37023	ACVRL1	N96S	P37023/N96S	ACVRL1/N96S	VARIANT	N -> S (in HHT2)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	E111D	P37023/E111D	ACVRL1/E111D	VARIANT	E -> D (no loss of receptor activity in response to BMP9; mutant protein is capable of targeting the cell surface appropriately; dbSNP:rs1481094868)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	L138P	P37023/L138P	ACVRL1/L138P	VARIANT	L -> P	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	E159V	P37023/E159V	ACVRL1/E159V	VARIANT	E -> V (found in a patient with pulmonary arterial hypertension; unknown pathological significance)	ECO:0000269|PubMed:24936649	24936649
P37023	ACVRL1	D176Y	P37023/D176Y	ACVRL1/D176Y	VARIANT	D -> Y (in HHT2)	ECO:0000269|PubMed:16525724	16525724
P37023	ACVRL1	D179A	P37023/D179A	ACVRL1/D179A	VARIANT	D -> A (in HHT2; mutant protein is capable of targeting the cell surface appropriately; dbSNP:rs753792569)	ECO:0000269|PubMed:14684682	14684682
P37023	ACVRL1	T197I	P37023/T197I	ACVRL1/T197I	VARIANT	T -> I (in HHT2)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	G211D	P37023/G211D	ACVRL1/G211D	VARIANT	G -> D (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs28936687)	ECO:0000269|PubMed:14684682, ECO:0000269|PubMed:26176610	14684682,26176610
P37023	ACVRL1	G211S	P37023/G211S	ACVRL1/G211S	VARIANT	G -> S (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	E215K	P37023/E215K	ACVRL1/E215K	VARIANT	E -> K (in HHT2; dbSNP:rs754283265)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	W217G	P37023/W217G	ACVRL1/W217G	VARIANT	W -> G (in HHT2)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	G219D	P37023/G219D	ACVRL1/G219D	VARIANT	G -> D (in HHT2)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	G223R	P37023/G223R	ACVRL1/G223R	VARIANT	G -> R (in HHT2)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	S225C	P37023/S225C	ACVRL1/S225C	VARIANT	S -> C (found in a patient with pulmonary arterial hypertension; unknown pathological significance)	ECO:0000269|PubMed:24936649	24936649
P37023	ACVRL1	V226E	P37023/V226E	ACVRL1/V226E	VARIANT	V -> E (in HHT2; dbSNP:rs1565593639)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	K229R	P37023/K229R	ACVRL1/K229R	VARIANT	K -> R (in HHT2)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	S233L	P37023/S233L	ACVRL1/S233L	VARIANT	S -> L (in HHT2; dbSNP:rs762773076)	ECO:0000269|PubMed:16525724	16525724
P37023	ACVRL1	Q237K	P37023/Q237K	ACVRL1/Q237K	VARIANT	Q -> K (in HHT2)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	I245N	P37023/I245N	ACVRL1/I245N	VARIANT	I -> N (in dbSNP:rs1804508)		
P37023	ACVRL1	I245V	P37023/I245V	ACVRL1/I245V	VARIANT	I -> V (in HHT2; no loss of receptor activity in response to BMP9; mutant protein is capable of targeting the cell surface appropriately; affects splicing by inducing the creation of a new donor splice site and the loss of the 3' end of exon 6)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	I260L	P37023/I260L	ACVRL1/I260L	VARIANT	I -> L (in HHT2)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	T265P	P37023/T265P	ACVRL1/T265P	VARIANT	T -> P (in HHT2; dbSNP:rs1592223978)	ECO:0000269|PubMed:16525724	16525724
P37023	ACVRL1	T277K	P37023/T277K	ACVRL1/T277K	VARIANT	T -> K (found in a patient with hereditary hemorrhagic talagiectasia; unknown pathological significance)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	H280R	P37023/H280R	ACVRL1/H280R	VARIANT	H -> R (in HHT2)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	L285F	P37023/L285F	ACVRL1/L285F	VARIANT	L -> F (in HHT2; dbSNP:rs1085307410)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	L289P	P37023/L289P	ACVRL1/L289P	VARIANT	L -> P (in HHT2)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	L294R	P37023/L294R	ACVRL1/L294R	VARIANT	L -> R (in HHT2)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	A306P	P37023/A306P	ACVRL1/A306P	VARIANT	A -> P (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1940807179)	ECO:0000269|PubMed:15024723, ECO:0000269|PubMed:26176610	15024723,26176610
P37023	ACVRL1	L313V	P37023/L313V	ACVRL1/L313V	VARIANT	L -> V (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	H314Y	P37023/H314Y	ACVRL1/H314Y	VARIANT	H -> Y (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1565594311)	ECO:0000269|PubMed:15024723, ECO:0000269|PubMed:26176610	15024723,26176610
P37023	ACVRL1	H328Q	P37023/H328Q	ACVRL1/H328Q	VARIANT	H -> Q (in HHT2; dbSNP:rs1565594410)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	S333I	P37023/S333I	ACVRL1/S333I	VARIANT	S -> I (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs863223413)	ECO:0000269|PubMed:10767348, ECO:0000269|PubMed:14684682, ECO:0000269|PubMed:9245985	10767348,14684682,9245985
P37023	ACVRL1	N335H	P37023/N335H	ACVRL1/N335H	VARIANT	N -> H (in HHT2)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	L337P	P37023/L337P	ACVRL1/L337P	VARIANT	L -> P (in HHT2; dbSNP:rs1592224349)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	L342P	P37023/L342P	ACVRL1/L342P	VARIANT	L -> P (in dbSNP:rs762287966)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	C344R	P37023/C344R	ACVRL1/C344R	VARIANT	C -> R (in HHT2; dbSNP:rs1592224412)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	C344Y	P37023/C344Y	ACVRL1/C344Y	VARIANT	C -> Y (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs28936688)	ECO:0000269|PubMed:10767348, ECO:0000269|PubMed:14684682	10767348,14684682
P37023	ACVRL1	A347D	P37023/A347D	ACVRL1/A347D	VARIANT	A -> D (in HHT2)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	A347P	P37023/A347P	ACVRL1/A347P	VARIANT	A -> P (in HHT2)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	R374Q	P37023/R374Q	ACVRL1/R374Q	VARIANT	R -> Q (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs1060503248)	ECO:0000269|PubMed:14684682, ECO:0000269|PubMed:15024723	14684682,15024723
P37023	ACVRL1	R374W	P37023/R374W	ACVRL1/R374W	VARIANT	R -> W (in HHT2; dbSNP:rs28936401)	ECO:0000269|PubMed:11170071, ECO:0000269|PubMed:14684682, ECO:0000269|PubMed:15712270, ECO:0000269|PubMed:9245985	11170071,14684682,15712270,9245985
P37023	ACVRL1	M376R	P37023/M376R	ACVRL1/M376R	VARIANT	M -> R (in HHT2; dbSNP:rs28936399)	ECO:0000269|PubMed:8640225	8640225
P37023	ACVRL1	M376V	P37023/M376V	ACVRL1/M376V	VARIANT	M -> V (in HHT2; dbSNP:rs1555153277)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	P378L	P37023/P378L	ACVRL1/P378L	VARIANT	P -> L (in HHT2; retained in the endoplasmic reticulum)	ECO:0000269|PubMed:14684682	14684682
P37023	ACVRL1	P378S	P37023/P378S	ACVRL1/P378S	VARIANT	P -> S (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs959973779)	ECO:0000269|PubMed:20414677, ECO:0000269|PubMed:26176610	20414677,26176610
P37023	ACVRL1	E379D	P37023/E379D	ACVRL1/E379D	VARIANT	E -> D (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	E379K	P37023/E379K	ACVRL1/E379K	VARIANT	E -> K (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1131691686)	ECO:0000269|PubMed:15024723, ECO:0000269|PubMed:15712270, ECO:0000269|PubMed:26176610	15024723,15712270,26176610
P37023	ACVRL1	T396A	P37023/T396A	ACVRL1/T396A	VARIANT	T -> A (found in patients with pulmonary arterial hypertension; unknown pathological significance)	ECO:0000269|PubMed:24936649	24936649
P37023	ACVRL1	D397G	P37023/D397G	ACVRL1/D397G	VARIANT	D -> G (in HHT2)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	I398N	P37023/I398N	ACVRL1/I398N	VARIANT	I -> N (in HHT2; dbSNP:rs121909286)	ECO:0000269|PubMed:11170071	11170071
P37023	ACVRL1	W399S	P37023/W399S	ACVRL1/W399S	VARIANT	W -> S (in HHT2; dbSNP:rs121909289)	ECO:0000269|PubMed:14684682	14684682
P37023	ACVRL1	A400T	P37023/A400T	ACVRL1/A400T	VARIANT	A -> T (found in a patient with hereditary hemorrhagic talagiectasia; unknown pathological significance)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	L403P	P37023/L403P	ACVRL1/L403P	VARIANT	L -> P (in HHT2)	ECO:0000269|PubMed:16525724	16525724
P37023	ACVRL1	V404G	P37023/V404G	ACVRL1/V404G	VARIANT	V -> G (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	E407D	P37023/E407D	ACVRL1/E407D	VARIANT	E -> D (in HHT2; dbSNP:rs1565595129)	ECO:0000269|PubMed:10767348, ECO:0000269|PubMed:15712270	10767348,15712270
P37023	ACVRL1	R411P	P37023/R411P	ACVRL1/R411P	VARIANT	R -> P (in HHT2; dbSNP:rs121909284)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	R411Q	P37023/R411Q	ACVRL1/R411Q	VARIANT	R -> Q (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs121909284)	ECO:0000269|PubMed:14684682, ECO:0000269|PubMed:15024723, ECO:0000269|PubMed:8640225	14684682,15024723,8640225
P37023	ACVRL1	R411W	P37023/R411W	ACVRL1/R411W	VARIANT	R -> W (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum; dbSNP:rs121909287)	ECO:0000269|PubMed:11484689, ECO:0000269|PubMed:15024723, ECO:0000269|PubMed:15712270, ECO:0000269|PubMed:26176610	11484689,15024723,15712270,26176610
P37023	ACVRL1	G416S	P37023/G416S	ACVRL1/G416S	VARIANT	G -> S (in HHT2)	ECO:0000269|PubMed:16525724	16525724
P37023	ACVRL1	I417F	P37023/I417F	ACVRL1/I417F	VARIANT	I -> F (no loss of receptor activity in response to BMP9; mutant protein is capable of targeting the cell surface appropriately; dbSNP:rs141653630)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	P424R	P37023/P424R	ACVRL1/P424R	VARIANT	P -> R (in HHT2; dbSNP:rs1940906429)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	P424T	P37023/P424T	ACVRL1/P424T	VARIANT	P -> T (in HHT2; dbSNP:rs1085307419)	ECO:0000269|PubMed:9245985	9245985
P37023	ACVRL1	F425L	P37023/F425L	ACVRL1/F425L	VARIANT	F -> L (in HHT2)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	F425V	P37023/F425V	ACVRL1/F425V	VARIANT	F -> V (in HHT2)	ECO:0000269|PubMed:15712270	15712270
P37023	ACVRL1	Y426C	P37023/Y426C	ACVRL1/Y426C	VARIANT	Y -> C (in HHT2)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	P433R	P37023/P433R	ACVRL1/P433R	VARIANT	P -> R (in HHT2)	ECO:0000269|PubMed:16752392	16752392
P37023	ACVRL1	V441M	P37023/V441M	ACVRL1/V441M	VARIANT	V -> M (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs1565596498)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	C443Y	P37023/C443Y	ACVRL1/C443Y	VARIANT	C -> Y (in HHT2; retained in the endoplasmic reticulum)	ECO:0000269|PubMed:26176610	26176610
P37023	ACVRL1	P449S	P37023/P449S	ACVRL1/P449S	VARIANT	P -> S (in HHT2; dbSNP:rs1940908457)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	R479L	P37023/R479L	ACVRL1/R479L	VARIANT	R -> L (in HHT2)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	R479P	P37023/R479P	ACVRL1/R479P	VARIANT	R -> P (in HHT2; dbSNP:rs1085307426)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	A482V	P37023/A482V	ACVRL1/A482V	VARIANT	A -> V (in HHT2; dbSNP:rs139142865)	ECO:0000269|PubMed:15024723	15024723
P37023	ACVRL1	R484W	P37023/R484W	ACVRL1/R484W	VARIANT	R -> W (in HHT2; dbSNP:rs121909288)	ECO:0000269|PubMed:11484689, ECO:0000269|PubMed:15024723	11484689,15024723
P37023	ACVRL1	K486E	P37023/K486E	ACVRL1/K486E	VARIANT	K -> E (found in a patient with hereditary hemorrhagic talagiectasia; unknown pathological significance; dbSNP:rs113700354)	ECO:0000269|PubMed:20414677	20414677
P37023	ACVRL1	K487T	P37023/K487T	ACVRL1/K487T	VARIANT	K -> T (in HHT2; mutant protein is capable of targeting the cell surface appropriately; dbSNP:rs1085307428)	ECO:0000269|PubMed:14684682	14684682

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P37173	TGFBR2	M36V	P37173/M36V	TGFBR2/M36V	VARIANT	M -> V (in dbSNP:rs17025864)	ECO:0000269|Ref.8	
P37173	TGFBR2	C61R	P37173/C61R	TGFBR2/C61R	VARIANT	C -> R (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P37173	TGFBR2	I73V	P37173/I73V	TGFBR2/I73V	VARIANT	I -> V (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
P37173	TGFBR2	R190H	P37173/R190H	TGFBR2/R190H	VARIANT	R -> H (in LDS2; dbSNP:rs780542125)	ECO:0000269|PubMed:19533785	19533785
P37173	TGFBR2	V191I	P37173/V191I	TGFBR2/V191I	VARIANT	V -> I (in dbSNP:rs56105708)	ECO:0000269|PubMed:12202987, ECO:0000269|PubMed:17344846	12202987,17344846
P37173	TGFBR2	D247V	P37173/D247V	TGFBR2/D247V	VARIANT	D -> V (in LDS2; dbSNP:rs761231369)	ECO:0000269|PubMed:19533785	19533785
P37173	TGFBR2	Q306HE	P37173/Q306HE	TGFBR2/Q306HE	VARIANT	Q -> HE (in LDS2)	ECO:0000269|PubMed:22113417	22113417
P37173	TGFBR2	L308P	P37173/L308P	TGFBR2/L308P	VARIANT	L -> P (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs28934568)	ECO:0000269|PubMed:15235604, ECO:0000269|PubMed:20358619	15235604,20358619
P37173	TGFBR2	T315M	P37173/T315M	TGFBR2/T315M	VARIANT	T -> M (in HNPCC6; dbSNP:rs34833812)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9590282	17344846,9590282
P37173	TGFBR2	T325P	P37173/T325P	TGFBR2/T325P	VARIANT	T -> P (in LDS2)	ECO:0000269|PubMed:19533785	19533785
P37173	TGFBR2	H328Y	P37173/H328Y	TGFBR2/H328Y	VARIANT	H -> Y (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P37173	TGFBR2	Y336N	P37173/Y336N	TGFBR2/Y336N	VARIANT	Y -> N (in LDS2; dbSNP:rs104893812)	ECO:0000269|PubMed:15731757	15731757
P37173	TGFBR2	A355P	P37173/A355P	TGFBR2/A355P	VARIANT	A -> P (in LDS2; dbSNP:rs104893813)	ECO:0000269|PubMed:15731757	15731757
P37173	TGFBR2	G357R	P37173/G357R	TGFBR2/G357R	VARIANT	G -> R (in LDS2)	ECO:0000269|PubMed:19533785	19533785
P37173	TGFBR2	G357W	P37173/G357W	TGFBR2/G357W	VARIANT	G -> W (in LDS2; dbSNP:rs104893814)	ECO:0000269|PubMed:15731757	15731757
P37173	TGFBR2	M373I	P37173/M373I	TGFBR2/M373I	VARIANT	M -> I (in dbSNP:rs35719192)	ECO:0000269|PubMed:17344846	17344846
P37173	TGFBR2	H377R	P37173/H377R	TGFBR2/H377R	VARIANT	H -> R (in LDS2; dbSNP:rs1553630274)	ECO:0000269|PubMed:22113417	22113417
P37173	TGFBR2	V387M	P37173/V387M	TGFBR2/V387M	VARIANT	V -> M (in a breast tumor; dbSNP:rs35766612)	ECO:0000269|PubMed:11212236, ECO:0000269|PubMed:17344846	11212236,17344846
P37173	TGFBR2	N435S	P37173/N435S	TGFBR2/N435S	VARIANT	N -> S (in a breast tumor; signaling of TGF-beta significantly inhibited)	ECO:0000269|PubMed:11212236	11212236
P37173	TGFBR2	V439A	P37173/V439A	TGFBR2/V439A	VARIANT	V -> A (in dbSNP:rs1050833)	ECO:0000269|PubMed:1310899, ECO:0000269|PubMed:8812462, ECO:0000269|PubMed:8840968, ECO:0000269|PubMed:8973329	1310899,8812462,8840968,8973329
P37173	TGFBR2	D446N	P37173/D446N	TGFBR2/D446N	VARIANT	D -> N (in LDS2; dbSNP:rs886039551)	ECO:0000269|PubMed:16251899	16251899
P37173	TGFBR2	V447A	P37173/V447A	TGFBR2/V447A	VARIANT	V -> A (in a breast tumor; signaling of TGF-beta significantly inhibited)	ECO:0000269|PubMed:11212236	11212236
P37173	TGFBR2	S449F	P37173/S449F	TGFBR2/S449F	VARIANT	S -> F (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs104893807)	ECO:0000269|PubMed:15235604, ECO:0000269|PubMed:22113417	15235604,22113417
P37173	TGFBR2	L452M	P37173/L452M	TGFBR2/L452M	VARIANT	L -> M (in a breast tumor; signaling of TGF-beta significantly inhibited)	ECO:0000269|PubMed:11212236	11212236
P37173	TGFBR2	M457K	P37173/M457K	TGFBR2/M457K	VARIANT	M -> K (in LDS2)	ECO:0000269|PubMed:20101701	20101701
P37173	TGFBR2	R460C	P37173/R460C	TGFBR2/R460C	VARIANT	R -> C (in LDS2; dbSNP:rs104893811)	ECO:0000269|PubMed:16027248	16027248
P37173	TGFBR2	R460H	P37173/R460H	TGFBR2/R460H	VARIANT	R -> H (in LDS2; dbSNP:rs104893816)	ECO:0000269|PubMed:16027248	16027248
P37173	TGFBR2	N490S	P37173/N490S	TGFBR2/N490S	VARIANT	N -> S (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P37173	TGFBR2	G509V	P37173/G509V	TGFBR2/G509V	VARIANT	G -> V (in LDS2; dbSNP:rs863223853)	ECO:0000269|PubMed:21949523	21949523
P37173	TGFBR2	I510F	P37173/I510F	TGFBR2/I510F	VARIANT	I -> F (in LDS2)	ECO:0000269|PubMed:21949523	21949523
P37173	TGFBR2	I510S	P37173/I510S	TGFBR2/I510S	VARIANT	I -> S (in LDS2)	ECO:0000269|PubMed:19883511	19883511
P37173	TGFBR2	C514R	P37173/C514R	TGFBR2/C514R	VARIANT	C -> R (in LDS2; dbSNP:rs193922664)	ECO:0000269|PubMed:22113417	22113417
P37173	TGFBR2	W521R	P37173/W521R	TGFBR2/W521R	VARIANT	W -> R (in LDS2; dbSNP:rs1575166666)	ECO:0000269|PubMed:20358619	20358619
P37173	TGFBR2	E526Q	P37173/E526Q	TGFBR2/E526Q	VARIANT	E -> Q (in esophageal cancer; dbSNP:rs121918714)	ECO:0000269|PubMed:10789724	10789724
P37173	TGFBR2	R528C	P37173/R528C	TGFBR2/R528C	VARIANT	R -> C (in LDS2; dbSNP:rs104893810)	ECO:0000269|PubMed:15731757	15731757
P37173	TGFBR2	R528H	P37173/R528H	TGFBR2/R528H	VARIANT	R -> H (in LDS2; dbSNP:rs104893815)	ECO:0000269|PubMed:15731757, ECO:0000269|PubMed:16959974	15731757,16959974
P37173	TGFBR2	T530I	P37173/T530I	TGFBR2/T530I	VARIANT	T -> I (in LDS2)	ECO:0000269|PubMed:19533785	19533785
P37173	TGFBR2	R537C	P37173/R537C	TGFBR2/R537C	VARIANT	R -> C (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs104893809)	ECO:0000269|PubMed:15235604	15235604
P37173	TGFBR2	K277R	P37173/K277R	TGFBR2/K277R	MUTAGEN	K->R: Abolishes kinase activity, TGF-beta signaling and interaction with DAXX.	ECO:0000269|PubMed:11483955	11483955

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P41240	CSK	P45L	P41240/P45L	CSK/P45L	VARIANT	P -> L	ECO:0000269|PubMed:17344846	17344846
P41240	CSK	G287D	P41240/G287D	CSK/G287D	VARIANT	G -> D (in dbSNP:rs34866753)	ECO:0000269|Ref.6	
P41240	CSK	R398Q	P41240/R398Q	CSK/R398Q	VARIANT	R -> Q (in dbSNP:rs34616395)	ECO:0000269|Ref.6	
P41240	CSK	H442R	P41240/H442R	CSK/H442R	VARIANT	H -> R (in dbSNP:rs35556162)	ECO:0000269|Ref.6	
P41240	CSK	Y184F	P41240/Y184F	CSK/Y184F	MUTAGEN	Y->F: Abolishes phosphorylation.	ECO:0000269|PubMed:9148770	9148770
P41240	CSK	Y304F	P41240/Y304F	CSK/Y304F	MUTAGEN	Y->F: Decreases activity by two-thirds and alters conformation.	ECO:0000269|PubMed:9148770	9148770
P41240	CSK	S364A	P41240/S364A	CSK/S364A	MUTAGEN	S->A: Strong decrease of phosphorylation by PRKACA (catalytic subunit of PKA).	ECO:0000269|PubMed:11181701	11181701

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P41279	MAP3K8	S214F	P41279/S214F	MAP3K8/S214F	VARIANT	S -> F (in dbSNP:rs3087944)		
P41279	MAP3K8	T290A	P41279/T290A	MAP3K8/T290A	MUTAGEN			
P41279	MAP3K8	T290D	P41279/T290D	MAP3K8/T290D	MUTAGEN	T->D: Impaired MEK phosphorylation and autophosphorylation activities. No effect on KSR2 binding.	ECO:0000269|PubMed:15466476	15466476
P41279	MAP3K8	T290E	P41279/T290E	MAP3K8/T290E	MUTAGEN			

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P41743	PRKCI	P118L	P41743/P118L	PRKCI/P118L	VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P41743	PRKCI	R130C	P41743/R130C	PRKCI/R130C	VARIANT	R -> C (in dbSNP:rs56154494)	ECO:0000269|PubMed:17344846	17344846
P41743	PRKCI	K29A	P41743/K29A	PRKCI/K29A	MUTAGEN	K->A: No effect on interaction with SQSTM1.	ECO:0000269|PubMed:15143057	15143057
P41743	PRKCI	D72A	P41743/D72A	PRKCI/D72A	MUTAGEN	D->A: Loss of interaction with ECT2, PARD6A and with SQSTM1.	ECO:0000269|PubMed:15143057, ECO:0000269|PubMed:15590654, ECO:0000269|PubMed:19617897	15143057,15590654,19617897
P41743	PRKCI	E85A	P41743/E85A	PRKCI/E85A	MUTAGEN	E->A: Slight decrease of interaction with PARD6A. Loss of interaction with PARD6A; when associated with A-91.	ECO:0000269|PubMed:15590654	15590654
P41743	PRKCI	R91A	P41743/R91A	PRKCI/R91A	MUTAGEN	R->A: Slight decrease of interaction with PARD6A. Loss of interaction with PARD6A; when associated with A-85.	ECO:0000269|PubMed:15590654	15590654
P41743	PRKCI	Y265F	P41743/Y265F	PRKCI/Y265F	MUTAGEN	Y->F: No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. Little effect on TRAF6-mediated activation of NF-kappa-B. Decreased binding to KPNB1/importin-beta.	ECO:0000269|PubMed:11713277, ECO:0000269|PubMed:11891849	11713277,11891849
P41743	PRKCI	K274R	P41743/K274R	PRKCI/K274R	MUTAGEN	K->R: No effect on activity.	ECO:0000269|PubMed:10906326	10906326
P41743	PRKCI	K274W	P41743/K274W	PRKCI/K274W	MUTAGEN	K->W: Abolishes activity.	ECO:0000269|PubMed:10906326	10906326
P41743	PRKCI	Y280F	P41743/Y280F	PRKCI/Y280F	MUTAGEN	Y->F: No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. No effect on TRAF6-mediated activation of NF-kappa-B.	ECO:0000269|PubMed:11713277	11713277
P41743	PRKCI	Y334F	P41743/Y334F	PRKCI/Y334F	MUTAGEN	Y->F: No effect on the SRC-mediated phosphorylation state. Significant reduction of SRC-induced enzyme activity. Greatly reduced TRAF6-mediated activation of NF-kappa-B. Reduces NGF-dependent cell survival.	ECO:0000269|PubMed:11713277	11713277

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P42345	MTOR	A8S	P42345/A8S	MTOR/A8S	VARIANT	A -> S (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P42345	MTOR	M135T	P42345/M135T	MTOR/M135T	VARIANT	M -> T (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P42345	MTOR	R624H	P42345/R624H	MTOR/R624H	VARIANT	R -> H (in FCORD2; somatic mutation; unknown pathological significance; dbSNP:rs913197212)	ECO:0000269|PubMed:25799227	25799227
P42345	MTOR	M1083V	P42345/M1083V	MTOR/M1083V	VARIANT	M -> V (in dbSNP:rs56164650)	ECO:0000269|PubMed:17344846	17344846
P42345	MTOR	A1134V	P42345/A1134V	MTOR/A1134V	VARIANT	A -> V (in dbSNP:rs28730685)	ECO:0000269|PubMed:17344846	17344846
P42345	MTOR	S1178F	P42345/S1178F	MTOR/S1178F	VARIANT	S -> F (in dbSNP:rs55975118)	ECO:0000269|PubMed:17344846	17344846
P42345	MTOR	D1376E	P42345/D1376E	MTOR/D1376E	VARIANT	D -> E (found in a patient with focal epilepsy; unknown pathological significance; dbSNP:rs975577894)	ECO:0000269|PubMed:27830187	27830187
P42345	MTOR	Y1450D	P42345/Y1450D	MTOR/Y1450D	VARIANT	Y -> D (in FCORD2; somatic mutation)	ECO:0000269|PubMed:25799227	25799227
P42345	MTOR	W1456G	P42345/W1456G	MTOR/W1456G	VARIANT	W -> G (in FCORD2; somatic mutation; dbSNP:rs1085307114)	ECO:0000269|PubMed:25878179	25878179
P42345	MTOR	A1459D	P42345/A1459D	MTOR/A1459D	VARIANT	A -> D (in FCORD2; somatic mutation; increased TOR signaling)	ECO:0000269|PubMed:26018084	26018084
P42345	MTOR	A1459S	P42345/A1459S	MTOR/A1459S	VARIANT	A -> S (in FCORD2; somatic mutation)	ECO:0000269|PubMed:27830187	27830187
P42345	MTOR	L1460P	P42345/L1460P	MTOR/L1460P	VARIANT	L -> P (in FCORD2; somatic mutation; increased TOR signaling; dbSNP:rs1057519779)	ECO:0000269|PubMed:26018084, ECO:0000269|PubMed:27830187	26018084,27830187
P42345	MTOR	C1483R	P42345/C1483R	MTOR/C1483R	VARIANT	C -> R (in FCORD2; somatic mutation; increased TOR signaling; increased kinase activity; dbSNP:rs1057519914)	ECO:0000269|PubMed:25799227	25799227
P42345	MTOR	W1490R	P42345/W1490R	MTOR/W1490R	VARIANT	W -> R (in SKS)	ECO:0000269|PubMed:27830187	27830187
P42345	MTOR	M1595I	P42345/M1595I	MTOR/M1595I	VARIANT	M -> I (in SKS; dbSNP:rs869312671)	ECO:0000269|PubMed:27830187	27830187
P42345	MTOR	R1709H	P42345/R1709H	MTOR/R1709H	VARIANT	R -> H (in FCORD2; somatic mutation; unknown pathological significance; dbSNP:rs587777895)	ECO:0000269|PubMed:25799227	25799227
P42345	MTOR	E1799K	P42345/E1799K	MTOR/E1799K	VARIANT	E -> K (in SKS; results in increased mTOR signaling; dbSNP:rs863225264)	ECO:0000269|PubMed:25851998, ECO:0000269|PubMed:26542245	25851998,26542245
P42345	MTOR	A1832T	P42345/A1832T	MTOR/A1832T	VARIANT	A -> T (in SKS; dbSNP:rs369088781)	ECO:0000269|PubMed:27830187	27830187
P42345	MTOR	F1888C	P42345/F1888C	MTOR/F1888C	VARIANT	F -> C (in SKS; dbSNP:rs869312666)	ECO:0000269|PubMed:27830187	27830187
P42345	MTOR	T1977K	P42345/T1977K	MTOR/T1977K	VARIANT	T -> K (in FCORD2; somatic mutation; dbSNP:rs587777893)	ECO:0000269|PubMed:25799227	25799227
P42345	MTOR	M2011V	P42345/M2011V	MTOR/M2011V	VARIANT	M -> V (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P42345	MTOR	R2193C	P42345/R2193C	MTOR/R2193C	VARIANT	R -> C (in FCORD2; somatic mutation)	ECO:0000269|PubMed:25799227	25799227
P42345	MTOR	S2215F	P42345/S2215F	MTOR/S2215F	VARIANT	S -> F (in FCORD2; somatic mutation; increased TOR signaling; dbSNP:rs587777894)	ECO:0000269|PubMed:25799227, ECO:0000269|PubMed:26018084, ECO:0000269|PubMed:27830187	25799227,26018084,27830187
P42345	MTOR	S2215Y	P42345/S2215Y	MTOR/S2215Y	VARIANT	S -> Y (in FCORD2; also found in a colorectal adenocarcinoma sample; somatic mutation; increased TOR signaling; dbSNP:rs587777894)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:26018084, ECO:0000269|PubMed:27830187	17344846,26018084,27830187
P42345	MTOR	L2220F	P42345/L2220F	MTOR/L2220F	VARIANT	L -> F (found in a renal cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:21248752	21248752
P42345	MTOR	M2327I	P42345/M2327I	MTOR/M2327I	VARIANT	M -> I (in SKS; dbSNP:rs878855328)	ECO:0000269|PubMed:27830187	27830187
P42345	MTOR	V2406A	P42345/V2406A	MTOR/V2406A	VARIANT	V -> A (found in a renal cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:21248752	21248752
P42345	MTOR	L2427P	P42345/L2427P	MTOR/L2427P	VARIANT	L -> P (in FCORD2; somatic mutation; increased TOR signaling; increased kinase activity; dbSNP:rs1085307113)	ECO:0000269|PubMed:25799227	25799227
P42345	MTOR	L2427Q	P42345/L2427Q	MTOR/L2427Q	VARIANT	L -> Q (in FCORD2; somatic mutation; increased TOR signaling; increased kinase activity; dbSNP:rs1085307113)	ECO:0000269|PubMed:25799227	25799227
P42345	MTOR	P2476L	P42345/P2476L	MTOR/P2476L	VARIANT	P -> L (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P42345	MTOR	I2501V	P42345/I2501V	MTOR/I2501V	VARIANT	I -> V (found in a patient with non-lesional nocturnal frontal epilepsy; unknown pathological significance; dbSNP:rs968817513)	ECO:0000269|PubMed:27830187	27830187
P42345	MTOR	S2159A	P42345/S2159A	MTOR/S2159A	MUTAGEN	S->A: Reduces mTORC1-associated S-2481 autophosphorylation; when associated with A-2164.	ECO:0000269|PubMed:21576368	21576368
P42345	MTOR	S2159D	P42345/S2159D	MTOR/S2159D	MUTAGEN	S->D: Stronger phosphorylation of RPS6KB1; when associated with E-2164.	ECO:0000269|PubMed:21576368	21576368
P42345	MTOR	T2164A	P42345/T2164A	MTOR/T2164A	MUTAGEN	T->A: Reduces mTORC1-associated S-2481 autophosphorylation; when associated with A-2159.	ECO:0000269|PubMed:21576368	21576368
P42345	MTOR	T2164E	P42345/T2164E	MTOR/T2164E	MUTAGEN	T->E: Stronger phosphorylation of RPS6KB1; when associated with D-2159.	ECO:0000269|PubMed:21576368	21576368
P42345	MTOR	T2173A	P42345/T2173A	MTOR/T2173A	MUTAGEN	T->A: Increased mTOR kinase activity.	ECO:0000269|PubMed:24247430	24247430
P42345	MTOR	H2340A	P42345/H2340A	MTOR/H2340A	MUTAGEN	H->A: Barely detectable kinase activity.	ECO:0000269|PubMed:23636326	23636326
P42345	MTOR	D2357E	P42345/D2357E	MTOR/D2357E	MUTAGEN	D->E: Kinase-dead mutant, loss of interaction with TM4SF5 and loss of lysosome membrane localization; when associated with I-2364.	ECO:0000269|PubMed:30956113	30956113
P42345	MTOR	V2364I	P42345/V2364I	MTOR/V2364I	MUTAGEN	V->I: Kinase-dead mutant, loss of interaction with TM4SF5 and loss of lysosome membrane localization; when associated with E-2357.	ECO:0000269|PubMed:30956113	30956113

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P42679	MATK	A354T	P42679/A354T	MATK/A354T	VARIANT	A -> T (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P42679	MATK	A496T	P42679/A496T	MATK/A496T	VARIANT	A -> T (in dbSNP:rs35351680)	ECO:0000269|PubMed:17344846	17344846
P42679	MATK	R503Q	P42679/R503Q	MATK/R503Q	VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs778726488)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P42680	TEC	R44Q	P42680/R44Q	TEC/R44Q	VARIANT	R -> Q (in dbSNP:rs35374286)	ECO:0000269|PubMed:17344846	17344846
P42680	TEC	R563K	P42680/R563K	TEC/R563K	VARIANT	R -> K (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P42681	TXK	R45H	P42681/R45H	TXK/R45H	VARIANT	R -> H (in dbSNP:rs7658300)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7951233	17344846,7951233
P42681	TXK	R63C	P42681/R63C	TXK/R63C	VARIANT	R -> C (in dbSNP:rs41265727)	ECO:0000269|PubMed:17344846	17344846
P42681	TXK	R336Q	P42681/R336Q	TXK/R336Q	VARIANT	R -> Q (in dbSNP:rs11724347)	ECO:0000269|PubMed:17344846	17344846
P42681	TXK	Y91A	P42681/Y91A	TXK/Y91A	MUTAGEN	Y->A: Reduces expression levels if IFN-gamma.	ECO:0000269|PubMed:12081135	12081135
P42681	TXK	K299A	P42681/K299A	TXK/K299A	MUTAGEN	K->A: Impairs kinase activity.	ECO:0000269|PubMed:9813138	9813138

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P42684-4	ABL2	S12T	P42684-4/S12T	ABL2/S12T	VARIANT	S -> T (in dbSNP:rs1318056)	ECO:0000269|PubMed:18810762, ECO:0007744|PubMed:17344846	18810762,17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P42684	ABL2	R78H	P42684/R78H	ABL2/R78H	VARIANT	R -> H (in dbSNP:rs55655202)	ECO:0000269|PubMed:17344846	17344846
P42684	ABL2	E99Q	P42684/E99Q	ABL2/E99Q	VARIANT	E -> Q (somatic mutation in a breast cancer sample)	ECO:0000269|PubMed:17344846	17344846
P42684	ABL2	R519I	P42684/R519I	ABL2/R519I	VARIANT	R -> I (somatic mutation in a lung squamous cell carcinoma)	ECO:0000269|PubMed:17344846	17344846
P42684	ABL2	T769S	P42684/T769S	ABL2/T769S	VARIANT	T -> S (in dbSNP:rs55892721)	ECO:0000269|PubMed:17344846	17344846
P42684	ABL2	K930R	P42684/K930R	ABL2/K930R	VARIANT	K -> R (in dbSNP:rs17277288)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5	17344846
P42684	ABL2	V946M	P42684/V946M	ABL2/V946M	VARIANT	V -> M (in dbSNP:rs28913889)	ECO:0000269|Ref.5	
P42684	ABL2	P996R	P42684/P996R	ABL2/P996R	VARIANT	P -> R (in dbSNP:rs28913890)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5	17344846
P42684	ABL2	S1085N	P42684/S1085N	ABL2/S1085N	VARIANT	S -> N (in dbSNP:rs28913891)	ECO:0000269|Ref.5	
P42684	ABL2	T1101A	P42684/T1101A	ABL2/T1101A	VARIANT	T -> A (in dbSNP:rs28913892)	ECO:0000269|Ref.5	

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P42685	FRK	I100V	P42685/I100V	FRK/I100V	VARIANT	I -> V (in dbSNP:rs34704018)	ECO:0000269|PubMed:17344846	17344846
P42685	FRK	G122R	P42685/G122R	FRK/G122R	VARIANT	G -> R (in dbSNP:rs3756772)	ECO:0000269|PubMed:17344846	17344846
P42685	FRK	S133L	P42685/S133L	FRK/S133L	VARIANT	S -> L (in dbSNP:rs34064900)	ECO:0000269|PubMed:17344846	17344846
P42685	FRK	K262R	P42685/K262R	FRK/K262R	MUTAGEN	K->R: Loss of ability to phosphorylate PTEN.	ECO:0000269|PubMed:19345329	19345329

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P43250	GRK6	R31Q	P43250/R31Q	GRK6/R31Q	VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs141014084)	ECO:0000269|PubMed:17344846	17344846
P43250	GRK6	T73M	P43250/T73M	GRK6/T73M	VARIANT	T -> M (in dbSNP:rs56382815)	ECO:0000269|PubMed:17344846	17344846
P43250	GRK6	I275M	P43250/I275M	GRK6/I275M	VARIANT	I -> M (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P43250	GRK6	I6A	P43250/I6A	GRK6/I6A	MUTAGEN	I->A: 12-13 fold defects in kinase activity; 180-fold defects in kinase activity; when associated with A-7.	ECO:0000269|PubMed:20729810	20729810
P43250	GRK6	V7A	P43250/V7A	GRK6/V7A	MUTAGEN	V->A: 12-13 fold defects in kinase activity; 180-fold defects in kinase activity; when associated with A-6.	ECO:0000269|PubMed:20729810	20729810
P43250	GRK6	N9A	P43250/N9A	GRK6/N9A	MUTAGEN	N->A: 140-fold defects in kinase activity.	ECO:0000269|PubMed:20729810	20729810
P43250	GRK6	L12A	P43250/L12A	GRK6/L12A	MUTAGEN	L->A: 1100-fold defects in kinase activity.	ECO:0000269|PubMed:20729810	20729810
P43250	GRK6	C561S	P43250/C561S	GRK6/C561S	MUTAGEN	C->S: Abolishes palmitoylation; when associated with S-562 and S-565.	ECO:0000269|PubMed:7961702	7961702
P43250	GRK6	C562S	P43250/C562S	GRK6/C562S	MUTAGEN	C->S: Abolishes palmitoylation; when associated with S-561 and S-565.	ECO:0000269|PubMed:7961702	7961702
P43250	GRK6	C565S	P43250/C565S	GRK6/C565S	MUTAGEN	C->S: Abolishes palmitoylation; when associated with S-561 and S-562.	ECO:0000269|PubMed:7961702	7961702

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P43403	ZAP70	R175L	P43403/R175L	ZAP70/R175L	VARIANT	R -> L (in dbSNP:rs55964305)	ECO:0000269|PubMed:17344846	17344846
P43403	ZAP70	P191L	P43403/P191L	ZAP70/P191L	VARIANT	P -> L (in dbSNP:rs56403250)	ECO:0000269|PubMed:17344846	17344846
P43403	ZAP70	R192W	P43403/R192W	ZAP70/R192W	VARIANT	R -> W (in ADMIO2; decreases interaction with phosphorylated CD247; decreases ZAP70 phosphorylation; no effect on subcellular localization of CD69 at the cell surface; dbSNP:rs199840952)	ECO:0000269|PubMed:26783323	26783323
P43403	ZAP70	L337R	P43403/L337R	ZAP70/L337R	VARIANT	L -> R (in IMD48; dbSNP:rs1254428002)	ECO:0000269|PubMed:18509675	18509675
P43403	ZAP70	R360P	P43403/R360P	ZAP70/R360P	VARIANT	R -> P (in ADMIO2; no effect on interaction with phosphorylated CD247; increases TCR-induced Y-319 and Y-493 phosphorylation of ZAP70 and phosphorylation of LAT and LCP2; increases subcellular localization of CD69 at the cell surface; weakly decreases autoinhibition conformation; dbSNP:rs869025224)	ECO:0000269|PubMed:26783323	26783323
P43403	ZAP70	G448E	P43403/G448E	ZAP70/G448E	VARIANT	G -> E (in a head and neck squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P43403	ZAP70	R465C	P43403/R465C	ZAP70/R465C	VARIANT	R -> C (in IMD48; dbSNP:rs113994174)	ECO:0000269|PubMed:11123350	11123350
P43403	ZAP70	R465H	P43403/R465H	ZAP70/R465H	VARIANT	R -> H (in IMD48; dbSNP:rs137853201)	ECO:0000269|PubMed:11412303	11412303
P43403	ZAP70	A507V	P43403/A507V	ZAP70/A507V	VARIANT	A -> V (in IMD48)	ECO:0000269|PubMed:18509675	18509675
P43403	ZAP70	S518R	P43403/S518R	ZAP70/S518R	VARIANT	S -> R (in IMD48; dbSNP:rs104893674)	ECO:0000269|PubMed:8202713	8202713
P43403	ZAP70	W523L	P43403/W523L	ZAP70/W523L	VARIANT	W -> L (in dbSNP:rs56189815)	ECO:0000269|PubMed:17344846	17344846
P43403	ZAP70	K541KLEQ	P43403/K541KLEQ	ZAP70/K541KLEQ	VARIANT	K -> KLEQ (in IMD48)	ECO:0000269|PubMed:8124727	8124727
P43403	ZAP70	C564R	P43403/C564R	ZAP70/C564R	VARIANT	C -> R (in IMD48)	ECO:0000269|PubMed:18509675	18509675
P43403	ZAP70	R37K	P43403/R37K	ZAP70/R37K	MUTAGEN	R->K: Decreases interaction with phosphorylated CD247; when associated with K-190.	ECO:0000269|PubMed:26783323	26783323
P43403	ZAP70	W131A	P43403/W131A	ZAP70/W131A	MUTAGEN	W->A: Increased constitutive kinase activity.	ECO:0000269|PubMed:17512407	17512407
P43403	ZAP70	L133A	P43403/L133A	ZAP70/L133A	MUTAGEN	L->A: Increased constitutive kinase activity.	ECO:0000269|PubMed:17512407	17512407
P43403	ZAP70	A141E	P43403/A141E	ZAP70/A141E	MUTAGEN	A->E: Increased constitutive kinase activity.	ECO:0000269|PubMed:17512407	17512407
P43403	ZAP70	S144A	P43403/S144A	ZAP70/S144A	MUTAGEN	S->A: Increased kinase activity after activation by LCK.	ECO:0000269|PubMed:17512407	17512407
P43403	ZAP70	Q145A	P43403/Q145A	ZAP70/Q145A	MUTAGEN	Q->A: Increased kinase activity after activation by LCK.	ECO:0000269|PubMed:17512407	17512407
P43403	ZAP70	P147A	P43403/P147A	ZAP70/P147A	MUTAGEN	P->A: Increased kinase activity after activation by LCK.	ECO:0000269|PubMed:17512407	17512407
P43403	ZAP70	R190K	P43403/R190K	ZAP70/R190K	MUTAGEN	R->K: Decreases interaction with phosphorylated CD247; when associated with K-37.	ECO:0000269|PubMed:26783323	26783323
P43403	ZAP70	Y292F	P43403/Y292F	ZAP70/Y292F	MUTAGEN	Y->F: Induces constitutive TCR stimulation-independent NFAT induction.	ECO:0000269|PubMed:8943331	8943331
P43403	ZAP70	K304R	P43403/K304R	ZAP70/K304R	MUTAGEN	K->R: No effect on ubiquitination.	ECO:0000269|PubMed:26903241	26903241
P43403	ZAP70	V314A	P43403/V314A	ZAP70/V314A	MUTAGEN	V->A: Increased constitutive kinase activity.		
P43403	ZAP70	Y315A	P43403/Y315A	ZAP70/Y315A	MUTAGEN	Y->A: Increased constitutive kinase activity; when associated with F-319.	ECO:0000269|PubMed:10037717, ECO:0000269|PubMed:11828374, ECO:0000269|PubMed:17512407, ECO:0000269|PubMed:9151714	10037717,11828374,17512407,9151714
P43403	ZAP70	Y315F	P43403/Y315F	ZAP70/Y315F	MUTAGEN	Y->F: Increased constitutive kinase activity; when associated with F-319. About 75% loss of CD247/CD3Z-binding in stimulated TCR and complete loss of VAV1 interaction.	ECO:0000269|PubMed:10037717, ECO:0000269|PubMed:11828374, ECO:0000269|PubMed:17512407, ECO:0000269|PubMed:9151714	10037717,11828374,17512407,9151714
P43403	ZAP70	Y319A	P43403/Y319A	ZAP70/Y319A	MUTAGEN	Y->A: Increased constitutive kinase activity; when associated with F-315.	ECO:0000269|PubMed:10037717, ECO:0000269|PubMed:17512407	10037717,17512407
P43403	ZAP70	Y319F	P43403/Y319F	ZAP70/Y319F	MUTAGEN	Y->F: Increased constitutive kinase activity; when associated with F-315. About 80% loss of TCR-induced NFAT activation.	ECO:0000269|PubMed:10037717, ECO:0000269|PubMed:17512407	10037717,17512407
P43403	ZAP70	D327P	P43403/D327P	ZAP70/D327P	MUTAGEN	D->P: Increases constitutive kinase activity on LAT phosphorylation, strongly increases subcellular localization of CD69 at the cell surface and decreases autoinhibition conformation.	ECO:0000269|PubMed:26783323	26783323
P43403	ZAP70	K362E	P43403/K362E	ZAP70/K362E	MUTAGEN	K->E: Increases constitutive kinase activity on LAT phosphorylation, strongly increases subcellular localization of CD69 at the cell surface and decreases autoinhibition conformation.	ECO:0000269|PubMed:26783323	26783323
P43403	ZAP70	D461N	P43403/D461N	ZAP70/D461N	MUTAGEN	D->N: Abolishes kinase activity.	ECO:0000269|PubMed:17512407	17512407
P43403	ZAP70	D479N	P43403/D479N	ZAP70/D479N	MUTAGEN	D->N: Abolishes kinase activity.	ECO:0000269|PubMed:15292186	15292186
P43403	ZAP70	Y492F	P43403/Y492F	ZAP70/Y492F	MUTAGEN	Y->F: Increases kinase activity.	ECO:0000269|PubMed:7781602	7781602
P43403	ZAP70	Y493F	P43403/Y493F	ZAP70/Y493F	MUTAGEN	Y->F: Impairs kinase activity.	ECO:0000269|PubMed:7781602	7781602
P43403	ZAP70	K538R	P43403/K538R	ZAP70/K538R	MUTAGEN	K->R: No effect on ubiquitination.	ECO:0000269|PubMed:26903241	26903241
P43403	ZAP70	K544R	P43403/K544R	ZAP70/K544R	MUTAGEN	K->R: Strongly decreased ubiquitination.	ECO:0000269|PubMed:26903241	26903241
P43403	ZAP70	Y597A	P43403/Y597A	ZAP70/Y597A	MUTAGEN	Y->A: Increased kinase activity after activation by LCK.	ECO:0000269|PubMed:17512407	17512407
P43403	ZAP70	Y598A	P43403/Y598A	ZAP70/Y598A	MUTAGEN	Y->A: Increased kinase activity after activation by LCK.	ECO:0000269|PubMed:17512407	17512407

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P43405	SYK	R45H	P43405/R45H	SYK/R45H	VARIANT	R -> H (in dbSNP:rs16906862)		
P43405	SYK	P342T	P43405/P342T	SYK/P342T	VARIANT	P -> T (in IMD82; constitutively active protein tyrosine kinase activity)	ECO:0000269|PubMed:33782605	33782605
P43405	SYK	A353T	P43405/A353T	SYK/A353T	VARIANT	A -> T (in IMD82; constitutively active protein tyrosine kinase activity)	ECO:0000269|PubMed:33782605	33782605
P43405	SYK	M450I	P43405/M450I	SYK/M450I	VARIANT	M -> I (in IMD82; constitutively active protein tyrosine kinase activity)	ECO:0000269|PubMed:33782605	33782605
P43405	SYK	S550F	P43405/S550F	SYK/S550F	VARIANT	S -> F (in IMD82; constitutively active protein tyrosine kinase activity)	ECO:0000269|PubMed:33782605	33782605
P43405	SYK	S550Y	P43405/S550Y	SYK/S550Y	VARIANT	S -> Y (in IMD82; constitutively active protein tyrosine kinase activity)	ECO:0000269|PubMed:33782605	33782605
P43405	SYK	S297A	P43405/S297A	SYK/S297A	MUTAGEN	S->A: Abolishes YWHAG binding.	ECO:0000269|PubMed:21469132	21469132
P43405	SYK	Y630F	P43405/Y630F	SYK/Y630F	MUTAGEN	Y->F: Loss of interaction with BLNK.	ECO:0000269|PubMed:18369315	18369315

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P45983	MAPK8	G171S	P45983/G171S	MAPK8/G171S	VARIANT	G -> S (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P45983	MAPK8	G177R	P45983/G177R	MAPK8/G177R	VARIANT	G -> R (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P45983	MAPK8	E365K	P45983/E365K	MAPK8/E365K	VARIANT	E -> K (in dbSNP:rs45483593)		
P45983	MAPK8	K55D	P45983/K55D	MAPK8/K55D	MUTAGEN	K->D: Abolished protein kinase activity.	ECO:0000269|PubMed:22966201, ECO:0000269|PubMed:28943315	22966201,28943315
P45983	MAPK8	T183A	P45983/T183A	MAPK8/T183A	MUTAGEN	T->A: Phosphorylation blocked.	ECO:0000269|PubMed:7839144	7839144
P45983	MAPK8	Y185F	P45983/Y185F	MAPK8/Y185F	MUTAGEN	Y->F: Phosphorylation blocked.	ECO:0000269|PubMed:7839144	7839144

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P45984	MAPK9	V13M	P45984/V13M	MAPK9/V13M	VARIANT	V -> M (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P45984	MAPK9	K56N	P45984/K56N	MAPK9/K56N	VARIANT	K -> N (in a head & Neck squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P45984	MAPK9	A246T	P45984/A246T	MAPK9/A246T	VARIANT	A -> T (in dbSNP:rs35421153)	ECO:0000269|PubMed:17344846	17344846
P45984	MAPK9	G268A	P45984/G268A	MAPK9/G268A	VARIANT	G -> A (in dbSNP:rs35693958)	ECO:0000269|Ref.7	
P45984	MAPK9	R366I	P45984/R366I	MAPK9/R366I	VARIANT	R -> I (in dbSNP:rs55736180)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P45985	MAP2K4	S16R	P45985/S16R	MAP2K4/S16R	VARIANT	S -> R (in dbSNP:rs17855590)	ECO:0000269|PubMed:15489334	15489334
P45985	MAP2K4	Q142L	P45985/Q142L	MAP2K4/Q142L	VARIANT	Q -> L (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P45985	MAP2K4	R154W	P45985/R154W	MAP2K4/R154W	VARIANT	R -> W (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs1567657403)	ECO:0000269|PubMed:17344846	17344846
P45985	MAP2K4	N234I	P45985/N234I	MAP2K4/N234I	VARIANT	N -> I (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P45985	MAP2K4	S251N	P45985/S251N	MAP2K4/S251N	VARIANT	S -> N (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P45985	MAP2K4	A279T	P45985/A279T	MAP2K4/A279T	VARIANT	A -> T (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs753665559)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P46734	MAP2K3	R26T	P46734/R26T	MAP2K3/R26T	VARIANT	R -> T	ECO:0000269|PubMed:17344846	17344846
P46734	MAP2K3	P40T	P46734/P40T	MAP2K3/P40T	VARIANT	P -> T (in dbSNP:rs33911218)		
P46734	MAP2K3	R55T	P46734/R55T	MAP2K3/R55T	VARIANT	R -> T (in dbSNP:rs36047035)		
P46734	MAP2K3	S68P	P46734/S68P	MAP2K3/S68P	VARIANT	S -> P (in dbSNP:rs34105301)	ECO:0000269|PubMed:17344846	17344846
P46734	MAP2K3	A84T	P46734/A84T	MAP2K3/A84T	VARIANT	A -> T (in dbSNP:rs2305873)	ECO:0000269|PubMed:17344846	17344846
P46734	MAP2K3	M90I	P46734/M90I	MAP2K3/M90I	VARIANT	M -> I (in dbSNP:rs36076766)	ECO:0000269|PubMed:17344846	17344846
P46734	MAP2K3	R94L	P46734/R94L	MAP2K3/R94L	VARIANT	R -> L (in dbSNP:rs56067280)	ECO:0000269|PubMed:17344846	17344846
P46734	MAP2K3	R96W	P46734/R96W	MAP2K3/R96W	VARIANT	R -> W (in dbSNP:rs56216806)	ECO:0000269|PubMed:17344846	17344846
P46734	MAP2K3	R175W	P46734/R175W	MAP2K3/R175W	VARIANT	R -> W (in colon cancer; dbSNP:rs1339756947)	ECO:0000269|PubMed:11414763	11414763
P46734	MAP2K3	L215V	P46734/L215V	MAP2K3/L215V	VARIANT	L -> V (in colon cancer; dbSNP:rs989026404)	ECO:0000269|PubMed:11414763	11414763
P46734	MAP2K3	R293H	P46734/R293H	MAP2K3/R293H	VARIANT	R -> H (in dbSNP:rs35206134)	ECO:0000269|PubMed:17344846	17344846
P46734	MAP2K3	V339M	P46734/V339M	MAP2K3/V339M	VARIANT	V -> M (in dbSNP:rs2363198)	ECO:0000269|PubMed:17344846	17344846
P46734	MAP2K3	S218A	P46734/S218A	MAP2K3/S218A	MUTAGEN	S->A: Inactivation.	ECO:0000269|PubMed:8622669	8622669
P46734	MAP2K3	S218E	P46734/S218E	MAP2K3/S218E	MUTAGEN	S->E: Constitutive activation.	ECO:0000269|PubMed:8622669	8622669
P46734	MAP2K3	T222A	P46734/T222A	MAP2K3/T222A	MUTAGEN	T->A: Inactivation.	ECO:0000269|PubMed:8622669	8622669
P46734	MAP2K3	T222E	P46734/T222E	MAP2K3/T222E	MUTAGEN	T->E: Constitutive activation.	ECO:0000269|PubMed:8622669	8622669

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P48729	CSNK1A1	D297H	P48729/D297H	CSNK1A1/D297H	VARIANT	D -> H (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P48730	CSNK1D	T44A	P48730/T44A	CSNK1D/T44A	VARIANT	T -> A (in FASPS2; strongly reduces kinase activity; dbSNP:rs104894561)	ECO:0000269|PubMed:15800623, ECO:0000269|PubMed:23636092	15800623,23636092
P48730	CSNK1D	H46R	P48730/H46R	CSNK1D/H46R	VARIANT	H -> R (in FASPS2; strongly reduces kinase activity; dbSNP:rs397514693)	ECO:0000269|PubMed:23636092	23636092
P48730	CSNK1D	S97C	P48730/S97C	CSNK1D/S97C	VARIANT	S -> C (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17344846	16959974,17344846
P48730	CSNK1D	P401A	P48730/P401A	CSNK1D/P401A	VARIANT	P -> A (in dbSNP:rs56124628)	ECO:0000269|PubMed:17344846	17344846
P48730	CSNK1D	K38M	P48730/K38M	CSNK1D/K38M	MUTAGEN	K->M: Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus.	ECO:0000269|PubMed:11161704	11161704
P48730	CSNK1D	T176I	P48730/T176I	CSNK1D/T176I	MUTAGEN	T->I: Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus.	ECO:0000269|PubMed:11161704	11161704

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P49137	MAPKAPK2	A173G	P49137/A173G	MAPKAPK2/A173G	VARIANT	A -> G (in dbSNP:rs35671930)	ECO:0000269|PubMed:17344846	17344846
P49137	MAPKAPK2	A361S	P49137/A361S	MAPKAPK2/A361S	VARIANT	A -> S (in dbSNP:rs55894011)	ECO:0000269|PubMed:17344846	17344846
P49137	MAPKAPK2	K93R	P49137/K93R	MAPKAPK2/K93R	MUTAGEN	K->R: Kinase defective mutant, abolishes activity.	ECO:0000269|PubMed:14517288	14517288
P49137	MAPKAPK2	D207A	P49137/D207A	MAPKAPK2/D207A	MUTAGEN	D->A: Kinase defective mutant, abolishes activity.	ECO:0000269|PubMed:8846784	8846784
P49137	MAPKAPK2	T222A	P49137/T222A	MAPKAPK2/T222A	MUTAGEN	T->A: Strong decrease in kinase activity.	ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:8846784	14517288,15014438,8846784
P49137	MAPKAPK2	T222D	P49137/T222D	MAPKAPK2/T222D	MUTAGEN	T->D: Mimicks phosphorylation state, leading to slight increase of basal kinase activity.	ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:8846784	14517288,15014438,8846784
P49137	MAPKAPK2	T222E	P49137/T222E	MAPKAPK2/T222E	MUTAGEN	T->E: Mimicks phosphorylation state and constitutive protein kinase activity; when associated with E-334.	ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:8846784	14517288,15014438,8846784
P49137	MAPKAPK2	S272A	P49137/S272A	MAPKAPK2/S272A	MUTAGEN	S->A: Strong decrease in kinase activity.	ECO:0000269|PubMed:8846784	8846784
P49137	MAPKAPK2	S272D	P49137/S272D	MAPKAPK2/S272D	MUTAGEN	S->D: Mimicks phosphorylation state, leading to slight increase of basal kinase activity.	ECO:0000269|PubMed:8846784	8846784
P49137	MAPKAPK2	T334A	P49137/T334A	MAPKAPK2/T334A	MUTAGEN	T->A: Slight decrease in kinase activity.	ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:8846784	14517288,15014438,8846784
P49137	MAPKAPK2	T334D	P49137/T334D	MAPKAPK2/T334D	MUTAGEN			
P49137	MAPKAPK2	T334E	P49137/T334E	MAPKAPK2/T334E	MUTAGEN	T->E: Mimicks phosphorylation state and constitutive protein kinase activity; when associated with E-222.	ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:8846784	14517288,15014438,8846784
P49137	MAPKAPK2	K353R	P49137/K353R	MAPKAPK2/K353R	MUTAGEN	K->R: Induces decreased sumoylation and increase in protein kinase activity.	ECO:0000269|PubMed:21131586	21131586

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P49336	CDK8	V27L	P49336/V27L	CDK8/V27L	VARIANT	V -> L (in IDDHBA; decreased protein kinase activity)	ECO:0000269|PubMed:30905399	30905399
P49336	CDK8	R29G	P49336/R29G	CDK8/R29G	VARIANT	R -> G (in IDDHBA; decreased protein kinase activity; dbSNP:rs1593218885)	ECO:0000269|PubMed:30905399	30905399
P49336	CDK8	G30S	P49336/G30S	CDK8/G30S	VARIANT	G -> S (in IDDHBA; decreased protein kinase activity; dbSNP:rs1593218890)	ECO:0000269|PubMed:30905399	30905399
P49336	CDK8	S62L	P49336/S62L	CDK8/S62L	VARIANT	S -> L (in IDDHBA; decreased protein kinase activity; dbSNP:rs1565977796)	ECO:0000269|PubMed:30905399	30905399
P49336	CDK8	F97L	P49336/F97L	CDK8/F97L	VARIANT	F -> L (in IDDHBA; unknown pathological significance)	ECO:0000269|PubMed:30905399	30905399
P49336	CDK8	R178Q	P49336/R178Q	CDK8/R178Q	VARIANT	R -> Q (in IDDHBA; decreased protein kinase activity; dbSNP:rs1418353379)	ECO:0000269|PubMed:30905399	30905399
P49336	CDK8	D189N	P49336/D189N	CDK8/D189N	VARIANT	D -> N (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P49336	CDK8	V193G	P49336/V193G	CDK8/V193G	VARIANT	V -> G (in IDDHBA; decreased protein kinase activity; dbSNP:rs1875421510)	ECO:0000269|PubMed:30905399	30905399
P49336	CDK8	I223M	P49336/I223M	CDK8/I223M	VARIANT	I -> M (in IDDHBA; decreased protein kinase activity; dbSNP:rs1593310364)	ECO:0000269|PubMed:30905399	30905399
P49336	CDK8	R424C	P49336/R424C	CDK8/R424C	VARIANT	R -> C (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P49336	CDK8	D173A	P49336/D173A	CDK8/D173A	MUTAGEN	D->A: Abrogates kinase activity and TFIIH-dependent transcriptional repression.	ECO:0000269|PubMed:10993082, ECO:0000269|PubMed:30905399	10993082,30905399

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P49674	CSNK1E	R256L	P49674/R256L	CSNK1E/R256L	VARIANT	R -> L (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P49674	CSNK1E	H413R	P49674/H413R	CSNK1E/H413R	VARIANT	H -> R (in dbSNP:rs35665927)	ECO:0000269|PubMed:17344846	17344846
P49674	CSNK1E	K38R	P49674/K38R	CSNK1E/K38R	MUTAGEN	K->R: Loss of kinase activity.	ECO:0000269|PubMed:29222110	29222110

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P49759	CLK1	S61F	P49759/S61F	CLK1/S61F	VARIANT	S -> F (in dbSNP:rs55989135)	ECO:0000269|PubMed:17344846	17344846
P49759	CLK1	N99D	P49759/N99D	CLK1/N99D	VARIANT	N -> D (in dbSNP:rs6735666)		
P49759	CLK1	R118G	P49759/R118G	CLK1/R118G	VARIANT	R -> G (in dbSNP:rs56135616)	ECO:0000269|PubMed:17344846	17344846
P49759	CLK1	P307S	P49759/P307S	CLK1/P307S	VARIANT	P -> S (in dbSNP:rs35412475)	ECO:0000269|PubMed:17344846	17344846
P49759	CLK1	M440T	P49759/M440T	CLK1/M440T	VARIANT	M -> T (in dbSNP:rs35393352)	ECO:0000269|PubMed:17344846	17344846
P49759	CLK1	E459G	P49759/E459G	CLK1/E459G	VARIANT	E -> G (in dbSNP:rs12709)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P49761	CLK3	R486C	P49761/R486C	CLK3/R486C	VARIANT	R -> C (in dbSNP:rs975796055)	ECO:0000269|PubMed:17344846	17344846
P49761	CLK3	Q607R	P49761/Q607R	CLK3/Q607R	VARIANT	Q -> R (in dbSNP:rs910378995)	ECO:0000269|PubMed:17344846	17344846
P49761	CLK3	R628W	P49761/R628W	CLK3/R628W	VARIANT	R -> W (in dbSNP:rs920443187)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P49840	GSK3A	Q109E	P49840/Q109E	GSK3A/Q109E	VARIANT	Q -> E (in dbSNP:rs35978177)		
P49840	GSK3A	L461F	P49840/L461F	GSK3A/L461F	VARIANT	L -> F (in dbSNP:rs35454502)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P49841	GSK3B	S9A	P49841/S9A	GSK3B/S9A	MUTAGEN	S->A: Loss of phosphorylation; abolished inhibition of activity, leading to constitutively active.	ECO:0000269|PubMed:17050006, ECO:0000269|PubMed:28992046, ECO:0000269|PubMed:7980435	17050006,28992046,7980435
P49841	GSK3B	R96A	P49841/R96A	GSK3B/R96A	MUTAGEN	R->A: Prevents the phosphorylation of phosphate-primed glycogen synthase.	ECO:0000269|PubMed:11430833	11430833
P49841	GSK3B	L128A	P49841/L128A	GSK3B/L128A	MUTAGEN	L->A: Abolishes activity toward AXIN1.	ECO:0000269|PubMed:11430833	11430833

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P49842	STK19	A39D	P49842/A39D	STK19/A39D	VARIANT	A -> D (in dbSNP:rs34843142)		
P49842	STK19	D89N	P49842/D89N	STK19/D89N	VARIANT	D -> N (recurrent gain-of-function variant found in metastatic melanoma; promotes NRAS signaling; somatic mutation; dbSNP:rs267600971)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:30712867	17344846,30712867
P49842	STK19	S311G	P49842/S311G	STK19/S311G	VARIANT	S -> G (in dbSNP:rs616634)	ECO:0000269|PubMed:14574404, ECO:0000269|PubMed:17344846	14574404,17344846
P49842	STK19	A331V	P49842/A331V	STK19/A331V	VARIANT	A -> V (in dbSNP:rs7743647)	ECO:0000269|PubMed:17344846	17344846
P49842	STK19	V134Y	P49842/V134Y	STK19/V134Y	MUTAGEN	V->Y: Prevents inhibition by ZT-12-037-01 (1a) without affecting much the serine/threonine-protein kinase activity.	ECO:0000269|PubMed:30712867	30712867
P49842	STK19	L139V	P49842/L139V	STK19/L139V	MUTAGEN	L->V: Prevents inhibition by ZT-12-037-01 (1a) without affecting much the serine/threonine-protein kinase activity.	ECO:0000269|PubMed:30712867	30712867
P49842	STK19	K300P	P49842/K300P	STK19/K300P	MUTAGEN	K->P: Partial loss of activity.	ECO:0000269|PubMed:9812991	9812991
P49842	STK19	K315P	P49842/K315P	STK19/K315P	MUTAGEN	K->P: Partial loss of activity.	ECO:0000269|PubMed:9812991	9812991
P49842	STK19	K317P	P49842/K317P	STK19/K317P	MUTAGEN	K->P: Complete loss of activity.	ECO:0000269|PubMed:9812991	9812991

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P50613	CDK7	G163A	P50613/G163A	CDK7/G163A	VARIANT	G -> A	ECO:0000269|Ref.6	
P50613	CDK7	T285M	P50613/T285M	CDK7/T285M	VARIANT	T -> M (in dbSNP:rs34584424)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.6	17344846
P50613	CDK7	K41A	P50613/K41A	CDK7/K41A	MUTAGEN	K->A: Total loss of activity.		
P50613	CDK7	K41M	P50613/K41M	CDK7/K41M	MUTAGEN	K->M: No effect on interaction with HINT1.	ECO:0000269|PubMed:10958787	10958787
P50613	CDK7	F91G	P50613/F91G	CDK7/F91G	MUTAGEN	F->G: Enhanced capacity to bind ATP analogs.	ECO:0000269|PubMed:16327805	16327805
P50613	CDK7	S164A	P50613/S164A	CDK7/S164A	MUTAGEN	S->A: No mitotic repression of transcriptional activity of the reconstituted TFIIH complex.	ECO:0000269|PubMed:9832506	9832506
P50613	CDK7	T170A	P50613/T170A	CDK7/T170A	MUTAGEN	T->A: Total loss of activity. Total loss of transcriptional activity of the reconstituted TFIIH complex.	ECO:0000269|PubMed:8069918, ECO:0000269|PubMed:9832506	8069918,9832506
P50613	CDK7	T170E	P50613/T170E	CDK7/T170E	MUTAGEN	T->E: No effect on interaction with HINT1.	ECO:0000269|PubMed:10958787	10958787

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P50750	CDK9	F59L	P50750/F59L	CDK9/F59L	VARIANT	F -> L (in dbSNP:rs55640715)	ECO:0000269|PubMed:17344846	17344846
P50750	CDK9	R225C	P50750/R225C	CDK9/R225C	VARIANT	R -> C (found in patients with global developmental delay and epilepsy with history of choanal atresia; unknown pathological significance; dbSNP:rs767418586)	ECO:0000269|PubMed:30237576	30237576
P50750	CDK9	G231A	P50750/G231A	CDK9/G231A	VARIANT	G -> A	ECO:0000269|PubMed:10903437, ECO:0000269|PubMed:7695608	10903437,7695608
P50750	CDK9	K44R	P50750/K44R	CDK9/K44R	MUTAGEN	K->R: Impaired kinase and transcriptional elongation activities, but normal cyclin T1 and HEXIM1 binding.	ECO:0000269|PubMed:17452463	17452463
P50750	CDK9	K48Q	P50750/K48Q	CDK9/K48Q	MUTAGEN	K->Q: Mimics acetylation; leading to impaired protein kinase activity.	ECO:0000269|PubMed:28426094	28426094
P50750	CDK9	K48R	P50750/K48R	CDK9/K48R	MUTAGEN	K->R: Decreased acetylation; leading to enhanced protein kinase activity.	ECO:0000269|PubMed:28426094	28426094
P50750	CDK9	D167N	P50750/D167N	CDK9/D167N	MUTAGEN	D->N: Abrogates kinase activity.	ECO:0000269|PubMed:10958691, ECO:0000269|PubMed:11145967	10958691,11145967
P50750	CDK9	S175A	P50750/S175A	CDK9/S175A	MUTAGEN	S->A: Constitutive kinase activity.	ECO:0000269|PubMed:21533037	21533037
P50750	CDK9	S175D	P50750/S175D	CDK9/S175D	MUTAGEN	S->D: Mimics phosphorylation, constitutive loss of kinase activity.	ECO:0000269|PubMed:21533037	21533037
P50750	CDK9	T186A	P50750/T186A	CDK9/T186A	MUTAGEN	T->A: Abrogates autophosphorylation; no effect on kinase activity, but impaired CTD phosphorylation.	ECO:0000269|PubMed:11145967, ECO:0000269|PubMed:18566585, ECO:0000269|PubMed:21448926	11145967,18566585,21448926
P50750	CDK9	T186D	P50750/T186D	CDK9/T186D	MUTAGEN	T->D: Mimics autophosphorylation; constitutive kinase activity, independently of calcium signaling.	ECO:0000269|PubMed:11145967, ECO:0000269|PubMed:18566585, ECO:0000269|PubMed:21448926	11145967,18566585,21448926

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P51451	BLK	T48I	P51451/T48I	BLK/T48I	VARIANT	T -> I (in dbSNP:rs35339715)	ECO:0000269|PubMed:17344846	17344846
P51451	BLK	A71T	P51451/A71T	BLK/A71T	VARIANT	A -> T (associated with MODY11; reduces the enhancing effect of BLK on insulin secretion; reduces the inducing effect of BLK on the expression of PDX1 and NKX6-1; found as somatic mutation in a colorectal adenocarcinoma sample; dbSNP:rs55758736)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19667185	17344846,19667185

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P51617	IRAK1	R194H	P51617/R194H	IRAK1/R194H	VARIANT	R -> H (in dbSNP:rs11465830)		
P51617	IRAK1	F196S	P51617/F196S	IRAK1/F196S	VARIANT	F -> S (in dbSNP:rs1059702)	ECO:0000269|PubMed:8599092	8599092
P51617	IRAK1	C203S	P51617/C203S	IRAK1/C203S	VARIANT	C -> S (in dbSNP:rs10127175)		
P51617	IRAK1	T398M	P51617/T398M	IRAK1/T398M	VARIANT	T -> M (in dbSNP:rs56340948)	ECO:0000269|PubMed:17344846	17344846
P51617	IRAK1	V412M	P51617/V412M	IRAK1/V412M	VARIANT	V -> M (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P51617	IRAK1	Q421H	P51617/Q421H	IRAK1/Q421H	VARIANT	Q -> H (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P51617	IRAK1	S532L	P51617/S532L	IRAK1/S532L	VARIANT	S -> L (in dbSNP:rs1059703)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8599092	17344846,8599092
P51617	IRAK1	G619S	P51617/G619S	IRAK1/G619S	VARIANT	G -> S (in dbSNP:rs34112487)	ECO:0000269|PubMed:17344846	17344846
P51617	IRAK1	T625M	P51617/T625M	IRAK1/T625M	VARIANT	T -> M (in dbSNP:rs35638718)	ECO:0000269|PubMed:17344846	17344846
P51617	IRAK1	R638W	P51617/R638W	IRAK1/R638W	VARIANT	R -> W (in dbSNP:rs56082801)	ECO:0000269|PubMed:17344846	17344846
P51617	IRAK1	S690G	P51617/S690G	IRAK1/S690G	VARIANT	S -> G (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P51617	IRAK1	T209A	P51617/T209A	IRAK1/T209A	MUTAGEN	T->A: Completely abolishes auto-phosphorylation in the kinase domain.	ECO:0000269|PubMed:14625308	14625308
P51617	IRAK1	K239S	P51617/K239S	IRAK1/K239S	MUTAGEN	K->S: Loss of kinase activity.	ECO:0000269|PubMed:15084582	15084582
P51617	IRAK1	D340N	P51617/D340N	IRAK1/D340N	MUTAGEN	D->N: Loss of kinase activity.	ECO:0000269|PubMed:18691762	18691762
P51617	IRAK1	T387A	P51617/T387A	IRAK1/T387A	MUTAGEN	T->A: Loss of kinase activity.	ECO:0000269|PubMed:14625308	14625308

Error: P51812 RPS6KA3 'NoneType' object has no attribute 'group' FT                   /note="Missing (in XLID19; dbSNP:rs398122813)"

Error: P51812 RPS6KA3 'NoneType' object has no attribute 'group' FT                   /note="Missing (in XLID19)"

Error: P51812 RPS6KA3 'NoneType' object has no attribute 'group' FT                   /note="Missing (in CLS)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P51812	RPS6KA3	I38S	P51812/I38S	RPS6KA3/I38S	VARIANT	I -> S (in dbSNP:rs56218010)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9837815	17344846,9837815
P51812	RPS6KA3	G75V	P51812/G75V	RPS6KA3/G75V	VARIANT	G -> V (in CLS; dbSNP:rs122454124)	ECO:0000269|PubMed:8955270	8955270
P51812	RPS6KA3	V82F	P51812/V82F	RPS6KA3/V82F	VARIANT	V -> F (in CLS; dbSNP:rs122454126)	ECO:0000269|PubMed:9837815	9837815
P51812	RPS6KA3	R114W	P51812/R114W	RPS6KA3/R114W	VARIANT	R -> W (in CLS; dbSNP:rs122454127)	ECO:0000269|PubMed:10094187	10094187
P51812	RPS6KA3	T115S	P51812/T115S	RPS6KA3/T115S	VARIANT	T -> S (in XLID19; dbSNP:rs387906703)	ECO:0000269|PubMed:17100996	17100996
P51812	RPS6KA3	H127Q	P51812/H127Q	RPS6KA3/H127Q	VARIANT	H -> Q (in CLS)	ECO:0000269|PubMed:9837815	9837815
P51812	RPS6KA3	D154Y	P51812/D154Y	RPS6KA3/D154Y	VARIANT	D -> Y (in CLS)	ECO:0000269|PubMed:9837815	9837815
P51812	RPS6KA3	I189K	P51812/I189K	RPS6KA3/I189K	VARIANT	I -> K (in CLS; dbSNP:rs122454130)	ECO:0000269|PubMed:10528858	10528858
P51812	RPS6KA3	A225V	P51812/A225V	RPS6KA3/A225V	VARIANT	A -> V (in CLS; dbSNP:rs879027948)	ECO:0000269|PubMed:9837815	9837815
P51812	RPS6KA3	S227A	P51812/S227A	RPS6KA3/S227A	VARIANT	S -> A (in CLS; dbSNP:rs122454125)	ECO:0000269|PubMed:8955270	8955270
P51812	RPS6KA3	F268S	P51812/F268S	RPS6KA3/F268S	VARIANT	F -> S (in CLS; dbSNP:rs122454131)	ECO:0000269|PubMed:14986828	14986828
P51812	RPS6KA3	R383W	P51812/R383W	RPS6KA3/R383W	VARIANT	R -> W (in XLID19; kinase activity is decreased but not abolished; dbSNP:rs122454129)	ECO:0000269|PubMed:10319851	10319851
P51812	RPS6KA3	I416V	P51812/I416V	RPS6KA3/I416V	VARIANT	I -> V (in a breast cancer sample; somatic mutation; dbSNP:rs148050184)	ECO:0000269|PubMed:16959974	16959974
P51812	RPS6KA3	G431D	P51812/G431D	RPS6KA3/G431D	VARIANT	G -> D (in CLS)	ECO:0000269|PubMed:9837815	9837815
P51812	RPS6KA3	Y483C	P51812/Y483C	RPS6KA3/Y483C	VARIANT	Y -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1271090915)	ECO:0000269|PubMed:17344846	17344846
P51812	RPS6KA3	L608F	P51812/L608F	RPS6KA3/L608F	VARIANT	L -> F (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P51812	RPS6KA3	R723C	P51812/R723C	RPS6KA3/R723C	VARIANT	R -> C (in dbSNP:rs35026425)	ECO:0000269|PubMed:17344846	17344846
P51812	RPS6KA3	R729Q	P51812/R729Q	RPS6KA3/R729Q	VARIANT	R -> Q (in CLS; dbSNP:rs28935171)	ECO:0000269|PubMed:10094187	10094187

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P51813	BMX	S284L	P51813/S284L	BMX/S284L	VARIANT	S -> L (in dbSNP:rs35353387)	ECO:0000269|PubMed:17344846	17344846
P51813	BMX	R670W	P51813/R670W	BMX/R670W	VARIANT	R -> W (in a lung large cell carcinoma sample; somatic mutation; dbSNP:rs1029888196)	ECO:0000269|PubMed:17344846	17344846
P51813	BMX	Y566F	P51813/Y566F	BMX/Y566F	MUTAGEN	Y->F: Abolishes almost completely the SRC-induced phosphorylation of BMX.	ECO:0000269|PubMed:10688651	10688651

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P51817	PRKX	V43A	P51817/V43A	PRKX/V43A	VARIANT	V -> A (in dbSNP:rs3752362)		
P51817	PRKX	K78R	P51817/K78R	PRKX/K78R	MUTAGEN	K->R: Loss of function.	ECO:0000269|PubMed:12082174	12082174
P51817	PRKX	H93Q	P51817/H93Q	PRKX/H93Q	MUTAGEN	H->Q: Constitutive kinase activity; when associated with R-202.	ECO:0000269|PubMed:16236808	16236808
P51817	PRKX	W202R	P51817/W202R	PRKX/W202R	MUTAGEN	W->R: Constitutive kinase activity; when associated with Q-93.	ECO:0000269|PubMed:16236808	16236808
P51817	PRKX	R283L	P51817/R283L	PRKX/R283L	MUTAGEN	R->L: Increases the affinity for PRKAR2A and PRKAR2B.	ECO:0000269|PubMed:20819953	20819953

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P51841	GUCY2F	R10P	P51841/R10P	GUCY2F/R10P	VARIANT	R -> P (in a breast cancer sample; somatic mutation; dbSNP:rs755991142)	ECO:0000269|PubMed:16959974	16959974
P51841	GUCY2F	S40C	P51841/S40C	GUCY2F/S40C	VARIANT	S -> C (in dbSNP:rs34228145)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	I160N	P51841/I160N	GUCY2F/I160N	VARIANT	I -> N (in dbSNP:rs33971675)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	R230W	P51841/R230W	GUCY2F/R230W	VARIANT	R -> W (in dbSNP:rs33973457)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	L284P	P51841/L284P	GUCY2F/L284P	VARIANT	L -> P (in dbSNP:rs12008095)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	R296Q	P51841/R296Q	GUCY2F/R296Q	VARIANT	R -> Q (in dbSNP:rs502209)	ECO:0000269|PubMed:7777544	7777544
P51841	GUCY2F	R305Q	P51841/R305Q	GUCY2F/R305Q	VARIANT	R -> Q (in dbSNP:rs55966326)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	Y308C	P51841/Y308C	GUCY2F/Y308C	VARIANT	Y -> C (in dbSNP:rs16985750)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	Q380H	P51841/Q380H	GUCY2F/Q380H	VARIANT	Q -> H (in dbSNP:rs2272925)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	G434R	P51841/G434R	GUCY2F/G434R	VARIANT	G -> R (in dbSNP:rs56293008)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	G568D	P51841/G568D	GUCY2F/G568D	VARIANT	G -> D (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs779221554)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	R628Q	P51841/R628Q	GUCY2F/R628Q	VARIANT	R -> Q (in dbSNP:rs7883913)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	V677L	P51841/V677L	GUCY2F/V677L	VARIANT	V -> L (in dbSNP:rs35474112)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	E794K	P51841/E794K	GUCY2F/E794K	VARIANT	E -> K (in dbSNP:rs35726803)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	G872D	P51841/G872D	GUCY2F/G872D	VARIANT	G -> D (in dbSNP:rs148663380)	ECO:0000269|PubMed:23033978	23033978
P51841	GUCY2F	A1010V	P51841/A1010V	GUCY2F/A1010V	VARIANT	A -> V (in dbSNP:rs55735218)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	K1052R	P51841/K1052R	GUCY2F/K1052R	VARIANT	K -> R (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P51841	GUCY2F	E1055D	P51841/E1055D	GUCY2F/E1055D	VARIANT	E -> D (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P51955	NEK2	N354S	P51955/N354S	NEK2/N354S	VARIANT	N -> S (in dbSNP:rs2230489)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5	17344846
P51955	NEK2	C410Y	P51955/C410Y	NEK2/C410Y	VARIANT	C -> Y (in dbSNP:rs56102977)	ECO:0000269|PubMed:17344846	17344846
P51955	NEK2	K37R	P51955/K37R	NEK2/K37R	MUTAGEN	K->R: Loss of kinase activity and of ability to activate NEK11. Loss of phosphorylation of CCDC102B.	ECO:0000269|PubMed:15161910, ECO:0000269|PubMed:17197699, ECO:0000269|PubMed:30404835	15161910,17197699,30404835
P51955	NEK2	D141A	P51955/D141A	NEK2/D141A	MUTAGEN	D->A: Loss of autophosphorylation.	ECO:0000269|PubMed:17197699	17197699
P51955	NEK2	T170A	P51955/T170A	NEK2/T170A	MUTAGEN	T->A: No effect on kinase activity.	ECO:0000269|PubMed:17197699	17197699
P51955	NEK2	T170E	P51955/T170E	NEK2/T170E	MUTAGEN	T->E: Kinase activity increased by two fold.	ECO:0000269|PubMed:17197699	17197699
P51955	NEK2	S171A	P51955/S171A	NEK2/S171A	MUTAGEN	S->A: No effect on kinase activity.	ECO:0000269|PubMed:17197699	17197699
P51955	NEK2	S171D	P51955/S171D	NEK2/S171D	MUTAGEN	S->D: Kinase activity increased by two fold.	ECO:0000269|PubMed:17197699	17197699
P51955	NEK2	T175A	P51955/T175A	NEK2/T175A	MUTAGEN	T->A: Kinase activity decreased by two fold.	ECO:0000269|PubMed:17197699	17197699
P51955	NEK2	T175E	P51955/T175E	NEK2/T175E	MUTAGEN	T->E: Kinase activity increased by two fold.	ECO:0000269|PubMed:17197699	17197699
P51955	NEK2	T179A	P51955/T179A	NEK2/T179A	MUTAGEN	T->A: Loss of kinase activity.	ECO:0000269|PubMed:17197699	17197699
P51955	NEK2	T179E	P51955/T179E	NEK2/T179E	MUTAGEN	T->E: Loss of kinase activity.	ECO:0000269|PubMed:17197699	17197699
P51955	NEK2	S241A	P51955/S241A	NEK2/S241A	MUTAGEN	S->A: Loss of kinase activity.	ECO:0000269|PubMed:17197699	17197699
P51955	NEK2	S241D	P51955/S241D	NEK2/S241D	MUTAGEN	S->D: Loss of kinase activity.	ECO:0000269|PubMed:17197699	17197699

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P51956	NEK3	H23L	P51956/H23L	NEK3/H23L	VARIANT	H -> L (in dbSNP:rs17482764)	ECO:0000269|PubMed:17344846	17344846
P51956	NEK3	P60R	P51956/P60R	NEK3/P60R	VARIANT	P -> R (in dbSNP:rs55946204)	ECO:0000269|PubMed:17344846	17344846
P51956	NEK3	R122H	P51956/R122H	NEK3/R122H	VARIANT	R -> H (in dbSNP:rs56190615)	ECO:0000269|PubMed:17344846	17344846
P51956	NEK3	P170L	P51956/P170L	NEK3/P170L	VARIANT	P -> L (in dbSNP:rs56021040)	ECO:0000269|PubMed:17344846	17344846
P51956	NEK3	R259G	P51956/R259G	NEK3/R259G	VARIANT	R -> G (in dbSNP:rs34077016)	ECO:0000269|PubMed:17344846	17344846
P51956	NEK3	E305D	P51956/E305D	NEK3/E305D	VARIANT	E -> D (in dbSNP:rs55969405)	ECO:0000269|PubMed:17344846	17344846
P51956	NEK3	D461N	P51956/D461N	NEK3/D461N	VARIANT	D -> N (in dbSNP:rs34076988)	ECO:0000269|PubMed:17344846	17344846
P51956	NEK3	E477K	P51956/E477K	NEK3/E477K	VARIANT	E -> K (in dbSNP:rs34488913)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P51957	NEK4	P225A	P51957/P225A	NEK4/P225A	VARIANT	P -> A (in dbSNP:rs1029871)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8208544, ECO:0000269|Ref.2	15489334,17344846,8208544
P51957	NEK4	R239G	P51957/R239G	NEK4/R239G	VARIANT	R -> G (in dbSNP:rs35778416)	ECO:0000269|PubMed:17344846	17344846
P51957	NEK4	P250L	P51957/P250L	NEK4/P250L	VARIANT	P -> L (in dbSNP:rs56408749)	ECO:0000269|PubMed:17344846	17344846
P51957	NEK4	T357I	P51957/T357I	NEK4/T357I	VARIANT	T -> I (in dbSNP:rs2230537)	ECO:0000269|PubMed:17344846	17344846
P51957	NEK4	Q456E	P51957/Q456E	NEK4/Q456E	VARIANT	Q -> E (in dbSNP:rs56019351)	ECO:0000269|PubMed:17344846	17344846
P51957	NEK4	F567L	P51957/F567L	NEK4/F567L	VARIANT	F -> L (in dbSNP:rs34986855)	ECO:0000269|PubMed:17344846	17344846
P51957	NEK4	R777K	P51957/R777K	NEK4/R777K	VARIANT	R -> K (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

Error: P52333 JAK3 'NoneType' object has no attribute 'group' FT                   /note="Missing (in T(-)B(+)NK(-) SCID)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P52333	JAK3	P12L	P52333/P12L	JAK3/P12L	VARIANT	P -> L (in dbSNP:rs56061056)	ECO:0000269|PubMed:17344846	17344846
P52333	JAK3	R40H	P52333/R40H	JAK3/R40H	VARIANT	R -> H (in dbSNP:rs56384680)	ECO:0000269|PubMed:17344846	17344846
P52333	JAK3	Y100C	P52333/Y100C	JAK3/Y100C	VARIANT	Y -> C (in T(-)B(+)NK(-) SCID; dbSNP:rs137852624)	ECO:0000269|PubMed:7659163	7659163
P52333	JAK3	P132T	P52333/P132T	JAK3/P132T	VARIANT	P -> T (in dbSNP:rs3212723)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
P52333	JAK3	P151R	P52333/P151R	JAK3/P151R	VARIANT	P -> R (in T(-)B(+)NK(-) SCID; likely benign variant; dbSNP:rs55778349)	ECO:0000269|PubMed:10982185, ECO:0000269|PubMed:17344846	10982185,17344846
P52333	JAK3	D169E	P52333/D169E	JAK3/D169E	VARIANT	D -> E (in T(-)B(+)NK(-) SCID; dbSNP:rs147181709)	ECO:0000269|PubMed:14615376	14615376
P52333	JAK3	E481G	P52333/E481G	JAK3/E481G	VARIANT	E -> G (in T(-)B(+)NK(-) SCID)	ECO:0000269|PubMed:9354668	9354668
P52333	JAK3	L521V	P52333/L521V	JAK3/L521V	VARIANT	L -> V (in dbSNP:rs55666418)	ECO:0000269|PubMed:17344846	17344846
P52333	JAK3	L527P	P52333/L527P	JAK3/L527P	VARIANT	L -> P (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P52333	JAK3	R582W	P52333/R582W	JAK3/R582W	VARIANT	R -> W (in T(-)B(+)NK(-) SCID; dbSNP:rs193922361)	ECO:0000269|PubMed:9753072	9753072
P52333	JAK3	G589S	P52333/G589S	JAK3/G589S	VARIANT	G -> S (in T(-)B(+)NK(-) SCID; dbSNP:rs886039394)	ECO:0000269|PubMed:14615376	14615376
P52333	JAK3	I688F	P52333/I688F	JAK3/I688F	VARIANT	I -> F (in dbSNP:rs35785705)	ECO:0000269|PubMed:17344846	17344846
P52333	JAK3	V722I	P52333/V722I	JAK3/V722I	VARIANT	V -> I (in dbSNP:rs3213409)	ECO:0000269|PubMed:10982185, ECO:0000269|PubMed:14615376, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	10982185,14615376,17344846
P52333	JAK3	C759R	P52333/C759R	JAK3/C759R	VARIANT	C -> R (in T(-)B(+)NK(-) SCID; constitutive phosphorylation)	ECO:0000269|PubMed:9354668	9354668
P52333	JAK3	L910S	P52333/L910S	JAK3/L910S	VARIANT	L -> S (in T(-)B(+)NK(-) SCID)	ECO:0000269|PubMed:10982185	10982185
P52333	JAK3	Y785F	P52333/Y785F	JAK3/Y785F	MUTAGEN	Y->F: Strong decrease of JAK3 phosphorylation.	ECO:0000269|PubMed:15121872	15121872
P52333	JAK3	K855A	P52333/K855A	JAK3/K855A	MUTAGEN	K->A: More than 90% loss of STAT5a activation.	ECO:0000269|PubMed:18250158	18250158
P52333	JAK3	Y904F	P52333/Y904F	JAK3/Y904F	MUTAGEN	Y->F: About 40% loss of STAT5a activation.	ECO:0000269|PubMed:18250158	18250158
P52333	JAK3	Y939F	P52333/Y939F	JAK3/Y939F	MUTAGEN	Y->F: About 80% loss of STAT5a activation.	ECO:0000269|PubMed:18250158	18250158

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P52564	MAP2K6	S207A	P52564/S207A	MAP2K6/S207A	MUTAGEN	S->A: Inactivation.		
P52564	MAP2K6	S207E	P52564/S207E	MAP2K6/S207E	MUTAGEN	S->E: Constitutive activation according to PubMed:8622669, but not to PubMed:8621675.		8622669,8621675
P52564	MAP2K6	T211A	P52564/T211A	MAP2K6/T211A	MUTAGEN	T->A: Inactivation.		
P52564	MAP2K6	T211E	P52564/T211E	MAP2K6/T211E	MUTAGEN	T->E: Constitutive activation according to PubMed:8622669, but not to PubMed:8621675.		8622669,8621675

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P53004	BLVRA	A3T	P53004/A3T	BLVRA/A3T	VARIANT	A -> T (in dbSNP:rs699512)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:8950184, ECO:0000269|Ref.4	15489334,8950184
P53004	BLVRA	L37V	P53004/L37V	BLVRA/L37V	VARIANT	L -> V (in dbSNP:rs17245918)	ECO:0000269|Ref.4	
P53004	BLVRA	Q56R	P53004/Q56R	BLVRA/Q56R	VARIANT	Q -> R (in dbSNP:rs1050916)	ECO:0000269|Ref.4	

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P53350	PLK1	R12L	P53350/R12L	PLK1/R12L	VARIANT	R -> L (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P53350	PLK1	L261F	P53350/L261F	PLK1/L261F	VARIANT	L -> F (in dbSNP:rs35056440)	ECO:0000269|PubMed:17344846	17344846
P53350	PLK1	N297D	P53350/N297D	PLK1/N297D	VARIANT	N -> D (in dbSNP:rs16972799)		
P53350	PLK1	L332V	P53350/L332V	PLK1/L332V	VARIANT	L -> V (in dbSNP:rs45489499)	ECO:0000269|PubMed:17344846	17344846
P53350	PLK1	L463H	P53350/L463H	PLK1/L463H	VARIANT	L -> H (in dbSNP:rs45569335)	ECO:0000269|PubMed:17344846	17344846
P53350	PLK1	R518H	P53350/R518H	PLK1/R518H	VARIANT	R -> H (in dbSNP:rs56027600)	ECO:0000269|PubMed:17344846	17344846
P53350	PLK1	S595L	P53350/S595L	PLK1/S595L	VARIANT	S -> L (in dbSNP:rs34001032)		
P53350	PLK1	R599H	P53350/R599H	PLK1/R599H	VARIANT	R -> H (in dbSNP:rs34954545)		
P53350	PLK1	C67V	P53350/C67V	PLK1/C67V	MUTAGEN	C->V: In analog-sensitive mutant; enlarged catalytic pocket to accommodate purine analogs; when associated with G-130.	ECO:0000269|PubMed:19468302	19468302
P53350	PLK1	K82M	P53350/K82M	PLK1/K82M	MUTAGEN	K->M: Loss of kinase activity. No effect on S-phase progression.	ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:12447691, ECO:0000269|PubMed:18174154, ECO:0000269|PubMed:24018379	12207013,12447691,18174154,24018379
P53350	PLK1	K82R	P53350/K82R	PLK1/K82R	MUTAGEN	K->R: Loss of kinase activity. No effect on RIOK2-binding.	ECO:0000269|PubMed:18615013, ECO:0000269|PubMed:19160488, ECO:0000269|PubMed:21880710	18615013,19160488,21880710
P53350	PLK1	L130G	P53350/L130G	PLK1/L130G	MUTAGEN	L->G: In analog-sensitive mutant; enlarged catalytic pocket to accommodate purine analogs; when associated with V-67.	ECO:0000269|PubMed:19468302	19468302
P53350	PLK1	S137A	P53350/S137A	PLK1/S137A	MUTAGEN	S->A: No change in activity. Increases activity and restores recovery after DNA damage checkpoint; when associated with D-210.	ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:18615013	12207013,18615013
P53350	PLK1	S137D	P53350/S137D	PLK1/S137D	MUTAGEN	S->D: Increases activity. Results in a block in G1/S.	ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:18615013	12207013,18615013
P53350	PLK1	D176N	P53350/D176N	PLK1/D176N	MUTAGEN	D->N: Abolishes kinase activity.	ECO:0000269|PubMed:18615013	18615013
P53350	PLK1	D194A	P53350/D194A	PLK1/D194A	MUTAGEN	D->A: Does not interfere with FRY-binding.	ECO:0000269|PubMed:22753416	22753416
P53350	PLK1	T210A	P53350/T210A	PLK1/T210A	MUTAGEN	T->A: Abolishes activity. Abolishes checkpoint recovery.	ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:12447691, ECO:0000269|PubMed:17461553, ECO:0000269|PubMed:18615013, ECO:0000269|PubMed:19160488	12207013,12447691,17461553,18615013,19160488
P53350	PLK1	T210D	P53350/T210D	PLK1/T210D	MUTAGEN	T->D: Increases activity and restores recovery after DNA damage checkpoint.	ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:12447691, ECO:0000269|PubMed:17461553, ECO:0000269|PubMed:18615013, ECO:0000269|PubMed:19160488	12207013,12447691,17461553,18615013,19160488
P53350	PLK1	T210V	P53350/T210V	PLK1/T210V	MUTAGEN	T->V: Reduced catalytic activity, but no effect on affinity for ATP.	ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:12447691, ECO:0000269|PubMed:17461553, ECO:0000269|PubMed:18615013, ECO:0000269|PubMed:19160488	12207013,12447691,17461553,18615013,19160488
P53350	PLK1	R337A	P53350/R337A	PLK1/R337A	MUTAGEN	R->A: Interferes with ubiquitination and subsequent proteasomal degradation in anaphase; when associated with A-340.	ECO:0000269|PubMed:14734534, ECO:0000269|PubMed:18662541	14734534,18662541
P53350	PLK1	L340A	P53350/L340A	PLK1/L340A	MUTAGEN	L->A: Interferes with ubiquitination and subsequent proteasomal degradation in anaphase; when associated with A-337.	ECO:0000269|PubMed:14734534, ECO:0000269|PubMed:18662541	14734534,18662541
P53350	PLK1	W414F	P53350/W414F	PLK1/W414F	MUTAGEN	W->F: No effect on centrosomal localization, nor on S-phase progression; when asscociated with A-427. Loss of centrosomal localization and of S-phase progression; when associated with A- 415 and A-427.	ECO:0000269|PubMed:24018379	24018379
P53350	PLK1	V415A	P53350/V415A	PLK1/V415A	MUTAGEN	V->A: Loss of centrosomal localization and of S-phase progression; when associated with A- 414 and A-427.	ECO:0000269|PubMed:24018379	24018379
P53350	PLK1	L427A	P53350/L427A	PLK1/L427A	MUTAGEN	L->A: No effect on centrosomal localization, nor on S-phase progression; when associated with A-414. Loss of centrosomal localization and of S-phase progression; when associated with A- 414 and A-415.	ECO:0000269|PubMed:24018379	24018379
P53350	PLK1	K492R	P53350/K492R	PLK1/K492R	MUTAGEN	K->R: Severe mitotic defects leading to prometaphase delay. Increased localization at kinetochores leading to increased levels of phosphorylated BUBR1.	ECO:0000269|PubMed:23455478	23455478
P53350	PLK1	H538A	P53350/H538A	PLK1/H538A	MUTAGEN	H->A: In pincer mutant; loss of centrosomal location and decreased interaction with phosphorylated CDC25C and BUB1; when associated with M-540.	ECO:0000269|PubMed:14532005, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:19468302	14532005,16760428,18477460,19468302
P53350	PLK1	K540M	P53350/K540M	PLK1/K540M	MUTAGEN	K->M: In pincer mutant; loss of centrosomal location and decreased interaction with phosphorylated CDC25C and BUB1; when associated with A-538.	ECO:0000269|PubMed:14532005, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:19468302	14532005,16760428,18477460,19468302

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P53355	DAPK1	V416I	P53355/V416I	DAPK1/V416I	VARIANT	V -> I (in dbSNP:rs12343465)	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	A461S	P53355/A461S	DAPK1/A461S	VARIANT	A -> S	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	S519A	P53355/S519A	DAPK1/S519A	VARIANT	S -> A	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	C540Y	P53355/C540Y	DAPK1/C540Y	VARIANT	C -> Y (in dbSNP:rs56327474)	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	P591L	P53355/P591L	DAPK1/P591L	VARIANT	P -> L (in dbSNP:rs36214022)	ECO:0000269|Ref.5	
P53355	DAPK1	I622M	P53355/I622M	DAPK1/I622M	VARIANT	I -> M (in dbSNP:rs36215047)	ECO:0000269|Ref.5	
P53355	DAPK1	M941T	P53355/M941T	DAPK1/M941T	VARIANT	M -> T	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	R977W	P53355/R977W	DAPK1/R977W	VARIANT	R -> W	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	K978N	P53355/K978N	DAPK1/K978N	VARIANT	K -> N	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	Y993C	P53355/Y993C	DAPK1/Y993C	VARIANT	Y -> C	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	D994E	P53355/D994E	DAPK1/D994E	VARIANT	D -> E	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	E1005Q	P53355/E1005Q	DAPK1/E1005Q	VARIANT	E -> Q	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	D1007Y	P53355/D1007Y	DAPK1/D1007Y	VARIANT	D -> Y	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	L1008P	P53355/L1008P	DAPK1/L1008P	VARIANT	L -> P	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	R1010C	P53355/R1010C	DAPK1/R1010C	VARIANT	R -> C (in dbSNP:rs371784492)	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	T1018A	P53355/T1018A	DAPK1/T1018A	VARIANT	T -> A	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	M1272I	P53355/M1272I	DAPK1/M1272I	VARIANT	M -> I (in dbSNP:rs56169226)	ECO:0000269|PubMed:17344846	17344846
P53355	DAPK1	S1346N	P53355/S1346N	DAPK1/S1346N	VARIANT	S -> N (in dbSNP:rs1056719)	ECO:0000269|PubMed:15164053, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:7828849, ECO:0000269|Ref.5	15164053,17344846,17974005,7828849
P53355	DAPK1	G1405V	P53355/G1405V	DAPK1/G1405V	VARIANT	G -> V (in dbSNP:rs36220450)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5	17344846
P53355	DAPK1	K42A	P53355/K42A	DAPK1/K42A	MUTAGEN	K->A: Loss of activity, apoptotic function and of autophosphorylation.	ECO:0000269|PubMed:11579085, ECO:0000269|PubMed:7828849	11579085,7828849
P53355	DAPK1	S289A	P53355/S289A	DAPK1/S289A	MUTAGEN	S->A: Loss of phosphorylation and significant increase in proapoptotic activity.		
P53355	DAPK1	S289E	P53355/S289E	DAPK1/S289E	MUTAGEN	S->E: Reduction in proapoptotic activity.		
P53355	DAPK1	S308A	P53355/S308A	DAPK1/S308A	MUTAGEN	S->A: Elevated Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Increases apoptotic activity.	ECO:0000269|PubMed:11579085	11579085
P53355	DAPK1	S308D	P53355/S308D	DAPK1/S308D	MUTAGEN	S->D: Reduced Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Decreases apoptotic activity.	ECO:0000269|PubMed:11579085	11579085
P53355	DAPK1	S313A	P53355/S313A	DAPK1/S313A	MUTAGEN	S->A: Minimal effect on activity.	ECO:0000269|PubMed:11579085	11579085

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P53667	LIMK1	G190A	P53667/G190A	LIMK1/G190A	VARIANT	G -> A (in dbSNP:rs35827364)	ECO:0000269|PubMed:17344846	17344846
P53667	LIMK1	S247N	P53667/S247N	LIMK1/S247N	VARIANT	S -> N (in dbSNP:rs55661242)	ECO:0000269|PubMed:17344846	17344846
P53667	LIMK1	R422Q	P53667/R422Q	LIMK1/R422Q	VARIANT	R -> Q (in dbSNP:rs55679316)	ECO:0000269|PubMed:17344846	17344846
P53667	LIMK1	F580Y	P53667/F580Y	LIMK1/F580Y	VARIANT	F -> Y (in dbSNP:rs178412)	ECO:0000269|PubMed:8689688, ECO:0000269|PubMed:8812460	8689688,8812460
P53667	LIMK1	C84S	P53667/C84S	LIMK1/C84S	MUTAGEN	C->S: Enhances actin aggregation.	ECO:0000269|PubMed:10196227	10196227
P53667	LIMK1	D460N	P53667/D460N	LIMK1/D460N	MUTAGEN	D->N,A: Abrogates kinase activity.		
P53667	LIMK1	D460A	P53667/D460A	LIMK1/D460A	MUTAGEN	D->N,A: Abrogates kinase activity.	ECO:0000269|PubMed:10196227, ECO:0000269|PubMed:22328514	10196227,22328514
P53667	LIMK1	T508A	P53667/T508A	LIMK1/T508A	MUTAGEN	T->A: Abolishes activation by ROCK1.	ECO:0000269|PubMed:10196227, ECO:0000269|PubMed:10652353	10196227,10652353
P53667	LIMK1	T508E	P53667/T508E	LIMK1/T508E	MUTAGEN	T->E: Phosphomimetic mutant; enhances kinase activity.	ECO:0000269|PubMed:22328514	22328514
P53667	LIMK1	T508EE	P53667/T508EE	LIMK1/T508EE	MUTAGEN	T->EE: Enhances kinase activity.	ECO:0000269|PubMed:10196227, ECO:0000269|PubMed:10652353	10196227,10652353
P53667	LIMK1	T508V	P53667/T508V	LIMK1/T508V	MUTAGEN	T->V: Reduces kinase activity.	ECO:0000269|PubMed:10196227, ECO:0000269|PubMed:10652353	10196227,10652353

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P53671	LIMK2	G35S	P53671/G35S	LIMK2/G35S	VARIANT	G -> S (in dbSNP:rs5997917)	ECO:0000269|PubMed:17344846	17344846
P53671	LIMK2	D45N	P53671/D45N	LIMK2/D45N	VARIANT	D -> N (in dbSNP:rs35923988)	ECO:0000269|PubMed:17344846	17344846
P53671	LIMK2	R213C	P53671/R213C	LIMK2/R213C	VARIANT	R -> C (in dbSNP:rs34930775)	ECO:0000269|PubMed:17344846	17344846
P53671	LIMK2	P296R	P53671/P296R	LIMK2/P296R	VARIANT	P -> R (in dbSNP:rs34875793)	ECO:0000269|PubMed:17344846	17344846
P53671	LIMK2	R381H	P53671/R381H	LIMK2/R381H	VARIANT	R -> H (in dbSNP:rs2229874)		
P53671	LIMK2	R418C	P53671/R418C	LIMK2/R418C	VARIANT	R -> C (in dbSNP:rs35422808)	ECO:0000269|PubMed:17344846	17344846
P53671	LIMK2	D451A	P53671/D451A	LIMK2/D451A	MUTAGEN	D->A: Abrogates kinase activity.	ECO:0000269|PubMed:22328514	22328514
P53671	LIMK2	T505E	P53671/T505E	LIMK2/T505E	MUTAGEN	T->E: Phosphomimetic mutant; enhances kinase activity.	ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:22328514	11018042,22328514
P53671	LIMK2	T505V	P53671/T505V	LIMK2/T505V	MUTAGEN	T->V: Abolishes cofilin phosphorylation and enhancement of stress fiber formation.	ECO:0000269|PubMed:11018042	11018042

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P53778	MAPK12	T103M	P53778/T103M	MAPK12/T103M	VARIANT	T -> M (in dbSNP:rs34422484)	ECO:0000269|PubMed:15461802, ECO:0000269|PubMed:17344846	15461802,17344846
P53778	MAPK12	D230N	P53778/D230N	MAPK12/D230N	VARIANT	D -> N (in dbSNP:rs35396905)	ECO:0000269|PubMed:17344846	17344846
P53778	MAPK12	T244M	P53778/T244M	MAPK12/T244M	VARIANT	T -> M (in dbSNP:rs2066776)		
P53778	MAPK12	D179A	P53778/D179A	MAPK12/D179A	MUTAGEN	D->A: Emulation of the active state.	ECO:0000269|PubMed:15284239	15284239
P53778	MAPK12	Y185F	P53778/Y185F	MAPK12/Y185F	MUTAGEN	Y->F: Loss of activity.	ECO:0000269|PubMed:8633070	8633070
P53778	MAPK12	F330S	P53778/F330S	MAPK12/F330S	MUTAGEN	F->S: No effect.	ECO:0000269|PubMed:15284239	15284239

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P53779	MAPK10	C462S	P53779/C462S	MAPK10/C462S	MUTAGEN	C->S: Loss of palmitoylation.	ECO:0000269|PubMed:21941371	21941371
P53779	MAPK10	C463S	P53779/C463S	MAPK10/C463S	MUTAGEN	C->S: Loss of palmitoylation.	ECO:0000269|PubMed:21941371	21941371

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P54646	PRKAA2	P371T	P54646/P371T	PRKAA2/P371T	VARIANT	P -> T (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17344846	16959974,17344846
P54646	PRKAA2	R407Q	P54646/R407Q	PRKAA2/R407Q	VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P54646	PRKAA2	S523G	P54646/S523G	PRKAA2/S523G	VARIANT	S -> G (in a breast cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
P54646	PRKAA2	T172D	P54646/T172D	PRKAA2/T172D	MUTAGEN	T->D: Phosphomimetic mutant.		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P54753	EPHB3	R168L	P54753/R168L	EPHB3/R168L	VARIANT	R -> L (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P54753	EPHB3	R440C	P54753/R440C	EPHB3/R440C	VARIANT	R -> C (in dbSNP:rs56029711)	ECO:0000269|PubMed:17344846	17344846
P54753	EPHB3	I579V	P54753/I579V	EPHB3/I579V	VARIANT	I -> V (in dbSNP:rs56103851)	ECO:0000269|PubMed:17344846	17344846
P54753	EPHB3	I601L	P54753/I601L	EPHB3/I601L	VARIANT	I -> L (in dbSNP:rs56129875)	ECO:0000269|PubMed:17344846	17344846
P54753	EPHB3	R724W	P54753/R724W	EPHB3/R724W	VARIANT	R -> W (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs371378866)	ECO:0000269|PubMed:17344846	17344846
P54753	EPHB3	Y614F	P54753/Y614F	EPHB3/Y614F	MUTAGEN	Y->F: Partial loss of phosphorylation and loss of interaction with SH2-containing proteins.	ECO:0000269|PubMed:9674711	9674711
P54753	EPHB3	K665R	P54753/K665R	EPHB3/K665R	MUTAGEN	K->R: Kinase-dead. Loss of autophosphorylation.	ECO:0000269|PubMed:9674711	9674711

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P54756	EPHA5	N81T	P54756/N81T	EPHA5/N81T	VARIANT	N -> T (in dbSNP:rs33932471)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	S235A	P54756/S235A	EPHA5/S235A	VARIANT	S -> A (in dbSNP:rs55710198)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	E330Q	P54756/E330Q	EPHA5/E330Q	VARIANT	E -> Q (in dbSNP:rs56205382)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	R417Q	P54756/R417Q	EPHA5/R417Q	VARIANT	R -> Q (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs199614818)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	E503K	P54756/E503K	EPHA5/E503K	VARIANT	E -> K (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	Y506C	P54756/Y506C	EPHA5/Y506C	VARIANT	Y -> C (in dbSNP:rs56074660)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	G582E	P54756/G582E	EPHA5/G582E	VARIANT	G -> E (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1057520012)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	A672T	P54756/A672T	EPHA5/A672T	VARIANT	A -> T (in dbSNP:rs36050417)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	S673T	P54756/S673T	EPHA5/S673T	VARIANT	S -> T (in dbSNP:rs56359290)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	T856I	P54756/T856I	EPHA5/T856I	VARIANT	T -> I (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	H959R	P54756/H959R	EPHA5/H959R	VARIANT	H -> R (in dbSNP:rs56312931)	ECO:0000269|PubMed:17344846	17344846
P54756	EPHA5	N1032S	P54756/N1032S	EPHA5/N1032S	VARIANT	N -> S (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

Error: P54760 EPHB4 'NoneType' object has no attribute 'group' FT                   /note="Missing (in CMAVM2; unknown pathological

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P54760	EPHB4	E59K	P54760/E59K	EPHB4/E59K	VARIANT	E -> K (in CMAVM2; unknown pathological significance; dbSNP:rs1584667224)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	P67L	P54760/P67L	EPHB4/P67L	VARIANT	P -> L (in dbSNP:rs34653459)	ECO:0000269|PubMed:17344846	17344846
P54760	EPHB4	R74P	P54760/R74P	EPHB4/R74P	VARIANT	R -> P (in CMAVM2; unknown pathological significance; dbSNP:rs61735971)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	C107R	P54760/C107R	EPHB4/C107R	VARIANT	C -> R (in CMAVM2; unknown pathological significance; dbSNP:rs1562974383)	ECO:0000269|PubMed:29444212	29444212
P54760	EPHB4	V113I	P54760/V113I	EPHB4/V113I	VARIANT	V -> I (in dbSNP:rs55866373)	ECO:0000269|PubMed:17344846	17344846
P54760	EPHB4	K162R	P54760/K162R	EPHB4/K162R	VARIANT	K -> R (in dbSNP:rs17854760)	ECO:0000269|PubMed:15489334	15489334
P54760	EPHB4	L187P	P54760/L187P	EPHB4/L187P	VARIANT	L -> P (in CMAVM2; unknown pathological significance; dbSNP:rs1584666053)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	C268R	P54760/C268R	EPHB4/C268R	VARIANT	C -> R (in CMAVM2; unknown pathological significance; dbSNP:rs201816920)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	P346L	P54760/P346L	EPHB4/P346L	VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267601191)	ECO:0000269|PubMed:17344846	17344846
P54760	EPHB4	A371V	P54760/A371V	EPHB4/A371V	VARIANT	A -> V (in dbSNP:rs55720981)	ECO:0000269|PubMed:17344846	17344846
P54760	EPHB4	V469G	P54760/V469G	EPHB4/V469G	VARIANT	V -> G (in CMAVM2; unknown pathological significance; dbSNP:rs1584662591)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	A509G	P54760/A509G	EPHB4/A509G	VARIANT	A -> G (does not affect tyrosine phosphorylation; does not affect interaction with RASA1; dbSNP:rs146937374)	ECO:0000269|PubMed:30578106	30578106
P54760	EPHB4	G516R	P54760/G516R	EPHB4/G516R	VARIANT	G -> R (in CMAVM2; unknown pathological significance; dbSNP:rs776305185)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	D576E	P54760/D576E	EPHB4/D576E	VARIANT	D -> E (in dbSNP:rs36050247)	ECO:0000269|PubMed:17344846	17344846
P54760	EPHB4	K650N	P54760/K650N	EPHB4/K650N	VARIANT	K -> N (in CMAVM2; highly decreased tyrosine phosphorylation; highly decreased interaction with RASA1; dbSNP:rs1584658113)	ECO:0000269|PubMed:30578106	30578106
P54760	EPHB4	R656W	P54760/R656W	EPHB4/R656W	VARIANT	R -> W (in CMAVM2; unknown pathological significance; dbSNP:rs745584371)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	E664K	P54760/E664K	EPHB4/E664K	VARIANT	E -> K (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs1562969219)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	R678H	P54760/R678H	EPHB4/R678H	VARIANT	R -> H (in dbSNP:rs55692440)	ECO:0000269|PubMed:17344846	17344846
P54760	EPHB4	A725T	P54760/A725T	EPHB4/A725T	VARIANT	A -> T (in CMAVM2; unknown pathological significance; dbSNP:rs1159930961)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	R739Q	P54760/R739Q	EPHB4/R739Q	VARIANT	R -> Q (in LMPHM7; loss of kinase activity; dbSNP:rs1057519263)	ECO:0000269|PubMed:27400125	27400125
P54760	EPHB4	N745D	P54760/N745D	EPHB4/N745D	VARIANT	N -> D (in CMAVM2; dbSNP:rs1584654433)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	I782S	P54760/I782S	EPHB4/I782S	VARIANT	I -> S (in LMPHM7; loss of kinase activity; dbSNP:rs1057519264)	ECO:0000269|PubMed:27400125	27400125
P54760	EPHB4	P789R	P54760/P789R	EPHB4/P789R	VARIANT	P -> R (in CMAVM2; unknown pathological significance; dbSNP:rs753075600)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	P789S	P54760/P789S	EPHB4/P789S	VARIANT	P -> S (in CMAVM2; unknown pathological significance; dbSNP:rs1417508111)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	D802G	P54760/D802G	EPHB4/D802G	VARIANT	D -> G (in CMAVM2; dbSNP:rs776410552)	ECO:0000269|PubMed:28730721	28730721
P54760	EPHB4	G807R	P54760/G807R	EPHB4/G807R	VARIANT	G -> R (in CMAVM2; unknown pathological significance; dbSNP:rs1330628156)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	P820L	P54760/P820L	EPHB4/P820L	VARIANT	P -> L (in CMAVM2; unknown pathological significance; dbSNP:rs1584653650)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	P820T	P54760/P820T	EPHB4/P820T	VARIANT	P -> T (in CMAVM2; unknown pathological significance; dbSNP:rs1584653653)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	R838W	P54760/R838W	EPHB4/R838W	VARIANT	R -> W (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs764827256)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	C845R	P54760/C845R	EPHB4/C845R	VARIANT	C -> R (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs1584653054)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	C856Y	P54760/C856Y	EPHB4/C856Y	VARIANT	C -> Y (in CMAVM2; dbSNP:rs1584653005)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	R864W	P54760/R864W	EPHB4/R864W	VARIANT	R -> W (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs769965440)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	F867L	P54760/F867L	EPHB4/F867L	VARIANT	F -> L (in CMAVM2; loss of tyrosine phosphorylation; loss of interaction with RASA1; dbSNP:rs1584652949)	ECO:0000269|PubMed:30578106	30578106
P54760	EPHB4	V870E	P54760/V870E	EPHB4/V870E	VARIANT	V -> E (in CMAVM2; unknown pathological significance; dbSNP:rs1584652920)	ECO:0000269|PubMed:29444212	29444212
P54760	EPHB4	L874P	P54760/L874P	EPHB4/L874P	VARIANT	L -> P (in CMAVM2; unknown pathological significance; dbSNP:rs1584652900)	ECO:0000269|PubMed:28687708	28687708
P54760	EPHB4	A882T	P54760/A882T	EPHB4/A882T	VARIANT	A -> T (in dbSNP:rs34918225)	ECO:0000269|PubMed:17344846	17344846
P54760	EPHB4	R889W	P54760/R889W	EPHB4/R889W	VARIANT	R -> W (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs762016655)	ECO:0000269|PubMed:17344846	17344846
P54760	EPHB4	E890D	P54760/E890D	EPHB4/E890D	VARIANT	E -> D (in dbSNP:rs35638378)	ECO:0000269|PubMed:17344846	17344846
P54760	EPHB4	L95R	P54760/L95R	EPHB4/L95R	MUTAGEN	L->R: Reduces binding affinity for EFNB2.	ECO:0000269|PubMed:16867992	16867992

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P54762	EPHB1	M18V	P54762/M18V	EPHB1/M18V	VARIANT	M -> V (in dbSNP:rs55650774)	ECO:0000269|PubMed:17344846	17344846
P54762	EPHB1	T87S	P54762/T87S	EPHB1/T87S	VARIANT	T -> S (in dbSNP:rs1042794)		
P54762	EPHB1	G152R	P54762/G152R	EPHB1/G152R	VARIANT	G -> R (in dbSNP:rs1042793)		
P54762	EPHB1	R367G	P54762/R367G	EPHB1/R367G	VARIANT	R -> G (in dbSNP:rs1042789)		
P54762	EPHB1	T387M	P54762/T387M	EPHB1/T387M	VARIANT	T -> M (in dbSNP:rs56396912)	ECO:0000269|PubMed:17344846	17344846
P54762	EPHB1	R485S	P54762/R485S	EPHB1/R485S	VARIANT	R -> S (in dbSNP:rs1042788)		
P54762	EPHB1	S707T	P54762/S707T	EPHB1/S707T	VARIANT	S -> T (in an ovarian undifferentiated carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P54762	EPHB1	I719V	P54762/I719V	EPHB1/I719V	VARIANT	I -> V (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P54762	EPHB1	R743Q	P54762/R743Q	EPHB1/R743Q	VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1338928289)	ECO:0000269|PubMed:17344846	17344846
P54762	EPHB1	M847T	P54762/M847T	EPHB1/M847T	VARIANT	M -> T (in dbSNP:rs1042785)		
P54762	EPHB1	A912T	P54762/A912T	EPHB1/A912T	VARIANT	A -> T (in dbSNP:rs56345346)	ECO:0000269|PubMed:17344846	17344846
P54762	EPHB1	R973W	P54762/R973W	EPHB1/R973W	VARIANT	R -> W (in dbSNP:rs1042784)	ECO:0000269|PubMed:9430661	9430661
P54762	EPHB1	T981M	P54762/T981M	EPHB1/T981M	VARIANT	T -> M (in dbSNP:rs56186270)	ECO:0000269|PubMed:17344846	17344846
P54762	EPHB1	Y594F	P54762/Y594F	EPHB1/Y594F	MUTAGEN	Y->F: Loss of interaction with NCK1.	ECO:0000269|PubMed:9430661	9430661
P54762	EPHB1	Y600F	P54762/Y600F	EPHB1/Y600F	MUTAGEN	Y->F: Loss of interaction with SHC1 and SRC.	ECO:0000269|PubMed:12925710	12925710
P54762	EPHB1	K651R	P54762/K651R	EPHB1/K651R	MUTAGEN	K->R: Kinase-dead mutant. Unable to autophosphorylate, to interact with SH2 domain-containing interactors, to activate the MAPK/ERK and JUN signaling cascades. Not ubiquitinated by CBL.	ECO:0000269|PubMed:18034775, ECO:0000269|PubMed:9430661	18034775,9430661
P54762	EPHB1	Y778F	P54762/Y778F	EPHB1/Y778F	MUTAGEN	Y->F: Loss of interaction with SHC1.	ECO:0000269|PubMed:12925710	12925710
P54762	EPHB1	Y928F	P54762/Y928F	EPHB1/Y928F	MUTAGEN	Y->F: Disrupts binding with the GRB10 SH2 domain, providing evidence for phosphorylation. Disrupts interaction with GRB7 and ACP1.	ECO:0000269|PubMed:12223469, ECO:0000269|PubMed:8798570, ECO:0000269|PubMed:9499402	12223469,8798570,9499402

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P54764	EPHA4	R269Q	P54764/R269Q	EPHA4/R269Q	VARIANT	R -> Q (in dbSNP:rs35084379)	ECO:0000269|PubMed:17344846	17344846
P54764	EPHA4	G370E	P54764/G370E	EPHA4/G370E	VARIANT	G -> E (in a bladder carcinoma NOS sample; somatic mutation; dbSNP:rs756952113)	ECO:0000269|PubMed:17344846	17344846
P54764	EPHA4	S399F	P54764/S399F	EPHA4/S399F	VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation; dbSNP:rs868224085)	ECO:0000269|PubMed:17344846	17344846
P54764	EPHA4	R953K	P54764/R953K	EPHA4/R953K	VARIANT	R -> K (in dbSNP:rs35341687)		
P54764	EPHA4	Q40A	P54764/Q40A	EPHA4/Q40A	MUTAGEN	Q->A: 10-fold reduced affinity for EFNB2; when associated with A-42.	ECO:0000269|PubMed:19875447	19875447
P54764	EPHA4	E42A	P54764/E42A	EPHA4/E42A	MUTAGEN	E->A: 10-fold reduced affinity for EFNB2; when associated with A-40.	ECO:0000269|PubMed:19875447	19875447

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P57058	HUNK	R157W	P57058/R157W	HUNK/R157W	VARIANT	R -> W (in dbSNP:rs35133981)	ECO:0000269|PubMed:17344846	17344846
P57058	HUNK	R591C	P57058/R591C	HUNK/R591C	VARIANT	R -> C (in dbSNP:rs10775648)	ECO:0000269|PubMed:17344846	17344846
P57058	HUNK	E625K	P57058/E625K	HUNK/E625K	VARIANT	E -> K (in dbSNP:rs56021554)	ECO:0000269|PubMed:17344846	17344846
P57058	HUNK	M648T	P57058/M648T	HUNK/M648T	VARIANT	M -> T (in dbSNP:rs56240027)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P57059	SIK1	G15S	P57059/G15S	SIK1/G15S	VARIANT	G -> S (in dbSNP:rs3746951)	ECO:0000269|PubMed:17344846	17344846
P57059	SIK1	D142N	P57059/D142N	SIK1/D142N	VARIANT	D -> N (in dbSNP:rs45491503)	ECO:0000269|PubMed:17344846	17344846
P57059	SIK1	G211S	P57059/G211S	SIK1/G211S	VARIANT	G -> S (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P57059	SIK1	P287T	P57059/P287T	SIK1/P287T	VARIANT	P -> T (in DEE30; no change in subcellular location; dbSNP:rs786205159)	ECO:0000269|PubMed:25839329	25839329
P57059	SIK1	S411C	P57059/S411C	SIK1/S411C	VARIANT	S -> C (in DEE30; no change in subcellular location)	ECO:0000269|PubMed:25839329	25839329
P57059	SIK1	R430W	P57059/R430W	SIK1/R430W	VARIANT	R -> W (in dbSNP:rs34164089)		
P57059	SIK1	G469D	P57059/G469D	SIK1/G469D	VARIANT	G -> D (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P57059	SIK1	A615V	P57059/A615V	SIK1/A615V	VARIANT	A -> V (in dbSNP:rs430554)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	14702039,15489334,17344846
P57059	SIK1	G636S	P57059/G636S	SIK1/G636S	VARIANT	G -> S (in DEE30; no change in subcellular location; dbSNP:rs786205163)	ECO:0000269|PubMed:25839329	25839329
P57059	SIK1	P696L	P57059/P696L	SIK1/P696L	VARIANT	P -> L (in dbSNP:rs56386767)	ECO:0000269|PubMed:17344846	17344846
P57059	SIK1	A725V	P57059/A725V	SIK1/A725V	VARIANT	A -> V (in dbSNP:rs35596465)	ECO:0000269|PubMed:17344846	17344846
P57059	SIK1	K56M	P57059/K56M	SIK1/K56M	MUTAGEN	K->M: Loss of kinase activity.	ECO:0000269|PubMed:18348280, ECO:0000269|PubMed:19622832	18348280,19622832
P57059	SIK1	S135A	P57059/S135A	SIK1/S135A	MUTAGEN	S->A: Decreased kinase activity without affecting much autophosphorylation status.	ECO:0000269|PubMed:18348280	18348280
P57059	SIK1	T182A	P57059/T182A	SIK1/T182A	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. Reduced inhibition of CRTC3-mediated transcriptional activity.	ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:29211348	14976552,29211348
P57059	SIK1	S186A	P57059/S186A	SIK1/S186A	MUTAGEN			
P57059	SIK1	S186D	P57059/S186D	SIK1/S186D	MUTAGEN			
P57059	SIK1	S186C	P57059/S186C	SIK1/S186C	MUTAGEN			
P57059	SIK1	S186G	P57059/S186G	SIK1/S186G	MUTAGEN	S->A,D,C,G: Impaired autophosphorylation and kinase activity.	ECO:0000269|PubMed:18348280	18348280
P57059	SIK1	S186T	P57059/S186T	SIK1/S186T	MUTAGEN	S->T: Does not autophosphorylation and kinase activity.	ECO:0000269|PubMed:18348280	18348280
P57059	SIK1	S209A	P57059/S209A	SIK1/S209A	MUTAGEN	S->A: Decreased kinase activity without affecting much autophosphorylation status.	ECO:0000269|PubMed:18348280	18348280
P57059	SIK1	S248A	P57059/S248A	SIK1/S248A	MUTAGEN	S->A: Decreased kinase activity without affecting much autophosphorylation status.	ECO:0000269|PubMed:18348280	18348280
P57059	SIK1	T473A	P57059/T473A	SIK1/T473A	MUTAGEN	T->A: Reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity. Resistant to inhibition by cAMP signaling and, thus, still able to inhibit TORC activity; when associated with A-575.	ECO:0000269|PubMed:29211348	29211348
P57059	SIK1	T473E	P57059/T473E	SIK1/T473E	MUTAGEN	T->E: Reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity.	ECO:0000269|PubMed:29211348	29211348
P57059	SIK1	S575A	P57059/S575A	SIK1/S575A	MUTAGEN	S->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity. Resistant to inhibition by cAMP signaling and, thus, still able to inhibit TORC activity; when associated with A-473.	ECO:0000269|PubMed:29211348	29211348
P57059	SIK1	S575E	P57059/S575E	SIK1/S575E	MUTAGEN	S->E: Strongly reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity.	ECO:0000269|PubMed:29211348	29211348

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P57078	RIPK4	A12G	P57078/A12G	RIPK4/A12G	VARIANT	A -> G (in dbSNP:rs6586239)		
P57078	RIPK4	I81N	P57078/I81N	RIPK4/I81N	VARIANT	I -> N (in BPS; dbSNP:rs387906922)	ECO:0000269|PubMed:22197488	22197488
P57078	RIPK4	I121N	P57078/I121N	RIPK4/I121N	VARIANT	I -> N (in BPS; loss of function; dbSNP:rs387906923)	ECO:0000269|PubMed:22197489	22197489
P57078	RIPK4	G163D	P57078/G163D	RIPK4/G163D	VARIANT	G -> D (in CHANDS; unknown pathological significance; dbSNP:rs764278537)	ECO:0000269|PubMed:23610050	23610050
P57078	RIPK4	S177N	P57078/S177N	RIPK4/S177N	VARIANT	S -> N (in dbSNP:rs12482626)		
P57078	RIPK4	T184I	P57078/T184I	RIPK4/T184I	VARIANT	T -> I (in BPS; loss of function)	ECO:0000269|PubMed:22197489	22197489
P57078	RIPK4	P189L	P57078/P189L	RIPK4/P189L	VARIANT	P -> L (in BPS; unknown pathological significance)	ECO:0000269|PubMed:25691407	25691407
P57078	RIPK4	E284K	P57078/E284K	RIPK4/E284K	VARIANT	E -> K (in CHANDS; unknown pathological significance)	ECO:0000269|PubMed:26129644	26129644
P57078	RIPK4	I462N	P57078/I462N	RIPK4/I462N	VARIANT	I -> N (in dbSNP:rs55809511)	ECO:0000269|PubMed:17344846	17344846
P57078	RIPK4	V463M	P57078/V463M	RIPK4/V463M	VARIANT	V -> M (in dbSNP:rs55645753)	ECO:0000269|PubMed:17344846	17344846
P57078	RIPK4	A496P	P57078/A496P	RIPK4/A496P	VARIANT	A -> P (in BPS; unknown pathological significance)	ECO:0000269|PubMed:25691407	25691407
P57078	RIPK4	N562Y	P57078/N562Y	RIPK4/N562Y	VARIANT	N -> Y (in dbSNP:rs55829311)	ECO:0000269|PubMed:17344846	17344846
P57078	RIPK4	R666H	P57078/R666H	RIPK4/R666H	VARIANT	R -> H (in BPS; unknown pathological significance; dbSNP:rs763794698)	ECO:0000269|PubMed:25691407	25691407
P57078	RIPK4	R669H	P57078/R669H	RIPK4/R669H	VARIANT	R -> H (in dbSNP:rs56056485)	ECO:0000269|PubMed:17344846	17344846
P57078	RIPK4	P749S	P57078/P749S	RIPK4/P749S	VARIANT	P -> S (in dbSNP:rs35537517)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P68400	CSNK2A1	R47Q	P68400/R47Q	CSNK2A1/R47Q	VARIANT	R -> Q (in OCNDS; dbSNP:rs869312845)	ECO:0000269|PubMed:27048600	27048600
P68400	CSNK2A1	Y50S	P68400/Y50S	CSNK2A1/Y50S	VARIANT	Y -> S (in OCNDS; dbSNP:rs869312849)	ECO:0000269|PubMed:27048600	27048600
P68400	CSNK2A1	D175G	P68400/D175G	CSNK2A1/D175G	VARIANT	D -> G (in OCNDS; dbSNP:rs869312848)	ECO:0000269|PubMed:27048600	27048600
P68400	CSNK2A1	K198R	P68400/K198R	CSNK2A1/K198R	VARIANT	K -> R (in OCNDS; dbSNP:rs869312840)	ECO:0000269|PubMed:27048600	27048600

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P78362	SRPK2	P43L	P78362/P43L	SRPK2/P43L	VARIANT	P -> L (in dbSNP:rs34699980)	ECO:0000269|PubMed:17344846	17344846
P78362	SRPK2	G243D	P78362/G243D	SRPK2/G243D	VARIANT	G -> D (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P78362	SRPK2	T426P	P78362/T426P	SRPK2/T426P	VARIANT	T -> P (in dbSNP:rs55743527)	ECO:0000269|PubMed:17344846	17344846
P78362	SRPK2	S486F	P78362/S486F	SRPK2/S486F	VARIANT	S -> F (in dbSNP:rs56112661)	ECO:0000269|PubMed:17344846	17344846
P78362	SRPK2	P515T	P78362/P515T	SRPK2/P515T	VARIANT	P -> T (in dbSNP:rs56017595)	ECO:0000269|PubMed:17344846	17344846
P78362	SRPK2	S608N	P78362/S608N	SRPK2/S608N	VARIANT	S -> N (in dbSNP:rs1050413)		
P78362	SRPK2	L615I	P78362/L615I	SRPK2/L615I	VARIANT	L -> I (in dbSNP:rs1050418)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P78368	CSNK1G2	F189L	P78368/F189L	CSNK1G2/F189L	VARIANT	F -> L (in dbSNP:rs55702630)	ECO:0000269|PubMed:17344846	17344846
P78368	CSNK1G2	E194G	P78368/E194G	CSNK1G2/E194G	VARIANT	E -> G (in dbSNP:rs55780547)	ECO:0000269|PubMed:17344846	17344846
P78368	CSNK1G2	I196T	P78368/I196T	CSNK1G2/I196T	VARIANT	I -> T (in dbSNP:rs55923222)	ECO:0000269|PubMed:17344846	17344846
P78368	CSNK1G2	Y206C	P78368/Y206C	CSNK1G2/Y206C	VARIANT	Y -> C (in dbSNP:rs56264133)	ECO:0000269|PubMed:17344846	17344846
P78368	CSNK1G2	Y206H	P78368/Y206H	CSNK1G2/Y206H	VARIANT	Y -> H (in dbSNP:rs56108438)	ECO:0000269|PubMed:17344846	17344846
P78368	CSNK1G2	R207S	P78368/R207S	CSNK1G2/R207S	VARIANT	R -> S (in dbSNP:rs56340103)	ECO:0000269|PubMed:17344846	17344846
P78368	CSNK1G2	E208Q	P78368/E208Q	CSNK1G2/E208Q	VARIANT	E -> Q (in dbSNP:rs55818316)	ECO:0000269|PubMed:17344846	17344846
P78368	CSNK1G2	R217C	P78368/R217C	CSNK1G2/R217C	VARIANT	R -> C (in dbSNP:rs55754218)	ECO:0000269|PubMed:17344846	17344846
P78368	CSNK1G2	T223M	P78368/T223M	CSNK1G2/T223M	VARIANT	T -> M (in dbSNP:rs56038081)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P78527	PRKDC	A6S	P78527/A6S	PRKDC/A6S	VARIANT	A -> S (in dbSNP:rs8177999)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	K263N	P78527/K263N	PRKDC/K263N	VARIANT	K -> N (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs758032015)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	M333I	P78527/M333I	PRKDC/M333I	VARIANT	M -> I (in dbSNP:rs8178017)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	V420I	P78527/V420I	PRKDC/V420I	VARIANT	V -> I (in dbSNP:rs55925466)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	G500S	P78527/G500S	PRKDC/G500S	VARIANT	G -> S (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	T605S	P78527/T605S	PRKDC/T605S	VARIANT	T -> S (in dbSNP:rs8178033)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	F649L	P78527/F649L	PRKDC/F649L	VARIANT	F -> L (in dbSNP:rs55811715)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	I680M	P78527/I680M	PRKDC/I680M	VARIANT	I -> M (in dbSNP:rs8178040)	ECO:0000269|Ref.3	
P78527	PRKDC	P695S	P78527/P695S	PRKDC/P695S	VARIANT	P -> S (in dbSNP:rs8178046)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	N1071S	P78527/N1071S	PRKDC/N1071S	VARIANT	N -> S (in dbSNP:rs8178070)	ECO:0000269|Ref.3	
P78527	PRKDC	R1136H	P78527/R1136H	PRKDC/R1136H	VARIANT	R -> H (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs781401034)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	L1190V	P78527/L1190V	PRKDC/L1190V	VARIANT	L -> V (in dbSNP:rs34598508)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	A1237T	P78527/A1237T	PRKDC/A1237T	VARIANT	A -> T (in dbSNP:rs191531119)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	L1279F	P78527/L1279F	PRKDC/L1279F	VARIANT	L -> F	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	G1314V	P78527/G1314V	PRKDC/G1314V	VARIANT	G -> V (in dbSNP:rs8178090)	ECO:0000269|Ref.3	
P78527	PRKDC	R1447M	P78527/R1447M	PRKDC/R1447M	VARIANT	R -> M (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	D1588V	P78527/D1588V	PRKDC/D1588V	VARIANT	D -> V (in dbSNP:rs8178104)	ECO:0000269|Ref.3	
P78527	PRKDC	Q1603H	P78527/Q1603H	PRKDC/Q1603H	VARIANT	Q -> H (in dbSNP:rs8178106)	ECO:0000269|Ref.3	
P78527	PRKDC	A1619G	P78527/A1619G	PRKDC/A1619G	VARIANT	A -> G (in dbSNP:rs56182356)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	A1680V	P78527/A1680V	PRKDC/A1680V	VARIANT	A -> V (in a metastatic melanoma sample; somatic mutation; dbSNP:rs55735910)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	S2023P	P78527/S2023P	PRKDC/S2023P	VARIANT	S -> P (in dbSNP:rs56042895)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	A2095V	P78527/A2095V	PRKDC/A2095V	VARIANT	A -> V (in dbSNP:rs8178147)	ECO:0000269|Ref.3	
P78527	PRKDC	R2598Q	P78527/R2598Q	PRKDC/R2598Q	VARIANT	R -> Q (in dbSNP:rs55923149)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	K2702E	P78527/K2702E	PRKDC/K2702E	VARIANT	K -> E (in dbSNP:rs8178178)	ECO:0000269|Ref.3	
P78527	PRKDC	S2810N	P78527/S2810N	PRKDC/S2810N	VARIANT	S -> N (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	R2899C	P78527/R2899C	PRKDC/R2899C	VARIANT	R -> C (in dbSNP:rs4278157)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	G2941A	P78527/G2941A	PRKDC/G2941A	VARIANT	G -> A (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	L3062R	P78527/L3062R	PRKDC/L3062R	VARIANT	L -> R (in IMD26; shows increased long palindromic (P)-nucleotide stretches in the immunoglobulin coding joints indicating a defect in hairpin opening and insufficient DCLRE1C activation; dbSNP:rs587777685)	ECO:0000269|PubMed:19075392	19075392
P78527	PRKDC	E3085D	P78527/E3085D	PRKDC/E3085D	VARIANT	E -> D (in dbSNP:rs56135402)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	G3149D	P78527/G3149D	PRKDC/G3149D	VARIANT	G -> D (in dbSNP:rs8178208)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	T3198S	P78527/T3198S	PRKDC/T3198S	VARIANT	T -> S (in dbSNP:rs55793951)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	P3201S	P78527/P3201S	PRKDC/P3201S	VARIANT	P -> S (in dbSNP:rs8178216)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	G3404E	P78527/G3404E	PRKDC/G3404E	VARIANT	G -> E (in dbSNP:rs8178225)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	I3434T	P78527/I3434T	PRKDC/I3434T	VARIANT	I -> T (in dbSNP:rs7830743)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	N3459S	P78527/N3459S	PRKDC/N3459S	VARIANT	N -> S (in dbSNP:rs8178228)	ECO:0000269|Ref.3	
P78527	PRKDC	L3562M	P78527/L3562M	PRKDC/L3562M	VARIANT	L -> M (in dbSNP:rs8178232)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	A3574V	P78527/A3574V	PRKDC/A3574V	VARIANT	A -> V (in IMD26; shows impaired function in response to irradiation and a less severe defect in V(D)J end-joining suggesting that the missense mutation retained some functional capacity; consistent with a loss of function mutation; dbSNP:rs587777686)	ECO:0000269|PubMed:23722905	23722905
P78527	PRKDC	L3584F	P78527/L3584F	PRKDC/L3584F	VARIANT	L -> F (in dbSNP:rs55866966)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	P3702L	P78527/P3702L	PRKDC/P3702L	VARIANT	P -> L (in dbSNP:rs8178236)		
P78527	PRKDC	L3800I	P78527/L3800I	PRKDC/L3800I	VARIANT	L -> I (in dbSNP:rs56216442)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	P3836L	P78527/P3836L	PRKDC/P3836L	VARIANT	P -> L (in dbSNP:rs8178245)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
P78527	PRKDC	M3932V	P78527/M3932V	PRKDC/M3932V	VARIANT	M -> V (in dbSNP:rs8178248)	ECO:0000269|Ref.3	
P78527	PRKDC	G3936S	P78527/G3936S	PRKDC/G3936S	VARIANT	G -> S (in dbSNP:rs55670423)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	V3937M	P78527/V3937M	PRKDC/V3937M	VARIANT	V -> M (in dbSNP:rs56090750)	ECO:0000269|PubMed:17344846	17344846
P78527	PRKDC	L1510P	P78527/L1510P	PRKDC/L1510P	MUTAGEN	L->P: Loss of interaction with C1D.	ECO:0000269|PubMed:9679063	9679063
P78527	PRKDC	T2609A	P78527/T2609A	PRKDC/T2609A	MUTAGEN	T->A: Leads to radiation sensitivity and impaired DSB joining. Gives rise to reduced phosphorylation; when associated with A-2612.	ECO:0000269|PubMed:12231622	12231622
P78527	PRKDC	S2612A	P78527/S2612A	PRKDC/S2612A	MUTAGEN	S->A: Reduced phosphorylation; when associated with A-2609.		
P78527	PRKDC	T2638A	P78527/T2638A	PRKDC/T2638A	MUTAGEN	T->A: Alleviates phosphorylation, leaves a fully active enzyme with compromised cellular resistance to ionizing radiation without affecting DNA end joining; when associated with A-2647.	ECO:0000269|PubMed:12649176	12649176
P78527	PRKDC	T2647A	P78527/T2647A	PRKDC/T2647A	MUTAGEN	T->A: Alleviates phosphorylation, leaves a fully active enzyme with compromised cellular resistance to ionizing radiation without affecting DNA end joining; when associated with A-2638.	ECO:0000269|PubMed:12649176	12649176

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
P80192	MAP3K9	A246V	P80192/A246V	MAP3K9/A246V	VARIANT	A -> V (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
P80192	MAP3K9	R467C	P80192/R467C	MAP3K9/R467C	VARIANT	R -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs773256562)	ECO:0000269|PubMed:17344846	17344846
P80192	MAP3K9	R497Q	P80192/R497Q	MAP3K9/R497Q	VARIANT	R -> Q (in dbSNP:rs56196343)	ECO:0000269|PubMed:17344846	17344846
P80192	MAP3K9	Y646C	P80192/Y646C	MAP3K9/Y646C	VARIANT	Y -> C (in dbSNP:rs34322726)	ECO:0000269|PubMed:17344846	17344846
P80192	MAP3K9	K171A	P80192/K171A	MAP3K9/K171A	MUTAGEN	K->A: Loss of kinase activity and threonine phosphorylation.	ECO:0000269|PubMed:15610029	15610029
P80192	MAP3K9	T304A	P80192/T304A	MAP3K9/T304A	MUTAGEN	T->A: Reduces threonine phosphorylation. Impairs JNK activation.	ECO:0000269|PubMed:15610029	15610029
P80192	MAP3K9	T305A	P80192/T305A	MAP3K9/T305A	MUTAGEN	T->A: Little effect on threonine phosphorylation. Mildly impairs JNK activation.	ECO:0000269|PubMed:15610029	15610029
P80192	MAP3K9	S308A	P80192/S308A	MAP3K9/S308A	MUTAGEN	S->A: Impairs JNK activation.	ECO:0000269|PubMed:15610029	15610029
P80192	MAP3K9	T312A	P80192/T312A	MAP3K9/T312A	MUTAGEN	T->A: Loss of threonine phosphorylation. Strongly impairs JNK activation.	ECO:0000269|PubMed:15610029	15610029

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q00526	CDK3	S106N	Q00526/S106N	CDK3/S106N	VARIANT	S -> N (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q00526	CDK3	I124T	Q00526/I124T	CDK3/I124T	VARIANT	I -> T (in dbSNP:rs34918446)	ECO:0000269|PubMed:17344846	17344846
Q00526	CDK3	R214H	Q00526/R214H	CDK3/R214H	VARIANT	R -> H (in dbSNP:rs34670267)	ECO:0000269|PubMed:17344846	17344846
Q00526	CDK3	T226I	Q00526/T226I	CDK3/T226I	VARIANT	T -> I (in dbSNP:rs2069532)	ECO:0000269|Ref.2	
Q00526	CDK3	M264T	Q00526/M264T	CDK3/M264T	VARIANT	M -> T (in dbSNP:rs17884251)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.2	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q00532	CDKL1	L67P	Q00532/L67P	CDKL1/L67P	VARIANT	L -> P (in dbSNP:rs11570814)	ECO:0000269|Ref.3	
Q00532	CDKL1	Q275E	Q00532/Q275E	CDKL1/Q275E	VARIANT	Q -> E (in dbSNP:rs7161563)	ECO:0000269|PubMed:1639063, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:29420175, ECO:0000269|Ref.3	1639063,17344846,29420175
Q00532	CDKL1	L330V	Q00532/L330V	CDKL1/L330V	VARIANT	L -> V (in dbSNP:rs9323183)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	17344846
Q00532	CDKL1	K342N	Q00532/K342N	CDKL1/K342N	VARIANT	K -> N (in dbSNP:rs770928060)	ECO:0000269|Ref.3	

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q00534	CDK6	D110N	Q00534/D110N	CDK6/D110N	VARIANT	D -> N (in dbSNP:rs35654944)	ECO:0000269|PubMed:17344846	17344846
Q00534	CDK6	A197T	Q00534/A197T	CDK6/A197T	VARIANT	A -> T (in MCPH12; dbSNP:rs606231255)	ECO:0000269|PubMed:23918663	23918663
Q00534	CDK6	P199L	Q00534/P199L	CDK6/P199L	VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q00535	CDK5	E225D	Q00535/E225D	CDK5/E225D	VARIANT	E -> D (in dbSNP:rs35186917)	ECO:0000269|PubMed:17344846	17344846
Q00535	CDK5	S159A	Q00535/S159A	CDK5/S159A	MUTAGEN	S->A: No phenotype.	ECO:0000269|PubMed:11583627	11583627
Q00535	CDK5	S159T	Q00535/S159T	CDK5/S159T	MUTAGEN	S->T: Impaired p35/p25 (CDK5R1) binding.	ECO:0000269|PubMed:11583627	11583627

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q00536	CDK16	S12A	Q00536/S12A	CDK16/S12A	MUTAGEN	S->A: Abolishes phosphorylation by BRSK2. Abolishes effect on insulin secretion.	ECO:0000269|PubMed:22798068	22798068
Q00536	CDK16	S119A	Q00536/S119A	CDK16/S119A	MUTAGEN	S->A: Strongly reduces interaction with CCNY.	ECO:0000269|PubMed:22184064	22184064
Q00536	CDK16	S153A	Q00536/S153A	CDK16/S153A	MUTAGEN	S->A: Constitutively activated, due to loss of an inhibitory phosphorylation site. Increases interaction with CCNY.	ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22798068	22184064,22798068
Q00536	CDK16	S153D	Q00536/S153D	CDK16/S153D	MUTAGEN	S->D: Abolishes interaction with CCNY.	ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22798068	22184064,22798068
Q00536	CDK16	K194A	Q00536/K194A	CDK16/K194A	MUTAGEN	K->A: Loss of kinase activity. Abolishes effect on insulin secretion.	ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22798068	22184064,22798068
Q00536	CDK16	K194R	Q00536/K194R	CDK16/K194R	MUTAGEN	K->R: Loss of kinase activity.	ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22798068	22184064,22798068

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q00537	CDK17	T214I	Q00537/T214I	CDK17/T214I	VARIANT	T -> I (found in a renal cell carcinoma sample; somatic mutation; dbSNP:rs764448325)	ECO:0000269|PubMed:21248752	21248752

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q01973	ROR1	G144E	Q01973/G144E	ROR1/G144E	VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q01973	ROR1	F150L	Q01973/F150L	ROR1/F150L	VARIANT	F -> L (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q01973	ROR1	I301V	Q01973/I301V	ROR1/I301V	VARIANT	I -> V (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q01973	ROR1	T518M	Q01973/T518M	ROR1/T518M	VARIANT	T -> M (in dbSNP:rs7527017)	ECO:0000269|PubMed:1334494, ECO:0000269|PubMed:17344846	1334494,17344846
Q01973	ROR1	E562D	Q01973/E562D	ROR1/E562D	VARIANT	E -> D (in a breast cancer sample; somatic mutation; dbSNP:rs760789417)	ECO:0000269|PubMed:16959974	16959974
Q01973	ROR1	R567I	Q01973/R567I	ROR1/R567I	VARIANT	R -> I (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q01973	ROR1	G624R	Q01973/G624R	ROR1/G624R	VARIANT	G -> R (in dbSNP:rs55832740)	ECO:0000269|PubMed:17344846	17344846
Q01973	ROR1	Y646C	Q01973/Y646C	ROR1/Y646C	VARIANT	Y -> C (in dbSNP:rs34109134)	ECO:0000269|PubMed:17344846	17344846
Q01973	ROR1	R736T	Q01973/R736T	ROR1/R736T	VARIANT	R -> T (in DFNB108; impairs plasma membrane location; abolishes downstream NFkB activation; dbSNP:rs1553163562)	ECO:0000269|PubMed:27162350	27162350
Q01973	ROR1	S776N	Q01973/S776N	ROR1/S776N	VARIANT	S -> N (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q01973	ROR1	C482G	Q01973/C482G	ROR1/C482G	MUTAGEN	C->G: No effect on kinase activity.	ECO:0000269|PubMed:25029443	25029443

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q01974	ROR2	C182Y	Q01974/C182Y	ROR2/C182Y	VARIANT	C -> Y (in RRS1)	ECO:0000269|PubMed:10932187	10932187
Q01974	ROR2	R184C	Q01974/R184C	ROR2/R184C	VARIANT	R -> C (in RRS1; dbSNP:rs121909084)	ECO:0000269|PubMed:10932186	10932186
Q01974	ROR2	R189W	Q01974/R189W	ROR2/R189W	VARIANT	R -> W (in RRS1; dbSNP:rs199975149)	ECO:0000269|PubMed:10932186	10932186
Q01974	ROR2	R244Q	Q01974/R244Q	ROR2/R244Q	VARIANT	R -> Q (in dbSNP:rs55737262)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	T245A	Q01974/T245A	ROR2/T245A	VARIANT	T -> A (in dbSNP:rs10820900)	ECO:0000269|PubMed:10700182, ECO:0000269|PubMed:10986040, ECO:0000269|PubMed:1334494, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	10700182,10986040,1334494,17344846
Q01974	ROR2	H349D	Q01974/H349D	ROR2/H349D	VARIANT	H -> D (in dbSNP:rs55983376)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	R366W	Q01974/R366W	ROR2/R366W	VARIANT	R -> W (in RRS1)	ECO:0000269|PubMed:10932186	10932186
Q01974	ROR2	G490A	Q01974/G490A	ROR2/G490A	VARIANT	G -> A (in dbSNP:rs56197744)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	R530Q	Q01974/R530Q	ROR2/R530Q	VARIANT	R -> Q (in dbSNP:rs35852786)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	V542M	Q01974/V542M	ROR2/V542M	VARIANT	V -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs140213020)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	P548S	Q01974/P548S	ROR2/P548S	VARIANT	P -> S (in dbSNP:rs35764413)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	S557L	Q01974/S557L	ROR2/S557L	VARIANT	S -> L (in dbSNP:rs56099091)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	N620K	Q01974/N620K	ROR2/N620K	VARIANT	N -> K (in RRS1)	ECO:0000269|PubMed:10932186	10932186
Q01974	ROR2	D644N	Q01974/D644N	ROR2/D644N	VARIANT	D -> N (in dbSNP:rs55798732)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	D672N	Q01974/D672N	ROR2/D672N	VARIANT	D -> N (in dbSNP:rs55651110)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	G695R	Q01974/G695R	ROR2/G695R	VARIANT	G -> R (in dbSNP:rs34431454)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	R738C	Q01974/R738C	ROR2/R738C	VARIANT	R -> C (in dbSNP:rs56231927)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	S762L	Q01974/S762L	ROR2/S762L	VARIANT	S -> L (in dbSNP:rs34491822)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	V819I	Q01974/V819I	ROR2/V819I	VARIANT	V -> I (in dbSNP:rs10761129)	ECO:0000269|PubMed:10700182, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	10700182,17344846
Q01974	ROR2	D935E	Q01974/D935E	ROR2/D935E	VARIANT	D -> E (in dbSNP:rs41277835)	ECO:0000269|PubMed:17344846	17344846
Q01974	ROR2	D482G	Q01974/D482G	ROR2/D482G	MUTAGEN	D->G: Slight increase in kinase activity.	ECO:0000269|PubMed:25029443	25029443

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q02156	PRKCE	E143K	Q02156/E143K	PRKCE/E143K	VARIANT	E -> K (in a colorectal cancer sample; somatic mutation; dbSNP:rs772834505)	ECO:0000269|PubMed:16959974	16959974
Q02156	PRKCE	A333V	Q02156/A333V	PRKCE/A333V	VARIANT	A -> V (in dbSNP:rs55989965)	ECO:0000269|PubMed:17344846	17344846
Q02156	PRKCE	P389R	Q02156/P389R	PRKCE/P389R	VARIANT	P -> R (in dbSNP:rs55767130)	ECO:0000269|PubMed:17344846	17344846
Q02156	PRKCE	T563M	Q02156/T563M	PRKCE/T563M	VARIANT	T -> M (in dbSNP:rs34077350)	ECO:0000269|PubMed:17344846	17344846
Q02156	PRKCE	A654T	Q02156/A654T	PRKCE/A654T	VARIANT	A -> T (in dbSNP:rs35777875)		
Q02156	PRKCE	K437W	Q02156/K437W	PRKCE/K437W	MUTAGEN	K->W: Abolishes activity and S-729 phosphorylation.	ECO:0000269|PubMed:11964154	11964154
Q02156	PRKCE	T566A	Q02156/T566A	PRKCE/T566A	MUTAGEN	T->A: Abolishes phosphorylation by PDK1, and S-729 phosphorylation.	ECO:0000269|PubMed:11964154	11964154
Q02156	PRKCE	T566E	Q02156/T566E	PRKCE/T566E	MUTAGEN	T->E: No effect on S-729 phosphorylation.	ECO:0000269|PubMed:11964154	11964154
Q02156	PRKCE	T710E	Q02156/T710E	PRKCE/T710E	MUTAGEN	T->E: No effect on activity; no effect on S-729 phosphorylation.	ECO:0000269|PubMed:11964154	11964154
Q02156	PRKCE	S729A	Q02156/S729A	PRKCE/S729A	MUTAGEN	S->A: Enhances T-566 dephosphorylation.	ECO:0000269|PubMed:11964154	11964154

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q02750	MAP2K1	F53S	Q02750/F53S	MAP2K1/F53S	VARIANT	F -> S (in CFC3; dbSNP:rs121908594)	ECO:0000269|PubMed:16439621	16439621
Q02750	MAP2K1	Q56P	Q02750/Q56P	MAP2K1/Q56P	VARIANT	Q -> P (in MEL; somatic mutation; dbSNP:rs1057519729)	ECO:0000269|PubMed:29643386	29643386
Q02750	MAP2K1	K57E	Q02750/K57E	MAP2K1/K57E	VARIANT	K -> E (in MEL; somatic mutation; dbSNP:rs397516790)	ECO:0000269|PubMed:29643386	29643386
Q02750	MAP2K1	K57N	Q02750/K57N	MAP2K1/K57N	VARIANT	K -> N (in MEL; somatic mutation; results in increased MAPK signal transduction; dbSNP:rs869025608)	ECO:0000269|PubMed:29643386	29643386
Q02750	MAP2K1	G128V	Q02750/G128V	MAP2K1/G128V	VARIANT	G -> V (in CFC3; dbSNP:rs121908596)	ECO:0000269|PubMed:18042262	18042262
Q02750	MAP2K1	Y130C	Q02750/Y130C	MAP2K1/Y130C	VARIANT	Y -> C (in CFC3; dbSNP:rs121908595)	ECO:0000269|PubMed:16439621	16439621
Q02750	MAP2K1	K97A	Q02750/K97A	MAP2K1/K97A	MUTAGEN	K->A: Loss of catalytic activity. Strongly reduces phosphorylation upon UV irradiation.	ECO:0000269|PubMed:20956560	20956560
Q02750	MAP2K1	K97R	Q02750/K97R	MAP2K1/K97R	MUTAGEN	K->R: Loss of catalytic activity. No effect on BRAF-KSR1 or BRAF-KSR2 dimerization.	ECO:0000269|PubMed:29433126, ECO:0000269|PubMed:8131746	29433126,8131746
Q02750	MAP2K1	S150A	Q02750/S150A	MAP2K1/S150A	MUTAGEN	S->A: No loss of activity.	ECO:0000269|PubMed:8131746	8131746
Q02750	MAP2K1	S212A	Q02750/S212A	MAP2K1/S212A	MUTAGEN	S->A: No loss of activity.	ECO:0000269|PubMed:8131746	8131746
Q02750	MAP2K1	S218A	Q02750/S218A	MAP2K1/S218A	MUTAGEN	S->A: Loss of catalytic activity. No effect on BRAF-KSR1 dimerization; when associated with A-222.	ECO:0000269|PubMed:29433126, ECO:0000269|PubMed:8131746	29433126,8131746
Q02750	MAP2K1	S218D	Q02750/S218D	MAP2K1/S218D	MUTAGEN	S->D: No effect on BRAF-KSR1 dimerization; when associated with D-222.	ECO:0000269|PubMed:29433126	29433126
Q02750	MAP2K1	M219V	Q02750/M219V	MAP2K1/M219V	MUTAGEN	M->V: Increases interaction with KSR1 and BRAF.	ECO:0000269|PubMed:29433126	29433126
Q02750	MAP2K1	M219W	Q02750/M219W	MAP2K1/M219W	MUTAGEN	M->W: Increases interaction with KSR1 and BRAF; when associated with L-220.	ECO:0000269|PubMed:29433126	29433126
Q02750	MAP2K1	A220L	Q02750/A220L	MAP2K1/A220L	MUTAGEN	A->L: Increases interaction with KSR1 and BRAF; when associated with w-219.	ECO:0000269|PubMed:29433126	29433126
Q02750	MAP2K1	N221Y	Q02750/N221Y	MAP2K1/N221Y	MUTAGEN	N->Y: Increases interaction with KSR1 and BRAF.	ECO:0000269|PubMed:29433126	29433126
Q02750	MAP2K1	S222A	Q02750/S222A	MAP2K1/S222A	MUTAGEN	S->A: Loss of catalytic activity. No effect on BRAF-KSR1 dimerization; when associated with A-218.	ECO:0000269|PubMed:29433126, ECO:0000269|PubMed:8131746	29433126,8131746
Q02750	MAP2K1	S222D	Q02750/S222D	MAP2K1/S222D	MUTAGEN	S->D: No effect on BRAF-KSR1 dimerization; when associated with D-218.	ECO:0000269|PubMed:29433126	29433126
Q02750	MAP2K1	F311S	Q02750/F311S	MAP2K1/F311S	MUTAGEN	F->S: Loss of interaction with BRAF and KSR1. Loss of BRAF-KSR1 dimerization.	ECO:0000269|PubMed:29433126	29433126

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q02763	TEK	K117N	Q02763/K117N	TEK/K117N	VARIANT	K -> N (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17344846	16959974,17344846
Q02763	TEK	I148T	Q02763/I148T	TEK/I148T	VARIANT	I -> T (in dbSNP:rs35969327)	ECO:0000269|PubMed:17344846	17344846
Q02763	TEK	A226V	Q02763/A226V	TEK/A226V	VARIANT	A -> V (in dbSNP:rs35814893)	ECO:0000269|PubMed:17344846	17344846
Q02763	TEK	C233Y	Q02763/C233Y	TEK/C233Y	VARIANT	C -> Y (in GLC3E; enhanced proteasomal degradation)	ECO:0000269|PubMed:27270174	27270174
Q02763	TEK	K294N	Q02763/K294N	TEK/K294N	VARIANT	K -> N (in GLC3E; unknown pathological significance; 10-fold decrease of Tyr-1102 phosphorylation; no effect on membrane location; dbSNP:rs146169480)	ECO:0000269|PubMed:27270174	27270174
Q02763	TEK	Q346P	Q02763/Q346P	TEK/Q346P	VARIANT	Q -> P (in dbSNP:rs682632)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:8382358, ECO:0000269|Ref.4	14702039,15489334,8382358
Q02763	TEK	T391I	Q02763/T391I	TEK/T391I	VARIANT	T -> I (in dbSNP:rs34032300)		
Q02763	TEK	V486I	Q02763/V486I	TEK/V486I	VARIANT	V -> I (in dbSNP:rs1334811)	ECO:0000269|PubMed:17344846	17344846
Q02763	TEK	V600L	Q02763/V600L	TEK/V600L	VARIANT	V -> L (in dbSNP:rs35030851)	ECO:0000269|PubMed:17344846	17344846
Q02763	TEK	Y611C	Q02763/Y611C	TEK/Y611C	VARIANT	Y -> C (in GLC3E; reduced response to ligand; loss of ligand-induced phosphorylation; no effect on basal membrane location; dbSNP:rs1306527531)	ECO:0000269|PubMed:27270174	27270174
Q02763	TEK	L634F	Q02763/L634F	TEK/L634F	VARIANT	L -> F (in dbSNP:rs35378598)	ECO:0000269|PubMed:17344846	17344846
Q02763	TEK	V676I	Q02763/V676I	TEK/V676I	VARIANT	V -> I (in dbSNP:rs56367117)	ECO:0000269|PubMed:17344846	17344846
Q02763	TEK	A724T	Q02763/A724T	TEK/A724T	VARIANT	A -> T (in dbSNP:rs4631561)	ECO:0000269|PubMed:17344846	17344846
Q02763	TEK	R849W	Q02763/R849W	TEK/R849W	VARIANT	R -> W (in VMCM; increased ligand-independent autophosphorylation and kinase activation; no effect on location at membrane; dbSNP:rs80338908)	ECO:0000269|PubMed:10369874, ECO:0000269|PubMed:19079259, ECO:0000269|PubMed:19888299, ECO:0000269|PubMed:8980225	10369874,19079259,19888299,8980225
Q02763	TEK	P883A	Q02763/P883A	TEK/P883A	VARIANT	P -> A (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs1490428165)	ECO:0000269|PubMed:17344846	17344846
Q02763	TEK	Y897C	Q02763/Y897C	TEK/Y897C	VARIANT	Y -> C (in VMCM; increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs80338909)	ECO:0000269|PubMed:19888299	19888299
Q02763	TEK	Y897F	Q02763/Y897F	TEK/Y897F	VARIANT	Y -> F (found in a patient with multiple sporadic venous malformations; increased ligand-independent autophosphorylation; the hyperphosphorylation increases when associated with Leu-915)	ECO:0000269|PubMed:19079259	19079259
Q02763	TEK	Y897H	Q02763/Y897H	TEK/Y897H	VARIANT	Y -> H (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation)	ECO:0000269|PubMed:19079259	19079259
Q02763	TEK	Y897S	Q02763/Y897S	TEK/Y897S	VARIANT	Y -> S (in VMCM; also found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs80338909)	ECO:0000269|PubMed:10369874, ECO:0000269|PubMed:19079259, ECO:0000269|PubMed:19888299	10369874,19079259,19888299
Q02763	TEK	L914F	Q02763/L914F	TEK/L914F	VARIANT	L -> F (found in patients with solitary and multiple sporadic venous malformations; increased ligand-independent autophosphorylation; novel location at endoplasmic reticulum and Golgi apparatus; partially retained at endoplasmic reticulum and Golgi apparatus; dbSNP:rs1825682849)	ECO:0000269|PubMed:19079259	19079259
Q02763	TEK	R915C	Q02763/R915C	TEK/R915C	VARIANT	R -> C (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation; dbSNP:rs1825682922)	ECO:0000269|PubMed:19079259	19079259
Q02763	TEK	R915H	Q02763/R915H	TEK/R915H	VARIANT	R -> H (in VMCM; strongly increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs387906745)	ECO:0000269|PubMed:19888299	19888299
Q02763	TEK	R915L	Q02763/R915L	TEK/R915L	VARIANT	R -> L (found in a patient with multiple sporadic venous malformations; increased ligand-independent autophosphorylation; the autophosphorylation increases when associated with Phe-897)	ECO:0000269|PubMed:19079259	19079259
Q02763	TEK	S917I	Q02763/S917I	TEK/S917I	VARIANT	S -> I (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation)	ECO:0000269|PubMed:19079259	19079259
Q02763	TEK	R918C	Q02763/R918C	TEK/R918C	VARIANT	R -> C (in VMCM; strongly increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs1825683100)	ECO:0000269|PubMed:19888299	19888299
Q02763	TEK	V919L	Q02763/V919L	TEK/V919L	VARIANT	V -> L (in VMCM; increased ligand-independent autophosphorylation and kinase activation)	ECO:0000269|PubMed:19888299	19888299
Q02763	TEK	A925S	Q02763/A925S	TEK/A925S	VARIANT	A -> S (in VMCM; increased ligand-independent autophosphorylation and kinase activation)	ECO:0000269|PubMed:19888299	19888299
Q02763	TEK	K1100N	Q02763/K1100N	TEK/K1100N	VARIANT	K -> N (in VMCM; strongly increased ligand-independent autophosphorylation and kinase activation)	ECO:0000269|PubMed:19888299	19888299
Q02763	TEK	A1124V	Q02763/A1124V	TEK/A1124V	VARIANT	A -> V (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q02763	TEK	C224S	Q02763/C224S	TEK/C224S	MUTAGEN	C->S: Reduces protein abundance.	ECO:0000269|PubMed:27270174	27270174
Q02763	TEK	K855R	Q02763/K855R	TEK/K855R	MUTAGEN	K->R: Loss of kinase activity.	ECO:0000269|PubMed:12609966, ECO:0000269|PubMed:15851516	12609966,15851516
Q02763	TEK	Y1102F	Q02763/Y1102F	TEK/Y1102F	MUTAGEN	Y->F: Abolishes interaction with SHC1.	ECO:0000269|PubMed:14665640	14665640

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q02779	MAP3K10	G107E	Q02779/G107E	MAP3K10/G107E	VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q02779	MAP3K10	P168Q	Q02779/P168Q	MAP3K10/P168Q	VARIANT	P -> Q (in dbSNP:rs36102209)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q02846	GUCY2D	W21R	Q02846/W21R	GUCY2D/W21R	VARIANT	W -> R (in dbSNP:rs9905402)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	A52S	Q02846/A52S	GUCY2D/A52S	VARIANT	A -> S (in LCA1; unknown pathological significance; dbSNP:rs61749665)	ECO:0000269|PubMed:21602930, ECO:0000269|PubMed:8944027	21602930,8944027
Q02846	GUCY2D	T55M	Q02846/T55M	GUCY2D/T55M	VARIANT	T -> M (in LCA1; dbSNP:rs201414567)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	E103V	Q02846/E103V	GUCY2D/E103V	VARIANT	E -> V (in LCA1)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	C105Y	Q02846/C105Y	GUCY2D/C105Y	VARIANT	C -> Y (in LCA1; does not affect basal guanylate cyclase activity; reduces GUCA1A-induced guanylate cyclase activity; dbSNP:rs61749669)	ECO:0000269|PubMed:11035546, ECO:0000269|PubMed:15123990	11035546,15123990
Q02846	GUCY2D	T312M	Q02846/T312M	GUCY2D/T312M	VARIANT	T -> M (in LCA1; dbSNP:rs61749673)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	L325P	Q02846/L325P	GUCY2D/L325P	VARIANT	L -> P (in LCA1; does not affect basal guanylate cyclase activity; reduces GUCA1A-induced guanylate cyclase activity; dbSNP:rs61749675)	ECO:0000269|PubMed:11035546, ECO:0000269|PubMed:15123990	11035546,15123990
Q02846	GUCY2D	L325R	Q02846/L325R	GUCY2D/L325R	VARIANT	L -> R (found in a patient with LCA1)	ECO:0000269|PubMed:17724218	17724218
Q02846	GUCY2D	A328V	Q02846/A328V	GUCY2D/A328V	VARIANT	A -> V (in dbSNP:rs56280231)	ECO:0000269|PubMed:17344846	17344846
Q02846	GUCY2D	R331S	Q02846/R331S	GUCY2D/R331S	VARIANT	R -> S (in dbSNP:rs34596269)		
Q02846	GUCY2D	A362S	Q02846/A362S	GUCY2D/A362S	VARIANT	A -> S (in LCA1; dbSNP:rs61749677)		
Q02846	GUCY2D	G431D	Q02846/G431D	GUCY2D/G431D	VARIANT	G -> D (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1451501407)	ECO:0000269|PubMed:17344846	17344846
Q02846	GUCY2D	R438C	Q02846/R438C	GUCY2D/R438C	VARIANT	R -> C (in LCA1; dbSNP:rs565948960)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	V507M	Q02846/V507M	GUCY2D/V507M	VARIANT	V -> M (in dbSNP:rs746002871)	ECO:0000269|PubMed:17344846	17344846
Q02846	GUCY2D	F565S	Q02846/F565S	GUCY2D/F565S	VARIANT	F -> S (in LCA1; loss of activity; dbSNP:rs61749755)	ECO:0000269|PubMed:9888789	9888789
Q02846	GUCY2D	I573V	Q02846/I573V	GUCY2D/I573V	VARIANT	I -> V (in LCA1; dbSNP:rs61749756)		
Q02846	GUCY2D	R602W	Q02846/R602W	GUCY2D/R602W	VARIANT	R -> W (in dbSNP:rs770740012)		
Q02846	GUCY2D	W640L	Q02846/W640L	GUCY2D/W640L	VARIANT	W -> L (in LCA1)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	R660Q	Q02846/R660Q	GUCY2D/R660Q	VARIANT	R -> Q (in LCA1; dbSNP:rs61750162)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	A693E	Q02846/A693E	GUCY2D/A693E	VARIANT	A -> E (in dbSNP:rs35146471)	ECO:0000269|PubMed:17344846	17344846
Q02846	GUCY2D	P701S	Q02846/P701S	GUCY2D/P701S	VARIANT	P -> S (at homozygosity may be associated with Leber congenital amaurosis in some populations; dbSNP:rs34598902)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17724218, ECO:0000269|PubMed:21602930	17344846,17724218,21602930
Q02846	GUCY2D	A710V	Q02846/A710V	GUCY2D/A710V	VARIANT	A -> V (in LCA1; loss of basal and GUCA1A-induced guanylate cyclase activity; does not affect endoplasmic reticulum membrane localization; dbSNP:rs781725943)	ECO:0000269|PubMed:27475985, ECO:0000269|PubMed:30319355	27475985,30319355
Q02846	GUCY2D	R722W	Q02846/R722W	GUCY2D/R722W	VARIANT	R -> W (in dbSNP:rs34331388)		
Q02846	GUCY2D	D728H	Q02846/D728H	GUCY2D/D728H	VARIANT	D -> H (in LCA1)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	I734A	Q02846/I734A	GUCY2D/I734A	VARIANT	I -> A (in LCA1; requires 2 nucleotide substitutions)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	R768W	Q02846/R768W	GUCY2D/R768W	VARIANT	R -> W (in LCA1 and CSNB1I; dbSNP:rs61750168)	ECO:0000269|PubMed:17724218, ECO:0000269|PubMed:21602930, ECO:0000269|PubMed:29559409	17724218,21602930,29559409
Q02846	GUCY2D	L782H	Q02846/L782H	GUCY2D/L782H	VARIANT	L -> H (in dbSNP:rs8069344)	ECO:0000269|PubMed:17344846	17344846
Q02846	GUCY2D	M784R	Q02846/M784R	GUCY2D/M784R	VARIANT	M -> R (in LCA1; dbSNP:rs375010731)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	R795Q	Q02846/R795Q	GUCY2D/R795Q	VARIANT	R -> Q (in LCA1; dbSNP:rs61750171)	ECO:0000269|PubMed:17724218	17724218
Q02846	GUCY2D	E837D	Q02846/E837D	GUCY2D/E837D	VARIANT	E -> D (in CORD6; dbSNP:rs28933695)	ECO:0000269|PubMed:9618177	9618177
Q02846	GUCY2D	R838C	Q02846/R838C	GUCY2D/R838C	VARIANT	R -> C (in CORD6; dbSNP:rs61750172)	ECO:0000269|PubMed:12552567, ECO:0000269|PubMed:18487367, ECO:0000269|PubMed:25515582, ECO:0000269|PubMed:9618177	12552567,18487367,25515582,9618177
Q02846	GUCY2D	R838G	Q02846/R838G	GUCY2D/R838G	VARIANT	R -> G (in CORD6)	ECO:0000269|PubMed:18487367	18487367
Q02846	GUCY2D	R838H	Q02846/R838H	GUCY2D/R838H	VARIANT	R -> H (in CORD6; dbSNP:rs61750173)	ECO:0000269|PubMed:12552567, ECO:0000269|PubMed:18487367, ECO:0000269|PubMed:22194653, ECO:0000269|PubMed:24480840	12552567,18487367,22194653,24480840
Q02846	GUCY2D	R838P	Q02846/R838P	GUCY2D/R838P	VARIANT	R -> P (in CORD6; dbSNP:rs61750173)	ECO:0000269|PubMed:21552474	21552474
Q02846	GUCY2D	E841K	Q02846/E841K	GUCY2D/E841K	VARIANT	E -> K (in CORD6; decreases basal and GUCA1A-induced guanylate cyclase activity; inhibition by RD3 is less effective; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1341592819)	ECO:0000269|PubMed:25515582, ECO:0000269|PubMed:30319355	25515582,30319355
Q02846	GUCY2D	K846N	Q02846/K846N	GUCY2D/K846N	VARIANT	K -> N (in CORD6; decreases basal and GUCA1A-induced guanylate cyclase activity; inhibition by RD3 is less effective; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1598150539)	ECO:0000269|PubMed:25515582, ECO:0000269|PubMed:30319355	25515582,30319355
Q02846	GUCY2D	T849A	Q02846/T849A	GUCY2D/T849A	VARIANT	T -> A (in CORD6)	ECO:0000269|PubMed:23734073	23734073
Q02846	GUCY2D	P858S	Q02846/P858S	GUCY2D/P858S	VARIANT	P -> S (in LCA1; severely impairs basal and GUCA1A-induced guanylate cyclase activity; dbSNP:rs61750176)	ECO:0000269|PubMed:11035546, ECO:0000269|PubMed:15123990	11035546,15123990
Q02846	GUCY2D	P873R	Q02846/P873R	GUCY2D/P873R	VARIANT	P -> R (in CORD6; loss basal and GUCA1A-induced guanylate cyclase activity; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1567961680)	ECO:0000269|PubMed:30319355	30319355
Q02846	GUCY2D	V902L	Q02846/V902L	GUCY2D/V902L	VARIANT	V -> L (in LCA1; increases basal and GUCA1A-induced guanylate cyclase activity; inhibition by RD3 is less effective; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1598150793)	ECO:0000269|PubMed:30319355	30319355
Q02846	GUCY2D	V933A	Q02846/V933A	GUCY2D/V933A	VARIANT	V -> A (in CACD1; unknown pathological significance; dbSNP:rs1567961904)	ECO:0000269|PubMed:22695961	22695961
Q02846	GUCY2D	I949T	Q02846/I949T	GUCY2D/I949T	VARIANT	I -> T (in CORD6; dbSNP:rs267606857)	ECO:0000269|PubMed:20517349	20517349
Q02846	GUCY2D	L954P	Q02846/L954P	GUCY2D/L954P	VARIANT	L -> P (in LCA1; severely impairs basal and GUCA1A induced guanylate cyclase; dbSNP:rs61750182)	ECO:0000269|PubMed:12365911, ECO:0000269|PubMed:15123990	12365911,15123990
Q02846	GUCY2D	S1007L	Q02846/S1007L	GUCY2D/S1007L	VARIANT	S -> L (in LCA1)	ECO:0000269|PubMed:21602930	21602930
Q02846	GUCY2D	I1027IGI	Q02846/I1027IGI	GUCY2D/I1027IGI	VARIANT	I -> IGI (in LCA1)		
Q02846	GUCY2D	R822P	Q02846/R822P	GUCY2D/R822P	MUTAGEN	R->P: Fails to become activated by GUCA1A and by GUCA1B. Does not affect the binding to RP3.	ECO:0000269|PubMed:26100624	26100624
Q02846	GUCY2D	M823R	Q02846/M823R	GUCY2D/M823R	MUTAGEN	M->R: Fails to become activated by GUCA1A and by GUCA1B. Does not affect the binding to RP3.	ECO:0000269|PubMed:26100624	26100624
Q02846	GUCY2D	E925K	Q02846/E925K	GUCY2D/E925K	MUTAGEN	E->K: Changes the substrate specificity from GTP to ATP.	ECO:0000269|PubMed:9600905	9600905
Q02846	GUCY2D	C997D	Q02846/C997D	GUCY2D/C997D	MUTAGEN	C->D: Changes the substrate specificity from GTP to ATP.	ECO:0000269|PubMed:9600905	9600905

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q04759	PRKCQ	K240N	Q04759/K240N	PRKCQ/K240N	VARIANT	K -> N (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q04759	PRKCQ	D306V	Q04759/D306V	PRKCQ/D306V	VARIANT	D -> V (in dbSNP:rs45590231)	ECO:0000269|PubMed:17344846	17344846
Q04759	PRKCQ	P330L	Q04759/P330L	PRKCQ/P330L	VARIANT	P -> L (in dbSNP:rs2236379)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7686153, ECO:0000269|Ref.4	17344846,7686153
Q04759	PRKCQ	D354N	Q04759/D354N	PRKCQ/D354N	VARIANT	D -> N (in dbSNP:rs34524148)	ECO:0000269|PubMed:17344846	17344846
Q04759	PRKCQ	Y90F	Q04759/Y90F	PRKCQ/Y90F	MUTAGEN	Y->F: Loss of function in T-cells proliferation. No effect on kinase activity.	ECO:0000269|PubMed:10652356	10652356
Q04759	PRKCQ	A148E	Q04759/A148E	PRKCQ/A148E	MUTAGEN	A->E: Constitutively active form.	ECO:0000269|PubMed:10652356	10652356
Q04759	PRKCQ	T219A	Q04759/T219A	PRKCQ/T219A	MUTAGEN	T->A: Loss of transactivation of the IL2 promoter and translocation to the plasma membrane. No effect on kinase activity.	ECO:0000269|PubMed:16252004	16252004
Q04759	PRKCQ	K409A	Q04759/K409A	PRKCQ/K409A	MUTAGEN	K->A,E: Loss of kinase activity.		
Q04759	PRKCQ	K409E	Q04759/K409E	PRKCQ/K409E	MUTAGEN	K->A,E: Loss of kinase activity.	ECO:0000269|PubMed:10652356	10652356
Q04759	PRKCQ	T538A	Q04759/T538A	PRKCQ/T538A	MUTAGEN	T->A: Loss of kinase activity.	ECO:0000269|PubMed:11772397, ECO:0000269|PubMed:16252004	11772397,16252004
Q04759	PRKCQ	S676A	Q04759/S676A	PRKCQ/S676A	MUTAGEN	S->A: Reduction in kinase activity.	ECO:0000269|PubMed:16252004	16252004
Q04759	PRKCQ	S695A	Q04759/S695A	PRKCQ/S695A	MUTAGEN	S->A: Reduction in kinase activity.	ECO:0000269|PubMed:11772397, ECO:0000269|PubMed:16252004	11772397,16252004

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q04771	ACVR1	A15G	Q04771/A15G	ACVR1/A15G	VARIANT	A -> G (in dbSNP:rs13406336)	ECO:0000269|PubMed:17344846	17344846
Q04771	ACVR1	S41F	Q04771/S41F	ACVR1/S41F	VARIANT	S -> F (in dbSNP:rs55957214)	ECO:0000269|PubMed:17344846	17344846
Q04771	ACVR1	H47Q	Q04771/H47Q	ACVR1/H47Q	VARIANT	H -> Q (in dbSNP:rs34056189)	ECO:0000269|PubMed:17344846	17344846
Q04771	ACVR1	P115S	Q04771/P115S	ACVR1/P115S	VARIANT	P -> S (in a melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q04771	ACVR1	R202I	Q04771/R202I	ACVR1/R202I	VARIANT	R -> I (in FOP; with some atypical features; dbSNP:rs387906591)	ECO:0000269|PubMed:19330033	19330033
Q04771	ACVR1	R206H	Q04771/R206H	ACVR1/R206H	VARIANT	R -> H (in FOP; dbSNP:rs121912678)	ECO:0000269|PubMed:16642017, ECO:0000269|PubMed:19085907	16642017,19085907
Q04771	ACVR1	Q207E	Q04771/Q207E	ACVR1/Q207E	VARIANT	Q -> E (in FOP; with some atypical features)	ECO:0000269|PubMed:19085907	19085907
Q04771	ACVR1	G328E	Q04771/G328E	ACVR1/G328E	VARIANT	G -> E (in FOP; variant phenotype; dbSNP:rs387906589)	ECO:0000269|PubMed:19085907, ECO:0000269|PubMed:19330033	19085907,19330033
Q04771	ACVR1	G328R	Q04771/G328R	ACVR1/G328R	VARIANT	G -> R (in FOP; variant phenotype; dbSNP:rs387906588)	ECO:0000269|PubMed:19085907	19085907
Q04771	ACVR1	G328W	Q04771/G328W	ACVR1/G328W	VARIANT	G -> W (in FOP; variant phenotype; dbSNP:rs387906588)	ECO:0000269|PubMed:19085907	19085907
Q04771	ACVR1	G356D	Q04771/G356D	ACVR1/G356D	VARIANT	G -> D (in FOP; variant phenotype; dbSNP:rs121912679)	ECO:0000269|PubMed:19085907	19085907
Q04771	ACVR1	R375P	Q04771/R375P	ACVR1/R375P	VARIANT	R -> P (in FOP; variant phenotype; dbSNP:rs387906590)	ECO:0000269|PubMed:19085907	19085907
Q04771	ACVR1	T203V	Q04771/T203V	ACVR1/T203V	MUTAGEN	T->V: Almost complete loss of alcaline phosphatase induction; in association with A-325.	ECO:0000269|PubMed:25354296	25354296
Q04771	ACVR1	Q207D	Q04771/Q207D	ACVR1/Q207D	MUTAGEN	Q->D: Strong induction of SMAD1 phosphorylation.	ECO:0000269|PubMed:9748228	9748228
Q04771	ACVR1	G325A	Q04771/G325A	ACVR1/G325A	MUTAGEN	G->A: Almost complete loss of alcaline phosphatase induction; in association with V-203.	ECO:0000269|PubMed:25354296	25354296

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q04912	MST1R	R75S	Q04912/R75S	MST1R/R75S	VARIANT	R -> S (in dbSNP:rs35887539)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	P95T	Q04912/P95T	MST1R/P95T	VARIANT	P -> T (in dbSNP:rs55908300)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	R185C	Q04912/R185C	MST1R/R185C	VARIANT	R -> C (in dbSNP:rs55633379)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	R306H	Q04912/R306H	MST1R/R306H	VARIANT	R -> H (in NPCA3; dbSNP:rs200046052)	ECO:0000269|PubMed:26951679	26951679
Q04912	MST1R	R322Q	Q04912/R322Q	MST1R/R322Q	VARIANT	R -> Q (in dbSNP:rs2230593)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8386824	17344846,8386824
Q04912	MST1R	A327T	Q04912/A327T	MST1R/A327T	VARIANT	A -> T (in NPCA3; unknown pathological significance; dbSNP:rs200757776)	ECO:0000269|PubMed:26951679	26951679
Q04912	MST1R	G356D	Q04912/G356D	MST1R/G356D	VARIANT	G -> D (in dbSNP:rs35924402)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	S434L	Q04912/S434L	MST1R/S434L	VARIANT	S -> L (in dbSNP:rs2230591)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	N440S	Q04912/N440S	MST1R/N440S	VARIANT	N -> S (in dbSNP:rs2230592)		
Q04912	MST1R	G465D	Q04912/G465D	MST1R/G465D	VARIANT	G -> D (in dbSNP:rs34564898)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	R504C	Q04912/R504C	MST1R/R504C	VARIANT	R -> C (in dbSNP:rs34350470)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	Q523R	Q04912/Q523R	MST1R/Q523R	VARIANT	Q -> R (in dbSNP:rs2230590)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8386824	17344846,8386824
Q04912	MST1R	Q613P	Q04912/Q613P	MST1R/Q613P	VARIANT	Q -> P (in dbSNP:rs35986685)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	V670G	Q04912/V670G	MST1R/V670G	VARIANT	V -> G (in NPCA3; unknown pathological significance; dbSNP:rs201024956)	ECO:0000269|PubMed:26951679	26951679
Q04912	MST1R	V900M	Q04912/V900M	MST1R/V900M	VARIANT	V -> M (in dbSNP:rs56091918)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	A973T	Q04912/A973T	MST1R/A973T	VARIANT	A -> T (in NPCA3; unknown pathological significance; dbSNP:rs773053723)	ECO:0000269|PubMed:26951679	26951679
Q04912	MST1R	G1195S	Q04912/G1195S	MST1R/G1195S	VARIANT	G -> S (in dbSNP:rs7433231)		
Q04912	MST1R	R1304G	Q04912/R1304G	MST1R/R1304G	VARIANT	R -> G (in dbSNP:rs528985327)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	R1335G	Q04912/R1335G	MST1R/R1335G	VARIANT	R -> G (in dbSNP:rs1062633)	ECO:0000269|PubMed:17344846	17344846
Q04912	MST1R	Y1360C	Q04912/Y1360C	MST1R/Y1360C	VARIANT	Y -> C (in dbSNP:rs56330223)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q05397	PTK2	H292P	Q05397/H292P	PTK2/H292P	VARIANT	H -> P	ECO:0000269|PubMed:17344846	17344846
Q05397	PTK2	H292Q	Q05397/H292Q	PTK2/H292Q	VARIANT	H -> Q	ECO:0000269|PubMed:17344846	17344846
Q05397	PTK2	V793A	Q05397/V793A	PTK2/V793A	VARIANT	V -> A (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q05397	PTK2	D1030E	Q05397/D1030E	PTK2/D1030E	VARIANT	D -> E	ECO:0000269|PubMed:17344846	17344846
Q05397	PTK2	K1044E	Q05397/K1044E	PTK2/K1044E	VARIANT	K -> E (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q05397	PTK2	Y397F	Q05397/Y397F	PTK2/Y397F	MUTAGEN	Y->F: Abolishes autophosphorylation. Abolishes interaction with SRC and activation of BMX. Reduces phosphorylation of NEDD9.	ECO:0000269|PubMed:11331870, ECO:0000269|PubMed:9360983	11331870,9360983
Q05397	PTK2	V928G	Q05397/V928G	PTK2/V928G	MUTAGEN	V->G: Loss of interaction with TGFB1I1.	ECO:0000269|PubMed:9756887	9756887
Q05397	PTK2	L1034S	Q05397/L1034S	PTK2/L1034S	MUTAGEN	L->S: Loss of interaction with TGFB1I1.	ECO:0000269|PubMed:9756887	9756887

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q05513	PRKCZ	R49H	Q05513/R49H	PRKCZ/R49H	VARIANT	R -> H (in dbSNP:rs35271800)		
Q05513	PRKCZ	R84H	Q05513/R84H	PRKCZ/R84H	VARIANT	R -> H (in dbSNP:rs56017162)	ECO:0000269|PubMed:17344846	17344846
Q05513	PRKCZ	S514F	Q05513/S514F	PRKCZ/S514F	VARIANT	S -> F (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
Q05513	PRKCZ	R519C	Q05513/R519C	PRKCZ/R519C	VARIANT	R -> C (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs376894109)	ECO:0000269|PubMed:17344846	17344846
Q05513	PRKCZ	K19A	Q05513/K19A	PRKCZ/K19A	MUTAGEN	K->A: No effect on interaction with SQSTM1 and PARD6B.	ECO:0000269|PubMed:12887891	12887891
Q05513	PRKCZ	D62A	Q05513/D62A	PRKCZ/D62A	MUTAGEN	D->A: Loss of interaction with SQSTM1 and PARD6B.	ECO:0000269|PubMed:12887891	12887891
Q05513	PRKCZ	D66A	Q05513/D66A	PRKCZ/D66A	MUTAGEN	D->A: Loss of interaction with SQSTM1 and PARD6B.	ECO:0000269|PubMed:12887891	12887891

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q05655	PRKCD	N348S	Q05655/N348S	PRKCD/N348S	VARIANT	N -> S (in dbSNP:rs33911937)		
Q05655	PRKCD	F375S	Q05655/F375S	PRKCD/F375S	VARIANT	F -> S (in dbSNP:rs1056998)	ECO:0000269|PubMed:8357834	8357834
Q05655	PRKCD	L410F	Q05655/L410F	PRKCD/L410F	VARIANT	L -> F (in dbSNP:rs34502209)		
Q05655	PRKCD	R483W	Q05655/R483W	PRKCD/R483W	VARIANT	R -> W (in dbSNP:rs35891605)		
Q05655	PRKCD	M494V	Q05655/M494V	PRKCD/M494V	VARIANT	M -> V	ECO:0000269|PubMed:7988719	7988719
Q05655	PRKCD	V593M	Q05655/V593M	PRKCD/V593M	VARIANT	V -> M	ECO:0000269|PubMed:8357834	8357834
Q05655	PRKCD	S299A	Q05655/S299A	PRKCD/S299A	MUTAGEN	S->A: Loss of phosphorylation.	ECO:0000269|PubMed:17603046	17603046
Q05655	PRKCD	T507A	Q05655/T507A	PRKCD/T507A	MUTAGEN	T->A: No effect on kinase activity.	ECO:0000269|PubMed:11772397	11772397

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q05823	RNASEL	G59S	Q05823/G59S	RNASEL/G59S	VARIANT	G -> S (in dbSNP:rs151296858)	ECO:0000269|PubMed:11799394, ECO:0000269|PubMed:11941539	11799394,11941539
Q05823	RNASEL	I97L	Q05823/I97L	RNASEL/I97L	VARIANT	I -> L (in dbSNP:rs56250729)	ECO:0000269|PubMed:17344846	17344846
Q05823	RNASEL	A289T	Q05823/A289T	RNASEL/A289T	VARIANT	A -> T (in dbSNP:rs35553278)	ECO:0000269|PubMed:17344846	17344846
Q05823	RNASEL	S406F	Q05823/S406F	RNASEL/S406F	VARIANT	S -> F (in dbSNP:rs145787003)	ECO:0000269|PubMed:11941539	11941539
Q05823	RNASEL	R462Q	Q05823/R462Q	RNASEL/R462Q	VARIANT	R -> Q (risk factor for prostate cancer; reduced enzymatic activity; dbSNP:rs486907)	ECO:0000269|PubMed:11799394, ECO:0000269|PubMed:11941539, ECO:0000269|PubMed:12415269, ECO:0000269|PubMed:17344846	11799394,11941539,12415269,17344846
Q05823	RNASEL	D541E	Q05823/D541E	RNASEL/D541E	VARIANT	D -> E (no change in enzymatic activity; dbSNP:rs627928)	ECO:0000269|PubMed:11799394, ECO:0000269|PubMed:11941539, ECO:0000269|PubMed:12415269, ECO:0000269|PubMed:17344846	11799394,11941539,12415269,17344846
Q05823	RNASEL	R592H	Q05823/R592H	RNASEL/R592H	VARIANT	R -> H (in dbSNP:rs35896902)	ECO:0000269|PubMed:17344846	17344846
Q05823	RNASEL	K240N	Q05823/K240N	RNASEL/K240N	MUTAGEN	K->N: Reduced 2-5A binding activity; almost complete loss of 2-5A binding activity; when associated with N-274.	ECO:0000269|PubMed:7680958	7680958
Q05823	RNASEL	K274N	Q05823/K274N	RNASEL/K274N	MUTAGEN	K->N: Reduced 2-5A binding activity; almost complete loss of 2-5A binding activity; when associated with N-240.	ECO:0000269|PubMed:7680958	7680958
Q05823	RNASEL	K392R	Q05823/K392R	RNASEL/K392R	MUTAGEN	K->R: Complete loss of enzymatic activity and enzyme dimerization. No change in binding to 2-5A and RNA.	ECO:0000269|PubMed:9862963	9862963
Q05823	RNASEL	H583A	Q05823/H583A	RNASEL/H583A	MUTAGEN	H->A: No change in enzymatic activity.	ECO:0000269|PubMed:11333017	11333017
Q05823	RNASEL	P584A	Q05823/P584A	RNASEL/P584A	MUTAGEN	P->A: No change in enzymatic activity.	ECO:0000269|PubMed:11333017	11333017
Q05823	RNASEL	W632A	Q05823/W632A	RNASEL/W632A	MUTAGEN	W->A: No change in enzymatic activity.	ECO:0000269|PubMed:11333017	11333017
Q05823	RNASEL	D661A	Q05823/D661A	RNASEL/D661A	MUTAGEN	D->A: Complete loss of enzymatic activity.	ECO:0000269|PubMed:11333017	11333017
Q05823	RNASEL	R667A	Q05823/R667A	RNASEL/R667A	MUTAGEN	R->A: Complete loss of enzymatic activity. No change in 2-5A binding and enzyme dimerization.	ECO:0000269|PubMed:11333017	11333017
Q05823	RNASEL	H672A	Q05823/H672A	RNASEL/H672A	MUTAGEN	H->A: Complete loss of enzymatic activity. No change in 2-5A binding activity and enzyme dimerization.	ECO:0000269|PubMed:11333017	11333017

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

Error: Q06187 BTK 'NoneType' object has no attribute 'group' FT                   /note="Missing (in XLA)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q06187	BTK	L11P	Q06187/L11P	BTK/L11P	VARIANT	L -> P (in XLA; dbSNP:rs1603020228)		
Q06187	BTK	K12R	Q06187/K12R	BTK/K12R	VARIANT	K -> R (in XLA)	ECO:0000269|PubMed:8695804	8695804
Q06187	BTK	S14F	Q06187/S14F	BTK/S14F	VARIANT	S -> F (in XLA; dbSNP:rs1057520682)		
Q06187	BTK	K19E	Q06187/K19E	BTK/K19E	VARIANT	K -> E (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	F25S	Q06187/F25S	BTK/F25S	VARIANT	F -> S (in XLA)	ECO:0000269|PubMed:7711734	7711734
Q06187	BTK	K27R	Q06187/K27R	BTK/K27R	VARIANT	K -> R (in XLA)		
Q06187	BTK	R28C	Q06187/R28C	BTK/R28C	VARIANT	R -> C (in XLA; no effect on phosphorylation of GTF2I)		
Q06187	BTK	R28H	Q06187/R28H	BTK/R28H	VARIANT	R -> H (in XLA; moderate; dbSNP:rs128620185)	ECO:0000269|PubMed:7849721, ECO:0000269|PubMed:8162018, ECO:0000269|PubMed:9445504	7849721,8162018,9445504
Q06187	BTK	R28P	Q06187/R28P	BTK/R28P	VARIANT	R -> P (in XLA)	ECO:0000269|PubMed:8695804	8695804
Q06187	BTK	T33P	Q06187/T33P	BTK/T33P	VARIANT	T -> P (in XLA; severe; dbSNP:rs128620189)	ECO:0000269|PubMed:7633429, ECO:0000269|PubMed:7849721	7633429,7849721
Q06187	BTK	Y39S	Q06187/Y39S	BTK/Y39S	VARIANT	Y -> S (in XLA)	ECO:0000269|PubMed:10612838	10612838
Q06187	BTK	Y40C	Q06187/Y40C	BTK/Y40C	VARIANT	Y -> C (in XLA; dbSNP:rs1555980875)		
Q06187	BTK	Y40N	Q06187/Y40N	BTK/Y40N	VARIANT	Y -> N (in XLA)		
Q06187	BTK	I61N	Q06187/I61N	BTK/I61N	VARIANT	I -> N (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	V64D	Q06187/V64D	BTK/V64D	VARIANT	V -> D (in XLA)		
Q06187	BTK	V64F	Q06187/V64F	BTK/V64F	VARIANT	V -> F (in XLA)	ECO:0000269|PubMed:7849006	7849006
Q06187	BTK	R82K	Q06187/R82K	BTK/R82K	VARIANT	R -> K (in dbSNP:rs56035945)	ECO:0000269|PubMed:17344846	17344846
Q06187	BTK	Q103QSVFSSTR	Q06187/Q103QSVFSSTR	BTK/Q103QSVFSSTR	VARIANT	Q -> QSVFSSTR (in XLA)		
Q06187	BTK	V113D	Q06187/V113D	BTK/V113D	VARIANT	V -> D (in XLA; dbSNP:rs128621190)	ECO:0000269|PubMed:7849697	7849697
Q06187	BTK	S115F	Q06187/S115F	BTK/S115F	VARIANT	S -> F (in XLA)		
Q06187	BTK	T117P	Q06187/T117P	BTK/T117P	VARIANT	T -> P (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	Q127H	Q06187/Q127H	BTK/Q127H	VARIANT	Q -> H (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	C154S	Q06187/C154S	BTK/C154S	VARIANT	C -> S (in XLA)	ECO:0000269|PubMed:9280283	9280283
Q06187	BTK	C155G	Q06187/C155G	BTK/C155G	VARIANT	C -> G (in XLA)		
Q06187	BTK	C155R	Q06187/C155R	BTK/C155R	VARIANT	C -> R (in XLA)	ECO:0000269|PubMed:9280283, ECO:0000269|PubMed:9445504	9280283,9445504
Q06187	BTK	T184P	Q06187/T184P	BTK/T184P	VARIANT	T -> P (in XLA)		
Q06187	BTK	P190K	Q06187/P190K	BTK/P190K	VARIANT	P -> K (in a lung large cell carcinoma sample; somatic mutation; requires 2 nucleotide substitutions)	ECO:0000269|PubMed:17344846	17344846
Q06187	BTK	R288Q	Q06187/R288Q	BTK/R288Q	VARIANT	R -> Q (in XLA; dbSNP:rs1555978277)	ECO:0000269|PubMed:9545398	9545398
Q06187	BTK	R288W	Q06187/R288W	BTK/R288W	VARIANT	R -> W (in XLA; dbSNP:rs128621194)	ECO:0000269|PubMed:7711734, ECO:0000269|PubMed:8162018, ECO:0000269|PubMed:8162056, ECO:0000269|PubMed:8834236	7711734,8162018,8162056,8834236
Q06187	BTK	L295P	Q06187/L295P	BTK/L295P	VARIANT	L -> P (in XLA)	ECO:0000269|PubMed:8723128, ECO:0000269|PubMed:9445504	8723128,9445504
Q06187	BTK	G302E	Q06187/G302E	BTK/G302E	VARIANT	G -> E (in XLA)	ECO:0000269|PubMed:7627183, ECO:0000269|PubMed:8695804	7627183,8695804
Q06187	BTK	G302R	Q06187/G302R	BTK/G302R	VARIANT	G -> R (in XLA)		
Q06187	BTK	R307G	Q06187/R307G	BTK/R307G	VARIANT	R -> G (in XLA; loss of activity; dbSNP:rs128621195)	ECO:0000269|PubMed:8162056	8162056
Q06187	BTK	R307T	Q06187/R307T	BTK/R307T	VARIANT	R -> T (in XLA)	ECO:0000269|PubMed:9545398	9545398
Q06187	BTK	D308E	Q06187/D308E	BTK/D308E	VARIANT	D -> E (in XLA)		
Q06187	BTK	V319A	Q06187/V319A	BTK/V319A	VARIANT	V -> A (in XLA; moderate)		
Q06187	BTK	Y334S	Q06187/Y334S	BTK/Y334S	VARIANT	Y -> S (in XLA; dbSNP:rs128621196)	ECO:0000269|PubMed:7880320	7880320
Q06187	BTK	L358F	Q06187/L358F	BTK/L358F	VARIANT	L -> F (in XLA)	ECO:0000269|PubMed:7897635	7897635
Q06187	BTK	Y361C	Q06187/Y361C	BTK/Y361C	VARIANT	Y -> C (in XLA; mild; dbSNP:rs28935478)	ECO:0000269|PubMed:7849697	7849697
Q06187	BTK	H362Q	Q06187/H362Q	BTK/H362Q	VARIANT	H -> Q (in XLA)		
Q06187	BTK	H364P	Q06187/H364P	BTK/H364P	VARIANT	H -> P (in XLA)		
Q06187	BTK	N365Y	Q06187/N365Y	BTK/N365Y	VARIANT	N -> Y (in XLA)		
Q06187	BTK	S366F	Q06187/S366F	BTK/S366F	VARIANT	S -> F (in XLA)		
Q06187	BTK	L369F	Q06187/L369F	BTK/L369F	VARIANT	L -> F (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	I370M	Q06187/I370M	BTK/I370M	VARIANT	I -> M (in XLA)	ECO:0000269|PubMed:7711734	7711734
Q06187	BTK	R372G	Q06187/R372G	BTK/R372G	VARIANT	R -> G (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	L408P	Q06187/L408P	BTK/L408P	VARIANT	L -> P (in XLA; moderate; dbSNP:rs128621198)	ECO:0000269|PubMed:7849721	7849721
Q06187	BTK	G414R	Q06187/G414R	BTK/G414R	VARIANT	G -> R (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	Y418H	Q06187/Y418H	BTK/Y418H	VARIANT	Y -> H (in XLA; dbSNP:rs144079566)		
Q06187	BTK	I429N	Q06187/I429N	BTK/I429N	VARIANT	I -> N (in XLA)	ECO:0000269|PubMed:8634718	8634718
Q06187	BTK	K430E	Q06187/K430E	BTK/K430E	VARIANT	K -> E (in XLA; loss of phosphorylation of GTF2I; dbSNP:rs128620184)	ECO:0000269|PubMed:7809124	7809124
Q06187	BTK	K430R	Q06187/K430R	BTK/K430R	VARIANT	K -> R (in XLA)	ECO:0000269|PubMed:9545398	9545398
Q06187	BTK	E445D	Q06187/E445D	BTK/E445D	VARIANT	E -> D (in XLA)	ECO:0000269|PubMed:9545398	9545398
Q06187	BTK	G462D	Q06187/G462D	BTK/G462D	VARIANT	G -> D (in XLA)		
Q06187	BTK	G462V	Q06187/G462V	BTK/G462V	VARIANT	G -> V (in XLA)		
Q06187	BTK	Y476D	Q06187/Y476D	BTK/Y476D	VARIANT	Y -> D (in XLA)	ECO:0000269|PubMed:7627183	7627183
Q06187	BTK	M477R	Q06187/M477R	BTK/M477R	VARIANT	M -> R (in XLA)	ECO:0000269|PubMed:8634718	8634718
Q06187	BTK	C481S	Q06187/C481S	BTK/C481S	VARIANT	C -> S (found in patients with chronic lymphocytic leukemia; unknown pathological significance; results in resistance to ibrutinib therapy; results in a protein that is reversibly inhibited by ibrutinib; disrupts the covalent binding between the enzyme and ibrutinib; dbSNP:rs1057519825 and dbSNP:rs1057519826)	ECO:0000269|PubMed:24869597, ECO:0000269|PubMed:24869598, ECO:0000269|PubMed:25189416	24869597,24869598,25189416
Q06187	BTK	C502F	Q06187/C502F	BTK/C502F	VARIANT	C -> F (in XLA)		
Q06187	BTK	C502W	Q06187/C502W	BTK/C502W	VARIANT	C -> W (in XLA; dbSNP:rs41310709)	ECO:0000269|PubMed:8695804	8695804
Q06187	BTK	C506R	Q06187/C506R	BTK/C506R	VARIANT	C -> R (in XLA; dbSNP:rs128621200)	ECO:0000269|PubMed:7880320	7880320
Q06187	BTK	C506Y	Q06187/C506Y	BTK/C506Y	VARIANT	C -> Y (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	A508D	Q06187/A508D	BTK/A508D	VARIANT	A -> D (in XLA)		
Q06187	BTK	M509I	Q06187/M509I	BTK/M509I	VARIANT	M -> I (in XLA)		
Q06187	BTK	M509V	Q06187/M509V	BTK/M509V	VARIANT	M -> V (in XLA)	ECO:0000269|PubMed:7711734	7711734
Q06187	BTK	L512P	Q06187/L512P	BTK/L512P	VARIANT	L -> P (in XLA)	ECO:0000269|PubMed:10612838	10612838
Q06187	BTK	L512Q	Q06187/L512Q	BTK/L512Q	VARIANT	L -> Q (in XLA)	ECO:0000269|PubMed:10612838	10612838
Q06187	BTK	L518R	Q06187/L518R	BTK/L518R	VARIANT	L -> R (in XLA)		
Q06187	BTK	R520Q	Q06187/R520Q	BTK/R520Q	VARIANT	R -> Q (in XLA; severe; prevents activation due to absence of contact between the catalytic loop and the regulatory phosphorylated residue; dbSNP:rs128621202)	ECO:0000269|PubMed:7633429, ECO:0000269|PubMed:7809124, ECO:0000269|PubMed:7849697, ECO:0000269|PubMed:7880320	7633429,7809124,7849697,7880320
Q06187	BTK	D521G	Q06187/D521G	BTK/D521G	VARIANT	D -> G (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	D521H	Q06187/D521H	BTK/D521H	VARIANT	D -> H (in XLA; severe)	ECO:0000269|PubMed:8695804	8695804
Q06187	BTK	D521N	Q06187/D521N	BTK/D521N	VARIANT	D -> N (in XLA; severe)		
Q06187	BTK	A523E	Q06187/A523E	BTK/A523E	VARIANT	A -> E (in XLA)		
Q06187	BTK	R525G	Q06187/R525G	BTK/R525G	VARIANT	R -> G (in XLA; dbSNP:rs886041149)	ECO:0000269|PubMed:9545398	9545398
Q06187	BTK	R525P	Q06187/R525P	BTK/R525P	VARIANT	R -> P (in XLA)	ECO:0000269|PubMed:7711734	7711734
Q06187	BTK	R525Q	Q06187/R525Q	BTK/R525Q	VARIANT	R -> Q (in XLA; severe; disturbs ATP-binding; dbSNP:rs128620183)	ECO:0000269|PubMed:7809124, ECO:0000269|PubMed:9445504	7809124,9445504
Q06187	BTK	N526K	Q06187/N526K	BTK/N526K	VARIANT	N -> K (in XLA; dbSNP:rs1569291237)	ECO:0000269|PubMed:7711734	7711734
Q06187	BTK	V535F	Q06187/V535F	BTK/V535F	VARIANT	V -> F (in XLA)	ECO:0000269|PubMed:9545398	9545398
Q06187	BTK	L542P	Q06187/L542P	BTK/L542P	VARIANT	L -> P (in XLA; growth hormone deficiency; dbSNP:rs128621203)	ECO:0000269|PubMed:7849697	7849697
Q06187	BTK	R544G	Q06187/R544G	BTK/R544G	VARIANT	R -> G (in XLA)	ECO:0000269|PubMed:10612838	10612838
Q06187	BTK	R544K	Q06187/R544K	BTK/R544K	VARIANT	R -> K (in XLA)	ECO:0000269|PubMed:8834236	8834236
Q06187	BTK	F559S	Q06187/F559S	BTK/F559S	VARIANT	F -> S (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	R562P	Q06187/R562P	BTK/R562P	VARIANT	R -> P (in XLA; dbSNP:rs104894770)	ECO:0000269|PubMed:10678660, ECO:0000269|PubMed:7809124	10678660,7809124
Q06187	BTK	R562W	Q06187/R562W	BTK/R562W	VARIANT	R -> W (in XLA; dbSNP:rs128621204)	ECO:0000269|PubMed:7711734, ECO:0000269|PubMed:7849697, ECO:0000269|PubMed:7880320, ECO:0000269|PubMed:9445504	7711734,7849697,7880320,9445504
Q06187	BTK	W563L	Q06187/W563L	BTK/W563L	VARIANT	W -> L (in XLA; dbSNP:rs1555977474)	ECO:0000269|PubMed:9545398	9545398
Q06187	BTK	E567K	Q06187/E567K	BTK/E567K	VARIANT	E -> K (in XLA; severe)	ECO:0000269|PubMed:7633420	7633420
Q06187	BTK	S578Y	Q06187/S578Y	BTK/S578Y	VARIANT	S -> Y (in XLA)	ECO:0000269|PubMed:10612838	10612838
Q06187	BTK	W581R	Q06187/W581R	BTK/W581R	VARIANT	W -> R (in XLA; dbSNP:rs128621205)		
Q06187	BTK	A582V	Q06187/A582V	BTK/A582V	VARIANT	A -> V (in XLA)	ECO:0000269|PubMed:7711734, ECO:0000269|PubMed:7809124	7711734,7809124
Q06187	BTK	F583S	Q06187/F583S	BTK/F583S	VARIANT	F -> S (in XLA)		
Q06187	BTK	M587L	Q06187/M587L	BTK/M587L	VARIANT	M -> L (in XLA; mild; dbSNP:rs1603001822)	ECO:0000269|PubMed:7633420	7633420
Q06187	BTK	E589D	Q06187/E589D	BTK/E589D	VARIANT	E -> D (in XLA)		
Q06187	BTK	E589G	Q06187/E589G	BTK/E589G	VARIANT	E -> G (in XLA; moderate; interferes with substrate binding; dbSNP:rs128621206)	ECO:0000269|PubMed:7809124, ECO:0000269|PubMed:7849721	7809124,7849721
Q06187	BTK	E589K	Q06187/E589K	BTK/E589K	VARIANT	E -> K (in XLA)	ECO:0000269|PubMed:10612838	10612838
Q06187	BTK	S592P	Q06187/S592P	BTK/S592P	VARIANT	S -> P (in XLA; dbSNP:rs1603001783)	ECO:0000269|PubMed:8834236	8834236
Q06187	BTK	G594E	Q06187/G594E	BTK/G594E	VARIANT	G -> E (in XLA; mild; interferes with substrate binding)	ECO:0000269|PubMed:7809124, ECO:0000269|PubMed:9445504	7809124,9445504
Q06187	BTK	G594R	Q06187/G594R	BTK/G594R	VARIANT	G -> R (in XLA; dbSNP:rs1555977339)	ECO:0000269|PubMed:7711734	7711734
Q06187	BTK	Y598C	Q06187/Y598C	BTK/Y598C	VARIANT	Y -> C (in XLA)		
Q06187	BTK	A607D	Q06187/A607D	BTK/A607D	VARIANT	A -> D (in XLA; mild; dbSNP:rs128621208)	ECO:0000269|PubMed:8162056	8162056
Q06187	BTK	G613D	Q06187/G613D	BTK/G613D	VARIANT	G -> D (in XLA; mild; interferes with substrate binding and/or domain interactions; dbSNP:rs128621209)	ECO:0000269|PubMed:7809124, ECO:0000269|PubMed:7849721	7809124,7849721
Q06187	BTK	P619A	Q06187/P619A	BTK/P619A	VARIANT	P -> A (in XLA)		
Q06187	BTK	P619S	Q06187/P619S	BTK/P619S	VARIANT	P -> S (in XLA)		
Q06187	BTK	P619T	Q06187/P619T	BTK/P619T	VARIANT	P -> T (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	A622P	Q06187/A622P	BTK/A622P	VARIANT	A -> P (in XLA)	ECO:0000269|PubMed:9545398	9545398
Q06187	BTK	V626G	Q06187/V626G	BTK/V626G	VARIANT	V -> G (in XLA)	ECO:0000269|PubMed:9445504	9445504
Q06187	BTK	M630I	Q06187/M630I	BTK/M630I	VARIANT	M -> I		
Q06187	BTK	M630K	Q06187/M630K	BTK/M630K	VARIANT	M -> K (in XLA; dbSNP:rs128621210)	ECO:0000269|PubMed:7849697, ECO:0000269|PubMed:7880320	7849697,7880320
Q06187	BTK	M630T	Q06187/M630T	BTK/M630T	VARIANT	M -> T (in XLA)		
Q06187	BTK	C633Y	Q06187/C633Y	BTK/C633Y	VARIANT	C -> Y (in XLA)	ECO:0000269|PubMed:8695804	8695804
Q06187	BTK	R641C	Q06187/R641C	BTK/R641C	VARIANT	R -> C (in XLA)	ECO:0000269|PubMed:7633429	7633429
Q06187	BTK	R641H	Q06187/R641H	BTK/R641H	VARIANT	R -> H (in XLA; severe)	ECO:0000269|PubMed:7633420, ECO:0000269|PubMed:9445504	7633420,9445504
Q06187	BTK	F644L	Q06187/F644L	BTK/F644L	VARIANT	F -> L (in XLA)		
Q06187	BTK	F644S	Q06187/F644S	BTK/F644S	VARIANT	F -> S (in XLA)	ECO:0000269|PubMed:8695804	8695804
Q06187	BTK	L647P	Q06187/L647P	BTK/L647P	VARIANT	L -> P (in XLA)		
Q06187	BTK	L652P	Q06187/L652P	BTK/L652P	VARIANT	L -> P (in XLA; dbSNP:rs128622212)	ECO:0000269|PubMed:7849697	7849697
Q06187	BTK	E41K	Q06187/E41K	BTK/E41K	MUTAGEN	E->K: No effect on phosphorylation of GTF2I.	ECO:0000269|PubMed:9012831	9012831
Q06187	BTK	P189A	Q06187/P189A	BTK/P189A	MUTAGEN	P->A: No effect on phosphorylation of GTF2I.	ECO:0000269|PubMed:9012831	9012831
Q06187	BTK	Y223F	Q06187/Y223F	BTK/Y223F	MUTAGEN	Y->F: Loss of phosphorylation of GTF2I.	ECO:0000269|PubMed:8630736, ECO:0000269|PubMed:9012831	8630736,9012831
Q06187	BTK	W251L	Q06187/W251L	BTK/W251L	MUTAGEN	W->L: No effect on phosphorylation of GTF2I.	ECO:0000269|PubMed:9012831	9012831
Q06187	BTK	R307K	Q06187/R307K	BTK/R307K	MUTAGEN	R->K: Loss of phosphorylation of GTF2I.	ECO:0000269|PubMed:9012831	9012831
Q06187	BTK	Y551F	Q06187/Y551F	BTK/Y551F	MUTAGEN	Y->F: Loss of phosphorylation of GTF2I.	ECO:0000269|PubMed:9012831	9012831
Q06187	BTK	Y617E	Q06187/Y617E	BTK/Y617E	MUTAGEN	Y->E: Defective in mediating calcium response.	ECO:0000269|PubMed:15375214	15375214

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q06418	TYRO3	P21L	Q06418/P21L	TYRO3/P21L	VARIANT	P -> L (in dbSNP:rs17854578)	ECO:0000269|PubMed:15489334	15489334
Q06418	TYRO3	I346N	Q06418/I346N	TYRO3/I346N	VARIANT	I -> N (in dbSNP:rs12148316)		
Q06418	TYRO3	G542S	Q06418/G542S	TYRO3/G542S	VARIANT	G -> S (in dbSNP:rs17857363)	ECO:0000269|PubMed:15489334	15489334
Q06418	TYRO3	A815V	Q06418/A815V	TYRO3/A815V	VARIANT	A -> V (in dbSNP:rs1042057)	ECO:0000269|PubMed:7857658	7857658
Q06418	TYRO3	L819M	Q06418/L819M	TYRO3/L819M	VARIANT	L -> M (in dbSNP:rs17854579)	ECO:0000269|PubMed:15489334	15489334
Q06418	TYRO3	R824G	Q06418/R824G	TYRO3/R824G	VARIANT	R -> G (in dbSNP:rs17857364)	ECO:0000269|PubMed:15489334	15489334
Q06418	TYRO3	A831T	Q06418/A831T	TYRO3/A831T	VARIANT	A -> T	ECO:0000269|PubMed:17344846	17344846
Q06418	TYRO3	I99R	Q06418/I99R	TYRO3/I99R	MUTAGEN	I->R: Abolishes dimerization.	ECO:0000269|PubMed:14623883	14623883

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q07002	CDK18	G48S	Q07002/G48S	CDK18/G48S	VARIANT	G -> S (in dbSNP:rs35134237)	ECO:0000269|PubMed:17344846	17344846
Q07002	CDK18	G67R	Q07002/G67R	CDK18/G67R	VARIANT	G -> R (in dbSNP:rs4623769)	ECO:0000269|PubMed:17344846	17344846
Q07002	CDK18	T166M	Q07002/T166M	CDK18/T166M	VARIANT	T -> M (in dbSNP:rs17850752)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.2	15489334,17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q07912	TNK2	R34L	Q07912/R34L	TNK2/R34L	VARIANT	R -> L (in a lung adenocarcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates; no effect on subcellular localization to perinuclear region)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:20110370	17344846,20110370
Q07912	TNK2	K71R	Q07912/K71R	TNK2/K71R	VARIANT	K -> R (in dbSNP:rs56036945)	ECO:0000269|PubMed:17344846	17344846
Q07912	TNK2	R99Q	Q07912/R99Q	TNK2/R99Q	VARIANT	R -> Q (in an ovarian mucinous carcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on subcellular localization to perinuclear region; dbSNP:rs113498671)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:20110370	17344846,20110370
Q07912	TNK2	R99W	Q07912/R99W	TNK2/R99W	VARIANT	R -> W (in dbSNP:rs3747673)	ECO:0000269|PubMed:17344846	17344846
Q07912	TNK2	T152M	Q07912/T152M	TNK2/T152M	VARIANT	T -> M (in dbSNP:rs56161912)	ECO:0000269|PubMed:17344846	17344846
Q07912	TNK2	E346K	Q07912/E346K	TNK2/E346K	VARIANT	E -> K (in an ovarian endometrioid cancer sample; somatic mutation; undergoes autoactivation and causes phosphorylation on Y-284 leading to activation of AKT1; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on catalytic activity itself as the purified kinase domain has activity in vitro comparable to wild-type protein; no effect on subcellular localization to perinuclear region; dbSNP:rs970946035)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:20110370, ECO:0000269|PubMed:20333297	17344846,20110370,20333297
Q07912	TNK2	M409I	Q07912/M409I	TNK2/M409I	VARIANT	M -> I (in a gastric adenocarcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on subcellular localization to perinuclear region)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:20110370	17344846,20110370
Q07912	TNK2	P507S	Q07912/P507S	TNK2/P507S	VARIANT	P -> S (in dbSNP:rs35759128)	ECO:0000269|PubMed:17344846	17344846
Q07912	TNK2	V638M	Q07912/V638M	TNK2/V638M	VARIANT	V -> M (found in patients with childhood-onset epilepsy; unknown pathological significance; loss of interaction with NEDD4 and NEDD4L; increased protein abundance; dbSNP:rs201407161)	ECO:0000269|PubMed:23686771	23686771
Q07912	TNK2	P725L	Q07912/P725L	TNK2/P725L	VARIANT	P -> L (in dbSNP:rs56260729)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q07912	TNK2	R748Q	Q07912/R748Q	TNK2/R748Q	VARIANT	R -> Q (in dbSNP:rs57872314)	ECO:0000269|PubMed:17344846	17344846
Q07912	TNK2	P802L	Q07912/P802L	TNK2/P802L	VARIANT	P -> L (in dbSNP:rs3749333)		
Q07912	TNK2	R1038H	Q07912/R1038H	TNK2/R1038H	VARIANT	R -> H (in dbSNP:rs13433937)	ECO:0000269|PubMed:17344846	17344846
Q07912	TNK2	L120Q	Q07912/L120Q	TNK2/L120Q	MUTAGEN	L->Q: No effect on autophosphorylation at Y-284.	ECO:0000269|PubMed:20110370	20110370
Q07912	TNK2	K158R	Q07912/K158R	TNK2/K158R	MUTAGEN	K->R: Loss of autophosphorylation at Y-284.	ECO:0000269|PubMed:16288044, ECO:0000269|PubMed:20110370	16288044,20110370
Q07912	TNK2	L197Q	Q07912/L197Q	TNK2/L197Q	MUTAGEN	L->Q: No effect on autophosphorylation at Y-284.	ECO:0000269|PubMed:20110370	20110370
Q07912	TNK2	V365R	Q07912/V365R	TNK2/V365R	MUTAGEN	V->R: Increased autophosphorylation at Y-284.	ECO:0000269|PubMed:20110370	20110370
Q07912	TNK2	L487F	Q07912/L487F	TNK2/L487F	MUTAGEN	L->F: Constantly active kinase.	ECO:0000269|PubMed:16288044	16288044

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q08345	DDR1	S17G	Q08345/S17G	DDR1/S17G	VARIANT	S -> G (in dbSNP:rs55901302)	ECO:0000269|PubMed:17344846	17344846
Q08345	DDR1	V100A	Q08345/V100A	DDR1/V100A	VARIANT	V -> A (in dbSNP:rs34544756)	ECO:0000269|PubMed:17344846	17344846
Q08345	DDR1	R169Q	Q08345/R169Q	DDR1/R169Q	VARIANT	R -> Q (in dbSNP:rs55980643)	ECO:0000269|PubMed:17344846	17344846
Q08345	DDR1	A170D	Q08345/A170D	DDR1/A170D	VARIANT	A -> D (in dbSNP:rs56231803)	ECO:0000269|PubMed:17344846	17344846
Q08345	DDR1	R306W	Q08345/R306W	DDR1/R306W	VARIANT	R -> W (in dbSNP:rs56024191)	ECO:0000269|PubMed:17344846	17344846
Q08345	DDR1	S496A	Q08345/S496A	DDR1/S496A	VARIANT	S -> A (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q08345	DDR1	L833V	Q08345/L833V	DDR1/L833V	VARIANT	L -> V (in dbSNP:rs2524235)	ECO:0000269|PubMed:8390675, ECO:0000269|PubMed:8977099	8390675,8977099
Q08345	DDR1	R105A	Q08345/R105A	DDR1/R105A	MUTAGEN	R->A: Inhibits collagen-induced phosphorylation.	ECO:0000269|PubMed:24509848	24509848
Q08345	DDR1	N211A	Q08345/N211A	DDR1/N211A	MUTAGEN	N->A: Phosphorylates regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation.	ECO:0000269|PubMed:24509848	24509848
Q08345	DDR1	N211Q	Q08345/N211Q	DDR1/N211Q	MUTAGEN	N->Q: Sustained phosphorylation regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation. Located intracellularly and at the cell surface. Displays a reduced rate of receptor internalization, which is not altered in the presence of collagen. Able to bind collagen as wild-type. Exhibits enhanced collagen-independent receptor dimerization. Complete loss of the collagen-independent constitutive activation; when associated with A-655.	ECO:0000269|PubMed:24509848	24509848
Q08345	DDR1	S213A	Q08345/S213A	DDR1/S213A	MUTAGEN	S->A: Phosphorylates regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation.	ECO:0000269|PubMed:24509848	24509848
Q08345	DDR1	N260Q	Q08345/N260Q	DDR1/N260Q	MUTAGEN	N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.	ECO:0000269|PubMed:24509848	24509848
Q08345	DDR1	N371Q	Q08345/N371Q	DDR1/N371Q	MUTAGEN	N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.	ECO:0000269|PubMed:24509848	24509848
Q08345	DDR1	T379A	Q08345/T379A	DDR1/T379A	MUTAGEN	T->A: Phosphorylates in response to collagen, but at lower levels compared to wild-type. Phosphorylates in response to collagen, but at lower levels compared to wild-type; when associated with A-393.	ECO:0000269|PubMed:24509848	24509848
Q08345	DDR1	T393A	Q08345/T393A	DDR1/T393A	MUTAGEN	T->A: Phosphorylates in response to collagen, but at lower levels compared to wild-type. Phosphorylates in response to collagen, but at lower levels compared to wild-type; when associated with A-379.	ECO:0000269|PubMed:24509848	24509848
Q08345	DDR1	N394Q	Q08345/N394Q	DDR1/N394Q	MUTAGEN	N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.	ECO:0000269|PubMed:24509848	24509848
Q08345	DDR1	K655A	Q08345/K655A	DDR1/K655A	MUTAGEN	K->A: Loss of kinase activity. Complete loss of the collagen-independent constitutive activation; when associated with Q-211.	ECO:0000269|PubMed:24509848	24509848
Q08345	DDR1	G707A	Q08345/G707A	DDR1/G707A	MUTAGEN	G->A: Confers over 20-fold resistance to the ability of an inhibitor to inhibit autophosphorylation.	ECO:0000269|PubMed:23899692	23899692
Q08345	DDR1	Y740F	Q08345/Y740F	DDR1/Y740F	MUTAGEN	Y->F: Abolishes interaction with PTPN11.	ECO:0000269|PubMed:16337946	16337946

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q08881	ITK	R19K	Q08881/R19K	ITK/R19K	VARIANT	R -> K (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q08881	ITK	P23L	Q08881/P23L	ITK/P23L	VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q08881	ITK	R193Q	Q08881/R193Q	ITK/R193Q	VARIANT	R -> Q (in dbSNP:rs17054374)		
Q08881	ITK	R335W	Q08881/R335W	ITK/R335W	VARIANT	R -> W (in LPFS1; shows nearly undetectable mutant ITK protein consistent with severe protein instability; dbSNP:rs121908191)	ECO:0000269|PubMed:19425169	19425169
Q08881	ITK	R451Q	Q08881/R451Q	ITK/R451Q	VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs779372373)	ECO:0000269|PubMed:17344846	17344846
Q08881	ITK	R581W	Q08881/R581W	ITK/R581W	VARIANT	R -> W (in dbSNP:rs34482255)	ECO:0000269|PubMed:17344846	17344846
Q08881	ITK	V587I	Q08881/V587I	ITK/V587I	VARIANT	V -> I (in dbSNP:rs56005928)	ECO:0000269|PubMed:17344846	17344846
Q08881	ITK	P288G	Q08881/P288G	ITK/P288G	MUTAGEN	P->G: Complete loss of interaction with PPIA/CYPA.	ECO:0000269|PubMed:15308100	15308100

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q09013	DMPK	L423V	Q09013/L423V	DMPK/L423V	VARIANT	L -> V (in dbSNP:rs527221)	ECO:0000269|PubMed:1310900, ECO:0000269|PubMed:7905855, ECO:0000269|PubMed:8469976, ECO:0000269|PubMed:8499920	1310900,7905855,8469976,8499920
Q09013	DMPK	L428V	Q09013/L428V	DMPK/L428V	VARIANT	L -> V (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q09013	DMPK	K100A	Q09013/K100A	DMPK/K100A	MUTAGEN	K->A: Loss of kinase activity.	ECO:0000269|PubMed:15598648	15598648

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q12852	MAP3K12	E409K	Q12852/E409K	MAP3K12/E409K	VARIANT	E -> K (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q12852	MAP3K12	G628R	Q12852/G628R	MAP3K12/G628R	VARIANT	G -> R (in dbSNP:rs34366500)	ECO:0000269|PubMed:17344846	17344846
Q12852	MAP3K12	G640S	Q12852/G640S	MAP3K12/G640S	VARIANT	G -> S (in dbSNP:rs55794887)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q12866	MERTK	R20S	Q12866/R20S	MERTK/R20S	VARIANT	R -> S (in dbSNP:rs35898499)	ECO:0000269|PubMed:11062461, ECO:0000269|PubMed:17344846	11062461,17344846
Q12866	MERTK	S118N	Q12866/S118N	MERTK/S118N	VARIANT	S -> N (in dbSNP:rs13027171)	ECO:0000269|PubMed:11062461, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8086340	11062461,17344846,8086340
Q12866	MERTK	V185M	Q12866/V185M	MERTK/V185M	VARIANT	V -> M (in dbSNP:rs56205303)	ECO:0000269|PubMed:17344846	17344846
Q12866	MERTK	F214V	Q12866/F214V	MERTK/F214V	VARIANT	F -> V (found in a patient with Leber congenital amaurosis; dbSNP:rs1475870132)	ECO:0000269|PubMed:21602930	21602930
Q12866	MERTK	A282T	Q12866/A282T	MERTK/A282T	VARIANT	A -> T (in dbSNP:rs7588635)	ECO:0000269|PubMed:11062461, ECO:0000269|PubMed:17344846	11062461,17344846
Q12866	MERTK	E289K	Q12866/E289K	MERTK/E289K	VARIANT	E -> K (in dbSNP:rs766215580)	ECO:0000269|PubMed:17344846	17344846
Q12866	MERTK	R293H	Q12866/R293H	MERTK/R293H	VARIANT	R -> H (in dbSNP:rs34072093)	ECO:0000269|PubMed:11062461, ECO:0000269|PubMed:17344846	11062461,17344846
Q12866	MERTK	N329S	Q12866/N329S	MERTK/N329S	VARIANT	N -> S (in dbSNP:rs34943572)		
Q12866	MERTK	A446G	Q12866/A446G	MERTK/A446G	VARIANT	A -> G (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q12866	MERTK	V452L	Q12866/V452L	MERTK/V452L	VARIANT	V -> L (in dbSNP:rs34010621)	ECO:0000269|PubMed:17344846	17344846
Q12866	MERTK	R466K	Q12866/R466K	MERTK/R466K	VARIANT	R -> K (in dbSNP:rs7604639)	ECO:0000269|PubMed:11062461, ECO:0000269|PubMed:17344846	11062461,17344846
Q12866	MERTK	N498S	Q12866/N498S	MERTK/N498S	VARIANT	N -> S (in dbSNP:rs35858762)	ECO:0000269|PubMed:11062461, ECO:0000269|PubMed:17344846	11062461,17344846
Q12866	MERTK	I518V	Q12866/I518V	MERTK/I518V	VARIANT	I -> V (in dbSNP:rs2230515)	ECO:0000269|PubMed:11062461, ECO:0000269|PubMed:17344846	11062461,17344846
Q12866	MERTK	E540K	Q12866/E540K	MERTK/E540K	VARIANT	E -> K (in RP38; dbSNP:rs113485015)	ECO:0000269|PubMed:11062461	11062461
Q12866	MERTK	S661C	Q12866/S661C	MERTK/S661C	VARIANT	S -> C (in RP38)	ECO:0000269|PubMed:11062461	11062461
Q12866	MERTK	Q662E	Q12866/Q662E	MERTK/Q662E	VARIANT	Q -> E (in dbSNP:rs56209758)	ECO:0000269|PubMed:17344846	17344846
Q12866	MERTK	A708S	Q12866/A708S	MERTK/A708S	VARIANT	A -> S (in a head & Neck squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q12866	MERTK	E823Q	Q12866/E823Q	MERTK/E823Q	VARIANT	E -> Q (in dbSNP:rs55924349)	ECO:0000269|PubMed:17344846	17344846
Q12866	MERTK	R865W	Q12866/R865W	MERTK/R865W	VARIANT	R -> W (in dbSNP:rs2230516)	ECO:0000269|PubMed:17344846	17344846
Q12866	MERTK	V870I	Q12866/V870I	MERTK/V870I	VARIANT	V -> I (in dbSNP:rs2230517)	ECO:0000269|PubMed:17344846	17344846
Q12866	MERTK	I871T	Q12866/I871T	MERTK/I871T	VARIANT	I -> T (in RP38; dbSNP:rs377341255)	ECO:0000269|PubMed:11062461	11062461
Q12866	MERTK	I871V	Q12866/I871V	MERTK/I871V	VARIANT	I -> V	ECO:0000269|PubMed:11062461	11062461
Q12866	MERTK	P958L	Q12866/P958L	MERTK/P958L	VARIANT	P -> L (found in a patient with Leber congenital amaurosis; dbSNP:rs201460398)	ECO:0000269|PubMed:21602930	21602930

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q12979	ABR	K517R	Q12979/K517R	ABR/K517R	VARIANT	K -> R (in dbSNP:rs34169260)	ECO:0000269|PubMed:14702039	14702039
Q12979	ABR	R683A	Q12979/R683A	ABR/R683A	MUTAGEN	R->A: Reduces GAP activity. Loss of GAP activity; when associated with A-795.	ECO:0000269|PubMed:17116687	17116687
Q12979	ABR	N795A	Q12979/N795A	ABR/N795A	MUTAGEN	N->A: Loss of GAP activity; when associated with A-683.	ECO:0000269|PubMed:17116687	17116687
Q12979	ABR	V859A	Q12979/V859A	ABR/V859A	MUTAGEN	V->A: Abolishes interaction with DLG4. No effect on synaptic localization.	ECO:0000269|PubMed:20962234	20962234

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13043	STK4	H162N	Q13043/H162N	STK4/H162N	VARIANT	H -> N (in dbSNP:rs55850759)	ECO:0000269|PubMed:17344846	17344846
Q13043	STK4	R310Q	Q13043/R310Q	STK4/R310Q	VARIANT	R -> Q (in dbSNP:rs35447878)	ECO:0000269|PubMed:17344846	17344846
Q13043	STK4	V312M	Q13043/V312M	STK4/V312M	VARIANT	V -> M (in dbSNP:rs17420378)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7665586	17344846,7665586
Q13043	STK4	I355T	Q13043/I355T	STK4/I355T	VARIANT	I -> T (in dbSNP:rs35944046)	ECO:0000269|PubMed:17344846	17344846
Q13043	STK4	P416L	Q13043/P416L	STK4/P416L	VARIANT	P -> L (in dbSNP:rs33963346)	ECO:0000269|PubMed:17344846	17344846
Q13043	STK4	K59R	Q13043/K59R	STK4/K59R	MUTAGEN	K->R: Loss of activity.	ECO:0000269|PubMed:15109305, ECO:0000269|PubMed:16930133	15109305,16930133
Q13043	STK4	T175A	Q13043/T175A	STK4/T175A	MUTAGEN	T->A: No effect on activity.	ECO:0000269|PubMed:15109305	15109305
Q13043	STK4	T177A	Q13043/T177A	STK4/T177A	MUTAGEN	T->A: No effect on activity.	ECO:0000269|PubMed:15109305	15109305
Q13043	STK4	T183A	Q13043/T183A	STK4/T183A	MUTAGEN	T->A: Loss of activity.	ECO:0000269|PubMed:15109305	15109305
Q13043	STK4	D326N	Q13043/D326N	STK4/D326N	MUTAGEN	D->N: Resistant to proteolytic cleavage by caspase during apoptosis; when associated with N-349.	ECO:0000269|PubMed:11278283	11278283
Q13043	STK4	D349N	Q13043/D349N	STK4/D349N	MUTAGEN	D->N: Resistant to proteolytic cleavage by caspase during apoptosis; when associated with N-326.	ECO:0000269|PubMed:11278283	11278283
Q13043	STK4	L444P	Q13043/L444P	STK4/L444P	MUTAGEN	L->P: Loss of homodimerization, activation, and autophosphorylation.	ECO:0000269|PubMed:15109305	15109305

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13131	PRKAA1	M10L	Q13131/M10L	PRKAA1/M10L	VARIANT	M -> L (in dbSNP:rs17855679)	ECO:0000269|PubMed:15489334	15489334
Q13131	PRKAA1	Q16R	Q13131/Q16R	PRKAA1/Q16R	VARIANT	Q -> R (in a breast cancer sample; somatic mutation; dbSNP:rs928784854)	ECO:0000269|PubMed:16959974	16959974
Q13131	PRKAA1	V307G	Q13131/V307G	PRKAA1/V307G	MUTAGEN	V->G,Q: Activates the kinase activity.		
Q13131	PRKAA1	V307Q	Q13131/V307Q	PRKAA1/V307Q	MUTAGEN	V->G,Q: Activates the kinase activity.	ECO:0000269|PubMed:17088252	17088252

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13153	PAK1	Y131C	Q13153/Y131C	PAK1/Y131C	VARIANT	Y -> C (in IDDMSSD; gain of function; enhanced PAK1 kinase activity and significantly reduced homodimerization; dbSNP:rs1565638316)	ECO:0000269|PubMed:30290153	30290153
Q13153	PAK1	Y429C	Q13153/Y429C	PAK1/Y429C	VARIANT	Y -> C (in IDDMSSD; gain-of-function; enhanced PAK1 kinase activity and significantly reduced homodimerization; dbSNP:rs1565583382)	ECO:0000269|PubMed:30290153	30290153
Q13153	PAK1	L515V	Q13153/L515V	PAK1/L515V	VARIANT	L -> V (in dbSNP:rs35345144)		
Q13153	PAK1	H83L	Q13153/H83L	PAK1/H83L	MUTAGEN	H->L: Abolishes interaction with CDC42, leading to strongly decreased activity; when associated with L-86.	ECO:0000269|PubMed:10551809, ECO:0000269|PubMed:9774440	10551809,9774440
Q13153	PAK1	H86L	Q13153/H86L	PAK1/H86L	MUTAGEN	H->L: Abolishes interaction with CDC42, leading to strongly decreased activity; when associated with L-83.	ECO:0000269|PubMed:10551809, ECO:0000269|PubMed:9774440	10551809,9774440
Q13153	PAK1	L107F	Q13153/L107F	PAK1/L107F	MUTAGEN	L->F: Abolishes autoinhibition, leading to constitutive kinase activity.	ECO:0000269|PubMed:10551809	10551809
Q13153	PAK1	K299R	Q13153/K299R	PAK1/K299R	MUTAGEN	K->R: Strongly decreases activity. Abolishes kinase activity; when associated with N-389.	ECO:0000269|PubMed:22153498	22153498
Q13153	PAK1	D389N	Q13153/D389N	PAK1/D389N	MUTAGEN	D->N: Abolishes kinase activity; when associated with R-299.	ECO:0000269|PubMed:22153498	22153498
Q13153	PAK1	D393A	Q13153/D393A	PAK1/D393A	MUTAGEN	D->A: Abolishes autophosphorylation at Thr-423.	ECO:0000269|PubMed:22153498	22153498
Q13153	PAK1	T423A	Q13153/T423A	PAK1/T423A	MUTAGEN	T->A: Decreases CDC42-stimulated activity and autophosphorylation.	ECO:0000269|PubMed:10551809	10551809
Q13153	PAK1	T423E	Q13153/T423E	PAK1/T423E	MUTAGEN	T->E: Constitutive kinase activity.	ECO:0000269|PubMed:10551809	10551809

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13163	MAP2K5	H118R	Q13163/H118R	MAP2K5/H118R	VARIANT	H -> R (in dbSNP:rs56241934)	ECO:0000269|PubMed:17344846	17344846
Q13163	MAP2K5	A427V	Q13163/A427V	MAP2K5/A427V	VARIANT	A -> V (in dbSNP:rs1226964455)	ECO:0000269|PubMed:17344846	17344846
Q13163	MAP2K5	A428T	Q13163/A428T	MAP2K5/A428T	VARIANT	A -> T (in dbSNP:rs55811347)	ECO:0000269|PubMed:17344846	17344846
Q13163	MAP2K5	K195M	Q13163/K195M	MAP2K5/K195M	MUTAGEN	K->M: Inactivation.	ECO:0000269|PubMed:7759517	7759517
Q13163	MAP2K5	S311A	Q13163/S311A	MAP2K5/S311A	MUTAGEN	S->A: Inactivation.	ECO:0000269|PubMed:7759517	7759517
Q13163	MAP2K5	T315A	Q13163/T315A	MAP2K5/T315A	MUTAGEN	T->A: Inactivation.	ECO:0000269|PubMed:7759517	7759517

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13164	MAPK7	R535H	Q13164/R535H	MAPK7/R535H	VARIANT	R -> H	ECO:0000269|PubMed:17344846	17344846
Q13164	MAPK7	G550A	Q13164/G550A	MAPK7/G550A	VARIANT	G -> A (in dbSNP:rs56388327)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13177	PAK2	E435K	Q13177/E435K	PAK2/E435K	VARIANT	E -> K (in KNO2; loss of protein serine/threonine kinase activity)	ECO:0000269|PubMed:33693784	33693784
Q13177	PAK2	D212N	Q13177/D212N	PAK2/D212N	MUTAGEN	D->N: Inhibits caspase-mediated cleavage.	ECO:0000269|PubMed:9171063	9171063
Q13177	PAK2	G213A	Q13177/G213A	PAK2/G213A	MUTAGEN	G->A: Abolishes myristoylation of PAK-2p34 and membrane location.	ECO:0000269|PubMed:16617111	16617111
Q13177	PAK2	K278R	Q13177/K278R	PAK2/K278R	MUTAGEN	K->R: Abolishes kinase activity and autophosphorylation.	ECO:0000269|PubMed:9786869	9786869
Q13177	PAK2	T402A	Q13177/T402A	PAK2/T402A	MUTAGEN	T->A: Abolishes kinase activity and greatly inhibits autophosphorylation of PAK-2p27 and PAK-2p34.	ECO:0000269|PubMed:9786869	9786869

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13188	STK3	V60L	Q13188/V60L	STK3/V60L	VARIANT	V -> L (in an ovarian clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13188	STK3	F418C	Q13188/F418C	STK3/F418C	VARIANT	F -> C (in dbSNP:rs36047674)		
Q13188	STK3	K56R	Q13188/K56R	STK3/K56R	MUTAGEN	K->R: Loss of activity.	ECO:0000269|PubMed:16930133	16930133
Q13188	STK3	D322N	Q13188/D322N	STK3/D322N	MUTAGEN	D->N: Resistant to proteolytic cleavage.	ECO:0000269|PubMed:11278283	11278283

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13233	MAP3K1	S92N	Q13233/S92N	MAP3K1/S92N	VARIANT	S -> N	ECO:0000269|PubMed:17344846	17344846
Q13233	MAP3K1	L189P	Q13233/L189P	MAP3K1/L189P	VARIANT	L -> P (in SRXY6; increases phosphorylation of the downstream target MAPK3/MAPK1 compared to wild-type and enhances binding of RHOA to the mutant MAP3K1 complex; dbSNP:rs387906788)	ECO:0000269|PubMed:21129722	21129722
Q13233	MAP3K1	L189R	Q13233/L189R	MAP3K1/L189R	VARIANT	L -> R (in SRXY6; increases phosphorylation of the downstream targets MAPK14 and MAPK3/MAPK1 compared to wild-type and enhances binding of RHOA to the mutant MAP3K1 complex; dbSNP:rs387906788)	ECO:0000269|PubMed:21129722	21129722
Q13233	MAP3K1	V211VIQ	Q13233/V211VIQ	MAP3K1/V211VIQ	VARIANT	V -> VIQ (in SRXY6)		
Q13233	MAP3K1	C443S	Q13233/C443S	MAP3K1/C443S	VARIANT	C -> S	ECO:0000269|PubMed:17344846	17344846
Q13233	MAP3K1	G616R	Q13233/G616R	MAP3K1/G616R	VARIANT	G -> R (in SRXY6; unknown pathological significance; dbSNP:rs143853590)	ECO:0000269|PubMed:21129722	21129722
Q13233	MAP3K1	D806N	Q13233/D806N	MAP3K1/D806N	VARIANT	D -> N (in dbSNP:rs702689)		
Q13233	MAP3K1	V906I	Q13233/V906I	MAP3K1/V906I	VARIANT	V -> I (in dbSNP:rs832582)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13237	PRKG2	T22S	Q13237/T22S	PRKG2/T22S	VARIANT	T -> S (in dbSNP:rs34956759)		
Q13237	PRKG2	H106R	Q13237/H106R	PRKG2/H106R	VARIANT	H -> R (in dbSNP:rs34616910)	ECO:0000269|PubMed:17344846	17344846
Q13237	PRKG2	W716R	Q13237/W716R	PRKG2/W716R	VARIANT	W -> R (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13237	PRKG2	D412A	Q13237/D412A	PRKG2/D412A	MUTAGEN	D->A: Reduces cGMP binding affinity; when associated with A-415.	ECO:0000269|PubMed:26769964	26769964
Q13237	PRKG2	R415A	Q13237/R415A	PRKG2/R415A	MUTAGEN	R->A: Reduces cGMP binding affinity; when associated with A-412.	ECO:0000269|PubMed:26769964	26769964

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13263	TRIM28	T794M	Q13263/T794M	TRIM28/T794M	VARIANT	T -> M (in dbSNP:rs56229738)	ECO:0000269|PubMed:17344846	17344846
Q13263	TRIM28	C65A	Q13263/C65A	TRIM28/C65A	MUTAGEN	C->A: Reduces nuclear localization activity of ZNF268; when associated with A-68.	ECO:0000269|PubMed:23665872	23665872
Q13263	TRIM28	C68A	Q13263/C68A	TRIM28/C68A	MUTAGEN	C->A: Reduces nuclear localization activity of ZNF268; when associated with A-65.	ECO:0000269|PubMed:23665872	23665872
Q13263	TRIM28	L306P	Q13263/L306P	TRIM28/L306P	MUTAGEN	L->P: Disrupts the interaction with ZNF350 and amost completely relieves the transcription repressive effect of sumoylated TRIM28.	ECO:0000269|PubMed:17942393	17942393
Q13263	TRIM28	K366G	Q13263/K366G	TRIM28/K366G	MUTAGEN	K->G: Greatly reduced interaction with PPP1CA.	ECO:0000269|PubMed:20424263	20424263
Q13263	TRIM28	I368G	Q13263/I368G	TRIM28/I368G	MUTAGEN	I->G: Increased interaction with PPP1CA. Greatly decreased phosphorylation on S-824.	ECO:0000269|PubMed:20424263	20424263
Q13263	TRIM28	F370A	Q13263/F370A	TRIM28/F370A	MUTAGEN	F->A: Some reduction in interaction with PPP1CA.	ECO:0000269|PubMed:20424263	20424263
Q13263	TRIM28	F370G	Q13263/F370G	TRIM28/F370G	MUTAGEN	F->G: Some reduction in interaction with PPP1CA.	ECO:0000269|PubMed:20424263	20424263
Q13263	TRIM28	S440A	Q13263/S440A	TRIM28/S440A	MUTAGEN	S->A: No effect on interaction with PPP1CA nor on sumoylation levels. Decreased sumoylation levels; when associated with D-501 and D-824.	ECO:0000269|PubMed:20424263	20424263
Q13263	TRIM28	V488E	Q13263/V488E	TRIM28/V488E	MUTAGEN	V->E: Abolishes interaction with CBX5; when associated with E-490.	ECO:0000269|PubMed:20562864	20562864
Q13263	TRIM28	L490E	Q13263/L490E	TRIM28/L490E	MUTAGEN	L->E: Abolishes interaction with CBX5; when associated with E-488.	ECO:0000269|PubMed:20562864	20562864
Q13263	TRIM28	S501A	Q13263/S501A	TRIM28/S501A	MUTAGEN	S->A: No effect on interaction with PPP1CA nor on sumoylation levels. Decreased sumoylation levels; when associated with D-440 and D-824.	ECO:0000269|PubMed:20424263	20424263
Q13263	TRIM28	K554R	Q13263/K554R	TRIM28/K554R	MUTAGEN	K->R: Moderately reduces sumoylation and repression. Abolishes both sumoylation and repression; when associated with R-575. Relieves the repressor activity on Dox-induced GADD45A transcription and 2-fold increase in phosphorylation at Ser-824; when associated with R-779 and R-804.	ECO:0000269|PubMed:17079232, ECO:0000269|PubMed:17942393, ECO:0000269|PubMed:18082607	17079232,17942393,18082607
Q13263	TRIM28	K575R	Q13263/K575R	TRIM28/K575R	MUTAGEN	K->R: Modestly reduced sumoylation and repression. Abolishes both sumoylation and repression; when associated with R-554.	ECO:0000269|PubMed:17079232, ECO:0000269|PubMed:18082607	17079232,18082607
Q13263	TRIM28	C651A	Q13263/C651A	TRIM28/C651A	MUTAGEN	C->A: Complete loss of the PHD finger-mediated stimulatory effect on sumoylation. Loss of binding UBE2I.	ECO:0000269|PubMed:18082607, ECO:0000269|PubMed:18488044	18082607,18488044
Q13263	TRIM28	L653A	Q13263/L653A	TRIM28/L653A	MUTAGEN	L->A: Greatly reduced sumoylation. Little further effect on sumoylation; when associated with A-668 and/or A-709.	ECO:0000269|PubMed:18488044	18488044
Q13263	TRIM28	L668A	Q13263/L668A	TRIM28/L668A	MUTAGEN	L->A: Little effect on sumoylation. Little further effect on sumoylation; when associated with A-653 and/or A-709.	ECO:0000269|PubMed:18488044	18488044
Q13263	TRIM28	K676R	Q13263/K676R	TRIM28/K676R	MUTAGEN	K->R: Modestly reduces sumoylation and repression.	ECO:0000269|PubMed:17079232, ECO:0000269|PubMed:18082607	17079232,18082607
Q13263	TRIM28	L709A	Q13263/L709A	TRIM28/L709A	MUTAGEN	L->A: Greatly reduced sumoylation. Little further effect on sumoylation; when associated with A-653 and/or A-668.	ECO:0000269|PubMed:18488044	18488044
Q13263	TRIM28	K750R	Q13263/K750R	TRIM28/K750R	MUTAGEN	K->R: Some reduced sumoylation and repression.	ECO:0000269|PubMed:18082607	18082607
Q13263	TRIM28	K779R	Q13263/K779R	TRIM28/K779R	MUTAGEN	K->R: Abolishes both sumoylation and repression; when associated with R-804. Relieves the repressor activity on Dox-induced GADD45A transcription and 2-fold increase in phosphorylation at Ser-824; when associated with R-554 and R-804.	ECO:0000269|PubMed:17079232, ECO:0000269|PubMed:17942393, ECO:0000269|PubMed:18082607	17079232,17942393,18082607
Q13263	TRIM28	K804R	Q13263/K804R	TRIM28/K804R	MUTAGEN	K->R: Abolishes both sumoylation and repression; when associated with R-779. Relieves the repressor activity on Dox-induced GADD45A transcription and 2-fold increase in phosphorylation at Ser-824; when associated with R-554 and R-779.	ECO:0000269|PubMed:17079232, ECO:0000269|PubMed:17942393, ECO:0000269|PubMed:18082607	17079232,17942393,18082607
Q13263	TRIM28	S824A	Q13263/S824A	TRIM28/S824A	MUTAGEN	S->A: Suppresses Dox-induced CDKN1A/p21 promoter activation. No effect on sumoylation levels. Decreased sumoylation levels; when associated with D-440 and D-501.	ECO:0000269|PubMed:17942393, ECO:0000269|PubMed:20424263	17942393,20424263
Q13263	TRIM28	S824D	Q13263/S824D	TRIM28/S824D	MUTAGEN	S->D: Enhances Dox-induced CDKN1A/p21 promoter activation. Decreased sumoylation with or without Dox-treatment.	ECO:0000269|PubMed:17942393, ECO:0000269|PubMed:20424263	17942393,20424263

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13308	PTK7	R276H	Q13308/R276H	PTK7/R276H	VARIANT	R -> H (in dbSNP:rs56188167)	ECO:0000269|PubMed:17344846	17344846
Q13308	PTK7	T410S	Q13308/T410S	PTK7/T410S	VARIANT	T -> S (in dbSNP:rs34021075)	ECO:0000269|PubMed:17344846	17344846
Q13308	PTK7	E745D	Q13308/E745D	PTK7/E745D	VARIANT	E -> D (in dbSNP:rs9472017)	ECO:0000269|PubMed:17344846	17344846
Q13308	PTK7	E766Q	Q13308/E766Q	PTK7/E766Q	VARIANT	E -> Q (in dbSNP:rs56216742)	ECO:0000269|PubMed:17344846	17344846
Q13308	PTK7	A777V	Q13308/A777V	PTK7/A777V	VARIANT	A -> V (in dbSNP:rs34764696)	ECO:0000269|PubMed:17344846	17344846
Q13308	PTK7	H783R	Q13308/H783R	PTK7/H783R	VARIANT	H -> R (in dbSNP:rs55820547)	ECO:0000269|PubMed:17344846	17344846
Q13308	PTK7	A933V	Q13308/A933V	PTK7/A933V	VARIANT	A -> V (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13308	PTK7	P1029T	Q13308/P1029T	PTK7/P1029T	VARIANT	P -> T (in dbSNP:rs55755163)	ECO:0000269|PubMed:17344846	17344846
Q13308	PTK7	R1038Q	Q13308/R1038Q	PTK7/R1038Q	VARIANT	R -> Q (in dbSNP:rs34865794)	ECO:0000269|PubMed:17344846	17344846
Q13308	PTK7	L622D	Q13308/L622D	PTK7/L622D	MUTAGEN	L->D: Prevents proteolysis by MMP14.	ECO:0000269|PubMed:20837484	20837484
Q13308	PTK7	M641R	Q13308/M641R	PTK7/M641R	MUTAGEN	M->R: No impact on proteolysis by MMP14.	ECO:0000269|PubMed:20837484	20837484
Q13308	PTK7	M701D	Q13308/M701D	PTK7/M701D	MUTAGEN	M->D: No impact on proteolysis by MMP14.	ECO:0000269|PubMed:20837484	20837484

Error: Q13315 ATM 'NoneType' object has no attribute 'group' FT                   /note="Missing (in AT)"

Error: Q13315 ATM 'NoneType' object has no attribute 'group' FT                   /note="Missing (in AT; unknown pathological significance;

Error: Q13315 ATM 'NoneType' object has no attribute 'group' FT                   /note="Missing (in T-prolymphocytic leukemia)"

Error: Q13315 ATM 'NoneType' object has no attribute 'group' FT                   /note="Missing (in AT)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13315	ATM	R23Q	Q13315/R23Q	ATM/R23Q	VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs587779858)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	R45W	Q13315/R45W	ATM/R45W	VARIANT	R -> W (found in a patient with breast cancer; unknown pathological significance; dbSNP:rs3218684)	ECO:0000269|PubMed:11897822	11897822
Q13315	ATM	S49C	Q13315/S49C	ATM/S49C	VARIANT	S -> C (in AT; increases protein abundance; dbSNP:rs1800054)	ECO:0000269|PubMed:10425038, ECO:0000269|PubMed:10534763, ECO:0000269|PubMed:10873394, ECO:0000269|PubMed:11897822, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:18384426, ECO:0000269|PubMed:8665503, ECO:0000269|PubMed:8797579, ECO:0000269|PubMed:9887333	10425038,10534763,10873394,11897822,17344846,18384426,8665503,8797579,9887333
Q13315	ATM	I68V	Q13315/I68V	ATM/I68V	VARIANT	I -> V (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	D126E	Q13315/D126E	ATM/D126E	VARIANT	D -> E (in dbSNP:rs2234997)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9711876	17344846,9711876
Q13315	ATM	D140H	Q13315/D140H	ATM/D140H	VARIANT	D -> H (in dbSNP:rs55633650)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	V182L	Q13315/V182L	ATM/V182L	VARIANT	V -> L (in dbSNP:rs3218707)	ECO:0000269|PubMed:10534763	10534763
Q13315	ATM	K224E	Q13315/K224E	ATM/K224E	VARIANT	K -> E (in AT; unknown pathological significance; dbSNP:rs145053092)	ECO:0000269|PubMed:10817650	10817650
Q13315	ATM	R250Q	Q13315/R250Q	ATM/R250Q	VARIANT	R -> Q (in dbSNP:rs56123940)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	P292L	Q13315/P292L	ATM/P292L	VARIANT	P -> L (in AT; associated with lymphoma; decrease phosphorylation of target proteins; increases protein abundance; dbSNP:rs747727055)	ECO:0000269|PubMed:10873394, ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:9463314	10873394,19431188,9463314
Q13315	ATM	I323V	Q13315/I323V	ATM/I323V	VARIANT	I -> V (in AT; loss of protein expression; dbSNP:rs587781511)	ECO:0000269|PubMed:10817650, ECO:0000269|PubMed:27664052	10817650,27664052
Q13315	ATM	Y332C	Q13315/Y332C	ATM/Y332C	VARIANT	Y -> C (in B-cell chronic lymphocytic leukemia)	ECO:0000269|PubMed:9892178	9892178
Q13315	ATM	S333F	Q13315/S333F	ATM/S333F	VARIANT	S -> F (in dbSNP:rs28904919)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	R337C	Q13315/R337C	ATM/R337C	VARIANT	R -> C (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs138398778)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	R337H	Q13315/R337H	ATM/R337H	VARIANT	R -> H (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs202160435)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	V341I	Q13315/V341I	ATM/V341I	VARIANT	V -> I (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	A350T	Q13315/A350T	ATM/A350T	VARIANT	A -> T (in B-cell chronic lymphocytic leukemia; dbSNP:rs371713984)	ECO:0000269|PubMed:10023947	10023947
Q13315	ATM	I352T	Q13315/I352T	ATM/I352T	VARIANT	I -> T (in B-cell chronic lymphocytic leukemia; dbSNP:rs369203092)	ECO:0000269|PubMed:10023947	10023947
Q13315	ATM	V410A	Q13315/V410A	ATM/V410A	VARIANT	V -> A (in dbSNP:rs56128736)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	N504S	Q13315/N504S	ATM/N504S	VARIANT	N -> S (in dbSNP:rs56365018)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	G514D	Q13315/G514D	ATM/G514D	VARIANT	G -> D (in dbSNP:rs2235000)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9711876	17344846,9711876
Q13315	ATM	C540Y	Q13315/C540Y	ATM/C540Y	VARIANT	C -> Y (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	L546V	Q13315/L546V	ATM/L546V	VARIANT	L -> V (no effect on phosphorylation of target proteins; dbSNP:rs2227924)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19431188	17344846,19431188
Q13315	ATM	F570S	Q13315/F570S	ATM/F570S	VARIANT	F -> S (in AT; dbSNP:rs777301065)	ECO:0000269|PubMed:9887333	9887333
Q13315	ATM	F582L	Q13315/F582L	ATM/F582L	VARIANT	F -> L (in dbSNP:rs2235006)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	P597L	Q13315/P597L	ATM/P597L	VARIANT	P -> L (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	D661A	Q13315/D661A	ATM/D661A	VARIANT	D -> A (found in a patient with familial breast cancer; unknown pathological significance)	ECO:0000269|PubMed:28202063	28202063
Q13315	ATM	E699G	Q13315/E699G	ATM/E699G	VARIANT	E -> G (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	S707P	Q13315/S707P	ATM/S707P	VARIANT	S -> P (in dbSNP:rs4986761)	ECO:0000269|PubMed:10534763, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:28202063	10534763,17344846,28202063
Q13315	ATM	S759G	Q13315/S759G	ATM/S759G	VARIANT	S -> G (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	T761S	Q13315/T761S	ATM/T761S	VARIANT	T -> S (in dbSNP:rs2235011)		
Q13315	ATM	N768D	Q13315/N768D	ATM/N768D	VARIANT	N -> D (in AT)	ECO:0000269|PubMed:9463314	9463314
Q13315	ATM	R785C	Q13315/R785C	ATM/R785C	VARIANT	R -> C (in AT; dbSNP:rs587778065)	ECO:0000269|PubMed:9887333	9887333
Q13315	ATM	S788R	Q13315/S788R	ATM/S788R	VARIANT	S -> R (in dbSNP:rs641252)		
Q13315	ATM	N813S	Q13315/N813S	ATM/N813S	VARIANT	N -> S (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	D814E	Q13315/D814E	ATM/D814E	VARIANT	D -> E (in dbSNP:rs3218695)		
Q13315	ATM	E848Q	Q13315/E848Q	ATM/E848Q	VARIANT	E -> Q (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs879254046)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	F858L	Q13315/F858L	ATM/F858L	VARIANT	F -> L (in dbSNP:rs1800056)	ECO:0000269|PubMed:10534763, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:18384426, ECO:0000269|PubMed:28202063, ECO:0000269|PubMed:8797579, ECO:0000269|PubMed:9043869, ECO:0000269|PubMed:9792409, ECO:0000269|PubMed:9887333	10534763,17344846,18384426,28202063,8797579,9043869,9792409,9887333
Q13315	ATM	A869G	Q13315/A869G	ATM/A869G	VARIANT	A -> G (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	P872S	Q13315/P872S	ATM/P872S	VARIANT	P -> S (in dbSNP:rs3218673)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	F897I	Q13315/F897I	ATM/F897I	VARIANT	F -> I (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	R924W	Q13315/R924W	ATM/R924W	VARIANT	R -> W (found in a patient with familial breast cancer; unknown pathological significance; dbSNP:rs55723361)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:28202063	17344846,28202063
Q13315	ATM	T935A	Q13315/T935A	ATM/T935A	VARIANT	T -> A (in dbSNP:rs35813135)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	T935M	Q13315/T935M	ATM/T935M	VARIANT	T -> M (in dbSNP:rs3218708)		
Q13315	ATM	L942F	Q13315/L942F	ATM/L942F	VARIANT	L -> F (in dbSNP:rs3218688)		
Q13315	ATM	L950R	Q13315/L950R	ATM/L950R	VARIANT	L -> R (in AT; dbSNP:rs786203054)		
Q13315	ATM	L1001Q	Q13315/L1001Q	ATM/L1001Q	VARIANT	L -> Q (in AT; associated with T-cell acute lymphoblastic leukemia)	ECO:0000269|PubMed:9463314	9463314
Q13315	ATM	M1040V	Q13315/M1040V	ATM/M1040V	VARIANT	M -> V (found in B-cell non-Hodgkin lymphoma; unknown pathological significance; dbSNP:rs3092857)	ECO:0000269|PubMed:9288106	9288106
Q13315	ATM	L1046P	Q13315/L1046P	ATM/L1046P	VARIANT	L -> P (in AT; loss of protein expression; dbSNP:rs568461905)	ECO:0000269|PubMed:27664052	27664052
Q13315	ATM	P1054R	Q13315/P1054R	ATM/P1054R	VARIANT	P -> R (in AT, B-cell chronic lymphocytic leukemia, breast cancer patients and familial cancer patients; no effect on phosphorylation of target proteins; dbSNP:rs1800057)	ECO:0000269|PubMed:10023947, ECO:0000269|PubMed:10217116, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:18384426, ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:28202063, ECO:0000269|PubMed:8665503, ECO:0000269|PubMed:8797579, ECO:0000269|PubMed:9043869, ECO:0000269|PubMed:9792409, ECO:0000269|PubMed:9887333	10023947,10217116,17344846,18384426,19431188,28202063,8665503,8797579,9043869,9792409,9887333
Q13315	ATM	H1082L	Q13315/H1082L	ATM/H1082L	VARIANT	H -> L (in AT; unknown pathological significance)	ECO:0000269|PubMed:10873394	10873394
Q13315	ATM	E1091D	Q13315/E1091D	ATM/E1091D	VARIANT	E -> D (in AT)	ECO:0000269|PubMed:9792409	9792409
Q13315	ATM	S1179F	Q13315/S1179F	ATM/S1179F	VARIANT	S -> F (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	L1255V	Q13315/L1255V	ATM/L1255V	VARIANT	L -> V (found in a patient with early-onset breast cancer; unknown pathological significance)	ECO:0000269|PubMed:18384426	18384426
Q13315	ATM	E1313Q	Q13315/E1313Q	ATM/E1313Q	VARIANT	E -> Q (in dbSNP:rs3092841)		
Q13315	ATM	M1321I	Q13315/M1321I	ATM/M1321I	VARIANT	M -> I (in dbSNP:rs35184530)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	L1322I	Q13315/L1322I	ATM/L1322I	VARIANT	L -> I (no effect on phosphorylation of target proteins; dbSNP:rs144535256)	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	H1380Y	Q13315/H1380Y	ATM/H1380Y	VARIANT	H -> Y (in dbSNP:rs3092856)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	P1382S	Q13315/P1382S	ATM/P1382S	VARIANT	P -> S (in dbSNP:rs55859590)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	I1407T	Q13315/I1407T	ATM/I1407T	VARIANT	I -> T (in T-prolymphocytic leukemia; dbSNP:rs1234250980)	ECO:0000269|PubMed:9288106	9288106
Q13315	ATM	L1420F	Q13315/L1420F	ATM/L1420F	VARIANT	L -> F (in dbSNP:rs1800058)	ECO:0000269|PubMed:10534763, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8665503, ECO:0000269|PubMed:8797579	10534763,17344846,8665503,8797579
Q13315	ATM	L1420P	Q13315/L1420P	ATM/L1420P	VARIANT	L -> P (in AT)	ECO:0000269|PubMed:10817650	10817650
Q13315	ATM	A1427T	Q13315/A1427T	ATM/A1427T	VARIANT	A -> T (in dbSNP:rs2229021)		
Q13315	ATM	F1463S	Q13315/F1463S	ATM/F1463S	VARIANT	F -> S (found in B-cell non-Hodgkin lymphoma; unknown pathological significance)	ECO:0000269|PubMed:9288106	9288106
Q13315	ATM	L1465P	Q13315/L1465P	ATM/L1465P	VARIANT	L -> P (in AT; decreased phosphorylation of target proteins; dbSNP:rs730881391)	ECO:0000269|PubMed:10234507, ECO:0000269|PubMed:19431188	10234507,19431188
Q13315	ATM	I1469M	Q13315/I1469M	ATM/I1469M	VARIANT	I -> M (in a renal papillary cancer sample; somatic mutation; dbSNP:rs775047783)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	H1474D	Q13315/H1474D	ATM/H1474D	VARIANT	H -> D (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	Y1475C	Q13315/Y1475C	ATM/Y1475C	VARIANT	Y -> C (in dbSNP:rs34640941)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	L1488V	Q13315/L1488V	ATM/L1488V	VARIANT	L -> V (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	L1541F	Q13315/L1541F	ATM/L1541F	VARIANT	L -> F (in dbSNP:rs3092849)		
Q13315	ATM	P1566R	Q13315/P1566R	ATM/P1566R	VARIANT	P -> R (in AT)	ECO:0000269|PubMed:9792409	9792409
Q13315	ATM	V1570A	Q13315/V1570A	ATM/V1570A	VARIANT	V -> A (in dbSNP:rs140856217)	ECO:0000269|PubMed:10534763	10534763
Q13315	ATM	N1650S	Q13315/N1650S	ATM/N1650S	VARIANT	N -> S (in dbSNP:rs55870064)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	D1682H	Q13315/D1682H	ATM/D1682H	VARIANT	D -> H (in T-prolymphocytic leukemia; dbSNP:rs121434217)	ECO:0000269|PubMed:9288106	9288106
Q13315	ATM	S1691R	Q13315/S1691R	ATM/S1691R	VARIANT	S -> R (in AT, B-cell chronic lymphocytic leukemia and familial cancer patients; no effect on phosphorylation of target proteins; dbSNP:rs1800059)	ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:28202063, ECO:0000269|PubMed:8797579, ECO:0000269|PubMed:9463314, ECO:0000269|PubMed:9892178	19431188,28202063,8797579,9463314,9892178
Q13315	ATM	V1729L	Q13315/V1729L	ATM/V1729L	VARIANT	V -> L (in dbSNP:rs3092907)		
Q13315	ATM	N1739T	Q13315/N1739T	ATM/N1739T	VARIANT	N -> T (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	T1743I	Q13315/T1743I	ATM/T1743I	VARIANT	T -> I (in AT; associated with preleukemic T-cell proliferation; decreased phosphorylation of target proteins; dbSNP:rs587779844)	ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:9463314	19431188,9463314
Q13315	ATM	D1853N	Q13315/D1853N	ATM/D1853N	VARIANT	D -> N (in dbSNP:rs1801516)	ECO:0000269|PubMed:10397742, ECO:0000269|PubMed:10425038, ECO:0000269|PubMed:10534763, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:18384426, ECO:0000269|PubMed:9711876, ECO:0000269|PubMed:9887333	10397742,10425038,10534763,17344846,18384426,9711876,9887333
Q13315	ATM	D1853V	Q13315/D1853V	ATM/D1853V	VARIANT	D -> V (might contribute to B-cell chronic lymphocytic leukemia; dbSNP:rs1801673)	ECO:0000269|PubMed:10397742, ECO:0000269|PubMed:10817650, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:28202063, ECO:0000269|PubMed:9872980, ECO:0000269|PubMed:9887333	10397742,10817650,17344846,28202063,9872980,9887333
Q13315	ATM	L1910H	Q13315/L1910H	ATM/L1910H	VARIANT	L -> H (in T-prolymphocytic leukemia)	ECO:0000269|PubMed:9288106	9288106
Q13315	ATM	V1913G	Q13315/V1913G	ATM/V1913G	VARIANT	V -> G (in AT; dbSNP:rs1060501688)	ECO:0000269|PubMed:9887333	9887333
Q13315	ATM	M1916I	Q13315/M1916I	ATM/M1916I	VARIANT	M -> I (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	A1945T	Q13315/A1945T	ATM/A1945T	VARIANT	A -> T (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	T1953R	Q13315/T1953R	ATM/T1953R	VARIANT	T -> R (in B-cell chronic lymphocytic leukemia)	ECO:0000269|PubMed:10397742	10397742
Q13315	ATM	Y1961C	Q13315/Y1961C	ATM/Y1961C	VARIANT	Y -> C (found in a patient with familial pancreatic cancer; also found in a lung adenocarcinoma sample; unknown pathological significance; decreased phosphorylation of target proteins; dbSNP:rs56399311)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:28726808	17344846,19431188,28726808
Q13315	ATM	S1983N	Q13315/S1983N	ATM/S1983N	VARIANT	S -> N (in dbSNP:rs659243)	ECO:0000269|PubMed:16554811	16554811
Q13315	ATM	E1991D	Q13315/E1991D	ATM/E1991D	VARIANT	E -> D (in a renal clear cell carcinoma sample; somatic mutation; dbSNP:rs587782274)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	D2016G	Q13315/D2016G	ATM/D2016G	VARIANT	D -> G (in AT; unknown pathological significance; dbSNP:rs587781302)	ECO:0000269|PubMed:10425038, ECO:0000269|PubMed:9887333	10425038,9887333
Q13315	ATM	G2023R	Q13315/G2023R	ATM/G2023R	VARIANT	G -> R (in AT; loss of protein expression; dbSNP:rs11212587)	ECO:0000269|PubMed:27664052	27664052
Q13315	ATM	R2034Q	Q13315/R2034Q	ATM/R2034Q	VARIANT	R -> Q (in dbSNP:rs3218670)		
Q13315	ATM	G2063E	Q13315/G2063E	ATM/G2063E	VARIANT	G -> E (in AT; unknown pathological significance; reduces protein abundance; dbSNP:rs866290641)	ECO:0000269|PubMed:10873394	10873394
Q13315	ATM	A2067D	Q13315/A2067D	ATM/A2067D	VARIANT	A -> D (in AT; dbSNP:rs397514577)	ECO:0000269|PubMed:9887333	9887333
Q13315	ATM	L2068S	Q13315/L2068S	ATM/L2068S	VARIANT	L -> S (in AT; decreased protein abundance; loss of DNA damage induced protein autophosphorylation; dbSNP:rs1555114558)	ECO:0000269|PubMed:27664052	27664052
Q13315	ATM	V2079I	Q13315/V2079I	ATM/V2079I	VARIANT	V -> I (in dbSNP:rs1800060)	ECO:0000269|PubMed:8665503	8665503
Q13315	ATM	Y2080D	Q13315/Y2080D	ATM/Y2080D	VARIANT	Y -> D (in AT; loss of DNA damage induced protein autophosphorylation; dbSNP:rs1064795467)	ECO:0000269|PubMed:27664052	27664052
Q13315	ATM	R2105T	Q13315/R2105T	ATM/R2105T	VARIANT	R -> T (found in a patient with early-onset breast cancer; unknown pathological significance)	ECO:0000269|PubMed:18384426	18384426
Q13315	ATM	E2139G	Q13315/E2139G	ATM/E2139G	VARIANT	E -> G (in T-prolymphocytic leukemia; somatic mutation)	ECO:0000269|PubMed:9488043	9488043
Q13315	ATM	E2164K	Q13315/E2164K	ATM/E2164K	VARIANT	E -> K (in T-prolymphocytic leukemia; dbSNP:rs1317619286)	ECO:0000269|PubMed:9288106	9288106
Q13315	ATM	S2218C	Q13315/S2218C	ATM/S2218C	VARIANT	S -> C (in AT)	ECO:0000269|PubMed:10817650	10817650
Q13315	ATM	R2227C	Q13315/R2227C	ATM/R2227C	VARIANT	R -> C (in AT; unknown pathological significance; reduces protein abundance; dbSNP:rs564652222)	ECO:0000269|PubMed:10873394, ECO:0000269|PubMed:9887333	10873394,9887333
Q13315	ATM	A2274T	Q13315/A2274T	ATM/A2274T	VARIANT	A -> T (in B-cell chronic lymphocytic leukemia; unknown pathological significance; no effect on phosphorylation of target proteins; dbSNP:rs567060474)	ECO:0000269|PubMed:10023947, ECO:0000269|PubMed:19431188	10023947,19431188
Q13315	ATM	G2287A	Q13315/G2287A	ATM/G2287A	VARIANT	G -> A (found in a patient with familial pancreatic cancer; unknown pathological significance; dbSNP:rs1800061)	ECO:0000269|PubMed:28726808, ECO:0000269|PubMed:8665503	28726808,8665503
Q13315	ATM	L2307F	Q13315/L2307F	ATM/L2307F	VARIANT	L -> F (found in patients with familial pancreatic cancer; also found in a lung adenocarcinoma sample; unknown pathological significance; dbSNP:rs56009889)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:28726808	17344846,28726808
Q13315	ATM	L2332P	Q13315/L2332P	ATM/L2332P	VARIANT	L -> P (in dbSNP:rs4988111)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	T2335K	Q13315/T2335K	ATM/T2335K	VARIANT	T -> K (in dbSNP:rs3092831)		
Q13315	ATM	I2356F	Q13315/I2356F	ATM/I2356F	VARIANT	I -> F (in a renal clear cell carcinoma sample; somatic mutation; dbSNP:rs876658517)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	T2396S	Q13315/T2396S	ATM/T2396S	VARIANT	T -> S (in T-prolymphocytic leukemia; also found in a patient with early-onset breast cancer; unknown pathological significance; dbSNP:rs370559102)	ECO:0000269|PubMed:18384426, ECO:0000269|PubMed:9288106	18384426,9288106
Q13315	ATM	S2408L	Q13315/S2408L	ATM/S2408L	VARIANT	S -> L (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs730881315)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	K2418KK	Q13315/K2418KK	ATM/K2418KK	VARIANT	K -> KK (in mantle cell lymphoma)	ECO:0000269|PubMed:10397742, ECO:0000269|PubMed:10706620	10397742,10706620
Q13315	ATM	A2420P	Q13315/A2420P	ATM/A2420P	VARIANT	A -> P (in B-cell chronic lymphocytic leukemia)	ECO:0000269|PubMed:10397742	10397742
Q13315	ATM	E2423G	Q13315/E2423G	ATM/E2423G	VARIANT	E -> G (in mantle cell lymphoma; dbSNP:rs121434221)	ECO:0000269|PubMed:10397742, ECO:0000269|PubMed:10706620	10397742,10706620
Q13315	ATM	V2424G	Q13315/V2424G	ATM/V2424G	VARIANT	V -> G (in AT; also found in B-cell chronic lymphocytic leukemia and T-prolymphocytic leukemia; may be associated with increased risk for breast cancer; decreased phosphorylation of target proteins; dbSNP:rs28904921)	ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:8755918, ECO:0000269|PubMed:9288106, ECO:0000269|PubMed:9463314, ECO:0000269|PubMed:9892178	19431188,8755918,9288106,9463314,9892178
Q13315	ATM	T2438I	Q13315/T2438I	ATM/T2438I	VARIANT	T -> I (in dbSNP:rs147604227)	ECO:0000269|PubMed:10817650, ECO:0000269|PubMed:8808599	10817650,8808599
Q13315	ATM	Q2442P	Q13315/Q2442P	ATM/Q2442P	VARIANT	Q -> P (in T-prolymphocytic leukemia; also in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9288106	17344846,9288106
Q13315	ATM	R2443Q	Q13315/R2443Q	ATM/R2443Q	VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs587782310)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	C2464R	Q13315/C2464R	ATM/C2464R	VARIANT	C -> R (found in patients with familial pancreatic cancer; also found in a small cell lung cancer sample; unknown pathological significance; dbSNP:rs55801750)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:28726808	17344846,28726808
Q13315	ATM	Y2470D	Q13315/Y2470D	ATM/Y2470D	VARIANT	Y -> D (in AT; dbSNP:rs876659365)	ECO:0000269|PubMed:9887333	9887333
Q13315	ATM	R2486G	Q13315/R2486G	ATM/R2486G	VARIANT	R -> G (in T-prolymphocytic leukemia)	ECO:0000269|PubMed:9573030	9573030
Q13315	ATM	W2491R	Q13315/W2491R	ATM/W2491R	VARIANT	W -> R (in AT)	ECO:0000269|PubMed:9792410	9792410
Q13315	ATM	L2492R	Q13315/L2492R	ATM/L2492R	VARIANT	L -> R (in dbSNP:rs56399857)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	A2524P	Q13315/A2524P	ATM/A2524P	VARIANT	A -> P (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	M2531T	Q13315/M2531T	ATM/M2531T	VARIANT	M -> T (found in patients with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	H2554D	Q13315/H2554D	ATM/H2554D	VARIANT	H -> D (in AT; lack of phosphorylation of target proteins)	ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:9463314	19431188,9463314
Q13315	ATM	E2570G	Q13315/E2570G	ATM/E2570G	VARIANT	E -> G (in dbSNP:rs28904920)		
Q13315	ATM	D2625E	Q13315/D2625E	ATM/D2625E	VARIANT	D -> E (in AT; unknown pathological significance; dbSNP:rs1196903858)	ECO:0000269|PubMed:10873394	10873394
Q13315	ATM	D2625Q	Q13315/D2625Q	ATM/D2625Q	VARIANT	D -> Q (in AT; requires 2 nucleotide substitutions)	ECO:0000269|PubMed:10817650	10817650
Q13315	ATM	A2626P	Q13315/A2626P	ATM/A2626P	VARIANT	A -> P (in AT; unknown pathological significance; dbSNP:rs267606669)	ECO:0000269|PubMed:10873394	10873394
Q13315	ATM	Y2627H	Q13315/Y2627H	ATM/Y2627H	VARIANT	Y -> H (in AT; loss of protein expression)	ECO:0000269|PubMed:27664052	27664052
Q13315	ATM	T2640I	Q13315/T2640I	ATM/T2640I	VARIANT	T -> I (in dbSNP:rs4988125)		
Q13315	ATM	L2656P	Q13315/L2656P	ATM/L2656P	VARIANT	L -> P (in AT; dbSNP:rs121434218)	ECO:0000269|PubMed:9450874	9450874
Q13315	ATM	T2666A	Q13315/T2666A	ATM/T2666A	VARIANT	T -> A (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs745775382)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	E2668G	Q13315/E2668G	ATM/E2668G	VARIANT	E -> G (in AT; unknown pathological significance; no effect on phosphorylation of target proteins)	ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:9463314	19431188,9463314
Q13315	ATM	G2695A	Q13315/G2695A	ATM/G2695A	VARIANT	G -> A (in T-prolymphocytic leukemia and B-cell chronic lymphocytic leukemia)	ECO:0000269|PubMed:10023947, ECO:0000269|PubMed:9288106	10023947,9288106
Q13315	ATM	I2702R	Q13315/I2702R	ATM/I2702R	VARIANT	I -> R (in AT; dbSNP:rs876659735)		
Q13315	ATM	G2709S	Q13315/G2709S	ATM/G2709S	VARIANT	G -> S (in dbSNP:rs3218680)		
Q13315	ATM	R2719H	Q13315/R2719H	ATM/R2719H	VARIANT	R -> H (found in a patient with early-onset breast cancer; unknown pathological significance; dbSNP:rs55982963)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:18384426	17344846,18384426
Q13315	ATM	L2722R	Q13315/L2722R	ATM/L2722R	VARIANT	L -> R (in T-prolymphocytic leukemia)	ECO:0000269|PubMed:9288106	9288106
Q13315	ATM	D2725G	Q13315/D2725G	ATM/D2725G	VARIANT	D -> G (found in T-prolymphocytic leukemia; unknown pathological significance; dbSNP:rs1555128314)	ECO:0000269|PubMed:9334731	9334731
Q13315	ATM	D2725V	Q13315/D2725V	ATM/D2725V	VARIANT	D -> V (in T-prolymphocytic leukemia)	ECO:0000269|PubMed:9288106	9288106
Q13315	ATM	A2726V	Q13315/A2726V	ATM/A2726V	VARIANT	A -> V (in AT; unknown pathological significance)	ECO:0000269|PubMed:10425038	10425038
Q13315	ATM	F2732L	Q13315/F2732L	ATM/F2732L	VARIANT	F -> L (in T-prolymphocytic leukemia; dbSNP:rs876659619)	ECO:0000269|PubMed:9288106	9288106
Q13315	ATM	G2765S	Q13315/G2765S	ATM/G2765S	VARIANT	G -> S (may contribute to breast cancer; lack of phosphorylation of target proteins; dbSNP:rs748634900)	ECO:0000269|PubMed:10534763, ECO:0000269|PubMed:19431188	10534763,19431188
Q13315	ATM	K2810Q	Q13315/K2810Q	ATM/K2810Q	VARIANT	K -> Q (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	C2824Y	Q13315/C2824Y	ATM/C2824Y	VARIANT	C -> Y (in AT; dbSNP:rs876660927)	ECO:0000269|PubMed:9150358	9150358
Q13315	ATM	F2827C	Q13315/F2827C	ATM/F2827C	VARIANT	F -> C (in AT; mild; decreased phosphorylation of target proteins; dbSNP:rs121434216)	ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:8755918, ECO:0000269|PubMed:9463314	19431188,8755918,9463314
Q13315	ATM	P2829L	Q13315/P2829L	ATM/P2829L	VARIANT	P -> L (in AT; dbSNP:rs938431501)	ECO:0000269|PubMed:9711876	9711876
Q13315	ATM	R2832C	Q13315/R2832C	ATM/R2832C	VARIANT	R -> C (in AT; also found in B-cell non-Hodgkin lymphoma; increases protein abundance; dbSNP:rs587779872)	ECO:0000269|PubMed:10817650, ECO:0000269|PubMed:10873394, ECO:0000269|PubMed:9288106, ECO:0000269|PubMed:9443866	10817650,10873394,9288106,9443866
Q13315	ATM	R2832H	Q13315/R2832H	ATM/R2832H	VARIANT	R -> H (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	F2834L	Q13315/F2834L	ATM/F2834L	VARIANT	F -> L (in AT; decreased protein abundance)	ECO:0000269|PubMed:27664052	27664052
Q13315	ATM	P2842R	Q13315/P2842R	ATM/P2842R	VARIANT	P -> R (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs879254065)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	R2849P	Q13315/R2849P	ATM/R2849P	VARIANT	R -> P (in AT; dbSNP:rs587782202)	ECO:0000269|PubMed:9887333	9887333
Q13315	ATM	S2855R	Q13315/S2855R	ATM/S2855R	VARIANT	S -> R (in AT; unknown pathological significance; dbSNP:rs780905851)	ECO:0000269|PubMed:10425038	10425038
Q13315	ATM	G2867R	Q13315/G2867R	ATM/G2867R	VARIANT	G -> R (in AT)	ECO:0000269|PubMed:8698354, ECO:0000269|PubMed:9887333	8698354,9887333
Q13315	ATM	D2870N	Q13315/D2870N	ATM/D2870N	VARIANT	D -> N (in dbSNP:rs55798854)	ECO:0000269|PubMed:17344846	17344846
Q13315	ATM	L2890V	Q13315/L2890V	ATM/L2890V	VARIANT	L -> V (in T-prolymphocytic leukemia; dbSNP:rs587779874)	ECO:0000269|PubMed:9288106, ECO:0000269|PubMed:9488043	9288106,9488043
Q13315	ATM	E2904G	Q13315/E2904G	ATM/E2904G	VARIANT	E -> G (in AT; dbSNP:rs786202826)	ECO:0000269|PubMed:8845835	8845835
Q13315	ATM	R2909G	Q13315/R2909G	ATM/R2909G	VARIANT	R -> G (in AT)	ECO:0000269|PubMed:9792410	9792410
Q13315	ATM	P2974L	Q13315/P2974L	ATM/P2974L	VARIANT	P -> L (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	N3003D	Q13315/N3003D	ATM/N3003D	VARIANT	N -> D (in AT; decreased protein abundance; dbSNP:rs1137889)	ECO:0000269|PubMed:27664052, ECO:0000269|PubMed:7792600, ECO:0000269|PubMed:8589678, ECO:0000269|PubMed:8665503	27664052,7792600,8589678,8665503
Q13315	ATM	A3006P	Q13315/A3006P	ATM/A3006P	VARIANT	A -> P (found in T-prolymphocytic leukemia; unknown pathological significance; dbSNP:rs876658767)	ECO:0000269|PubMed:9334731	9334731
Q13315	ATM	R3008C	Q13315/R3008C	ATM/R3008C	VARIANT	R -> C (in AT; also found in T-prolymphocytic leukemia and mantle cell lymphoma; lack of phosphorylation of target proteins; dbSNP:rs587782292)	ECO:0000269|PubMed:10706620, ECO:0000269|PubMed:10817650, ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:9334731, ECO:0000269|PubMed:9488043, ECO:0000269|PubMed:9872980	10706620,10817650,19431188,9334731,9488043,9872980
Q13315	ATM	R3008H	Q13315/R3008H	ATM/R3008H	VARIANT	R -> H (in B-cell chronic lymphocytic leukemia; dbSNP:rs587781894)	ECO:0000269|PubMed:10397742	10397742
Q13315	ATM	K3018N	Q13315/K3018N	ATM/K3018N	VARIANT	K -> N (in B-cell chronic lymphocytic leukemia)	ECO:0000269|PubMed:10397742	10397742
Q13315	ATM	G3029D	Q13315/G3029D	ATM/G3029D	VARIANT	G -> D (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	V3056L	Q13315/V3056L	ATM/V3056L	VARIANT	V -> L (found in a patient with familial pancreatic cancer; unknown pathological significance)	ECO:0000269|PubMed:28726808	28726808
Q13315	ATM	S367A	Q13315/S367A	ATM/S367A	MUTAGEN	S->A: Loss of IR-induced S-367 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-1893 nor S-1981 autophosphorylation.	ECO:0000269|PubMed:16858402	16858402
Q13315	ATM	K1807E	Q13315/K1807E	ATM/K1807E	MUTAGEN	K->E: Decreased phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	S1893A	Q13315/S1893A	ATM/S1893A	MUTAGEN	S->A: Loss of IR-induced S-1893 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-367 nor S-1981 autophosphorylation.	ECO:0000269|PubMed:16858402	16858402
Q13315	ATM	V1941L	Q13315/V1941L	ATM/V1941L	MUTAGEN	V->L: Decreased phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	S1981A	Q13315/S1981A	ATM/S1981A	MUTAGEN	S->A: Loss of IR-induced S-1981 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-367 nor S-1893 autophosphorylation. No dimer disruption.	ECO:0000269|PubMed:12556884, ECO:0000269|PubMed:16858402	12556884,16858402
Q13315	ATM	S1981D	Q13315/S1981D	ATM/S1981D	MUTAGEN	S->D,E: Disrupts the dimer.		
Q13315	ATM	S1981E	Q13315/S1981E	ATM/S1981E	MUTAGEN	S->D,E: Disrupts the dimer.	ECO:0000269|PubMed:12556884, ECO:0000269|PubMed:16858402	12556884,16858402
Q13315	ATM	Y2019C	Q13315/Y2019C	ATM/Y2019C	MUTAGEN	Y->C: Loss of phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	E2039K	Q13315/E2039K	ATM/E2039K	MUTAGEN	E->K: Decreased phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	L2338P	Q13315/L2338P	ATM/L2338P	MUTAGEN	L->P: Loss of phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	S2394L	Q13315/S2394L	ATM/S2394L	MUTAGEN	S->L: Loss of phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	L2452P	Q13315/L2452P	ATM/L2452P	MUTAGEN	L->P: Loss of phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	S2685T	Q13315/S2685T	ATM/S2685T	MUTAGEN	S->T: No effect on phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	P2699L	Q13315/P2699L	ATM/P2699L	MUTAGEN	P->L: Loss of phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	D2708N	Q13315/D2708N	ATM/D2708N	MUTAGEN	D->N: Decreased phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	Q2730P	Q13315/Q2730P	ATM/Q2730P	MUTAGEN	Q->P: Loss of phosphorylation of target proteins.	ECO:0000269|PubMed:19431188	19431188
Q13315	ATM	D2870A	Q13315/D2870A	ATM/D2870A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:9733515	9733515
Q13315	ATM	N2875K	Q13315/N2875K	ATM/N2875K	MUTAGEN	N->K: Loss of kinase activity.	ECO:0000269|PubMed:9733515	9733515
Q13315	ATM	K3016Q	Q13315/K3016Q	ATM/K3016Q	MUTAGEN	K->Q: Mimics acetylation, preventing dephosphorylation and subsequent ATM deactivation during the late stage of DNA damage response.	ECO:0000269|PubMed:30944854	30944854
Q13315	ATM	K3016R	Q13315/K3016R	ATM/K3016R	MUTAGEN	K->R: Loss of DNA damage-inducible acetylation. Retains constitutive kinase activity, but blocks DNA damage-induced kinase activation. Disrupts dimer and abolishes S-1981 autophosphorylation.	ECO:0000269|PubMed:17923702	17923702
Q13315	ATM	K3018R	Q13315/K3018R	ATM/K3018R	MUTAGEN			
Q13315	ATM	R3047Q	Q13315/R3047Q	ATM/R3047Q	MUTAGEN	R->Q: Abolished interaction with PEX5 and translocation to peroxisomes in response to reactive oxygen species (ROS).	ECO:0000269|PubMed:26344566	26344566

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13418	ILK	A262V	Q13418/A262V	ILK/A262V	VARIANT	A -> V (found in a patient with severe dilated cardiomyopathy; unknown pathological significance; dbSNP:rs387907366)	ECO:0000269|PubMed:17646580	17646580
Q13418	ILK	H99D	Q13418/H99D	ILK/H99D	MUTAGEN	H->D: Alters interaction with LIMS1.	ECO:0000269|PubMed:19074270	19074270
Q13418	ILK	E359K	Q13418/E359K	ILK/E359K	MUTAGEN	E->K: Inactivation of ILK.	ECO:0000269|PubMed:9736715	9736715

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13464	ROCK1	S108N	Q13464/S108N	ROCK1/S108N	VARIANT	S -> N (in dbSNP:rs55811609)	ECO:0000269|PubMed:17344846	17344846
Q13464	ROCK1	T773S	Q13464/T773S	ROCK1/T773S	VARIANT	T -> S (in dbSNP:rs45562542)	ECO:0000269|PubMed:17344846	17344846
Q13464	ROCK1	T1112P	Q13464/T1112P	ROCK1/T1112P	VARIANT	T -> P (in dbSNP:rs35881519)	ECO:0000269|PubMed:17344846	17344846
Q13464	ROCK1	P1193S	Q13464/P1193S	ROCK1/P1193S	VARIANT	P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs1057520015)	ECO:0000269|PubMed:17344846	17344846
Q13464	ROCK1	Q1217E	Q13464/Q1217E	ROCK1/Q1217E	VARIANT	Q -> E (in dbSNP:rs2847092)	ECO:0000269|PubMed:17344846	17344846
Q13464	ROCK1	R1262Q	Q13464/R1262Q	ROCK1/R1262Q	VARIANT	R -> Q (in dbSNP:rs1045142)	ECO:0000269|PubMed:17344846	17344846
Q13464	ROCK1	C1264R	Q13464/C1264R	ROCK1/C1264R	VARIANT	C -> R (in dbSNP:rs2663698)	ECO:0000269|PubMed:17344846	17344846
Q13464	ROCK1	D1113A	Q13464/D1113A	ROCK1/D1113A	MUTAGEN	D->A: Abolishes cleavage by caspase-3.	ECO:0000269|PubMed:11283607	11283607

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13470	TNK1	V278I	Q13470/V278I	TNK1/V278I	VARIANT	V -> I (in dbSNP:rs55939858)	ECO:0000269|PubMed:17344846	17344846
Q13470	TNK1	R339K	Q13470/R339K	TNK1/R339K	VARIANT	R -> K (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13470	TNK1	T514K	Q13470/T514K	TNK1/T514K	VARIANT	T -> K (in dbSNP:rs55641092)	ECO:0000269|PubMed:17344846	17344846
Q13470	TNK1	R539C	Q13470/R539C	TNK1/R539C	VARIANT	R -> C (in dbSNP:rs36046975)	ECO:0000269|PubMed:17344846	17344846
Q13470	TNK1	S546C	Q13470/S546C	TNK1/S546C	VARIANT	S -> C (in dbSNP:rs56093628)	ECO:0000269|PubMed:17344846	17344846
Q13470	TNK1	V598M	Q13470/V598M	TNK1/V598M	VARIANT	V -> M (in dbSNP:rs6503018)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8632913, ECO:0000269|Ref.2	17344846,8632913

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13523	PRPF4B	I83V	Q13523/I83V	PRPF4B/I83V	VARIANT	I -> V (in dbSNP:rs9503893)	ECO:0000269|PubMed:11418604, ECO:0000269|PubMed:12077342, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:9628581, ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163	11418604,12077342,14702039,9628581,17081983,18669648,19413330,20068231,21406692,23186163
Q13523	PRPF4B	I584V	Q13523/I584V	PRPF4B/I584V	VARIANT	I -> V (in dbSNP:rs56267049)	ECO:0000269|PubMed:17344846	17344846
Q13523	PRPF4B	F658L	Q13523/F658L	PRPF4B/F658L	VARIANT	F -> L (in a breast cancer sample; somatic mutation; dbSNP:rs1230491406)	ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17344846	16959974,17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13535	ATR	T64A	Q13535/T64A	ATR/T64A	VARIANT	T -> A (in dbSNP:rs35306038)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	H90Y	Q13535/H90Y	ATR/H90Y	VARIANT	H -> Y (in dbSNP:rs28897763)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	M211T	Q13535/M211T	ATR/M211T	VARIANT	M -> T (in dbSNP:rs2227928)		
Q13535	ATR	K297N	Q13535/K297N	ATR/K297N	VARIANT	K -> N (in dbSNP:rs2229033)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	V316I	Q13535/V316I	ATR/V316I	VARIANT	V -> I (in dbSNP:rs28897764)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	V959M	Q13535/V959M	ATR/V959M	VARIANT	V -> M (in dbSNP:rs28910271)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	Y1087H	Q13535/Y1087H	ATR/Y1087H	VARIANT	Y -> H (in dbSNP:rs34253059)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	S1213G	Q13535/S1213G	ATR/S1213G	VARIANT	S -> G (in dbSNP:rs34766606)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	A1488P	Q13535/A1488P	ATR/A1488P	VARIANT	A -> P (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	I1526V	Q13535/I1526V	ATR/I1526V	VARIANT	I -> V (in dbSNP:rs34124242)		
Q13535	ATR	S1607N	Q13535/S1607N	ATR/S1607N	VARIANT	S -> N (in dbSNP:rs55724025)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	N1612S	Q13535/N1612S	ATR/N1612S	VARIANT	N -> S (in dbSNP:rs55894265)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	A2002G	Q13535/A2002G	ATR/A2002G	VARIANT	A -> G (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	G2120A	Q13535/G2120A	ATR/G2120A	VARIANT	G -> A (in dbSNP:rs35134774)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	Y2132D	Q13535/Y2132D	ATR/Y2132D	VARIANT	Y -> D (in dbSNP:rs28910273)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	Q2144R	Q13535/Q2144R	ATR/Q2144R	VARIANT	Q -> R (in FCTCS; dbSNP:rs387906797)	ECO:0000269|PubMed:22341969	22341969
Q13535	ATR	S2233I	Q13535/S2233I	ATR/S2233I	VARIANT	S -> I (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	R2425Q	Q13535/R2425Q	ATR/R2425Q	VARIANT	R -> Q (in dbSNP:rs2229032)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	P2434A	Q13535/P2434A	ATR/P2434A	VARIANT	P -> A (in dbSNP:rs33972295)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	E2438K	Q13535/E2438K	ATR/E2438K	VARIANT	E -> K (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	E2537Q	Q13535/E2537Q	ATR/E2537Q	VARIANT	E -> Q (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13535	ATR	K2327R	Q13535/K2327R	ATR/K2327R	MUTAGEN	K->R: Abolishes kinase activity.	ECO:0000269|PubMed:11114888, ECO:0000269|PubMed:12011431, ECO:0000269|PubMed:9925639	11114888,12011431,9925639
Q13535	ATR	D2475A	Q13535/D2475A	ATR/D2475A	MUTAGEN	D->A: Abolishes kinase activity; increases sensitivity to IR and impairs translocation to nuclear foci upon DNA damage.	ECO:0000269|PubMed:12814551, ECO:0000269|PubMed:9427750, ECO:0000269|PubMed:9925639	12814551,9427750,9925639
Q13535	ATR	D2494E	Q13535/D2494E	ATR/D2494E	MUTAGEN	D->E: Abolishes kinase activity; reduces cell viability, augments sensitivity to IR and UV.	ECO:0000269|PubMed:10597277, ECO:0000269|PubMed:9636169	10597277,9636169

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13546	RIPK1	A64V	Q13546/A64V	RIPK1/A64V	VARIANT	A -> V (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs774996232)	ECO:0000269|PubMed:17344846	17344846
Q13546	RIPK1	V81I	Q13546/V81I	RIPK1/V81I	VARIANT	V -> I (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs758268804)	ECO:0000269|PubMed:17344846	17344846
Q13546	RIPK1	A220V	Q13546/A220V	RIPK1/A220V	VARIANT	A -> V (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs759012409)	ECO:0000269|PubMed:17344846	17344846
Q13546	RIPK1	E234K	Q13546/E234K	RIPK1/E234K	VARIANT	E -> K (in dbSNP:rs17548383)	ECO:0000269|Ref.4	
Q13546	RIPK1	D324H	Q13546/D324H	RIPK1/D324H	VARIANT	D -> H (in AIEFL; prevents cleavage by CASP8; increased kinase activity; increased inflammatory response)	ECO:0000269|PubMed:31827280, ECO:0000269|PubMed:31827281	31827280,31827281
Q13546	RIPK1	D324N	Q13546/D324N	RIPK1/D324N	VARIANT	D -> N (in AIEFL; prevents cleavage by CASP8; changed inflammatory response; dbSNP:rs1760720617)	ECO:0000269|PubMed:31827281	31827281
Q13546	RIPK1	D324V	Q13546/D324V	RIPK1/D324V	VARIANT	D -> V (in AIEFL; prevents cleavage by CASP8; increased kinase activity; increased inflammatory response)	ECO:0000269|PubMed:31827280	31827280
Q13546	RIPK1	D324Y	Q13546/D324Y	RIPK1/D324Y	VARIANT	D -> Y (in AIEFL; prevents cleavage by CASP8; changed inflammatory response)	ECO:0000269|PubMed:31827281	31827281
Q13546	RIPK1	A404S	Q13546/A404S	RIPK1/A404S	VARIANT	A -> S (in dbSNP:rs34872409)	ECO:0000269|PubMed:17344846	17344846
Q13546	RIPK1	A438V	Q13546/A438V	RIPK1/A438V	VARIANT	A -> V (in dbSNP:rs3173519)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:7538908, ECO:0000269|PubMed:8612133	15489334,7538908,8612133
Q13546	RIPK1	A443V	Q13546/A443V	RIPK1/A443V	VARIANT	A -> V (in dbSNP:rs35722193)	ECO:0000269|PubMed:17344846	17344846
Q13546	RIPK1	A569V	Q13546/A569V	RIPK1/A569V	VARIANT	A -> V (in dbSNP:rs55861377)	ECO:0000269|PubMed:17344846	17344846
Q13546	RIPK1	S25D	Q13546/S25D	RIPK1/S25D	MUTAGEN	S->D: Phophomimetic mutant. Significant loss of kinase activity.	ECO:0000269|PubMed:30988283	30988283
Q13546	RIPK1	K45A	Q13546/K45A	RIPK1/K45A	MUTAGEN	K->A: Abolishes kinase activity.	ECO:0000269|PubMed:30988283, ECO:0000269|PubMed:8612133	30988283,8612133
Q13546	RIPK1	S161A	Q13546/S161A	RIPK1/S161A	MUTAGEN	S->A: Decreases RIPK1 kinase activity.	ECO:0000269|PubMed:18408713	18408713
Q13546	RIPK1	S161E	Q13546/S161E	RIPK1/S161E	MUTAGEN	S->E: No effect on RIPK1 autophosphorylation.	ECO:0000269|PubMed:18408713	18408713
Q13546	RIPK1	D324K	Q13546/D324K	RIPK1/D324K	MUTAGEN	D->K: Abolishes cleavage by caspase-8.	ECO:0000269|PubMed:10521396	10521396
Q13546	RIPK1	K377R	Q13546/K377R	RIPK1/K377R	MUTAGEN	K->R: Abolishes RIP-mediated NF-Kappa-B activation.	ECO:0000269|PubMed:16603398	16603398
Q13546	RIPK1	S536C	Q13546/S536C	RIPK1/S536C	MUTAGEN	S->C: Strongly reduced homodimerization and interaction with RIPK3.	ECO:0000269|PubMed:29681455	29681455
Q13546	RIPK1	K599R	Q13546/K599R	RIPK1/K599R	MUTAGEN	K->R: Blocks homodimerization, necroptosis and apoptosis.	ECO:0000269|PubMed:29440439	29440439
Q13546	RIPK1	R603A	Q13546/R603A	RIPK1/R603A	MUTAGEN	R->A: Abolished GlcNAcylation by E.coli NleB1.	ECO:0000269|PubMed:30979585	30979585

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13554	CAMK2B	E110K	Q13554/E110K	CAMK2B/E110K	VARIANT	E -> K (in MRD54; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554402092)	ECO:0000269|PubMed:29100089	29100089
Q13554	CAMK2B	P139L	Q13554/P139L	CAMK2B/P139L	VARIANT	P -> L (in MRD54; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554389088)	ECO:0000269|PubMed:29100089	29100089
Q13554	CAMK2B	P213L	Q13554/P213L	CAMK2B/P213L	VARIANT	P -> L (in MRD54; dbSNP:rs1554387293)	ECO:0000269|PubMed:29560374	29560374
Q13554	CAMK2B	E237K	Q13554/E237K	CAMK2B/E237K	VARIANT	E -> K (in MRD54; no effect on protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554386687)	ECO:0000269|PubMed:29100089	29100089
Q13554	CAMK2B	R284S	Q13554/R284S	CAMK2B/R284S	VARIANT	R -> S (in MRD54; dbSNP:rs1554385203)	ECO:0000269|PubMed:29560374	29560374
Q13554	CAMK2B	K301E	Q13554/K301E	CAMK2B/K301E	VARIANT	K -> E (in MRD54; no effect on protein abundance; loss of autophosphorylation; changed function in neuronal migration; dbSNP:rs1554385111)	ECO:0000269|PubMed:29100089	29100089
Q13554	CAMK2B	P489L	Q13554/P489L	CAMK2B/P489L	VARIANT	P -> L (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs555460132)	ECO:0000269|PubMed:17344846	17344846
Q13554	CAMK2B	E510K	Q13554/E510K	CAMK2B/E510K	VARIANT	E -> K (in dbSNP:rs35452727)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13555	CAMK2G	S36P	Q13555/S36P	CAMK2G/S36P	VARIANT	S -> P (in dbSNP:rs17853266)	ECO:0000269|PubMed:15489334, ECO:0000269|Ref.2	15489334
Q13555	CAMK2G	R292P	Q13555/R292P	CAMK2G/R292P	VARIANT	R -> P (in MRD59; gain-of-function variant affecting regulation of neurite formation and arborization; results in constitutive autophosphorylation; dbSNP:rs397514627)	ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:30184290	23033978,30184290

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13557	CAMK2D	D167E	Q13557/D167E	CAMK2D/D167E	VARIANT	D -> E (in dbSNP:rs35367671)	ECO:0000269|PubMed:17344846	17344846
Q13557	CAMK2D	Q463E	Q13557/Q463E	CAMK2D/Q463E	VARIANT	Q -> E (in dbSNP:rs1053668)		
Q13557	CAMK2D	T493I	Q13557/T493I	CAMK2D/T493I	VARIANT	T -> I (in dbSNP:rs35765784)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13627	DYRK1A	Y415F	Q13627/Y415F	DYRK1A/Y415F	VARIANT	Y -> F	ECO:0000269|PubMed:10329007	10329007
Q13627	DYRK1A	A679P	Q13627/A679P	DYRK1A/A679P	VARIANT	A -> P (in dbSNP:rs55720916)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8975710	17344846,8975710
Q13627	DYRK1A	Q681H	Q13627/Q681H	DYRK1A/Q681H	VARIANT	Q -> H	ECO:0000269|PubMed:10329007	10329007
Q13627	DYRK1A	K188R	Q13627/K188R	DYRK1A/K188R	MUTAGEN	K->R: Abolished protein kinase activity.	ECO:0000269|PubMed:23665168, ECO:0000269|PubMed:25620562	23665168,25620562
Q13627	DYRK1A	Y321F	Q13627/Y321F	DYRK1A/Y321F	MUTAGEN	Y->F: Mildly reduces kinase activity. Does not abolish autophosphorylation on tyrosine residues.	ECO:0000269|PubMed:23665168	23665168

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13705	ACVR2B	R40H	Q13705/R40H	ACVR2B/R40H	VARIANT	R -> H (in HTX4; dbSNP:rs121434437)	ECO:0000269|PubMed:9916847	9916847
Q13705	ACVR2B	P176R	Q13705/P176R	ACVR2B/P176R	VARIANT	P -> R (in dbSNP:rs35882617)	ECO:0000269|PubMed:17344846	17344846
Q13705	ACVR2B	E459D	Q13705/E459D	ACVR2B/E459D	VARIANT	E -> D (in dbSNP:rs500611)	ECO:0000269|PubMed:9621519	9621519
Q13705	ACVR2B	V494I	Q13705/V494I	ACVR2B/V494I	VARIANT	V -> I (in HTX4; dbSNP:rs121434438)	ECO:0000269|PubMed:9916847	9916847

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13873	BMPR2	C60Y	Q13873/C60Y	BMPR2/C60Y	VARIANT	C -> Y (in PPH1; dbSNP:rs1085307172)	ECO:0000269|PubMed:11015450	11015450
Q13873	BMPR2	S64R	Q13873/S64R	BMPR2/S64R	VARIANT	S -> R (in PPH1; unknown pathological significance; unchanged subcellular localization)	ECO:0000269|PubMed:28507310	28507310
Q13873	BMPR2	Y67C	Q13873/Y67C	BMPR2/Y67C	VARIANT	Y -> C (in PPH1; significant decrease in nitric oxide synthesis by endothelial cells; dbSNP:rs1085307177)	ECO:0000269|PubMed:25187962	25187962
Q13873	BMPR2	I77L	Q13873/I77L	BMPR2/I77L	VARIANT	I -> L (in PPH1; unknown pathological significance; unchanged subcellular localization)	ECO:0000269|PubMed:24936649, ECO:0000269|PubMed:28507310	24936649,28507310
Q13873	BMPR2	Q82H	Q13873/Q82H	BMPR2/Q82H	VARIANT	Q -> H (in PPH1; dbSNP:rs1085307185)	ECO:0000269|PubMed:12358323	12358323
Q13873	BMPR2	C84F	Q13873/C84F	BMPR2/C84F	VARIANT			
Q13873	BMPR2	H87Y	Q13873/H87Y	BMPR2/H87Y	VARIANT	H -> Y (in PPH1; unknown pathological significance; unchanged subcellular localization)	ECO:0000269|PubMed:24936649, ECO:0000269|PubMed:28507310	24936649,28507310
Q13873	BMPR2	Q92L	Q13873/Q92L	BMPR2/Q92L	VARIANT	Q -> L (in PPH1; unknown pathological significance; unchanged subcellular localization)	ECO:0000269|PubMed:24936649, ECO:0000269|PubMed:28507310	24936649,28507310
Q13873	BMPR2	Q109H	Q13873/Q109H	BMPR2/Q109H	VARIANT	Q -> H (in PPH1; unknown pathological significance; unchanged subcellular localization)	ECO:0000269|PubMed:28507310	28507310
Q13873	BMPR2	C117Y	Q13873/C117Y	BMPR2/C117Y	VARIANT	C -> Y (in PPH1; dbSNP:rs1085307215)	ECO:0000269|PubMed:11015450	11015450
Q13873	BMPR2	C118W	Q13873/C118W	BMPR2/C118W	VARIANT	C -> W (in PPH1; dbSNP:rs137852743)	ECO:0000269|PubMed:10973254	10973254
Q13873	BMPR2	C123R	Q13873/C123R	BMPR2/C123R	VARIANT	C -> R (in PPH1; dbSNP:rs137852750)	ECO:0000269|PubMed:11115378	11115378
Q13873	BMPR2	C123S	Q13873/C123S	BMPR2/C123S	VARIANT	C -> S (in PPH1; dbSNP:rs137852750)	ECO:0000269|PubMed:11115378	11115378
Q13873	BMPR2	P138A	Q13873/P138A	BMPR2/P138A	VARIANT	P -> A (in PPH1; unknown pathological significance; unchanged subcellular localization)	ECO:0000269|PubMed:28507310	28507310
Q13873	BMPR2	A162P	Q13873/A162P	BMPR2/A162P	VARIANT	A -> P (in PPH1; unknown pathological significance; unchanged subcellular localization)	ECO:0000269|PubMed:24936649, ECO:0000269|PubMed:28507310	24936649,28507310
Q13873	BMPR2	G182D	Q13873/G182D	BMPR2/G182D	VARIANT	G -> D (in PPH1; dbSNP:rs137852754)	ECO:0000269|PubMed:12358323	12358323
Q13873	BMPR2	E224D	Q13873/E224D	BMPR2/E224D	VARIANT	E -> D (in dbSNP:rs754343081)	ECO:0000269|PubMed:11115378	11115378
Q13873	BMPR2	R248G	Q13873/R248G	BMPR2/R248G	VARIANT	R -> G (in PPH1; unknown pathological significance; unchanged subcellular localization)	ECO:0000269|PubMed:28507310	28507310
Q13873	BMPR2	D264N	Q13873/D264N	BMPR2/D264N	VARIANT	D -> N (in PPH1; unknown pathological significance; unchanged subcellular localization)	ECO:0000269|PubMed:24936649, ECO:0000269|PubMed:28507310	24936649,28507310
Q13873	BMPR2	V341M	Q13873/V341M	BMPR2/V341M	VARIANT	V -> M (in PPH1; unknown pathological significance; unchanged subcellular localization; dbSNP:rs767882551)	ECO:0000269|PubMed:24936649, ECO:0000269|PubMed:28507310	24936649,28507310
Q13873	BMPR2	C347Y	Q13873/C347Y	BMPR2/C347Y	VARIANT	C -> Y (in PPH1; dbSNP:rs137852744)	ECO:0000269|PubMed:10973254	10973254
Q13873	BMPR2	C420R	Q13873/C420R	BMPR2/C420R	VARIANT	C -> R (in PPH1; dbSNP:rs1085307324)	ECO:0000269|PubMed:11115378	11115378
Q13873	BMPR2	K467R	Q13873/K467R	BMPR2/K467R	VARIANT	K -> R (in PPH1; unknown pathological significance; unchanged subcellular localization)	ECO:0000269|PubMed:28507310	28507310
Q13873	BMPR2	C483R	Q13873/C483R	BMPR2/C483R	VARIANT	C -> R (in PPH1; sporadic; dbSNP:rs1085307354)	ECO:0000269|PubMed:11015450, ECO:0000269|PubMed:12358323	11015450,12358323
Q13873	BMPR2	D485G	Q13873/D485G	BMPR2/D485G	VARIANT	D -> G (in PPH1; complete loss of function; dbSNP:rs137852745)	ECO:0000269|PubMed:10973254, ECO:0000269|PubMed:11115378	10973254,11115378
Q13873	BMPR2	R491Q	Q13873/R491Q	BMPR2/R491Q	VARIANT	R -> Q (in PPH1; sporadic; dbSNP:rs137852749)	ECO:0000269|PubMed:10903931	10903931
Q13873	BMPR2	R491W	Q13873/R491W	BMPR2/R491W	VARIANT	R -> W (in PPH1; dbSNP:rs137852746)	ECO:0000269|PubMed:10903931	10903931
Q13873	BMPR2	K512T	Q13873/K512T	BMPR2/K512T	VARIANT	K -> T (in PPH1; dbSNP:rs1085307364)	ECO:0000269|PubMed:11115378	11115378
Q13873	BMPR2	N519K	Q13873/N519K	BMPR2/N519K	VARIANT	N -> K (in PPH1; dbSNP:rs1085307365)		
Q13873	BMPR2	S775N	Q13873/S775N	BMPR2/S775N	VARIANT	S -> N (unchanged subcellular localization; dbSNP:rs2228545)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:24936649, ECO:0000269|PubMed:28507310	17344846,24936649,28507310
Q13873	BMPR2	S863N	Q13873/S863N	BMPR2/S863N	VARIANT	S -> N (in PPH1; abnormal subcellular localization; significant increase in apoptosis of endothelial cells; significant decrease in proliferation of endothelial cells; significant decrease in nitric oxide synthesis by endothelial cells; significant increase in endothelin 1 synthesis by endothelial cells; dbSNP:rs1006246556)	ECO:0000269|PubMed:25187962	25187962
Q13873	BMPR2	R899P	Q13873/R899P	BMPR2/R899P	VARIANT	R -> P (in PPH1; leads to constitutive activation of the MAPK14 pathway; dbSNP:rs137852752)	ECO:0000269|PubMed:15965979	15965979

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13882	PTK6	L16F	Q13882/L16F	PTK6/L16F	VARIANT	L -> F (in a renal papillary sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q13882	PTK6	A436T	Q13882/A436T	PTK6/A436T	VARIANT	A -> T (in dbSNP:rs56145017)	ECO:0000269|PubMed:17344846	17344846
Q13882	PTK6	W44A	Q13882/W44A	PTK6/W44A	MUTAGEN	W->A: Strong decrease in STAP2 phosphorylation. Markedly decreased interaction between SH3 domain the linker region.	ECO:0000269|PubMed:10980601, ECO:0000269|PubMed:17822667	10980601,17822667
Q13882	PTK6	Y66A	Q13882/Y66A	PTK6/Y66A	MUTAGEN	Y->A: Decrease in STAP2 phosphorylation.	ECO:0000269|PubMed:10980601	10980601
Q13882	PTK6	R105L	Q13882/R105L	PTK6/R105L	MUTAGEN	R->L: Decrease in STAP2 phosphorylation.	ECO:0000269|PubMed:10980601	10980601
Q13882	PTK6	W184A	Q13882/W184A	PTK6/W184A	MUTAGEN	W->A: Abrogates interaction between PTK6-domain kinase and PTK6-linker. Abrogates autophosphorylation and phosphorylation of KHDRBS1.	ECO:0000269|PubMed:15961400	15961400
Q13882	PTK6	K219M	Q13882/K219M	PTK6/K219M	MUTAGEN	K->M: Abolishes kinase activity and cell transformation, and phosphorylation of STAP2.	ECO:0000269|PubMed:10980601, ECO:0000269|PubMed:15471878, ECO:0000269|PubMed:8940083	10980601,15471878,8940083
Q13882	PTK6	K219R	Q13882/K219R	PTK6/K219R	MUTAGEN	K->R: Abolishes kinase activity.	ECO:0000269|PubMed:27480927	27480927
Q13882	PTK6	Y342A	Q13882/Y342A	PTK6/Y342A	MUTAGEN	Y->A: 3-fold lower specific kinase activity. Decreased, but still significant, autophosphorylation. Decreased, but still significant, autophosphorylation; when associated with A-447.	ECO:0000269|PubMed:12121988	12121988
Q13882	PTK6	Y447F	Q13882/Y447F	PTK6/Y447F	MUTAGEN	Y->F: Decrease in transforming potential and increase in the kinase activity level. Decreased, but still significant, autophosphorylation; when associated with A-342.	ECO:0000269|PubMed:12121988, ECO:0000269|PubMed:15471878, ECO:0000269|PubMed:8940083	12121988,15471878,8940083

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q13976	PRKG1	R177Q	Q13976/R177Q	PRKG1/R177Q	VARIANT	R -> Q (in AAT8; impairs cGMP binding; the mutant protein is constitutively active; dbSNP:rs397515330)	ECO:0000269|PubMed:23910461	23910461
Q13976	PRKG1	I249V	Q13976/I249V	PRKG1/I249V	VARIANT	I -> V (in dbSNP:rs56082459)	ECO:0000269|PubMed:17344846	17344846
Q13976	PRKG1	N267S	Q13976/N267S	PRKG1/N267S	VARIANT	N -> S (in dbSNP:rs34997494)	ECO:0000269|PubMed:17344846	17344846
Q13976	PRKG1	Y474F	Q13976/Y474F	PRKG1/Y474F	VARIANT	Y -> F (in dbSNP:rs149710600)	ECO:0000269|PubMed:23910461	23910461
Q13976	PRKG1	G666A	Q13976/G666A	PRKG1/G666A	VARIANT	G -> A (in dbSNP:rs750949508)	ECO:0000269|PubMed:23910461	23910461
Q13976	PRKG1	L12A	Q13976/L12A	PRKG1/L12A	MUTAGEN	L->A: Loss of binding to PPP1R12A.	ECO:0000269|PubMed:10567269	10567269
Q13976	PRKG1	I19A	Q13976/I19A	PRKG1/I19A	MUTAGEN	I->A: Loss of binding to PPP1R12A.	ECO:0000269|PubMed:10567269	10567269
Q13976	PRKG1	L26P	Q13976/L26P	PRKG1/L26P	MUTAGEN	L->P: Loss of binding to PPP1R12A.	ECO:0000269|PubMed:10567269	10567269
Q13976	PRKG1	I33A	Q13976/I33A	PRKG1/I33A	MUTAGEN	I->A: Loss of binding to PPP1R12A.	ECO:0000269|PubMed:10567269	10567269
Q13976	PRKG1	L40A	Q13976/L40A	PRKG1/L40A	MUTAGEN	L->A: Loss of binding to PPP1R12A.	ECO:0000269|PubMed:10567269	10567269
Q13976	PRKG1	L281A	Q13976/L281A	PRKG1/L281A	MUTAGEN	L->A: Reduces cGMP binding affinity.	ECO:0000269|PubMed:24239458	24239458
Q13976	PRKG1	R282A	Q13976/R282A	PRKG1/R282A	MUTAGEN	R->A: Reduces cGMP binding affinity.	ECO:0000269|PubMed:24239458	24239458
Q13976	PRKG1	T302A	Q13976/T302A	PRKG1/T302A	MUTAGEN	T->A: Reduces cGMP binding affinity.	ECO:0000269|PubMed:24239458	24239458
Q13976	PRKG1	Y336A	Q13976/Y336A	PRKG1/Y336A	MUTAGEN	Y->A: Reduces cGMP binding affinity.	ECO:0000269|PubMed:24239458	24239458

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q14004	CDK13	Q103R	Q14004/Q103R	CDK13/Q103R	VARIANT	Q -> R (in RNA edited version)		
Q14004	CDK13	S340F	Q14004/S340F	CDK13/S340F	VARIANT	S -> F (in dbSNP:rs13622)		
Q14004	CDK13	P356A	Q14004/P356A	CDK13/P356A	VARIANT	P -> A (in dbSNP:rs17537669)	ECO:0000269|Ref.2	
Q14004	CDK13	L403F	Q14004/L403F	CDK13/L403F	VARIANT	L -> F (in dbSNP:rs3735137)	ECO:0000269|Ref.2	
Q14004	CDK13	R410Q	Q14004/R410Q	CDK13/R410Q	VARIANT	R -> Q (in dbSNP:rs17496261)	ECO:0000269|Ref.2	
Q14004	CDK13	T494A	Q14004/T494A	CDK13/T494A	VARIANT	T -> A (in dbSNP:rs34624759)	ECO:0000269|PubMed:17344846	17344846
Q14004	CDK13	T500A	Q14004/T500A	CDK13/T500A	VARIANT	T -> A (in dbSNP:rs3735135)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.2	17344846
Q14004	CDK13	S624G	Q14004/S624G	CDK13/S624G	VARIANT	S -> G (in dbSNP:rs17496275)	ECO:0000269|Ref.2	
Q14004	CDK13	T670R	Q14004/T670R	CDK13/T670R	VARIANT	T -> R (in dbSNP:rs34775357)	ECO:0000269|PubMed:17344846	17344846
Q14004	CDK13	R700L	Q14004/R700L	CDK13/R700L	VARIANT	R -> L (in dbSNP:rs1057000)	ECO:0000269|PubMed:11162436, ECO:0000269|PubMed:1731328	11162436,1731328
Q14004	CDK13	G714R	Q14004/G714R	CDK13/G714R	VARIANT	G -> R (in CHDFIDD; dbSNP:rs1057519633)	ECO:0000269|PubMed:27479907	27479907
Q14004	CDK13	G717R	Q14004/G717R	CDK13/G717R	VARIANT	G -> R (in CHDFIDD; dbSNP:rs1057519632)	ECO:0000269|PubMed:27479907	27479907
Q14004	CDK13	K734E	Q14004/K734E	CDK13/K734E	VARIANT	K -> E (in CHDFIDD; dbSNP:rs1064795731)	ECO:0000269|PubMed:28807008	28807008
Q14004	CDK13	R751Q	Q14004/R751Q	CDK13/R751Q	VARIANT	R -> Q (in CHDFIDD; dbSNP:rs1057519634)	ECO:0000269|PubMed:27479907	27479907
Q14004	CDK13	N842D	Q14004/N842D	CDK13/N842D	VARIANT	N -> D (in CHDFIDD; dbSNP:rs1554333853)	ECO:0000269|PubMed:28807008	28807008
Q14004	CDK13	N842S	Q14004/N842S	CDK13/N842S	VARIANT	N -> S (in CHDFIDD; dbSNP:rs878853160)	ECO:0000269|PubMed:27479907, ECO:0000269|PubMed:28807008	27479907,28807008
Q14004	CDK13	V1062M	Q14004/V1062M	CDK13/V1062M	VARIANT	V -> M (in dbSNP:rs17496712)	ECO:0000269|Ref.2	
Q14004	CDK13	V1170M	Q14004/V1170M	CDK13/V1170M	VARIANT	V -> M (in dbSNP:rs3204309)	ECO:0000269|PubMed:11162436, ECO:0000269|PubMed:17344846	11162436,17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q14012	CAMK1	P217S	Q14012/P217S	CAMK1/P217S	VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation; dbSNP:rs907102077)	ECO:0000269|PubMed:17344846	17344846
Q14012	CAMK1	E361K	Q14012/E361K	CAMK1/E361K	VARIANT	E -> K (in dbSNP:rs56033923)	ECO:0000269|PubMed:17344846	17344846
Q14012	CAMK1	K49A	Q14012/K49A	CAMK1/K49A	MUTAGEN	K->A: Catalytically inactive form; prevents CDK4 activation.	ECO:0000269|PubMed:14754892, ECO:0000269|PubMed:7641687	14754892,7641687
Q14012	CAMK1	T177A	Q14012/T177A	CAMK1/T177A	MUTAGEN	T->A: Loss of activation by CaMKK1.	ECO:0000269|PubMed:7641687	7641687
Q14012	CAMK1	T177D	Q14012/T177D	CAMK1/T177D	MUTAGEN	T->D: Partial activation in absence of CaMKK1.	ECO:0000269|PubMed:7641687	7641687

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q14164	IKBKE	E128K	Q14164/E128K	IKBKE/E128K	VARIANT	E -> K (in dbSNP:rs41296028)	ECO:0000269|Ref.4	
Q14164	IKBKE	A371T	Q14164/A371T	IKBKE/A371T	VARIANT	A -> T (in dbSNP:rs17021877)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
Q14164	IKBKE	T483M	Q14164/T483M	IKBKE/T483M	VARIANT	T -> M (in dbSNP:rs52817862)	ECO:0000269|PubMed:17344846	17344846
Q14164	IKBKE	E515D	Q14164/E515D	IKBKE/E515D	VARIANT	E -> D (in dbSNP:rs41299015)	ECO:0000269|Ref.4	
Q14164	IKBKE	I543M	Q14164/I543M	IKBKE/I543M	VARIANT	I -> M (in dbSNP:rs41299037)	ECO:0000269|Ref.4	
Q14164	IKBKE	A602V	Q14164/A602V	IKBKE/A602V	VARIANT	A -> V (in dbSNP:rs12059562)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
Q14164	IKBKE	G660E	Q14164/G660E	IKBKE/G660E	VARIANT	G -> E (in dbSNP:rs55822317)	ECO:0000269|PubMed:17344846	17344846
Q14164	IKBKE	P713L	Q14164/P713L	IKBKE/P713L	VARIANT	P -> L (in dbSNP:rs3748022)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
Q14164	IKBKE	K30A	Q14164/K30A	IKBKE/K30A	MUTAGEN	K->A: Loss of ubiquitination and decreased kinase activity. No effect on homodimerization.	ECO:0000269|PubMed:23453969	23453969
Q14164	IKBKE	K30R	Q14164/K30R	IKBKE/K30R	MUTAGEN	K->R: Loss of ubiquitination and decreased kinase activity. Decreases interaction with IKBKB, IKBKG and MYD88. No effect on homodimerization.	ECO:0000269|PubMed:23453969	23453969
Q14164	IKBKE	K38A	Q14164/K38A	IKBKE/K38A	MUTAGEN	K->A: Loss of kinase activity and loss of nuclear import.	ECO:0000269|PubMed:10421793	10421793
Q14164	IKBKE	E168A	Q14164/E168A	IKBKE/E168A	MUTAGEN	E->A: Slight decrease of kinase activity.	ECO:0000269|PubMed:10421793	10421793
Q14164	IKBKE	S172A	Q14164/S172A	IKBKE/S172A	MUTAGEN	S->A: Loss of autophosphorylation and of kinase activity.	ECO:0000269|PubMed:10421793	10421793
Q14164	IKBKE	S172E	Q14164/S172E	IKBKE/S172E	MUTAGEN	S->E: Decrease in kinase activity.	ECO:0000269|PubMed:10421793	10421793
Q14164	IKBKE	K231R	Q14164/K231R	IKBKE/K231R	MUTAGEN	K->R: Loss of sumoylation and loss of targeting to nuclear bodies.	ECO:0000269|PubMed:20188669	20188669
Q14164	IKBKE	K401A	Q14164/K401A	IKBKE/K401A	MUTAGEN	K->A: Loss of ubiquitination and decreased kinase activity. No effect on homodimerization.	ECO:0000269|PubMed:23453969	23453969
Q14164	IKBKE	K401R	Q14164/K401R	IKBKE/K401R	MUTAGEN	K->R: Loss of ubiquitination and decreased kinase activity. Decreases interaction with IKBKB, IKBKG and MYD88. No effect on homodimerization.	ECO:0000269|PubMed:23453969	23453969
Q14164	IKBKE	K416A	Q14164/K416A	IKBKE/K416A	MUTAGEN	K->A: No effect on ubiquitination.	ECO:0000269|PubMed:23453969	23453969
Q14164	IKBKE	K416R	Q14164/K416R	IKBKE/K416R	MUTAGEN	K->R: No effect on ubiquitination.	ECO:0000269|PubMed:23453969	23453969

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q14289	PTK2B	Q359E	Q14289/Q359E	PTK2B/Q359E	VARIANT	Q -> E (in dbSNP:rs56175011)	ECO:0000269|PubMed:17344846	17344846
Q14289	PTK2B	R698H	Q14289/R698H	PTK2B/R698H	VARIANT	R -> H (in dbSNP:rs35174236)	ECO:0000269|PubMed:17344846	17344846
Q14289	PTK2B	L808P	Q14289/L808P	PTK2B/L808P	VARIANT	L -> P (in dbSNP:rs55747955)	ECO:0000269|PubMed:17344846	17344846
Q14289	PTK2B	K838T	Q14289/K838T	PTK2B/K838T	VARIANT	K -> T (in dbSNP:rs751019)	ECO:0000269|PubMed:17344846, ECO:0007744|PubMed:19369195	17344846,19369195
Q14289	PTK2B	E970K	Q14289/E970K	PTK2B/E970K	VARIANT	E -> K (in dbSNP:rs56263944)	ECO:0000269|PubMed:17344846	17344846
Q14289	PTK2B	Y402F	Q14289/Y402F	PTK2B/Y402F	MUTAGEN	Y->F: Abolishes autophosphorylation. Abolishes interaction with SRC.	ECO:0000269|PubMed:8849729	8849729
Q14289	PTK2B	K457A	Q14289/K457A	PTK2B/K457A	MUTAGEN	K->A: Abolishes kinase activity.	ECO:0000269|PubMed:15166227	15166227
Q14289	PTK2B	P859A	Q14289/P859A	PTK2B/P859A	MUTAGEN	P->A: Loss of interaction with NPHP1.	ECO:0000269|PubMed:11493697	11493697
Q14289	PTK2B	Y881F	Q14289/Y881F	PTK2B/Y881F	MUTAGEN	Y->F: Loss of phosphorylation site. Strongly reduced interaction with GRB2.	ECO:0000269|PubMed:20521079	20521079

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q14296	FASTK	V424L	Q14296/V424L	FASTK/V424L	VARIANT	V -> L (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs758691941)	ECO:0000269|PubMed:17344846	17344846
Q14296	FASTK	A436V	Q14296/A436V	FASTK/A436V	VARIANT	A -> V (in dbSNP:rs2288648)		
Q14296	FASTK	M35G	Q14296/M35G	FASTK/M35G	MUTAGEN	M->G: Abolishes isoform 4 expression.	ECO:0000269|PubMed:25704814	25704814

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q14680	MELK	T56M	Q14680/T56M	MELK/T56M	VARIANT	T -> M (in dbSNP:rs35233455)	ECO:0000269|PubMed:17344846	17344846
Q14680	MELK	K219R	Q14680/K219R	MELK/K219R	VARIANT	K -> R (in dbSNP:rs35142210)	ECO:0000269|PubMed:17344846	17344846
Q14680	MELK	R333K	Q14680/R333K	MELK/R333K	VARIANT	R -> K (in dbSNP:rs34655121)	ECO:0000269|PubMed:17344846	17344846
Q14680	MELK	T348I	Q14680/T348I	MELK/T348I	VARIANT	T -> I (in dbSNP:rs55845414)	ECO:0000269|PubMed:17344846	17344846
Q14680	MELK	T460M	Q14680/T460M	MELK/T460M	VARIANT	T -> M (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs144052967)	ECO:0000269|PubMed:17344846	17344846
Q14680	MELK	C29V	Q14680/C29V	MELK/C29V	MUTAGEN	C->V: Abolishes dependence to reducing agents; when associated with V-70; A-89; A-154; A-168; A-169; A-204; A-286 and A-339.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	C70V	Q14680/C70V	MELK/C70V	MUTAGEN	C->V: Abolishes dependence to reducing agents; when associated with V-29; A-89; A-154; A-168; A-169; A-204; A-286 and A-339.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	C89A	Q14680/C89A	MELK/C89A	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-154; A-168; A-169; A-204; A-286 and A-339.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	D150A	Q14680/D150A	MELK/D150A	MUTAGEN	D->A: Abolishes enzymatic activity.	ECO:0000269|PubMed:14699119, ECO:0000269|PubMed:16216881, ECO:0000269|PubMed:17280616	14699119,16216881,17280616
Q14680	MELK	C154A	Q14680/C154A	MELK/C154A	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-168; A-169; A-204; A-286 and A-339.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	Y163F	Q14680/Y163F	MELK/Y163F	MUTAGEN	Y->F: Abolishes autophosphorylation on tyrosine but still active on exogenous substrates.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	T167A	Q14680/T167A	MELK/T167A	MUTAGEN	T->A: Abolishes activation of serine/threonine-protein kinase activity and has only weak activity.	ECO:0000269|PubMed:14976552	14976552
Q14680	MELK	T167D	Q14680/T167D	MELK/T167D	MUTAGEN			
Q14680	MELK	T167E	Q14680/T167E	MELK/T167E	MUTAGEN	T->D,E: Phosphomimetic mutant that has similar kinase activity as wild-type.	ECO:0000269|PubMed:14976552	14976552
Q14680	MELK	C168A	Q14680/C168A	MELK/C168A	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-169; A-204; A-286 and A-339.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	C169A	Q14680/C169A	MELK/C169A	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-204; A-286 and A-339.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	S171A	Q14680/S171A	MELK/S171A	MUTAGEN	S->A: Abolishes activation of serine/threonine-protein kinase activity and has only weak activity.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	S171D	Q14680/S171D	MELK/S171D	MUTAGEN	S->D: Inactive.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	C204A	Q14680/C204A	MELK/C204A	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-169; A-286 and A-339.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	C286A	Q14680/C286A	MELK/C286A	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-169; A-204; and A-339.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	C339A	Q14680/C339A	MELK/C339A	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-169; A-204 and A-286.	ECO:0000269|PubMed:16216881	16216881
Q14680	MELK	T345A	Q14680/T345A	MELK/T345A	MUTAGEN	T->A: No effect on interaction with PPP1R8.	ECO:0000269|PubMed:14699119	14699119
Q14680	MELK	T387A	Q14680/T387A	MELK/T387A	MUTAGEN	T->A: No effect on interaction with PPP1R8.	ECO:0000269|PubMed:14699119	14699119
Q14680	MELK	T409A	Q14680/T409A	MELK/T409A	MUTAGEN	T->A: No effect on interaction with PPP1R8.	ECO:0000269|PubMed:14699119	14699119
Q14680	MELK	T415A	Q14680/T415A	MELK/T415A	MUTAGEN	T->A: No effect on interaction with PPP1R8.	ECO:0000269|PubMed:14699119	14699119
Q14680	MELK	T428A	Q14680/T428A	MELK/T428A	MUTAGEN	T->A: No effect on interaction with PPP1R8.	ECO:0000269|PubMed:14699119	14699119
Q14680	MELK	T446A	Q14680/T446A	MELK/T446A	MUTAGEN	T->A: Inhibits interaction with PPP1R8.	ECO:0000269|PubMed:14699119	14699119
Q14680	MELK	T460A	Q14680/T460A	MELK/T460A	MUTAGEN	T->A: Inhibits interaction with PPP1R8.	ECO:0000269|PubMed:14699119	14699119
Q14680	MELK	T466A	Q14680/T466A	MELK/T466A	MUTAGEN	T->A: Inhibits interaction with PPP1R8.	ECO:0000269|PubMed:14699119	14699119
Q14680	MELK	T478A	Q14680/T478A	MELK/T478A	MUTAGEN	T->A: Strongly inhibits interaction with PPP1R8. Enhances enzymatic activity.	ECO:0000269|PubMed:14699119	14699119
Q14680	MELK	T518A	Q14680/T518A	MELK/T518A	MUTAGEN	T->A: No effect on interaction with PPP1R8.	ECO:0000269|PubMed:14699119	14699119

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15059	BRD3	T36N	Q15059/T36N	BRD3/T36N	VARIANT	T -> N (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15059	BRD3	A161T	Q15059/A161T	BRD3/A161T	VARIANT	A -> T (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15059	BRD3	A172V	Q15059/A172V	BRD3/A172V	VARIANT	A -> V (in dbSNP:rs34609592)	ECO:0000269|PubMed:17344846	17344846
Q15059	BRD3	K435Q	Q15059/K435Q	BRD3/K435Q	VARIANT	K -> Q (in dbSNP:rs36093130)	ECO:0000269|PubMed:17344846	17344846
Q15059	BRD3	R441H	Q15059/R441H	BRD3/R441H	VARIANT	R -> H (in dbSNP:rs56017928)	ECO:0000269|PubMed:17344846	17344846
Q15059	BRD3	S447P	Q15059/S447P	BRD3/S447P	VARIANT	S -> P (in dbSNP:rs55754444)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15118	PDK1	A134T	Q15118/A134T	PDK1/A134T	VARIANT	A -> T (in dbSNP:rs35661499)		
Q15118	PDK1	N412T	Q15118/N412T	PDK1/N412T	VARIANT	N -> T (in dbSNP:rs34250425)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15119	PDK2	G342R	Q15119/G342R	PDK2/G342R	VARIANT	G -> R (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs17855787)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15120	PDK3	K114T	Q15120/K114T	PDK3/K114T	VARIANT	K -> T (in dbSNP:rs146331370)	ECO:0000269|PubMed:23297365	23297365
Q15120	PDK3	R158H	Q15120/R158H	PDK3/R158H	VARIANT	R -> H (in CMTX6; gain of function; results in a 5-fold increase in kinase activity, decreased sensitivity to pyruvate inhibition, reduced affinity for nucleotides and increased affinity for pyruvate dehydrogenase complex component E2 (PDC-E2), leading to PDC hyperphosphorylation and increased inactivation; dbSNP:rs397515323)	ECO:0000269|PubMed:23297365	23297365
Q15120	PDK3	E219A	Q15120/E219A	PDK3/E219A	VARIANT	E -> A (in a head & neck squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15120	PDK3	Y334S	Q15120/Y334S	PDK3/Y334S	VARIANT	Y -> S	ECO:0000269|PubMed:23297365	23297365
Q15120	PDK3	N120H	Q15120/N120H	PDK3/N120H	MUTAGEN	N->H: No effect on kinase activity; when associated with N-121.	ECO:0000269|PubMed:23297365	23297365
Q15120	PDK3	D121N	Q15120/D121N	PDK3/D121N	MUTAGEN	D->N: No effect on kinase activity; when associated with H-120.	ECO:0000269|PubMed:23297365	23297365

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15131	CDK10	P96L	Q15131/P96L	CDK10/P96L	VARIANT	P -> L (in dbSNP:rs55819627)	ECO:0000269|PubMed:17344846	17344846
Q15131	CDK10	N168S	Q15131/N168S	CDK10/N168S	VARIANT	N -> S (in dbSNP:rs56340740)	ECO:0000269|PubMed:17344846	17344846
Q15131	CDK10	R342H	Q15131/R342H	CDK10/R342H	VARIANT	R -> H (in dbSNP:rs55757604)	ECO:0000269|PubMed:17344846	17344846
Q15131	CDK10	C358Y	Q15131/C358Y	CDK10/C358Y	VARIANT	C -> Y (in dbSNP:rs56242003)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15139	PRKD1	H152Y	Q15139/H152Y	PRKD1/H152Y	VARIANT	H -> Y (in a colorectal cancer sample; somatic mutation; dbSNP:rs1383618278)	ECO:0000269|PubMed:16959974	16959974
Q15139	PRKD1	S225P	Q15139/S225P	PRKD1/S225P	VARIANT	S -> P	ECO:0000269|PubMed:17344846	17344846
Q15139	PRKD1	L299W	Q15139/L299W	PRKD1/L299W	VARIANT	L -> W (in CHDED; dbSNP:rs1057519636)	ECO:0000269|PubMed:27479907	27479907
Q15139	PRKD1	K478Q	Q15139/K478Q	PRKD1/K478Q	VARIANT	K -> Q (in dbSNP:rs55852813)	ECO:0000269|PubMed:17344846	17344846
Q15139	PRKD1	P585S	Q15139/P585S	PRKD1/P585S	VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15139	PRKD1	G592R	Q15139/G592R	PRKD1/G592R	VARIANT	G -> R (in CHDED; dbSNP:rs1057519635)	ECO:0000269|PubMed:27479907	27479907
Q15139	PRKD1	R677M	Q15139/R677M	PRKD1/R677M	VARIANT	R -> M (in a lung bronchoalveolar carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15139	PRKD1	P679L	Q15139/P679L	PRKD1/P679L	VARIANT	P -> L (in dbSNP:rs34588699)	ECO:0000269|PubMed:17344846	17344846
Q15139	PRKD1	R825K	Q15139/R825K	PRKD1/R825K	VARIANT	R -> K (in dbSNP:rs11161065)		
Q15139	PRKD1	E857K	Q15139/E857K	PRKD1/E857K	VARIANT	E -> K (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
Q15139	PRKD1	H891R	Q15139/H891R	PRKD1/H891R	VARIANT	H -> R (in dbSNP:rs45582934)	ECO:0000269|PubMed:17344846	17344846
Q15139	PRKD1	P157G	Q15139/P157G	PRKD1/P157G	MUTAGEN	P->G: Increase in ability to bind phorbol ester, loss of ability to bind DAG.	ECO:0000269|PubMed:18076381	18076381
Q15139	PRKD1	P281G	Q15139/P281G	PRKD1/P281G	MUTAGEN	P->G: No effect on ability to bind phorbol ester, slight increase in ability to bind DAG.	ECO:0000269|PubMed:18076381	18076381
Q15139	PRKD1	Y432E	Q15139/Y432E	PRKD1/Y432E	MUTAGEN	Y->E: Decreased phosphorylation level when coexpressed with SRC in HeLa cells. Unchanged phosphorylation level when coexpressed with ABL.	ECO:0000269|PubMed:12637538	12637538
Q15139	PRKD1	Y432F	Q15139/Y432F	PRKD1/Y432F	MUTAGEN	Y->F: Decreased phosphorylation level when coexpressed with SRC in HeLa cells. Unchanged phosphorylation level when coexpressed with ABL. Unaltered kinase activity. Decreased kinase activity; when associated with F-463 and F-502.	ECO:0000269|PubMed:12637538	12637538
Q15139	PRKD1	Y463E	Q15139/Y463E	PRKD1/Y463E	MUTAGEN	Y->E: Constitutive activation and constitutive phosphorylation of S-738 and S-742.	ECO:0000269|PubMed:12637538	12637538
Q15139	PRKD1	Y463F	Q15139/Y463F	PRKD1/Y463F	MUTAGEN	Y->F: Decreased phosphorylation level when coexpressed with either SRC or ABL in HeLa cells. Decreased kinase activity.	ECO:0000269|PubMed:12637538	12637538
Q15139	PRKD1	Y502E	Q15139/Y502E	PRKD1/Y502E	MUTAGEN	Y->E: Loss of activation.	ECO:0000269|PubMed:12637538	12637538
Q15139	PRKD1	Y502F	Q15139/Y502F	PRKD1/Y502F	MUTAGEN	Y->F: Decreased phosphorylation level when coexpressed with SRC in HeLa cells. Unchanged phosphorylation level when coexpressed with ABL. Unaltered kinase activity. Decreased kinase activity; when associated with F-432 and F-502.	ECO:0000269|PubMed:12637538	12637538
Q15139	PRKD1	K612W	Q15139/K612W	PRKD1/K612W	MUTAGEN	K->W: Loss of kinase activity.	ECO:0000269|PubMed:12637538	12637538

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15208	STK38	E18K	Q15208/E18K	STK38/E18K	VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15208	STK38	D145N	Q15208/D145N	STK38/D145N	VARIANT	D -> N (in dbSNP:rs56005153)	ECO:0000269|PubMed:17344846	17344846
Q15208	STK38	K267R	Q15208/K267R	STK38/K267R	VARIANT	K -> R (in dbSNP:rs56105564)	ECO:0000269|PubMed:17344846	17344846
Q15208	STK38	T74A	Q15208/T74A	STK38/T74A	MUTAGEN	T->A: Decreases autophosphorylation and kinase activity. Reduced binding of S100B.	ECO:0000269|PubMed:12493777	12493777
Q15208	STK38	K118A	Q15208/K118A	STK38/K118A	MUTAGEN	K->A: Loss of autophosphorylation and kinase activity.	ECO:0000269|PubMed:12493777, ECO:0000269|PubMed:7761441	12493777,7761441
Q15208	STK38	S281A	Q15208/S281A	STK38/S281A	MUTAGEN	S->A: Loss of autophosphorylation and kinase activity.	ECO:0000269|PubMed:12493777	12493777
Q15208	STK38	T444A	Q15208/T444A	STK38/T444A	MUTAGEN	T->A: Decreases autophosphorylation and kinase activity.	ECO:0000269|PubMed:12493777	12493777

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15303	ERBB4	T140I	Q15303/T140I	ERBB4/T140I	VARIANT	T -> I (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15303	ERBB4	S303Y	Q15303/S303Y	ERBB4/S303Y	VARIANT	S -> Y (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15303	ERBB4	R927Q	Q15303/R927Q	ERBB4/R927Q	VARIANT	R -> Q (in ALS19; reduces autophosphorylation upon NRG1 stimulation; dbSNP:rs397514262)	ECO:0000269|PubMed:24119685	24119685
Q15303	ERBB4	R1275W	Q15303/R1275W	ERBB4/R1275W	VARIANT	R -> W (in ALS19; reduces autophosphorylation upon NRG1 stimulation; dbSNP:rs397514263)	ECO:0000269|PubMed:24119685	24119685
Q15303	ERBB4	Q646C	Q15303/Q646C	ERBB4/Q646C	MUTAGEN	Q->C: Constitutively activated kinase.	ECO:0000269|PubMed:17120616	17120616
Q15303	ERBB4	V675A	Q15303/V675A	ERBB4/V675A	MUTAGEN	V->A: Abolishes proteolytic processing and nuclear localization.	ECO:0000269|PubMed:15746097, ECO:0000269|PubMed:17638867	15746097,17638867
Q15303	ERBB4	L710N	Q15303/L710N	ERBB4/L710N	MUTAGEN	L->N: Strongly reduced autophosphorylation.	ECO:0000269|PubMed:18287036	18287036
Q15303	ERBB4	V721I	Q15303/V721I	ERBB4/V721I	MUTAGEN	V->I: No effect on kinase activity.	ECO:0000269|PubMed:19098003	19098003
Q15303	ERBB4	K751R	Q15303/K751R	ERBB4/K751R	MUTAGEN	K->R: Abolishes kinase activity. Abolishes phosphorylation, proteolytic processing and nuclear localization.	ECO:0000269|PubMed:11390655, ECO:0000269|PubMed:17486069, ECO:0000269|PubMed:17638867	11390655,17486069,17638867
Q15303	ERBB4	M766R	Q15303/M766R	ERBB4/M766R	MUTAGEN	M->R: Strongly reduced autophosphorylation.	ECO:0000269|PubMed:18287036	18287036
Q15303	ERBB4	A773S	Q15303/A773S	ERBB4/A773S	MUTAGEN	A->S: No effect on kinase activity.	ECO:0000269|PubMed:19098003	19098003
Q15303	ERBB4	R782Q	Q15303/R782Q	ERBB4/R782Q	MUTAGEN	R->Q: No effect on kinase activity.	ECO:0000269|PubMed:19098003	19098003
Q15303	ERBB4	E810K	Q15303/E810K	ERBB4/E810K	MUTAGEN	E->K: No effect on kinase activity.	ECO:0000269|PubMed:19098003	19098003
Q15303	ERBB4	D843N	Q15303/D843N	ERBB4/D843N	MUTAGEN	D->N: Loss of kinase activity.	ECO:0000269|PubMed:16978839	16978839
Q15303	ERBB4	P854Q	Q15303/P854Q	ERBB4/P854Q	MUTAGEN	P->Q: No effect on kinase activity.	ECO:0000269|PubMed:19098003	19098003
Q15303	ERBB4	D861Y	Q15303/D861Y	ERBB4/D861Y	MUTAGEN	D->Y: Loss of kinase activity.	ECO:0000269|PubMed:19098003	19098003
Q15303	ERBB4	L864R	Q15303/L864R	ERBB4/L864R	MUTAGEN	L->R: Strongly reduced autophosphorylation.	ECO:0000269|PubMed:18287036	18287036
Q15303	ERBB4	E872K	Q15303/E872K	ERBB4/E872K	MUTAGEN	E->K: No effect on kinase activity.	ECO:0000269|PubMed:19098003	19098003
Q15303	ERBB4	T926M	Q15303/T926M	ERBB4/T926M	MUTAGEN	T->M: No effect on kinase activity.	ECO:0000269|PubMed:19098003	19098003
Q15303	ERBB4	I947R	Q15303/I947R	ERBB4/I947R	MUTAGEN	I->R: Constitutively autophosphorylated.	ECO:0000269|PubMed:18287036	18287036
Q15303	ERBB4	R992A	Q15303/R992A	ERBB4/R992A	MUTAGEN	R->A: Abolishes APC/C-mediated degradation; when associated with A-995 and A-1000.	ECO:0000269|PubMed:17638867	17638867
Q15303	ERBB4	L995A	Q15303/L995A	ERBB4/L995A	MUTAGEN	L->A: Abolishes APC/C-mediated degradation; when associated with A-992 and A-1000.	ECO:0000269|PubMed:17638867	17638867
Q15303	ERBB4	D1000A	Q15303/D1000A	ERBB4/D1000A	MUTAGEN	D->A: Abolishes APC/C-mediated degradation; when associated with A-992 and A-995.	ECO:0000269|PubMed:17638867	17638867
Q15303	ERBB4	Y1035A	Q15303/Y1035A	ERBB4/Y1035A	MUTAGEN	Y->A: No effect on interaction with WWOX. Abolishes interaction with WWOX; when associated with A-1301.	ECO:0000269|PubMed:16061658	16061658
Q15303	ERBB4	Y1056A	Q15303/Y1056A	ERBB4/Y1056A	MUTAGEN	Y->A: Abolishes interaction with NEDD4 and impairs ubiquitination. Promotes nuclear translocation of ERBB4 intracellular domain E4ICD1.	ECO:0000269|PubMed:19561640	19561640
Q15303	ERBB4	Y1056F	Q15303/Y1056F	ERBB4/Y1056F	MUTAGEN	Y->F: Abolishes interaction with WWP1; when associated with F-1301.	ECO:0000269|PubMed:19561640	19561640
Q15303	ERBB4	Y1301A	Q15303/Y1301A	ERBB4/Y1301A	MUTAGEN	Y->A: No effect on interaction with WWOX. Abolishes interaction with WWOX; when associated with A-1035. Loss of interaction with YAP1 and stimulation of transcription.	ECO:0000269|PubMed:12807903, ECO:0000269|PubMed:16061658, ECO:0000269|PubMed:19561640	12807903,16061658,19561640
Q15303	ERBB4	Y1301F	Q15303/Y1301F	ERBB4/Y1301F	MUTAGEN	Y->F: Abolishes interaction with WWP1; when associated with F-1056.	ECO:0000269|PubMed:12807903, ECO:0000269|PubMed:16061658, ECO:0000269|PubMed:19561640	12807903,16061658,19561640

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15349	RPS6KA2	E311K	Q15349/E311K	RPS6KA2/E311K	VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267600891)	ECO:0000269|PubMed:17344846	17344846
Q15349	RPS6KA2	R732Q	Q15349/R732Q	RPS6KA2/R732Q	VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs376029388)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15375	EPHA7	I138V	Q15375/I138V	EPHA7/I138V	VARIANT	I -> V (in dbSNP:rs2278107)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
Q15375	EPHA7	E170K	Q15375/E170K	EPHA7/E170K	VARIANT	E -> K (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15375	EPHA7	G232R	Q15375/G232R	EPHA7/G232R	VARIANT	G -> R (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15375	EPHA7	P278S	Q15375/P278S	EPHA7/P278S	VARIANT	P -> S (in dbSNP:rs2278106)	ECO:0000269|PubMed:17344846	17344846
Q15375	EPHA7	R371W	Q15375/R371W	EPHA7/R371W	VARIANT	R -> W (in a colorectal cancer sample; somatic mutation; dbSNP:rs371089003)	ECO:0000269|PubMed:16959974	16959974
Q15375	EPHA7	P903S	Q15375/P903S	EPHA7/P903S	VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15418	RPS6KA1	K335T	Q15418/K335T	RPS6KA1/K335T	VARIANT	K -> T (in dbSNP:rs2229712)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8141249	17344846,8141249

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15569	TESK1	H539Y	Q15569/H539Y	TESK1/H539Y	VARIANT	H -> Y (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation; dbSNP:rs1373248755)	ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17344846	16959974,17344846
Q15569	TESK1	G574S	Q15569/G574S	TESK1/G574S	VARIANT	G -> S (in dbSNP:rs55673450)	ECO:0000269|PubMed:17344846	17344846
Q15569	TESK1	D175A	Q15569/D175A	TESK1/D175A	MUTAGEN	D->A: Abolishes inhibition of SPRY4-mediated repression of cell spreading. No effect on interaction with SPRY4 or colocalization with SPRY4 at vesicular spots in the cytoplasm.	ECO:0000269|PubMed:15584898	15584898

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15746	MYLK	P21H	Q15746/P21H	MYLK/P21H	VARIANT	P -> H (in dbSNP:rs28497577)		
Q15746	MYLK	A128V	Q15746/A128V	MYLK/A128V	VARIANT	A -> V (in dbSNP:rs143896146)	ECO:0000269|PubMed:21055718	21055718
Q15746	MYLK	Q133H	Q15746/Q133H	MYLK/Q133H	VARIANT	Q -> H (in dbSNP:rs140148380)	ECO:0000269|PubMed:21055718	21055718
Q15746	MYLK	P160R	Q15746/P160R	MYLK/P160R	VARIANT	P -> R (in dbSNP:rs111256888)	ECO:0000269|PubMed:21055718	21055718
Q15746	MYLK	V261A	Q15746/V261A	MYLK/V261A	VARIANT	V -> A (in dbSNP:rs3796164)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	T276A	Q15746/T276A	MYLK/T276A	VARIANT	T -> A (in dbSNP:rs55846245)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	P336L	Q15746/P336L	MYLK/P336L	VARIANT	P -> L (in dbSNP:rs35912339)		
Q15746	MYLK	R378H	Q15746/R378H	MYLK/R378H	VARIANT	R -> H (in dbSNP:rs56378658)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	M405V	Q15746/M405V	MYLK/M405V	VARIANT	M -> V (in dbSNP:rs35436690)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	P443S	Q15746/P443S	MYLK/P443S	VARIANT	P -> S (in dbSNP:rs35156360)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	R607G	Q15746/R607G	MYLK/R607G	VARIANT	R -> G	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	P652A	Q15746/P652A	MYLK/P652A	VARIANT	P -> A (in dbSNP:rs750686734)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	W656C	Q15746/W656C	MYLK/W656C	VARIANT	W -> C (in dbSNP:rs138172035)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21055718	17344846,21055718
Q15746	MYLK	T692M	Q15746/T692M	MYLK/T692M	VARIANT	T -> M (in dbSNP:rs776858093)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	A701T	Q15746/A701T	MYLK/A701T	VARIANT	A -> T (in dbSNP:rs142835596)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	V709M	Q15746/V709M	MYLK/V709M	VARIANT	V -> M (in dbSNP:rs112537316)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	R845C	Q15746/R845C	MYLK/R845C	VARIANT	R -> C (in dbSNP:rs3732485)		
Q15746	MYLK	L861P	Q15746/L861P	MYLK/L861P	VARIANT	L -> P (in dbSNP:rs3732486)		
Q15746	MYLK	V877M	Q15746/V877M	MYLK/V877M	VARIANT	V -> M (in dbSNP:rs34542174)		
Q15746	MYLK	D914E	Q15746/D914E	MYLK/D914E	VARIANT	D -> E (in dbSNP:rs3732487)		
Q15746	MYLK	T1085A	Q15746/T1085A	MYLK/T1085A	VARIANT	T -> A (in dbSNP:rs75370906)	ECO:0000269|PubMed:21055718	21055718
Q15746	MYLK	V1213M	Q15746/V1213M	MYLK/V1213M	VARIANT	V -> M (in AAT7; unknown pathological significance; dbSNP:rs368390254)	ECO:0000269|PubMed:21055718	21055718
Q15746	MYLK	E1399K	Q15746/E1399K	MYLK/E1399K	VARIANT	E -> K (in dbSNP:rs181663420)	ECO:0000269|PubMed:21055718	21055718
Q15746	MYLK	A1491S	Q15746/A1491S	MYLK/A1491S	VARIANT	A -> S (in AAT7; decreases kinase activity; dbSNP:rs1576422965)	ECO:0000269|PubMed:29544503	29544503
Q15746	MYLK	A1527V	Q15746/A1527V	MYLK/A1527V	VARIANT	A -> V (in dbSNP:rs34982967)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	P1588L	Q15746/P1588L	MYLK/P1588L	VARIANT	P -> L (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs1576401641)	ECO:0000269|PubMed:17344846	17344846
Q15746	MYLK	A1754T	Q15746/A1754T	MYLK/A1754T	VARIANT	A -> T (in AAT7; 4-fold reduced affinity for calmodulin; decreased kinase activity compared to wild-type protein)	ECO:0000269|PubMed:21055718	21055718
Q15746	MYLK	S1759P	Q15746/S1759P	MYLK/S1759P	VARIANT	S -> P (in AAT7; 7-fold reduced affinity for calmodulin; 6-fold decreased Vmax; dbSNP:rs387906781)	ECO:0000269|PubMed:21055718	21055718
Q15746	MYLK	K608A	Q15746/K608A	MYLK/K608A	MUTAGEN	K->A: Loss of acetylation and no kinase activity repression by NAA10/ARD1.	ECO:0000269|PubMed:19826488	19826488

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15759	MAPK11	A221V	Q15759/A221V	MAPK11/A221V	VARIANT	A -> V (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q15759	MAPK11	R275H	Q15759/R275H	MAPK11/R275H	VARIANT	R -> H (in dbSNP:rs33932986)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.9	17344846
Q15759	MAPK11	T180A	Q15759/T180A	MAPK11/T180A	MUTAGEN	T->A: Inactivation.	ECO:0000269|PubMed:15356147	15356147
Q15759	MAPK11	Y182F	Q15759/Y182F	MAPK11/Y182F	MUTAGEN	Y->F: Inactivation.	ECO:0000269|PubMed:15356147	15356147

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15772	SPEG	R206H	Q15772/R206H	SPEG/R206H	VARIANT	R -> H (in dbSNP:rs55821435)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	R934C	Q15772/R934C	SPEG/R934C	VARIANT	R -> C (in dbSNP:rs34398769)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	R966Q	Q15772/R966Q	SPEG/R966Q	VARIANT	R -> Q (in dbSNP:rs34861443)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	P1103L	Q15772/P1103L	SPEG/P1103L	VARIANT	P -> L (in dbSNP:rs56334571)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	A1135V	Q15772/A1135V	SPEG/A1135V	VARIANT	A -> V (in dbSNP:rs55670811)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	E1178D	Q15772/E1178D	SPEG/E1178D	VARIANT	E -> D (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs757589345)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	R1234W	Q15772/R1234W	SPEG/R1234W	VARIANT	R -> W (in dbSNP:rs55916864)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	R1340Q	Q15772/R1340Q	SPEG/R1340Q	VARIANT	R -> Q (in dbSNP:rs34994343)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	R1621C	Q15772/R1621C	SPEG/R1621C	VARIANT	R -> C (in dbSNP:rs55646900)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	R1903W	Q15772/R1903W	SPEG/R1903W	VARIANT	R -> W (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs762000831)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	P2189L	Q15772/P2189L	SPEG/P2189L	VARIANT	P -> L (in dbSNP:rs10755037)		
Q15772	SPEG	P2687T	Q15772/P2687T	SPEG/P2687T	VARIANT	P -> T (in dbSNP:rs13026308)	ECO:0000269|PubMed:10718198, ECO:0000269|PubMed:15185077, ECO:0000269|PubMed:17344846	10718198,15185077,17344846
Q15772	SPEG	V2742M	Q15772/V2742M	SPEG/V2742M	VARIANT	V -> M (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs566841339)	ECO:0000269|PubMed:17344846	17344846
Q15772	SPEG	G2757V	Q15772/G2757V	SPEG/G2757V	VARIANT	G -> V (in CNM5; dbSNP:rs587777676)	ECO:0000269|PubMed:25087613	25087613
Q15772	SPEG	H3079R	Q15772/H3079R	SPEG/H3079R	VARIANT	H -> R (in dbSNP:rs12464085)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

Error: Q15831 STK11 'NoneType' object has no attribute 'group' FT                   /note="Missing (in PJS)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15831	STK11	E14K	Q15831/E14K	STK11/E14K	VARIANT	E -> K (in cervical cancer; somatic mutation)	ECO:0000269|PubMed:12533684	12533684
Q15831	STK11	E16G	Q15831/E16G	STK11/E16G	VARIANT	E -> G (in PJS)	ECO:0000269|PubMed:21411391	21411391
Q15831	STK11	Y49D	Q15831/Y49D	STK11/Y49D	VARIANT	Y -> D (in melanoma; sporadic malignant; somatic mutation; dbSNP:rs137853080)	ECO:0000269|PubMed:10201537	10201537
Q15831	STK11	V66M	Q15831/V66M	STK11/V66M	VARIANT	V -> M (in cervical carcinoma; somatic mutation; dbSNP:rs1599915144)	ECO:0000269|PubMed:12533684, ECO:0000269|PubMed:19892943	12533684,19892943
Q15831	STK11	L67P	Q15831/L67P	STK11/L67P	VARIANT	L -> P (in PJS; abolishes kinase activity, leading to loss of autophosphorylation; dbSNP:rs137853077)	ECO:0000269|PubMed:9428765, ECO:0000269|PubMed:9837816	9428765,9837816
Q15831	STK11	R86G	Q15831/R86G	STK11/R86G	VARIANT	R -> G (in sporadic cancer; somatic mutation; no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1057520039)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	R87K	Q15831/R87K	STK11/R87K	VARIANT	R -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1568690463)	ECO:0000269|PubMed:17344846	17344846
Q15831	STK11	Q123R	Q15831/Q123R	STK11/Q123R	VARIANT	Q -> R (in sporadic cancer; somatic mutation; no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs764449808)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	G135R	Q15831/G135R	STK11/G135R	VARIANT	G -> R (in melanoma; sporadic malignant; somatic mutation; dbSNP:rs137853081)	ECO:0000269|PubMed:10201537	10201537
Q15831	STK11	F157S	Q15831/F157S	STK11/F157S	VARIANT	F -> S (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	L160P	Q15831/L160P	STK11/L160P	VARIANT	L -> P (in cervical cancer; somatic mutation)	ECO:0000269|PubMed:12533684	12533684
Q15831	STK11	G163D	Q15831/G163D	STK11/G163D	VARIANT	G -> D (in TGCT; a tumor with seminoma and teratoma components; associated with severely impaired but detectable kinase activity; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; predominantly nuclear localization; dbSNP:rs137853078)	ECO:0000269|PubMed:19892943, ECO:0000269|PubMed:9605748, ECO:0000269|PubMed:9887330	19892943,9605748,9887330
Q15831	STK11	Q170P	Q15831/Q170P	STK11/Q170P	VARIANT	Q -> P (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	G171S	Q15831/G171S	STK11/G171S	VARIANT			
Q15831	STK11	H174R	Q15831/H174R	STK11/H174R	VARIANT	H -> R (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	D176N	Q15831/D176N	STK11/D176N	VARIANT	D -> N (in PJS; loss of kinase activity, leading to greatly reduced autophosphorylation; fails to phosphorylate PTEN in vitro; no significant effect on nucleocytoplasmic localization; dbSNP:rs730881979)	ECO:0000269|PubMed:15987703, ECO:0000269|PubMed:9837816	15987703,9837816
Q15831	STK11	D176Y	Q15831/D176Y	STK11/D176Y	VARIANT	D -> Y (in sporadic cancer; somatic mutation; Loss of kinase activity)	ECO:0000269|PubMed:12805220, ECO:0000269|PubMed:19892943	12805220,19892943
Q15831	STK11	I177N	Q15831/I177N	STK11/I177N	VARIANT			
Q15831	STK11	N181E	Q15831/N181E	STK11/N181E	VARIANT	N -> E (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; requires 2 nucleotide substitutions; dbSNP:rs1568707668)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	D194N	Q15831/D194N	STK11/D194N	VARIANT	D -> N (in PJS; dbSNP:rs121913315)	ECO:0000269|PubMed:10408777	10408777
Q15831	STK11	D194V	Q15831/D194V	STK11/D194V	VARIANT	D -> V (in lung cancer; somatic mutation; dbSNP:rs121913316)	ECO:0000269|PubMed:10079245	10079245
Q15831	STK11	D194Y	Q15831/D194Y	STK11/D194Y	VARIANT	D -> Y (in melanoma; sporadic malignant; somatic mutation; dbSNP:rs121913315)	ECO:0000269|PubMed:10208439	10208439
Q15831	STK11	E199K	Q15831/E199K	STK11/E199K	VARIANT	E -> K (in colorectal cancer; somatic mutation; impaired kinase activity; dbSNP:rs121913317)	ECO:0000269|PubMed:9731485	9731485
Q15831	STK11	E199Q	Q15831/E199Q	STK11/E199Q	VARIANT	E -> Q (in sporadic cancer; somatic mutation; does not affect kinase activity)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	A205T	Q15831/A205T	STK11/A205T	VARIANT			
Q15831	STK11	D208N	Q15831/D208N	STK11/D208N	VARIANT			
Q15831	STK11	G215D	Q15831/G215D	STK11/G215D	VARIANT	G -> D (in colorectal cancer; somatic mutation; dbSNP:rs1057520038)	ECO:0000269|PubMed:9731485	9731485
Q15831	STK11	S216F	Q15831/S216F	STK11/S216F	VARIANT			
Q15831	STK11	E223V	Q15831/E223V	STK11/E223V	VARIANT	E -> V (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	T230P	Q15831/T230P	STK11/T230P	VARIANT	T -> P (in sporadic cancer; somatic mutation; no effect heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	F231L	Q15831/F231L	STK11/F231L	VARIANT	F -> L (in cervical cancer; somatic mutation; dbSNP:rs929783669)	ECO:0000269|PubMed:12533684	12533684
Q15831	STK11	S232P	Q15831/S232P	STK11/S232P	VARIANT	S -> P (in sporadic cancer; somatic mutation; no effect heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	W239C	Q15831/W239C	STK11/W239C	VARIANT	W -> C (in PJS; late onset suggests reduced penetrance; dbSNP:rs137853082)	ECO:0000269|PubMed:12372054	12372054
Q15831	STK11	L245R	Q15831/L245R	STK11/L245R	VARIANT	L -> R (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	T250P	Q15831/T250P	STK11/T250P	VARIANT	T -> P (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	Y272H	Q15831/Y272H	STK11/Y272H	VARIANT	Y -> H (in sporadic cancer; somatic mutation; no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	D277Y	Q15831/D277Y	STK11/D277Y	VARIANT	D -> Y (in sporadic cancer; somatic mutation; no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	P281L	Q15831/P281L	STK11/P281L	VARIANT	P -> L (in ovarian carcinoma; somatic mutation; dbSNP:rs121913322)	ECO:0000269|PubMed:10429654	10429654
Q15831	STK11	L285Q	Q15831/L285Q	STK11/L285Q	VARIANT	L -> Q (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	R297K	Q15831/R297K	STK11/R297K	VARIANT	R -> K (in PJS; dbSNP:rs1568710381)	ECO:0000269|PubMed:10408777	10408777
Q15831	STK11	W308C	Q15831/W308C	STK11/W308C	VARIANT	W -> C (in PJS; abolishes kinase activity, leading to loss of autophosphorylation; dbSNP:rs1057520042)	ECO:0000269|PubMed:9837816	9837816
Q15831	STK11	P314H	Q15831/P314H	STK11/P314H	VARIANT	P -> H (in colorectal cancer; no effect heterotrimeric complex assembly with STRADA and CAB39)	ECO:0000269|PubMed:9809980	9809980
Q15831	STK11	P315S	Q15831/P315S	STK11/P315S	VARIANT	P -> S (in PJS; pathogenicity uncertain; no effect heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs786202431)	ECO:0000269|PubMed:12372054, ECO:0000269|PubMed:19892943	12372054,19892943
Q15831	STK11	P324L	Q15831/P324L	STK11/P324L	VARIANT	P -> L (in gastric carcinoma; no effect heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs367807476)	ECO:0000269|PubMed:9683800	9683800
Q15831	STK11	F354L	Q15831/F354L	STK11/F354L	VARIANT	F -> L (in colorectal cancer; somatic mutation; dbSNP:rs59912467)	ECO:0000269|PubMed:9731485	9731485
Q15831	STK11	T367M	Q15831/T367M	STK11/T367M	VARIANT	T -> M (in colorectal cancer; somatic mutation; dbSNP:rs587782835)	ECO:0000269|PubMed:9731485	9731485
Q15831	STK11	K44R	Q15831/K44R	STK11/K44R	MUTAGEN	K->R: No effect on kinase activity.	ECO:0000269|PubMed:18687677	18687677
Q15831	STK11	K48Q	Q15831/K48Q	STK11/K48Q	MUTAGEN	K->Q: No effect on basal nucleocytoplasmic localization, but fails to translocate to the cytoplasm when coexpressed with SIRT1.	ECO:0000269|PubMed:18687677	18687677
Q15831	STK11	K48R	Q15831/K48R	STK11/K48R	MUTAGEN	K->R: Enhanced phosphorylation at Thr-336 and Ser-428, enhanced cytoplasmic localization and increased kinase activity.	ECO:0000269|PubMed:18687677	18687677
Q15831	STK11	R74A	Q15831/R74A	STK11/R74A	MUTAGEN	R->A: Impaired formation of a heterotrimeric complex with STRADA and CAB39; when associated with A-204.	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	K78I	Q15831/K78I	STK11/K78I	MUTAGEN	K->I: Loss of kinase activity, leading to greatly reduced autophosphorylation.	ECO:0000269|PubMed:11430832, ECO:0000269|PubMed:9837816	11430832,9837816
Q15831	STK11	K78M	Q15831/K78M	STK11/K78M	MUTAGEN	K->M: Loss of kinase activity, leading to reduced autophosphorylation and acting as a dominant-negative mutant.	ECO:0000269|PubMed:11430832, ECO:0000269|PubMed:9837816	11430832,9837816
Q15831	STK11	K96R	Q15831/K96R	STK11/K96R	MUTAGEN	K->R: No effect on kinase activity.	ECO:0000269|PubMed:18687677	18687677
Q15831	STK11	K97R	Q15831/K97R	STK11/K97R	MUTAGEN	K->R: No effect on kinase activity.	ECO:0000269|PubMed:18687677	18687677
Q15831	STK11	T189A	Q15831/T189A	STK11/T189A	MUTAGEN	T->A: Reduced phosphorylation.	ECO:0000269|PubMed:11430832	11430832
Q15831	STK11	D194A	Q15831/D194A	STK11/D194A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:14517248, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:19892943	14517248,14976552,19892943
Q15831	STK11	F204A	Q15831/F204A	STK11/F204A	MUTAGEN	F->A: No effect. Impaired formation of a heterotrimeric complex with STRADA and CAB39; when associated with A-74.	ECO:0000269|PubMed:19892943	19892943
Q15831	STK11	S428A	Q15831/S428A	STK11/S428A	MUTAGEN	S->A,E: No effect on kinase activity.		
Q15831	STK11	S428E	Q15831/S428E	STK11/S428E	MUTAGEN	S->A,E: No effect on kinase activity.	ECO:0000269|PubMed:18854309	18854309

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q15835	GRK1	E136Q	Q15835/E136Q	GRK1/E136Q	VARIANT	E -> Q (in dbSNP:rs542688076)	ECO:0000269|PubMed:9268593	9268593
Q15835	GRK1	T298M	Q15835/T298M	GRK1/T298M	VARIANT	T -> M (in dbSNP:rs572803634)	ECO:0000269|PubMed:9268593	9268593
Q15835	GRK1	N330S	Q15835/N330S	GRK1/N330S	VARIANT	N -> S (in dbSNP:rs375409897)	ECO:0000269|PubMed:9268593	9268593
Q15835	GRK1	V380D	Q15835/V380D	GRK1/V380D	VARIANT	V -> D (in CSNBO2; dbSNP:rs777094000)	ECO:0000269|PubMed:9020843	9020843
Q15835	GRK1	P391H	Q15835/P391H	GRK1/P391H	VARIANT	P -> H (in CSNBO2; dbSNP:rs570621429)	ECO:0000269|PubMed:17070587	17070587
Q15835	GRK1	R438H	Q15835/R438H	GRK1/R438H	VARIANT	R -> H (in dbSNP:rs750619057)	ECO:0000269|PubMed:9268593	9268593
Q15835	GRK1	C514S	Q15835/C514S	GRK1/C514S	VARIANT	C -> S (in dbSNP:rs771561763)	ECO:0000269|PubMed:9268593	9268593
Q15835	GRK1	M522T	Q15835/M522T	GRK1/M522T	VARIANT	M -> T (in dbSNP:rs779749742)	ECO:0000269|PubMed:9268593	9268593
Q15835	GRK1	S536L	Q15835/S536L	GRK1/S536L	VARIANT	S -> L (in dbSNP:rs553969577)	ECO:0000269|PubMed:9268593	9268593
Q15835	GRK1	S21E	Q15835/S21E	GRK1/S21E	MUTAGEN	S->E: Not phosphorylated by PKA.	ECO:0000269|PubMed:15946941	15946941
Q15835	GRK1	K219A	Q15835/K219A	GRK1/K219A	MUTAGEN	K->A: Loss of autophosphorylation and RHO phosphorylation.	ECO:0000269|PubMed:15946941	15946941

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16288	NTRK3	V21F	Q16288/V21F	NTRK3/V21F	VARIANT	V -> F (in dbSNP:rs200822610)	ECO:0000269|PubMed:25196463	25196463
Q16288	NTRK3	I71V	Q16288/I71V	NTRK3/I71V	VARIANT	I -> V (found in patients with CHD; unknown pathological significance; dbSNP:rs200923715)	ECO:0000269|PubMed:25196463	25196463
Q16288	NTRK3	T93M	Q16288/T93M	NTRK3/T93M	VARIANT			
Q16288	NTRK3	T149R	Q16288/T149R	NTRK3/T149R	VARIANT	T -> R (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs368222977)	ECO:0000269|PubMed:17344846	17344846
Q16288	NTRK3	N163I	Q16288/N163I	NTRK3/N163I	VARIANT	N -> I (found in patients with CHD; unknown pathological significance; no change in autophosphorylation; no effect on NTRK3 signaling; dbSNP:rs547862658)	ECO:0000269|PubMed:25196463	25196463
Q16288	NTRK3	R306C	Q16288/R306C	NTRK3/R306C	VARIANT	R -> C (in dbSNP:rs56386352)	ECO:0000269|PubMed:17344846	17344846
Q16288	NTRK3	V307L	Q16288/V307L	NTRK3/V307L	VARIANT	V -> L (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1388363572)	ECO:0000269|PubMed:17344846	17344846
Q16288	NTRK3	L336Q	Q16288/L336Q	NTRK3/L336Q	VARIANT	L -> Q (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q16288	NTRK3	I533F	Q16288/I533F	NTRK3/I533F	VARIANT	I -> F (probable disease-associated variant found in patients with CHD; associated with CHD susceptibility; no change in autophosphorylation; changed NTRK3 signaling with decreased apoptosis in absence of NTF3; dbSNP:rs869112057)	ECO:0000269|PubMed:25196463	25196463
Q16288	NTRK3	A664S	Q16288/A664S	NTRK3/A664S	VARIANT	A -> S (in a lung carcinoma sample; somatic mutation)	ECO:0000269|PubMed:18293376	18293376
Q16288	NTRK3	H677Y	Q16288/H677Y	NTRK3/H677Y	VARIANT	H -> Y (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:18293376	17344846,18293376
Q16288	NTRK3	R678Q	Q16288/R678Q	NTRK3/R678Q	VARIANT	R -> Q (in dbSNP:rs55890138)	ECO:0000269|PubMed:17344846	17344846
Q16288	NTRK3	R735F	Q16288/R735F	NTRK3/R735F	VARIANT	R -> F (in a lung large cell carcinoma sample; somatic mutation; requires 2 nucleotide substitutions)		
Q16288	NTRK3	W736C	Q16288/W736C	NTRK3/W736C	VARIANT	W -> C (in a lung carcinoma sample; somatic mutation)	ECO:0000269|PubMed:18293376	18293376
Q16288	NTRK3	R745P	Q16288/R745P	NTRK3/R745P	VARIANT	R -> P (in a lung carcinoma sample; somatic mutation)	ECO:0000269|PubMed:18293376	18293376
Q16288	NTRK3	Y766F	Q16288/Y766F	NTRK3/Y766F	VARIANT	Y -> F (in a lung carcinoma sample; somatic mutation)	ECO:0000269|PubMed:18293376	18293376
Q16288	NTRK3	K768R	Q16288/K768R	NTRK3/K768R	VARIANT	K -> R (in dbSNP:rs55770052)	ECO:0000269|PubMed:17344846	17344846
Q16288	NTRK3	E781K	Q16288/E781K	NTRK3/E781K	VARIANT	E -> K (in dbSNP:rs56393451)	ECO:0000269|PubMed:17344846	17344846
Q16288	NTRK3	I817M	Q16288/I817M	NTRK3/I817M	VARIANT	I -> M (probable disease-associated variant found in patients with CHD; associated with CHD susceptibility; no change in autophosphorylation; changed NTRK3 signaling with decreased apoptosis in absence of NTF3; dbSNP:rs869209165)	ECO:0000269|PubMed:25196463	25196463
Q16288	NTRK3	K572N	Q16288/K572N	NTRK3/K572N	MUTAGEN	K->N: Loss of autophosphorylation and loss of NTRK3 signaling.	ECO:0000269|PubMed:25196463	25196463

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16512	PKN1	R185C	Q16512/R185C	PKN1/R185C	VARIANT	R -> C (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267605306)	ECO:0000269|PubMed:17344846	17344846
Q16512	PKN1	A197E	Q16512/A197E	PKN1/A197E	VARIANT	A -> E (in dbSNP:rs1287763348)	ECO:0000269|PubMed:17344846	17344846
Q16512	PKN1	R436W	Q16512/R436W	PKN1/R436W	VARIANT	R -> W (in dbSNP:rs35132656)	ECO:0000269|PubMed:17344846	17344846
Q16512	PKN1	R520Q	Q16512/R520Q	PKN1/R520Q	VARIANT	R -> Q (in dbSNP:rs56273055)	ECO:0000269|PubMed:17344846	17344846
Q16512	PKN1	L555I	Q16512/L555I	PKN1/L555I	VARIANT	L -> I (in dbSNP:rs34309238)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q16512	PKN1	R635Q	Q16512/R635Q	PKN1/R635Q	VARIANT	R -> Q (in dbSNP:rs35416389)	ECO:0000269|PubMed:17344846	17344846
Q16512	PKN1	I718V	Q16512/I718V	PKN1/I718V	VARIANT	I -> V (in dbSNP:rs2230539)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7988719	17344846,7988719
Q16512	PKN1	F873L	Q16512/F873L	PKN1/F873L	VARIANT	F -> L (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q16512	PKN1	V901I	Q16512/V901I	PKN1/V901I	VARIANT	V -> I (in dbSNP:rs10846)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	14702039,15489334,17344846
Q16512	PKN1	A921V	Q16512/A921V	PKN1/A921V	VARIANT	A -> V (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q16512	PKN1	D108A	Q16512/D108A	PKN1/D108A	MUTAGEN	D->A: Abolishes cleavage by caspase-3 and formation of AF1 fragment.	ECO:0000269|PubMed:9751706	9751706
Q16512	PKN1	R181A	Q16512/R181A	PKN1/R181A	MUTAGEN	R->A: Abolishes interaction with bacterial SspH1.	ECO:0000269|PubMed:24248594	24248594
Q16512	PKN1	R181K	Q16512/R181K	PKN1/R181K	MUTAGEN	R->K: Decreases interaction with bacterial SspH1.	ECO:0000269|PubMed:24248594	24248594
Q16512	PKN1	R185A	Q16512/R185A	PKN1/R185A	MUTAGEN	R->A: Abolishes interaction with bacterial SspH1.	ECO:0000269|PubMed:24248594	24248594
Q16512	PKN1	D451A	Q16512/D451A	PKN1/D451A	MUTAGEN	D->A: Abolishes cleavage by caspase-3 and formation of 70 kDa fragment.	ECO:0000269|PubMed:9751706	9751706
Q16512	PKN1	D454A	Q16512/D454A	PKN1/D454A	MUTAGEN	D->A: Abolishes cleavage by caspase-3 and formation of 70 kDa fragment.	ECO:0000269|PubMed:9751706	9751706
Q16512	PKN1	D558A	Q16512/D558A	PKN1/D558A	MUTAGEN	D->A: Abolishes cleavage by caspase-3 and formation of AF3 fragment.	ECO:0000269|PubMed:9751706	9751706
Q16512	PKN1	D560A	Q16512/D560A	PKN1/D560A	MUTAGEN	D->A: Abolishes cleavage by caspase-3 and formation of AF3 fragment.	ECO:0000269|PubMed:9751706	9751706
Q16512	PKN1	K644E	Q16512/K644E	PKN1/K644E	MUTAGEN	K->E: Abolishes Serine/threonine-protein kinase activity.	ECO:0000269|PubMed:18066052, ECO:0000269|PubMed:8135837	18066052,8135837
Q16512	PKN1	K644R	Q16512/K644R	PKN1/K644R	MUTAGEN	K->R: Substantial reduction of autophosphorylation.	ECO:0000269|PubMed:18066052, ECO:0000269|PubMed:8135837	18066052,8135837

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16513	PKN2	E94D	Q16513/E94D	PKN2/E94D	VARIANT	E -> D (in dbSNP:rs12039846)		
Q16513	PKN2	A197E	Q16513/A197E	PKN2/A197E	VARIANT	A -> E (in dbSNP:rs35207128)		
Q16513	PKN2	Q655R	Q16513/Q655R	PKN2/Q655R	VARIANT	Q -> R (in dbSNP:rs12085658)		
Q16513	PKN2	D117A	Q16513/D117A	PKN2/D117A	MUTAGEN	D->A: Prevents proteolytic processing by caspase-3 during apoptosis. Diminishes pro-apoptotic function; when associated with E-700.	ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:9368003	10926925,9368003
Q16513	PKN2	T121A	Q16513/T121A	PKN2/T121A	MUTAGEN	T->A: Does not suppress ciliogenesis; when associated with A-124.	ECO:0000269|PubMed:27104747	27104747
Q16513	PKN2	T124A	Q16513/T124A	PKN2/T124A	MUTAGEN	T->A: Does not suppress ciliogenesis; when associated with A-121.	ECO:0000269|PubMed:27104747	27104747
Q16513	PKN2	K686R	Q16513/K686R	PKN2/K686R	MUTAGEN	K->R: Does not inhibit interaction with PTPN13.	ECO:0000269|PubMed:11356191	11356191
Q16513	PKN2	D700E	Q16513/D700E	PKN2/D700E	MUTAGEN	D->E: Prevents proteolytic processing by caspase-3 during apoptosis. Diminishes pro-apoptotic function; when associated with A-117.	ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:9368003	10926925,9368003
Q16513	PKN2	T816A	Q16513/T816A	PKN2/T816A	MUTAGEN	T->A: Reduces catalytic activity.	ECO:0000269|PubMed:18835241	18835241
Q16513	PKN2	T958A	Q16513/T958A	PKN2/T958A	MUTAGEN	T->A: Abolishes catalytic activity.	ECO:0000269|PubMed:18835241	18835241
Q16513	PKN2	F974A	Q16513/F974A	PKN2/F974A	MUTAGEN	F->A: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'.	ECO:0000269|PubMed:10226025	10226025
Q16513	PKN2	F977A	Q16513/F977A	PKN2/F977A	MUTAGEN			
Q16513	PKN2	F977L	Q16513/F977L	PKN2/F977L	MUTAGEN	F->A,L: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'. Reduces catalytic activity by 90%.	ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	10226025,18835241
Q16513	PKN2	F977W	Q16513/F977W	PKN2/F977W	MUTAGEN	F->W,Y: Reduces catalytic activity by 50%.		
Q16513	PKN2	F977Y	Q16513/F977Y	PKN2/F977Y	MUTAGEN	F->W,Y: Reduces catalytic activity by 50%.	ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	10226025,18835241
Q16513	PKN2	D978A	Q16513/D978A	PKN2/D978A	MUTAGEN	D->A: Does not inhibit catalytic activity.	ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	10226025,18835241
Q16513	PKN2	D978S	Q16513/D978S	PKN2/D978S	MUTAGEN	D->A,S: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'.	ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	10226025,18835241
Q16513	PKN2	Y979A	Q16513/Y979A	PKN2/Y979A	MUTAGEN	Y->A: Reduces catalytic activity by 50%.	ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	10226025,18835241
Q16513	PKN2	Y979F	Q16513/Y979F	PKN2/Y979F	MUTAGEN	Y->F,L,W: Reduces catalytic activity by 25%.		
Q16513	PKN2	Y979L	Q16513/Y979L	PKN2/Y979L	MUTAGEN	Y->F,L,W: Reduces catalytic activity by 25%.		
Q16513	PKN2	Y979W	Q16513/Y979W	PKN2/Y979W	MUTAGEN	Y->F,L,W: Reduces catalytic activity by 25%.	ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:18835241	10226025,18835241
Q16513	PKN2	C984S	Q16513/C984S	PKN2/C984S	MUTAGEN	C->S: Inhibits interaction with PTPN13.	ECO:0000269|PubMed:11356191	11356191

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16539	MAPK14	A51V	Q16539/A51V	MAPK14/A51V	VARIANT	A -> V (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q16539	MAPK14	P322R	Q16539/P322R	MAPK14/P322R	VARIANT	P -> R (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q16539	MAPK14	D343G	Q16539/D343G	MAPK14/D343G	VARIANT	D -> G (in dbSNP:rs45496794)	ECO:0000269|PubMed:17344846	17344846
Q16539	MAPK14	A34V	Q16539/A34V	MAPK14/A34V	MUTAGEN	A->V: Lowered kinase activity.	ECO:0000269|PubMed:7493921	7493921
Q16539	MAPK14	K53R	Q16539/K53R	MAPK14/K53R	MUTAGEN	K->R: Loss of kinase activity.	ECO:0000269|PubMed:7493921	7493921
Q16539	MAPK14	K54R	Q16539/K54R	MAPK14/K54R	MUTAGEN	K->R: Impairs MAP2K6/MKK6-dependent autophosphorylation.	ECO:0000269|PubMed:11010976	11010976
Q16539	MAPK14	Y69H	Q16539/Y69H	MAPK14/Y69H	MUTAGEN	Y->H: Lowered kinase activity.	ECO:0000269|PubMed:15284239	15284239
Q16539	MAPK14	D168A	Q16539/D168A	MAPK14/D168A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:7493921	7493921
Q16539	MAPK14	T175A	Q16539/T175A	MAPK14/T175A	MUTAGEN	T->A: No effect on either the kinase activity or tyrosine phosphorylation.	ECO:0000269|PubMed:7493921	7493921
Q16539	MAPK14	D176A	Q16539/D176A	MAPK14/D176A	MUTAGEN	D->A: Emulation of the active state. Increase in activity; when associated with S-327 or L-327.	ECO:0000269|PubMed:15284239	15284239
Q16539	MAPK14	D177A	Q16539/D177A	MAPK14/D177A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:15284239	15284239
Q16539	MAPK14	T180E	Q16539/T180E	MAPK14/T180E	MUTAGEN	T->E: Loss of kinase activity.	ECO:0000269|PubMed:7493921	7493921
Q16539	MAPK14	Y182F	Q16539/Y182F	MAPK14/Y182F	MUTAGEN	Y->F: Loss of kinase activity.	ECO:0000269|PubMed:7493921	7493921
Q16539	MAPK14	A320T	Q16539/A320T	MAPK14/A320T	MUTAGEN	A->T: Lowered kinase activity.	ECO:0000269|PubMed:15284239	15284239
Q16539	MAPK14	F327L	Q16539/F327L	MAPK14/F327L	MUTAGEN	F->L: Emulation of the active state. Increase in activity; when associated with A-176.	ECO:0000269|PubMed:15284239	15284239
Q16539	MAPK14	F327S	Q16539/F327S	MAPK14/F327S	MUTAGEN	F->S: Emulation of the active state. Increase in activity; when associated with A-176.	ECO:0000269|PubMed:15284239	15284239
Q16539	MAPK14	W337R	Q16539/W337R	MAPK14/W337R	MUTAGEN	W->R: Loss of kinase activity.	ECO:0000269|PubMed:15284239	15284239

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16566	CAMK4	E150G	Q16566/E150G	CAMK4/E150G	VARIANT	E -> G (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q16566	CAMK4	D178N	Q16566/D178N	CAMK4/D178N	VARIANT	D -> N (in dbSNP:rs35548075)	ECO:0000269|PubMed:17344846	17344846
Q16566	CAMK4	Q465R	Q16566/Q465R	CAMK4/Q465R	VARIANT	Q -> R (in dbSNP:rs56360861)	ECO:0000269|PubMed:17344846	17344846
Q16566	CAMK4	I469M	Q16566/I469M	CAMK4/I469M	VARIANT	I -> M (in a lung large cell carcinoma sample; somatic mutation; dbSNP:rs1239950009)	ECO:0000269|PubMed:17344846	17344846
Q16566	CAMK4	S12A	Q16566/S12A	CAMK4/S12A	MUTAGEN	S->A: Loss of activity.	ECO:0000269|PubMed:8702940	8702940
Q16566	CAMK4	S13A	Q16566/S13A	CAMK4/S13A	MUTAGEN	S->A: Loss of activity.	ECO:0000269|PubMed:8702940	8702940
Q16566	CAMK4	K75E	Q16566/K75E	CAMK4/K75E	MUTAGEN	K->E: Loss of activity; dominant negative form.	ECO:0000269|PubMed:10617605	10617605
Q16566	CAMK4	S189A	Q16566/S189A	CAMK4/S189A	MUTAGEN	S->A: Increases phosphorylation of CREB1 2-fold. Decreases total O-linked glycosylation 2-fold. Increases ATP-binding affinity.	ECO:0000269|PubMed:19506079	19506079
Q16566	CAMK4	T200A	Q16566/T200A	CAMK4/T200A	MUTAGEN	T->A: Loss of activation by CaMKK1 or CaMKK2.	ECO:0000269|PubMed:8855261	8855261

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16584	MAP3K11	D151V	Q16584/D151V	MAP3K11/D151V	VARIANT	D -> V (in dbSNP:rs34178129)	ECO:0000269|PubMed:17344846	17344846
Q16584	MAP3K11	P252H	Q16584/P252H	MAP3K11/P252H	VARIANT	P -> H (in dbSNP:rs17855912)	ECO:0000269|PubMed:15489334	15489334
Q16584	MAP3K11	A282G	Q16584/A282G	MAP3K11/A282G	VARIANT	A -> G (in dbSNP:rs34594252)	ECO:0000269|PubMed:17344846	17344846
Q16584	MAP3K11	K144A	Q16584/K144A	MAP3K11/K144A	MUTAGEN	K->A: Greatly reduced autophosphorylation activity.	ECO:0000269|PubMed:11053428, ECO:0000269|PubMed:8195146	11053428,8195146
Q16584	MAP3K11	K144R	Q16584/K144R	MAP3K11/K144R	MUTAGEN	K->R: Loss of kinase activity. Prevents activation of SAPK and MAPK14.	ECO:0000269|PubMed:11053428, ECO:0000269|PubMed:8195146	11053428,8195146
Q16584	MAP3K11	E164A	Q16584/E164A	MAP3K11/E164A	MUTAGEN	E->A: Greatly reduced autophosphorylation activity.	ECO:0000269|PubMed:8195146	8195146
Q16584	MAP3K11	T277A	Q16584/T277A	MAP3K11/T277A	MUTAGEN	T->A: Severely reduced autophosphorylation activity. Prevents phosphorylation of SAPK and MAPK14.	ECO:0000269|PubMed:11053428	11053428
Q16584	MAP3K11	T277E	Q16584/T277E	MAP3K11/T277E	MUTAGEN	T->E: No effect on SAPK activation.	ECO:0000269|PubMed:11053428	11053428
Q16584	MAP3K11	T278A	Q16584/T278A	MAP3K11/T278A	MUTAGEN	T->A: No effect on autophosphorylation activity or activation of SAPK and MAPK14.	ECO:0000269|PubMed:11053428	11053428
Q16584	MAP3K11	S281A	Q16584/S281A	MAP3K11/S281A	MUTAGEN	S->A: Reduced autophosphorylation activity. Reduced activation of SAPK and MAPK14.	ECO:0000269|PubMed:11053428	11053428
Q16584	MAP3K11	S281E	Q16584/S281E	MAP3K11/S281E	MUTAGEN	S->E: No effect on SAPK activation.	ECO:0000269|PubMed:11053428	11053428

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16620	NTRK2	L138F	Q16620/L138F	NTRK2/L138F	VARIANT	L -> F (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q16620	NTRK2	G309R	Q16620/G309R	NTRK2/G309R	VARIANT	G -> R	ECO:0000269|Ref.5	
Q16620	NTRK2	N338Y	Q16620/N338Y	NTRK2/N338Y	VARIANT	N -> Y (in dbSNP:rs1047856)		
Q16620	NTRK2	Y434C	Q16620/Y434C	NTRK2/Y434C	VARIANT	Y -> C (in DEE58; unknown pathological significance; dbSNP:rs886041091)	ECO:0000269|PubMed:29100083	29100083
Q16620	NTRK2	G545V	Q16620/G545V	NTRK2/G545V	VARIANT	G -> V (in dbSNP:rs1075108)		
Q16620	NTRK2	M697I	Q16620/M697I	NTRK2/M697I	VARIANT	M -> I (in a lung carcinoma sample; somatic mutation)	ECO:0000269|PubMed:18293376	18293376
Q16620	NTRK2	R699G	Q16620/R699G	NTRK2/R699G	VARIANT	R -> G (in a lung carcinoma sample; somatic mutation)	ECO:0000269|PubMed:18293376	18293376
Q16620	NTRK2	T704I	Q16620/T704I	NTRK2/T704I	VARIANT	T -> I (in OBHD; unknown pathological significance; dbSNP:rs1554774973)	ECO:0000269|PubMed:29100083	29100083
Q16620	NTRK2	Y706C	Q16620/Y706C	NTRK2/Y706C	VARIANT	Y -> C (in OBHD; expressed normally on the cell surface; results in markedly impaired ligand-induced phosphorylation as well as impaired downstream MAPK1 phosphorylation; dbSNP:rs121434633)	ECO:0000269|PubMed:15494731	15494731
Q16620	NTRK2	R718C	Q16620/R718C	NTRK2/R718C	VARIANT	R -> C (in a lung carcinoma sample; somatic mutation; dbSNP:rs1324578301)	ECO:0000269|PubMed:18293376	18293376

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16644	MAPKAPK3	P28S	Q16644/P28S	MAPKAPK3/P28S	VARIANT	P -> S (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs375412266)	ECO:0000269|PubMed:17344846	17344846
Q16644	MAPKAPK3	E105A	Q16644/E105A	MAPKAPK3/E105A	VARIANT	E -> A (in an ovarian endometrioid sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q16644	MAPKAPK3	L173P	Q16644/L173P	MAPKAPK3/L173P	VARIANT	L -> P (in MDPT3; decreased localization to the nucleus; dbSNP:rs886037913)	ECO:0000269|PubMed:26744326	26744326
Q16644	MAPKAPK3	D276Y	Q16644/D276Y	MAPKAPK3/D276Y	VARIANT	D -> Y (in dbSNP:rs56107897)	ECO:0000269|PubMed:17344846	17344846
Q16644	MAPKAPK3	K73M	Q16644/K73M	MAPKAPK3/K73M	MUTAGEN	K->M: Higher affinity toward PCH2.	ECO:0000269|PubMed:15563468	15563468

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16654	PDK4	A17V	Q16654/A17V	PDK4/A17V	VARIANT	A -> V (in dbSNP:rs56391840)	ECO:0000269|PubMed:17344846	17344846
Q16654	PDK4	L19M	Q16654/L19M	PDK4/L19M	VARIANT	L -> M (in dbSNP:rs55761955)	ECO:0000269|PubMed:17344846	17344846
Q16654	PDK4	D109G	Q16654/D109G	PDK4/D109G	VARIANT	D -> G (in dbSNP:rs34898343)	ECO:0000269|PubMed:17344846	17344846
Q16654	PDK4	Y157F	Q16654/Y157F	PDK4/Y157F	MUTAGEN	Y->F: Loss of activity.	ECO:0000269|PubMed:18658136	18658136
Q16654	PDK4	R161A	Q16654/R161A	PDK4/R161A	MUTAGEN	R->A: Loss of activity.	ECO:0000269|PubMed:18658136	18658136
Q16654	PDK4	D394A	Q16654/D394A	PDK4/D394A	MUTAGEN	D->A: Loss of activity; when associated with A-395.	ECO:0000269|PubMed:18658136	18658136
Q16654	PDK4	W395A	Q16654/W395A	PDK4/W395A	MUTAGEN	W->A: Loss of activity; when associated with A-394.	ECO:0000269|PubMed:18658136	18658136

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16659	MAPK6	L290V	Q16659/L290V	MAPK6/L290V	VARIANT	L -> V (in dbSNP:rs35697691)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16671	AMHR2	R54C	Q16671/R54C	AMHR2/R54C	VARIANT	R -> C (in PMDS2; dbSNP:rs534999427)	ECO:0000269|PubMed:8872466	8872466
Q16671	AMHR2	G142V	Q16671/G142V	AMHR2/G142V	VARIANT	G -> V (in PMDS2)	ECO:0000269|PubMed:8872466	8872466
Q16671	AMHR2	H282Q	Q16671/H282Q	AMHR2/H282Q	VARIANT	H -> Q (in PMDS2; dbSNP:rs539695176)	ECO:0000269|PubMed:8872466	8872466
Q16671	AMHR2	R319H	Q16671/R319H	AMHR2/R319H	VARIANT	R -> H (in dbSNP:rs144236183)	ECO:0000269|Ref.4	
Q16671	AMHR2	R406Q	Q16671/R406Q	AMHR2/R406Q	VARIANT	R -> Q (in PMDS2; dbSNP:rs137853104)	ECO:0000269|PubMed:11549681	11549681
Q16671	AMHR2	D426G	Q16671/D426G	AMHR2/D426G	VARIANT	D -> G (in PMDS2)	ECO:0000269|PubMed:8872466	8872466
Q16671	AMHR2	V458A	Q16671/V458A	AMHR2/V458A	VARIANT	V -> A (in PMDS2; dbSNP:rs775889926)	ECO:0000269|PubMed:8872466	8872466
Q16671	AMHR2	D491H	Q16671/D491H	AMHR2/D491H	VARIANT	D -> H (in PMDS2; dbSNP:rs780680518)	ECO:0000269|PubMed:8872466	8872466
Q16671	AMHR2	R504C	Q16671/R504C	AMHR2/R504C	VARIANT	R -> C (in PMDS2; dbSNP:rs772294564)	ECO:0000269|PubMed:8872466	8872466

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16816	PHKG1	V48M	Q16816/V48M	PHKG1/V48M	VARIANT	V -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs368370244)	ECO:0000269|PubMed:17344846	17344846
Q16816	PHKG1	R323C	Q16816/R323C	PHKG1/R323C	VARIANT	R -> C (in dbSNP:rs149458708)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q16832	DDR2	R105S	Q16832/R105S	DDR2/R105S	VARIANT	R -> S (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:16140923, ECO:0000269|PubMed:17344846	16140923,17344846
Q16832	DDR2	E113K	Q16832/E113K	DDR2/E113K	VARIANT	E -> K (in SEMD-SL; abolishes collagen binding; dbSNP:rs397514747)	ECO:0000269|PubMed:20223752	20223752
Q16832	DDR2	R124W	Q16832/R124W	DDR2/R124W	VARIANT	R -> W (in SEMD-SL)	ECO:0000269|PubMed:26463668	26463668
Q16832	DDR2	M441I	Q16832/M441I	DDR2/M441I	VARIANT	M -> I (in dbSNP:rs34722354)	ECO:0000269|PubMed:17344846	17344846
Q16832	DDR2	R478C	Q16832/R478C	DDR2/R478C	VARIANT	R -> C (in dbSNP:rs34869543)	ECO:0000269|PubMed:17344846	17344846
Q16832	DDR2	V543F	Q16832/V543F	DDR2/V543F	VARIANT	V -> F (in dbSNP:rs55973200)	ECO:0000269|PubMed:17344846	17344846
Q16832	DDR2	L610P	Q16832/L610P	DDR2/L610P	VARIANT	L -> P (in WRCN; increased autophosphorylation in patient fibroblasts)	ECO:0000269|PubMed:30449416	30449416
Q16832	DDR2	T713I	Q16832/T713I	DDR2/T713I	VARIANT	T -> I (in SEMD-SL; causes retention in an intracellular compartment and thereby abolishes signaling in response collagen binding; dbSNP:rs121964865)	ECO:0000269|PubMed:19110212, ECO:0000269|PubMed:20223752	19110212,20223752
Q16832	DDR2	I726R	Q16832/I726R	DDR2/I726R	VARIANT	I -> R (in SEMD-SL; causes retention in an intracellular compartment and thereby abolishes signaling in response collagen binding; dbSNP:rs121964864)	ECO:0000269|PubMed:19110212, ECO:0000269|PubMed:20223752	19110212,20223752
Q16832	DDR2	Y740C	Q16832/Y740C	DDR2/Y740C	VARIANT	Y -> C (in WRCN; increased autophosphorylation in patient fibroblasts)	ECO:0000269|PubMed:30449416	30449416
Q16832	DDR2	R752C	Q16832/R752C	DDR2/R752C	VARIANT	R -> C (in SEMD-SL; causes retention in an intracellular compartment and thereby abolishes signaling in response collagen binding; dbSNP:rs121964863)	ECO:0000269|PubMed:19110212, ECO:0000269|PubMed:20223752	19110212,20223752
Q16832	DDR2	W52A	Q16832/W52A	DDR2/W52A	MUTAGEN	W->A: Abolishes collagen binding.	ECO:0000269|PubMed:20004161, ECO:0000269|PubMed:20223752	20004161,20223752
Q16832	DDR2	K608A	Q16832/K608A	DDR2/K608A	MUTAGEN	K->A: Abolishes kinase activity.	ECO:0000269|PubMed:16186108	16186108
Q16832	DDR2	Y736F	Q16832/Y736F	DDR2/Y736F	MUTAGEN	Y->F: Reduces autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-740 and F-741.	ECO:0000269|PubMed:16186108	16186108
Q16832	DDR2	Y740F	Q16832/Y740F	DDR2/Y740F	MUTAGEN	Y->F: Promotes autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-736 and F-741.	ECO:0000269|PubMed:16186108	16186108
Q16832	DDR2	Y741F	Q16832/Y741F	DDR2/Y741F	MUTAGEN	Y->F: Reduces autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-736 and F-740.	ECO:0000269|PubMed:16186108	16186108

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q2M2I8	AAK1	I59V	Q2M2I8/I59V	AAK1/I59V	VARIANT	I -> V (in dbSNP:rs34535244)	ECO:0000269|PubMed:17344846	17344846
Q2M2I8	AAK1	K509Q	Q2M2I8/K509Q	AAK1/K509Q	VARIANT	K -> Q (in dbSNP:rs6715776)	ECO:0000269|PubMed:10470851, ECO:0000269|PubMed:15489334	10470851,15489334
Q2M2I8	AAK1	Q533H	Q2M2I8/Q533H	AAK1/Q533H	VARIANT	Q -> H (in dbSNP:rs1263928487)	ECO:0000269|PubMed:17344846	17344846
Q2M2I8	AAK1	V603A	Q2M2I8/V603A	AAK1/V603A	VARIANT	V -> A (in dbSNP:rs56038532)	ECO:0000269|PubMed:17344846	17344846
Q2M2I8	AAK1	T694M	Q2M2I8/T694M	AAK1/T694M	VARIANT	T -> M (in dbSNP:rs55889248)	ECO:0000269|PubMed:17344846	17344846
Q2M2I8	AAK1	P725T	Q2M2I8/P725T	AAK1/P725T	VARIANT	P -> T (in dbSNP:rs35285785)	ECO:0000269|PubMed:17344846	17344846
Q2M2I8	AAK1	P771R	Q2M2I8/P771R	AAK1/P771R	VARIANT	P -> R (in dbSNP:rs34422616)	ECO:0000269|PubMed:17344846	17344846
Q2M2I8	AAK1	G835D	Q2M2I8/G835D	AAK1/G835D	VARIANT	G -> D	ECO:0000269|PubMed:17344846	17344846
Q2M2I8	AAK1	K74A	Q2M2I8/K74A	AAK1/K74A	MUTAGEN	K->A: Inhibits autophosphorylation and phosphorylation of AP2M1. Does not affect NUMB localization. Does not interact with monoubiquitinated NOTCH1.	ECO:0000269|PubMed:12952931, ECO:0000269|PubMed:18657069, ECO:0000269|PubMed:21464124	12952931,18657069,21464124
Q2M2I8	AAK1	D176A	Q2M2I8/D176A	AAK1/D176A	MUTAGEN	D->A: Inhibits autophosphorylation and phosphorylation of AP2M1. Does not affect NUMB localization.	ECO:0000269|PubMed:12952931, ECO:0000269|PubMed:18657069	12952931,18657069

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q32MK0	MYLK3	S70T	Q32MK0/S70T	MYLK3/S70T	VARIANT	S -> T (in dbSNP:rs9923813)		
Q32MK0	MYLK3	V180L	Q32MK0/V180L	MYLK3/V180L	VARIANT	V -> L (in dbSNP:rs28407821)	ECO:0000269|PubMed:15489334, ECO:0000269|Ref.1	15489334
Q32MK0	MYLK3	G390R	Q32MK0/G390R	MYLK3/G390R	VARIANT	G -> R (in a colorectal cancer sample; somatic mutation; dbSNP:rs141602742)	ECO:0000269|PubMed:16959974	16959974

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q38SD2	LRRK1	A1803T	Q38SD2/A1803T	LRRK1/A1803T	VARIANT	A -> T	ECO:0000269|PubMed:17344846	17344846
Q38SD2	LRRK1	L1824F	Q38SD2/L1824F	LRRK1/L1824F	VARIANT	L -> F	ECO:0000269|PubMed:17344846	17344846
Q38SD2	LRRK1	S1847N	Q38SD2/S1847N	LRRK1/S1847N	VARIANT	S -> N	ECO:0000269|PubMed:17344846	17344846
Q38SD2	LRRK1	D1927G	Q38SD2/D1927G	LRRK1/D1927G	VARIANT	D -> G	ECO:0000269|PubMed:17344846	17344846
Q38SD2	LRRK1	K651A	Q38SD2/K651A	LRRK1/K651A	MUTAGEN	K->A: Loss of GTP/GDP-binding.	ECO:0000269|PubMed:16243488	16243488
Q38SD2	LRRK1	K746G	Q38SD2/K746G	LRRK1/K746G	MUTAGEN	K->G: No effect on GTP-binding but reduction in subsequent stimulation of kinase activity.	ECO:0000269|PubMed:16243488	16243488
Q38SD2	LRRK1	F1022C	Q38SD2/F1022C	LRRK1/F1022C	MUTAGEN	F->C: No effect on GTP-binding but loss of subsequent stimulation of kinase activity.	ECO:0000269|PubMed:16243488	16243488
Q38SD2	LRRK1	K1270W	Q38SD2/K1270W	LRRK1/K1270W	MUTAGEN	K->W: Loss of autophosphorylation.	ECO:0000269|PubMed:16243488	16243488
Q38SD2	LRRK1	I1412T	Q38SD2/I1412T	LRRK1/I1412T	MUTAGEN	I->T: No effect on GTP-binding but reduction in subsequent stimulation of kinase activity.	ECO:0000269|PubMed:16243488	16243488

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q3MIX3	ADCK5	S17R	Q3MIX3/S17R	ADCK5/S17R	VARIANT	S -> R (in dbSNP:rs6599528)	ECO:0000269|PubMed:14702039	14702039

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q52WX2	SBK1	R12H	Q52WX2/R12H	SBK1/R12H	VARIANT	R -> H (in dbSNP:rs35448675)		
Q52WX2	SBK1	K92E	Q52WX2/K92E	SBK1/K92E	VARIANT	K -> E (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q52WX2	SBK1	N250T	Q52WX2/N250T	SBK1/N250T	VARIANT	N -> T (in dbSNP:rs56072383)	ECO:0000269|PubMed:17344846	17344846
Q52WX2	SBK1	A261S	Q52WX2/A261S	SBK1/A261S	VARIANT	A -> S	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q56UN5	MAP3K19	T438I	Q56UN5/T438I	MAP3K19/T438I	VARIANT	T -> I (in dbSNP:rs16831235)		
Q56UN5	MAP3K19	I500M	Q56UN5/I500M	MAP3K19/I500M	VARIANT	I -> M (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q56UN5	MAP3K19	E676Q	Q56UN5/E676Q	MAP3K19/E676Q	VARIANT	E -> Q (in dbSNP:rs1112542)		
Q56UN5	MAP3K19	E812G	Q56UN5/E812G	MAP3K19/E812G	VARIANT	E -> G (in dbSNP:rs3905317)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q58A45	PAN3	Y203A	Q58A45/Y203A	PAN3/Y203A	MUTAGEN	Y->A: Reduces interaction with polyadenylate-binding protein.	ECO:0000269|PubMed:18056425	18056425
Q58A45	PAN3	F293A	Q58A45/F293A	PAN3/F293A	MUTAGEN	F->A: Reduces interaction with polyadenylate-binding protein.	ECO:0000269|PubMed:17595167, ECO:0000269|PubMed:18056425	17595167,18056425

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q58F21	BRDT	S2F	Q58F21/S2F	BRDT/S2F	VARIANT	S -> F (in dbSNP:rs55806733)	ECO:0000269|PubMed:17344846	17344846
Q58F21	BRDT	R6Q	Q58F21/R6Q	BRDT/R6Q	VARIANT	R -> Q (in dbSNP:rs56273490)	ECO:0000269|PubMed:17344846	17344846
Q58F21	BRDT	Q62K	Q58F21/Q62K	BRDT/Q62K	VARIANT	Q -> K (in dbSNP:rs10783071)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:15647849, ECO:0000269|PubMed:9367677, ECO:0000269|Ref.5	14702039,15489334,15647849,9367677
Q58F21	BRDT	A89V	Q58F21/A89V	BRDT/A89V	VARIANT	A -> V (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs781375003)	ECO:0000269|PubMed:17344846	17344846
Q58F21	BRDT	K238N	Q58F21/K238N	BRDT/K238N	VARIANT	K -> N (in dbSNP:rs1156281)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
Q58F21	BRDT	H288Y	Q58F21/H288Y	BRDT/H288Y	VARIANT	H -> Y (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q58F21	BRDT	K336T	Q58F21/K336T	BRDT/K336T	VARIANT	K -> T (in dbSNP:rs1064567)		
Q58F21	BRDT	E357K	Q58F21/E357K	BRDT/E357K	VARIANT	E -> K (in dbSNP:rs34674879)	ECO:0000269|PubMed:17344846	17344846
Q58F21	BRDT	N410K	Q58F21/N410K	BRDT/N410K	VARIANT	N -> K (in dbSNP:rs3088232)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
Q58F21	BRDT	P542A	Q58F21/P542A	BRDT/P542A	VARIANT	P -> A (in dbSNP:rs55912588)	ECO:0000269|PubMed:17344846	17344846
Q58F21	BRDT	R605Q	Q58F21/R605Q	BRDT/R605Q	VARIANT	R -> Q (in dbSNP:rs35327986)		
Q58F21	BRDT	P696L	Q58F21/P696L	BRDT/P696L	VARIANT	P -> L (in dbSNP:rs10747493)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15647849, ECO:0000269|PubMed:9367677, ECO:0000269|Ref.5	14702039,15647849,9367677
Q58F21	BRDT	G928D	Q58F21/G928D	BRDT/G928D	VARIANT	G -> D (in SPGF21; no effect on protein expression; unknown pathological significance; dbSNP:rs754258809)	ECO:0000269|PubMed:28199965	28199965

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q59H18	TNNI3K	D151H	Q59H18/D151H	TNNI3K/D151H	VARIANT	D -> H (in dbSNP:rs34874695)	ECO:0000269|PubMed:17344846	17344846
Q59H18	TNNI3K	P263L	Q59H18/P263L	TNNI3K/P263L	VARIANT	P -> L (in dbSNP:rs34521608)	ECO:0000269|PubMed:17344846	17344846
Q59H18	TNNI3K	F309L	Q59H18/F309L	TNNI3K/F309L	VARIANT	F -> L	ECO:0000269|PubMed:17344846	17344846
Q59H18	TNNI3K	S430L	Q59H18/S430L	TNNI3K/S430L	VARIANT	S -> L (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q59H18	TNNI3K	V510L	Q59H18/V510L	TNNI3K/V510L	VARIANT	V -> L (in dbSNP:rs34335537)	ECO:0000269|PubMed:17344846	17344846
Q59H18	TNNI3K	G526D	Q59H18/G526D	TNNI3K/G526D	VARIANT	G -> D (in CCDD; the mutation results in decreased protein solubility; causes abnormal aggregation; markedly reduced protein expression is observed in the sarcoplasm and nuclei of patient cardiomyocytes; dbSNP:rs606231469)	ECO:0000269|PubMed:24925317	24925317
Q59H18	TNNI3K	R629G	Q59H18/R629G	TNNI3K/R629G	VARIANT	R -> G (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
Q59H18	TNNI3K	T637M	Q59H18/T637M	TNNI3K/T637M	VARIANT	T -> M (in dbSNP:rs2274260)	ECO:0000269|PubMed:17344846	17344846
Q59H18	TNNI3K	I686T	Q59H18/I686T	TNNI3K/I686T	VARIANT	I -> T (in dbSNP:rs3737564)	ECO:0000269|PubMed:17344846	17344846
Q59H18	TNNI3K	A785G	Q59H18/A785G	TNNI3K/A785G	VARIANT	A -> G (in dbSNP:rs45578635)	ECO:0000269|Ref.5	
Q59H18	TNNI3K	M798I	Q59H18/M798I	TNNI3K/M798I	VARIANT	M -> I (in a head & Neck squamous cell carcinoma sample; somatic mutation; dbSNP:rs201613442)	ECO:0000269|PubMed:17344846	17344846
Q59H18	TNNI3K	D833Y	Q59H18/D833Y	TNNI3K/D833Y	VARIANT	D -> Y (in dbSNP:rs45614933)	ECO:0000269|Ref.5	
Q59H18	TNNI3K	K490R	Q59H18/K490R	TNNI3K/K490R	MUTAGEN	K->R: Loss of autophosphorylation activity.	ECO:0000269|PubMed:12721663	12721663

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q5JZY3	EPHA10	V103L	Q5JZY3/V103L	EPHA10/V103L	VARIANT	V -> L (in dbSNP:rs34557762)		
Q5JZY3	EPHA10	R150H	Q5JZY3/R150H	EPHA10/R150H	VARIANT	R -> H (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs771803475)	ECO:0000269|PubMed:17344846	17344846
Q5JZY3	EPHA10	T220K	Q5JZY3/T220K	EPHA10/T220K	VARIANT	T -> K (in dbSNP:rs56276182)	ECO:0000269|PubMed:17344846	17344846
Q5JZY3	EPHA10	F281I	Q5JZY3/F281I	EPHA10/F281I	VARIANT	F -> I (in dbSNP:rs4653328)	ECO:0000269|PubMed:17344846	17344846
Q5JZY3	EPHA10	L629P	Q5JZY3/L629P	EPHA10/L629P	VARIANT	L -> P (in dbSNP:rs17511304)		
Q5JZY3	EPHA10	L630P	Q5JZY3/L630P	EPHA10/L630P	VARIANT	L -> P	ECO:0000269|PubMed:17344846	17344846
Q5JZY3	EPHA10	V645I	Q5JZY3/V645I	EPHA10/V645I	VARIANT	V -> I (in dbSNP:rs12405650)		
Q5JZY3	EPHA10	G749E	Q5JZY3/G749E	EPHA10/G749E	VARIANT	G -> E (in dbSNP:rs6671088)		
Q5JZY3	EPHA10	H775R	Q5JZY3/H775R	EPHA10/H775R	VARIANT	H -> R (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q5JZY3	EPHA10	R807Q	Q5JZY3/R807Q	EPHA10/R807Q	VARIANT	R -> Q (in dbSNP:rs6670599)		
Q5JZY3	EPHA10	A956T	Q5JZY3/A956T	EPHA10/A956T	VARIANT	A -> T	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q5S007	LRRK2	R50H	Q5S007/R50H	LRRK2/R50H	VARIANT	R -> H (in dbSNP:rs2256408)		
Q5S007	LRRK2	L119P	Q5S007/L119P	LRRK2/L119P	VARIANT	L -> P (in dbSNP:rs33995463)	ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:17344846	16172858,17344846
Q5S007	LRRK2	C228S	Q5S007/C228S	LRRK2/C228S	VARIANT	C -> S (in dbSNP:rs56108242)	ECO:0000269|PubMed:18213618	18213618
Q5S007	LRRK2	A419V	Q5S007/A419V	LRRK2/A419V	VARIANT	A -> V (in dbSNP:rs34594498)	ECO:0000269|PubMed:17344846	17344846
Q5S007	LRRK2	N551K	Q5S007/N551K	LRRK2/N551K	VARIANT	N -> K (in dbSNP:rs7308720)	ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:16251215, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:22415848	16172858,16251215,17344846,22415848
Q5S007	LRRK2	M712V	Q5S007/M712V	LRRK2/M712V	VARIANT	M -> V (in PARK8; dbSNP:rs199566791)	ECO:0000269|PubMed:18213618	18213618
Q5S007	LRRK2	A716V	Q5S007/A716V	LRRK2/A716V	VARIANT	A -> V (in dbSNP:rs281865043)	ECO:0000269|PubMed:18213618	18213618
Q5S007	LRRK2	I723V	Q5S007/I723V	LRRK2/I723V	VARIANT	I -> V (in dbSNP:rs10878307)	ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:22415848	16172858,17344846,22415848
Q5S007	LRRK2	P755L	Q5S007/P755L	LRRK2/P755L	VARIANT	P -> L (in dbSNP:rs34410987)		
Q5S007	LRRK2	R793M	Q5S007/R793M	LRRK2/R793M	VARIANT	R -> M (in PARK8; unknown pathological significance; dbSNP:rs35173587)	ECO:0000269|PubMed:16157908, ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:16251215	16157908,16172858,16251215
Q5S007	LRRK2	K871E	Q5S007/K871E	LRRK2/K871E	VARIANT	K -> E (in dbSNP:rs281865044)	ECO:0000269|PubMed:18213618	18213618
Q5S007	LRRK2	Q930R	Q5S007/Q930R	LRRK2/Q930R	VARIANT	Q -> R (in PARK8; unknown pathological significance; dbSNP:rs281865045)	ECO:0000269|PubMed:16251215	16251215
Q5S007	LRRK2	D944Y	Q5S007/D944Y	LRRK2/D944Y	VARIANT	D -> Y (in dbSNP:rs17519916)		
Q5S007	LRRK2	R1067Q	Q5S007/R1067Q	LRRK2/R1067Q	VARIANT	R -> Q (in PARK8; dbSNP:rs111341148)	ECO:0000269|PubMed:16247070	16247070
Q5S007	LRRK2	S1096C	Q5S007/S1096C	LRRK2/S1096C	VARIANT	S -> C (in PARK8; unknown pathological significance; dbSNP:rs76535406)		
Q5S007	LRRK2	I1122V	Q5S007/I1122V	LRRK2/I1122V	VARIANT	I -> V (in PARK8; dbSNP:rs34805604)	ECO:0000269|PubMed:15541309, ECO:0000269|PubMed:16172858	15541309,16172858
Q5S007	LRRK2	S1228T	Q5S007/S1228T	LRRK2/S1228T	VARIANT	S -> T (in PARK8; dbSNP:rs60185966)	ECO:0000269|PubMed:16251215	16251215
Q5S007	LRRK2	P1262A	Q5S007/P1262A	LRRK2/P1262A	VARIANT	P -> A (in dbSNP:rs4640000)	ECO:0000269|PubMed:16172858	16172858
Q5S007	LRRK2	K1359I	Q5S007/K1359I	LRRK2/K1359I	VARIANT	K -> I (found in a renal cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:21248752	21248752
Q5S007	LRRK2	I1371V	Q5S007/I1371V	LRRK2/I1371V	VARIANT	I -> V (in PARK8; unknown pathological significance; dbSNP:rs17466213)	ECO:0000269|PubMed:16157901, ECO:0000269|PubMed:16333314	16157901,16333314
Q5S007	LRRK2	D1375E	Q5S007/D1375E	LRRK2/D1375E	VARIANT	D -> E (in dbSNP:rs28365226)		
Q5S007	LRRK2	R1398H	Q5S007/R1398H	LRRK2/R1398H	VARIANT	R -> H (in dbSNP:rs7133914)	ECO:0000269|PubMed:16157901, ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:22415848	16157901,16172858,17344846,22415848
Q5S007	LRRK2	R1441C	Q5S007/R1441C	LRRK2/R1441C	VARIANT	R -> C (in PARK8; shows an increase in activity in both autophosphorylation and phosphorylation of a generic substrate; loss of interaction with SEC16A; shows an increase in activity in phosphorylation of RAB10; decreases phosphorylation-dependent binding to YWHAG; dbSNP:rs33939927)	ECO:0000269|PubMed:15541309, ECO:0000269|PubMed:16157909, ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:16269541, ECO:0000269|PubMed:16333314, ECO:0000269|PubMed:16533964, ECO:0000269|PubMed:25201882, ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:28202711, ECO:0000269|PubMed:29212815	15541309,16157909,16172858,16269541,16333314,16533964,25201882,26824392,28202711,29212815
Q5S007	LRRK2	R1441G	Q5S007/R1441G	LRRK2/R1441G	VARIANT	R->G: Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	R1441H	Q5S007/R1441H	LRRK2/R1441H	VARIANT	R -> H (in PARK8; shows an increase in activity in phosphorylation of RAB8A and RAB10; decreases phosphorylation-dependent binding to YWHAG; dbSNP:rs34995376)	ECO:0000269|PubMed:16157909, ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:29212815	16157909,16172858,26824392,29212815
Q5S007	LRRK2	R1514Q	Q5S007/R1514Q	LRRK2/R1514Q	VARIANT	R -> Q (in PARK8; unknown pathological significance; dbSNP:rs35507033)	ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:22415848	16172858,17344846,22415848
Q5S007	LRRK2	P1542S	Q5S007/P1542S	LRRK2/P1542S	VARIANT	P -> S (in PARK8; unknown pathological significance; dbSNP:rs33958906)	ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:22415848	16172858,17344846,22415848
Q5S007	LRRK2	R1550Q	Q5S007/R1550Q	LRRK2/R1550Q	VARIANT	R -> Q (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs200212150)	ECO:0000269|PubMed:17344846	17344846
Q5S007	LRRK2	V1598E	Q5S007/V1598E	LRRK2/V1598E	VARIANT	V -> E (in PARK8; unknown pathological significance; dbSNP:rs721710)	ECO:0000269|PubMed:16172858	16172858
Q5S007	LRRK2	R1628P	Q5S007/R1628P	LRRK2/R1628P	VARIANT	R -> P (may be associated with Parkinson disease in some populations; dbSNP:rs33949390)	ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:21641266, ECO:0000269|PubMed:22415848	16172858,21641266,22415848
Q5S007	LRRK2	M1646T	Q5S007/M1646T	LRRK2/M1646T	VARIANT	M -> T (in dbSNP:rs35303786)	ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:22415848	16172858,22415848
Q5S007	LRRK2	S1647T	Q5S007/S1647T	LRRK2/S1647T	VARIANT	S -> T (in dbSNP:rs11564148)	ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:22415848	16172858,22415848
Q5S007	LRRK2	Y1699C	Q5S007/Y1699C	LRRK2/Y1699C	VARIANT	Y->C: Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	R1723P	Q5S007/R1723P	LRRK2/R1723P	VARIANT	R -> P (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q5S007	LRRK2	R1728H	Q5S007/R1728H	LRRK2/R1728H	VARIANT	R -> H (in PARK8; shows an increase in activity in phosphorylation of RAB8A and RAB10; dbSNP:rs145364431)	ECO:0000269|PubMed:18213618, ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:29212815	18213618,26824392,29212815
Q5S007	LRRK2	R1728L	Q5S007/R1728L	LRRK2/R1728L	VARIANT	R -> L (in PARK8; dbSNP:rs145364431)	ECO:0000269|PubMed:18213618	18213618
Q5S007	LRRK2	M1869T	Q5S007/M1869T	LRRK2/M1869T	VARIANT	M -> T (in PARK8; unknown pathological significance; dbSNP:rs35602796)	ECO:0000269|PubMed:16157908, ECO:0000269|PubMed:16172858	16157908,16172858
Q5S007	LRRK2	L1870F	Q5S007/L1870F	LRRK2/L1870F	VARIANT	L -> F (in dbSNP:rs281865053)	ECO:0000269|PubMed:18213618	18213618
Q5S007	LRRK2	K1906M	Q5S007/K1906M	LRRK2/K1906M	VARIANT	K -> M (does not inhibit interaction with RAB29; shows a progressive increase in neurite length and branching)	ECO:0000269|PubMed:17114044, ECO:0000269|PubMed:23395371	17114044,23395371
Q5S007	LRRK2	R1941H	Q5S007/R1941H	LRRK2/R1941H	VARIANT	R -> H (in PARK8; dbSNP:rs77428810)	ECO:0000269|PubMed:16272164	16272164
Q5S007	LRRK2	I2012T	Q5S007/I2012T	LRRK2/I2012T	VARIANT	I -> T (in PARK8; unknown pathological significance; dbSNP:rs34015634)	ECO:0000269|PubMed:16172858	16172858
Q5S007	LRRK2	G2019S	Q5S007/G2019S	LRRK2/G2019S	VARIANT	G->S: Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	I2020T	Q5S007/I2020T	LRRK2/I2020T	VARIANT	I -> T (in PARK8; significant increase in autophosphorylation of about 40% in comparison to wild-type protein in vitro; shows a progressive reduction in neurite length and branching; shows an increase in activity in phosphorylation of RAB8A and RAB10; dbSNP:rs35870237)	ECO:0000269|PubMed:15541309, ECO:0000269|PubMed:15880653, ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:16251215, ECO:0000269|PubMed:16321986, ECO:0000269|PubMed:17114044, ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:29212815	15541309,15880653,16172858,16251215,16321986,17114044,26824392,29212815
Q5S007	LRRK2	T2031S	Q5S007/T2031S	LRRK2/T2031S	VARIANT	T -> S (in PARK8; shows an increase in activity in phosphorylation of RAB8A and RAB10; dbSNP:rs78029637)	ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:29212815	26824392,29212815
Q5S007	LRRK2	N2081D	Q5S007/N2081D	LRRK2/N2081D	VARIANT	N -> D (in dbSNP:rs33995883)	ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:22415848	16172858,22415848
Q5S007	LRRK2	P2119L	Q5S007/P2119L	LRRK2/P2119L	VARIANT	P -> L (in dbSNP:rs12423862)	ECO:0000269|PubMed:16172858	16172858
Q5S007	LRRK2	T2141M	Q5S007/T2141M	LRRK2/T2141M	VARIANT	T -> M (in PARK8; dbSNP:rs111691891)	ECO:0000269|PubMed:18213618	18213618
Q5S007	LRRK2	R2143H	Q5S007/R2143H	LRRK2/R2143H	VARIANT	R -> H (in PARK8; dbSNP:rs201271001)	ECO:0000269|PubMed:18213618	18213618
Q5S007	LRRK2	D2175H	Q5S007/D2175H	LRRK2/D2175H	VARIANT	D -> H (in PARK8; shows decreased WD domain homodimerization; no effect on kinase activity; dbSNP:rs72547981)	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	Y2189C	Q5S007/Y2189C	LRRK2/Y2189C	VARIANT	Y -> C (in PARK8; no effect on WD domain homodimerization; no effect on kinase activity; dbSNP:rs35658131)	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	N2261I	Q5S007/N2261I	LRRK2/N2261I	VARIANT	N -> I (in dbSNP:rs12581902)	ECO:0000269|PubMed:16172858	16172858
Q5S007	LRRK2	T2356I	Q5S007/T2356I	LRRK2/T2356I	VARIANT	T -> I (in PARK8; shows decreased WD domain homodimerization; no effect on kinase activity; dbSNP:rs113511708)	ECO:0000269|PubMed:16272164, ECO:0000269|PubMed:30635421	16272164,30635421
Q5S007	LRRK2	G2385R	Q5S007/G2385R	LRRK2/G2385R	VARIANT	G -> R (in PARK8; under conditions of oxidative stress the variant protein is more toxic and is associated with a higher rate of apoptosis; reduced binding to synaptic vesicles; no loss of interaction with SEC16A; shows an increase in activity in phosphorylation of RAB8A and RAB10; shows decreased WD domain homodimerization; reduced autophosphorylation at Ser-935; dbSNP:rs34778348)	ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:17019612, ECO:0000269|PubMed:24687852, ECO:0000269|PubMed:25201882, ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:29212815, ECO:0000269|PubMed:30635421	16172858,17019612,24687852,25201882,26824392,29212815,30635421
Q5S007	LRRK2	V2390M	Q5S007/V2390M	LRRK2/V2390M	VARIANT	V -> M (in PARK8; shows decreased WD domain homodimerization; no effect on kinase activity; dbSNP:rs79546190)	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	E2395K	Q5S007/E2395K	LRRK2/E2395K	VARIANT	E -> K (in dbSNP:rs78964014)	ECO:0000269|PubMed:18213618	18213618
Q5S007	LRRK2	M2397T	Q5S007/M2397T	LRRK2/M2397T	VARIANT	M -> T (in dbSNP:rs3761863)	ECO:0000269|PubMed:16157901, ECO:0000269|PubMed:16172858, ECO:0000269|PubMed:22415848	16157901,16172858,22415848
Q5S007	LRRK2	L2439I	Q5S007/L2439I	LRRK2/L2439I	VARIANT	L -> I (in PARK8; shows decreased WD domain homodimerization; no effect on kinase activity; dbSNP:rs72547983)	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	L2466H	Q5S007/L2466H	LRRK2/L2466H	VARIANT	L -> H (in PARK8; dbSNP:rs281865057)	ECO:0000269|PubMed:18213618	18213618
Q5S007	LRRK2	C727D	Q5S007/C727D	LRRK2/C727D	MUTAGEN	C->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	L728D	Q5S007/L728D	LRRK2/L728D	MUTAGEN	L->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	L729D	Q5S007/L729D	LRRK2/L729D	MUTAGEN	L->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	L760D	Q5S007/L760D	LRRK2/L760D	MUTAGEN	L->D: Decreased kinase activity and loss of RAB29-mediated activation.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	L761D	Q5S007/L761D	LRRK2/L761D	MUTAGEN	L->D: Decreased kinase activity and loss of RAB29-mediated activation.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	L762D	Q5S007/L762D	LRRK2/L762D	MUTAGEN	L->D: Decreased kinase activity and loss of RAB29-mediated activation.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	L789D	Q5S007/L789D	LRRK2/L789D	MUTAGEN	L->D: No effect on kinase activity and RAB29-mediated activation.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	L790D	Q5S007/L790D	LRRK2/L790D	MUTAGEN	L->D: No effect on kinase activity and RAB29-mediated activation.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	L791D	Q5S007/L791D	LRRK2/L791D	MUTAGEN	L->D: No effect on kinase activity and RAB29-mediated activation.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	T1343G	Q5S007/T1343G	LRRK2/T1343G	MUTAGEN	T->G: Decreased kinase activity; when associated with Q-1398.	ECO:0000269|PubMed:18230735	18230735
Q5S007	LRRK2	K1347A	Q5S007/K1347A	LRRK2/K1347A	MUTAGEN	K->A: GTPase-dead mutant. Loss of interaction with SEC16A and impaired ability to recruit SEC16A to endoplasmic reticulum exit sites.	ECO:0000269|PubMed:25201882	25201882
Q5S007	LRRK2	T1348N	Q5S007/T1348N	LRRK2/T1348N	MUTAGEN	T->N: Loss of GTP binding. Inhibits autophosphorylation and RAB10 phosphorylation; when associated with G-1441, C-1699, or S-2019.	ECO:0000269|PubMed:29212815	29212815
Q5S007	LRRK2	R1398Q	Q5S007/R1398Q	LRRK2/R1398Q	MUTAGEN	R->Q: Decreased kinase activity; when associated with G-1343.	ECO:0000269|PubMed:18230735	18230735
Q5S007	LRRK2	K1906A	Q5S007/K1906A	LRRK2/K1906A	MUTAGEN	K->A: Loss of kinase activity. Decreases proteosomal degradation of MAPT; when associated with N-1994 and A-2017.	ECO:0000269|PubMed:26014385	26014385
Q5S007	LRRK2	D1994A	Q5S007/D1994A	LRRK2/D1994A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:28720718	28720718
Q5S007	LRRK2	D1994N	Q5S007/D1994N	LRRK2/D1994N	MUTAGEN	D->N: Loss of kinase activity. No loss of interaction with SEC16A and no loss of ability to recruit SEC16A to endoplasmic reticulum exit sites. Decreases proteosomal degradation of MAPT; when associated with A-1906 and A-2017.	ECO:0000269|PubMed:25201882, ECO:0000269|PubMed:26014385, ECO:0000269|PubMed:26824392	25201882,26014385,26824392
Q5S007	LRRK2	D2017A	Q5S007/D2017A	LRRK2/D2017A	MUTAGEN	D->A: Loss of kinase activity. Decreases proteosomal degradation of MAPT; when associated with A-1906 and N-1994. Loss of phosphorylation of RAB10; when associated with G-1441, C-1699, or S-2019.	ECO:0000269|PubMed:26014385, ECO:0000269|PubMed:29125462, ECO:0000269|PubMed:29212815, ECO:0000269|PubMed:30635421	26014385,29125462,29212815,30635421
Q5S007	LRRK2	L2343D	Q5S007/L2343D	LRRK2/L2343D	MUTAGEN	L->D: Decreases WD domain homodimerization. No effect on kinase activity.	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	F2344A	Q5S007/F2344A	LRRK2/F2344A	MUTAGEN	F->A: Decreases WD domain homodimerization. No effect on kinase activity.	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	S2345D	Q5S007/S2345D	LRRK2/S2345D	MUTAGEN	S->D: Decreases WD domain homodimerization. No effect on kinase activity.	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	Y2346A	Q5S007/Y2346A	LRRK2/Y2346A	MUTAGEN	Y->A: Decreases WD domain homodimerization. No effect on kinase activity.	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	H2391D	Q5S007/H2391D	LRRK2/H2391D	MUTAGEN	H->D: Increases kinase activity.	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	R2394E	Q5S007/R2394E	LRRK2/R2394E	MUTAGEN	R->E: Decreases WD domain homodimerization. Increases kinase activity and autophosphorylation at Ser-1292.	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	E2395R	Q5S007/E2395R	LRRK2/E2395R	MUTAGEN	E->R: Decreases WD domain homodimerization. No effect on kinase activity.	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	M2408A	Q5S007/M2408A	LRRK2/M2408A	MUTAGEN			
Q5S007	LRRK2	M2408E	Q5S007/M2408E	LRRK2/M2408E	MUTAGEN	M->A,E: No effect on WD domain homodimerization. No effect on kinase activity.	ECO:0000269|PubMed:30635421	30635421
Q5S007	LRRK2	S2409A	Q5S007/S2409A	LRRK2/S2409A	MUTAGEN	S->A: Decreases WD domain homodimerization.	ECO:0000269|PubMed:30635421	30635421

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q5TCX8	MAP3K21	D420N	Q5TCX8/D420N	MAP3K21/D420N	VARIANT	D -> N (in dbSNP:rs35465006)	ECO:0000269|PubMed:17344846	17344846
Q5TCX8	MAP3K21	E563D	Q5TCX8/E563D	MAP3K21/E563D	VARIANT	E -> D (in dbSNP:rs35758282)	ECO:0000269|PubMed:17344846	17344846
Q5TCX8	MAP3K21	S597F	Q5TCX8/S597F	MAP3K21/S597F	VARIANT	S -> F (in dbSNP:rs34984140)	ECO:0000269|PubMed:17344846	17344846
Q5TCX8	MAP3K21	V728I	Q5TCX8/V728I	MAP3K21/V728I	VARIANT	V -> I (in dbSNP:rs3795375)	ECO:0000269|PubMed:17344846	17344846
Q5TCX8	MAP3K21	E741D	Q5TCX8/E741D	MAP3K21/E741D	VARIANT	E -> D (in dbSNP:rs3795374)	ECO:0000269|PubMed:17344846	17344846
Q5TCX8	MAP3K21	C784G	Q5TCX8/C784G	MAP3K21/C784G	VARIANT	C -> G (in dbSNP:rs963981)	ECO:0000269|PubMed:17344846	17344846
Q5TCX8	MAP3K21	R892W	Q5TCX8/R892W	MAP3K21/R892W	VARIANT	R -> W (in dbSNP:rs55681416)	ECO:0000269|PubMed:17344846	17344846
Q5TCX8	MAP3K21	T900I	Q5TCX8/T900I	MAP3K21/T900I	VARIANT	T -> I (in dbSNP:rs34499091)	ECO:0000269|PubMed:17344846	17344846
Q5TCX8	MAP3K21	R977C	Q5TCX8/R977C	MAP3K21/R977C	VARIANT	R -> C (in dbSNP:rs56065162)	ECO:0000269|PubMed:17344846	17344846
Q5TCX8	MAP3K21	P982L	Q5TCX8/P982L	MAP3K21/P982L	VARIANT	P -> L (in dbSNP:rs34794284)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q5TCY1	TTBK1	P613L	Q5TCY1/P613L	TTBK1/P613L	VARIANT	P -> L (in dbSNP:rs34993661)	ECO:0000269|PubMed:17344846	17344846
Q5TCY1	TTBK1	G623A	Q5TCY1/G623A	TTBK1/G623A	VARIANT	G -> A (in dbSNP:rs3800294)	ECO:0000269|PubMed:17344846	17344846
Q5TCY1	TTBK1	P649R	Q5TCY1/P649R	TTBK1/P649R	VARIANT	P -> R (in dbSNP:rs35175743)	ECO:0000269|PubMed:17344846	17344846
Q5TCY1	TTBK1	D741E	Q5TCY1/D741E	TTBK1/D741E	VARIANT	D -> E (in dbSNP:rs56377340)	ECO:0000269|PubMed:17344846	17344846
Q5TCY1	TTBK1	E744D	Q5TCY1/E744D	TTBK1/E744D	VARIANT	E -> D (in dbSNP:rs3800295)	ECO:0000269|PubMed:17344846	17344846
Q5TCY1	TTBK1	S806F	Q5TCY1/S806F	TTBK1/S806F	VARIANT	S -> F (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q5TCY1	TTBK1	P855S	Q5TCY1/P855S	TTBK1/P855S	VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267601046)	ECO:0000269|PubMed:17344846	17344846
Q5TCY1	TTBK1	K1145R	Q5TCY1/K1145R	TTBK1/K1145R	VARIANT	K -> R (in dbSNP:rs3800297)	ECO:0000269|PubMed:17344846	17344846
Q5TCY1	TTBK1	L1184S	Q5TCY1/L1184S	TTBK1/L1184S	VARIANT	L -> S (in dbSNP:rs3800298)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q5VST9	OBSCN	A51T	Q5VST9/A51T	OBSCN/A51T	VARIANT	A -> T (in dbSNP:rs1771487)	ECO:0000269|PubMed:11448995	11448995
Q5VST9	OBSCN	Q502R	Q5VST9/Q502R	OBSCN/Q502R	VARIANT	Q -> R (in dbSNP:rs1771487)	ECO:0000269|PubMed:11448995, ECO:0000269|PubMed:17344846	11448995,17344846
Q5VST9	OBSCN	G804S	Q5VST9/G804S	OBSCN/G804S	VARIANT	G -> S (in dbSNP:rs55950009)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	A908T	Q5VST9/A908T	OBSCN/A908T	VARIANT	A -> T (in dbSNP:rs1757153)		
Q5VST9	OBSCN	K1027R	Q5VST9/K1027R	OBSCN/K1027R	VARIANT	K -> R (in dbSNP:rs55760713)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	A1086S	Q5VST9/A1086S	OBSCN/A1086S	VARIANT	A -> S (in dbSNP:rs117147433)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	A1090T	Q5VST9/A1090T	OBSCN/A1090T	VARIANT	A -> T (in dbSNP:rs752906025)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	S1091T	Q5VST9/S1091T	OBSCN/S1091T	VARIANT	S -> T (in dbSNP:rs965007403)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	A1101P	Q5VST9/A1101P	OBSCN/A1101P	VARIANT	A -> P (in dbSNP:rs780907202)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	G1121R	Q5VST9/G1121R	OBSCN/G1121R	VARIANT	G -> R	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	L1133V	Q5VST9/L1133V	OBSCN/L1133V	VARIANT	L -> V (in dbSNP:rs777214598)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	A1136V	Q5VST9/A1136V	OBSCN/A1136V	VARIANT	A -> V (in a colorectal cancer sample; somatic mutation; dbSNP:rs950055015)	ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17344846	16959974,17344846
Q5VST9	OBSCN	H1156Q	Q5VST9/H1156Q	OBSCN/H1156Q	VARIANT	H -> Q	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	Q1248H	Q5VST9/Q1248H	OBSCN/Q1248H	VARIANT	Q -> H (in dbSNP:rs199523598)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	V1508D	Q5VST9/V1508D	OBSCN/V1508D	VARIANT	V -> D (in dbSNP:rs7532342)		
Q5VST9	OBSCN	A1532V	Q5VST9/A1532V	OBSCN/A1532V	VARIANT	A -> V (in dbSNP:rs453140)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	T1566M	Q5VST9/T1566M	OBSCN/T1566M	VARIANT	T -> M (in dbSNP:rs56217040)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	A1601T	Q5VST9/A1601T	OBSCN/A1601T	VARIANT	A -> T (in dbSNP:rs55706639)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	R1792H	Q5VST9/R1792H	OBSCN/R1792H	VARIANT	R -> H (in a colorectal cancer sample; somatic mutation; dbSNP:rs750681123)	ECO:0000269|PubMed:16959974	16959974
Q5VST9	OBSCN	V1930M	Q5VST9/V1930M	OBSCN/V1930M	VARIANT	V -> M (in a colorectal cancer sample; somatic mutation; dbSNP:rs545316651)	ECO:0000269|PubMed:16959974	16959974
Q5VST9	OBSCN	E2090K	Q5VST9/E2090K	OBSCN/E2090K	VARIANT	E -> K (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
Q5VST9	OBSCN	D2106E	Q5VST9/D2106E	OBSCN/D2106E	VARIANT	D -> E (in dbSNP:rs1188721)		
Q5VST9	OBSCN	F2116L	Q5VST9/F2116L	OBSCN/F2116L	VARIANT	F -> L (in dbSNP:rs1188722)		
Q5VST9	OBSCN	S2314F	Q5VST9/S2314F	OBSCN/S2314F	VARIANT	S -> F (in a breast cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
Q5VST9	OBSCN	R2529Q	Q5VST9/R2529Q	OBSCN/R2529Q	VARIANT	R -> Q (in dbSNP:rs3795783)		
Q5VST9	OBSCN	V2720M	Q5VST9/V2720M	OBSCN/V2720M	VARIANT	V -> M (in dbSNP:rs1188697)		
Q5VST9	OBSCN	R2812W	Q5VST9/R2812W	OBSCN/R2812W	VARIANT	R -> W (in dbSNP:rs3795785)		
Q5VST9	OBSCN	A3300T	Q5VST9/A3300T	OBSCN/A3300T	VARIANT	A -> T (in dbSNP:rs437129)	ECO:0000269|PubMed:11448995	11448995
Q5VST9	OBSCN	E3372D	Q5VST9/E3372D	OBSCN/E3372D	VARIANT	E -> D (in dbSNP:rs3795789)		
Q5VST9	OBSCN	S3373C	Q5VST9/S3373C	OBSCN/S3373C	VARIANT	S -> C (in dbSNP:rs3795790)		
Q5VST9	OBSCN	A3389V	Q5VST9/A3389V	OBSCN/A3389V	VARIANT	A -> V (in dbSNP:rs770177081)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	D3426E	Q5VST9/D3426E	OBSCN/D3426E	VARIANT	D -> E	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	R3834G	Q5VST9/R3834G	OBSCN/R3834G	VARIANT	R -> G	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	R3983Q	Q5VST9/R3983Q	OBSCN/R3983Q	VARIANT	R -> Q (in a colorectal cancer sample; somatic mutation; dbSNP:rs539154039)	ECO:0000269|PubMed:16959974	16959974
Q5VST9	OBSCN	G4039R	Q5VST9/G4039R	OBSCN/G4039R	VARIANT	G -> R (in dbSNP:rs435776)		
Q5VST9	OBSCN	H4381R	Q5VST9/H4381R	OBSCN/H4381R	VARIANT	H -> R (in dbSNP:rs1150912)	ECO:0000269|PubMed:11448995	11448995
Q5VST9	OBSCN	C4450R	Q5VST9/C4450R	OBSCN/C4450R	VARIANT	C -> R (in dbSNP:rs1188732)	ECO:0000269|PubMed:11448995	11448995
Q5VST9	OBSCN	L4492R	Q5VST9/L4492R	OBSCN/L4492R	VARIANT	L -> R (in dbSNP:rs369570923)	ECO:0000269|PubMed:25173926	25173926
Q5VST9	OBSCN	R4516W	Q5VST9/R4516W	OBSCN/R4516W	VARIANT	R -> W (in dbSNP:rs11810627)		
Q5VST9	OBSCN	R4534H	Q5VST9/R4534H	OBSCN/R4534H	VARIANT	R -> H (in dbSNP:rs4653942)	ECO:0000269|PubMed:11448995	11448995
Q5VST9	OBSCN	R4558H	Q5VST9/R4558H	OBSCN/R4558H	VARIANT	R -> H (in a colorectal cancer sample; somatic mutation; dbSNP:rs199865640)	ECO:0000269|PubMed:16959974	16959974
Q5VST9	OBSCN	S4642C	Q5VST9/S4642C	OBSCN/S4642C	VARIANT	S -> C (in dbSNP:rs1188729)		
Q5VST9	OBSCN	R4662C	Q5VST9/R4662C	OBSCN/R4662C	VARIANT	R -> C (in dbSNP:rs3795800)		
Q5VST9	OBSCN	G4666S	Q5VST9/G4666S	OBSCN/G4666S	VARIANT	G -> S (in dbSNP:rs3795801)		
Q5VST9	OBSCN	R4810Q	Q5VST9/R4810Q	OBSCN/R4810Q	VARIANT	R -> Q (in a breast cancer sample; somatic mutation; dbSNP:rs570805670)	ECO:0000269|PubMed:16959974	16959974
Q5VST9	OBSCN	A4823S	Q5VST9/A4823S	OBSCN/A4823S	VARIANT	A -> S	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	D4962G	Q5VST9/D4962G	OBSCN/D4962G	VARIANT	D -> G (in dbSNP:rs373610)		
Q5VST9	OBSCN	A5071T	Q5VST9/A5071T	OBSCN/A5071T	VARIANT	A -> T (in a breast cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
Q5VST9	OBSCN	L5269V	Q5VST9/L5269V	OBSCN/L5269V	VARIANT	L -> V (in dbSNP:rs369909)		
Q5VST9	OBSCN	R5575H	Q5VST9/R5575H	OBSCN/R5575H	VARIANT	R -> H (in dbSNP:rs3795809)		
Q5VST9	OBSCN	R5598Q	Q5VST9/R5598Q	OBSCN/R5598Q	VARIANT	R -> Q (in dbSNP:rs867550675)	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	Q5891E	Q5VST9/Q5891E	OBSCN/Q5891E	VARIANT	Q -> E (in dbSNP:rs1188710)		
Q5VST9	OBSCN	E6473Q	Q5VST9/E6473Q	OBSCN/E6473Q	VARIANT	E -> Q	ECO:0000269|PubMed:17344846	17344846
Q5VST9	OBSCN	A7172V	Q5VST9/A7172V	OBSCN/A7172V	VARIANT	A -> V (in dbSNP:rs500049)	ECO:0000269|PubMed:10997877	10997877
Q5VST9	OBSCN	R5975A	Q5VST9/R5975A	OBSCN/R5975A	MUTAGEN	R->A: Reduced binding to phosphatidylinositol 4,5-bisphosphate.	ECO:0000269|PubMed:28826662	28826662
Q5VST9	OBSCN	R5980A	Q5VST9/R5980A	OBSCN/R5980A	MUTAGEN	R->A: Reduced binding to phosphatidylinositol 3,4-bisphosphate.	ECO:0000269|PubMed:28826662	28826662

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q5VT25	CDC42BPA	E50K	Q5VT25/E50K	CDC42BPA/E50K	VARIANT	E -> K (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q5VT25	CDC42BPA	T231M	Q5VT25/T231M	CDC42BPA/T231M	VARIANT	T -> M (in dbSNP:rs34614709)	ECO:0000269|PubMed:17344846	17344846
Q5VT25	CDC42BPA	I537T	Q5VT25/I537T	CDC42BPA/I537T	VARIANT	I -> T (in dbSNP:rs56364976)	ECO:0000269|PubMed:17344846	17344846
Q5VT25	CDC42BPA	T780M	Q5VT25/T780M	CDC42BPA/T780M	VARIANT	T -> M (in dbSNP:rs56119119)	ECO:0000269|PubMed:17344846	17344846
Q5VT25	CDC42BPA	Y790C	Q5VT25/Y790C	CDC42BPA/Y790C	VARIANT	Y -> C (in dbSNP:rs34943764)	ECO:0000269|PubMed:17344846	17344846
Q5VT25	CDC42BPA	A1148T	Q5VT25/A1148T	CDC42BPA/A1148T	VARIANT	A -> T (in dbSNP:rs56219089)	ECO:0000269|PubMed:17344846	17344846
Q5VT25	CDC42BPA	R1211H	Q5VT25/R1211H	CDC42BPA/R1211H	VARIANT	R -> H (in dbSNP:rs961490)	ECO:0000269|PubMed:17344846	17344846
Q5VT25	CDC42BPA	V1317I	Q5VT25/V1317I	CDC42BPA/V1317I	VARIANT	V -> I (in dbSNP:rs1929860)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17974005	17344846,17974005
Q5VT25	CDC42BPA	I1418K	Q5VT25/I1418K	CDC42BPA/I1418K	VARIANT	I -> K	ECO:0000269|PubMed:17344846	17344846
Q5VT25	CDC42BPA	A1469V	Q5VT25/A1469V	CDC42BPA/A1469V	VARIANT	A -> V (in dbSNP:rs55687355)	ECO:0000269|PubMed:17344846	17344846
Q5VT25	CDC42BPA	T1618A	Q5VT25/T1618A	CDC42BPA/T1618A	VARIANT	T -> A (in dbSNP:rs2297417)	ECO:0000269|PubMed:17344846	17344846
Q5VT25	CDC42BPA	A1699V	Q5VT25/A1699V	CDC42BPA/A1699V	VARIANT	A -> V (in dbSNP:rs2802269)		
Q5VT25	CDC42BPA	A1712V	Q5VT25/A1712V	CDC42BPA/A1712V	VARIANT	A -> V (in dbSNP:rs2802269)	ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:9455484, ECO:0000269|Ref.2	17974005,9455484
Q5VT25	CDC42BPA	K106A	Q5VT25/K106A	CDC42BPA/K106A	MUTAGEN	K->A: Loss of kinase activity.	ECO:0000269|PubMed:11283256	11283256
Q5VT25	CDC42BPA	S222L	Q5VT25/S222L	CDC42BPA/S222L	MUTAGEN	S->L: Increase in autophosphorylation but not kinase activity.	ECO:0000269|PubMed:11283256	11283256
Q5VT25	CDC42BPA	S234A	Q5VT25/S234A	CDC42BPA/S234A	MUTAGEN	S->A: Loss of autophosphorylation and kinase activity.	ECO:0000269|PubMed:11283256	11283256
Q5VT25	CDC42BPA	T240A	Q5VT25/T240A	CDC42BPA/T240A	MUTAGEN	T->A: Loss of autophosphorylation and kinase activity.	ECO:0000269|PubMed:11283256	11283256
Q5VT25	CDC42BPA	T403A	Q5VT25/T403A	CDC42BPA/T403A	MUTAGEN	T->A: Loss of autophosphorylation and kinase activity.	ECO:0000269|PubMed:11283256	11283256
Q5VT25	CDC42BPA	D478A	Q5VT25/D478A	CDC42BPA/D478A	MUTAGEN	D->A: Prevents cleavage by CASP3, impairs the increase of its kinase activity and impairs extrusion apical actin ring assembly.	ECO:0000269|PubMed:29162624	29162624
Q5VT25	CDC42BPA	D984A	Q5VT25/D984A	CDC42BPA/D984A	MUTAGEN	D->A: Prevents cleavage by CASP3.	ECO:0000269|PubMed:29162624	29162624
Q5VT25	CDC42BPA	H1579A	Q5VT25/H1579A	CDC42BPA/H1579A	MUTAGEN	H->A: Loss of CDC42 binding; when associated with A-1582.	ECO:0000269|PubMed:9418861	9418861
Q5VT25	CDC42BPA	H1582A	Q5VT25/H1582A	CDC42BPA/H1582A	MUTAGEN	H->A: Loss of CDC42 binding; when associated with A-1579.	ECO:0000269|PubMed:9418861	9418861

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6DT37	CDC42BPG	P168L	Q6DT37/P168L	CDC42BPG/P168L	VARIANT	P -> L (in dbSNP:rs34454471)	ECO:0000269|PubMed:17344846	17344846
Q6DT37	CDC42BPG	S280F	Q6DT37/S280F	CDC42BPG/S280F	VARIANT	S -> F (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs770462360)	ECO:0000269|PubMed:17344846	17344846
Q6DT37	CDC42BPG	T362P	Q6DT37/T362P	CDC42BPG/T362P	VARIANT	T -> P (in dbSNP:rs55688429)	ECO:0000269|PubMed:17344846	17344846
Q6DT37	CDC42BPG	A537D	Q6DT37/A537D	CDC42BPG/A537D	VARIANT	A -> D (in dbSNP:rs34241745)	ECO:0000269|PubMed:17344846	17344846
Q6DT37	CDC42BPG	Q1135R	Q6DT37/Q1135R	CDC42BPG/Q1135R	VARIANT	Q -> R (in dbSNP:rs3741395)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6IQ55	TTBK2	L8P	Q6IQ55/L8P	TTBK2/L8P	VARIANT	L -> P (in dbSNP:rs6493068)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19533200	15489334,17344846,19533200
Q6IQ55	TTBK2	R120Q	Q6IQ55/R120Q	TTBK2/R120Q	VARIANT	R -> Q (in dbSNP:rs35328266)	ECO:0000269|PubMed:17344846	17344846
Q6IQ55	TTBK2	T313A	Q6IQ55/T313A	TTBK2/T313A	VARIANT	T -> A (in dbSNP:rs56017612)	ECO:0000269|PubMed:17344846	17344846
Q6IQ55	TTBK2	K367I	Q6IQ55/K367I	TTBK2/K367I	VARIANT	K -> I (in dbSNP:rs764753481)	ECO:0000269|PubMed:26063658	26063658
Q6IQ55	TTBK2	V440M	Q6IQ55/V440M	TTBK2/V440M	VARIANT	V -> M (in dbSNP:rs56311523)	ECO:0000269|PubMed:17344846	17344846
Q6IQ55	TTBK2	R500P	Q6IQ55/R500P	TTBK2/R500P	VARIANT	R -> P (in dbSNP:rs56039839)	ECO:0000269|PubMed:17344846	17344846
Q6IQ55	TTBK2	D635G	Q6IQ55/D635G	TTBK2/D635G	VARIANT	D -> G (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6IQ55	TTBK2	G724E	Q6IQ55/G724E	TTBK2/G724E	VARIANT	G -> E (in dbSNP:rs201524659)	ECO:0000269|PubMed:26063658	26063658
Q6IQ55	TTBK2	E842G	Q6IQ55/E842G	TTBK2/E842G	VARIANT	E -> G (found in a patient with SCA11; unknown pathological significance; dbSNP:rs202004988)	ECO:0000269|PubMed:19533200	19533200
Q6IQ55	TTBK2	T1062I	Q6IQ55/T1062I	TTBK2/T1062I	VARIANT	T -> I (in dbSNP:rs55833708)	ECO:0000269|PubMed:17344846	17344846
Q6IQ55	TTBK2	T1084M	Q6IQ55/T1084M	TTBK2/T1084M	VARIANT	T -> M (in dbSNP:rs34348991)	ECO:0000269|PubMed:17344846	17344846
Q6IQ55	TTBK2	V1097A	Q6IQ55/V1097A	TTBK2/V1097A	VARIANT	V -> A (in dbSNP:rs55796513)	ECO:0000269|PubMed:17344846	17344846
Q6IQ55	TTBK2	R1110H	Q6IQ55/R1110H	TTBK2/R1110H	VARIANT	R -> H (found in a patient with SCA11; unknown pathological significance; dbSNP:rs146279300)	ECO:0000269|PubMed:19533200	19533200
Q6IQ55	TTBK2	P1122R	Q6IQ55/P1122R	TTBK2/P1122R	VARIANT	P -> R (in dbSNP:rs56142516)	ECO:0000269|PubMed:17344846	17344846
Q6IQ55	TTBK2	K1241T	Q6IQ55/K1241T	TTBK2/K1241T	VARIANT	K -> T (in dbSNP:rs36104367)	ECO:0000269|PubMed:17344846	17344846
Q6IQ55	TTBK2	K50E	Q6IQ55/K50E	TTBK2/K50E	MUTAGEN			
Q6IQ55	TTBK2	K50A	Q6IQ55/K50A	TTBK2/K50A	MUTAGEN	K->E,A: Leads to inactivation/destabilization of the protein.	ECO:0000269|PubMed:21548880	21548880
Q6IQ55	TTBK2	K143E	Q6IQ55/K143E	TTBK2/K143E	MUTAGEN			
Q6IQ55	TTBK2	K143A	Q6IQ55/K143A	TTBK2/K143A	MUTAGEN	K->E,A: Leads to inactivation/destabilization of the protein.	ECO:0000269|PubMed:21548880	21548880
Q6IQ55	TTBK2	D163A	Q6IQ55/D163A	TTBK2/D163A	MUTAGEN	D->A: Abolishes serine/threonine-protein kinase activity.	ECO:0000269|PubMed:21548880	21548880
Q6IQ55	TTBK2	R181E	Q6IQ55/R181E	TTBK2/R181E	MUTAGEN			
Q6IQ55	TTBK2	R181A	Q6IQ55/R181A	TTBK2/R181A	MUTAGEN	R->E,A: Impaired serine/threonine-protein kinase activity.	ECO:0000269|PubMed:21548880	21548880
Q6IQ55	TTBK2	A184E	Q6IQ55/A184E	TTBK2/A184E	MUTAGEN			
Q6IQ55	TTBK2	A184G	Q6IQ55/A184G	TTBK2/A184G	MUTAGEN	A->E,G: Impaired serine/threonine-protein kinase activity.	ECO:0000269|PubMed:21548880	21548880

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6J9G0	STYK1	R71G	Q6J9G0/R71G	STYK1/R71G	VARIANT	R -> G (in dbSNP:rs6650202)		
Q6J9G0	STYK1	S204G	Q6J9G0/S204G	STYK1/S204G	VARIANT	S -> G (in dbSNP:rs3759259)	ECO:0000269|PubMed:12841579, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17974005, ECO:0000269|Ref.6	12841579,14702039,15489334,17344846,17974005
Q6J9G0	STYK1	R210W	Q6J9G0/R210W	STYK1/R210W	VARIANT	R -> W (in dbSNP:rs34981955)	ECO:0000269|PubMed:17344846	17344846
Q6J9G0	STYK1	L237S	Q6J9G0/L237S	STYK1/L237S	VARIANT	L -> S (in dbSNP:rs55877878)	ECO:0000269|PubMed:17344846	17344846
Q6J9G0	STYK1	R379H	Q6J9G0/R379H	STYK1/R379H	VARIANT	R -> H (in dbSNP:rs34638573)	ECO:0000269|PubMed:17344846	17344846
Q6J9G0	STYK1	V395I	Q6J9G0/V395I	STYK1/V395I	VARIANT	V -> I (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6J9G0	STYK1	V400L	Q6J9G0/V400L	STYK1/V400L	VARIANT	V -> L (in dbSNP:rs55766125)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6P0Q8	MAST2	L69F	Q6P0Q8/L69F	MAST2/L69F	VARIANT	L -> F (in dbSNP:rs55914403)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	K275E	Q6P0Q8/K275E	MAST2/K275E	VARIANT	K -> E (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	D388E	Q6P0Q8/D388E	MAST2/D388E	VARIANT	D -> E (in dbSNP:rs11211247)	ECO:0000269|PubMed:12117771, ECO:0000269|PubMed:17344846	12117771,17344846
Q6P0Q8	MAST2	G655A	Q6P0Q8/G655A	MAST2/G655A	VARIANT	G -> A (in a breast mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	I659M	Q6P0Q8/I659M	MAST2/I659M	VARIANT	I -> M (in dbSNP:rs1707336)	ECO:0000269|PubMed:12117771, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9872452	12117771,15489334,17344846,9872452
Q6P0Q8	MAST2	R991L	Q6P0Q8/R991L	MAST2/R991L	VARIANT	R -> L (in dbSNP:rs56114653)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	K1197R	Q6P0Q8/K1197R	MAST2/K1197R	VARIANT	K -> R (in dbSNP:rs1052607)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	D1221E	Q6P0Q8/D1221E	MAST2/D1221E	VARIANT	D -> E (in dbSNP:rs56060730)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	R1246L	Q6P0Q8/R1246L	MAST2/R1246L	VARIANT	R -> L (in dbSNP:rs56309943)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	V1304M	Q6P0Q8/V1304M	MAST2/V1304M	VARIANT	V -> M (in dbSNP:rs33931638)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	A1463T	Q6P0Q8/A1463T	MAST2/A1463T	VARIANT	A -> T (in dbSNP:rs3737738)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	G1468A	Q6P0Q8/G1468A	MAST2/G1468A	VARIANT	G -> A (in dbSNP:rs3737737)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	D1551G	Q6P0Q8/D1551G	MAST2/D1551G	VARIANT	D -> G (in dbSNP:rs1052610)	ECO:0000269|PubMed:12117771, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9872452	12117771,17344846,9872452
Q6P0Q8	MAST2	T1608I	Q6P0Q8/T1608I	MAST2/T1608I	VARIANT	T -> I (in dbSNP:rs35474583)		
Q6P0Q8	MAST2	K1673R	Q6P0Q8/K1673R	MAST2/K1673R	VARIANT	K -> R (in dbSNP:rs34070850)	ECO:0000269|PubMed:17344846	17344846
Q6P0Q8	MAST2	G1703E	Q6P0Q8/G1703E	MAST2/G1703E	VARIANT	G -> E	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6P2M8	PNCK	Q262H	Q6P2M8/Q262H	PNCK/Q262H	VARIANT	Q -> H (in dbSNP:rs56060609)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6P3R8	NEK5	K255Q	Q6P3R8/K255Q	NEK5/K255Q	VARIANT	K -> Q (in dbSNP:rs34756139)		
Q6P3R8	NEK5	R290H	Q6P3R8/R290H	NEK5/R290H	VARIANT	R -> H	ECO:0000269|PubMed:17344846	17344846
Q6P3R8	NEK5	C531R	Q6P3R8/C531R	NEK5/C531R	VARIANT	C -> R	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6P3W7	SCYL2	P357L	Q6P3W7/P357L	SCYL2/P357L	VARIANT	P -> L (in dbSNP:rs33968174)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q6P3W7	SCYL2	T720S	Q6P3W7/T720S	SCYL2/T720S	VARIANT	T -> S (in dbSNP:rs763873645)	ECO:0000269|PubMed:17344846	17344846
Q6P3W7	SCYL2	Q863H	Q6P3W7/Q863H	SCYL2/Q863H	VARIANT	Q -> H (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6P5Z2	PKN3	A180E	Q6P5Z2/A180E	PKN3/A180E	VARIANT	A -> E (in dbSNP:rs56251280)	ECO:0000269|PubMed:17344846	17344846
Q6P5Z2	PKN3	V404L	Q6P5Z2/V404L	PKN3/V404L	VARIANT	V -> L (in dbSNP:rs12932)		
Q6P5Z2	PKN3	K588E	Q6P5Z2/K588E	PKN3/K588E	MUTAGEN	K->E: Abolishes autophosphorylation and catalytic activity.	ECO:0000269|PubMed:10441506, ECO:0000269|PubMed:15282551	10441506,15282551
Q6P5Z2	PKN3	K588R	Q6P5Z2/K588R	PKN3/K588R	MUTAGEN	K->R: Abolishes catalytic activity.	ECO:0000269|PubMed:10441506, ECO:0000269|PubMed:15282551	10441506,15282551
Q6P5Z2	PKN3	T718A	Q6P5Z2/T718A	PKN3/T718A	MUTAGEN	T->A: Abolishes phosphorylation.	ECO:0000269|PubMed:15282551	15282551

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6PHR2	ULK3	R101H	Q6PHR2/R101H	ULK3/R101H	VARIANT	R -> H (in dbSNP:rs34945944)		
Q6PHR2	ULK3	K445R	Q6PHR2/K445R	ULK3/K445R	VARIANT	K -> R (in dbSNP:rs12898397)		
Q6PHR2	ULK3	K44R	Q6PHR2/K44R	ULK3/K44R	MUTAGEN	K->R: Decreased kinase activity.	ECO:0000269|PubMed:19878745	19878745
Q6PHR2	ULK3	K139R	Q6PHR2/K139R	ULK3/K139R	MUTAGEN	K->R: Loss of kinase activity. Does not promote GLI1 nuclear localization.	ECO:0000269|PubMed:19878745, ECO:0000269|PubMed:20643644	19878745,20643644

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6SA08	TSSK4	H33Y	Q6SA08/H33Y	TSSK4/H33Y	VARIANT	H -> Y (in dbSNP:rs36036137)	ECO:0000269|PubMed:17344846	17344846
Q6SA08	TSSK4	Y89C	Q6SA08/Y89C	TSSK4/Y89C	VARIANT	Y -> C (in dbSNP:rs34083933)	ECO:0000269|PubMed:17344846	17344846
Q6SA08	TSSK4	V145M	Q6SA08/V145M	TSSK4/V145M	VARIANT	V -> M (in dbSNP:rs35468205)	ECO:0000269|PubMed:17344846	17344846
Q6SA08	TSSK4	Q196R	Q6SA08/Q196R	TSSK4/Q196R	VARIANT	Q -> R (in dbSNP:rs1270764)	ECO:0000269|PubMed:17344846	17344846
Q6SA08	TSSK4	T327M	Q6SA08/T327M	TSSK4/T327M	VARIANT	T -> M (in dbSNP:rs35244223)	ECO:0000269|PubMed:17344846	17344846
Q6SA08	TSSK4	K54M	Q6SA08/K54M	TSSK4/K54M	MUTAGEN	K->M: Loss of kinase activity.	ECO:0000269|PubMed:15964553	15964553

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6VAB6	KSR2	R676S	Q6VAB6/R676S	KSR2/R676S	VARIANT	R -> S (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6VAB6	KSR2	R718H	Q6VAB6/R718H	KSR2/R718H	MUTAGEN	R->H: Impairs formation of heterotetramers with MAP2K1, but not the formation of heterodimers.	ECO:0000269|PubMed:21441910	21441910
Q6VAB6	KSR2	D786A	Q6VAB6/D786A	KSR2/D786A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:21441910	21441910
Q6VAB6	KSR2	A879L	Q6VAB6/A879L	KSR2/A879L	MUTAGEN	A->L: Impairs MAP2K1 binding.	ECO:0000269|PubMed:21441910	21441910

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6XUX3	DSTYK	R29Q	Q6XUX3/R29Q	DSTYK/R29Q	VARIANT	R -> Q (in CAKUT1; unknown pathological significance; dbSNP:rs200780796)	ECO:0000269|PubMed:23862974	23862974
Q6XUX3	DSTYK	D200G	Q6XUX3/D200G	DSTYK/D200G	VARIANT	D -> G (in CAKUT1)	ECO:0000269|PubMed:23862974	23862974
Q6XUX3	DSTYK	L432V	Q6XUX3/L432V	DSTYK/L432V	VARIANT	L -> V (in dbSNP:rs35845538)		
Q6XUX3	DSTYK	S843L	Q6XUX3/S843L	DSTYK/S843L	VARIANT	S -> L (in CAKUT1; dbSNP:rs778586547)	ECO:0000269|PubMed:23862974	23862974
Q6XUX3	DSTYK	K681Q	Q6XUX3/K681Q	DSTYK/K681Q	MUTAGEN	K->Q: No change.	ECO:0000269|PubMed:15178406	15178406

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6ZMQ8	AATK	S81F	Q6ZMQ8/S81F	AATK/S81F	VARIANT	S -> F (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6ZMQ8	AATK	L97V	Q6ZMQ8/L97V	AATK/L97V	VARIANT	L -> V (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6ZMQ8	AATK	M104V	Q6ZMQ8/M104V	AATK/M104V	VARIANT	M -> V (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs1337040042)	ECO:0000269|PubMed:17344846	17344846
Q6ZMQ8	AATK	T118M	Q6ZMQ8/T118M	AATK/T118M	VARIANT	T -> M (in dbSNP:rs8082016)		
Q6ZMQ8	AATK	G703C	Q6ZMQ8/G703C	AATK/G703C	VARIANT	G -> C (in dbSNP:rs7503604)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9734811	14702039,17344846,9734811
Q6ZMQ8	AATK	S815R	Q6ZMQ8/S815R	AATK/S815R	VARIANT	S -> R (in dbSNP:rs56032966)	ECO:0000269|PubMed:17344846	17344846
Q6ZMQ8	AATK	S923L	Q6ZMQ8/S923L	AATK/S923L	VARIANT	S -> L (in dbSNP:rs56313973)	ECO:0000269|PubMed:17344846	17344846
Q6ZMQ8	AATK	E1160K	Q6ZMQ8/E1160K	AATK/E1160K	VARIANT	E -> K (in dbSNP:rs55793641)	ECO:0000269|PubMed:17344846	17344846
Q6ZMQ8	AATK	P1192S	Q6ZMQ8/P1192S	AATK/P1192S	VARIANT	P -> S (in dbSNP:rs55856613)	ECO:0000269|PubMed:17344846	17344846
Q6ZMQ8	AATK	F1266S	Q6ZMQ8/F1266S	AATK/F1266S	VARIANT	F -> S (in dbSNP:rs36000545)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
Q6ZMQ8	AATK	A1332T	Q6ZMQ8/A1332T	AATK/A1332T	VARIANT	A -> T (in dbSNP:rs55713566)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6ZN16	MAP3K15	A192T	Q6ZN16/A192T	MAP3K15/A192T	VARIANT	A -> T (in dbSNP:rs5909299)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	S199N	Q6ZN16/S199N	MAP3K15/S199N	VARIANT	S -> N (in dbSNP:rs55916006)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	D226H	Q6ZN16/D226H	MAP3K15/D226H	VARIANT	D -> H (in dbSNP:rs56338727)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	R255S	Q6ZN16/R255S	MAP3K15/R255S	VARIANT	R -> S (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	S456G	Q6ZN16/S456G	MAP3K15/S456G	VARIANT	S -> G (in dbSNP:rs56212339)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	R494C	Q6ZN16/R494C	MAP3K15/R494C	VARIANT	R -> C (in dbSNP:rs41305349)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	S562L	Q6ZN16/S562L	MAP3K15/S562L	VARIANT	S -> L (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	R677Q	Q6ZN16/R677Q	MAP3K15/R677Q	VARIANT	R -> Q (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	G838S	Q6ZN16/G838S	MAP3K15/G838S	VARIANT	G -> S (in dbSNP:rs56381411)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	S993L	Q6ZN16/S993L	MAP3K15/S993L	VARIANT	S -> L (in dbSNP:rs56233219)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	N1029H	Q6ZN16/N1029H	MAP3K15/N1029H	VARIANT	N -> H (in dbSNP:rs55787622)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	W1247R	Q6ZN16/W1247R	MAP3K15/W1247R	VARIANT	W -> R (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6ZN16	MAP3K15	Q1251E	Q6ZN16/Q1251E	MAP3K15/Q1251E	VARIANT	Q -> E (in dbSNP:rs15943)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q6ZWH5	NEK10	F50L	Q6ZWH5/F50L	NEK10/F50L	VARIANT	F -> L (in dbSNP:rs56125830)	ECO:0000269|PubMed:17344846	17344846
Q6ZWH5	NEK10	A66V	Q6ZWH5/A66V	NEK10/A66V	VARIANT	A -> V (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs201821707)	ECO:0000269|PubMed:17344846	17344846
Q6ZWH5	NEK10	G67S	Q6ZWH5/G67S	NEK10/G67S	VARIANT	G -> S (in dbSNP:rs55958314)	ECO:0000269|PubMed:17344846	17344846
Q6ZWH5	NEK10	E379K	Q6ZWH5/E379K	NEK10/E379K	VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q6ZWH5	NEK10	L513S	Q6ZWH5/L513S	NEK10/L513S	VARIANT	L -> S (in dbSNP:rs10510592)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17974005	17344846,17974005
Q6ZWH5	NEK10	N659S	Q6ZWH5/N659S	NEK10/N659S	VARIANT	N -> S (in dbSNP:rs55833401)	ECO:0000269|PubMed:17344846	17344846
Q6ZWH5	NEK10	L701V	Q6ZWH5/L701V	NEK10/L701V	VARIANT	L -> V (in dbSNP:rs34313679)	ECO:0000269|PubMed:17344846	17344846
Q6ZWH5	NEK10	P748L	Q6ZWH5/P748L	NEK10/P748L	VARIANT	P -> L (in CILD44; unknown pathological significance; dbSNP:rs1575215909)	ECO:0000269|PubMed:31959991	31959991
Q6ZWH5	NEK10	R773C	Q6ZWH5/R773C	NEK10/R773C	VARIANT	R -> C (in CILD44; unknown pathological significance; dbSNP:rs766982731)	ECO:0000269|PubMed:31959991	31959991
Q6ZWH5	NEK10	K548R	Q6ZWH5/K548R	NEK10/K548R	MUTAGEN	K->R: Catalytically inactive. Impaired mucociliary transport.	ECO:0000269|PubMed:20956560, ECO:0000269|PubMed:31959991	20956560,31959991
Q6ZWH5	NEK10	S684D	Q6ZWH5/S684D	NEK10/S684D	MUTAGEN	S->D: Increased mucociliary transport.	ECO:0000269|PubMed:31959991	31959991

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q76MJ5	ERN2	V69I	Q76MJ5/V69I	ERN2/V69I	VARIANT	V -> I (in dbSNP:rs9932495)	ECO:0000269|PubMed:17344846	17344846
Q76MJ5	ERN2	R118C	Q76MJ5/R118C	ERN2/R118C	VARIANT	R -> C (in dbSNP:rs56117885)	ECO:0000269|PubMed:17344846	17344846
Q76MJ5	ERN2	R184C	Q76MJ5/R184C	ERN2/R184C	VARIANT	R -> C (in dbSNP:rs34683474)	ECO:0000269|PubMed:17344846	17344846
Q76MJ5	ERN2	R271Q	Q76MJ5/R271Q	ERN2/R271Q	VARIANT	R -> Q (in dbSNP:rs55772851)	ECO:0000269|PubMed:11175748, ECO:0000269|PubMed:17344846	11175748,17344846
Q76MJ5	ERN2	A318T	Q76MJ5/A318T	ERN2/A318T	VARIANT	A -> T (in dbSNP:rs56191901)	ECO:0000269|PubMed:17344846	17344846
Q76MJ5	ERN2	L410F	Q76MJ5/L410F	ERN2/L410F	VARIANT	L -> F (in dbSNP:rs55687638)	ECO:0000269|PubMed:17344846	17344846
Q76MJ5	ERN2	S487T	Q76MJ5/S487T	ERN2/S487T	VARIANT	S -> T (in dbSNP:rs26764)	ECO:0000269|PubMed:11175748, ECO:0000269|PubMed:17344846	11175748,17344846
Q76MJ5	ERN2	L504F	Q76MJ5/L504F	ERN2/L504F	VARIANT	L -> F (in dbSNP:rs56001432)	ECO:0000269|PubMed:17344846	17344846
Q76MJ5	ERN2	R537Q	Q76MJ5/R537Q	ERN2/R537Q	VARIANT	R -> Q (in dbSNP:rs56176960)	ECO:0000269|PubMed:17344846	17344846
Q76MJ5	ERN2	H858Y	Q76MJ5/H858Y	ERN2/H858Y	VARIANT	H -> Y (in dbSNP:rs56137182)	ECO:0000269|PubMed:17344846	17344846
Q76MJ5	ERN2	K548A	Q76MJ5/K548A	ERN2/K548A	MUTAGEN	K->A: Loss of autophosphorylation, of induction of apoptosis and of 28S rRNA cleavage, attenuation of repression of protein synthesis.	ECO:0000269|PubMed:11175748	11175748

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q7KZI7	MARK2	T208A	Q7KZI7/T208A	MARK2/T208A	MUTAGEN			
Q7KZI7	MARK2	T596A	Q7KZI7/T596A	MARK2/T596A	MUTAGEN	T->A: Loss of membrane dissociation and binding to YWHAZ.	ECO:0000269|PubMed:15084291, ECO:0000269|PubMed:15324659	15084291,15324659

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q7L7X3	TAOK1	E17G	Q7L7X3/E17G	TAOK1/E17G	VARIANT	E -> G (in DDIB)	ECO:0000269|PubMed:31230721	31230721
Q7L7X3	TAOK1	S111F	Q7L7X3/S111F	TAOK1/S111F	VARIANT	S -> F (in DDIB; dbSNP:rs2030976698)	ECO:0000269|PubMed:31230721	31230721
Q7L7X3	TAOK1	R150I	Q7L7X3/R150I	TAOK1/R150I	VARIANT	R -> I (in DDIB)	ECO:0000269|PubMed:33565190	33565190
Q7L7X3	TAOK1	L167R	Q7L7X3/L167R	TAOK1/L167R	VARIANT	L -> R (in DDIB; affects neuron maturation and migration)	ECO:0000269|PubMed:33565190	33565190
Q7L7X3	TAOK1	M231V	Q7L7X3/M231V	TAOK1/M231V	VARIANT	M -> V (in DDIB; unknown pathological significance)	ECO:0000269|PubMed:33565190	33565190
Q7L7X3	TAOK1	K298E	Q7L7X3/K298E	TAOK1/K298E	VARIANT	K -> E (in DDIB)	ECO:0000269|PubMed:31230721	31230721
Q7L7X3	TAOK1	D305A	Q7L7X3/D305A	TAOK1/D305A	VARIANT	D -> A (in DDIB)	ECO:0000269|PubMed:31230721	31230721
Q7L7X3	TAOK1	L315F	Q7L7X3/L315F	TAOK1/L315F	VARIANT	L -> F (in DDIB; unknown pathological significance)	ECO:0000269|PubMed:33565190	33565190
Q7L7X3	TAOK1	L548P	Q7L7X3/L548P	TAOK1/L548P	VARIANT	L -> P (in DDIB; affects neuron maturation and migration)	ECO:0000269|PubMed:33565190	33565190
Q7L7X3	TAOK1	A855T	Q7L7X3/A855T	TAOK1/A855T	VARIANT	A -> T (in dbSNP:rs34151057)	ECO:0000269|PubMed:17344846	17344846
Q7L7X3	TAOK1	K57A	Q7L7X3/K57A	TAOK1/K57A	MUTAGEN	K->A: Abolishes kinase activity, ability to activate the MAPK8/JNK cascade and cleavage by caspase-3 (CASP3).	ECO:0000269|PubMed:16407310	16407310
Q7L7X3	TAOK1	D169A	Q7L7X3/D169A	TAOK1/D169A	MUTAGEN	D->A: Loss of serine/threonine-protein kinase activity.	ECO:0000269|PubMed:17396146	17396146
Q7L7X3	TAOK1	D376N	Q7L7X3/D376N	TAOK1/D376N	MUTAGEN	D->N: Does not abolish cleavage by caspase-3 (CASP3).	ECO:0000269|PubMed:16407310	16407310
Q7L7X3	TAOK1	T643A	Q7L7X3/T643A	TAOK1/T643A	MUTAGEN	T->A: Abolishes phosphorylation by ATM; when associated with A-785 and A-990.	ECO:0000269|PubMed:17396146	17396146
Q7L7X3	TAOK1	T785A	Q7L7X3/T785A	TAOK1/T785A	MUTAGEN	T->A: Abolishes phosphorylation by ATM; when associated with A-643 and A-990.	ECO:0000269|PubMed:17396146	17396146
Q7L7X3	TAOK1	S990A	Q7L7X3/S990A	TAOK1/S990A	MUTAGEN	S->A: Abolishes phosphorylation by ATM; when associated with A-643 and A-785.	ECO:0000269|PubMed:17396146	17396146

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q7RTN6	STRADA	R13W	Q7RTN6/R13W	STRADA/R13W	VARIANT	R -> W (in dbSNP:rs35808156)	ECO:0000269|PubMed:17344846	17344846
Q7RTN6	STRADA	S60I	Q7RTN6/S60I	STRADA/S60I	VARIANT	S -> I (in dbSNP:rs56271007)	ECO:0000269|PubMed:17344846	17344846
Q7RTN6	STRADA	P64S	Q7RTN6/P64S	STRADA/P64S	VARIANT	P -> S (in dbSNP:rs55695051)	ECO:0000269|PubMed:17344846	17344846
Q7RTN6	STRADA	Y185F	Q7RTN6/Y185F	STRADA/Y185F	MUTAGEN	Y->F: Suppresses STK11/LKB1 activation without affecting complex assembly.	ECO:0000269|PubMed:19892943	19892943
Q7RTN6	STRADA	H231A	Q7RTN6/H231A	STRADA/H231A	MUTAGEN	H->A: Inhibits interaction with STK11/LKB1; when associated with A-.	ECO:0000269|PubMed:19892943	19892943
Q7RTN6	STRADA	F233A	Q7RTN6/F233A	STRADA/F233A	MUTAGEN	F->A: Inhibits interaction with STK11/LKB1; when associated with A-.	ECO:0000269|PubMed:19892943	19892943
Q7RTN6	STRADA	L241A	Q7RTN6/L241A	STRADA/L241A	MUTAGEN	L->A: Inhibits interaction with STK11/LKB1.	ECO:0000269|PubMed:19892943	19892943
Q7RTN6	STRADA	Q251A	Q7RTN6/Q251A	STRADA/Q251A	MUTAGEN	Q->A: Inhibits interaction with STK11/LKB1.	ECO:0000269|PubMed:19892943	19892943
Q7RTN6	STRADA	T329A	Q7RTN6/T329A	STRADA/T329A	MUTAGEN	T->A: Loss of STK11/LKB1-mediated phosphorylation.	ECO:0000269|PubMed:12805220	12805220
Q7RTN6	STRADA	T419A	Q7RTN6/T419A	STRADA/T419A	MUTAGEN	T->A: Loss of STK11/LKB1-mediated phosphorylation.	ECO:0000269|PubMed:12805220	12805220

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q7Z2Y5	NRK	Q355H	Q7Z2Y5/Q355H	NRK/Q355H	VARIANT	Q -> H (in dbSNP:rs55862725)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	V358M	Q7Z2Y5/V358M	NRK/V358M	VARIANT	V -> M (in dbSNP:rs209373)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	S424C	Q7Z2Y5/S424C	NRK/S424C	VARIANT	S -> C (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	P426A	Q7Z2Y5/P426A	NRK/P426A	VARIANT	P -> A (in dbSNP:rs55635933)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	E579G	Q7Z2Y5/E579G	NRK/E579G	VARIANT	E -> G (in dbSNP:rs56350428)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	E679G	Q7Z2Y5/E679G	NRK/E679G	VARIANT	E -> G (in dbSNP:rs35115195)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	R727H	Q7Z2Y5/R727H	NRK/R727H	VARIANT	R -> H (in dbSNP:rs33936206)		
Q7Z2Y5	NRK	I880L	Q7Z2Y5/I880L	NRK/I880L	VARIANT	I -> L (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs764355898)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	D971G	Q7Z2Y5/D971G	NRK/D971G	VARIANT	D -> G (in dbSNP:rs35334892)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	A993E	Q7Z2Y5/A993E	NRK/A993E	VARIANT	A -> E (in dbSNP:rs16984889)		
Q7Z2Y5	NRK	P1106S	Q7Z2Y5/P1106S	NRK/P1106S	VARIANT	P -> S (in dbSNP:rs35393519)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	A1121P	Q7Z2Y5/A1121P	NRK/A1121P	VARIANT	A -> P (in dbSNP:rs35720774)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	H1276L	Q7Z2Y5/H1276L	NRK/H1276L	VARIANT	H -> L (in dbSNP:rs35942881)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	G1471A	Q7Z2Y5/G1471A	NRK/G1471A	VARIANT	G -> A (in dbSNP:rs34232354)	ECO:0000269|PubMed:17344846	17344846
Q7Z2Y5	NRK	M1472L	Q7Z2Y5/M1472L	NRK/M1472L	VARIANT	M -> L (in dbSNP:rs35609510)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q7Z695	ADCK2	S66G	Q7Z695/S66G	ADCK2/S66G	VARIANT	S -> G (in dbSNP:rs2968558)		
Q7Z695	ADCK2	S307P	Q7Z695/S307P	ADCK2/S307P	VARIANT	S -> P (in dbSNP:rs1140034)	ECO:0000269|PubMed:17344846	17344846
Q7Z695	ADCK2	V418L	Q7Z695/V418L	ADCK2/V418L	VARIANT	V -> L (in dbSNP:rs3748092)	ECO:0000269|PubMed:17344846	17344846
Q7Z695	ADCK2	V418M	Q7Z695/V418M	ADCK2/V418M	VARIANT	V -> M (in dbSNP:rs3748092)		
Q7Z695	ADCK2	P622L	Q7Z695/P622L	ADCK2/P622L	VARIANT	P -> L (in dbSNP:rs1046515)	ECO:0000269|PubMed:17344846	17344846
Q7Z695	ADCK2	P626L	Q7Z695/P626L	ADCK2/P626L	VARIANT	P -> L (in dbSNP:rs55922126)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q7Z7A4	PXK	I426V	Q7Z7A4/I426V	PXK/I426V	VARIANT	I -> V (in dbSNP:rs55973253)	ECO:0000269|PubMed:17344846	17344846
Q7Z7A4	PXK	K481R	Q7Z7A4/K481R	PXK/K481R	VARIANT	K -> R (in dbSNP:rs56384862)	ECO:0000269|PubMed:16142408, ECO:0000269|PubMed:17344846	16142408,17344846
Q7Z7A4	PXK	A525V	Q7Z7A4/A525V	PXK/A525V	VARIANT	A -> V (in dbSNP:rs34579268)		
Q7Z7A4	PXK	A535V	Q7Z7A4/A535V	PXK/A535V	VARIANT	A -> V (in dbSNP:rs34579268)		
Q7Z7A4	PXK	R54Q	Q7Z7A4/R54Q	PXK/R54Q	MUTAGEN	R->Q: No effect on subcellular location.	ECO:0000269|PubMed:16142408	16142408
Q7Z7A4	PXK	Y56A	Q7Z7A4/Y56A	PXK/Y56A	MUTAGEN	Y->A: Results in redistribution of protein from cytoplasm throughout entire cell.	ECO:0000269|PubMed:16142408	16142408
Q7Z7A4	PXK	R92L	Q7Z7A4/R92L	PXK/R92L	MUTAGEN	R->L: Results in redistribution of protein from cytoplasm throughout entire cell.	ECO:0000269|PubMed:16142408	16142408

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q86SG6	NEK8	L330F	Q86SG6/L330F	NEK8/L330F	VARIANT	L -> F (in NPHP9; a full-length mouse NEK8 construct containing the mutation shows a defect in ciliary localization with no apparent effect on ciliation, mitosis or centriole number; dbSNP:rs199962228)	ECO:0000269|PubMed:18199800	18199800
Q86SG6	NEK8	H425Y	Q86SG6/H425Y	NEK8/H425Y	VARIANT	H -> Y (in NPHP9; a full-length mouse NEK8 construct containing the mutation shows a defect in ciliary localization with no apparent effect on ciliation, mitosis or centriole number; dbSNP:rs118204032)	ECO:0000269|PubMed:18199800	18199800
Q86SG6	NEK8	A497P	Q86SG6/A497P	NEK8/A497P	VARIANT	A -> P (in NPHP9; a full-length mouse NEK8 construct containing the mutation shows a defect in ciliary localization with no apparent effect on ciliation, mitosis or centriole number; dbSNP:rs146326420)	ECO:0000269|PubMed:18199800	18199800

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q86TB3	ALPK2	K2T	Q86TB3/K2T	ALPK2/K2T	VARIANT	K -> T (in dbSNP:rs6566987)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	A29V	Q86TB3/A29V	ALPK2/A29V	VARIANT	A -> V (in dbSNP:rs138405027)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	R136S	Q86TB3/R136S	ALPK2/R136S	VARIANT	R -> S (in dbSNP:rs9944810)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	A202T	Q86TB3/A202T	ALPK2/A202T	VARIANT	A -> T (in dbSNP:rs115979836)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	S388L	Q86TB3/S388L	ALPK2/S388L	VARIANT	S -> L (in dbSNP:rs147887741)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	T397I	Q86TB3/T397I	ALPK2/T397I	VARIANT	T -> I (in dbSNP:rs79863383)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	A457V	Q86TB3/A457V	ALPK2/A457V	VARIANT	A -> V (in dbSNP:rs199872766)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	H719Q	Q86TB3/H719Q	ALPK2/H719Q	VARIANT	H -> Q (in dbSNP:rs12103986)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:28668886	10021370,14702039,17974005,28668886
Q86TB3	ALPK2	G810S	Q86TB3/G810S	ALPK2/G810S	VARIANT	G -> S (in dbSNP:rs3809970)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:28668886	10021370,14702039,17974005,28668886
Q86TB3	ALPK2	R825T	Q86TB3/R825T	ALPK2/R825T	VARIANT	R -> T (in dbSNP:rs3809972)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:28668886	10021370,14702039,17974005,28668886
Q86TB3	ALPK2	K829N	Q86TB3/K829N	ALPK2/K829N	VARIANT	K -> N (in dbSNP:rs3809973)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	T875P	Q86TB3/T875P	ALPK2/T875P	VARIANT	T -> P (in dbSNP:rs34109891)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	S884L	Q86TB3/S884L	ALPK2/S884L	VARIANT	S -> L (in dbSNP:rs3809974)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	T891I	Q86TB3/T891I	ALPK2/T891I	VARIANT	T -> I (in dbSNP:rs3826593)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:28668886	10021370,14702039,17974005,28668886
Q86TB3	ALPK2	N916K	Q86TB3/N916K	ALPK2/N916K	VARIANT	N -> K (in dbSNP:rs4940404)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:28668886	10021370,14702039,17974005,28668886
Q86TB3	ALPK2	E942K	Q86TB3/E942K	ALPK2/E942K	VARIANT	E -> K (in an ovarian undifferentiated carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q86TB3	ALPK2	A969T	Q86TB3/A969T	ALPK2/A969T	VARIANT	A -> T (in dbSNP:rs371835741)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	S977T	Q86TB3/S977T	ALPK2/S977T	VARIANT	S -> T (in dbSNP:rs3809975)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	L1057V	Q86TB3/L1057V	ALPK2/L1057V	VARIANT	L -> V (in dbSNP:rs3809976)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:28668886	10021370,14702039,17974005,28668886
Q86TB3	ALPK2	G1063V	Q86TB3/G1063V	ALPK2/G1063V	VARIANT	G -> V (in dbSNP:rs34347938)		
Q86TB3	ALPK2	K1134N	Q86TB3/K1134N	ALPK2/K1134N	VARIANT	K -> N (in dbSNP:rs35791514)		
Q86TB3	ALPK2	H1174P	Q86TB3/H1174P	ALPK2/H1174P	VARIANT	H -> P (in dbSNP:rs3809977)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:28668886	10021370,14702039,17974005,28668886
Q86TB3	ALPK2	L1288S	Q86TB3/L1288S	ALPK2/L1288S	VARIANT	L -> S (in dbSNP:rs35882005)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	L1296V	Q86TB3/L1296V	ALPK2/L1296V	VARIANT	L -> V (in dbSNP:rs3809976)		
Q86TB3	ALPK2	P1449S	Q86TB3/P1449S	ALPK2/P1449S	VARIANT	P -> S (in dbSNP:rs3809982)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:28668886	10021370,14702039,17974005,28668886
Q86TB3	ALPK2	K1476T	Q86TB3/K1476T	ALPK2/K1476T	VARIANT	K -> T (in a melanoma metastatic sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q86TB3	ALPK2	A1551S	Q86TB3/A1551S	ALPK2/A1551S	VARIANT	A -> S (in dbSNP:rs3809983)	ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:28668886	17974005,28668886
Q86TB3	ALPK2	Q1579R	Q86TB3/Q1579R	ALPK2/Q1579R	VARIANT	Q -> R (in dbSNP:rs33910491)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	K1729E	Q86TB3/K1729E	ALPK2/K1729E	VARIANT	K -> E (in dbSNP:rs34409558)		
Q86TB3	ALPK2	K1730E	Q86TB3/K1730E	ALPK2/K1730E	VARIANT	K -> E (in dbSNP:rs17065127)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	K1745N	Q86TB3/K1745N	ALPK2/K1745N	VARIANT	K -> N (in dbSNP:rs56206581)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	H1767Y	Q86TB3/H1767Y	ALPK2/H1767Y	VARIANT	H -> Y (in dbSNP:rs7234999)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	Q1853E	Q86TB3/Q1853E	ALPK2/Q1853E	VARIANT	Q -> E (rare variant found in East Asian patients; decreases luminal apoptosis, cell aggregation and basolateral membrane localization in colorectal cancer cells; dbSNP:rs55674018)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	R1884C	Q86TB3/R1884C	ALPK2/R1884C	VARIANT	R -> C (in dbSNP:rs33969768)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	A1919T	Q86TB3/A1919T	ALPK2/A1919T	VARIANT	A -> T (in dbSNP:rs374271622)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	E1969K	Q86TB3/E1969K	ALPK2/E1969K	VARIANT	E -> K (in dbSNP:rs1313881443)		
Q86TB3	ALPK2	A1978T	Q86TB3/A1978T	ALPK2/A1978T	VARIANT	A -> T (in dbSNP:rs146618330)	ECO:0000269|PubMed:28668886	28668886
Q86TB3	ALPK2	I2157V	Q86TB3/I2157V	ALPK2/I2157V	VARIANT	I -> V (in dbSNP:rs7240666)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:28668886	14702039,17974005,28668886

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q86TW2	ADCK1	A164G	Q86TW2/A164G	ADCK1/A164G	MUTAGEN	A->G: No effect on role in maintaining mitochondrial structure and function.	ECO:0000269|PubMed:31125351	31125351
Q86TW2	ADCK1	K183I	Q86TW2/K183I	ADCK1/K183I	MUTAGEN	K->I: No effect on role in maintaining mitochondrial structure and function.	ECO:0000269|PubMed:31125351	31125351
Q86TW2	ADCK1	D315A	Q86TW2/D315A	ADCK1/D315A	MUTAGEN	D->A: No effect on role in maintaining mitochondrial structure and function.	ECO:0000269|PubMed:31125351	31125351

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q86UE8	TLK2	H6R	Q86UE8/H6R	TLK2/H6R	VARIANT	H -> R (in dbSNP:rs45550140)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9427565	17344846,9427565
Q86UE8	TLK2	E54D	Q86UE8/E54D	TLK2/E54D	VARIANT	E -> D	ECO:0000269|PubMed:17344846	17344846
Q86UE8	TLK2	A95G	Q86UE8/A95G	TLK2/A95G	VARIANT	A -> G (in dbSNP:rs2598147)	ECO:0000269|PubMed:17344846	17344846
Q86UE8	TLK2	A108G	Q86UE8/A108G	TLK2/A108G	VARIANT	A -> G	ECO:0000269|PubMed:17344846	17344846
Q86UE8	TLK2	R109L	Q86UE8/R109L	TLK2/R109L	VARIANT	R -> L (in dbSNP:rs1555617262)	ECO:0000269|PubMed:17344846	17344846
Q86UE8	TLK2	F173L	Q86UE8/F173L	TLK2/F173L	VARIANT	F -> L (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1331331651)	ECO:0000269|PubMed:17344846	17344846
Q86UE8	TLK2	R262Q	Q86UE8/R262Q	TLK2/R262Q	VARIANT	R -> Q (in dbSNP:rs762409144)	ECO:0000269|PubMed:17344846	17344846
Q86UE8	TLK2	G297D	Q86UE8/G297D	TLK2/G297D	VARIANT	G -> D (in MRD57; unknown pathological significance; dbSNP:rs1555639254)	ECO:0000269|PubMed:29861108	29861108
Q86UE8	TLK2	R339Q	Q86UE8/R339Q	TLK2/R339Q	VARIANT	R -> Q (in MRD57; unknown pathological significance; dbSNP:rs1567948287)	ECO:0000269|PubMed:29861108	29861108
Q86UE8	TLK2	R339W	Q86UE8/R339W	TLK2/R339W	VARIANT	R -> W (in MRD57; unknown pathological significance; dbSNP:rs1567948262)	ECO:0000269|PubMed:29861108	29861108
Q86UE8	TLK2	E447K	Q86UE8/E447K	TLK2/E447K	VARIANT	E -> K (in MRD57; unknown pathological significance; dbSNP:rs1567959483)	ECO:0000269|PubMed:29861108	29861108
Q86UE8	TLK2	H493R	Q86UE8/H493R	TLK2/H493R	VARIANT	H -> R (in MRD57; reduced kinase activity; dbSNP:rs1567974030)	ECO:0000269|PubMed:29861108, ECO:0000269|PubMed:29955062	29861108,29955062
Q86UE8	TLK2	H518R	Q86UE8/H518R	TLK2/H518R	VARIANT	H -> R (in MRD57; severely reduced kinase activity; dbSNP:rs1567995650)	ECO:0000269|PubMed:29861108, ECO:0000269|PubMed:29955062	29861108,29955062
Q86UE8	TLK2	D551G	Q86UE8/D551G	TLK2/D551G	VARIANT	D -> G (in MRD57; unknown pathological significance; exhibits abnormal perinuclear localization instead of diffuse nuclear localization; mildly impairs kinase activity; reduced phosphorylation of ASF1A; dbSNP:rs2082811958)	ECO:0000269|PubMed:33323470	33323470
Q86UE8	TLK2	R568W	Q86UE8/R568W	TLK2/R568W	VARIANT	R -> W (in MRD57; dbSNP:rs1283838287)	ECO:0000269|PubMed:29861108	29861108
Q86UE8	TLK2	S617L	Q86UE8/S617L	TLK2/S617L	VARIANT	S -> L (in MRD57; exhibits abnormal perinuclear localization instead of diffuse nuclear localization; impairs kinase activity; reduced phosphorylation of ASF1A; dbSNP:rs2082914686)	ECO:0000269|PubMed:21572417, ECO:0000269|PubMed:33323470	21572417,33323470
Q86UE8	TLK2	D629N	Q86UE8/D629N	TLK2/D629N	VARIANT	D -> N (in MRD57; reduced phosphorylation of ASF1A; dbSNP:rs1568006217)	ECO:0000269|PubMed:29861108, ECO:0000269|PubMed:29955062	29861108,29955062
Q86UE8	TLK2	P680R	Q86UE8/P680R	TLK2/P680R	VARIANT	P -> R (in MRD57; dbSNP:rs1568018905)	ECO:0000269|PubMed:29861108	29861108
Q86UE8	TLK2	H518N	Q86UE8/H518N	TLK2/H518N	MUTAGEN	H->N: Reduced kinase activity.	ECO:0000269|PubMed:29955062	29955062
Q86UE8	TLK2	D592V	Q86UE8/D592V	TLK2/D592V	MUTAGEN	D->V: Loss of kinase activity. No impact on interaction with ASF1A.	ECO:0000269|PubMed:33323470, ECO:0000269|PubMed:35136069	33323470,35136069
Q86UE8	TLK2	D613A	Q86UE8/D613A	TLK2/D613A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:11470414, ECO:0000269|PubMed:29955062	10523312,11470414,29955062
Q86UE8	TLK2	S617A	Q86UE8/S617A	TLK2/S617A	MUTAGEN	S->A: Increase in autophosphorylation.	ECO:0000269|PubMed:29955062	29955062
Q86UE8	TLK2	S617D	Q86UE8/S617D	TLK2/S617D	MUTAGEN	S->D: Loss of kinase activity.	ECO:0000269|PubMed:29955062	29955062
Q86UE8	TLK2	S659A	Q86UE8/S659A	TLK2/S659A	MUTAGEN	S->A: Reduced kinase activity.	ECO:0000269|PubMed:29955062	29955062
Q86UE8	TLK2	S686A	Q86UE8/S686A	TLK2/S686A	MUTAGEN	S->A: Reduced kinase activity.	ECO:0000269|PubMed:29955062	29955062
Q86UE8	TLK2	S686D	Q86UE8/S686D	TLK2/S686D	MUTAGEN	S->D: Reduced kinase activity.	ECO:0000269|PubMed:29955062	29955062
Q86UE8	TLK2	T695A	Q86UE8/T695A	TLK2/T695A	MUTAGEN	T->A: Reduced kinase activity.	ECO:0000269|PubMed:29955062	29955062
Q86UE8	TLK2	R720A	Q86UE8/R720A	TLK2/R720A	MUTAGEN	R->A: Reduced phosphorylation of ASF1A.	ECO:0000269|PubMed:29955062	29955062

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q86UX6	STK32C	V151L	Q86UX6/V151L	STK32C/V151L	VARIANT	V -> L (found in a patient with global developmental delay; unknown pathological significance)	ECO:0000269|PubMed:28940097	28940097
Q86UX6	STK32C	T334A	Q86UX6/T334A	STK32C/T334A	VARIANT	T -> A (in dbSNP:rs17854384)	ECO:0000269|PubMed:15489334	15489334
Q86UX6	STK32C	R376H	Q86UX6/R376H	STK32C/R376H	VARIANT	R -> H (in a colorectal cancer sample; somatic mutation; dbSNP:rs764558009)	ECO:0000269|PubMed:16959974	16959974
Q86UX6	STK32C	A454T	Q86UX6/A454T	STK32C/A454T	VARIANT	A -> T (in dbSNP:rs56109103)	ECO:0000269|PubMed:17344846	17344846
Q86UX6	STK32C	E467K	Q86UX6/E467K	STK32C/E467K	VARIANT	E -> K (in dbSNP:rs55812591)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q86Y07	VRK2	N50D	Q86Y07/N50D	VRK2/N50D	VARIANT	N -> D (in dbSNP:rs34130684)	ECO:0000269|PubMed:17344846	17344846
Q86Y07	VRK2	I157M	Q86Y07/I157M	VRK2/I157M	VARIANT	I -> M (in dbSNP:rs35966666)	ECO:0000269|PubMed:17344846	17344846
Q86Y07	VRK2	I167V	Q86Y07/I167V	VRK2/I167V	VARIANT	I -> V (in dbSNP:rs1051061)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16704422, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9344656	15489334,16704422,17344846,9344656
Q86Y07	VRK2	N211S	Q86Y07/N211S	VRK2/N211S	VARIANT	N -> S (in dbSNP:rs36081172)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q86YV5	PRAG1	L122I	Q86YV5/L122I	PRAG1/L122I	VARIANT	L -> I (in dbSNP:rs55764617)	ECO:0000269|PubMed:17344846	17344846
Q86YV5	PRAG1	R137G	Q86YV5/R137G	PRAG1/R137G	VARIANT	R -> G (in dbSNP:rs56290960)	ECO:0000269|PubMed:17344846	17344846
Q86YV5	PRAG1	V139I	Q86YV5/V139I	PRAG1/V139I	VARIANT	V -> I (in dbSNP:rs34346032)	ECO:0000269|PubMed:17344846	17344846
Q86YV5	PRAG1	R404Q	Q86YV5/R404Q	PRAG1/R404Q	VARIANT	R -> Q (in dbSNP:rs3896980)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.2	17344846
Q86YV5	PRAG1	P569L	Q86YV5/P569L	PRAG1/P569L	VARIANT	P -> L (in dbSNP:rs4840955)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.2	17344846
Q86YV5	PRAG1	S578C	Q86YV5/S578C	PRAG1/S578C	VARIANT	S -> C (in dbSNP:rs4840953)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.2	17344846
Q86YV5	PRAG1	P595A	Q86YV5/P595A	PRAG1/P595A	VARIANT	P -> A (in dbSNP:rs55994745)	ECO:0000269|PubMed:17344846	17344846
Q86YV5	PRAG1	P662T	Q86YV5/P662T	PRAG1/P662T	VARIANT	P -> T (in dbSNP:rs56351643)	ECO:0000269|PubMed:17344846	17344846
Q86YV5	PRAG1	P814L	Q86YV5/P814L	PRAG1/P814L	VARIANT	P -> L (in dbSNP:rs56207906)	ECO:0000269|PubMed:17344846	17344846
Q86YV5	PRAG1	H851R	Q86YV5/H851R	PRAG1/H851R	VARIANT	H -> R (in dbSNP:rs56215812)	ECO:0000269|PubMed:17344846	17344846
Q86YV5	PRAG1	S1003L	Q86YV5/S1003L	PRAG1/S1003L	VARIANT	S -> L (in dbSNP:rs56289289)	ECO:0000269|PubMed:17344846	17344846
Q86YV5	PRAG1	V1041M	Q86YV5/V1041M	PRAG1/V1041M	VARIANT	V -> M (in dbSNP:rs28533138)	ECO:0000269|PubMed:17344846	17344846
Q86YV5	PRAG1	A1113T	Q86YV5/A1113T	PRAG1/A1113T	VARIANT	A -> T (in dbSNP:rs12549973)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17974005, ECO:0000269|Ref.2	17344846,17974005
Q86YV5	PRAG1	R1315H	Q86YV5/R1315H	PRAG1/R1315H	VARIANT	R -> H (in dbSNP:rs1314830862)	ECO:0000269|PubMed:17344846	17344846
Q86YV5	PRAG1	L955A	Q86YV5/L955A	PRAG1/L955A	MUTAGEN	L->A: Decreases homodimerization. Abolished interaction with PEAK1. No effect on cell migration.	ECO:0000269|PubMed:29079850	29079850
Q86YV5	PRAG1	L966A	Q86YV5/L966A	PRAG1/L966A	MUTAGEN	L->A: Decreases homodimerization. Abolished interaction with PEAK1. Decreases cell migration.	ECO:0000269|PubMed:29079850	29079850
Q86YV5	PRAG1	I1243A	Q86YV5/I1243A	PRAG1/I1243A	MUTAGEN	I->A: No effect on homodimerization. Decreases oligomerization. Decreases interaction with PEAK1.	ECO:0000269|PubMed:29079850	29079850
Q86YV5	PRAG1	F1271A	Q86YV5/F1271A	PRAG1/F1271A	MUTAGEN	F->A: Decreases homodimerization. Decreases interaction with PEAK1.	ECO:0000269|PubMed:29079850	29079850
Q86YV5	PRAG1	R1278A	Q86YV5/R1278A	PRAG1/R1278A	MUTAGEN	R->A: Decreases homodimerization.	ECO:0000269|PubMed:29079850	29079850
Q86YV5	PRAG1	Y1282A	Q86YV5/Y1282A	PRAG1/Y1282A	MUTAGEN	Y->A: No effect on homodimerization. Decreases oligomerization. Decreases interaction with PEAK1. No effect on cell migration.	ECO:0000269|PubMed:29079850	29079850
Q86YV5	PRAG1	F1366A	Q86YV5/F1366A	PRAG1/F1366A	MUTAGEN	F->A: Decreases homodimerization. Abolished interaction with PEAK1. Decreases cell migration.	ECO:0000269|PubMed:29079850	29079850
Q86YV5	PRAG1	W1382A	Q86YV5/W1382A	PRAG1/W1382A	MUTAGEN	W->A: Decreases homodimerization. Abolished interaction with PEAK1. Decreases cell migration.	ECO:0000269|PubMed:29079850	29079850

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q86Z02	HIPK1	Q6R	Q86Z02/Q6R	HIPK1/Q6R	VARIANT	Q -> R (in dbSNP:rs35324789)		
Q86Z02	HIPK1	G310C	Q86Z02/G310C	HIPK1/G310C	VARIANT	G -> C (in dbSNP:rs34335651)	ECO:0000269|PubMed:17344846	17344846
Q86Z02	HIPK1	L1165V	Q86Z02/L1165V	HIPK1/L1165V	VARIANT	L -> V	ECO:0000269|PubMed:17344846	17344846
Q86Z02	HIPK1	K25R	Q86Z02/K25R	HIPK1/K25R	MUTAGEN	K->R: Reduced sumoylation and cytoplasmic subcellular location. Impaired sumoylation and cytoplasmic subcellular location; when associated with R-317; R-440; R-556 and R-1203.	ECO:0000269|PubMed:15701637	15701637
Q86Z02	HIPK1	K219A	Q86Z02/K219A	HIPK1/K219A	MUTAGEN	K->A: Loss of kinase activity.	ECO:0000269|PubMed:19646965	19646965
Q86Z02	HIPK1	D315N	Q86Z02/D315N	HIPK1/D315N	MUTAGEN			
Q86Z02	HIPK1	K317R	Q86Z02/K317R	HIPK1/K317R	MUTAGEN	K->R: Nuclear subcellular location. Impaired sumoylation and cytoplasmic subcellular location; when associated with R-25; R-440; R-556 and R-1203.	ECO:0000269|PubMed:15701637	15701637
Q86Z02	HIPK1	K440R	Q86Z02/K440R	HIPK1/K440R	MUTAGEN	K->R: Nuclear subcellular location. Impaired sumoylation and cytoplasmic subcellular location; when associated with R-25; R-317; R-556 and R-1203.	ECO:0000269|PubMed:15701637	15701637
Q86Z02	HIPK1	K556R	Q86Z02/K556R	HIPK1/K556R	MUTAGEN	K->R: Nuclear subcellular location. Impaired sumoylation and cytoplasmic subcellular location; when associated with R-25; R-317; R-440 and R-1203.	ECO:0000269|PubMed:15701637	15701637
Q86Z02	HIPK1	K1203R	Q86Z02/K1203R	HIPK1/K1203R	MUTAGEN	K->R: Nuclear subcellular location. Impaired sumoylation and cytoplasmic subcellular location; when associated with R-25; R-317; R-440 and R-556.	ECO:0000269|PubMed:15701637	15701637

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IU85	CAMK1D	I66M	Q8IU85/I66M	CAMK1D/I66M	VARIANT	I -> M (in dbSNP:rs34194224)	ECO:0000269|PubMed:17344846	17344846
Q8IU85	CAMK1D	K52A	Q8IU85/K52A	CAMK1D/K52A	MUTAGEN	K->A: Catalytically inactive form.	ECO:0000269|PubMed:16324104	16324104
Q8IU85	CAMK1D	T180A	Q8IU85/T180A	CAMK1D/T180A	MUTAGEN	T->A: Loss of ionomycin-induced activation.	ECO:0000269|PubMed:12935886, ECO:0000269|PubMed:16324104	12935886,16324104

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IV63	VRK3	S59F	Q8IV63/S59F	VRK3/S59F	VARIANT	S -> F (in dbSNP:rs2033262)	ECO:0000269|PubMed:17344846	17344846
Q8IV63	VRK3	P105T	Q8IV63/P105T	VRK3/P105T	VARIANT	P -> T (in dbSNP:rs11547882)	ECO:0000269|PubMed:17344846	17344846
Q8IV63	VRK3	S170P	Q8IV63/S170P	VRK3/S170P	VARIANT	S -> P (in dbSNP:rs11547881)		
Q8IV63	VRK3	F171L	Q8IV63/F171L	VRK3/F171L	VARIANT	F -> L (in dbSNP:rs11547883)	ECO:0000269|PubMed:17344846	17344846
Q8IV63	VRK3	T188A	Q8IV63/T188A	VRK3/T188A	VARIANT	T -> A (in dbSNP:rs11879620)		
Q8IV63	VRK3	S268L	Q8IV63/S268L	VRK3/S268L	VARIANT	S -> L (in dbSNP:rs10410075)	ECO:0000269|PubMed:17344846	17344846
Q8IV63	VRK3	C288Y	Q8IV63/C288Y	VRK3/C288Y	VARIANT	C -> Y (in dbSNP:rs10409482)	ECO:0000269|PubMed:17344846	17344846
Q8IV63	VRK3	H304L	Q8IV63/H304L	VRK3/H304L	VARIANT	H -> L (in dbSNP:rs35261919)		
Q8IV63	VRK3	R370C	Q8IV63/R370C	VRK3/R370C	VARIANT	R -> C (in dbSNP:rs35331034)	ECO:0000269|PubMed:17344846	17344846
Q8IV63	VRK3	S371G	Q8IV63/S371G	VRK3/S371G	VARIANT	S -> G (in dbSNP:rs56407496)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IVH8	MAP4K3	V200L	Q8IVH8/V200L	MAP4K3/V200L	VARIANT	V -> L (in dbSNP:rs35957290)	ECO:0000269|PubMed:17344846	17344846
Q8IVH8	MAP4K3	H424Q	Q8IVH8/H424Q	MAP4K3/H424Q	VARIANT	H -> Q (in dbSNP:rs56317466)	ECO:0000269|PubMed:17344846	17344846
Q8IVH8	MAP4K3	T669S	Q8IVH8/T669S	MAP4K3/T669S	VARIANT	T -> S (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8IVH8	MAP4K3	K45E	Q8IVH8/K45E	MAP4K3/K45E	MUTAGEN	K->E: Loss of kinase activity and ability to activate JNK family.	ECO:0000269|PubMed:9275185	9275185

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IVT5	KSR1	S227P	Q8IVT5/S227P	KSR1/S227P	VARIANT	S -> P	ECO:0000269|PubMed:17344846	17344846
Q8IVT5	KSR1	V359A	Q8IVT5/V359A	KSR1/V359A	VARIANT	V -> A	ECO:0000269|PubMed:17344846	17344846
Q8IVT5	KSR1	Q663H	Q8IVT5/Q663H	KSR1/Q663H	VARIANT	Q -> H	ECO:0000269|PubMed:17344846	17344846
Q8IVT5	KSR1	L47D	Q8IVT5/L47D	KSR1/L47D	MUTAGEN	L->D: Reduces interaction with BRAF and MAP2K1 and thus phosphorylation of MAP2K1.	ECO:0000269|PubMed:29433126	29433126
Q8IVT5	KSR1	C62D	Q8IVT5/C62D	KSR1/C62D	MUTAGEN	C->D: Reduces interaction with BRAF and MAP2K1 and thus phosphorylation of MAP2K1.	ECO:0000269|PubMed:29433126	29433126
Q8IVT5	KSR1	E72K	Q8IVT5/E72K	KSR1/E72K	MUTAGEN	E->K: Loss of interaction with BRAF and MAP2K1 and severe decrease in MAP2K1 phosphorylation levels.	ECO:0000269|PubMed:29433126	29433126
Q8IVT5	KSR1	A637F	Q8IVT5/A637F	KSR1/A637F	MUTAGEN	A->F: No effect on MAP2K1 or MAP2K2 mediated-BRAF-KSR1 dimerization and BRAF activation.	ECO:0000269|PubMed:29433126	29433126
Q8IVT5	KSR1	R639M	Q8IVT5/R639M	KSR1/R639M	MUTAGEN	R->M: No effect on MAP2K1 mediated-BRAF-KSR1 dimerization and BRAF activation.	ECO:0000269|PubMed:29433126	29433126
Q8IVT5	KSR1	R665H	Q8IVT5/R665H	KSR1/R665H	MUTAGEN	R->H: Loss of MAP2K1 mediated-BRAF-KSR1 dimerization.	ECO:0000269|PubMed:29433126	29433126
Q8IVT5	KSR1	W831R	Q8IVT5/W831R	KSR1/W831R	MUTAGEN	W->R: Loss of the interaction with MAP2K1 resulting in loss of BRAF-KSR1 dimerization and BRAF activation. No effect on ATP binding or interaction with HSP90AA1, 14-3-3 and CDC37.	ECO:0000269|PubMed:29433126	29433126

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IVW4	CDKL3	M394T	Q8IVW4/M394T	CDKL3/M394T	VARIANT	M -> T (in dbSNP:rs35687772)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IW41	MAPKAPK5	M67I	Q8IW41/M67I	MAPKAPK5/M67I	VARIANT	M -> I (in dbSNP:rs34132040)	ECO:0000269|PubMed:17344846	17344846
Q8IW41	MAPKAPK5	R282K	Q8IW41/R282K	MAPKAPK5/R282K	VARIANT	R -> K (in dbSNP:rs34843470)	ECO:0000269|PubMed:17344846	17344846
Q8IW41	MAPKAPK5	K51M	Q8IW41/K51M	MAPKAPK5/K51M	MUTAGEN	K->M: Kinase defective mutant, abolishes activity.	ECO:0000269|PubMed:12808055	12808055
Q8IW41	MAPKAPK5	T182A	Q8IW41/T182A	MAPKAPK5/T182A	MUTAGEN	T->A: No p38-beta/MAPK11-induced activation.	ECO:0000269|PubMed:12808055, ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:9628874	12808055,21329882,9628874
Q8IW41	MAPKAPK5	T182D	Q8IW41/T182D	MAPKAPK5/T182D	MUTAGEN	T->D: Mimicks phosphorylation state and induces constitutive protein kinase activity.	ECO:0000269|PubMed:12808055, ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:9628874	12808055,21329882,9628874
Q8IW41	MAPKAPK5	S212D	Q8IW41/S212D	MAPKAPK5/S212D	MUTAGEN	S->D: Mimicks phosphorylation state and displays a slightly higher protein kinase activity.	ECO:0000269|PubMed:12808055	12808055
Q8IW41	MAPKAPK5	L337G	Q8IW41/L337G	MAPKAPK5/L337G	MUTAGEN	L->G: Induces constitutive protein kinase activity.	ECO:0000269|PubMed:21329882	21329882

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IWB6	TEX14	D88G	Q8IWB6/D88G	TEX14/D88G	VARIANT	D -> G (in dbSNP:rs56292204)	ECO:0000269|PubMed:17344846	17344846
Q8IWB6	TEX14	K321E	Q8IWB6/K321E	TEX14/K321E	VARIANT	K -> E (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8IWB6	TEX14	S443C	Q8IWB6/S443C	TEX14/S443C	VARIANT	S -> C	ECO:0000269|PubMed:17344846	17344846
Q8IWB6	TEX14	I559M	Q8IWB6/I559M	TEX14/I559M	VARIANT	I -> M	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IWQ3	BRSK2	K48M	Q8IWQ3/K48M	BRSK2/K48M	MUTAGEN	K->M: Loss of catalytic activity. Causes disintegration of actin stress fibers.	ECO:0000269|PubMed:22669945, ECO:0000269|PubMed:22798068	22669945,22798068
Q8IWQ3	BRSK2	T174A	Q8IWQ3/T174A	BRSK2/T174A	MUTAGEN			
Q8IWQ3	BRSK2	T174E	Q8IWQ3/T174E	BRSK2/T174E	MUTAGEN	T->E: Constitutively activated.	ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:18339622, ECO:0000269|PubMed:22798068	14976552,18339622,22798068
Q8IWQ3	BRSK2	T260A	Q8IWQ3/T260A	BRSK2/T260A	MUTAGEN	T->A: Decreased phosphorylation. Nearly abolishes stimulation of insulin secretion.	ECO:0000269|PubMed:16870137, ECO:0000269|PubMed:22669945	16870137,22669945
Q8IWQ3	BRSK2	G310A	Q8IWQ3/G310A	BRSK2/G310A	MUTAGEN	G->A: Decreased activation of kinase activity.	ECO:0000269|PubMed:18339622	18339622
Q8IWQ3	BRSK2	T443A	Q8IWQ3/T443A	BRSK2/T443A	MUTAGEN	T->A: Constitutively activated. Promotes formation of actin stress fibers.	ECO:0000269|PubMed:22669945	22669945

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IWU2	LMTK2	P30A	Q8IWU2/P30A	LMTK2/P30A	VARIANT	P -> A (in dbSNP:rs3735252)		
Q8IWU2	LMTK2	D484H	Q8IWU2/D484H	LMTK2/D484H	VARIANT	D -> H (in a lung large cell carcinoma sample; somatic mutation; dbSNP:rs147940573)	ECO:0000269|PubMed:17344846	17344846
Q8IWU2	LMTK2	V595I	Q8IWU2/V595I	LMTK2/V595I	VARIANT	V -> I (in dbSNP:rs34461195)	ECO:0000269|PubMed:17344846	17344846
Q8IWU2	LMTK2	V624M	Q8IWU2/V624M	LMTK2/V624M	VARIANT	V -> M (in dbSNP:rs34628253)	ECO:0000269|PubMed:17344846	17344846
Q8IWU2	LMTK2	I693T	Q8IWU2/I693T	LMTK2/I693T	VARIANT	I -> T (in dbSNP:rs56204700)	ECO:0000269|PubMed:17344846	17344846
Q8IWU2	LMTK2	L780M	Q8IWU2/L780M	LMTK2/L780M	VARIANT	L -> M (in dbSNP:rs11765552)	ECO:0000269|PubMed:10470851, ECO:0000269|PubMed:17344846	10470851,17344846
Q8IWU2	LMTK2	V849F	Q8IWU2/V849F	LMTK2/V849F	VARIANT	V -> F (in dbSNP:rs56196840)	ECO:0000269|PubMed:17344846	17344846
Q8IWU2	LMTK2	A862T	Q8IWU2/A862T	LMTK2/A862T	VARIANT	A -> T (in dbSNP:rs34005293)	ECO:0000269|PubMed:17344846	17344846
Q8IWU2	LMTK2	S916R	Q8IWU2/S916R	LMTK2/S916R	VARIANT	S -> R (in dbSNP:rs55867257)	ECO:0000269|PubMed:17344846	17344846
Q8IWU2	LMTK2	D1061N	Q8IWU2/D1061N	LMTK2/D1061N	VARIANT	D -> N (in dbSNP:rs3801295)	ECO:0000269|PubMed:17344846	17344846
Q8IWU2	LMTK2	D1220N	Q8IWU2/D1220N	LMTK2/D1220N	VARIANT	D -> N (in dbSNP:rs35912712)	ECO:0000269|PubMed:17344846	17344846
Q8IWU2	LMTK2	A1341G	Q8IWU2/A1341G	LMTK2/A1341G	VARIANT	A -> G (in dbSNP:rs56343792)	ECO:0000269|PubMed:17344846	17344846
Q8IWU2	LMTK2	S1401N	Q8IWU2/S1401N	LMTK2/S1401N	VARIANT	S -> N (in dbSNP:rs45488394)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IY84	NIM1K	R21W	Q8IY84/R21W	NIM1K/R21W	VARIANT	R -> W (in dbSNP:rs55664335)	ECO:0000269|PubMed:17344846	17344846
Q8IY84	NIM1K	E64Q	Q8IY84/E64Q	NIM1K/E64Q	VARIANT	E -> Q (in dbSNP:rs55663207)	ECO:0000269|PubMed:17344846	17344846
Q8IY84	NIM1K	L260I	Q8IY84/L260I	NIM1K/L260I	VARIANT	L -> I (in dbSNP:rs35659008)	ECO:0000269|PubMed:17344846	17344846
Q8IY84	NIM1K	M320I	Q8IY84/M320I	NIM1K/M320I	VARIANT	M -> I (in dbSNP:rs55770078)	ECO:0000269|PubMed:17344846	17344846
Q8IY84	NIM1K	P333S	Q8IY84/P333S	NIM1K/P333S	VARIANT	P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs866026698)	ECO:0000269|PubMed:17344846	17344846
Q8IY84	NIM1K	P411T	Q8IY84/P411T	NIM1K/P411T	VARIANT	P -> T (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8IY84	NIM1K	T229A	Q8IY84/T229A	NIM1K/T229A	MUTAGEN	T->A: Loss of autophosphorylation and kinase activity.	ECO:0000269|PubMed:15733851	15733851
Q8IY84	NIM1K	T229E	Q8IY84/T229E	NIM1K/T229E	MUTAGEN	T->E: Constitutively active.	ECO:0000269|PubMed:15733851	15733851

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IYT8	ULK2	P242S	Q8IYT8/P242S	ULK2/P242S	VARIANT	P -> S (in dbSNP:rs34670978)	ECO:0000269|PubMed:17344846	17344846
Q8IYT8	ULK2	V370M	Q8IYT8/V370M	ULK2/V370M	VARIANT	V -> M (in dbSNP:rs150122)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9734811	15489334,9734811
Q8IYT8	ULK2	T533I	Q8IYT8/T533I	ULK2/T533I	VARIANT	T -> I (in dbSNP:rs4462660)		
Q8IYT8	ULK2	G627E	Q8IYT8/G627E	ULK2/G627E	VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8IYT8	ULK2	A662V	Q8IYT8/A662V	ULK2/A662V	VARIANT	A -> V (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8IYT8	ULK2	G752R	Q8IYT8/G752R	ULK2/G752R	VARIANT	G -> R (in dbSNP:rs55730189)	ECO:0000269|PubMed:17344846	17344846
Q8IYT8	ULK2	D842E	Q8IYT8/D842E	ULK2/D842E	VARIANT	D -> E (in dbSNP:rs35107651)	ECO:0000269|PubMed:17344846	17344846
Q8IYT8	ULK2	K39R	Q8IYT8/K39R	ULK2/K39R	MUTAGEN	K->R: Decreased kinase activity and decreased autophosphorylation.	ECO:0000269|PubMed:18936157	18936157

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IZE3	SCYL3	G597A	Q8IZE3/G597A	SCYL3/G597A	VARIANT	G -> A (in dbSNP:rs12143301)	ECO:0000269|PubMed:15489334	15489334
Q8IZE3	SCYL3	Q621R	Q8IZE3/Q621R	SCYL3/Q621R	VARIANT	Q -> R (in dbSNP:rs4656197)	ECO:0000269|PubMed:12651155, ECO:0000269|PubMed:14702039, ECO:0000269|Ref.5	12651155,14702039

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IZL9	CDK20	S86L	Q8IZL9/S86L	CDK20/S86L	VARIANT	S -> L (in dbSNP:rs28364953)	ECO:0000269|Ref.4	
Q8IZL9	CDK20	S106N	Q8IZL9/S106N	CDK20/S106N	VARIANT	S -> N (in dbSNP:rs41286029)	ECO:0000269|PubMed:17344846	17344846
Q8IZL9	CDK20	A137T	Q8IZL9/A137T	CDK20/A137T	VARIANT	A -> T (in dbSNP:rs28364955)	ECO:0000269|Ref.4	
Q8IZL9	CDK20	K281R	Q8IZL9/K281R	CDK20/K281R	VARIANT	K -> R (in dbSNP:rs28364963)	ECO:0000269|Ref.4	
Q8IZL9	CDK20	T161A	Q8IZL9/T161A	CDK20/T161A	MUTAGEN	T->A: Impairs CDK2 T-160 phosphorylation and activity.	ECO:0000269|PubMed:14597612	14597612

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8IZX4	TAF1L	G47A	Q8IZX4/G47A	TAF1L/G47A	VARIANT	G -> A (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	Q171E	Q8IZX4/Q171E	TAF1L/Q171E	VARIANT	Q -> E (in dbSNP:rs56352331)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	G256A	Q8IZX4/G256A	TAF1L/G256A	VARIANT	G -> A (in dbSNP:rs55991718)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	M371V	Q8IZX4/M371V	TAF1L/M371V	VARIANT	M -> V (in dbSNP:rs17219559)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	I532N	Q8IZX4/I532N	TAF1L/I532N	VARIANT	I -> N (in dbSNP:rs56128445)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	P637S	Q8IZX4/P637S	TAF1L/P637S	VARIANT	P -> S (in dbSNP:rs56157814)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	L750F	Q8IZX4/L750F	TAF1L/L750F	VARIANT	L -> F (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	L762I	Q8IZX4/L762I	TAF1L/L762I	VARIANT	L -> I (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	E794D	Q8IZX4/E794D	TAF1L/E794D	VARIANT	E -> D (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	R845Q	Q8IZX4/R845Q	TAF1L/R845Q	VARIANT	R -> Q (in dbSNP:rs34787787)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	R1016C	Q8IZX4/R1016C	TAF1L/R1016C	VARIANT	R -> C (in dbSNP:rs35905429)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	K1038N	Q8IZX4/K1038N	TAF1L/K1038N	VARIANT	K -> N (in dbSNP:rs55767137)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	T1169I	Q8IZX4/T1169I	TAF1L/T1169I	VARIANT	T -> I (in dbSNP:rs55976674)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	V1312L	Q8IZX4/V1312L	TAF1L/V1312L	VARIANT	V -> L (in dbSNP:rs55824107)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	R1356C	Q8IZX4/R1356C	TAF1L/R1356C	VARIANT	R -> C (in dbSNP:rs56107531)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	P1389S	Q8IZX4/P1389S	TAF1L/P1389S	VARIANT	P -> S (in dbSNP:rs56393725)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	I1411V	Q8IZX4/I1411V	TAF1L/I1411V	VARIANT	I -> V (in dbSNP:rs34500740)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	A1540T	Q8IZX4/A1540T	TAF1L/A1540T	VARIANT	A -> T (in dbSNP:rs55782058)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	H1549Y	Q8IZX4/H1549Y	TAF1L/H1549Y	VARIANT	H -> Y (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs1587670372)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	K1731N	Q8IZX4/K1731N	TAF1L/K1731N	VARIANT	K -> N (in dbSNP:rs34241003)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	I1805V	Q8IZX4/I1805V	TAF1L/I1805V	VARIANT	I -> V (in dbSNP:rs16918393)		
Q8IZX4	TAF1L	P1810L	Q8IZX4/P1810L	TAF1L/P1810L	VARIANT	P -> L (in dbSNP:rs56342342)	ECO:0000269|PubMed:17344846	17344846
Q8IZX4	TAF1L	H1824Q	Q8IZX4/H1824Q	TAF1L/H1824Q	VARIANT	H -> Q (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8N2I9	STK40	A10V	Q8N2I9/A10V	STK40/A10V	VARIANT	A -> V (in dbSNP:rs56314546)	ECO:0000269|PubMed:17344846	17344846
Q8N2I9	STK40	M133T	Q8N2I9/M133T	STK40/M133T	VARIANT	M -> T (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs755089893)	ECO:0000269|PubMed:17344846	17344846
Q8N2I9	STK40	R211Q	Q8N2I9/R211Q	STK40/R211Q	VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs539738963)	ECO:0000269|PubMed:17344846	17344846
Q8N2I9	STK40	A395T	Q8N2I9/A395T	STK40/A395T	VARIANT	A -> T (in dbSNP:rs3795498)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	14702039,15489334,17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8N4C8	MINK1	A514T	Q8N4C8/A514T	MINK1/A514T	VARIANT	A -> T (in dbSNP:rs56131206)	ECO:0000269|PubMed:17344846	17344846
Q8N4C8	MINK1	V771A	Q8N4C8/V771A	MINK1/V771A	VARIANT	V -> A (in dbSNP:rs11556634)	ECO:0000269|PubMed:15469942, ECO:0000269|PubMed:15489334	15469942,15489334
Q8N4C8	MINK1	P775L	Q8N4C8/P775L	MINK1/P775L	VARIANT	P -> L (in dbSNP:rs11556635)	ECO:0000269|PubMed:15469942, ECO:0000269|PubMed:15489334, ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163	15469942,15489334,18669648,18691976,19369195,19413330,19690332,23186163
Q8N4C8	MINK1	V863I	Q8N4C8/V863I	MINK1/V863I	VARIANT	V -> I (in dbSNP:rs2302319)	ECO:0000269|PubMed:17344846	17344846
Q8N4C8	MINK1	E1010V	Q8N4C8/E1010V	MINK1/E1010V	VARIANT	E -> V (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8N4C8	MINK1	I1200V	Q8N4C8/I1200V	MINK1/I1200V	VARIANT	I -> V	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8N568	DCLK2	G119C	Q8N568/G119C	DCLK2/G119C	VARIANT	G -> C (in dbSNP:rs56327537)	ECO:0000269|PubMed:17344846	17344846
Q8N568	DCLK2	V212M	Q8N568/V212M	DCLK2/V212M	VARIANT	V -> M (found in a patient with hereditary motor and sensory neuropathy; unknown pathological significance; dbSNP:rs759398144)	ECO:0000269|PubMed:25512093	25512093
Q8N568	DCLK2	R372H	Q8N568/R372H	DCLK2/R372H	VARIANT	R -> H (in dbSNP:rs34386880)	ECO:0000269|PubMed:17344846	17344846
Q8N568	DCLK2	I583V	Q8N568/I583V	DCLK2/I583V	VARIANT	I -> V (in dbSNP:rs35745104)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8N5S9	CAMKK1	E375G	Q8N5S9/E375G	CAMKK1/E375G	VARIANT	E -> G (in dbSNP:rs7214723)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8N752	CSNK1A1L	S5G	Q8N752/S5G	CSNK1A1L/S5G	VARIANT	S -> G (in dbSNP:rs56224973)	ECO:0000269|PubMed:17344846	17344846
Q8N752	CSNK1A1L	R21Q	Q8N752/R21Q	CSNK1A1L/R21Q	VARIANT	R -> Q (in a colorectal cancer sample; somatic mutation; dbSNP:rs373362769)	ECO:0000269|PubMed:16959974	16959974
Q8N752	CSNK1A1L	R21W	Q8N752/R21W	CSNK1A1L/R21W	VARIANT	R -> W (in dbSNP:rs56158728)	ECO:0000269|PubMed:17344846	17344846
Q8N752	CSNK1A1L	D42E	Q8N752/D42E	CSNK1A1L/D42E	VARIANT	D -> E (in dbSNP:rs9576175)	ECO:0000269|PubMed:15489334	15489334
Q8N752	CSNK1A1L	R170S	Q8N752/R170S	CSNK1A1L/R170S	VARIANT	R -> S (in dbSNP:rs17773251)	ECO:0000269|PubMed:17344846	17344846
Q8N752	CSNK1A1L	E177K	Q8N752/E177K	CSNK1A1L/E177K	VARIANT	E -> K (in dbSNP:rs17054882)	ECO:0000269|PubMed:17344846	17344846
Q8N752	CSNK1A1L	P220L	Q8N752/P220L	CSNK1A1L/P220L	VARIANT	P -> L (in dbSNP:rs56252856)	ECO:0000269|PubMed:17344846	17344846
Q8N752	CSNK1A1L	K230N	Q8N752/K230N	CSNK1A1L/K230N	VARIANT	K -> N (in dbSNP:rs56252523)	ECO:0000269|PubMed:17344846	17344846
Q8N752	CSNK1A1L	A257T	Q8N752/A257T	CSNK1A1L/A257T	VARIANT	A -> T (in dbSNP:rs55895045)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8NB16	MLKL	S52T	Q8NB16/S52T	MLKL/S52T	VARIANT	S -> T (in dbSNP:rs34251827)	ECO:0000269|PubMed:17344846	17344846
Q8NB16	MLKL	D100E	Q8NB16/D100E	MLKL/D100E	VARIANT	D -> E (in dbSNP:rs33987771)	ECO:0000269|PubMed:17344846	17344846
Q8NB16	MLKL	S132P	Q8NB16/S132P	MLKL/S132P	VARIANT	S -> P (in dbSNP:rs35589326)	ECO:0000269|PubMed:17344846	17344846
Q8NB16	MLKL	R146Q	Q8NB16/R146Q	MLKL/R146Q	VARIANT	R -> Q (in dbSNP:rs34515646)	ECO:0000269|PubMed:17344846	17344846
Q8NB16	MLKL	M169L	Q8NB16/M169L	MLKL/M169L	VARIANT	M -> L (in dbSNP:rs55929310)	ECO:0000269|PubMed:17344846	17344846
Q8NB16	MLKL	L291P	Q8NB16/L291P	MLKL/L291P	VARIANT	L -> P (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1313508921)	ECO:0000269|PubMed:17344846	17344846
Q8NB16	MLKL	T364M	Q8NB16/T364M	MLKL/T364M	VARIANT	T -> M (in dbSNP:rs34389205)	ECO:0000269|PubMed:17344846	17344846
Q8NB16	MLKL	F398I	Q8NB16/F398I	MLKL/F398I	VARIANT	F -> I (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8NB16	MLKL	R421H	Q8NB16/R421H	MLKL/R421H	VARIANT	R -> H (in dbSNP:rs55987292)	ECO:0000269|PubMed:17344846	17344846
Q8NB16	MLKL	L58G	Q8NB16/L58G	MLKL/L58G	MUTAGEN	L->G: Does not affect formation of homotrimers, while translocation to the plasma membrane on necroptosis induction is impaired; when associated with G-76.	ECO:0000269|PubMed:24316671	24316671
Q8NB16	MLKL	I76G	Q8NB16/I76G	MLKL/I76G	MUTAGEN	I->G: Does not affect formation of homotrimers, while translocation to the plasma membrane on necroptosis induction is impaired; when associated with G-58.	ECO:0000269|PubMed:24316671	24316671
Q8NB16	MLKL	C86S	Q8NB16/C86S	MLKL/C86S	MUTAGEN	C->S: Abolishes binding to necrosulfonamide inhibitor.	ECO:0000269|PubMed:22265413	22265413
Q8NB16	MLKL	L162G	Q8NB16/L162G	MLKL/L162G	MUTAGEN	L->G: Impairs formation of homotrimers and translocation to the plasma membrane on necroptosis induction; when associated with G-165.	ECO:0000269|PubMed:24316671	24316671
Q8NB16	MLKL	L165G	Q8NB16/L165G	MLKL/L165G	MUTAGEN	L->G: Impairs formation of homotrimers and translocation to the plasma membrane on necroptosis induction; when associated with G-162.	ECO:0000269|PubMed:24316671	24316671
Q8NB16	MLKL	K230M	Q8NB16/K230M	MLKL/K230M	MUTAGEN	K->M: Abolishes ATP-binding.	ECO:0000269|PubMed:24219132	24219132
Q8NB16	MLKL	K331N	Q8NB16/K331N	MLKL/K331N	MUTAGEN	K->N: Impairs ATP-binding.	ECO:0000269|PubMed:24219132	24219132
Q8NB16	MLKL	E351K	Q8NB16/E351K	MLKL/E351K	MUTAGEN	E->K: Binds ATP with an enhanced affinity.	ECO:0000269|PubMed:24219132	24219132
Q8NB16	MLKL	T357A	Q8NB16/T357A	MLKL/T357A	MUTAGEN	T->A: No effect. Abolishes ability to mediate necroptosis; when associated with A-358.	ECO:0000269|PubMed:22265413	22265413
Q8NB16	MLKL	S358A	Q8NB16/S358A	MLKL/S358A	MUTAGEN	S->A: No effect. Abolishes ability to mediate necroptosis; when associated with A-357.	ECO:0000269|PubMed:22265413	22265413

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8NCB2	CAMKV	R40W	Q8NCB2/R40W	CAMKV/R40W	VARIANT	R -> W (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs1407808379)	ECO:0000269|PubMed:17344846	17344846
Q8NCB2	CAMKV	G60S	Q8NCB2/G60S	CAMKV/G60S	VARIANT	G -> S (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8NCB2	CAMKV	R274W	Q8NCB2/R274W	CAMKV/R274W	VARIANT	R -> W (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8NCB2	CAMKV	E279D	Q8NCB2/E279D	CAMKV/E279D	VARIANT	E -> D (in dbSNP:rs56071455)	ECO:0000269|PubMed:17344846	17344846
Q8NCB2	CAMKV	P472L	Q8NCB2/P472L	CAMKV/P472L	VARIANT	P -> L (in dbSNP:rs56307047)	ECO:0000269|PubMed:17344846	17344846
Q8NCB2	CAMKV	Y491C	Q8NCB2/Y491C	CAMKV/Y491C	VARIANT	Y -> C (in dbSNP:rs17849325)	ECO:0000269|PubMed:15489334	15489334

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8NE28	STKLD1	G139D	Q8NE28/G139D	STKLD1/G139D	VARIANT	G -> D (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8NE28	STKLD1	E473K	Q8NE28/E473K	STKLD1/E473K	VARIANT	E -> K (in dbSNP:rs3124747)		
Q8NE28	STKLD1	R568Q	Q8NE28/R568Q	STKLD1/R568Q	VARIANT	R -> Q (in dbSNP:rs17150554)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8NE63	HIPK4	A106T	Q8NE63/A106T	HIPK4/A106T	VARIANT	A -> T (in dbSNP:rs34434715)	ECO:0000269|PubMed:17344846	17344846
Q8NE63	HIPK4	V171M	Q8NE63/V171M	HIPK4/V171M	VARIANT	V -> M (in dbSNP:rs55964225)	ECO:0000269|PubMed:17344846	17344846
Q8NE63	HIPK4	R302Q	Q8NE63/R302Q	HIPK4/R302Q	VARIANT	R -> Q (in dbSNP:rs11670988)		
Q8NE63	HIPK4	T381M	Q8NE63/T381M	HIPK4/T381M	VARIANT	T -> M (in dbSNP:rs55760165)	ECO:0000269|PubMed:17344846	17344846
Q8NE63	HIPK4	A386T	Q8NE63/A386T	HIPK4/A386T	VARIANT	A -> T (in dbSNP:rs56365273)	ECO:0000269|PubMed:17344846	17344846
Q8NE63	HIPK4	S406R	Q8NE63/S406R	HIPK4/S406R	VARIANT	S -> R (in dbSNP:rs56094851)	ECO:0000269|PubMed:17344846	17344846
Q8NE63	HIPK4	G421S	Q8NE63/G421S	HIPK4/G421S	VARIANT	G -> S (in dbSNP:rs56117722)	ECO:0000269|PubMed:17344846	17344846
Q8NE63	HIPK4	R481C	Q8NE63/R481C	HIPK4/R481C	VARIANT	R -> C (in dbSNP:rs55801979)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8NER5	ACVR1C	I195T	Q8NER5/I195T	ACVR1C/I195T	VARIANT	I -> T (in dbSNP:rs56188432)	ECO:0000269|PubMed:17344846	17344846
Q8NER5	ACVR1C	G216R	Q8NER5/G216R	ACVR1C/G216R	VARIANT	G -> R (in dbSNP:rs34742924)	ECO:0000269|PubMed:17344846	17344846
Q8NER5	ACVR1C	W267R	Q8NER5/W267R	ACVR1C/W267R	VARIANT	W -> R (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8NER5	ACVR1C	I355V	Q8NER5/I355V	ACVR1C/I355V	VARIANT	I -> V (in dbSNP:rs35500979)	ECO:0000269|PubMed:17344846	17344846
Q8NER5	ACVR1C	I482V	Q8NER5/I482V	ACVR1C/I482V	VARIANT	I -> V (in dbSNP:rs7594480)	ECO:0000269|PubMed:17344846	17344846
Q8NER5	ACVR1C	T194D	Q8NER5/T194D	ACVR1C/T194D	MUTAGEN	T->D: Pro-apoptotic.	ECO:0000269|PubMed:15531507	15531507
Q8NER5	ACVR1C	K222R	Q8NER5/K222R	ACVR1C/K222R	MUTAGEN	K->R: Loss of response to NODAL and SMAD2 phosphorylation.	ECO:0000269|PubMed:12063393, ECO:0000269|PubMed:15531507	12063393,15531507

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8NEV4	MYO3A	T178I	Q8NEV4/T178I	MYO3A/T178I	VARIANT	T -> I (in dbSNP:rs33968748)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	D204N	Q8NEV4/D204N	MYO3A/D204N	VARIANT	D -> N (in dbSNP:rs3737274)		
Q8NEV4	MYO3A	R319H	Q8NEV4/R319H	MYO3A/R319H	VARIANT	R -> H (in dbSNP:rs3824700)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	I348V	Q8NEV4/I348V	MYO3A/I348V	VARIANT	I -> V (in dbSNP:rs3824699)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	V369I	Q8NEV4/V369I	MYO3A/V369I	VARIANT	V -> I (in dbSNP:rs3817420)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	N525K	Q8NEV4/N525K	MYO3A/N525K	VARIANT	N -> K (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs1423134583)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	A833S	Q8NEV4/A833S	MYO3A/A833S	VARIANT	A -> S (in dbSNP:rs33947968)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	S956N	Q8NEV4/S956N	MYO3A/S956N	VARIANT	S -> N (in dbSNP:rs3758449)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	S956R	Q8NEV4/S956R	MYO3A/S956R	VARIANT	S -> R (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	A1032T	Q8NEV4/A1032T	MYO3A/A1032T	VARIANT	A -> T (in dbSNP:rs34918608)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	V1045M	Q8NEV4/V1045M	MYO3A/V1045M	VARIANT	V -> M (in dbSNP:rs35447806)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	V1137M	Q8NEV4/V1137M	MYO3A/V1137M	VARIANT	V -> M (in dbSNP:rs35449183)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	V1195A	Q8NEV4/V1195A	MYO3A/V1195A	VARIANT	V -> A (in dbSNP:rs35675577)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	T1284S	Q8NEV4/T1284S	MYO3A/T1284S	VARIANT	T -> S (in dbSNP:rs3740231)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	P1287T	Q8NEV4/P1287T	MYO3A/P1287T	VARIANT	P -> T (in dbSNP:rs35575696)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	R1313S	Q8NEV4/R1313S	MYO3A/R1313S	VARIANT	R -> S (in dbSNP:rs1999240)	ECO:0000269|PubMed:10936054, ECO:0000269|PubMed:12032315, ECO:0000269|PubMed:17344846	10936054,12032315,17344846
Q8NEV4	MYO3A	D1347H	Q8NEV4/D1347H	MYO3A/D1347H	VARIANT	D -> H (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	T1417I	Q8NEV4/T1417I	MYO3A/T1417I	VARIANT	T -> I (in dbSNP:rs34151474)	ECO:0000269|PubMed:17344846	17344846
Q8NEV4	MYO3A	K1488E	Q8NEV4/K1488E	MYO3A/K1488E	VARIANT	K -> E (in dbSNP:rs34204285)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8NFD2	ANKK1	D4Y	Q8NFD2/D4Y	ANKK1/D4Y	VARIANT	D -> Y (in dbSNP:rs35657708)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	R122H	Q8NFD2/R122H	ANKK1/R122H	VARIANT	R -> H (in dbSNP:rs35877321)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	A239T	Q8NFD2/A239T	ANKK1/A239T	VARIANT	A -> T (in dbSNP:rs7118900)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	P276L	Q8NFD2/P276L	ANKK1/P276L	VARIANT	P -> L (in dbSNP:rs35488601)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	G318R	Q8NFD2/G318R	ANKK1/G318R	VARIANT	G -> R (in dbSNP:rs11604671)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	K347T	Q8NFD2/K347T	ANKK1/K347T	VARIANT	K -> T (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	L366F	Q8NFD2/L366F	ANKK1/L366F	VARIANT	L -> F (in dbSNP:rs56339158)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	H367Q	Q8NFD2/H367Q	ANKK1/H367Q	VARIANT	H -> Q (in dbSNP:rs34298987)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	E376K	Q8NFD2/E376K	ANKK1/E376K	VARIANT	E -> K (in dbSNP:rs56299709)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	E426K	Q8NFD2/E426K	ANKK1/E426K	VARIANT	E -> K (in dbSNP:rs55699907)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	G442R	Q8NFD2/G442R	ANKK1/G442R	VARIANT	G -> R (in dbSNP:rs4938016)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	G451R	Q8NFD2/G451R	ANKK1/G451R	VARIANT	G -> R (in dbSNP:rs34983219)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	H490R	Q8NFD2/H490R	ANKK1/H490R	VARIANT	H -> R (in dbSNP:rs2734849)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	T595I	Q8NFD2/T595I	ANKK1/T595I	VARIANT	T -> I (in dbSNP:rs55787008)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	P596L	Q8NFD2/P596L	ANKK1/P596L	VARIANT	P -> L (in dbSNP:rs7104979)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	N653S	Q8NFD2/N653S	ANKK1/N653S	VARIANT	N -> S (in dbSNP:rs55849504)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	S670G	Q8NFD2/S670G	ANKK1/S670G	VARIANT	S -> G (in dbSNP:rs56006094)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	E713K	Q8NFD2/E713K	ANKK1/E713K	VARIANT	E -> K (in dbSNP:rs1800497)	ECO:0000269|PubMed:14741327, ECO:0000269|PubMed:17344846	14741327,17344846
Q8NFD2	ANKK1	Q717L	Q8NFD2/Q717L	ANKK1/Q717L	VARIANT	Q -> L (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	R736L	Q8NFD2/R736L	ANKK1/R736L	VARIANT	R -> L (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8NFD2	ANKK1	E764K	Q8NFD2/E764K	ANKK1/E764K	VARIANT	E -> K (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8NG66	NEK11	T108M	Q8NG66/T108M	NEK11/T108M	VARIANT	T -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs200709914)	ECO:0000269|PubMed:17344846	17344846
Q8NG66	NEK11	Y123C	Q8NG66/Y123C	NEK11/Y123C	VARIANT	Y -> C (in dbSNP:rs55806123)	ECO:0000269|PubMed:17344846	17344846
Q8NG66	NEK11	S213L	Q8NG66/S213L	NEK11/S213L	VARIANT	S -> L (in dbSNP:rs55920129)	ECO:0000269|PubMed:17344846	17344846
Q8NG66	NEK11	I263V	Q8NG66/I263V	NEK11/I263V	VARIANT	I -> V (in dbSNP:rs35567155)	ECO:0000269|PubMed:17344846	17344846
Q8NG66	NEK11	E451K	Q8NG66/E451K	NEK11/E451K	VARIANT	E -> K (in dbSNP:rs35409692)	ECO:0000269|PubMed:17344846	17344846
Q8NG66	NEK11	E488V	Q8NG66/E488V	NEK11/E488V	VARIANT	E -> V (in dbSNP:rs3738000)	ECO:0000269|PubMed:12154088, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17974005	12154088,14702039,17344846,17974005
Q8NG66	NEK11	E492K	Q8NG66/E492K	NEK11/E492K	VARIANT	E -> K (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs140599545)	ECO:0000269|PubMed:17344846	17344846
Q8NG66	NEK11	M548T	Q8NG66/M548T	NEK11/M548T	VARIANT	M -> T (in dbSNP:rs55813244)	ECO:0000269|PubMed:17344846	17344846
Q8NG66	NEK11	V562A	Q8NG66/V562A	NEK11/V562A	VARIANT	V -> A (in dbSNP:rs16836266)	ECO:0000269|PubMed:17344846	17344846
Q8NG66	NEK11	E606K	Q8NG66/E606K	NEK11/E606K	VARIANT	E -> K (in dbSNP:rs55944737)	ECO:0000269|PubMed:17344846	17344846
Q8NG66	NEK11	D617N	Q8NG66/D617N	NEK11/D617N	VARIANT	D -> N (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs765563230)	ECO:0000269|PubMed:17344846	17344846
Q8NG66	NEK11	K61R	Q8NG66/K61R	NEK11/K61R	MUTAGEN	K->R: Loss of kinase activity.	ECO:0000269|PubMed:12154088	12154088

Error: Q8NI60 COQ8A 'NoneType' object has no attribute 'group' FT                   /note="Missing (in COQ10D4; dbSNP:rs387906299)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8NI60	COQ8A	H85Q	Q8NI60/H85Q	COQ8A/H85Q	VARIANT	H -> Q (in dbSNP:rs2297411)		
Q8NI60	COQ8A	R213W	Q8NI60/R213W	COQ8A/R213W	VARIANT	R -> W (in COQ10D4; dbSNP:rs119468005)	ECO:0000269|PubMed:18319072, ECO:0000269|PubMed:22036850	18319072,22036850
Q8NI60	COQ8A	R271C	Q8NI60/R271C	COQ8A/R271C	VARIANT	R -> C (in COQ10D4; dbSNP:rs145034527)	ECO:0000269|PubMed:22036850	22036850
Q8NI60	COQ8A	G272D	Q8NI60/G272D	COQ8A/G272D	VARIANT	G -> D (in COQ10D4; dbSNP:rs119468006)	ECO:0000269|PubMed:18319072, ECO:0000269|PubMed:22036850	18319072,22036850
Q8NI60	COQ8A	G272V	Q8NI60/G272V	COQ8A/G272V	VARIANT	G -> V (in COQ10D4; dbSNP:rs119468006)	ECO:0000269|PubMed:18319072, ECO:0000269|PubMed:22036850	18319072,22036850
Q8NI60	COQ8A	R299W	Q8NI60/R299W	COQ8A/R299W	VARIANT	R -> W (in COQ10D4; decreased stability; dbSNP:rs201908721)	ECO:0000269|PubMed:22036850, ECO:0000269|PubMed:25498144, ECO:0000269|PubMed:27106809	22036850,25498144,27106809
Q8NI60	COQ8A	A304T	Q8NI60/A304T	COQ8A/A304T	VARIANT	A -> T (in COQ10D4; dbSNP:rs778798354)	ECO:0000269|PubMed:22036850	22036850
Q8NI60	COQ8A	A304V	Q8NI60/A304V	COQ8A/A304V	VARIANT	A -> V (in COQ10D4; dbSNP:rs748118737)	ECO:0000269|PubMed:22036850	22036850
Q8NI60	COQ8A	I341T	Q8NI60/I341T	COQ8A/I341T	VARIANT	I -> T (in dbSNP:rs55798516)	ECO:0000269|PubMed:17344846	17344846
Q8NI60	COQ8A	Y429C	Q8NI60/Y429C	COQ8A/Y429C	VARIANT	Y -> C (in COQ10D4; decreased stability; dbSNP:rs144147839)	ECO:0000269|PubMed:22036850, ECO:0000269|PubMed:25498144	22036850,25498144
Q8NI60	COQ8A	Y514C	Q8NI60/Y514C	COQ8A/Y514C	VARIANT	Y -> C (in COQ10D4; dbSNP:rs119468008)	ECO:0000269|PubMed:18319074	18319074
Q8NI60	COQ8A	G549S	Q8NI60/G549S	COQ8A/G549S	VARIANT	G -> S (in COQ10D4; decreased stability; dbSNP:rs119468009)	ECO:0000269|PubMed:18319074, ECO:0000269|PubMed:22036850, ECO:0000269|PubMed:25498144	18319074,22036850,25498144
Q8NI60	COQ8A	E551K	Q8NI60/E551K	COQ8A/E551K	VARIANT	E -> K (in COQ10D4; decreased stability; dbSNP:rs119468004)	ECO:0000269|PubMed:18319072, ECO:0000269|PubMed:22036850, ECO:0000269|PubMed:25498144	18319072,22036850,25498144
Q8NI60	COQ8A	F578V	Q8NI60/F578V	COQ8A/F578V	VARIANT	F -> V (in COQ10D4; unknown pathological significance)	ECO:0000269|PubMed:27106809	27106809
Q8NI60	COQ8A	P602R	Q8NI60/P602R	COQ8A/P602R	VARIANT	P -> R (in COQ10D4; dbSNP:rs61995958)	ECO:0000269|PubMed:24048965	24048965
Q8NI60	COQ8A	L214A	Q8NI60/L214A	COQ8A/L214A	MUTAGEN	L->A,I,L,F: Strongly impairs homodimerization.		
Q8NI60	COQ8A	L214I	Q8NI60/L214I	COQ8A/L214I	MUTAGEN	L->I,F,G,V: Slightly impaired homodimerization.		
Q8NI60	COQ8A	L214L	Q8NI60/L214L	COQ8A/L214L	MUTAGEN	L->A,I,L,F: Strongly impairs homodimerization.		
Q8NI60	COQ8A	L214F	Q8NI60/L214F	COQ8A/L214F	MUTAGEN	L->I,F,G,V: Slightly impaired homodimerization.		
Q8NI60	COQ8A	L214G	Q8NI60/L214G	COQ8A/L214G	MUTAGEN	L->I,F,G,V: Slightly impaired homodimerization.		
Q8NI60	COQ8A	L214V	Q8NI60/L214V	COQ8A/L214V	MUTAGEN	L->I,F,G,V: Slightly impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	A215I	Q8NI60/A215I	COQ8A/A215I	MUTAGEN	A->I,L,G: Does not impair homodimerization.		
Q8NI60	COQ8A	A215L	Q8NI60/A215L	COQ8A/A215L	MUTAGEN	A->I,L,G: Does not impair homodimerization.		
Q8NI60	COQ8A	A215G	Q8NI60/A215G	COQ8A/A215G	MUTAGEN	A->I,L,G: Does not impair homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	N216A	Q8NI60/N216A	COQ8A/N216A	MUTAGEN	N->A,L,F,M: Does not impair homodimerization.		
Q8NI60	COQ8A	N216L	Q8NI60/N216L	COQ8A/N216L	MUTAGEN	N->A,L,F,M: Does not impair homodimerization.		
Q8NI60	COQ8A	N216F	Q8NI60/N216F	COQ8A/N216F	MUTAGEN	N->A,L,F,M: Does not impair homodimerization.		
Q8NI60	COQ8A	N216M	Q8NI60/N216M	COQ8A/N216M	MUTAGEN	N->A,L,F,M: Does not impair homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	F217A	Q8NI60/F217A	COQ8A/F217A	MUTAGEN	F->A: Slightly impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	G218I	Q8NI60/G218I	COQ8A/G218I	MUTAGEN	G->I,L,F: Slightly impaired homodimerization.		
Q8NI60	COQ8A	G218L	Q8NI60/G218L	COQ8A/G218L	MUTAGEN	G->I,L,F: Slightly impaired homodimerization.		
Q8NI60	COQ8A	G218F	Q8NI60/G218F	COQ8A/G218F	MUTAGEN	G->I,L,F: Slightly impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	G219A	Q8NI60/G219A	COQ8A/G219A	MUTAGEN	G->A,F: Slightly impaired homodimerization.		
Q8NI60	COQ8A	G219F	Q8NI60/G219F	COQ8A/G219F	MUTAGEN	G->A,F: Slightly impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	G219I	Q8NI60/G219I	COQ8A/G219I	MUTAGEN	G->I: Strongly impairs homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	L220G	Q8NI60/L220G	COQ8A/L220G	MUTAGEN	L->G: Impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	A221L	Q8NI60/A221L	COQ8A/A221L	MUTAGEN	A->L: Slightly impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	V222A	Q8NI60/V222A	COQ8A/V222A	MUTAGEN	V->A: Slightly impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	G223A	Q8NI60/G223A	COQ8A/G223A	MUTAGEN	G->A,I,L,F: Strongly impairs homodimerization.		
Q8NI60	COQ8A	G223I	Q8NI60/G223I	COQ8A/G223I	MUTAGEN	G->A,I,L,F: Strongly impairs homodimerization.		
Q8NI60	COQ8A	G223L	Q8NI60/G223L	COQ8A/G223L	MUTAGEN	G->A,I,L,F: Strongly impairs homodimerization.		
Q8NI60	COQ8A	G223F	Q8NI60/G223F	COQ8A/G223F	MUTAGEN	G->A,I,L,F: Strongly impairs homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	L224V	Q8NI60/L224V	COQ8A/L224V	MUTAGEN	L->V: Impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	G225L	Q8NI60/G225L	COQ8A/G225L	MUTAGEN	G->L: Slightly impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	F226A	Q8NI60/F226A	COQ8A/F226A	MUTAGEN	F->A: Slightly impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	G227V	Q8NI60/G227V	COQ8A/G227V	MUTAGEN	G->V,F,L,I: Strongly impairs homodimerization.		
Q8NI60	COQ8A	G227F	Q8NI60/G227F	COQ8A/G227F	MUTAGEN	G->V,F,L,I: Strongly impairs homodimerization.		
Q8NI60	COQ8A	G227L	Q8NI60/G227L	COQ8A/G227L	MUTAGEN	G->V,F,L,I: Strongly impairs homodimerization.		
Q8NI60	COQ8A	G227I	Q8NI60/G227I	COQ8A/G227I	MUTAGEN	G->V,F,L,I: Strongly impairs homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	A228I	Q8NI60/A228I	COQ8A/A228I	MUTAGEN	A->I,L,F: Does not impair homodimerization.		
Q8NI60	COQ8A	A228L	Q8NI60/A228L	COQ8A/A228L	MUTAGEN	A->I,L,F: Does not impair homodimerization.		
Q8NI60	COQ8A	A228F	Q8NI60/A228F	COQ8A/A228F	MUTAGEN	A->I,L,F: Does not impair homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	L229A	Q8NI60/L229A	COQ8A/L229A	MUTAGEN	L->A: Slightly impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	A230I	Q8NI60/A230I	COQ8A/A230I	MUTAGEN	A->I: Slightly impaired homodimerization.	ECO:0000269|PubMed:25216398	25216398
Q8NI60	COQ8A	K276R	Q8NI60/K276R	COQ8A/K276R	MUTAGEN			
Q8NI60	COQ8A	K276H	Q8NI60/K276H	COQ8A/K276H	MUTAGEN	K->R,H: Does not affect selectivity for binding ADP or ATP. Impaired multi-subunit COQ enzyme complex.	ECO:0000269|PubMed:25498144, ECO:0000269|PubMed:27499294	25498144,27499294
Q8NI60	COQ8A	Q279R	Q8NI60/Q279R	COQ8A/Q279R	MUTAGEN			
Q8NI60	COQ8A	Q279H	Q8NI60/Q279H	COQ8A/Q279H	MUTAGEN	Q->R,H: Does not affect selectivity for binding ADP or ATP.	ECO:0000269|PubMed:25498144	25498144
Q8NI60	COQ8A	A339G	Q8NI60/A339G	COQ8A/A339G	MUTAGEN	A->G: Enables autophosphorylation but inhibits coenzyme Q biosynthesis in vivo.	ECO:0000269|PubMed:25498144	25498144
Q8NI60	COQ8A	K358R	Q8NI60/K358R	COQ8A/K358R	MUTAGEN	K->R: Abolishes binding ADP or ATP.	ECO:0000269|PubMed:25498144	25498144
Q8NI60	COQ8A	E405A	Q8NI60/E405A	COQ8A/E405A	MUTAGEN			
Q8NI60	COQ8A	E405Q	Q8NI60/E405Q	COQ8A/E405Q	MUTAGEN	E->A,Q: Slightly affects selectivity for binding ADP or ATP.	ECO:0000269|PubMed:25498144	25498144
Q8NI60	COQ8A	E411Q	Q8NI60/E411Q	COQ8A/E411Q	MUTAGEN	E->Q: Impaired binding ADP or ATP.	ECO:0000269|PubMed:25498144	25498144
Q8NI60	COQ8A	D488N	Q8NI60/D488N	COQ8A/D488N	MUTAGEN	D->N: Impaired binding ADP or ATP.	ECO:0000269|PubMed:25498144	25498144
Q8NI60	COQ8A	N493A	Q8NI60/N493A	COQ8A/N493A	MUTAGEN	N->A: Impaired binding ADP or ATP.	ECO:0000269|PubMed:25498144	25498144
Q8NI60	COQ8A	D507N	Q8NI60/D507N	COQ8A/D507N	MUTAGEN	D->N: Strongly impairs binding ADP or ATP. Impaired multi-subunit COQ enzyme complex.	ECO:0000269|PubMed:25498144, ECO:0000269|PubMed:27499294	25498144,27499294
Q8NI60	COQ8A	R611A	Q8NI60/R611A	COQ8A/R611A	MUTAGEN			
Q8NI60	COQ8A	R611Q	Q8NI60/R611Q	COQ8A/R611Q	MUTAGEN	R->A,Q: Does not affect selectivity for binding ADP or ATP.	ECO:0000269|PubMed:25498144	25498144

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8TAS1	UHMK1	L159V	Q8TAS1/L159V	UHMK1/L159V	VARIANT	L -> V (in dbSNP:rs34466082)	ECO:0000269|PubMed:17344846	17344846
Q8TAS1	UHMK1	Y197D	Q8TAS1/Y197D	UHMK1/Y197D	VARIANT	Y -> D (in dbSNP:rs56201055)	ECO:0000269|PubMed:17344846	17344846
Q8TAS1	UHMK1	K54A	Q8TAS1/K54A	UHMK1/K54A	MUTAGEN	K->A: Loss of kinase activity.	ECO:0000269|PubMed:12093740	12093740

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8TD08	MAPK15	T221K	Q8TD08/T221K	MAPK15/T221K	VARIANT	T -> K (in dbSNP:rs60732298)		
Q8TD08	MAPK15	S505P	Q8TD08/S505P	MAPK15/S505P	VARIANT	S -> P (in dbSNP:rs56038219)		
Q8TD08	MAPK15	K42A	Q8TD08/K42A	MAPK15/K42A	MUTAGEN	K->A: Not phosphorylated at Thr-175 and Tyr-177.	ECO:0000269|PubMed:16336213	16336213
Q8TD08	MAPK15	K42R	Q8TD08/K42R	MAPK15/K42R	MUTAGEN	K->R: Loss of autophosphorylation and activity. Does not increase dopamine transporter activity. Impairs kinase activity. Does not rescue cilium assembly in MAPK15-depleted cells.	ECO:0000269|PubMed:11875070, ECO:0000269|PubMed:28842414, ECO:0000269|PubMed:29021280	11875070,28842414,29021280
Q8TD08	MAPK15	R59Q	Q8TD08/R59Q	MAPK15/R59Q	MUTAGEN	R->Q: Does not increase dopamine transporter activity. Impairs kinase activity.	ECO:0000269|PubMed:28842414	28842414
Q8TD08	MAPK15	D155A	Q8TD08/D155A	MAPK15/D155A	MUTAGEN	D->A: Unable to induce the formation of autophagosomal structures. Is able to bind to MAP1LC3B and to colocalize with this protein to autophagosomal structures. Does not induce phosphorylation by methyl methanesulfonate. Loas of phosphorylation. Dominant negative mutant. Not phosphorylated at Thr-175 and Tyr-177.	ECO:0000269|PubMed:16336213, ECO:0000269|PubMed:19166846, ECO:0000269|PubMed:22948227	16336213,19166846,22948227
Q8TD08	MAPK15	T175A	Q8TD08/T175A	MAPK15/T175A	MUTAGEN	T->A: Loss of autophosphorylation and activity. Still heavily phosphorylated at Tyr-177. Does not rescues inhibition of O-glycosylation in MAPK15-depleted cells; when associated with F-177.	ECO:0000269|PubMed:11875070, ECO:0000269|PubMed:16336213, ECO:0000269|PubMed:24618899	11875070,16336213,24618899
Q8TD08	MAPK15	Y177A	Q8TD08/Y177A	MAPK15/Y177A	MUTAGEN	Y->A: Loss of autophosphorylation and activity. Heavily phosphorylated at Thr-175.	ECO:0000269|PubMed:11875070, ECO:0000269|PubMed:16336213	11875070,16336213
Q8TD08	MAPK15	Y177F	Q8TD08/Y177F	MAPK15/Y177F	MUTAGEN	Y->F: Does not rescue inhibition of O-glycosylation in MAPK15-depleted cells; when associated with A-175.	ECO:0000269|PubMed:24618899	24618899
Q8TD08	MAPK15	Q300A	Q8TD08/Q300A	MAPK15/Q300A	MUTAGEN	Q->A: Impairs interaction with PCNA. Associates with chromatin.	ECO:0000269|PubMed:20733054	20733054
Q8TD08	MAPK15	P390A	Q8TD08/P390A	MAPK15/P390A	MUTAGEN	P->A: Impairs chromatin binding; when associated with A-398. Increases kinase activity; when associated with A-398.	ECO:0000269|PubMed:20733054	20733054
Q8TD08	MAPK15	P398A	Q8TD08/P398A	MAPK15/P398A	MUTAGEN	P->A: Impairs chromatin binding; when associated with A-390. Increases kinase activity; when associated with A-390.	ECO:0000269|PubMed:20733054	20733054

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8TD19	NEK9	I167T	Q8TD19/I167T	NEK9/I167T	VARIANT			
Q8TD19	NEK9	R429H	Q8TD19/R429H	NEK9/R429H	VARIANT	R -> H (in dbSNP:rs10146482)	ECO:0000269|PubMed:11864968, ECO:0000269|PubMed:12056414, ECO:0000269|PubMed:17344846	11864968,12056414,17344846
Q8TD19	NEK9	I573T	Q8TD19/I573T	NEK9/I573T	VARIANT			
Q8TD19	NEK9	R681H	Q8TD19/R681H	NEK9/R681H	VARIANT	R -> H (in APUG; dbSNP:rs142859694)	ECO:0000269|PubMed:26633546	26633546
Q8TD19	NEK9	P828T	Q8TD19/P828T	NEK9/P828T	VARIANT	P -> T (in dbSNP:rs36014869)	ECO:0000269|PubMed:17344846	17344846
Q8TD19	NEK9	P870S	Q8TD19/P870S	NEK9/P870S	VARIANT	P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8TD19	NEK9	K81M	Q8TD19/K81M	NEK9/K81M	MUTAGEN	K->M: Loss of activity and autophosphorylation.	ECO:0000269|PubMed:12101123	12101123
Q8TD19	NEK9	T210A	Q8TD19/T210A	NEK9/T210A	MUTAGEN	T->A: Significant reduction of autophosphorylation.	ECO:0000269|PubMed:11864968	11864968
Q8TD19	NEK9	T214A	Q8TD19/T214A	NEK9/T214A	MUTAGEN	T->A: No effect on autophosphorylation.	ECO:0000269|PubMed:11864968	11864968

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8TDC3	BRSK1	R303W	Q8TDC3/R303W	BRSK1/R303W	VARIANT	R -> W (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs144130246)	ECO:0000269|PubMed:17344846	17344846
Q8TDC3	BRSK1	V319I	Q8TDC3/V319I	BRSK1/V319I	VARIANT	V -> I (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8TDC3	BRSK1	G391E	Q8TDC3/G391E	BRSK1/G391E	VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8TDC3	BRSK1	T531N	Q8TDC3/T531N	BRSK1/T531N	VARIANT	T -> N (in dbSNP:rs55892637)	ECO:0000269|PubMed:17344846	17344846
Q8TDC3	BRSK1	G749S	Q8TDC3/G749S	BRSK1/G749S	VARIANT	G -> S (in dbSNP:rs12978445)	ECO:0000269|PubMed:17344846	17344846
Q8TDC3	BRSK1	P764A	Q8TDC3/P764A	BRSK1/P764A	VARIANT	P -> A (in dbSNP:rs55796422)	ECO:0000269|PubMed:17344846	17344846
Q8TDC3	BRSK1	K59A	Q8TDC3/K59A	BRSK1/K59A	MUTAGEN	K->A: Loss of kinase activity.	ECO:0000269|PubMed:15150265	15150265
Q8TDC3	BRSK1	T189A	Q8TDC3/T189A	BRSK1/T189A	MUTAGEN			
Q8TDC3	BRSK1	G327A	Q8TDC3/G327A	BRSK1/G327A	MUTAGEN	G->A: Abolishes activation of kinase activity.	ECO:0000269|PubMed:18339622	18339622

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8TDR2	STK35	K231M	Q8TDR2/K231M	STK35/K231M	MUTAGEN	K->M: No autophosphorylation.	ECO:0000269|PubMed:11973348	11973348

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8TDX7	NEK7	R35G	Q8TDX7/R35G	NEK7/R35G	VARIANT	R -> G (in dbSNP:rs55833332)	ECO:0000269|PubMed:17344846	17344846
Q8TDX7	NEK7	I275M	Q8TDX7/I275M	NEK7/I275M	VARIANT	I -> M (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8TDX7	NEK7	Y28A	Q8TDX7/Y28A	NEK7/Y28A	MUTAGEN	Y->A: Significant decrease in catalytic activity; when associated with A-31.	ECO:0000269|PubMed:19941817	19941817
Q8TDX7	NEK7	L31A	Q8TDX7/L31A	NEK7/L31A	MUTAGEN	L->A: Significant decrease in catalytic activity; when associated with A-28.	ECO:0000269|PubMed:19941817	19941817
Q8TDX7	NEK7	N33D	Q8TDX7/N33D	NEK7/N33D	MUTAGEN	N->D: Significant decrease in catalytic activity.	ECO:0000269|PubMed:19941817	19941817
Q8TDX7	NEK7	N90A	Q8TDX7/N90A	NEK7/N90A	MUTAGEN	N->A: Reduced protein kinase activity.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	N90R	Q8TDX7/N90R	NEK7/N90R	MUTAGEN	N->R,K: Strongly reduced protein kinase activity.		
Q8TDX7	NEK7	N90K	Q8TDX7/N90K	NEK7/N90K	MUTAGEN	N->R,K: Strongly reduced protein kinase activity.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	K96E	Q8TDX7/K96E	NEK7/K96E	MUTAGEN	K->E: Strongly increased protein kinase activity.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	Y97A	Q8TDX7/Y97A	NEK7/Y97A	MUTAGEN	Y->A: 5-fold increase in catalytic activity.	ECO:0000269|PubMed:19941817, ECO:0000269|PubMed:26522158	19941817,26522158
Q8TDX7	NEK7	Y97F	Q8TDX7/Y97F	NEK7/Y97F	MUTAGEN	Y->F,L: Moderate increase in catalytic activity.		
Q8TDX7	NEK7	Y97L	Q8TDX7/Y97L	NEK7/Y97L	MUTAGEN	Y->F,L: Moderate increase in catalytic activity.	ECO:0000269|PubMed:19941817	19941817
Q8TDX7	NEK7	M122A	Q8TDX7/M122A	NEK7/M122A	MUTAGEN			
Q8TDX7	NEK7	M122R	Q8TDX7/M122R	NEK7/M122R	MUTAGEN	M->A,R: Decreased interaction with NEK9 and subsequent activation of NEK7 kinase activity.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	H125A	Q8TDX7/H125A	NEK7/H125A	MUTAGEN	H->A: Does not affect interaction with NEK9.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	K128E	Q8TDX7/K128E	NEK7/K128E	MUTAGEN	K->E: Does not affect interaction with NLRP3.	ECO:0000269|PubMed:31189953	31189953
Q8TDX7	NEK7	Q129R	Q8TDX7/Q129R	NEK7/Q129R	MUTAGEN	Q->R: Decreased interaction with NLRP3.	ECO:0000269|PubMed:31189953	31189953
Q8TDX7	NEK7	K130A	Q8TDX7/K130A	NEK7/K130A	MUTAGEN	K->A,E: Does not affect interaction with NEK9.		
Q8TDX7	NEK7	K130E	Q8TDX7/K130E	NEK7/K130E	MUTAGEN	K->A,E: Does not affect interaction with NEK9.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	R131A	Q8TDX7/R131A	NEK7/R131A	MUTAGEN			
Q8TDX7	NEK7	R131D	Q8TDX7/R131D	NEK7/R131D	MUTAGEN	R->A,D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	R131E	Q8TDX7/R131E	NEK7/R131E	MUTAGEN	R->E: Decreased interaction with NLRP3.	ECO:0000269|PubMed:31189953	31189953
Q8TDX7	NEK7	L132D	Q8TDX7/L132D	NEK7/L132D	MUTAGEN	L->D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	L132W	Q8TDX7/L132W	NEK7/L132W	MUTAGEN	L->W: Does not affect interaction with NEK9.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	R136E	Q8TDX7/R136E	NEK7/R136E	MUTAGEN	R->E: Decreased interaction with NLRP3.	ECO:0000269|PubMed:31189953	31189953
Q8TDX7	NEK7	R155E	Q8TDX7/R155E	NEK7/R155E	MUTAGEN	R->E: Strongly reduced protein kinase activity.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	I169F	Q8TDX7/I169F	NEK7/I169F	MUTAGEN	I->F: Does not affect interaction with NEK9.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	T172A	Q8TDX7/T172A	NEK7/T172A	MUTAGEN	T->A: Does not affect interaction with NEK9.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	S195A	Q8TDX7/S195A	NEK7/S195A	MUTAGEN	S->A: Abolished phosphorylation with NEK9 and protein kinase activity.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	D261A	Q8TDX7/D261A	NEK7/D261A	MUTAGEN	D->A: Does not affect interaction with NEK9.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	H262A	Q8TDX7/H262A	NEK7/H262A	MUTAGEN	H->A: Does not affect interaction with NEK9.	ECO:0000269|PubMed:26522158	26522158
Q8TDX7	NEK7	E280V	Q8TDX7/E280V	NEK7/E280V	MUTAGEN	E->V,R: Does not affect interaction with NLRP3.		
Q8TDX7	NEK7	E280R	Q8TDX7/E280R	NEK7/E280R	MUTAGEN	E->V,R: Does not affect interaction with NLRP3.	ECO:0000269|PubMed:31189953	31189953
Q8TDX7	NEK7	D290R	Q8TDX7/D290R	NEK7/D290R	MUTAGEN	D->R: Does not affect interaction with NLRP3.	ECO:0000269|PubMed:31189953	31189953
Q8TDX7	NEK7	R294E	Q8TDX7/R294E	NEK7/R294E	MUTAGEN	R->E: Does not affect interaction with NLRP3.	ECO:0000269|PubMed:31189953	31189953

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8TEA7	TBCK	R66L	Q8TEA7/R66L	TBCK/R66L	VARIANT	R -> L (in dbSNP:rs35784409)	ECO:0000269|PubMed:17344846	17344846
Q8TEA7	TBCK	I151M	Q8TEA7/I151M	TBCK/I151M	VARIANT	I -> M (in dbSNP:rs35835241)	ECO:0000269|PubMed:17344846	17344846
Q8TEA7	TBCK	D265N	Q8TEA7/D265N	TBCK/D265N	VARIANT	D -> N (in dbSNP:rs34770077)	ECO:0000269|PubMed:17344846	17344846
Q8TEA7	TBCK	Q266E	Q8TEA7/Q266E	TBCK/Q266E	VARIANT	Q -> E (in dbSNP:rs3775091)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15815621, ECO:0000269|PubMed:19077034, ECO:0000269|Ref.6	14702039,15815621,19077034
Q8TEA7	TBCK	T425M	Q8TEA7/T425M	TBCK/T425M	VARIANT	T -> M (in dbSNP:rs34307452)	ECO:0000269|PubMed:17344846	17344846
Q8TEA7	TBCK	M471I	Q8TEA7/M471I	TBCK/M471I	VARIANT	M -> I (in dbSNP:rs34961213)	ECO:0000269|PubMed:17344846	17344846
Q8TEA7	TBCK	K489N	Q8TEA7/K489N	TBCK/K489N	VARIANT	K -> N (in dbSNP:rs2305685)	ECO:0000269|PubMed:17344846	17344846
Q8TEA7	TBCK	R503I	Q8TEA7/R503I	TBCK/R503I	VARIANT	R -> I (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8TEA7	TBCK	R511H	Q8TEA7/R511H	TBCK/R511H	VARIANT	R -> H (in IHPRF3; dbSNP:rs869320711)	ECO:0000269|PubMed:27040692	27040692
Q8TEA7	TBCK	L551P	Q8TEA7/L551P	TBCK/L551P	VARIANT	L -> P (in IHPRF3)	ECO:0000269|PubMed:27040691	27040691
Q8TEA7	TBCK	R692C	Q8TEA7/R692C	TBCK/R692C	VARIANT	R -> C (in dbSNP:rs35790205)	ECO:0000269|PubMed:17344846	17344846
Q8TEA7	TBCK	I806V	Q8TEA7/I806V	TBCK/I806V	VARIANT	I -> V (in a head & Neck squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8TF76	HASPIN	V76E	Q8TF76/V76E	HASPIN/V76E	VARIANT	V -> E (in dbSNP:rs11653889)	ECO:0000269|PubMed:17344846	17344846
Q8TF76	HASPIN	R82C	Q8TF76/R82C	HASPIN/R82C	VARIANT	R -> C (in dbSNP:rs9907144)	ECO:0000269|PubMed:11311556, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	11311556,14702039,15489334,17344846
Q8TF76	HASPIN	R145H	Q8TF76/R145H	HASPIN/R145H	VARIANT	R -> H (in dbSNP:rs55991903)	ECO:0000269|PubMed:17344846	17344846
Q8TF76	HASPIN	G204D	Q8TF76/G204D	HASPIN/G204D	VARIANT	G -> D (in dbSNP:rs220462)	ECO:0000269|PubMed:11311556, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	11311556,15489334,17344846
Q8TF76	HASPIN	G283S	Q8TF76/G283S	HASPIN/G283S	VARIANT	G -> S (in dbSNP:rs56224301)	ECO:0000269|PubMed:17344846	17344846
Q8TF76	HASPIN	Q301L	Q8TF76/Q301L	HASPIN/Q301L	VARIANT	Q -> L (in dbSNP:rs55649477)	ECO:0000269|PubMed:17344846	17344846
Q8TF76	HASPIN	I328T	Q8TF76/I328T	HASPIN/I328T	VARIANT	I -> T (in dbSNP:rs220461)	ECO:0000269|PubMed:11311556, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	11311556,15489334,17344846
Q8TF76	HASPIN	V378A	Q8TF76/V378A	HASPIN/V378A	VARIANT	V -> A (in dbSNP:rs3809806)	ECO:0000269|PubMed:11311556, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	11311556,15489334,17344846
Q8TF76	HASPIN	N422D	Q8TF76/N422D	HASPIN/N422D	VARIANT	N -> D (in dbSNP:rs7223226)		
Q8TF76	HASPIN	M706V	Q8TF76/M706V	HASPIN/M706V	VARIANT	M -> V (in dbSNP:rs56134695)	ECO:0000269|PubMed:17344846	17344846
Q8TF76	HASPIN	E492A	Q8TF76/E492A	HASPIN/E492A	MUTAGEN	E->A: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	ECO:0000269|PubMed:19918049	19918049
Q8TF76	HASPIN	K511A	Q8TF76/K511A	HASPIN/K511A	MUTAGEN	K->A: Strongly reduced enzyme activity.	ECO:0000269|PubMed:19918057	19918057
Q8TF76	HASPIN	H651A	Q8TF76/H651A	HASPIN/H651A	MUTAGEN	H->A: Strongly reduced enzyme activity, markedly reduced affinity for histone H3.	ECO:0000269|PubMed:19918049, ECO:0000269|PubMed:19918057	19918049,19918057
Q8TF76	HASPIN	D707L	Q8TF76/D707L	HASPIN/D707L	MUTAGEN	D->L: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	ECO:0000269|PubMed:19918049	19918049
Q8TF76	HASPIN	D709N	Q8TF76/D709N	HASPIN/D709N	MUTAGEN	D->N: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	ECO:0000269|PubMed:19918049	19918049
Q8TF76	HASPIN	G713F	Q8TF76/G713F	HASPIN/G713F	MUTAGEN	G->F: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	ECO:0000269|PubMed:19918049	19918049
Q8TF76	HASPIN	D716L	Q8TF76/D716L	HASPIN/D716L	MUTAGEN	D->L: Markedly reduced histone H3 phosphorylation.	ECO:0000269|PubMed:19918049	19918049

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8WTQ7	GRK7	R81H	Q8WTQ7/R81H	GRK7/R81H	VARIANT	R -> H (in dbSNP:rs34429284)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	C113W	Q8WTQ7/C113W	GRK7/C113W	VARIANT	C -> W (in dbSNP:rs56070798)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	S115C	Q8WTQ7/S115C	GRK7/S115C	VARIANT	S -> C (in dbSNP:rs34769632)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	S127T	Q8WTQ7/S127T	GRK7/S127T	VARIANT	S -> T (in dbSNP:rs35318124)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	V196G	Q8WTQ7/V196G	GRK7/V196G	VARIANT	V -> G (in dbSNP:rs55707760)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	V196M	Q8WTQ7/V196M	GRK7/V196M	VARIANT	V -> M (in dbSNP:rs56019094)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	R226W	Q8WTQ7/R226W	GRK7/R226W	VARIANT	R -> W (in dbSNP:rs35566288)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	S253F	Q8WTQ7/S253F	GRK7/S253F	VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	E309Q	Q8WTQ7/E309Q	GRK7/E309Q	VARIANT	E -> Q (in dbSNP:rs55824414)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	V313I	Q8WTQ7/V313I	GRK7/V313I	VARIANT	V -> I (in dbSNP:rs56076641)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	E443G	Q8WTQ7/E443G	GRK7/E443G	VARIANT	E -> G (in dbSNP:rs36009541)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	P460T	Q8WTQ7/P460T	GRK7/P460T	VARIANT	P -> T (in dbSNP:rs33928105)	ECO:0000269|PubMed:17344846	17344846
Q8WTQ7	GRK7	R461C	Q8WTQ7/R461C	GRK7/R461C	VARIANT	R -> C (in dbSNP:rs36004830)		
Q8WTQ7	GRK7	S23A	Q8WTQ7/S23A	GRK7/S23A	MUTAGEN	S->A: No effect on kinase activity. Increase kinase activity; when associated with A-36.	ECO:0000269|PubMed:15946941	15946941
Q8WTQ7	GRK7	S36A	Q8WTQ7/S36A	GRK7/S36A	MUTAGEN	S->A: No effect on kinase activity. Increase kinase activity; when associated with A-23.	ECO:0000269|PubMed:15946941	15946941

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8WU08	STK32A	K58M	Q8WU08/K58M	STK32A/K58M	VARIANT	K -> M (in dbSNP:rs35852718)	ECO:0000269|PubMed:17344846	17344846
Q8WU08	STK32A	S89F	Q8WU08/S89F	STK32A/S89F	VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WU08	STK32A	M316I	Q8WU08/M316I	STK32A/M316I	VARIANT	M -> I (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WU08	STK32A	G2A	Q8WU08/G2A	STK32A/G2A	MUTAGEN	G->A: Localizes to cytoplasm.	ECO:0000269|PubMed:25043870	25043870

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8WXR4	MYO3B	P21S	Q8WXR4/P21S	MYO3B/P21S	VARIANT	P -> S (in dbSNP:rs35391761)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	R185H	Q8WXR4/R185H	MYO3B/R185H	VARIANT	R -> H (in dbSNP:rs55911154)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	N267S	Q8WXR4/N267S	MYO3B/N267S	VARIANT	N -> S (in dbSNP:rs34509373)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	I275V	Q8WXR4/I275V	MYO3B/I275V	VARIANT	I -> V (in dbSNP:rs10209102)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	K309E	Q8WXR4/K309E	MYO3B/K309E	VARIANT	K -> E (in dbSNP:rs4668246)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q8WXR4	MYO3B	H316L	Q8WXR4/H316L	MYO3B/H316L	VARIANT	H -> L (in dbSNP:rs55633190)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	E352Q	Q8WXR4/E352Q	MYO3B/E352Q	VARIANT	E -> Q (in dbSNP:rs56179904)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	N388S	Q8WXR4/N388S	MYO3B/N388S	VARIANT	N -> S (in dbSNP:rs34273653)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	A406T	Q8WXR4/A406T	MYO3B/A406T	VARIANT	A -> T (in dbSNP:rs10168181)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	Q638P	Q8WXR4/Q638P	MYO3B/Q638P	VARIANT	Q -> P (in dbSNP:rs55911627)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	V770I	Q8WXR4/V770I	MYO3B/V770I	VARIANT	V -> I (in dbSNP:rs6736609)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q8WXR4	MYO3B	E773G	Q8WXR4/E773G	MYO3B/E773G	VARIANT	E -> G (in dbSNP:rs33962844)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q8WXR4	MYO3B	E798K	Q8WXR4/E798K	MYO3B/E798K	VARIANT	E -> K (in dbSNP:rs11892763)		
Q8WXR4	MYO3B	R918Q	Q8WXR4/R918Q	MYO3B/R918Q	VARIANT	R -> Q (in dbSNP:rs55769829)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	S969C	Q8WXR4/S969C	MYO3B/S969C	VARIANT	S -> C (in dbSNP:rs35857918)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	R990C	Q8WXR4/R990C	MYO3B/R990C	VARIANT	R -> C (in dbSNP:rs34236931)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	R1082K	Q8WXR4/R1082K	MYO3B/R1082K	VARIANT	R -> K (in dbSNP:rs10185178)	ECO:0000269|PubMed:11991710, ECO:0000269|PubMed:14702039	11991710,14702039
Q8WXR4	MYO3B	I1092V	Q8WXR4/I1092V	MYO3B/I1092V	VARIANT	I -> V (in dbSNP:rs34219776)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	V1137I	Q8WXR4/V1137I	MYO3B/V1137I	VARIANT	V -> I (in dbSNP:rs34546065)	ECO:0000269|PubMed:17344846	17344846
Q8WXR4	MYO3B	R1165C	Q8WXR4/R1165C	MYO3B/R1165C	VARIANT	R -> C (in dbSNP:rs56052422)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q8WZ42	TTN	V54M	Q8WZ42/V54M	TTN/V54M	VARIANT	V -> M (in CMD1G; affects interaction with TCAP/telethonin; dbSNP:rs139517732)	ECO:0000269|PubMed:11846417	11846417
Q8WZ42	TTN	D60Y	Q8WZ42/D60Y	TTN/D60Y	VARIANT	D -> Y (in dbSNP:rs35683768)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V115M	Q8WZ42/V115M	TTN/V115M	VARIANT	V -> M (in a metastatic melanoma sample; somatic mutation; dbSNP:rs564777385)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R279W	Q8WZ42/R279W	TTN/R279W	VARIANT	R -> W (in MFM9; disrupts NBR1-binding; dbSNP:rs138060032)	ECO:0000269|PubMed:15802564	15802564
Q8WZ42	TTN	R328C	Q8WZ42/R328C	TTN/R328C	VARIANT	R -> C (in dbSNP:rs16866538)	ECO:0000269|PubMed:11846417, ECO:0000269|PubMed:17344846	11846417,17344846
Q8WZ42	TTN	R360T	Q8WZ42/R360T	TTN/R360T	VARIANT	R -> T (in dbSNP:rs56128843)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V498I	Q8WZ42/V498I	TTN/V498I	VARIANT	V -> I (in dbSNP:rs72647851)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7569978	17344846,7569978
Q8WZ42	TTN	R740L	Q8WZ42/R740L	TTN/R740L	VARIANT	R -> L (in CMH9; dbSNP:rs28933405)	ECO:0000269|PubMed:10462489	10462489
Q8WZ42	TTN	A743V	Q8WZ42/A743V	TTN/A743V	VARIANT	A -> V (in CMD1G; affects interaction with TCAP/telethonin; dbSNP:rs267607157)	ECO:0000269|PubMed:11846417	11846417
Q8WZ42	TTN	T799M	Q8WZ42/T799M	TTN/T799M	VARIANT	T -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs149061352)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T811I	Q8WZ42/T811I	TTN/T811I	VARIANT	T -> I (in dbSNP:rs35813871)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R922H	Q8WZ42/R922H	TTN/R922H	VARIANT	R -> H (in dbSNP:rs56046320)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E937D	Q8WZ42/E937D	TTN/E937D	VARIANT	E -> D (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	W976R	Q8WZ42/W976R	TTN/W976R	VARIANT	W -> R (in CMD1G; dbSNP:rs267607155)	ECO:0000269|PubMed:11788824	11788824
Q8WZ42	TTN	A1081T	Q8WZ42/A1081T	TTN/A1081T	VARIANT	A -> T (in dbSNP:rs55914517)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G1137R	Q8WZ42/G1137R	TTN/G1137R	VARIANT	G -> R (in dbSNP:rs72647870)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	K1201E	Q8WZ42/K1201E	TTN/K1201E	VARIANT	K -> E (in dbSNP:rs10497520)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7569978	17344846,7569978
Q8WZ42	TTN	V1202A	Q8WZ42/V1202A	TTN/V1202A	VARIANT	V -> A (in dbSNP:rs150667217)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S1249L	Q8WZ42/S1249L	TTN/S1249L	VARIANT	S -> L (in dbSNP:rs1552280)		
Q8WZ42	TTN	S1295L	Q8WZ42/S1295L	TTN/S1295L	VARIANT	S -> L (in dbSNP:rs1552280)	ECO:0000269|PubMed:10850961, ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:17344846	10850961,11717165,17344846
Q8WZ42	TTN	G1345D	Q8WZ42/G1345D	TTN/G1345D	VARIANT	G -> D (in dbSNP:rs36021856)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A1347T	Q8WZ42/A1347T	TTN/A1347T	VARIANT	A -> T (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267599092)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R1350H	Q8WZ42/R1350H	TTN/R1350H	VARIANT	R -> H (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs539470256)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V1353L	Q8WZ42/V1353L	TTN/V1353L	VARIANT	V -> L (in dbSNP:rs36062108)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I1393V	Q8WZ42/I1393V	TTN/I1393V	VARIANT	I -> V (in dbSNP:rs16866531)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R1416C	Q8WZ42/R1416C	TTN/R1416C	VARIANT	R -> C (in dbSNP:rs72647875)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R1441P	Q8WZ42/R1441P	TTN/R1441P	VARIANT	R -> P (in dbSNP:rs72647876)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I1544V	Q8WZ42/I1544V	TTN/I1544V	VARIANT	I -> V (in dbSNP:rs72647877)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R1572Q	Q8WZ42/R1572Q	TTN/R1572Q	VARIANT	R -> Q (in dbSNP:rs12476289)	ECO:0000269|PubMed:10850961, ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:17344846	10850961,11717165,17344846
Q8WZ42	TTN	R1658G	Q8WZ42/R1658G	TTN/R1658G	VARIANT	R -> G (in dbSNP:rs56270960)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R1664Q	Q8WZ42/R1664Q	TTN/R1664Q	VARIANT	R -> Q (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs375029799)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G1692D	Q8WZ42/G1692D	TTN/G1692D	VARIANT	G -> D (in a lung squamous cell carcinoma sample; somatic mutation; dbSNP:rs370004591)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P1744L	Q8WZ42/P1744L	TTN/P1744L	VARIANT	P -> L (in dbSNP:rs75686037)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S1772G	Q8WZ42/S1772G	TTN/S1772G	VARIANT	S -> G (in dbSNP:rs150725992)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T1907I	Q8WZ42/T1907I	TTN/T1907I	VARIANT	T -> I (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R1998H	Q8WZ42/R1998H	TTN/R1998H	VARIANT	R -> H (in dbSNP:rs144135510)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P2107L	Q8WZ42/P2107L	TTN/P2107L	VARIANT	P -> L (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I2118T	Q8WZ42/I2118T	TTN/I2118T	VARIANT	I -> T (in dbSNP:rs56404770)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A2164T	Q8WZ42/A2164T	TTN/A2164T	VARIANT	A -> T (in dbSNP:rs56285559)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	D2240Y	Q8WZ42/D2240Y	TTN/D2240Y	VARIANT	D -> Y	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G2392S	Q8WZ42/G2392S	TTN/G2392S	VARIANT	G -> S (in dbSNP:rs4894048)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L2432F	Q8WZ42/L2432F	TTN/L2432F	VARIANT	L -> F (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs571572592)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	M2610I	Q8WZ42/M2610I	TTN/M2610I	VARIANT	M -> I (in dbSNP:rs56142888)	ECO:0000269|PubMed:10850961, ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:17344846	10850961,11717165,17344846
Q8WZ42	TTN	I2771M	Q8WZ42/I2771M	TTN/I2771M	VARIANT	I -> M (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs576644663)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V2823F	Q8WZ42/V2823F	TTN/V2823F	VARIANT	V -> F (in dbSNP:rs33917087)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S2831N	Q8WZ42/S2831N	TTN/S2831N	VARIANT	S -> N (in dbSNP:rs2306636)	ECO:0000269|PubMed:10850961, ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:17344846	10850961,11717165,17344846
Q8WZ42	TTN	V2930I	Q8WZ42/V2930I	TTN/V2930I	VARIANT	V -> I (in dbSNP:rs56373393)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T2963P	Q8WZ42/T2963P	TTN/T2963P	VARIANT	T -> P (in dbSNP:rs200875815)	ECO:0000269|PubMed:25173926	25173926
Q8WZ42	TTN	N3026I	Q8WZ42/N3026I	TTN/N3026I	VARIANT	N -> I (in dbSNP:rs11900987)		
Q8WZ42	TTN	K3154R	Q8WZ42/K3154R	TTN/K3154R	VARIANT	K -> R (in dbSNP:rs4893853)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	Q3191E	Q8WZ42/Q3191E	TTN/Q3191E	VARIANT	Q -> E (in dbSNP:rs33997263)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P3238L	Q8WZ42/P3238L	TTN/P3238L	VARIANT	P -> L (in a bladder carcinoma sample; somatic mutation; dbSNP:rs397517792)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V3250G	Q8WZ42/V3250G	TTN/V3250G	VARIANT	V -> G (in dbSNP:rs55634230)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V3261M	Q8WZ42/V3261M	TTN/V3261M	VARIANT	V -> M (in dbSNP:rs2291311)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7569978	17344846,7569978
Q8WZ42	TTN	R3367Q	Q8WZ42/R3367Q	TTN/R3367Q	VARIANT	R -> Q (in dbSNP:rs34819099)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S3419N	Q8WZ42/S3419N	TTN/S3419N	VARIANT	S -> N (in dbSNP:rs2291310)	ECO:0000269|PubMed:7569978	7569978
Q8WZ42	TTN	E3482K	Q8WZ42/E3482K	TTN/E3482K	VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P3491S	Q8WZ42/P3491S	TTN/P3491S	VARIANT	P -> S (in dbSNP:rs2627037)	ECO:0000269|PubMed:10850961, ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:7569978	10850961,11717165,7569978
Q8WZ42	TTN	E3570K	Q8WZ42/E3570K	TTN/E3570K	VARIANT	E -> K (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L3590V	Q8WZ42/L3590V	TTN/L3590V	VARIANT	L -> V (in dbSNP:rs55853696)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P3637S	Q8WZ42/P3637S	TTN/P3637S	VARIANT	P -> S (in dbSNP:rs757223770)		
Q8WZ42	TTN	I3762V	Q8WZ42/I3762V	TTN/I3762V	VARIANT	I -> V (in dbSNP:rs34070843)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S3799Y	Q8WZ42/S3799Y	TTN/S3799Y	VARIANT	S -> Y (in CMD1G)	ECO:0000269|PubMed:11846417	11846417
Q8WZ42	TTN	I3877F	Q8WZ42/I3877F	TTN/I3877F	VARIANT	I -> F (in dbSNP:rs34618570)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I3965L	Q8WZ42/I3965L	TTN/I3965L	VARIANT	I -> L (in dbSNP:rs56244420)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R4084Q	Q8WZ42/R4084Q	TTN/R4084Q	VARIANT	R -> Q (in dbSNP:rs200431386)	ECO:0000269|PubMed:11846417	11846417
Q8WZ42	TTN	T4215P	Q8WZ42/T4215P	TTN/T4215P	VARIANT	T -> P (in dbSNP:rs2562829)	ECO:0000269|PubMed:10051295, ECO:0000269|PubMed:10850961, ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:11846417, ECO:0000269|PubMed:17344846	10051295,10850961,11717165,11846417,17344846
Q8WZ42	TTN	G4238W	Q8WZ42/G4238W	TTN/G4238W	VARIANT	G -> W (in dbSNP:rs56030296)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L4283F	Q8WZ42/L4283F	TTN/L4283F	VARIANT	L -> F (in dbSNP:rs1883085)	ECO:0000269|PubMed:10051295, ECO:0000269|PubMed:10850961, ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:17344846	10051295,10850961,11717165,17344846
Q8WZ42	TTN	I4291T	Q8WZ42/I4291T	TTN/I4291T	VARIANT	I -> T (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G4303D	Q8WZ42/G4303D	TTN/G4303D	VARIANT	G -> D (in dbSNP:rs55857742)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	D4427E	Q8WZ42/D4427E	TTN/D4427E	VARIANT	D -> E (in dbSNP:rs55906845)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S4465N	Q8WZ42/S4465N	TTN/S4465N	VARIANT	S -> N (in CMD1G; dbSNP:rs281864908)	ECO:0000269|PubMed:11846417	11846417
Q8WZ42	TTN	A8288V	Q8WZ42/A8288V	TTN/A8288V	VARIANT	A -> V (in dbSNP:rs16866412)		
Q8WZ42	TTN	I8474T	Q8WZ42/I8474T	TTN/I8474T	VARIANT	I -> T (in dbSNP:rs4893852)		
Q8WZ42	TTN	G12310E	Q8WZ42/G12310E	TTN/G12310E	VARIANT	G -> E (in dbSNP:rs55723264)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	H12383R	Q8WZ42/H12383R	TTN/H12383R	VARIANT	H -> R (in dbSNP:rs2288563)	ECO:0000269|PubMed:10850961	10850961
Q8WZ42	TTN	V12469A	Q8WZ42/V12469A	TTN/V12469A	VARIANT	V -> A (in dbSNP:rs34706299)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R12642C	Q8WZ42/R12642C	TTN/R12642C	VARIANT	R -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs199684560)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E12657K	Q8WZ42/E12657K	TTN/E12657K	VARIANT	E -> K (in a Wilms tumor; somatic mutation; dbSNP:rs778634417)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	K12679E	Q8WZ42/K12679E	TTN/K12679E	VARIANT	K -> E (in dbSNP:rs6723526)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7569978	17344846,7569978
Q8WZ42	TTN	S12720F	Q8WZ42/S12720F	TTN/S12720F	VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R12798C	Q8WZ42/R12798C	TTN/R12798C	VARIANT	R -> C (in dbSNP:rs200914097)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E13049G	Q8WZ42/E13049G	TTN/E13049G	VARIANT	E -> G	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E13083K	Q8WZ42/E13083K	TTN/E13083K	VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1458591077)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R13096L	Q8WZ42/R13096L	TTN/R13096L	VARIANT	R -> L (in dbSNP:rs373298007)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	Q13099R	Q8WZ42/Q13099R	TTN/Q13099R	VARIANT	Q -> R (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V13297A	Q8WZ42/V13297A	TTN/V13297A	VARIANT	V -> A (in dbSNP:rs571522834)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I13399M	Q8WZ42/I13399M	TTN/I13399M	VARIANT	I -> M (in dbSNP:rs74580375)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A13418T	Q8WZ42/A13418T	TTN/A13418T	VARIANT	A -> T (in dbSNP:rs144668626)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E13428V	Q8WZ42/E13428V	TTN/E13428V	VARIANT	E -> V (in dbSNP:rs114331773)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I13430T	Q8WZ42/I13430T	TTN/I13430T	VARIANT	I -> T (in dbSNP:rs184078045)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R13434K	Q8WZ42/R13434K	TTN/R13434K	VARIANT	R -> K (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	D13469N	Q8WZ42/D13469N	TTN/D13469N	VARIANT	D -> N (in dbSNP:rs17354992)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	K13495N	Q8WZ42/K13495N	TTN/K13495N	VARIANT	K -> N (in dbSNP:rs72677225)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	N13785S	Q8WZ42/N13785S	TTN/N13785S	VARIANT	N -> S (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	Q13870H	Q8WZ42/Q13870H	TTN/Q13870H	VARIANT	Q -> H (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V14109I	Q8WZ42/V14109I	TTN/V14109I	VARIANT	V -> I (in dbSNP:rs72677232)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R14131Q	Q8WZ42/R14131Q	TTN/R14131Q	VARIANT	R -> Q (in dbSNP:rs72677233)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P14208T	Q8WZ42/P14208T	TTN/P14208T	VARIANT	P -> T (in dbSNP:rs146181477)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L14728V	Q8WZ42/L14728V	TTN/L14728V	VARIANT	L -> V (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R14750Q	Q8WZ42/R14750Q	TTN/R14750Q	VARIANT	R -> Q (in dbSNP:rs200944827)	ECO:0000269|PubMed:25173926	25173926
Q8WZ42	TTN	S14999T	Q8WZ42/S14999T	TTN/S14999T	VARIANT	S -> T (in dbSNP:rs55663050)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	N15021T	Q8WZ42/N15021T	TTN/N15021T	VARIANT	N -> T (in dbSNP:rs36043230)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A15520V	Q8WZ42/A15520V	TTN/A15520V	VARIANT	A -> V (in dbSNP:rs16866412)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R15555I	Q8WZ42/R15555I	TTN/R15555I	VARIANT	R -> I (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs751398376)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R15620Q	Q8WZ42/R15620Q	TTN/R15620Q	VARIANT	R -> Q (in dbSNP:rs201825412)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S15629I	Q8WZ42/S15629I	TTN/S15629I	VARIANT	S -> I (in dbSNP:rs200650668)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	Y15635C	Q8WZ42/Y15635C	TTN/Y15635C	VARIANT	Y -> C (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R15700Q	Q8WZ42/R15700Q	TTN/R15700Q	VARIANT	R -> Q (in dbSNP:rs370390570)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L15705P	Q8WZ42/L15705P	TTN/L15705P	VARIANT	L -> P (in dbSNP:rs755155531)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I15837M	Q8WZ42/I15837M	TTN/I15837M	VARIANT	I -> M (in dbSNP:rs554368924)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G16046V	Q8WZ42/G16046V	TTN/G16046V	VARIANT	G -> V (in dbSNP:rs780672348)	ECO:0000269|PubMed:23033978	23033978
Q8WZ42	TTN	R16058H	Q8WZ42/R16058H	TTN/R16058H	VARIANT	R -> H (in dbSNP:rs72646808)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	K16067I	Q8WZ42/K16067I	TTN/K16067I	VARIANT	K -> I (in dbSNP:rs2303832)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I16090T	Q8WZ42/I16090T	TTN/I16090T	VARIANT	I -> T (in dbSNP:rs72646809)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R16195H	Q8WZ42/R16195H	TTN/R16195H	VARIANT	R -> H (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs373526624)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R16409C	Q8WZ42/R16409C	TTN/R16409C	VARIANT	R -> C (in dbSNP:rs55734111)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R16424P	Q8WZ42/R16424P	TTN/R16424P	VARIANT	R -> P	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V16575M	Q8WZ42/V16575M	TTN/V16575M	VARIANT	V -> M (in dbSNP:rs3813243)		
Q8WZ42	TTN	I16629M	Q8WZ42/I16629M	TTN/I16629M	VARIANT	I -> M (in dbSNP:rs55809450)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	K16877R	Q8WZ42/K16877R	TTN/K16877R	VARIANT	K -> R (in dbSNP:rs72646823)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	N17060D	Q8WZ42/N17060D	TTN/N17060D	VARIANT	N -> D (in dbSNP:rs1001238)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I17637V	Q8WZ42/I17637V	TTN/I17637V	VARIANT	I -> V (in dbSNP:rs56025724)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R17838H	Q8WZ42/R17838H	TTN/R17838H	VARIANT	R -> H (in dbSNP:rs2288569)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	D17866N	Q8WZ42/D17866N	TTN/D17866N	VARIANT	D -> N	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G17906E	Q8WZ42/G17906E	TTN/G17906E	VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation; dbSNP:rs374713701)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E18094A	Q8WZ42/E18094A	TTN/E18094A	VARIANT	E -> A (in dbSNP:rs769852851)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G18109S	Q8WZ42/G18109S	TTN/G18109S	VARIANT	G -> S (in dbSNP:rs200732032)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R18164T	Q8WZ42/R18164T	TTN/R18164T	VARIANT	R -> T (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P18221L	Q8WZ42/P18221L	TTN/P18221L	VARIANT	P -> L (in dbSNP:rs16866406)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A18222T	Q8WZ42/A18222T	TTN/A18222T	VARIANT	A -> T	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R18726Q	Q8WZ42/R18726Q	TTN/R18726Q	VARIANT	R -> Q (in dbSNP:rs141973925)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V18835A	Q8WZ42/V18835A	TTN/V18835A	VARIANT	V -> A (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1336054298)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R18881K	Q8WZ42/R18881K	TTN/R18881K	VARIANT	R -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1204056923)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	N18939S	Q8WZ42/N18939S	TTN/N18939S	VARIANT	N -> S (in dbSNP:rs1470758075)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R19000Q	Q8WZ42/R19000Q	TTN/R19000Q	VARIANT	R -> Q (in dbSNP:rs199895260)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L19060Q	Q8WZ42/L19060Q	TTN/L19060Q	VARIANT	L -> Q (in a lung large cell carcinoma sample; somatic mutation; dbSNP:rs1383995916)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R19091K	Q8WZ42/R19091K	TTN/R19091K	VARIANT	R -> K (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P19224S	Q8WZ42/P19224S	TTN/P19224S	VARIANT	P -> S (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T19367I	Q8WZ42/T19367I	TTN/T19367I	VARIANT	T -> I (in dbSNP:rs72646850)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E19392K	Q8WZ42/E19392K	TTN/E19392K	VARIANT	E -> K (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A19480S	Q8WZ42/A19480S	TTN/A19480S	VARIANT	A -> S (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	D19495G	Q8WZ42/D19495G	TTN/D19495G	VARIANT	D -> G (in dbSNP:rs773075736)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R19665H	Q8WZ42/R19665H	TTN/R19665H	VARIANT	R -> H (in dbSNP:rs202240487)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T19762I	Q8WZ42/T19762I	TTN/T19762I	VARIANT	T -> I (in dbSNP:rs2042996)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7569978	17344846,7569978
Q8WZ42	TTN	G19947R	Q8WZ42/G19947R	TTN/G19947R	VARIANT	G -> R (in dbSNP:rs181717727)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V19956M	Q8WZ42/V19956M	TTN/V19956M	VARIANT	V -> M (in dbSNP:rs150661999)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R19992Q	Q8WZ42/R19992Q	TTN/R19992Q	VARIANT	R -> Q (in dbSNP:rs141965360)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R20057C	Q8WZ42/R20057C	TTN/R20057C	VARIANT	R -> C (in dbSNP:rs72646861)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S20075L	Q8WZ42/S20075L	TTN/S20075L	VARIANT	S -> L (in dbSNP:rs13021201)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T20179K	Q8WZ42/T20179K	TTN/T20179K	VARIANT	T -> K	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A20198T	Q8WZ42/A20198T	TTN/A20198T	VARIANT	A -> T (in dbSNP:rs56378177)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A20198V	Q8WZ42/A20198V	TTN/A20198V	VARIANT	A -> V (in dbSNP:rs55948748)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R20331H	Q8WZ42/R20331H	TTN/R20331H	VARIANT	R -> H (in dbSNP:rs200217934)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R20359K	Q8WZ42/R20359K	TTN/R20359K	VARIANT	R -> K (in dbSNP:rs9808036)		
Q8WZ42	TTN	A20408T	Q8WZ42/A20408T	TTN/A20408T	VARIANT	A -> T (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R20564K	Q8WZ42/R20564K	TTN/R20564K	VARIANT	R -> K (in dbSNP:rs72646869)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V20718I	Q8WZ42/V20718I	TTN/V20718I	VARIANT	V -> I (in dbSNP:rs2303838)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7569978	17344846,7569978
Q8WZ42	TTN	S20726P	Q8WZ42/S20726P	TTN/S20726P	VARIANT	S -> P (in dbSNP:rs72646873)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T20892N	Q8WZ42/T20892N	TTN/T20892N	VARIANT	T -> N	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S20894R	Q8WZ42/S20894R	TTN/S20894R	VARIANT	S -> R (in dbSNP:rs750847940)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	D21125E	Q8WZ42/D21125E	TTN/D21125E	VARIANT	D -> E (in dbSNP:rs534340303)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P21403S	Q8WZ42/P21403S	TTN/P21403S	VARIANT	P -> S (in dbSNP:rs55980498)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R21730C	Q8WZ42/R21730C	TTN/R21730C	VARIANT	R -> C (in dbSNP:rs56141309)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R21747Q	Q8WZ42/R21747Q	TTN/R21747Q	VARIANT	R -> Q (in dbSNP:rs55853138)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	C21851R	Q8WZ42/C21851R	TTN/C21851R	VARIANT	C -> R (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs55713867)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G21925R	Q8WZ42/G21925R	TTN/G21925R	VARIANT	G -> R (in dbSNP:rs55801134)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R21995H	Q8WZ42/R21995H	TTN/R21995H	VARIANT	R -> H (in dbSNP:rs56071233)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A22045V	Q8WZ42/A22045V	TTN/A22045V	VARIANT	A -> V (in dbSNP:rs55903402)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R22149H	Q8WZ42/R22149H	TTN/R22149H	VARIANT	R -> H (in dbSNP:rs55677134)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V22160I	Q8WZ42/V22160I	TTN/V22160I	VARIANT	V -> I (in dbSNP:rs55885640)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I22261T	Q8WZ42/I22261T	TTN/I22261T	VARIANT	I -> T (in dbSNP:rs55837610)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	K22306N	Q8WZ42/K22306N	TTN/K22306N	VARIANT	K -> N (in dbSNP:rs56019808)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R22357H	Q8WZ42/R22357H	TTN/R22357H	VARIANT	R -> H (in dbSNP:rs10164753)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L22408P	Q8WZ42/L22408P	TTN/L22408P	VARIANT	L -> P (in dbSNP:rs56399205)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	Q22537H	Q8WZ42/Q22537H	TTN/Q22537H	VARIANT	Q -> H (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P22584L	Q8WZ42/P22584L	TTN/P22584L	VARIANT	P -> L (in dbSNP:rs55992239)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L22646P	Q8WZ42/L22646P	TTN/L22646P	VARIANT	L -> P (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T22670A	Q8WZ42/T22670A	TTN/T22670A	VARIANT	T -> A (in dbSNP:rs56201325)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A22770D	Q8WZ42/A22770D	TTN/A22770D	VARIANT	A -> D (in dbSNP:rs55991022)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A22801T	Q8WZ42/A22801T	TTN/A22801T	VARIANT	A -> T (in a metastatic melanoma sample; somatic mutation; dbSNP:rs764005465)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R22823W	Q8WZ42/R22823W	TTN/R22823W	VARIANT	R -> W (in a metastatic melanoma sample; somatic mutation; dbSNP:rs369098292)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E22968Q	Q8WZ42/E22968Q	TTN/E22968Q	VARIANT	E -> Q (in dbSNP:rs55762754)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P23074L	Q8WZ42/P23074L	TTN/P23074L	VARIANT	P -> L (in dbSNP:rs55713856)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L23079F	Q8WZ42/L23079F	TTN/L23079F	VARIANT	L -> F (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	D23282N	Q8WZ42/D23282N	TTN/D23282N	VARIANT	D -> N (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	H23303Y	Q8WZ42/H23303Y	TTN/H23303Y	VARIANT	H -> Y (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R23306C	Q8WZ42/R23306C	TTN/R23306C	VARIANT	R -> C (in dbSNP:rs744426)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A23515S	Q8WZ42/A23515S	TTN/A23515S	VARIANT	A -> S (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E23551Q	Q8WZ42/E23551Q	TTN/E23551Q	VARIANT	E -> Q (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S23807N	Q8WZ42/S23807N	TTN/S23807N	VARIANT	S -> N (in dbSNP:rs3813243)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7569978	17344846,7569978
Q8WZ42	TTN	D23872N	Q8WZ42/D23872N	TTN/D23872N	VARIANT	D -> N (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V23891A	Q8WZ42/V23891A	TTN/V23891A	VARIANT	V -> A (in dbSNP:rs55984930)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	Y23933H	Q8WZ42/Y23933H	TTN/Y23933H	VARIANT	Y -> H (in dbSNP:rs3813245)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T23939M	Q8WZ42/T23939M	TTN/T23939M	VARIANT	T -> M (in dbSNP:rs56372592)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	F23952L	Q8WZ42/F23952L	TTN/F23952L	VARIANT	F -> L (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A24098G	Q8WZ42/A24098G	TTN/A24098G	VARIANT	A -> G (in dbSNP:rs56391938)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A24098T	Q8WZ42/A24098T	TTN/A24098T	VARIANT	A -> T (in dbSNP:rs4894028)		
Q8WZ42	TTN	N24119S	Q8WZ42/N24119S	TTN/N24119S	VARIANT	N -> S (in dbSNP:rs3813246)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V24133I	Q8WZ42/V24133I	TTN/V24133I	VARIANT	V -> I (in dbSNP:rs56340968)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V24159A	Q8WZ42/V24159A	TTN/V24159A	VARIANT	V -> A (in a head and neck squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T24239A	Q8WZ42/T24239A	TTN/T24239A	VARIANT	T -> A (in dbSNP:rs56018860)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E24265K	Q8WZ42/E24265K	TTN/E24265K	VARIANT	E -> K (in dbSNP:rs56341835)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I24584T	Q8WZ42/I24584T	TTN/I24584T	VARIANT	I -> T (in dbSNP:rs12463674)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I24781T	Q8WZ42/I24781T	TTN/I24781T	VARIANT	I -> T (in dbSNP:rs3731745)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R24799H	Q8WZ42/R24799H	TTN/R24799H	VARIANT	R -> H (in dbSNP:rs56044609)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	D24954H	Q8WZ42/D24954H	TTN/D24954H	VARIANT	D -> H (in dbSNP:rs56307213)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T24980M	Q8WZ42/T24980M	TTN/T24980M	VARIANT	T -> M (in dbSNP:rs3731746)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7569978	17344846,7569978
Q8WZ42	TTN	R25659H	Q8WZ42/R25659H	TTN/R25659H	VARIANT	R -> H (in dbSNP:rs55850344)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A25679T	Q8WZ42/A25679T	TTN/A25679T	VARIANT	A -> T (in dbSNP:rs56365600)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P25720A	Q8WZ42/P25720A	TTN/P25720A	VARIANT	P -> A (in dbSNP:rs56137800)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T25821K	Q8WZ42/T25821K	TTN/T25821K	VARIANT	T -> K (in dbSNP:rs55933739)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E25859K	Q8WZ42/E25859K	TTN/E25859K	VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs375422359)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	N25879K	Q8WZ42/N25879K	TTN/N25879K	VARIANT	N -> K (in dbSNP:rs56264840)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A25923V	Q8WZ42/A25923V	TTN/A25923V	VARIANT	A -> V (in dbSNP:rs55634791)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V26045I	Q8WZ42/V26045I	TTN/V26045I	VARIANT	V -> I (in dbSNP:rs56309296)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	K26059E	Q8WZ42/K26059E	TTN/K26059E	VARIANT	K -> E (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I26134V	Q8WZ42/I26134V	TTN/I26134V	VARIANT	I -> V (in dbSNP:rs3829746)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R26477C	Q8WZ42/R26477C	TTN/R26477C	VARIANT	R -> C (in dbSNP:rs56057221)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	D26843Y	Q8WZ42/D26843Y	TTN/D26843Y	VARIANT	D -> Y (in dbSNP:rs56330345)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	K27346R	Q8WZ42/K27346R	TTN/K27346R	VARIANT	K -> R (in dbSNP:rs1186947794)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R27652C	Q8WZ42/R27652C	TTN/R27652C	VARIANT	R -> C (in dbSNP:rs191482653)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G27728V	Q8WZ42/G27728V	TTN/G27728V	VARIANT	G -> V (in dbSNP:rs55898359)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	F27754L	Q8WZ42/F27754L	TTN/F27754L	VARIANT	F -> L (in dbSNP:rs55940667)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I27755T	Q8WZ42/I27755T	TTN/I27755T	VARIANT	I -> T (in dbSNP:rs9808377)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:7569978	17344846,7569978
Q8WZ42	TTN	I27929V	Q8WZ42/I27929V	TTN/I27929V	VARIANT	I -> V (in dbSNP:rs139506970)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I28132L	Q8WZ42/I28132L	TTN/I28132L	VARIANT	I -> L (in dbSNP:rs77853750)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R28168Q	Q8WZ42/R28168Q	TTN/R28168Q	VARIANT	R -> Q (in dbSNP:rs72648238)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R28538H	Q8WZ42/R28538H	TTN/R28538H	VARIANT	R -> H (in dbSNP:rs149567378)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I28572T	Q8WZ42/I28572T	TTN/I28572T	VARIANT	I -> T (in dbSNP:rs114026724)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A28948T	Q8WZ42/A28948T	TTN/A28948T	VARIANT	A -> T (in dbSNP:rs148617456)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I28986V	Q8WZ42/I28986V	TTN/I28986V	VARIANT	I -> V (in dbSNP:rs535151633)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G28993E	Q8WZ42/G28993E	TTN/G28993E	VARIANT	G -> E (in dbSNP:rs376628842)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L28998V	Q8WZ42/L28998V	TTN/L28998V	VARIANT	L -> V (in dbSNP:rs373049260)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V29070M	Q8WZ42/V29070M	TTN/V29070M	VARIANT	V -> M (in dbSNP:rs747122)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I29090V	Q8WZ42/I29090V	TTN/I29090V	VARIANT	I -> V (in dbSNP:rs16866391)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R29419C	Q8WZ42/R29419C	TTN/R29419C	VARIANT	R -> C (in dbSNP:rs750303653)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L29479P	Q8WZ42/L29479P	TTN/L29479P	VARIANT	L -> P (in dbSNP:rs1310673663)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S29880L	Q8WZ42/S29880L	TTN/S29880L	VARIANT	S -> L (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	D29976E	Q8WZ42/D29976E	TTN/D29976E	VARIANT	D -> E (in dbSNP:rs72648256)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S30042G	Q8WZ42/S30042G	TTN/S30042G	VARIANT	S -> G (in dbSNP:rs72648257)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R30107C	Q8WZ42/R30107C	TTN/R30107C	VARIANT	R -> C (in dbSNP:rs142525903)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	S30125F	Q8WZ42/S30125F	TTN/S30125F	VARIANT	S -> F (in dbSNP:rs191484894)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L30211P	Q8WZ42/L30211P	TTN/L30211P	VARIANT	L -> P (in dbSNP:rs62621206)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I30412T	Q8WZ42/I30412T	TTN/I30412T	VARIANT	I -> T (in dbSNP:rs62621236)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T30617S	Q8WZ42/T30617S	TTN/T30617S	VARIANT	T -> S (in a renal chromophobe cancer sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T30674I	Q8WZ42/T30674I	TTN/T30674I	VARIANT	T -> I (in dbSNP:rs56027402)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V30809I	Q8WZ42/V30809I	TTN/V30809I	VARIANT	V -> I (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs397517769)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	F30818I	Q8WZ42/F30818I	TTN/F30818I	VARIANT	F -> I (in dbSNP:rs56009327)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E30825K	Q8WZ42/E30825K	TTN/E30825K	VARIANT	E -> K (in dbSNP:rs55915651)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I30856T	Q8WZ42/I30856T	TTN/I30856T	VARIANT	I -> T (in dbSNP:rs55660660)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G30887D	Q8WZ42/G30887D	TTN/G30887D	VARIANT	G -> D (in dbSNP:rs56066673)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G30887S	Q8WZ42/G30887S	TTN/G30887S	VARIANT	G -> S (in dbSNP:rs56233675)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R30897H	Q8WZ42/R30897H	TTN/R30897H	VARIANT	R -> H (in dbSNP:rs3731749)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R30907H	Q8WZ42/R30907H	TTN/R30907H	VARIANT	R -> H (in dbSNP:rs55676195)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R30946H	Q8WZ42/R30946H	TTN/R30946H	VARIANT	R -> H (in dbSNP:rs55704830)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I31081F	Q8WZ42/I31081F	TTN/I31081F	VARIANT	I -> F (in dbSNP:rs72648270)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R31107C	Q8WZ42/R31107C	TTN/R31107C	VARIANT	R -> C (in dbSNP:rs72648272)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	A31124G	Q8WZ42/A31124G	TTN/A31124G	VARIANT	A -> G (in dbSNP:rs72648273)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	N31156S	Q8WZ42/N31156S	TTN/N31156S	VARIANT	N -> S (in dbSNP:rs149001703)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P31246T	Q8WZ42/P31246T	TTN/P31246T	VARIANT	P -> T (in dbSNP:rs55653324)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R31330H	Q8WZ42/R31330H	TTN/R31330H	VARIANT	R -> H (in dbSNP:rs4894028)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	C31690R	Q8WZ42/C31690R	TTN/C31690R	VARIANT	C -> R (in dbSNP:rs56061641)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R31724Q	Q8WZ42/R31724Q	TTN/R31724Q	VARIANT	R -> Q (in dbSNP:rs55742743)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V31725I	Q8WZ42/V31725I	TTN/V31725I	VARIANT	V -> I (in dbSNP:rs55675869)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G31732S	Q8WZ42/G31732S	TTN/G31732S	VARIANT	G -> S (in dbSNP:rs55880786)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V31886I	Q8WZ42/V31886I	TTN/V31886I	VARIANT	V -> I (in dbSNP:rs2278196)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R32097C	Q8WZ42/R32097C	TTN/R32097C	VARIANT	R -> C (in dbSNP:rs56273463)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T32171N	Q8WZ42/T32171N	TTN/T32171N	VARIANT	T -> N (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V32248I	Q8WZ42/V32248I	TTN/V32248I	VARIANT	V -> I (in dbSNP:rs34924609)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	Q32281H	Q8WZ42/Q32281H	TTN/Q32281H	VARIANT	Q -> H (in dbSNP:rs55886356)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R32323H	Q8WZ42/R32323H	TTN/R32323H	VARIANT	R -> H (in dbSNP:rs55669553)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R32411W	Q8WZ42/R32411W	TTN/R32411W	VARIANT	R -> W (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs756924372)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I32558V	Q8WZ42/I32558V	TTN/I32558V	VARIANT	I -> V (in dbSNP:rs56347248)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	M32610V	Q8WZ42/M32610V	TTN/M32610V	VARIANT	M -> V (in dbSNP:rs56173891)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	G32637V	Q8WZ42/G32637V	TTN/G32637V	VARIANT	G -> V (in dbSNP:rs3731752)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E32742Q	Q8WZ42/E32742Q	TTN/E32742Q	VARIANT	E -> Q (in dbSNP:rs148525155)	ECO:0000269|PubMed:23033978	23033978
Q8WZ42	TTN	V32922A	Q8WZ42/V32922A	TTN/V32922A	VARIANT	V -> A (in dbSNP:rs55945684)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L32943R	Q8WZ42/L32943R	TTN/L32943R	VARIANT	L -> R (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R32953H	Q8WZ42/R32953H	TTN/R32953H	VARIANT	R -> H (in dbSNP:rs3829747)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R32996Q	Q8WZ42/R32996Q	TTN/R32996Q	VARIANT	R -> Q (in CMD1G; dbSNP:rs199642423)	ECO:0000269|PubMed:16465475	16465475
Q8WZ42	TTN	V33213L	Q8WZ42/V33213L	TTN/V33213L	VARIANT	V -> L (in dbSNP:rs55866005)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	R33242C	Q8WZ42/R33242C	TTN/R33242C	VARIANT	R -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1003158162)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T33387M	Q8WZ42/T33387M	TTN/T33387M	VARIANT	T -> M (in dbSNP:rs56001826)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E33419D	Q8WZ42/E33419D	TTN/E33419D	VARIANT	E -> D (in dbSNP:rs56308529)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V33536M	Q8WZ42/V33536M	TTN/V33536M	VARIANT	V -> M (in dbSNP:rs55865284)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	K33568Q	Q8WZ42/K33568Q	TTN/K33568Q	VARIANT	K -> Q (in dbSNP:rs56365812)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E33616K	Q8WZ42/E33616K	TTN/E33616K	VARIANT	E -> K (in dbSNP:rs56324595)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	P33620L	Q8WZ42/P33620L	TTN/P33620L	VARIANT	P -> L (in dbSNP:rs16866380)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	E33886V	Q8WZ42/E33886V	TTN/E33886V	VARIANT	E -> V (in dbSNP:rs55725279)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I33899T	Q8WZ42/I33899T	TTN/I33899T	VARIANT	I -> T (in dbSNP:rs55880440)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	L33904P	Q8WZ42/L33904P	TTN/L33904P	VARIANT	L -> P (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	T33955I	Q8WZ42/T33955I	TTN/T33955I	VARIANT	T -> I (in dbSNP:rs55842557)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	V34115A	Q8WZ42/V34115A	TTN/V34115A	VARIANT	V -> A (in dbSNP:rs16866378)	ECO:0000269|PubMed:17344846	17344846
Q8WZ42	TTN	I34306N	Q8WZ42/I34306N	TTN/I34306N	VARIANT	I -> N (in TMD; dbSNP:rs281864928)	ECO:0000269|PubMed:12891679	12891679
Q8WZ42	TTN	L34315P	Q8WZ42/L34315P	TTN/L34315P	VARIANT	L -> P (in TMD; dbSNP:rs267607156)	ECO:0000269|PubMed:12145747	12145747
Q8WZ42	TTN	K32207A	Q8WZ42/K32207A	TTN/K32207A	MUTAGEN	K->A: Disrupts catalytic activity.	ECO:0000269|PubMed:9804419	9804419
Q8WZ42	TTN	Y32341E	Q8WZ42/Y32341E	TTN/Y32341E	MUTAGEN	Y->E: No phosphorylation on tyrosine.	ECO:0000269|PubMed:9804419	9804419

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q92519	TRIB2	H4R	Q92519/H4R	TRIB2/H4R	VARIANT	H -> R (in dbSNP:rs55813198)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q92630	DYRK2	S98G	Q92630/S98G	DYRK2/S98G	VARIANT	S -> G (in dbSNP:rs35139851)	ECO:0000269|PubMed:17344846	17344846
Q92630	DYRK2	P198L	Q92630/P198L	DYRK2/P198L	VARIANT	P -> L (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs1384093596)	ECO:0000269|PubMed:17344846	17344846
Q92630	DYRK2	H245N	Q92630/H245N	DYRK2/H245N	VARIANT	H -> N (in dbSNP:rs34166200)	ECO:0000269|PubMed:17344846	17344846
Q92630	DYRK2	N295S	Q92630/N295S	DYRK2/N295S	VARIANT	N -> S (in dbSNP:rs56293072)	ECO:0000269|PubMed:17344846	17344846
Q92630	DYRK2	R451Q	Q92630/R451Q	DYRK2/R451Q	VARIANT	R -> Q (in dbSNP:rs35688869)	ECO:0000269|PubMed:17344846	17344846
Q92630	DYRK2	F455Y	Q92630/F455Y	DYRK2/F455Y	VARIANT	F -> Y (in dbSNP:rs55774594)	ECO:0000269|PubMed:17344846	17344846
Q92630	DYRK2	T106A	Q92630/T106A	DYRK2/T106A	MUTAGEN	T->A: Impaired ATM-mediated phosphorylation, reduced affinity with MDM2 and altered MDM2-triggered ubiquitination.	ECO:0000269|PubMed:19965871	19965871
Q92630	DYRK2	K251R	Q92630/K251R	DYRK2/K251R	MUTAGEN	K->R: Abolishes protein serine/threonine kinase activity.	ECO:0000269|PubMed:23362280	23362280
Q92630	DYRK2	S442A	Q92630/S442A	DYRK2/S442A	MUTAGEN	S->A: Impaired ATM-mediated phosphorylation, reduced affinity with MDM2 and altered MDM2-triggered ubiquitination.	ECO:0000269|PubMed:19965871	19965871

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q92772	CDKL2	Y77S	Q92772/Y77S	CDKL2/Y77S	VARIANT	Y -> S (in dbSNP:rs35921414)		
Q92772	CDKL2	L98I	Q92772/L98I	CDKL2/L98I	VARIANT	L -> I (in an ovarian papillary serous adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q92772	CDKL2	I132T	Q92772/I132T	CDKL2/I132T	VARIANT	I -> T (in dbSNP:rs17000707)		
Q92772	CDKL2	R149Q	Q92772/R149Q	CDKL2/R149Q	VARIANT	R -> Q (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs755711267)	ECO:0000269|PubMed:17344846	17344846
Q92772	CDKL2	M197T	Q92772/M197T	CDKL2/M197T	VARIANT	M -> T (in dbSNP:rs56343717)	ECO:0000269|PubMed:17344846	17344846
Q92772	CDKL2	A411V	Q92772/A411V	CDKL2/A411V	VARIANT	A -> V (in dbSNP:rs56231363)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q92918	MAP4K1	P312T	Q92918/P312T	MAP4K1/P312T	VARIANT	P -> T (in dbSNP:rs55924696)	ECO:0000269|PubMed:17344846	17344846
Q92918	MAP4K1	P351S	Q92918/P351S	MAP4K1/P351S	VARIANT	P -> S (in dbSNP:rs34591617)	ECO:0000269|PubMed:17344846	17344846
Q92918	MAP4K1	P361L	Q92918/P361L	MAP4K1/P361L	VARIANT	P -> L (in dbSNP:rs56060067)	ECO:0000269|PubMed:17344846	17344846
Q92918	MAP4K1	S737F	Q92918/S737F	MAP4K1/S737F	VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1238066548)	ECO:0000269|PubMed:17344846	17344846
Q92918	MAP4K1	N811S	Q92918/N811S	MAP4K1/N811S	VARIANT	N -> S (in dbSNP:rs12975825)		
Q92918	MAP4K1	T355A	Q92918/T355A	MAP4K1/T355A	MUTAGEN	T->A: Retains kinase activity. Not degraded by the Cul7-RING ubiquitin-protein ligase complex containing FBXW8.	ECO:0000269|PubMed:24362026	24362026

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96BR1	SGK3	A92V	Q96BR1/A92V	SGK3/A92V	VARIANT	A -> V (in a breast cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
Q96BR1	SGK3	L355P	Q96BR1/L355P	SGK3/L355P	VARIANT	L -> P (in dbSNP:rs750700898)	ECO:0000269|PubMed:17344846	17344846
Q96BR1	SGK3	R90A	Q96BR1/R90A	SGK3/R90A	MUTAGEN	R->A: Partially localized to the membrane.	ECO:0000269|PubMed:16790420	16790420
Q96BR1	SGK3	K191M	Q96BR1/K191M	SGK3/K191M	MUTAGEN	K->M: Abolishes activity.	ECO:0000269|PubMed:16790420	16790420
Q96BR1	SGK3	S486D	Q96BR1/S486D	SGK3/S486D	MUTAGEN	S->D: Increased activation.	ECO:0000269|PubMed:10548550	10548550

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96C45	ULK4	V18A	Q96C45/V18A	ULK4/V18A	VARIANT	V -> A (in dbSNP:rs34538622)	ECO:0000269|PubMed:17344846	17344846
Q96C45	ULK4	K39R	Q96C45/K39R	ULK4/K39R	VARIANT	K -> R (in dbSNP:rs2272007)	ECO:0000269|PubMed:17344846	17344846
Q96C45	ULK4	N139K	Q96C45/N139K	ULK4/N139K	VARIANT	N -> K (in dbSNP:rs35833603)	ECO:0000269|PubMed:17344846	17344846
Q96C45	ULK4	S223N	Q96C45/S223N	ULK4/S223N	VARIANT	S -> N (in dbSNP:rs55840267)	ECO:0000269|PubMed:17344846	17344846
Q96C45	ULK4	I224V	Q96C45/I224V	ULK4/I224V	VARIANT	I -> V (in dbSNP:rs1716975)		
Q96C45	ULK4	S348G	Q96C45/S348G	ULK4/S348G	VARIANT	S -> G (in dbSNP:rs35263917)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q96C45	ULK4	T415M	Q96C45/T415M	ULK4/T415M	VARIANT	T -> M (in dbSNP:rs371185820)	ECO:0000269|PubMed:17344846	17344846
Q96C45	ULK4	S417P	Q96C45/S417P	ULK4/S417P	VARIANT	S -> P (in dbSNP:rs75907560)	ECO:0000269|PubMed:17344846	17344846
Q96C45	ULK4	A542T	Q96C45/A542T	ULK4/A542T	VARIANT	A -> T (in dbSNP:rs1052501)		
Q96C45	ULK4	K569R	Q96C45/K569R	ULK4/K569R	VARIANT	K -> R (in dbSNP:rs3774372)		
Q96C45	ULK4	L603S	Q96C45/L603S	ULK4/L603S	VARIANT	L -> S (in dbSNP:rs17063572)		
Q96C45	ULK4	S640A	Q96C45/S640A	ULK4/S640A	VARIANT	S -> A (in dbSNP:rs4973986)		
Q96C45	ULK4	A715T	Q96C45/A715T	ULK4/A715T	VARIANT	A -> T (in dbSNP:rs17215589)		
Q96C45	ULK4	S1260N	Q96C45/S1260N	ULK4/S1260N	VARIANT	S -> N (in dbSNP:rs12488691)		
Q96C45	ULK4	A1261V	Q96C45/A1261V	ULK4/A1261V	VARIANT	A -> V (in dbSNP:rs6769117)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96D53	COQ8B	R78C	Q96D53/R78C	COQ8B/R78C	VARIANT	R -> C (in dbSNP:rs11538384)	ECO:0000269|PubMed:17344846	17344846
Q96D53	COQ8B	L98R	Q96D53/L98R	COQ8B/L98R	VARIANT	L -> R (in NPHS9)	ECO:0000269|PubMed:25967120	25967120
Q96D53	COQ8B	H174R	Q96D53/H174R	COQ8B/H174R	VARIANT	H -> R (in dbSNP:rs3865452)	ECO:0000269|PubMed:17344846	17344846
Q96D53	COQ8B	R178W	Q96D53/R178W	COQ8B/R178W	VARIANT	R -> W (in NPHS9; dbSNP:rs398122978)	ECO:0000269|PubMed:24270420, ECO:0000269|PubMed:25967120	24270420,25967120
Q96D53	COQ8B	D286G	Q96D53/D286G	COQ8B/D286G	VARIANT	D -> G (in NPHS9; dbSNP:rs398122979)	ECO:0000269|PubMed:24270420	24270420
Q96D53	COQ8B	P310L	Q96D53/P310L	COQ8B/P310L	VARIANT	P -> L (in NPHS9)	ECO:0000269|PubMed:25967120	25967120
Q96D53	COQ8B	T318M	Q96D53/T318M	COQ8B/T318M	VARIANT	T -> M (in dbSNP:rs55899516)	ECO:0000269|PubMed:17344846	17344846
Q96D53	COQ8B	R320W	Q96D53/R320W	COQ8B/R320W	VARIANT	R -> W (in NPHS9; dbSNP:rs369573693)	ECO:0000269|PubMed:24270420	24270420
Q96D53	COQ8B	R343W	Q96D53/R343W	COQ8B/R343W	VARIANT	R -> W (in NPHS9; dbSNP:rs398122981)	ECO:0000269|PubMed:24270420	24270420
Q96D53	COQ8B	T352R	Q96D53/T352R	COQ8B/T352R	VARIANT	T -> R (in dbSNP:rs36012476)	ECO:0000269|PubMed:17344846	17344846
Q96D53	COQ8B	T462M	Q96D53/T462M	COQ8B/T462M	VARIANT	T -> M (in dbSNP:rs56083906)	ECO:0000269|PubMed:17344846	17344846
Q96D53	COQ8B	R477Q	Q96D53/R477Q	COQ8B/R477Q	VARIANT	R -> Q (in NPHS9; dbSNP:rs1057519347)	ECO:0000269|PubMed:24270420	24270420
Q96D53	COQ8B	A498E	Q96D53/A498E	COQ8B/A498E	VARIANT	A -> E (in NPHS9)	ECO:0000269|PubMed:25967120	25967120

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96GD4	AURKB	A52V	Q96GD4/A52V	AURKB/A52V	VARIANT	A -> V (in dbSNP:rs55878091)	ECO:0000269|PubMed:17344846	17344846
Q96GD4	AURKB	H100Q	Q96GD4/H100Q	AURKB/H100Q	VARIANT	H -> Q (in dbSNP:rs3027254)		
Q96GD4	AURKB	T179M	Q96GD4/T179M	AURKB/T179M	VARIANT	T -> M (in dbSNP:rs55871613)	ECO:0000269|PubMed:17344846	17344846
Q96GD4	AURKB	M298T	Q96GD4/M298T	AURKB/M298T	VARIANT	M -> T (in dbSNP:rs1059476)	ECO:0000269|PubMed:11471245, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16762494, ECO:0000269|PubMed:9514916, ECO:0000269|PubMed:9809983, ECO:0000269|PubMed:9858806, ECO:0000269|Ref.5, ECO:0000269|Ref.7	11471245,15489334,16762494,9514916,9809983,9858806
Q96GD4	AURKB	K106R	Q96GD4/K106R	AURKB/K106R	MUTAGEN	K->R: Leads to loss of kinase activity and severely impairs mitotic progression.	ECO:0000269|PubMed:12686604, ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:14722118, ECO:0000269|PubMed:16179162	12686604,12925766,14722118,16179162
Q96GD4	AURKB	K215Q	Q96GD4/K215Q	AURKB/K215Q	MUTAGEN	K->Q: Mimics acetylation, promoting accurate chromosome segregation.	ECO:0000269|PubMed:26829474	26829474
Q96GD4	AURKB	K215R	Q96GD4/K215R	AURKB/K215R	MUTAGEN	K->R: Abolished acetylation by KAT5, leading to impaired chromosome segregation.	ECO:0000269|PubMed:26829474	26829474

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96GX5	MASTL	E167D	Q96GX5/E167D	MASTL/E167D	VARIANT	E -> D (found in a large family with autosomal dominant thrombocytopenia; unknown pathological significance; no effect on nuclear localization; dbSNP:rs28941470)	ECO:0000269|PubMed:12890928, ECO:0000269|PubMed:19460416	12890928,19460416
Q96GX5	MASTL	T337K	Q96GX5/T337K	MASTL/T337K	VARIANT	T -> K (in dbSNP:rs36121140)	ECO:0000269|PubMed:17344846	17344846
Q96GX5	MASTL	D606Y	Q96GX5/D606Y	MASTL/D606Y	VARIANT	D -> Y (in dbSNP:rs35413630)		
Q96GX5	MASTL	V610I	Q96GX5/V610I	MASTL/V610I	VARIANT	V -> I (in dbSNP:rs35571315)	ECO:0000269|PubMed:17344846	17344846
Q96GX5	MASTL	P620A	Q96GX5/P620A	MASTL/P620A	VARIANT	P -> A (in dbSNP:rs3802526)	ECO:0000269|PubMed:17344846	17344846
Q96GX5	MASTL	K72M	Q96GX5/K72M	MASTL/K72M	MUTAGEN	K->M: Hyperactive form.	ECO:0000269|PubMed:21164014	21164014

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96J92	WNK4	E434D	Q96J92/E434D	WNK4/E434D	VARIANT	E -> D (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96J92	WNK4	E562K	Q96J92/E562K	WNK4/E562K	VARIANT	E -> K (in PHA2B; impaired interaction with KLHL3; dbSNP:rs137853093)	ECO:0000269|PubMed:11498583, ECO:0000269|PubMed:23387299, ECO:0000269|PubMed:23576762	11498583,23387299,23576762
Q96J92	WNK4	D564A	Q96J92/D564A	WNK4/D564A	VARIANT	D -> A (in PHA2B; impaired interaction with KLHL3; dbSNP:rs137853094)	ECO:0000269|PubMed:11498583, ECO:0000269|PubMed:23453970	11498583,23453970
Q96J92	WNK4	Q565E	Q96J92/Q565E	WNK4/Q565E	VARIANT	Q -> E (in PHA2B; impaired interaction with KLHL3; dbSNP:rs137853092)	ECO:0000269|PubMed:11498583, ECO:0000269|PubMed:23387299, ECO:0000269|PubMed:23576762	11498583,23387299,23576762
Q96J92	WNK4	A601S	Q96J92/A601S	WNK4/A601S	VARIANT	A -> S (in dbSNP:rs55781437)		
Q96J92	WNK4	R677W	Q96J92/R677W	WNK4/R677W	VARIANT	R -> W (in dbSNP:rs9896991)		
Q96J92	WNK4	P813L	Q96J92/P813L	WNK4/P813L	VARIANT	P -> L	ECO:0000269|PubMed:17344846	17344846
Q96J92	WNK4	P961S	Q96J92/P961S	WNK4/P961S	VARIANT	P -> S (in dbSNP:rs2290041)		
Q96J92	WNK4	P992S	Q96J92/P992S	WNK4/P992S	VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96J92	WNK4	L1013P	Q96J92/L1013P	WNK4/L1013P	VARIANT	L -> P	ECO:0000269|PubMed:17344846	17344846
Q96J92	WNK4	R1185C	Q96J92/R1185C	WNK4/R1185C	VARIANT	R -> C (in PHA2B; dbSNP:rs137853095)	ECO:0000269|PubMed:11498583	11498583

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96KB5	PBK	N107S	Q96KB5/N107S	PBK/N107S	VARIANT	N -> S (in dbSNP:rs3779620)	ECO:0000269|PubMed:10779557, ECO:0000269|PubMed:11378444, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	10779557,11378444,14702039,17344846
Q96KB5	PBK	E220D	Q96KB5/E220D	PBK/E220D	VARIANT	E -> D (in dbSNP:rs17057901)		
Q96KB5	PBK	M241L	Q96KB5/M241L	PBK/M241L	VARIANT	M -> L (in dbSNP:rs36086402)	ECO:0000269|PubMed:17344846	17344846
Q96KB5	PBK	T9E	Q96KB5/T9E	PBK/T9E	MUTAGEN	T->E: TP53-binding.	ECO:0000269|PubMed:17482142	17482142
Q96KB5	PBK	T320A	Q96KB5/T320A	PBK/T320A	MUTAGEN	T->A: Decrease in the binding to DLG1.	ECO:0000269|PubMed:10779557	10779557
Q96KB5	PBK	V322A	Q96KB5/V322A	PBK/V322A	MUTAGEN	V->A: Decrease in the binding to DLG1.	ECO:0000269|PubMed:10779557	10779557

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96KG9	SCYL1	P479L	Q96KG9/P479L	SCYL1/P479L	VARIANT	P -> L (in dbSNP:rs55977709)	ECO:0000269|PubMed:17344846	17344846
Q96KG9	SCYL1	H495Y	Q96KG9/H495Y	SCYL1/H495Y	VARIANT	H -> Y (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96KG9	SCYL1	Q663H	Q96KG9/Q663H	SCYL1/Q663H	VARIANT	Q -> H (in dbSNP:rs56076708)	ECO:0000269|PubMed:17344846	17344846
Q96KG9	SCYL1	W755S	Q96KG9/W755S	SCYL1/W755S	VARIANT	W -> S (in dbSNP:rs56077405)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96L34	MARK4	R377Q	Q96L34/R377Q	MARK4/R377Q	VARIANT	R -> Q (in dbSNP:rs35070611)	ECO:0000269|PubMed:17344846	17344846
Q96L34	MARK4	R418C	Q96L34/R418C	MARK4/R418C	VARIANT	R -> C (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs780763668)	ECO:0000269|PubMed:17344846	17344846
Q96L34	MARK4	T214A	Q96L34/T214A	MARK4/T214A	MUTAGEN			
Q96L34	MARK4	T214E	Q96L34/T214E	MARK4/T214E	MUTAGEN	T->E: Mimicks phosphorylation state, leading to increased activity. Decreases mTORC1 activity.	ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:23184942	14976552,23184942

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96L96	ALPK3	R336H	Q96L96/R336H	ALPK3/R336H	VARIANT	R -> H (in dbSNP:rs34407151)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	T338I	Q96L96/T338I	ALPK3/T338I	VARIANT	T -> I (in dbSNP:rs56015306)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	T414S	Q96L96/T414S	ALPK3/T414S	VARIANT	T -> S (in dbSNP:rs3803403)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	Q433E	Q96L96/Q433E	ALPK3/Q433E	VARIANT	Q -> E (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	G579E	Q96L96/G579E	ALPK3/G579E	VARIANT	G -> E (in dbSNP:rs3803405)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	Q602R	Q96L96/Q602R	ALPK3/Q602R	VARIANT	Q -> R (in dbSNP:rs55702300)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	G663D	Q96L96/G663D	ALPK3/G663D	VARIANT	G -> D (in dbSNP:rs34409363)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	T761M	Q96L96/T761M	ALPK3/T761M	VARIANT	T -> M (in dbSNP:rs16974569)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	R836L	Q96L96/R836L	ALPK3/R836L	VARIANT	R -> L (in dbSNP:rs34906636)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	E929D	Q96L96/E929D	ALPK3/E929D	VARIANT	E -> D (in dbSNP:rs56191073)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	E1013K	Q96L96/E1013K	ALPK3/E1013K	VARIANT	E -> K (in dbSNP:rs35633849)		
Q96L96	ALPK3	A1137G	Q96L96/A1137G	ALPK3/A1137G	VARIANT	A -> G (in dbSNP:rs34173528)		
Q96L96	ALPK3	P1299L	Q96L96/P1299L	ALPK3/P1299L	VARIANT	P -> L (in dbSNP:rs306197)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:10718198, ECO:0000269|PubMed:17344846	10021370,10718198,17344846
Q96L96	ALPK3	G1364E	Q96L96/G1364E	ALPK3/G1364E	VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	R1412W	Q96L96/R1412W	ALPK3/R1412W	VARIANT	R -> W (in dbSNP:rs55752937)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	A1557D	Q96L96/A1557D	ALPK3/A1557D	VARIANT	A -> D (in dbSNP:rs34775428)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	L1622P	Q96L96/L1622P	ALPK3/L1622P	VARIANT	L -> P (in dbSNP:rs187316)	ECO:0000269|PubMed:17344846	17344846
Q96L96	ALPK3	A1873V	Q96L96/A1873V	ALPK3/A1873V	VARIANT	A -> V (in dbSNP:rs36002219)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96NX5	CAMK1G	E259Q	Q96NX5/E259Q	CAMK1G/E259Q	VARIANT	E -> Q (in dbSNP:rs35561962)	ECO:0000269|PubMed:17344846	17344846
Q96NX5	CAMK1G	V329I	Q96NX5/V329I	CAMK1G/V329I	VARIANT	V -> I (in dbSNP:rs11119315)	ECO:0000269|PubMed:10645953, ECO:0000269|PubMed:17344846	10645953,17344846
Q96NX5	CAMK1G	A443T	Q96NX5/A443T	CAMK1G/A443T	VARIANT	A -> T (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1228276529)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96PF2	TSSK2	K27R	Q96PF2/K27R	TSSK2/K27R	VARIANT	K -> R (may be associated with infertility; dbSNP:rs3747052)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:19926886	17344846,19926886
Q96PF2	TSSK2	M61V	Q96PF2/M61V	TSSK2/M61V	VARIANT	M -> V (in dbSNP:rs35532431)	ECO:0000269|PubMed:17344846	17344846
Q96PF2	TSSK2	Y197C	Q96PF2/Y197C	TSSK2/Y197C	VARIANT	Y -> C (in dbSNP:rs56279111)	ECO:0000269|PubMed:17344846	17344846
Q96PF2	TSSK2	E244K	Q96PF2/E244K	TSSK2/E244K	VARIANT	E -> K (in dbSNP:rs35048893)		
Q96PF2	TSSK2	C245S	Q96PF2/C245S	TSSK2/C245S	VARIANT	C -> S (in dbSNP:rs8140743)		
Q96PF2	TSSK2	T280M	Q96PF2/T280M	TSSK2/T280M	VARIANT	T -> M (in dbSNP:rs1052763)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96PN8	TSSK3	I71V	Q96PN8/I71V	TSSK3/I71V	VARIANT	I -> V (in dbSNP:rs35508255)		
Q96PN8	TSSK3	A140T	Q96PN8/A140T	TSSK3/A140T	VARIANT	A -> T (in dbSNP:rs55786268)	ECO:0000269|PubMed:17344846	17344846
Q96PN8	TSSK3	S235L	Q96PN8/S235L	TSSK3/S235L	VARIANT	S -> L (in dbSNP:rs35457991)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96PY6	NEK1	I10F	Q96PY6/I10F	NEK1/I10F	VARIANT	I -> F (in dbSNP:rs34214559)	ECO:0000269|PubMed:17344846	17344846
Q96PY6	NEK1	E25K	Q96PY6/E25K	NEK1/E25K	VARIANT	E -> K (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96PY6	NEK1	L76V	Q96PY6/L76V	NEK1/L76V	VARIANT	L -> V (in dbSNP:rs35093214)	ECO:0000269|PubMed:17344846	17344846
Q96PY6	NEK1	G145R	Q96PY6/G145R	NEK1/G145R	VARIANT	G -> R (in SRTD6; dbSNP:rs431905508)	ECO:0000269|PubMed:22499340	22499340
Q96PY6	NEK1	L253S	Q96PY6/L253S	NEK1/L253S	VARIANT	L -> S (in SRTD6)	ECO:0000269|PubMed:22499340	22499340
Q96PY6	NEK1	R261H	Q96PY6/R261H	NEK1/R261H	VARIANT	R -> H (in ALS24; associated with disease susceptibility; dbSNP:rs200161705)	ECO:0000269|PubMed:27455347	27455347
Q96PY6	NEK1	A294P	Q96PY6/A294P	NEK1/A294P	VARIANT	A -> P (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96PY6	NEK1	R355G	Q96PY6/R355G	NEK1/R355G	VARIANT	R -> G (in dbSNP:rs35763578)	ECO:0000269|PubMed:17344846	17344846
Q96PY6	NEK1	A463V	Q96PY6/A463V	NEK1/A463V	VARIANT	A -> V (in dbSNP:rs34540355)	ECO:0000269|PubMed:17344846	17344846
Q96PY6	NEK1	A598T	Q96PY6/A598T	NEK1/A598T	VARIANT	A -> T (in dbSNP:rs33933790)	ECO:0000269|PubMed:17344846	17344846
Q96PY6	NEK1	N717K	Q96PY6/N717K	NEK1/N717K	VARIANT	N -> K (in dbSNP:rs34324114)		
Q96PY6	NEK1	E724G	Q96PY6/E724G	NEK1/E724G	VARIANT	E -> G (in dbSNP:rs34099167)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17974005	17344846,17974005
Q96PY6	NEK1	K745N	Q96PY6/K745N	NEK1/K745N	VARIANT	K -> N	ECO:0000269|PubMed:17344846	17344846
Q96PY6	NEK1	Q883E	Q96PY6/Q883E	NEK1/Q883E	VARIANT	Q -> E (in dbSNP:rs6828134)	ECO:0000269|PubMed:17344846	17344846
Q96PY6	NEK1	D1180N	Q96PY6/D1180N	NEK1/D1180N	VARIANT	D -> N (in dbSNP:rs35503975)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96Q04	LMTK3	V900L	Q96Q04/V900L	LMTK3/V900L	VARIANT	V -> L (in dbSNP:rs1643478)		
Q96Q04	LMTK3	L929V	Q96Q04/L929V	LMTK3/L929V	VARIANT	L -> V (in dbSNP:rs1643478)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96Q15	SMG1	A35T	Q96Q15/A35T	SMG1/A35T	VARIANT	A -> T (in dbSNP:rs12051350)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	R126C	Q96Q15/R126C	SMG1/R126C	VARIANT	R -> C (in dbSNP:rs752796432)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	S144C	Q96Q15/S144C	SMG1/S144C	VARIANT	S -> C (in dbSNP:rs766737607)	ECO:0000269|PubMed:15175154, ECO:0000269|PubMed:17344846	15175154,17344846
Q96Q15	SMG1	N151Y	Q96Q15/N151Y	SMG1/N151Y	VARIANT	N -> Y (in dbSNP:rs750788715)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	D160N	Q96Q15/D160N	SMG1/D160N	VARIANT	D -> N	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	A167V	Q96Q15/A167V	SMG1/A167V	VARIANT	A -> V (in dbSNP:rs1382468496)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	D320G	Q96Q15/D320G	SMG1/D320G	VARIANT	D -> G	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	G465S	Q96Q15/G465S	SMG1/G465S	VARIANT	G -> S (in dbSNP:rs200419100)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	H546R	Q96Q15/H546R	SMG1/H546R	VARIANT	H -> R (in dbSNP:rs376234691)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	A588S	Q96Q15/A588S	SMG1/A588S	VARIANT	A -> S (in dbSNP:rs750840136)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	I612K	Q96Q15/I612K	SMG1/I612K	VARIANT	I -> K (in dbSNP:rs17842615)	ECO:0000269|PubMed:15175154, ECO:0000269|PubMed:17344846	15175154,17344846
Q96Q15	SMG1	S753C	Q96Q15/S753C	SMG1/S753C	VARIANT	S -> C (in dbSNP:rs569679854)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	S809C	Q96Q15/S809C	SMG1/S809C	VARIANT	S -> C (in dbSNP:rs919788709)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	R812C	Q96Q15/R812C	SMG1/R812C	VARIANT	R -> C (in dbSNP:rs1233400465)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	V829I	Q96Q15/V829I	SMG1/V829I	VARIANT	V -> I	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	N832D	Q96Q15/N832D	SMG1/N832D	VARIANT	N -> D (in dbSNP:rs80176913)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	A952G	Q96Q15/A952G	SMG1/A952G	VARIANT	A -> G (in dbSNP:rs555078480)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	N969S	Q96Q15/N969S	SMG1/N969S	VARIANT	N -> S (in dbSNP:rs1412788971)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	F1016L	Q96Q15/F1016L	SMG1/F1016L	VARIANT	F -> L (in dbSNP:rs1394431566)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	R1029Q	Q96Q15/R1029Q	SMG1/R1029Q	VARIANT	R -> Q	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	T1072S	Q96Q15/T1072S	SMG1/T1072S	VARIANT	T -> S (in dbSNP:rs45516593)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	N1103H	Q96Q15/N1103H	SMG1/N1103H	VARIANT	N -> H (in dbSNP:rs563883658)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	P1275R	Q96Q15/P1275R	SMG1/P1275R	VARIANT	P -> R	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	Q1292P	Q96Q15/Q1292P	SMG1/Q1292P	VARIANT	Q -> P (in dbSNP:rs375411122)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	I1332V	Q96Q15/I1332V	SMG1/I1332V	VARIANT	I -> V (in dbSNP:rs949474935)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	S1358P	Q96Q15/S1358P	SMG1/S1358P	VARIANT	S -> P	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	R1418T	Q96Q15/R1418T	SMG1/R1418T	VARIANT	R -> T (in dbSNP:rs17731779)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	S2171C	Q96Q15/S2171C	SMG1/S2171C	VARIANT	S -> C (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	G2258S	Q96Q15/G2258S	SMG1/G2258S	VARIANT	G -> S (in dbSNP:rs35572280)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	M2345K	Q96Q15/M2345K	SMG1/M2345K	VARIANT	M -> K (in dbSNP:rs56276814)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	Q2730E	Q96Q15/Q2730E	SMG1/Q2730E	VARIANT	Q -> E (in dbSNP:rs34960798)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	G2889S	Q96Q15/G2889S	SMG1/G2889S	VARIANT	G -> S (in dbSNP:rs35952340)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	P2899A	Q96Q15/P2899A	SMG1/P2899A	VARIANT	P -> A (in dbSNP:rs55782217)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	I3239T	Q96Q15/I3239T	SMG1/I3239T	VARIANT	I -> T (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	K3583Q	Q96Q15/K3583Q	SMG1/K3583Q	VARIANT	K -> Q (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96Q15	SMG1	D2335A	Q96Q15/D2335A	SMG1/D2335A	MUTAGEN	D->A: Loss of function.	ECO:0000269|PubMed:11331269, ECO:0000269|PubMed:11544179, ECO:0000269|PubMed:15175154	11331269,11544179,15175154

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96Q40	CDK15	R64G	Q96Q40/R64G	CDK15/R64G	VARIANT	R -> G (in dbSNP:rs34776344)	ECO:0000269|PubMed:17344846	17344846
Q96Q40	CDK15	K93E	Q96Q40/K93E	CDK15/K93E	VARIANT	K -> E (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96Q40	CDK15	Q127R	Q96Q40/Q127R	CDK15/Q127R	VARIANT	Q -> R (in dbSNP:rs56135556)	ECO:0000269|PubMed:17344846	17344846
Q96Q40	CDK15	T255I	Q96Q40/T255I	CDK15/T255I	VARIANT	T -> I (in dbSNP:rs34851370)	ECO:0000269|PubMed:17344846	17344846
Q96Q40	CDK15	E276D	Q96Q40/E276D	CDK15/E276D	VARIANT	E -> D (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1490814436)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96QP1	ALPK1	Q67R	Q96QP1/Q67R	ALPK1/Q67R	VARIANT	Q -> R (in dbSNP:rs33943680)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	N175D	Q96QP1/N175D	ALPK1/N175D	VARIANT	N -> D (in dbSNP:rs6533616)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	T237M	Q96QP1/T237M	ALPK1/T237M	VARIANT	T -> M (in ROSAH)	ECO:0000269|PubMed:30967659, ECO:0000269|PubMed:31939038	30967659,31939038
Q96QP1	ALPK1	T292M	Q96QP1/T292M	ALPK1/T292M	VARIANT	T -> M (in dbSNP:rs34120296)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	L320M	Q96QP1/L320M	ALPK1/L320M	VARIANT	L -> M (in dbSNP:rs757602009)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	K339E	Q96QP1/K339E	ALPK1/K339E	VARIANT	K -> E (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	K383E	Q96QP1/K383E	ALPK1/K383E	VARIANT	K -> E (in dbSNP:rs147641444)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	G565D	Q96QP1/G565D	ALPK1/G565D	VARIANT	G -> D (in dbSNP:rs2074388)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:10819331, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5	10021370,10819331,14702039,17344846
Q96QP1	ALPK1	H642R	Q96QP1/H642R	ALPK1/H642R	VARIANT	H -> R (in dbSNP:rs13148353)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:10819331, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5	10021370,10819331,14702039,17344846
Q96QP1	ALPK1	P660L	Q96QP1/P660L	ALPK1/P660L	VARIANT	P -> L (in dbSNP:rs35389530)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	G681D	Q96QP1/G681D	ALPK1/G681D	VARIANT	G -> D (in dbSNP:rs35519493)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q96QP1	ALPK1	M732I	Q96QP1/M732I	ALPK1/M732I	VARIANT	M -> I (in dbSNP:rs2074379)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:10819331, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5	10021370,10819331,14702039,17344846
Q96QP1	ALPK1	M861T	Q96QP1/M861T	ALPK1/M861T	VARIANT	M -> T (in dbSNP:rs11726117)	ECO:0000269|PubMed:10021370, ECO:0000269|PubMed:10819331, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5	10021370,10819331,14702039,17344846
Q96QP1	ALPK1	G870S	Q96QP1/G870S	ALPK1/G870S	VARIANT	G -> S (in dbSNP:rs2074380)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	R873I	Q96QP1/R873I	ALPK1/R873I	VARIANT	R -> I (in dbSNP:rs34946272)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	E910D	Q96QP1/E910D	ALPK1/E910D	VARIANT	E -> D (in dbSNP:rs35308602)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	N916D	Q96QP1/N916D	ALPK1/N916D	VARIANT	N -> D (in dbSNP:rs2074381)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	P935L	Q96QP1/P935L	ALPK1/P935L	VARIANT	P -> L (in dbSNP:rs34780600)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	H1008P	Q96QP1/H1008P	ALPK1/H1008P	VARIANT	H -> P (in dbSNP:rs34079946)		
Q96QP1	ALPK1	R1084Q	Q96QP1/R1084Q	ALPK1/R1084Q	VARIANT	R -> Q (in dbSNP:rs34677416)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	L1117P	Q96QP1/L1117P	ALPK1/L1117P	VARIANT	L -> P (in dbSNP:rs35756863)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	A1160G	Q96QP1/A1160G	ALPK1/A1160G	VARIANT	A -> G (in dbSNP:rs55696324)	ECO:0000269|PubMed:17344846	17344846
Q96QP1	ALPK1	Q67A	Q96QP1/Q67A	ALPK1/Q67A	MUTAGEN	Q->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity; when associated with A-231.	ECO:0000269|PubMed:30111836	30111836
Q96QP1	ALPK1	R116A	Q96QP1/R116A	ALPK1/R116A	MUTAGEN	R->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.	ECO:0000269|PubMed:30111836	30111836
Q96QP1	ALPK1	R150A	Q96QP1/R150A	ALPK1/R150A	MUTAGEN	R->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.	ECO:0000269|PubMed:30111836	30111836
Q96QP1	ALPK1	R153A	Q96QP1/R153A	ALPK1/R153A	MUTAGEN	R->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.	ECO:0000269|PubMed:30111836	30111836
Q96QP1	ALPK1	D231A	Q96QP1/D231A	ALPK1/D231A	MUTAGEN	D->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity; when associated with A-67.	ECO:0000269|PubMed:30111836	30111836
Q96QP1	ALPK1	K233A	Q96QP1/K233A	ALPK1/K233A	MUTAGEN	K->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.	ECO:0000269|PubMed:30111836	30111836
Q96QP1	ALPK1	T237E	Q96QP1/T237E	ALPK1/T237E	MUTAGEN	T->E: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity; when associated with K-295.	ECO:0000269|PubMed:30111836	30111836
Q96QP1	ALPK1	F295K	Q96QP1/F295K	ALPK1/F295K	MUTAGEN	F->K: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity; when associated with E-237.	ECO:0000269|PubMed:30111836	30111836
Q96QP1	ALPK1	K1067M	Q96QP1/K1067M	ALPK1/K1067M	MUTAGEN	K->M: Abolishes the serine/threonine-protein kinase and ability to initiate the innate immune response.	ECO:0000269|PubMed:30111836	30111836

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96QS6	PSKH2	G72D	Q96QS6/G72D	PSKH2/G72D	VARIANT	G -> D (in dbSNP:rs56407605)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	R79K	Q96QS6/R79K	PSKH2/R79K	VARIANT	R -> K (in dbSNP:rs35315725)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	R114Q	Q96QS6/R114Q	PSKH2/R114Q	VARIANT	R -> Q (in dbSNP:rs35915498)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	S116I	Q96QS6/S116I	PSKH2/S116I	VARIANT	S -> I (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	Q132R	Q96QS6/Q132R	PSKH2/Q132R	VARIANT	Q -> R (in dbSNP:rs16879427)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	R148Q	Q96QS6/R148Q	PSKH2/R148Q	VARIANT	R -> Q (in dbSNP:rs56356246)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	A176S	Q96QS6/A176S	PSKH2/A176S	VARIANT	A -> S (in dbSNP:rs6998760)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	G211R	Q96QS6/G211R	PSKH2/G211R	VARIANT	G -> R (in dbSNP:rs36074412)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	K212I	Q96QS6/K212I	PSKH2/K212I	VARIANT	K -> I (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs778066815)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	T225A	Q96QS6/T225A	PSKH2/T225A	VARIANT	T -> A (in dbSNP:rs34457516)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	S266R	Q96QS6/S266R	PSKH2/S266R	VARIANT	S -> R (in dbSNP:rs34037815)	ECO:0000269|PubMed:17344846	17344846
Q96QS6	PSKH2	I336V	Q96QS6/I336V	PSKH2/I336V	VARIANT	I -> V (in dbSNP:rs16876805)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96QT4	TRPM7	G68V	Q96QT4/G68V	TRPM7/G68V	VARIANT	G -> V (in dbSNP:rs56064201)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	S406C	Q96QT4/S406C	TRPM7/S406C	VARIANT	S -> C (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	I459T	Q96QT4/I459T	TRPM7/I459T	VARIANT	I -> T (in dbSNP:rs55924090)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	K574N	Q96QT4/K574N	TRPM7/K574N	VARIANT	K -> N (in dbSNP:rs56040619)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	T720S	Q96QT4/T720S	TRPM7/T720S	VARIANT	T -> S (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1040254222)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	M830V	Q96QT4/M830V	TRPM7/M830V	VARIANT	M -> V (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	F949Y	Q96QT4/F949Y	TRPM7/F949Y	VARIANT	F -> Y (in dbSNP:rs55681028)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	A1033G	Q96QT4/A1033G	TRPM7/A1033G	VARIANT	A -> G (in dbSNP:rs34530969)		
Q96QT4	TRPM7	G1046D	Q96QT4/G1046D	TRPM7/G1046D	VARIANT	G -> D (probable disease-associated variant found in a patient with hypomagnesemia and secondary hypocalcemia; de novo variant; causes severely reduced Mg(2+) uptake in transfected cells; dbSNP:rs2059709974)	ECO:0000269|PubMed:35561741	35561741
Q96QT4	TRPM7	Q1064R	Q96QT4/Q1064R	TRPM7/Q1064R	VARIANT	Q -> R (in dbSNP:rs56298128)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	I1145V	Q96QT4/I1145V	TRPM7/I1145V	VARIANT	I -> V (in dbSNP:rs34711809)		
Q96QT4	TRPM7	I1211T	Q96QT4/I1211T	TRPM7/I1211T	VARIANT	I -> T (in dbSNP:rs56090496)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	A1254V	Q96QT4/A1254V	TRPM7/A1254V	VARIANT	A -> V (in dbSNP:rs56288221)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	D1306E	Q96QT4/D1306E	TRPM7/D1306E	VARIANT	D -> E (in dbSNP:rs55970334)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	R1444K	Q96QT4/R1444K	TRPM7/R1444K	VARIANT	R -> K (in dbSNP:rs55840070)	ECO:0000269|PubMed:17344846	17344846
Q96QT4	TRPM7	T1482I	Q96QT4/T1482I	TRPM7/T1482I	VARIANT	T -> I (mutant channels are functional but show increased susceptibility to inhibition by intracellular magnesium concentrations compared to wild-type channels; dbSNP:rs8042919)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:16051700, ECO:0000269|PubMed:17344846	14702039,16051700,17344846
Q96QT4	TRPM7	K1648R	Q96QT4/K1648R	TRPM7/K1648R	MUTAGEN	K->R: Loss of kinase activity.	ECO:0000269|PubMed:12887921	12887921
Q96QT4	TRPM7	G1799D	Q96QT4/G1799D	TRPM7/G1799D	MUTAGEN	G->D: Loss of kinase activity.	ECO:0000269|PubMed:12887921	12887921

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96RG2	PASK	E11K	Q96RG2/E11K	PASK/E11K	VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1277219458)	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	V250I	Q96RG2/V250I	PASK/V250I	VARIANT	V -> I (in dbSNP:rs1470414)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
Q96RG2	PASK	Q426R	Q96RG2/Q426R	PASK/Q426R	VARIANT	Q -> R (in dbSNP:rs35187712)	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	T512A	Q96RG2/T512A	PASK/T512A	VARIANT	T -> A (in dbSNP:rs56033464)	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	L514S	Q96RG2/L514S	PASK/L514S	VARIANT	L -> S (in dbSNP:rs2240543)	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	P684R	Q96RG2/P684R	PASK/P684R	VARIANT	P -> R (in dbSNP:rs56372985)	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	V694M	Q96RG2/V694M	PASK/V694M	VARIANT	V -> M (in dbSNP:rs6727226)	ECO:0000269|PubMed:8590280	8590280
Q96RG2	PASK	G725D	Q96RG2/G725D	PASK/G725D	VARIANT	G -> D (in dbSNP:rs2005771)	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	E796K	Q96RG2/E796K	PASK/E796K	VARIANT	E -> K (in dbSNP:rs35129131)	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	P844Q	Q96RG2/P844Q	PASK/P844Q	VARIANT	P -> Q (in dbSNP:rs36082918)	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	R937H	Q96RG2/R937H	PASK/R937H	VARIANT	R -> H (in dbSNP:rs56139954)	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	V1210M	Q96RG2/V1210M	PASK/V1210M	VARIANT	V -> M (in dbSNP:rs10167000)	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	F1266C	Q96RG2/F1266C	PASK/F1266C	VARIANT	F -> C (in dbSNP:rs1131293)	ECO:0000269|PubMed:11459942, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8590280	11459942,17344846,8590280
Q96RG2	PASK	P1301S	Q96RG2/P1301S	PASK/P1301S	VARIANT	P -> S	ECO:0000269|PubMed:17344846	17344846
Q96RG2	PASK	K1028R	Q96RG2/K1028R	PASK/K1028R	MUTAGEN	K->R: Loss of autophosphorylating activity.	ECO:0000269|PubMed:11459942, ECO:0000269|PubMed:20943661	11459942,20943661
Q96RG2	PASK	R1058A	Q96RG2/R1058A	PASK/R1058A	MUTAGEN	R->A: Induces lower protein kinase activity.	ECO:0000269|PubMed:20943661	20943661
Q96RG2	PASK	R1058K	Q96RG2/R1058K	PASK/R1058K	MUTAGEN	R->K: Does not affect protein kinase activity.	ECO:0000269|PubMed:20943661	20943661
Q96RG2	PASK	A1151K	Q96RG2/A1151K	PASK/A1151K	MUTAGEN	A->K: Induces lower protein kinase activity and ability to autophosphorylate.	ECO:0000269|PubMed:20943661	20943661
Q96RG2	PASK	Y1152F	Q96RG2/Y1152F	PASK/Y1152F	MUTAGEN	Y->F: Induces lower protein kinase activity.	ECO:0000269|PubMed:20943661	20943661
Q96RG2	PASK	T1161A	Q96RG2/T1161A	PASK/T1161A	MUTAGEN	T->A: Loss of catalytic activity (PubMed:11459942). According to another report, does not affect the protein kinase activity (PubMed:20943661). Does not affect protein translation.	ECO:0000269|PubMed:11459942, ECO:0000269|PubMed:17595531, ECO:0000269|PubMed:20943661	11459942,20943661,11459942,17595531,20943661
Q96RG2	PASK	T1165A	Q96RG2/T1165A	PASK/T1165A	MUTAGEN	T->A: Loss of catalytic activity. Does not affect protein translation.	ECO:0000269|PubMed:11459942, ECO:0000269|PubMed:17595531	11459942,17595531

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96RR4	CAMKK2	S10N	Q96RR4/S10N	CAMKK2/S10N	VARIANT	S -> N (in dbSNP:rs28360477)	ECO:0000269|PubMed:17344846	17344846
Q96RR4	CAMKK2	T85S	Q96RR4/T85S	CAMKK2/T85S	VARIANT	T -> S (in dbSNP:rs3817190)	ECO:0000269|PubMed:11395482, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9872452	11395482,15489334,17344846,9872452
Q96RR4	CAMKK2	C123Y	Q96RR4/C123Y	CAMKK2/C123Y	VARIANT	C -> Y (in dbSNP:rs35403710)	ECO:0000269|PubMed:17344846	17344846
Q96RR4	CAMKK2	P127L	Q96RR4/P127L	CAMKK2/P127L	VARIANT	P -> L (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96RR4	CAMKK2	A182T	Q96RR4/A182T	CAMKK2/A182T	VARIANT	A -> T (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs1207121718)	ECO:0000269|PubMed:17344846	17344846
Q96RR4	CAMKK2	R363C	Q96RR4/R363C	CAMKK2/R363C	VARIANT	R -> C (in dbSNP:rs1132780)		
Q96RR4	CAMKK2	R492H	Q96RR4/R492H	CAMKK2/R492H	VARIANT	R -> H (in dbSNP:rs34129994)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96RU7	TRIB3	T60I	Q96RU7/T60I	TRIB3/T60I	VARIANT	T -> I (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs757496714)	ECO:0000269|PubMed:17344846	17344846
Q96RU7	TRIB3	Q84R	Q96RU7/Q84R	TRIB3/Q84R	VARIANT	Q -> R (in dbSNP:rs2295490)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
Q96RU7	TRIB3	R153H	Q96RU7/R153H	TRIB3/R153H	VARIANT	R -> H (in dbSNP:rs35051116)	ECO:0000269|PubMed:17344846	17344846
Q96RU7	TRIB3	R274H	Q96RU7/R274H	TRIB3/R274H	VARIANT	R -> H (in dbSNP:rs56291463)	ECO:0000269|PubMed:17344846	17344846
Q96RU7	TRIB3	E347K	Q96RU7/E347K	TRIB3/E347K	VARIANT	E -> K (in dbSNP:rs56342286)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96RU8	TRIB1	S173R	Q96RU8/S173R	TRIB1/S173R	VARIANT	S -> R (in dbSNP:rs56285697)	ECO:0000269|PubMed:17344846	17344846
Q96RU8	TRIB1	T215M	Q96RU8/T215M	TRIB1/T215M	VARIANT	T -> M (in dbSNP:rs34349706)	ECO:0000269|PubMed:17344846	17344846
Q96RU8	TRIB1	V267I	Q96RU8/V267I	TRIB1/V267I	VARIANT	V -> I (in dbSNP:rs56056430)	ECO:0000269|PubMed:17344846	17344846
Q96RU8	TRIB1	R298C	Q96RU8/R298C	TRIB1/R298C	VARIANT	R -> C (in dbSNP:rs55953723)	ECO:0000269|PubMed:17344846	17344846
Q96RU8	TRIB1	E360A	Q96RU8/E360A	TRIB1/E360A	VARIANT	E->A: Decreased interaction with COP1.	ECO:0000269|PubMed:27041596	27041596
Q96RU8	TRIB1	E360D	Q96RU8/E360D	TRIB1/E360D	VARIANT	E -> D (in dbSNP:rs16900603)	ECO:0000269|PubMed:17344846	17344846
Q96RU8	TRIB1	F371L	Q96RU8/F371L	TRIB1/F371L	VARIANT	F -> L (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96RU8	TRIB1	D355A	Q96RU8/D355A	TRIB1/D355A	MUTAGEN	D->A: Decreased interaction with COP1.	ECO:0000269|PubMed:27041596	27041596
Q96RU8	TRIB1	Q356A	Q96RU8/Q356A	TRIB1/Q356A	MUTAGEN	Q->A: Decreased interaction with COP1.	ECO:0000269|PubMed:27041596	27041596
Q96RU8	TRIB1	I357A	Q96RU8/I357A	TRIB1/I357A	MUTAGEN	I->A: Decreased interaction with COP1.	ECO:0000269|PubMed:27041596	27041596
Q96RU8	TRIB1	V358I	Q96RU8/V358I	TRIB1/V358I	MUTAGEN	V->I,A: Loss of interaction with COP1.		
Q96RU8	TRIB1	V358A	Q96RU8/V358A	TRIB1/V358A	MUTAGEN	V->I,A: Loss of interaction with COP1.	ECO:0000269|PubMed:27041596	27041596
Q96RU8	TRIB1	P359A	Q96RU8/P359A	TRIB1/P359A	MUTAGEN	P->A: Strongly decreased interaction with COP1.	ECO:0000269|PubMed:27041596	27041596
Q96RU8	TRIB1	Y361A	Q96RU8/Y361A	TRIB1/Y361A	MUTAGEN	Y->A: No effect on interaction with COP1.	ECO:0000269|PubMed:27041596	27041596

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96S38	RPS6KC1	P42T	Q96S38/P42T	RPS6KC1/P42T	VARIANT	P -> T (in dbSNP:rs56087470)	ECO:0000269|PubMed:17344846	17344846
Q96S38	RPS6KC1	E96K	Q96S38/E96K	RPS6KC1/E96K	VARIANT	E -> K (in dbSNP:rs56032860)	ECO:0000269|PubMed:17344846	17344846
Q96S38	RPS6KC1	P319L	Q96S38/P319L	RPS6KC1/P319L	VARIANT	P -> L (in dbSNP:rs56369827)	ECO:0000269|PubMed:17344846	17344846
Q96S38	RPS6KC1	P424L	Q96S38/P424L	RPS6KC1/P424L	VARIANT	P -> L (in dbSNP:rs56183862)	ECO:0000269|PubMed:17344846	17344846
Q96S38	RPS6KC1	A546P	Q96S38/A546P	RPS6KC1/A546P	VARIANT	A -> P (in dbSNP:rs35281247)	ECO:0000269|PubMed:17344846	17344846
Q96S38	RPS6KC1	L554I	Q96S38/L554I	RPS6KC1/L554I	VARIANT	L -> I (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96S38	RPS6KC1	P561R	Q96S38/P561R	RPS6KC1/P561R	VARIANT	P -> R (in dbSNP:rs17020314)		
Q96S38	RPS6KC1	N575S	Q96S38/N575S	RPS6KC1/N575S	VARIANT	N -> S (in dbSNP:rs56060894)	ECO:0000269|PubMed:17344846	17344846
Q96S38	RPS6KC1	G663A	Q96S38/G663A	RPS6KC1/G663A	VARIANT	G -> A (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96S38	RPS6KC1	L853F	Q96S38/L853F	RPS6KC1/L853F	VARIANT	L -> F (in dbSNP:rs34080597)	ECO:0000269|PubMed:17344846	17344846
Q96S38	RPS6KC1	C1003Y	Q96S38/C1003Y	RPS6KC1/C1003Y	VARIANT	C -> Y (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q96S38	RPS6KC1	E1022K	Q96S38/E1022K	RPS6KC1/E1022K	VARIANT	E -> K (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96S44	TP53RK	A25T	Q96S44/A25T	TP53RK/A25T	VARIANT	A -> T	ECO:0000269|Ref.2	
Q96S44	TP53RK	G42D	Q96S44/G42D	TP53RK/G42D	VARIANT	G -> D (in GAMOS4; dbSNP:rs773814837)	ECO:0000269|PubMed:28805828	28805828
Q96S44	TP53RK	T81R	Q96S44/T81R	TP53RK/T81R	VARIANT	T -> R (in GAMOS4; abolished interaction with TPRKB; dbSNP:rs1432218739)	ECO:0000269|PubMed:28805828	28805828
Q96S44	TP53RK	R123Q	Q96S44/R123Q	TP53RK/R123Q	VARIANT	R -> Q (in dbSNP:rs34983477)	ECO:0000269|PubMed:17344846	17344846
Q96S44	TP53RK	T129A	Q96S44/T129A	TP53RK/T129A	VARIANT	T -> A (in dbSNP:rs11550540)	ECO:0000269|PubMed:17344846	17344846
Q96S44	TP53RK	T145A	Q96S44/T145A	TP53RK/T145A	VARIANT	T -> A (in dbSNP:rs56008408)	ECO:0000269|PubMed:17344846	17344846
Q96S44	TP53RK	R243L	Q96S44/R243L	TP53RK/R243L	VARIANT	R -> L (in GAMOS4; dbSNP:rs776588426)	ECO:0000269|PubMed:28805828	28805828

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96S53	TESK2	G11A	Q96S53/G11A	TESK2/G11A	VARIANT	G -> A (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1428512439)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q96SB4	SRPK1	I72T	Q96SB4/I72T	SRPK1/I72T	VARIANT	I -> T (in dbSNP:rs35519113)		
Q96SB4	SRPK1	S37A	Q96SB4/S37A	SRPK1/S37A	MUTAGEN	S->A: No effect on protein phosphorylation.	ECO:0000269|PubMed:12565829	12565829
Q96SB4	SRPK1	S51A	Q96SB4/S51A	SRPK1/S51A	MUTAGEN	S->A: Protein phosphorylation impaired at this position.	ECO:0000269|PubMed:12565829	12565829
Q96SB4	SRPK1	S222A	Q96SB4/S222A	SRPK1/S222A	MUTAGEN	S->A: No effect on protein phosphorylation.	ECO:0000269|PubMed:12565829	12565829
Q96SB4	SRPK1	S311G	Q96SB4/S311G	SRPK1/S311G	MUTAGEN	S->G: No effect on protein phosphorylation.	ECO:0000269|PubMed:12565829	12565829
Q96SB4	SRPK1	S436G	Q96SB4/S436G	SRPK1/S436G	MUTAGEN	S->G: No effect on protein phosphorylation.	ECO:0000269|PubMed:12565829	12565829
Q96SB4	SRPK1	S555A	Q96SB4/S555A	SRPK1/S555A	MUTAGEN	S->A: Protein phosphorylation impaired at this position.	ECO:0000269|PubMed:12565829	12565829
Q96SB4	SRPK1	S619A	Q96SB4/S619A	SRPK1/S619A	MUTAGEN	S->A: No effect on protein phosphorylation.	ECO:0000269|PubMed:12565829	12565829

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q99558	MAP3K14	S140N	Q99558/S140N	MAP3K14/S140N	VARIANT	S -> N (in dbSNP:rs11574819)	ECO:0000269|PubMed:17344846	17344846
Q99558	MAP3K14	T255M	Q99558/T255M	MAP3K14/T255M	VARIANT	T -> M (in dbSNP:rs11574820)		
Q99558	MAP3K14	G514K	Q99558/G514K	MAP3K14/G514K	VARIANT	G -> K (in a lung neuroendocrine carcinoma sample; somatic mutation; requires 2 nucleotide substitutions)	ECO:0000269|PubMed:17344846	17344846
Q99558	MAP3K14	H674Y	Q99558/H674Y	MAP3K14/H674Y	VARIANT	H -> Y (in dbSNP:rs11867907)		
Q99558	MAP3K14	T764A	Q99558/T764A	MAP3K14/T764A	VARIANT	T -> A (in dbSNP:rs56302559)	ECO:0000269|PubMed:17344846	17344846
Q99558	MAP3K14	T852I	Q99558/T852I	MAP3K14/T852I	VARIANT	T -> I (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q99558	MAP3K14	P928H	Q99558/P928H	MAP3K14/P928H	VARIANT	P -> H (in dbSNP:rs56036201)	ECO:0000269|PubMed:17344846	17344846
Q99558	MAP3K14	T559A	Q99558/T559A	MAP3K14/T559A	MUTAGEN	T->A: Abolishes 'Lys-63'-linked ubiquitination.	ECO:0000269|PubMed:20682767	20682767

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q99570	PIK3R4	F273L	Q99570/F273L	PIK3R4/F273L	VARIANT	F -> L (in dbSNP:rs55951445)	ECO:0000269|PubMed:17344846	17344846
Q99570	PIK3R4	R342H	Q99570/R342H	PIK3R4/R342H	VARIANT	R -> H (in dbSNP:rs56295394)	ECO:0000269|PubMed:17344846	17344846
Q99570	PIK3R4	R347W	Q99570/R347W	PIK3R4/R347W	VARIANT	R -> W (in dbSNP:rs34797184)	ECO:0000269|PubMed:17344846	17344846
Q99570	PIK3R4	T388I	Q99570/T388I	PIK3R4/T388I	VARIANT	T -> I (in dbSNP:rs34663155)	ECO:0000269|PubMed:17344846	17344846
Q99570	PIK3R4	D393N	Q99570/D393N	PIK3R4/D393N	VARIANT	D -> N (in dbSNP:rs34633532)	ECO:0000269|PubMed:17344846	17344846
Q99570	PIK3R4	L699V	Q99570/L699V	PIK3R4/L699V	VARIANT	L -> V (in dbSNP:rs56369596)	ECO:0000269|PubMed:17344846	17344846
Q99570	PIK3R4	R936Q	Q99570/R936Q	PIK3R4/R936Q	VARIANT	R -> Q (in a breast cancer sample; somatic mutation; dbSNP:rs181132426)	ECO:0000269|PubMed:16959974	16959974
Q99570	PIK3R4	G1043V	Q99570/G1043V	PIK3R4/G1043V	VARIANT	G -> V (in dbSNP:rs56160735)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q99640	PKMYT1	E103Q	Q99640/E103Q	PKMYT1/E103Q	VARIANT	E -> Q (in dbSNP:rs55834293)	ECO:0000269|PubMed:17344846	17344846
Q99640	PKMYT1	R140C	Q99640/R140C	PKMYT1/R140C	VARIANT	R -> C (in dbSNP:rs4149796)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	17344846
Q99640	PKMYT1	R246H	Q99640/R246H	PKMYT1/R246H	VARIANT	R -> H (in dbSNP:rs35192104)	ECO:0000269|PubMed:17344846	17344846
Q99640	PKMYT1	E351K	Q99640/E351K	PKMYT1/E351K	VARIANT	E -> K (in dbSNP:rs56382954)	ECO:0000269|PubMed:17344846	17344846
Q99640	PKMYT1	P417R	Q99640/P417R	PKMYT1/P417R	VARIANT	P -> R (in dbSNP:rs4149800)	ECO:0000269|Ref.4	
Q99640	PKMYT1	V445A	Q99640/V445A	PKMYT1/V445A	VARIANT	V -> A (in dbSNP:rs10546)	ECO:0000269|Ref.4	
Q99640	PKMYT1	N238A	Q99640/N238A	PKMYT1/N238A	MUTAGEN	N->A: Loss of kinase activity.	ECO:0000269|PubMed:10373560	10373560
Q99640	PKMYT1	D251A	Q99640/D251A	PKMYT1/D251A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:10504341	10504341

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q99683	MAP3K5	G1006R	Q99683/G1006R	MAP3K5/G1006R	VARIANT	G -> R (in dbSNP:rs45626535)	ECO:0000269|PubMed:17344846	17344846
Q99683	MAP3K5	I1214T	Q99683/I1214T	MAP3K5/I1214T	VARIANT	I -> T (in dbSNP:rs56379668)	ECO:0000269|PubMed:17344846	17344846
Q99683	MAP3K5	I1250V	Q99683/I1250V	MAP3K5/I1250V	VARIANT	I -> V (in dbSNP:rs35551087)	ECO:0000269|PubMed:17344846	17344846
Q99683	MAP3K5	T1314I	Q99683/T1314I	MAP3K5/T1314I	VARIANT	T -> I (in dbSNP:rs45599539)	ECO:0000269|PubMed:17344846	17344846
Q99683	MAP3K5	D1315N	Q99683/D1315N	MAP3K5/D1315N	VARIANT	D -> N (in dbSNP:rs41288957)	ECO:0000269|PubMed:17344846	17344846
Q99683	MAP3K5	R32K	Q99683/R32K	MAP3K5/R32K	MUTAGEN	R->K: No effect on methylation by PRMT1.	ECO:0000269|PubMed:22095282	22095282
Q99683	MAP3K5	R78K	Q99683/R78K	MAP3K5/R78K	MUTAGEN	R->K: Reduced methylation by PRMT1. Abolishes methylation by PRMT1 and PRMT1-mediated inhibition of MAPK35 activation; when associated with K-80.	ECO:0000269|PubMed:22095282	22095282
Q99683	MAP3K5	R80K	Q99683/R80K	MAP3K5/R80K	MUTAGEN	R->K: Reduced methylation by PRMT1. Abolishes methylation by PRMT1 and PRMT1-mediated inhibition of MAPK35 activation; when associated with K-78.	ECO:0000269|PubMed:22095282	22095282
Q99683	MAP3K5	K709M	Q99683/K709M	MAP3K5/K709M	MUTAGEN	K->M: Loss of kinase activity. Inhibits activation of JNK and apoptosis mediated by TNFRSF6 and DAXX. Does not affect interaction with TRIM48.	ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:29186683, ECO:0000269|PubMed:9743501	17210579,29186683,9743501
Q99683	MAP3K5	K709R	Q99683/K709R	MAP3K5/K709R	MUTAGEN	K->R: Loss of kinase activity. Abolishes DAXX-mediated apoptosis. Loss of RC3H2-mediated ubiquitination.	ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:24448648, ECO:0000269|PubMed:9743501	17210579,24448648,9743501
Q99683	MAP3K5	T838A	Q99683/T838A	MAP3K5/T838A	MUTAGEN	T->A: Does not affect interaction with TRIM48.	ECO:0000269|PubMed:29186683	29186683
Q99683	MAP3K5	S966A	Q99683/S966A	MAP3K5/S966A	MUTAGEN	S->A: Enhanced induction of apoptosis, increased kinase activity, and loss of YWHAG binding.	ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:15094778	10411906,15094778
Q99683	MAP3K5	S1033A	Q99683/S1033A	MAP3K5/S1033A	MUTAGEN	S->A: Enhanced induction of apoptosis and increased kinase activity.	ECO:0000269|PubMed:15094778	15094778

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q99759	MAP3K3	V281M	Q99759/V281M	MAP3K3/V281M	VARIANT	V -> M (in dbSNP:rs36109904)	ECO:0000269|PubMed:17344846	17344846
Q99759	MAP3K3	A325G	Q99759/A325G	MAP3K3/A325G	VARIANT	A -> G (in dbSNP:rs34042309)		
Q99759	MAP3K3	A435G	Q99759/A435G	MAP3K3/A435G	VARIANT	A -> G (in dbSNP:rs9910858)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q99986	VRK1	S14A	Q99986/S14A	VRK1/S14A	MUTAGEN	S->A: Does not abolish autophosphorylation.	ECO:0000269|PubMed:10951572	10951572
Q99986	VRK1	T102A	Q99986/T102A	VRK1/T102A	MUTAGEN	T->A: Does not abolish autophosphorylation.	ECO:0000269|PubMed:10951572	10951572
Q99986	VRK1	S125A	Q99986/S125A	VRK1/S125A	MUTAGEN	S->A: Does not abolish autophosphorylation.	ECO:0000269|PubMed:10951572	10951572
Q99986	VRK1	S150A	Q99986/S150A	VRK1/S150A	MUTAGEN	S->A: Does not abolish autophosphorylation.	ECO:0000269|PubMed:10951572	10951572
Q99986	VRK1	S158A	Q99986/S158A	VRK1/S158A	MUTAGEN	S->A: Does not abolish autophosphorylation.	ECO:0000269|PubMed:10951572	10951572
Q99986	VRK1	K179A	Q99986/K179A	VRK1/K179A	MUTAGEN	K->A: Does not affect phosphorylation at S-342.	ECO:0000269|PubMed:19103756	19103756
Q99986	VRK1	S239A	Q99986/S239A	VRK1/S239A	MUTAGEN	S->A: Does not abolish autophosphorylation.	ECO:0000269|PubMed:10951572	10951572
Q99986	VRK1	T305A	Q99986/T305A	VRK1/T305A	MUTAGEN	T->A: Does not abolish autophosphorylation.	ECO:0000269|PubMed:10951572	10951572
Q99986	VRK1	T312A	Q99986/T312A	VRK1/T312A	MUTAGEN	T->A: Does not abolish autophosphorylation.	ECO:0000269|PubMed:10951572	10951572
Q99986	VRK1	S342A	Q99986/S342A	VRK1/S342A	MUTAGEN	S->A: Abolishes phosphorylation by PLK3 and induction of Golgi fragmentation during mitosis. Strongly reduced autophosphorylation.	ECO:0000269|PubMed:19103756, ECO:0000269|PubMed:21543316	19103756,21543316
Q99986	VRK1	T353A	Q99986/T353A	VRK1/T353A	MUTAGEN	T->A: Strongly reduced autophosphorylation.	ECO:0000269|PubMed:21543316	21543316
Q99986	VRK1	T355A	Q99986/T355A	VRK1/T355A	MUTAGEN	T->A: Does not abolish autophosphorylation.	ECO:0000269|PubMed:10951572	10951572
Q99986	VRK1	T390A	Q99986/T390A	VRK1/T390A	MUTAGEN	T->A: Does not abolish autophosphorylation.	ECO:0000269|PubMed:10951572	10951572

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BQI3	EIF2AK1	R117T	Q9BQI3/R117T	EIF2AK1/R117T	VARIANT	R -> T (in dbSNP:rs34889754)	ECO:0000269|PubMed:17344846	17344846
Q9BQI3	EIF2AK1	K132T	Q9BQI3/K132T	EIF2AK1/K132T	VARIANT	K -> T (in dbSNP:rs34851195)	ECO:0000269|PubMed:17344846	17344846
Q9BQI3	EIF2AK1	R134K	Q9BQI3/R134K	EIF2AK1/R134K	VARIANT	R -> K (in dbSNP:rs55744865)	ECO:0000269|PubMed:17344846	17344846
Q9BQI3	EIF2AK1	P139S	Q9BQI3/P139S	EIF2AK1/P139S	VARIANT	P -> S (in dbSNP:rs55963745)	ECO:0000269|PubMed:17344846	17344846
Q9BQI3	EIF2AK1	R145H	Q9BQI3/R145H	EIF2AK1/R145H	VARIANT	R -> H (in dbSNP:rs55971369)	ECO:0000269|PubMed:17344846	17344846
Q9BQI3	EIF2AK1	G202S	Q9BQI3/G202S	EIF2AK1/G202S	VARIANT	G -> S (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1216460058)	ECO:0000269|PubMed:17344846	17344846
Q9BQI3	EIF2AK1	F292L	Q9BQI3/F292L	EIF2AK1/F292L	VARIANT	F -> L (in dbSNP:rs55982710)	ECO:0000269|PubMed:17344846	17344846
Q9BQI3	EIF2AK1	L319H	Q9BQI3/L319H	EIF2AK1/L319H	VARIANT	L -> H (in dbSNP:rs34909691)	ECO:0000269|PubMed:17344846	17344846
Q9BQI3	EIF2AK1	I448V	Q9BQI3/I448V	EIF2AK1/I448V	VARIANT	I -> V (in LEMSPAD; unknown pathological significance; mildly reduced phosphorylation of eukaryotic translation initiation factor 2-alpha; dbSNP:rs1583476115)	ECO:0000269|PubMed:32197074	32197074
Q9BQI3	EIF2AK1	K558R	Q9BQI3/K558R	EIF2AK1/K558R	VARIANT	K -> R (in dbSNP:rs2640)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:28501589, ECO:0000269|Ref.13	14702039,17344846,28501589

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BRS2	RIOK1	V375I	Q9BRS2/V375I	RIOK1/V375I	VARIANT	V -> I (in dbSNP:rs56067778)		
Q9BRS2	RIOK1	D324A	Q9BRS2/D324A	RIOK1/D324A	MUTAGEN	D->A: Abolishes autophosphorylation activity; enhances association with pre-40S ribosomal subunits; inhibits processing of 18S-E pre-rRNA to the mature 18S rRNA.	ECO:0000269|PubMed:22072790	22072790

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BUB5	MKNK1	K49Q	Q9BUB5/K49Q	MKNK1/K49Q	VARIANT	K -> Q (in dbSNP:rs56351860)	ECO:0000269|PubMed:17344846	17344846
Q9BUB5	MKNK1	L158V	Q9BUB5/L158V	MKNK1/L158V	VARIANT	L -> V (in dbSNP:rs56408722)	ECO:0000269|PubMed:17344846	17344846
Q9BUB5	MKNK1	D308N	Q9BUB5/D308N	MKNK1/D308N	VARIANT	D -> N (in dbSNP:rs55791614)	ECO:0000269|PubMed:17344846	17344846
Q9BUB5	MKNK1	R446Q	Q9BUB5/R446Q	MKNK1/R446Q	VARIANT	R -> Q (in dbSNP:rs34881418)	ECO:0000269|PubMed:17344846	17344846
Q9BUB5	MKNK1	K78M	Q9BUB5/K78M	MKNK1/K78M	MUTAGEN	K->M: Loss of kinase activity; when associated with D-232.	ECO:0000269|PubMed:11463832	11463832
Q9BUB5	MKNK1	D232A	Q9BUB5/D232A	MKNK1/D232A	MUTAGEN	D->A: Loss of kinase activity; when associated with K-78.	ECO:0000269|PubMed:11463832	11463832
Q9BUB5	MKNK1	T250A	Q9BUB5/T250A	MKNK1/T250A	MUTAGEN	T->A: Loss of kinase activity; when associated with T-255.	ECO:0000269|PubMed:11463832	11463832
Q9BUB5	MKNK1	T255A	Q9BUB5/T255A	MKNK1/T255A	MUTAGEN	T->A: Loss of kinase activity; when associated with T-250.	ECO:0000269|PubMed:11463832	11463832
Q9BUB5	MKNK1	T385D	Q9BUB5/T385D	MKNK1/T385D	MUTAGEN	T->D: Constitutively active.	ECO:0000269|PubMed:11463832	11463832

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BVS4	RIOK2	S96C	Q9BVS4/S96C	RIOK2/S96C	VARIANT	S -> C (in dbSNP:rs2544773)	ECO:0000269|PubMed:17344846	17344846
Q9BVS4	RIOK2	H144R	Q9BVS4/H144R	RIOK2/H144R	VARIANT	H -> R (in dbSNP:rs35165987)	ECO:0000269|PubMed:17344846	17344846
Q9BVS4	RIOK2	H144Y	Q9BVS4/H144Y	RIOK2/H144Y	VARIANT	H -> Y (in dbSNP:rs17849382)	ECO:0000269|PubMed:15489334	15489334
Q9BVS4	RIOK2	R155H	Q9BVS4/R155H	RIOK2/R155H	VARIANT	R -> H (in dbSNP:rs34916955)	ECO:0000269|PubMed:17344846	17344846
Q9BVS4	RIOK2	V175I	Q9BVS4/V175I	RIOK2/V175I	VARIANT	V -> I (in dbSNP:rs35713904)	ECO:0000269|PubMed:17344846	17344846
Q9BVS4	RIOK2	I216T	Q9BVS4/I216T	RIOK2/I216T	VARIANT	I -> T (in a renal clear cell carcinoma sample; somatic mutation; dbSNP:rs147608663)	ECO:0000269|PubMed:17344846	17344846
Q9BVS4	RIOK2	M244V	Q9BVS4/M244V	RIOK2/M244V	VARIANT	M -> V (in dbSNP:rs33996030)	ECO:0000269|PubMed:17344846	17344846
Q9BVS4	RIOK2	G349R	Q9BVS4/G349R	RIOK2/G349R	VARIANT	G -> R (in dbSNP:rs160632)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q9BVS4	RIOK2	N397S	Q9BVS4/N397S	RIOK2/N397S	VARIANT	N -> S (in dbSNP:rs12188395)	ECO:0000269|PubMed:17344846	17344846
Q9BVS4	RIOK2	E409D	Q9BVS4/E409D	RIOK2/E409D	VARIANT	E -> D (in dbSNP:rs35829000)	ECO:0000269|PubMed:17344846	17344846
Q9BVS4	RIOK2	R507H	Q9BVS4/R507H	RIOK2/R507H	VARIANT	R -> H (in dbSNP:rs34555783)	ECO:0000269|PubMed:17344846	17344846
Q9BVS4	RIOK2	K123A	Q9BVS4/K123A	RIOK2/K123A	MUTAGEN	K->A: Abolishes autophosphorylation; impairs release of pre-40S trans-acting factors and rRNA processing; when associated with A-246.	ECO:0000269|PubMed:19564402	19564402
Q9BVS4	RIOK2	D246A	Q9BVS4/D246A	RIOK2/D246A	MUTAGEN	D->A: Abolishes autophosphorylation; impairs release of pre-40S trans-acting factors and rRNA processing; when associated with A-123.	ECO:0000269|PubMed:19564402	19564402
Q9BVS4	RIOK2	S335A	Q9BVS4/S335A	RIOK2/S335A	MUTAGEN	S->A: Does not affect autophosphorylation activity; when associated with A-380 and A-548. Does not affect the timing of metaphase-anaphase transition; when associated with A-380 and A-548.	ECO:0000269|PubMed:21880710	21880710
Q9BVS4	RIOK2	S335D	Q9BVS4/S335D	RIOK2/S335D	MUTAGEN	S->D: Increases time spent in metaphase; when associated with D-380 and D-548.	ECO:0000269|PubMed:21880710	21880710
Q9BVS4	RIOK2	S380A	Q9BVS4/S380A	RIOK2/S380A	MUTAGEN	S->A: Does not affect autophosphorylation activity; when associated with A-335 and A-548. Does not affect the timing of metaphase-anaphase transition; when associated with A-335 and A-548.	ECO:0000269|PubMed:21880710	21880710
Q9BVS4	RIOK2	S380D	Q9BVS4/S380D	RIOK2/S380D	MUTAGEN	S->D: Increases time spent in metaphase; when associated with D-335 and D-548.	ECO:0000269|PubMed:21880710	21880710
Q9BVS4	RIOK2	L400A	Q9BVS4/L400A	RIOK2/L400A	MUTAGEN	L->A: Nuclear relocalization; when associated with A-403.	ECO:0000269|PubMed:19564402	19564402
Q9BVS4	RIOK2	I403A	Q9BVS4/I403A	RIOK2/I403A	MUTAGEN	I->A: Nuclear relocalization; when associated with A-400.	ECO:0000269|PubMed:19564402	19564402
Q9BVS4	RIOK2	S548A	Q9BVS4/S548A	RIOK2/S548A	MUTAGEN	S->A: Does not affect autophosphorylation activity; when associated with A-335 and A-380. Does not affect the timing of metaphase-anaphase transition; when associated with A-335 and A-380.	ECO:0000269|PubMed:21880710	21880710
Q9BVS4	RIOK2	S548D	Q9BVS4/S548D	RIOK2/S548D	MUTAGEN	S->D: Increases time spent in metaphase; when associated with D-335 and D-380.	ECO:0000269|PubMed:21880710	21880710

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BWU1	CDK19	G28A	Q9BWU1/G28A	CDK19/G28A	VARIANT	G -> A (in DEE87; dbSNP:rs1783518890)	ECO:0000269|PubMed:33495529	33495529
Q9BWU1	CDK19	G28R	Q9BWU1/G28R	CDK19/G28R	VARIANT	G -> R (in DEE87; decreased protein kinase activity)	ECO:0000269|PubMed:33495529	33495529
Q9BWU1	CDK19	Y32C	Q9BWU1/Y32C	CDK19/Y32C	VARIANT	Y -> C (in DEE87; dbSNP:rs1783517622)	ECO:0000269|PubMed:33495529	33495529
Q9BWU1	CDK19	Y32H	Q9BWU1/Y32H	CDK19/Y32H	VARIANT	Y -> H (in DEE87; fails to rescue neurologic phenotypes in a Drosophila model system; increased protein kinase activity; dbSNP:rs1236246272)	ECO:0000269|PubMed:32330417, ECO:0000269|PubMed:33134521, ECO:0000269|PubMed:33495529	32330417,33134521,33495529
Q9BWU1	CDK19	T196A	Q9BWU1/T196A	CDK19/T196A	VARIANT	T -> A (in DEE87; fails to rescue neurologic phenotypes in a Drosophila model system; dbSNP:rs1779473650)	ECO:0000269|PubMed:32330417	32330417
Q9BWU1	CDK19	F197L	Q9BWU1/F197L	CDK19/F197L	VARIANT	F -> L (in DEE87; dbSNP:rs1779473436)	ECO:0000269|PubMed:33495529	33495529
Q9BWU1	CDK19	W198C	Q9BWU1/W198C	CDK19/W198C	VARIANT	W -> C (in DEE87; dbSNP:rs1779473213)	ECO:0000269|PubMed:33495529	33495529
Q9BWU1	CDK19	R200W	Q9BWU1/R200W	CDK19/R200W	VARIANT	R -> W (in DEE87; dbSNP:rs1779472995)	ECO:0000269|PubMed:33495529	33495529

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BX84	TRPM6	G75V	Q9BX84/G75V	TRPM6/G75V	VARIANT	G -> V (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1193127627)	ECO:0000269|PubMed:17344846	17344846
Q9BX84	TRPM6	S141L	Q9BX84/S141L	TRPM6/S141L	VARIANT	S -> L (in HOMG1; impairs heterodimer formation resulting in intracellular retention; dbSNP:rs121912625)	ECO:0000269|PubMed:12032568, ECO:0000269|PubMed:14976260	12032568,14976260
Q9BX84	TRPM6	M338I	Q9BX84/M338I	TRPM6/M338I	VARIANT	M -> I (in dbSNP:rs56155062)	ECO:0000269|PubMed:17344846	17344846
Q9BX84	TRPM6	L708P	Q9BX84/L708P	TRPM6/L708P	VARIANT	L -> P (in HOMG1; loss of function; no effect on cell membrane localization)	ECO:0000269|PubMed:23942199	23942199
Q9BX84	TRPM6	E872G	Q9BX84/E872G	TRPM6/E872G	VARIANT	E -> G (in HOMG1; loss of function; no effect on cell membrane localization)	ECO:0000269|PubMed:23942199	23942199
Q9BX84	TRPM6	F948L	Q9BX84/F948L	TRPM6/F948L	VARIANT	F -> L (in dbSNP:rs13290391)		
Q9BX84	TRPM6	W1007C	Q9BX84/W1007C	TRPM6/W1007C	VARIANT	W -> C (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9BX84	TRPM6	Y1053C	Q9BX84/Y1053C	TRPM6/Y1053C	VARIANT	Y -> C (in HOMG1; loss of function; no effect on cell membrane localization)	ECO:0000269|PubMed:23942199	23942199
Q9BX84	TRPM6	N1071D	Q9BX84/N1071D	TRPM6/N1071D	VARIANT	N -> D (in dbSNP:rs2274922)		
Q9BX84	TRPM6	L1143P	Q9BX84/L1143P	TRPM6/L1143P	VARIANT	L -> P (in HOMG1; loss of function; no effect on cell membrane localization)	ECO:0000269|PubMed:23942199	23942199
Q9BX84	TRPM6	H1243R	Q9BX84/H1243R	TRPM6/H1243R	VARIANT	H -> R (in dbSNP:rs55694430)	ECO:0000269|PubMed:17344846	17344846
Q9BX84	TRPM6	Q1274R	Q9BX84/Q1274R	TRPM6/Q1274R	VARIANT	Q -> R (in dbSNP:rs34608911)	ECO:0000269|PubMed:17344846	17344846
Q9BX84	TRPM6	V1393I	Q9BX84/V1393I	TRPM6/V1393I	VARIANT	V -> I (in dbSNP:rs3750425)	ECO:0000269|PubMed:17344846	17344846
Q9BX84	TRPM6	K1584E	Q9BX84/K1584E	TRPM6/K1584E	VARIANT	K -> E (in dbSNP:rs2274924)	ECO:0000269|PubMed:17344846	17344846
Q9BX84	TRPM6	Q1663R	Q9BX84/Q1663R	TRPM6/Q1663R	VARIANT	Q -> R (no effect on function or cell membrane localization; dbSNP:rs55679040)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:23942199	17344846,23942199
Q9BX84	TRPM6	L1673S	Q9BX84/L1673S	TRPM6/L1673S	VARIANT	L -> S (in dbSNP:rs56254742)	ECO:0000269|PubMed:17344846	17344846
Q9BX84	TRPM6	T1724I	Q9BX84/T1724I	TRPM6/T1724I	VARIANT	T -> I (in dbSNP:rs56290308)	ECO:0000269|PubMed:17344846	17344846
Q9BX84	TRPM6	S1754N	Q9BX84/S1754N	TRPM6/S1754N	VARIANT	S -> N (in HOMG1; loss of function; no effect on cell membrane localization)	ECO:0000269|PubMed:23942199	23942199
Q9BX84	TRPM6	K1804R	Q9BX84/K1804R	TRPM6/K1804R	MUTAGEN	K->R: Abolishes kinase activity but does not affect expression levels or binding to RACK1.	ECO:0000269|PubMed:18258429	18258429
Q9BX84	TRPM6	T1851A	Q9BX84/T1851A	TRPM6/T1851A	MUTAGEN	T->A: Significantly decreases autophosphorylation. Does not alter binding to RACK1 but prevents inhibition by RACK1.	ECO:0000269|PubMed:18258429	18258429
Q9BX84	TRPM6	T1851D	Q9BX84/T1851D	TRPM6/T1851D	MUTAGEN	T->D: Significantly decreases autophosphorylation. Does not alter binding to RACK1 or inhibition by RACK1.	ECO:0000269|PubMed:18258429	18258429

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BXA6	TSSK6	K41M	Q9BXA6/K41M	TSSK6/K41M	MUTAGEN	K->M: Loss of kinase activity. Loss of binding to TSACC.	ECO:0000269|PubMed:15870294, ECO:0000269|PubMed:20829357	15870294,20829357
Q9BXA6	TSSK6	D135N	Q9BXA6/D135N	TSSK6/D135N	MUTAGEN	D->N: Loss of kinase activity. No effect of binding to TSACC.	ECO:0000269|PubMed:15870294, ECO:0000269|PubMed:20829357	15870294,20829357

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BXA7	TSSK1B	A50T	Q9BXA7/A50T	TSSK1B/A50T	VARIANT	A -> T (in dbSNP:rs747955728)	ECO:0000269|PubMed:17344846	17344846
Q9BXA7	TSSK1B	H83Y	Q9BXA7/H83Y	TSSK1B/H83Y	VARIANT	H -> Y (in dbSNP:rs55930004)	ECO:0000269|PubMed:17344846	17344846
Q9BXA7	TSSK1B	V233L	Q9BXA7/V233L	TSSK1B/V233L	VARIANT	V -> L (in dbSNP:rs55940513)	ECO:0000269|PubMed:17344846	17344846
Q9BXA7	TSSK1B	R237C	Q9BXA7/R237C	TSSK1B/R237C	VARIANT	R -> C (in dbSNP:rs55738530)	ECO:0000269|PubMed:17344846	17344846
Q9BXA7	TSSK1B	G288W	Q9BXA7/G288W	TSSK1B/G288W	VARIANT	G -> W (in dbSNP:rs34696815)	ECO:0000269|PubMed:17344846	17344846
Q9BXA7	TSSK1B	G293E	Q9BXA7/G293E	TSSK1B/G293E	VARIANT	G -> E (in dbSNP:rs11953478)	ECO:0000269|PubMed:17344846	17344846
Q9BXA7	TSSK1B	T174A	Q9BXA7/T174A	TSSK1B/T174A	MUTAGEN	T->A: Loss of kinase activity.	ECO:0000269|PubMed:15733851	15733851
Q9BXA7	TSSK1B	T174E	Q9BXA7/T174E	TSSK1B/T174E	MUTAGEN	T->E: Constitutively active.	ECO:0000269|PubMed:15733851	15733851

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BXM7	PINK1	L67F	Q9BXM7/L67F	PINK1/L67F	VARIANT	L -> F (in dbSNP:rs763142730)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	R68P	Q9BXM7/R68P	PINK1/R68P	VARIANT	R -> P (in dbSNP:rs1385309950)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	C92F	Q9BXM7/C92F	PINK1/C92F	VARIANT	C -> F (in PARK6; dbSNP:rs1553145550)	ECO:0000269|PubMed:15349860	15349860
Q9BXM7	PINK1	R98W	Q9BXM7/R98W	PINK1/R98W	VARIANT	R -> W (in dbSNP:rs575668171)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	I111S	Q9BXM7/I111S	PINK1/I111S	VARIANT	I -> S (in dbSNP:rs1553145560)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	Q115L	Q9BXM7/Q115L	PINK1/Q115L	VARIANT	Q -> L (in dbSNP:rs148871409)	ECO:0000269|PubMed:15970950, ECO:0000269|PubMed:16009891	15970950,16009891
Q9BXM7	PINK1	A124V	Q9BXM7/A124V	PINK1/A124V	VARIANT	A -> V (in dbSNP:rs1274588239)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	C125G	Q9BXM7/C125G	PINK1/C125G	VARIANT	C -> G (in PARK6)	ECO:0000269|PubMed:16401616	16401616
Q9BXM7	PINK1	Q126P	Q9BXM7/Q126P	PINK1/Q126P	VARIANT			
Q9BXM7	PINK1	T145M	Q9BXM7/T145M	PINK1/T145M	VARIANT	T -> M (in dbSNP:rs45604240)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	R147H	Q9BXM7/R147H	PINK1/R147H	VARIANT	R -> H (in PARK6; unknown pathological significance; dbSNP:rs138050841)	ECO:0000269|PubMed:15505171	15505171
Q9BXM7	PINK1	L148W	Q9BXM7/L148W	PINK1/L148W	VARIANT	L -> W (in dbSNP:rs56297806)	ECO:0000269|PubMed:17344846	17344846
Q9BXM7	PINK1	A168P	Q9BXM7/A168P	PINK1/A168P	VARIANT	A -> P (in PARK6; no effect on autophosphorylation; localizes to the mitochondria and immunogold experiments reveal that both wild-type and mutant proteins face the mitochondrial intermembrane space; dbSNP:rs768091663)	ECO:0000269|PubMed:15349860, ECO:0000269|PubMed:16009891, ECO:0000269|PubMed:16207731, ECO:0000269|PubMed:24784582	15349860,16009891,16207731,24784582
Q9BXM7	PINK1	V170G	Q9BXM7/V170G	PINK1/V170G	VARIANT	V -> G (in PARK6; dbSNP:rs1553145929)	ECO:0000269|PubMed:24652937	24652937
Q9BXM7	PINK1	K186N	Q9BXM7/K186N	PINK1/K186N	VARIANT	K -> N (in dbSNP:rs143204084)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	P196L	Q9BXM7/P196L	PINK1/P196L	VARIANT	P -> L (in PARK6; dbSNP:rs138302371)	ECO:0000269|PubMed:16009891	16009891
Q9BXM7	PINK1	P196S	Q9BXM7/P196S	PINK1/P196S	VARIANT	P -> S (in dbSNP:rs35802484)	ECO:0000269|PubMed:17344846	17344846
Q9BXM7	PINK1	P209L	Q9BXM7/P209L	PINK1/P209L	VARIANT	P -> L (in dbSNP:rs34677717)	ECO:0000269|PubMed:17344846	17344846
Q9BXM7	PINK1	P215L	Q9BXM7/P215L	PINK1/P215L	VARIANT	P -> L (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs371854396)	ECO:0000269|PubMed:17344846	17344846
Q9BXM7	PINK1	A217D	Q9BXM7/A217D	PINK1/A217D	VARIANT	A -> D (in PARK6; dbSNP:rs74315360)	ECO:0000269|PubMed:16966503	16966503
Q9BXM7	PINK1	E231G	Q9BXM7/E231G	PINK1/E231G	VARIANT	E -> G (in dbSNP:rs1303935100)	ECO:0000269|PubMed:15596610	15596610
Q9BXM7	PINK1	N235I	Q9BXM7/N235I	PINK1/N235I	VARIANT	N -> I (in dbSNP:rs1557562082)	ECO:0000269|PubMed:15596610	15596610
Q9BXM7	PINK1	E240K	Q9BXM7/E240K	PINK1/E240K	VARIANT	E -> K (in PARK6; dbSNP:rs573931674)	ECO:0000269|PubMed:15596610, ECO:0000269|PubMed:16401616	15596610,16401616
Q9BXM7	PINK1	T257I	Q9BXM7/T257I	PINK1/T257I	VARIANT	T -> I (in dbSNP:rs370906995)		
Q9BXM7	PINK1	R263G	Q9BXM7/R263G	PINK1/R263G	VARIANT	R -> G (in dbSNP:rs1553146419)	ECO:0000269|PubMed:15596610	15596610
Q9BXM7	PINK1	L268V	Q9BXM7/L268V	PINK1/L268V	VARIANT	L -> V (in PARK6; dbSNP:rs372280083)	ECO:0000269|PubMed:16207217, ECO:0000269|PubMed:18330912	16207217,18330912
Q9BXM7	PINK1	H271Q	Q9BXM7/H271Q	PINK1/H271Q	VARIANT	H -> Q (in PARK6; dbSNP:rs28940284)	ECO:0000269|PubMed:15349870	15349870
Q9BXM7	PINK1	R276Q	Q9BXM7/R276Q	PINK1/R276Q	VARIANT	R -> Q (in dbSNP:rs548506734)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	R279H	Q9BXM7/R279H	PINK1/R279H	VARIANT	R -> H (in PARK6; dbSNP:rs74315358)	ECO:0000269|PubMed:15970950	15970950
Q9BXM7	PINK1	A280T	Q9BXM7/A280T	PINK1/A280T	VARIANT	A -> T (in PARK6; early-onset; dbSNP:rs772510148)	ECO:0000269|PubMed:16482571	16482571
Q9BXM7	PINK1	P296L	Q9BXM7/P296L	PINK1/P296L	VARIANT	P -> L (in dbSNP:rs779060308)	ECO:0000269|PubMed:15349860, ECO:0000269|PubMed:18330912	15349860,18330912
Q9BXM7	PINK1	P305L	Q9BXM7/P305L	PINK1/P305L	VARIANT	P -> L (in dbSNP:rs7349186)		
Q9BXM7	PINK1	G309D	Q9BXM7/G309D	PINK1/G309D	VARIANT	G -> D (in PARK6; fails to maintain mitochondrial membrane potential; full-length mutant has no effect on autophosphorylation; strongly reduces interaction with PRKN; decreases PRKN and SNCAIP ubiquitination and degradation; decreases Drp1 phosphorylation; dbSNP:rs74315355)	ECO:0000269|PubMed:15087508, ECO:0000269|PubMed:16207731, ECO:0000269|PubMed:19229105, ECO:0000269|PubMed:20798600, ECO:0000269|PubMed:32484300	15087508,16207731,19229105,20798600,32484300
Q9BXM7	PINK1	T313M	Q9BXM7/T313M	PINK1/T313M	VARIANT	T -> M (in PARK6; decreases PRKN and SNCAIP ubiquitination and degradation; slightly decreases Drp1 phosphorylation; dbSNP:rs74315359)	ECO:0000269|PubMed:17030667, ECO:0000269|PubMed:18785233, ECO:0000269|PubMed:19229105, ECO:0000269|PubMed:32484300	17030667,18785233,19229105,32484300
Q9BXM7	PINK1	V317I	Q9BXM7/V317I	PINK1/V317I	VARIANT	V -> I (in dbSNP:rs200949139)	ECO:0000269|PubMed:16969854, ECO:0000269|PubMed:18330912	16969854,18330912
Q9BXM7	PINK1	M318L	Q9BXM7/M318L	PINK1/M318L	VARIANT	M -> L (in dbSNP:rs139226733)	ECO:0000269|PubMed:15596610	15596610
Q9BXM7	PINK1	P322L	Q9BXM7/P322L	PINK1/P322L	VARIANT	P -> L (in dbSNP:rs768019187)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	A339T	Q9BXM7/A339T	PINK1/A339T	VARIANT	A -> T (in dbSNP:rs55831733)	ECO:0000269|PubMed:15596610, ECO:0000269|PubMed:16969854, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:18330912	15596610,16969854,17344846,18330912
Q9BXM7	PINK1	A340T	Q9BXM7/A340T	PINK1/A340T	VARIANT	A -> T (in dbSNP:rs3738136)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15349860, ECO:0000269|PubMed:15596610, ECO:0000269|PubMed:16009891, ECO:0000269|PubMed:16257123, ECO:0000269|PubMed:16482571, ECO:0000269|PubMed:17344846	14702039,15349860,15596610,16009891,16257123,16482571,17344846
Q9BXM7	PINK1	M341I	Q9BXM7/M341I	PINK1/M341I	VARIANT	M -> I (in dbSNP:rs35813094)	ECO:0000269|PubMed:17344846	17344846
Q9BXM7	PINK1	L347P	Q9BXM7/L347P	PINK1/L347P	VARIANT	L -> P (in PARK6; strongly reduces interaction with PRKN; reduced ubiquitination of MIRO1; dbSNP:rs28940285)	ECO:0000269|PubMed:15349870, ECO:0000269|PubMed:15596610, ECO:0000269|PubMed:20798600, ECO:0000269|PubMed:22396657, ECO:0000269|PubMed:22956510	15349870,15596610,20798600,22396657,22956510
Q9BXM7	PINK1	D362H	Q9BXM7/D362H	PINK1/D362H	VARIANT	D -> H	ECO:0000269|PubMed:15596610	15596610
Q9BXM7	PINK1	L369P	Q9BXM7/L369P	PINK1/L369P	VARIANT	L -> P (in PARK6; dbSNP:rs1195888869)	ECO:0000269|PubMed:16401616	16401616
Q9BXM7	PINK1	C377F	Q9BXM7/C377F	PINK1/C377F	VARIANT	C -> F (in dbSNP:rs34203620)	ECO:0000269|PubMed:17344846	17344846
Q9BXM7	PINK1	A383T	Q9BXM7/A383T	PINK1/A383T	VARIANT	A -> T (in dbSNP:rs45515602)	ECO:0000269|PubMed:16969854, ECO:0000269|PubMed:18330912	16969854,18330912
Q9BXM7	PINK1	G386A	Q9BXM7/G386A	PINK1/G386A	VARIANT	G -> A (in PARK6; abolishes kinase activity)	ECO:0000269|PubMed:16401616, ECO:0000269|PubMed:24784582	16401616,24784582
Q9BXM7	PINK1	C388R	Q9BXM7/C388R	PINK1/C388R	VARIANT	C -> R (in PARK6; dbSNP:rs1553146806)	ECO:0000269|PubMed:15955953	15955953
Q9BXM7	PINK1	G395V	Q9BXM7/G395V	PINK1/G395V	VARIANT	G -> V (in dbSNP:rs1035071310)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	P399L	Q9BXM7/P399L	PINK1/P399L	VARIANT	P -> L (probable disease-associated variant found in early-onset Parkinson disease with digenic inheritance; found in a patient also carrying mutation S-39 in PARK7; decreases PRKN and SNCAIP ubiquitination and degradation; dbSNP:rs119451946)	ECO:0000269|PubMed:16632486, ECO:0000269|PubMed:19229105	16632486,19229105
Q9BXM7	PINK1	R407Q	Q9BXM7/R407Q	PINK1/R407Q	VARIANT	R -> Q (in PARK6; early-onset; dbSNP:rs556540177)	ECO:0000269|PubMed:16257123	16257123
Q9BXM7	PINK1	G409V	Q9BXM7/G409V	PINK1/G409V	VARIANT	G -> V (in PARK6; dbSNP:rs1553146818)	ECO:0000269|PubMed:16401616	16401616
Q9BXM7	PINK1	G411S	Q9BXM7/G411S	PINK1/G411S	VARIANT	G -> S (in dbSNP:rs45478900)	ECO:0000269|PubMed:16969854	16969854
Q9BXM7	PINK1	E417G	Q9BXM7/E417G	PINK1/E417G	VARIANT	E -> G (in PARK6; dbSNP:rs1553146822)	ECO:0000269|PubMed:15349870	15349870
Q9BXM7	PINK1	P425S	Q9BXM7/P425S	PINK1/P425S	VARIANT	P -> S (in dbSNP:rs554114655)	ECO:0000269|PubMed:15596610	15596610
Q9BXM7	PINK1	Y431H	Q9BXM7/Y431H	PINK1/Y431H	VARIANT	Y -> H (may predispose to Parkinson disease development; shows decreased mitochondrial membrane potential under stress conditions; dbSNP:rs74315361)	ECO:0000269|PubMed:16969854	16969854
Q9BXM7	PINK1	I442T	Q9BXM7/I442T	PINK1/I442T	VARIANT	I -> T (in dbSNP:rs1553146877)	ECO:0000269|PubMed:15349860, ECO:0000269|PubMed:18330912	15349860,18330912
Q9BXM7	PINK1	N451S	Q9BXM7/N451S	PINK1/N451S	VARIANT	N -> S (may predispose to Parkinson disease development; shows decreased mitochondrial membrane potential under stress conditions; dbSNP:rs747400197)	ECO:0000269|PubMed:16969854	16969854
Q9BXM7	PINK1	L461S	Q9BXM7/L461S	PINK1/L461S	VARIANT	L -> S	ECO:0000269|PubMed:16969854	16969854
Q9BXM7	PINK1	R464H	Q9BXM7/R464H	PINK1/R464H	VARIANT	R -> H (in PARK6; dbSNP:rs764328076)	ECO:0000269|PubMed:15349860	15349860
Q9BXM7	PINK1	E476K	Q9BXM7/E476K	PINK1/E476K	VARIANT	E -> K (may predispose to Parkinson disease development; shows decreased mitochondrial membrane potential under stress conditions; dbSNP:rs115477764)	ECO:0000269|PubMed:15349860, ECO:0000269|PubMed:15596610, ECO:0000269|PubMed:16009891, ECO:0000269|PubMed:16969854, ECO:0000269|PubMed:18330912	15349860,15596610,16009891,16969854,18330912
Q9BXM7	PINK1	S477T	Q9BXM7/S477T	PINK1/S477T	VARIANT	S -> T (in dbSNP:rs34416410)	ECO:0000269|PubMed:17344846	17344846
Q9BXM7	PINK1	L489P	Q9BXM7/L489P	PINK1/L489P	VARIANT	L -> P (in PARK6; dbSNP:rs1553146903)	ECO:0000269|PubMed:15596610	15596610
Q9BXM7	PINK1	R501P	Q9BXM7/R501P	PINK1/R501P	VARIANT	R -> P (may predispose to Parkinson disease development; shows decreased mitochondrial membrane potential under stress conditions; dbSNP:rs61744200)	ECO:0000269|PubMed:16969854	16969854
Q9BXM7	PINK1	N521T	Q9BXM7/N521T	PINK1/N521T	VARIANT	N -> T (in dbSNP:rs1043424)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15349860, ECO:0000269|PubMed:15596610, ECO:0000269|PubMed:16009891, ECO:0000269|PubMed:16257123, ECO:0000269|PubMed:16482571, ECO:0000269|PubMed:17344846	14702039,15349860,15596610,16009891,16257123,16482571,17344846
Q9BXM7	PINK1	D525N	Q9BXM7/D525N	PINK1/D525N	VARIANT	D -> N (in dbSNP:rs531477772)	ECO:0000269|PubMed:15349860, ECO:0000269|PubMed:18330912	15349860,18330912
Q9BXM7	PINK1	Q534QQ	Q9BXM7/Q534QQ	PINK1/Q534QQ	VARIANT	Q -> QQ (in PARK6)	ECO:0000269|PubMed:15970950	15970950
Q9BXM7	PINK1	A537T	Q9BXM7/A537T	PINK1/A537T	VARIANT	A -> T (in dbSNP:rs771032673)	ECO:0000269|PubMed:18330912	18330912
Q9BXM7	PINK1	C575R	Q9BXM7/C575R	PINK1/C575R	VARIANT	C -> R (may predispose to Parkinson disease development; shows decreased mitochondrial membrane potential under stress conditions; dbSNP:rs1553147052)	ECO:0000269|PubMed:16969854	16969854
Q9BXM7	PINK1	K219A	Q9BXM7/K219A	PINK1/K219A	MUTAGEN	K->A: Abolishes MFN2 phosphorylation and interaction with PRKN; when associated with Ala-362 and Ala-384.	ECO:0000269|PubMed:23620051	23620051
Q9BXM7	PINK1	K219M	Q9BXM7/K219M	PINK1/K219M	MUTAGEN	K->M: Loss of enzyme activity and impaired localization of PRKN to mitochondria; when associated with A-362 and A-384.	ECO:0000269|PubMed:18957282, ECO:0000269|PubMed:32047033	18957282,32047033
Q9BXM7	PINK1	D362A	Q9BXM7/D362A	PINK1/D362A	MUTAGEN	D->A: Abolishes MFN2 phosphorylation and interaction with PRKN; when associated with A-219 and A-384. Loss of enzyme activity and impaired localization of PRKN to mitochondria; when associated with M-219 and A-384.	ECO:0000269|PubMed:18957282, ECO:0000269|PubMed:23620051, ECO:0000269|PubMed:32047033	18957282,23620051,32047033
Q9BXM7	PINK1	D384A	Q9BXM7/D384A	PINK1/D384A	MUTAGEN	D->A: Abolishes MFN2 phosphorylation and interaction with PRKN; when associated with A-219 and A-362. Loss of enzyme activity and impaired localization of PRKN to mitochondria; when associated with M-219 and A-362.	ECO:0000269|PubMed:18957282, ECO:0000269|PubMed:23620051, ECO:0000269|PubMed:32047033	18957282,23620051,32047033
Q9BXM7	PINK1	D384N	Q9BXM7/D384N	PINK1/D384N	MUTAGEN	D->N: Loss of activity. Abolishes Drp1 phosphorylation. No effect on localization to mitochondria.	ECO:0000269|PubMed:32484300	32484300

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BXU1	STK31	Q71H	Q9BXU1/Q71H	STK31/Q71H	VARIANT	Q -> H (in dbSNP:rs6945306)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
Q9BXU1	STK31	S125F	Q9BXU1/S125F	STK31/S125F	VARIANT	S -> F (in dbSNP:rs56268851)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	E261K	Q9BXU1/E261K	STK31/E261K	VARIANT	E -> K (in dbSNP:rs10264952)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	K268N	Q9BXU1/K268N	STK31/K268N	VARIANT	K -> N (in dbSNP:rs10264967)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	I277K	Q9BXU1/I277K	STK31/I277K	VARIANT	I -> K (in dbSNP:rs55950645)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	T362P	Q9BXU1/T362P	STK31/T362P	VARIANT	T -> P (in dbSNP:rs35545265)		
Q9BXU1	STK31	R385C	Q9BXU1/R385C	STK31/R385C	VARIANT	R -> C (in dbSNP:rs35995607)		
Q9BXU1	STK31	A393T	Q9BXU1/A393T	STK31/A393T	VARIANT	A -> T (in dbSNP:rs56244148)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	G410E	Q9BXU1/G410E	STK31/G410E	VARIANT	G -> E (in dbSNP:rs4722266)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	A489P	Q9BXU1/A489P	STK31/A489P	VARIANT	A -> P (in dbSNP:rs34414354)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	A600T	Q9BXU1/A600T	STK31/A600T	VARIANT	A -> T (in dbSNP:rs55796076)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	N621K	Q9BXU1/N621K	STK31/N621K	VARIANT	N -> K (in dbSNP:rs10263079)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	S623I	Q9BXU1/S623I	STK31/S623I	VARIANT	S -> I (in dbSNP:rs10247878)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	H684R	Q9BXU1/H684R	STK31/H684R	VARIANT	H -> R (in dbSNP:rs41273999)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	H684Y	Q9BXU1/H684Y	STK31/H684Y	VARIANT	H -> Y (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	E709K	Q9BXU1/E709K	STK31/E709K	VARIANT	E -> K (in dbSNP:rs56181834)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	V860L	Q9BXU1/V860L	STK31/V860L	VARIANT	V -> L (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	T1000M	Q9BXU1/T1000M	STK31/T1000M	VARIANT	T -> M (in dbSNP:rs55794023)	ECO:0000269|PubMed:17344846	17344846
Q9BXU1	STK31	K1009T	Q9BXU1/K1009T	STK31/K1009T	VARIANT	K -> T (in dbSNP:rs33998018)		
Q9BXU1	STK31	T1010S	Q9BXU1/T1010S	STK31/T1010S	VARIANT	T -> S (in dbSNP:rs56391043)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BYP7	WNK3	Q704H	Q9BYP7/Q704H	WNK3/Q704H	VARIANT	Q -> H (in dbSNP:rs56077971)	ECO:0000269|PubMed:17344846	17344846
Q9BYP7	WNK3	S854C	Q9BYP7/S854C	WNK3/S854C	VARIANT	S -> C (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9BYP7	WNK3	A998T	Q9BYP7/A998T	WNK3/A998T	VARIANT	A -> T (in dbSNP:rs56404148)	ECO:0000269|PubMed:17344846	17344846
Q9BYP7	WNK3	K1169E	Q9BYP7/K1169E	WNK3/K1169E	VARIANT	K -> E (in dbSNP:rs55903619)	ECO:0000269|PubMed:17344846	17344846
Q9BYP7	WNK3	T1375I	Q9BYP7/T1375I	WNK3/T1375I	VARIANT	T -> I (in dbSNP:rs55879434)	ECO:0000269|PubMed:17344846	17344846
Q9BYP7	WNK3	L1533F	Q9BYP7/L1533F	WNK3/L1533F	VARIANT	L -> F (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9BYP7	WNK3	S1634P	Q9BYP7/S1634P	WNK3/S1634P	VARIANT	S -> P (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9BYP7	WNK3	D294A	Q9BYP7/D294A	WNK3/D294A	MUTAGEN	D->A: Catalytically inactive form. Inhibits sodium-coupled chloride cotransporters and activates potassium-coupled chloride cotransporters.	ECO:0000269|PubMed:16275913, ECO:0000269|PubMed:21613606	16275913,21613606

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BYT3	STK33	K60E	Q9BYT3/K60E	STK33/K60E	VARIANT	K -> E (in dbSNP:rs60786172)		
Q9BYT3	STK33	E98D	Q9BYT3/E98D	STK33/E98D	VARIANT	E -> D (in dbSNP:rs34525052)	ECO:0000269|PubMed:17344846	17344846
Q9BYT3	STK33	L160V	Q9BYT3/L160V	STK33/L160V	VARIANT	L -> V (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9BYT3	STK33	D436E	Q9BYT3/D436E	STK33/D436E	VARIANT	D -> E (in dbSNP:rs3751096)	ECO:0000269|PubMed:17344846	17344846
Q9BYT3	STK33	A437T	Q9BYT3/A437T	STK33/A437T	VARIANT	A -> T (in dbSNP:rs3751095)	ECO:0000269|PubMed:17344846	17344846
Q9BYT3	STK33	A458E	Q9BYT3/A458E	STK33/A458E	VARIANT	A -> E (in dbSNP:rs35296353)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9BZL6	PRKD2	V324M	Q9BZL6/V324M	PRKD2/V324M	VARIANT	V -> M (in dbSNP:rs45455991)	ECO:0000269|PubMed:17344846	17344846
Q9BZL6	PRKD2	A496V	Q9BZL6/A496V	PRKD2/A496V	VARIANT	A -> V (in dbSNP:rs55716765)	ECO:0000269|PubMed:17344846	17344846
Q9BZL6	PRKD2	S604G	Q9BZL6/S604G	PRKD2/S604G	VARIANT	S -> G (in dbSNP:rs34325043)	ECO:0000269|PubMed:17344846	17344846
Q9BZL6	PRKD2	W773R	Q9BZL6/W773R	PRKD2/W773R	VARIANT	W -> R (in dbSNP:rs55933311)	ECO:0000269|PubMed:17344846	17344846
Q9BZL6	PRKD2	A835V	Q9BZL6/A835V	PRKD2/A835V	VARIANT	A -> V (in dbSNP:rs314665)		
Q9BZL6	PRKD2	G848E	Q9BZL6/G848E	PRKD2/G848E	VARIANT	G -> E (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9BZL6	PRKD2	G870E	Q9BZL6/G870E	PRKD2/G870E	VARIANT	G -> E (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9BZL6	PRKD2	Y87F	Q9BZL6/Y87F	PRKD2/Y87F	MUTAGEN	Y->F: Loss of phosphorylation. No effect on the interaction with PRKCD. No effect on Ser-706 or/and Ser-710 phosphorylation.	ECO:0000269|PubMed:28428613	28428613
Q9BZL6	PRKD2	S244E	Q9BZL6/S244E	PRKD2/S244E	MUTAGEN	S->E: Constitutive kinase activity; when associated with E-706 and E-710.	ECO:0000269|PubMed:23503467	23503467
Q9BZL6	PRKD2	P275G	Q9BZL6/P275G	PRKD2/P275G	MUTAGEN	P->G: Increase in ability to bind phorbol ester, slight increase in ability to bind DAG.	ECO:0000269|PubMed:18076381	18076381
Q9BZL6	PRKD2	Y438D	Q9BZL6/Y438D	PRKD2/Y438D	MUTAGEN	Y->D: Slight increase in Tyr-717 phosphorylation. No effect on Ser-706 or/and Ser-710 phosphorylation. Increase in Tyr-717 phosphorylation; when associated with E-706 and E-710.	ECO:0000269|PubMed:28428613	28428613
Q9BZL6	PRKD2	Y438F	Q9BZL6/Y438F	PRKD2/Y438F	MUTAGEN	Y->F: Loss of phosphorylation. No effect on phosphorylation of Tyr-717 and on Ser-706 or/and Ser-710 phosphorylation.	ECO:0000269|PubMed:15604256, ECO:0000269|PubMed:28428613	15604256,28428613
Q9BZL6	PRKD2	D695A	Q9BZL6/D695A	PRKD2/D695A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:23503467	23503467
Q9BZL6	PRKD2	S706A	Q9BZL6/S706A	PRKD2/S706A	MUTAGEN	S->A: Abolishes phosphorylation. Loss of Tyr-717 phosphorylation and any other tyrosine phosphorylation, and increases NF-kappa-B activation in response to oxidative stress; when associated with A-710.	ECO:0000269|PubMed:28428613	28428613
Q9BZL6	PRKD2	S706E	Q9BZL6/S706E	PRKD2/S706E	MUTAGEN	S->E: Constitutive kinase activity; when associated with E-710 or with E-244 and E-710. Increases Tyr-717 phosphorylation; when associated with E-710 or with E-710 and D-438.	ECO:0000269|PubMed:23503467, ECO:0000269|PubMed:28428613	23503467,28428613
Q9BZL6	PRKD2	S710A	Q9BZL6/S710A	PRKD2/S710A	MUTAGEN	S->A: Abolishes phosphorylation. Loss of Tyr-717 phosphorylation and any other tyrosine phosphorylation, and increases NF-kappa-B activation in response to oxidative stress; when associated with A-706.	ECO:0000269|PubMed:28428613	28428613
Q9BZL6	PRKD2	S710E	Q9BZL6/S710E	PRKD2/S710E	MUTAGEN	S->E: Constitutive kinase activity; when associated with E-706 or with E-244 and E-706. when associated with E-710 or with E-244 and E-710. Increases Tyr-717 phosphorylation; when associated with E-710 or with E-710 and D-438.	ECO:0000269|PubMed:23503467, ECO:0000269|PubMed:28428613	23503467,28428613
Q9BZL6	PRKD2	Y717F	Q9BZL6/Y717F	PRKD2/Y717F	MUTAGEN	Y->F: Abolishes phosphorylation. Decreases substrate affinity and increases catalytic efficiency. Increases Ser-706 or/and Ser-710 phosphorylation. Increases NF-kappa-B activation in response to oxidative stress.	ECO:0000269|PubMed:28428613	28428613

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9C098	DCLK3	R24Q	Q9C098/R24Q	DCLK3/R24Q	VARIANT	R -> Q (in dbSNP:rs56070233)	ECO:0000269|PubMed:17344846	17344846
Q9C098	DCLK3	P108L	Q9C098/P108L	DCLK3/P108L	VARIANT	P -> L (in a breast infiltrating ductal carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9C098	DCLK3	E422K	Q9C098/E422K	DCLK3/E422K	VARIANT	E -> K (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs373605259)	ECO:0000269|PubMed:17344846	17344846
Q9C098	DCLK3	S472N	Q9C098/S472N	DCLK3/S472N	VARIANT	S -> N (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9C098	DCLK3	R554C	Q9C098/R554C	DCLK3/R554C	VARIANT	R -> C (in a lung squamous cell carcinoma sample; somatic mutation; dbSNP:rs374711533)	ECO:0000269|PubMed:17344846	17344846
Q9C098	DCLK3	G570R	Q9C098/G570R	DCLK3/G570R	VARIANT	G -> R (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9C098	DCLK3	V596A	Q9C098/V596A	DCLK3/V596A	VARIANT	V -> A (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9C098	DCLK3	E633D	Q9C098/E633D	DCLK3/E633D	VARIANT	E -> D (in dbSNP:rs35704209)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9C0K7	STRADB	G155E	Q9C0K7/G155E	STRADB/G155E	VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9C0K7	STRADB	P386L	Q9C0K7/P386L	STRADB/P386L	VARIANT	P -> L (in dbSNP:rs35636836)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H093	NUAK2	T309S	Q9H093/T309S	NUAK2/T309S	VARIANT	T -> S (in dbSNP:rs55745939)	ECO:0000269|PubMed:17344846	17344846
Q9H093	NUAK2	R341L	Q9H093/R341L	NUAK2/R341L	VARIANT	R -> L (in dbSNP:rs35208615)	ECO:0000269|PubMed:17344846	17344846
Q9H093	NUAK2	K503R	Q9H093/K503R	NUAK2/K503R	VARIANT	K -> R (in an ovarian Endometrioid carcinoma sample; somatic mutation; dbSNP:rs1271546767)	ECO:0000269|PubMed:17344846	17344846
Q9H093	NUAK2	A516V	Q9H093/A516V	NUAK2/A516V	VARIANT	A -> V (in dbSNP:rs35070935)	ECO:0000269|PubMed:17344846	17344846
Q9H093	NUAK2	G541E	Q9H093/G541E	NUAK2/G541E	VARIANT	G -> E (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9H093	NUAK2	K81R	Q9H093/K81R	NUAK2/K81R	MUTAGEN	K->R: Loss of autophosphorylation, kinase activity and of anti-apoptotic activity.	ECO:0000269|PubMed:15345718	15345718
Q9H093	NUAK2	T208A	Q9H093/T208A	NUAK2/T208A	MUTAGEN			

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H0K1	SIK2	T458I	Q9H0K1/T458I	SIK2/T458I	VARIANT	T -> I (in dbSNP:rs35789057)	ECO:0000269|PubMed:17344846	17344846
Q9H0K1	SIK2	R809Q	Q9H0K1/R809Q	SIK2/R809Q	VARIANT	R -> Q (in dbSNP:rs34223841)	ECO:0000269|PubMed:17344846	17344846
Q9H0K1	SIK2	P825L	Q9H0K1/P825L	SIK2/P825L	VARIANT	P -> L (in dbSNP:rs55889697)	ECO:0000269|PubMed:17344846	17344846
Q9H0K1	SIK2	P828L	Q9H0K1/P828L	SIK2/P828L	VARIANT	P -> L (in dbSNP:rs45520245)		
Q9H0K1	SIK2	P829S	Q9H0K1/P829S	SIK2/P829S	VARIANT	P -> S (in dbSNP:rs45586732)		
Q9H0K1	SIK2	T175A	Q9H0K1/T175A	SIK2/T175A	MUTAGEN			
Q9H0K1	SIK2	T175E	Q9H0K1/T175E	SIK2/T175E	MUTAGEN	T->E: Constitutively active.	ECO:0000269|PubMed:14976552	14976552

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H1R3	MYLK2	A87V	Q9H1R3/A87V	MYLK2/A87V	VARIANT	A -> V (in CMH; dbSNP:rs121908107)	ECO:0000269|PubMed:11733062	11733062
Q9H1R3	MYLK2	A95E	Q9H1R3/A95E	MYLK2/A95E	VARIANT	A -> E (in CMH; dbSNP:rs121908108)	ECO:0000269|PubMed:11733062	11733062
Q9H1R3	MYLK2	A117V	Q9H1R3/A117V	MYLK2/A117V	VARIANT	A -> V (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs1229709568)	ECO:0000269|PubMed:17344846	17344846
Q9H1R3	MYLK2	G142V	Q9H1R3/G142V	MYLK2/G142V	VARIANT	G -> V (in dbSNP:rs56385445)	ECO:0000269|PubMed:17344846	17344846
Q9H1R3	MYLK2	P144A	Q9H1R3/P144A	MYLK2/P144A	VARIANT	P -> A (in dbSNP:rs34396614)	ECO:0000269|PubMed:17344846	17344846
Q9H1R3	MYLK2	K324N	Q9H1R3/K324N	MYLK2/K324N	VARIANT	K -> N (in dbSNP:rs34146416)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H2G2	SLK	Q405K	Q9H2G2/Q405K	SLK/Q405K	VARIANT	Q -> K (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9H2G2	SLK	C552Y	Q9H2G2/C552Y	SLK/C552Y	VARIANT	C -> Y (in dbSNP:rs805657)	ECO:0000269|PubMed:17344846	17344846
Q9H2G2	SLK	E604Q	Q9H2G2/E604Q	SLK/E604Q	VARIANT	E -> Q (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs190220654)	ECO:0000269|PubMed:17344846	17344846
Q9H2G2	SLK	A658G	Q9H2G2/A658G	SLK/A658G	VARIANT	A -> G (in dbSNP:rs56400929)	ECO:0000269|PubMed:17344846	17344846
Q9H2G2	SLK	G666E	Q9H2G2/G666E	SLK/G666E	VARIANT	G -> E (in dbSNP:rs7071400)		
Q9H2G2	SLK	I679T	Q9H2G2/I679T	SLK/I679T	VARIANT	I -> T (in dbSNP:rs34326537)	ECO:0000269|PubMed:17344846	17344846
Q9H2G2	SLK	K683N	Q9H2G2/K683N	SLK/K683N	VARIANT	K -> N (in dbSNP:rs35389916)	ECO:0000269|PubMed:17344846	17344846
Q9H2G2	SLK	T697I	Q9H2G2/T697I	SLK/T697I	VARIANT	T -> I (in dbSNP:rs3740469)	ECO:0000269|PubMed:17344846	17344846
Q9H2G2	SLK	K63R	Q9H2G2/K63R	SLK/K63R	MUTAGEN	K->R: Loss of activity.	ECO:0000269|PubMed:10699464	10699464

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H2K8	TAOK3	P20T	Q9H2K8/P20T	TAOK3/P20T	VARIANT	P -> T (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9H2K8	TAOK3	S47N	Q9H2K8/S47N	TAOK3/S47N	VARIANT	S -> N (in dbSNP:rs428073)	ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.4	13679851,17344846
Q9H2K8	TAOK3	S392Y	Q9H2K8/S392Y	TAOK3/S392Y	VARIANT	S -> Y (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9H2K8	TAOK3	C727Y	Q9H2K8/C727Y	TAOK3/C727Y	VARIANT	C -> Y (in dbSNP:rs55857273)	ECO:0000269|PubMed:17344846	17344846
Q9H2K8	TAOK3	D165A	Q9H2K8/D165A	TAOK3/D165A	MUTAGEN	D->A: Loss of serine/threonine-protein kinase activity.	ECO:0000269|PubMed:17396146	17396146
Q9H2K8	TAOK3	T181A	Q9H2K8/T181A	TAOK3/T181A	MUTAGEN	T->A: No autophosphorylation and no kinase activity; when associated with F-183.	ECO:0000269|PubMed:10559204	10559204
Q9H2K8	TAOK3	Y183F	Q9H2K8/Y183F	TAOK3/Y183F	MUTAGEN	Y->F: No autophosphorylation and no kinase activity; when associated with A-181.	ECO:0000269|PubMed:10559204	10559204
Q9H2K8	TAOK3	S324A	Q9H2K8/S324A	TAOK3/S324A	MUTAGEN	S->A: Inhibits activation of the p38/MAPK14 stress-activated MAPK cascade in response to DNA damage.	ECO:0000269|PubMed:17396146	17396146

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H2X6	HIPK2	R792Q	Q9H2X6/R792Q	HIPK2/R792Q	VARIANT	R -> Q (in dbSNP:rs56132157)	ECO:0000269|PubMed:17344846	17344846
Q9H2X6	HIPK2	R1027Q	Q9H2X6/R1027Q	HIPK2/R1027Q	VARIANT	R -> Q (in dbSNP:rs35255718)	ECO:0000269|PubMed:17344846	17344846
Q9H2X6	HIPK2	K228A	Q9H2X6/K228A	HIPK2/K228A	MUTAGEN	K->A: Locates in the nucleoplasm, no effect on interaction with RANBP9, but loss of kinase activity toward PML, RUNX1, EP300 and DAZAP2.	ECO:0000269|PubMed:11267674, ECO:0000269|PubMed:11740489, ECO:0000269|PubMed:11925430, ECO:0000269|PubMed:12220523, ECO:0000269|PubMed:12874272, ECO:0000269|PubMed:12907596, ECO:0000269|PubMed:14678985, ECO:0000269|PubMed:18695000, ECO:0000269|PubMed:19015637, ECO:0000269|PubMed:33591310	11267674,11740489,11925430,12220523,12874272,12907596,14678985,18695000,19015637,33591310
Q9H2X6	HIPK2	K228R	Q9H2X6/K228R	HIPK2/K228R	MUTAGEN	K->R: Abolishes enzymatic activity, no effect on interaction with TP53 and TP73 or on BMP-induced transcriptional activation. Enhances BMP-induced transcriptional activation; when associated with 359-AAF-361.	ECO:0000269|PubMed:11267674, ECO:0000269|PubMed:11740489, ECO:0000269|PubMed:11925430, ECO:0000269|PubMed:12220523, ECO:0000269|PubMed:12874272, ECO:0000269|PubMed:12907596, ECO:0000269|PubMed:14678985, ECO:0000269|PubMed:18695000, ECO:0000269|PubMed:19015637	11267674,11740489,11925430,12220523,12874272,12907596,14678985,18695000,19015637
Q9H2X6	HIPK2	K803A	Q9H2X6/K803A	HIPK2/K803A	MUTAGEN	K->A: Impaired nuclear localization; when associated with A-805.	ECO:0000269|PubMed:21145359	21145359
Q9H2X6	HIPK2	K805A	Q9H2X6/K805A	HIPK2/K805A	MUTAGEN	K->A: Impaired nuclear localization; when associated with A-803.	ECO:0000269|PubMed:21145359	21145359
Q9H2X6	HIPK2	R833A	Q9H2X6/R833A	HIPK2/R833A	MUTAGEN	R->A: Impaired nuclear localization.	ECO:0000269|PubMed:21145359	21145359
Q9H2X6	HIPK2	K835E	Q9H2X6/K835E	HIPK2/K835E	MUTAGEN	K->E: Impaired nuclear localization.	ECO:0000269|PubMed:21145359	21145359

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H3Y6	SRMS	R73C	Q9H3Y6/R73C	SRMS/R73C	VARIANT	R -> C (in dbSNP:rs56053583)	ECO:0000269|PubMed:17344846	17344846
Q9H3Y6	SRMS	G75R	Q9H3Y6/G75R	SRMS/G75R	VARIANT	G -> R (in dbSNP:rs55863722)	ECO:0000269|PubMed:17344846	17344846
Q9H3Y6	SRMS	I88V	Q9H3Y6/I88V	SRMS/I88V	VARIANT	I -> V (in dbSNP:rs35558836)	ECO:0000269|PubMed:17344846	17344846
Q9H3Y6	SRMS	P218L	Q9H3Y6/P218L	SRMS/P218L	VARIANT	P -> L (in dbSNP:rs378483)		
Q9H3Y6	SRMS	V255M	Q9H3Y6/V255M	SRMS/V255M	VARIANT	V -> M (in dbSNP:rs34969822)		
Q9H3Y6	SRMS	V301L	Q9H3Y6/V301L	SRMS/V301L	VARIANT	V -> L (in dbSNP:rs310657)	ECO:0000269|PubMed:17344846	17344846
Q9H3Y6	SRMS	P325L	Q9H3Y6/P325L	SRMS/P325L	VARIANT	P -> L (in dbSNP:rs8122355)		
Q9H3Y6	SRMS	D377E	Q9H3Y6/D377E	SRMS/D377E	VARIANT	D -> E (in dbSNP:rs55838540)	ECO:0000269|PubMed:17344846	17344846
Q9H3Y6	SRMS	A397V	Q9H3Y6/A397V	SRMS/A397V	VARIANT	A -> V (in dbSNP:rs6011889)	ECO:0000269|PubMed:17344846	17344846
Q9H3Y6	SRMS	P452L	Q9H3Y6/P452L	SRMS/P452L	VARIANT	P -> L (in dbSNP:rs8120713)	ECO:0000269|PubMed:17344846	17344846
Q9H3Y6	SRMS	A453T	Q9H3Y6/A453T	SRMS/A453T	VARIANT	A -> T (in dbSNP:rs310655)	ECO:0000269|PubMed:17344846	17344846
Q9H3Y6	SRMS	V457L	Q9H3Y6/V457L	SRMS/V457L	VARIANT	V -> L (in dbSNP:rs310654)	ECO:0000269|PubMed:17344846	17344846
Q9H3Y6	SRMS	S465T	Q9H3Y6/S465T	SRMS/S465T	VARIANT	S -> T (in dbSNP:rs33933649)	ECO:0000269|PubMed:17344846	17344846
Q9H3Y6	SRMS	W223A	Q9H3Y6/W223A	SRMS/W223A	MUTAGEN	W->A: Loss of kinase activity.	ECO:0000269|PubMed:23822091	23822091
Q9H3Y6	SRMS	K258M	Q9H3Y6/K258M	SRMS/K258M	MUTAGEN	K->M: Loss of kinase activity. Exhibits a diffused cytoplasmic localization. No effect on interaction with KHDRBS1 or VIM but abolishes tyrosine phosphorylation of both substrates.	ECO:0000269|PubMed:23822091, ECO:0000269|PubMed:29496907	23822091,29496907
Q9H3Y6	SRMS	Y380F	Q9H3Y6/Y380F	SRMS/Y380F	MUTAGEN	Y->F: Significant reduction in phosphorylation.	ECO:0000269|PubMed:23822091	23822091

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H422	HIPK3	Q142R	Q9H422/Q142R	HIPK3/Q142R	VARIANT	Q -> R (in dbSNP:rs34193811)	ECO:0000269|PubMed:17344846	17344846
Q9H422	HIPK3	G170E	Q9H422/G170E	HIPK3/G170E	VARIANT	G -> E (in dbSNP:rs34698015)	ECO:0000269|PubMed:17344846	17344846
Q9H422	HIPK3	C191R	Q9H422/C191R	HIPK3/C191R	VARIANT	C -> R (in dbSNP:rs35689361)	ECO:0000269|PubMed:17344846	17344846
Q9H422	HIPK3	V474I	Q9H422/V474I	HIPK3/V474I	VARIANT	V -> I (in dbSNP:rs266472)		
Q9H422	HIPK3	S500N	Q9H422/S500N	HIPK3/S500N	VARIANT	S -> N (in dbSNP:rs11032229)	ECO:0000269|PubMed:17344846	17344846
Q9H422	HIPK3	P729L	Q9H422/P729L	HIPK3/P729L	VARIANT	P -> L (in dbSNP:rs55807239)	ECO:0000269|PubMed:17344846	17344846
Q9H422	HIPK3	K226R	Q9H422/K226R	HIPK3/K226R	MUTAGEN	K->R: Loss of kinase activity and impaired activation of SF1.	ECO:0000269|PubMed:17210646	17210646

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H4A3	WNK1	A141T	Q9H4A3/A141T	WNK1/A141T	VARIANT	A -> T (in dbSNP:rs11554421)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	A149V	Q9H4A3/A149V	WNK1/A149V	VARIANT	A -> V (in dbSNP:rs34880640)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	E419Q	Q9H4A3/E419Q	WNK1/E419Q	VARIANT	E -> Q (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	I509T	Q9H4A3/I509T	WNK1/I509T	VARIANT	I -> T (in dbSNP:rs34728563)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	D527G	Q9H4A3/D527G	WNK1/D527G	VARIANT	D -> G (in dbSNP:rs34408667)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	T665I	Q9H4A3/T665I	WNK1/T665I	VARIANT	T -> I (in dbSNP:rs2286007)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	T674A	Q9H4A3/T674A	WNK1/T674A	VARIANT	T -> A (in dbSNP:rs11833299)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	H823R	Q9H4A3/H823R	WNK1/H823R	VARIANT	H -> R (in dbSNP:rs56015776)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	T1056P	Q9H4A3/T1056P	WNK1/T1056P	VARIANT	T -> P (in dbSNP:rs956868)	ECO:0000269|PubMed:11571656, ECO:0000269|PubMed:9205841, ECO:0000269|Ref.3	11571656,9205841
Q9H4A3	WNK1	E1199G	Q9H4A3/E1199G	WNK1/E1199G	VARIANT	E -> G (in a colorectal cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
Q9H4A3	WNK1	C1506S	Q9H4A3/C1506S	WNK1/C1506S	VARIANT	C -> S (in dbSNP:rs7955371)	ECO:0000269|PubMed:11571656, ECO:0000269|PubMed:9205841, ECO:0000269|Ref.3	11571656,9205841
Q9H4A3	WNK1	A1546V	Q9H4A3/A1546V	WNK1/A1546V	VARIANT	A -> V (in dbSNP:rs56351358)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	Q1799E	Q9H4A3/Q1799E	WNK1/Q1799E	VARIANT	Q -> E (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17344846	16959974,17344846
Q9H4A3	WNK1	M1808I	Q9H4A3/M1808I	WNK1/M1808I	VARIANT	M -> I (in dbSNP:rs12828016)	ECO:0000269|PubMed:11571656, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3	11571656,17344846
Q9H4A3	WNK1	P1823L	Q9H4A3/P1823L	WNK1/P1823L	VARIANT	P -> L (in dbSNP:rs17755373)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	R1957H	Q9H4A3/R1957H	WNK1/R1957H	VARIANT	R -> H (in dbSNP:rs36083875)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	S2190C	Q9H4A3/S2190C	WNK1/S2190C	VARIANT	S -> C (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	F2362L	Q9H4A3/F2362L	WNK1/F2362L	VARIANT	F -> L (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9H4A3	WNK1	R2380W	Q9H4A3/R2380W	WNK1/R2380W	VARIANT	R -> W (in dbSNP:rs56262445)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H4B4	PLK3	T61S	Q9H4B4/T61S	PLK3/T61S	VARIANT	T -> S (in dbSNP:rs17884581)	ECO:0000269|Ref.2	
Q9H4B4	PLK3	L68F	Q9H4B4/L68F	PLK3/L68F	VARIANT	L -> F (in dbSNP:rs17884316)	ECO:0000269|Ref.2	
Q9H4B4	PLK3	L283F	Q9H4B4/L283F	PLK3/L283F	VARIANT	L -> F (in dbSNP:rs17880471)	ECO:0000269|Ref.2	
Q9H4B4	PLK3	R483C	Q9H4B4/R483C	PLK3/R483C	VARIANT	R -> C (in dbSNP:rs17884653)	ECO:0000269|Ref.2	
Q9H4B4	PLK3	D491N	Q9H4B4/D491N	PLK3/D491N	VARIANT	D -> N (in dbSNP:rs17855444)	ECO:0000269|PubMed:15489334	15489334
Q9H4B4	PLK3	S498L	Q9H4B4/S498L	PLK3/S498L	VARIANT	S -> L (in dbSNP:rs17880829)	ECO:0000269|Ref.2	
Q9H4B4	PLK3	S618P	Q9H4B4/S618P	PLK3/S618P	VARIANT	S -> P (in dbSNP:rs17881786)	ECO:0000269|Ref.2	
Q9H4B4	PLK3	K91R	Q9H4B4/K91R	PLK3/K91R	MUTAGEN	K->R: Kinase defective mutant, abolishes activity.	ECO:0000269|PubMed:11447225, ECO:0000269|PubMed:14980500, ECO:0000269|PubMed:17804415, ECO:0000269|PubMed:19103756, ECO:0000269|PubMed:19490146, ECO:0000269|PubMed:20889502, ECO:0000269|PubMed:20940307	11447225,14980500,17804415,19103756,19490146,20889502,20940307
Q9H4B4	PLK3	D203A	Q9H4B4/D203A	PLK3/D203A	MUTAGEN	D->A: Kinase defective mutant, abolishes activity.	ECO:0000269|PubMed:11156373	11156373
Q9H4B4	PLK3	T219E	Q9H4B4/T219E	PLK3/T219E	MUTAGEN	T->E: Kinase-defective mutant.	ECO:0000269|PubMed:16478733	16478733

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H5K3	POMK	S48P	Q9H5K3/S48P	POMK/S48P	VARIANT	S -> P (in dbSNP:rs34466747)	ECO:0000269|PubMed:17344846	17344846
Q9H5K3	POMK	L137R	Q9H5K3/L137R	POMK/L137R	VARIANT	L -> R (in MDDGA12; loss of kinase activity; dbSNP:rs397509385)	ECO:0000269|PubMed:23519211, ECO:0000269|PubMed:23929950	23519211,23929950
Q9H5K3	POMK	Y140F	Q9H5K3/Y140F	POMK/Y140F	VARIANT	Y -> F (in dbSNP:rs34750053)	ECO:0000269|PubMed:17344846	17344846
Q9H5K3	POMK	V254M	Q9H5K3/V254M	POMK/V254M	VARIANT	V -> M (in dbSNP:rs34715198)	ECO:0000269|PubMed:17344846	17344846
Q9H5K3	POMK	Q258R	Q9H5K3/Q258R	POMK/Q258R	VARIANT	Q -> R (in MDDGA12; dbSNP:rs397509386)	ECO:0000269|PubMed:23519211	23519211
Q9H5K3	POMK	M301T	Q9H5K3/M301T	POMK/M301T	VARIANT	M -> T (in dbSNP:rs33920561)	ECO:0000269|PubMed:17344846	17344846
Q9H5K3	POMK	V302D	Q9H5K3/V302D	POMK/V302D	VARIANT	V -> D (in MDDGA12; dbSNP:rs199756983)	ECO:0000269|PubMed:24925318	24925318
Q9H5K3	POMK	M342I	Q9H5K3/M342I	POMK/M342I	VARIANT	M -> I (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9H792	PEAK1	G213R	Q9H792/G213R	PEAK1/G213R	VARIANT	G -> R (in dbSNP:rs35459975)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	V240I	Q9H792/V240I	PEAK1/V240I	VARIANT	V -> I (in dbSNP:rs56129428)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	S440P	Q9H792/S440P	PEAK1/S440P	VARIANT	S -> P (in dbSNP:rs35335169)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	H611Q	Q9H792/H611Q	PEAK1/H611Q	VARIANT	H -> Q (in a bladder carcinoma NOS sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	S792I	Q9H792/S792I	PEAK1/S792I	VARIANT	S -> I (in dbSNP:rs34885462)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	D836E	Q9H792/D836E	PEAK1/D836E	VARIANT	D -> E (in dbSNP:rs56388121)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	S1035F	Q9H792/S1035F	PEAK1/S1035F	VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	R1071K	Q9H792/R1071K	PEAK1/R1071K	VARIANT	R -> K (in dbSNP:rs12909704)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	T1077P	Q9H792/T1077P	PEAK1/T1077P	VARIANT	T -> P (in dbSNP:rs56133554)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	P1145L	Q9H792/P1145L	PEAK1/P1145L	VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	P1408Q	Q9H792/P1408Q	PEAK1/P1408Q	VARIANT	P -> Q (in dbSNP:rs56079860)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	S1542T	Q9H792/S1542T	PEAK1/S1542T	VARIANT	S -> T (in dbSNP:rs1867780)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	R1699G	Q9H792/R1699G	PEAK1/R1699G	VARIANT	R -> G (in dbSNP:rs34004337)	ECO:0000269|PubMed:17344846	17344846
Q9H792	PEAK1	Y635E	Q9H792/Y635E	PEAK1/Y635E	MUTAGEN	Y->E: 50% reduction in interaction with GRB2. No effect on interaction with SHC1.		
Q9H792	PEAK1	Y635F	Q9H792/Y635F	PEAK1/Y635F	MUTAGEN	Y->F: Impairs interaction with tensin TNS3 and association with integrin ITGB1. 50% reduction in interaction with GRB2. No effect on interaction with unphosphorylated SHC1 but reduces interaction with tyrosine-phosphorylated SHC1. Reduces focal adhesion localization. Reduces cell migration.	ECO:0000269|PubMed:35687021	35687021
Q9H792	PEAK1	Y665E	Q9H792/Y665E	PEAK1/Y665E	MUTAGEN	Y->E: No effect on localization with actin. Decreases localization in focal adhesion. Fails to regulate focal adhesion dynamics. Decreases cell migration.	ECO:0000269|PubMed:23105102	23105102
Q9H792	PEAK1	Y665F	Q9H792/Y665F	PEAK1/Y665F	MUTAGEN	Y->F: No effect on focal adhesion subcellular localization. Does not affect colocalization with F-actin.	ECO:0000269|PubMed:23105102	23105102
Q9H792	PEAK1	Y1188F	Q9H792/Y1188F	PEAK1/Y1188F	MUTAGEN	Y->F: Fails to bind SHC1. Reduced recruitment of SHC1 to focal adhesions. Slightly reduces interaction with GRB2. Does not affect interaction with RASAL2. Does not affect association with integrin ITGB1.	ECO:0000269|PubMed:23846654, ECO:0000269|PubMed:35687021	23846654,35687021
Q9H792	PEAK1	F1609A	Q9H792/F1609A	PEAK1/F1609A	MUTAGEN	F->A: No effect on interaction with PRAG1.	ECO:0000269|PubMed:29079850	29079850
Q9H792	PEAK1	A1707D	Q9H792/A1707D	PEAK1/A1707D	MUTAGEN	A->D: Disrupts homodimerization.	ECO:0000269|PubMed:29212708	29212708

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9HAZ1	CLK4	L352F	Q9HAZ1/L352F	CLK4/L352F	VARIANT	L -> F (in dbSNP:rs35272416)	ECO:0000269|PubMed:17344846	17344846
Q9HAZ1	CLK4	I363V	Q9HAZ1/I363V	CLK4/I363V	VARIANT	I -> V (in dbSNP:rs55746655)	ECO:0000269|PubMed:17344846	17344846
Q9HAZ1	CLK4	K189R	Q9HAZ1/K189R	CLK4/K189R	MUTAGEN	K->R: Loss of function.	ECO:0000269|PubMed:11170754	11170754

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9HBH9	MKNK2	Q10K	Q9HBH9/Q10K	MKNK2/Q10K	VARIANT	Q -> K (in dbSNP:rs3746101)		
Q9HBH9	MKNK2	D73N	Q9HBH9/D73N	MKNK2/D73N	VARIANT	D -> N (in dbSNP:rs56158214)	ECO:0000269|PubMed:17344846	17344846
Q9HBH9	MKNK2	R428Q	Q9HBH9/R428Q	MKNK2/R428Q	VARIANT	R -> Q (in dbSNP:rs34475638)		
Q9HBH9	MKNK2	D228G	Q9HBH9/D228G	MKNK2/D228G	MUTAGEN	D->G: Reduced phosphorylation.	ECO:0000269|PubMed:16917500	16917500
Q9HBH9	MKNK2	T244A	Q9HBH9/T244A	MKNK2/T244A	MUTAGEN	T->A: Loss of kinase activity; when associated with T-249.	ECO:0000269|PubMed:11463832	11463832
Q9HBH9	MKNK2	T249A	Q9HBH9/T249A	MKNK2/T249A	MUTAGEN	T->A: Loss of kinase activity; when associated with T-244.	ECO:0000269|PubMed:11463832	11463832
Q9HBH9	MKNK2	T379D	Q9HBH9/T379D	MKNK2/T379D	MUTAGEN	T->D: Constitutively active.	ECO:0000269|PubMed:11463832	11463832

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9HBY8-1	SGK2	S12T	Q9HBY8-1/S12T	SGK2/S12T	VARIANT	S -> T (in dbSNP:rs33969356)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9HBY8	SGK2	E199K	Q9HBY8/E199K	SGK2/E199K	VARIANT	E -> K (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9HBY8	SGK2	H289Y	Q9HBY8/H289Y	SGK2/H289Y	VARIANT	H -> Y (in dbSNP:rs35793869)	ECO:0000269|PubMed:17344846	17344846
Q9HBY8	SGK2	S356D	Q9HBY8/S356D	SGK2/S356D	MUTAGEN	S->D: Increased activation.	ECO:0000269|PubMed:10548550	10548550

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9HC98	NEK6	K74M	Q9HC98/K74M	NEK6/K74M	MUTAGEN	K->M: Loss of autophosphorylation and of kinase activity and induction of apoptosis; when associated with M-75.	ECO:0000269|PubMed:14563848, ECO:0000269|PubMed:19001501	14563848,19001501
Q9HC98	NEK6	K75M	Q9HC98/K75M	NEK6/K75M	MUTAGEN	K->M: Loss of autophosphorylation and of kinase activity and induction of apoptosis; when associated with M-74.	ECO:0000269|PubMed:14563848, ECO:0000269|PubMed:19001501	14563848,19001501
Q9HC98	NEK6	Y108A	Q9HC98/Y108A	NEK6/Y108A	MUTAGEN	Y->A: Increase in catalytic activity.	ECO:0000269|PubMed:19941817	19941817

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9HCP0	CSNK1G1	R206K	Q9HCP0/R206K	CSNK1G1/R206K	VARIANT	R -> K (in dbSNP:rs55799101)	ECO:0000269|PubMed:17344846	17344846
Q9HCP0	CSNK1G1	R230W	Q9HCP0/R230W	CSNK1G1/R230W	VARIANT	R -> W (probable disease-associated variant found in a patient with non-syndromic early-onset epilepsy associated with severe developmental delay and microcephaly; dbSNP:rs587777544)	ECO:0000269|PubMed:24463883	24463883
Q9HCP0	CSNK1G1	V329I	Q9HCP0/V329I	CSNK1G1/V329I	VARIANT	V -> I (in dbSNP:rs55699712)	ECO:0000269|PubMed:17344846	17344846
Q9HCP0	CSNK1G1	N169A	Q9HCP0/N169A	CSNK1G1/N169A	MUTAGEN	N->A: Loss of kinase activity.	ECO:0000269|PubMed:21680713	21680713

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NQU5	PAK6	R3H	Q9NQU5/R3H	PAK6/R3H	VARIANT	R -> H (in a colorectal cancer sample; somatic mutation; dbSNP:rs201346085)	ECO:0000269|PubMed:16959974	16959974
Q9NQU5	PAK6	M76V	Q9NQU5/M76V	PAK6/M76V	VARIANT	M -> V (in dbSNP:rs2412504)	ECO:0000269|PubMed:17344846	17344846
Q9NQU5	PAK6	R103C	Q9NQU5/R103C	PAK6/R103C	VARIANT	R -> C (in dbSNP:rs36081263)		
Q9NQU5	PAK6	T151I	Q9NQU5/T151I	PAK6/T151I	VARIANT	T -> I (in dbSNP:rs35593179)		
Q9NQU5	PAK6	E184K	Q9NQU5/E184K	PAK6/E184K	VARIANT	E -> K (in dbSNP:rs56349744)	ECO:0000269|PubMed:17344846	17344846
Q9NQU5	PAK6	G205E	Q9NQU5/G205E	PAK6/G205E	VARIANT	G -> E (in dbSNP:rs55920845)	ECO:0000269|PubMed:17344846	17344846
Q9NQU5	PAK6	P208T	Q9NQU5/P208T	PAK6/P208T	VARIANT	P -> T (in dbSNP:rs35501648)	ECO:0000269|PubMed:17344846	17344846
Q9NQU5	PAK6	T210M	Q9NQU5/T210M	PAK6/T210M	VARIANT	T -> M (in dbSNP:rs34869667)	ECO:0000269|PubMed:17344846	17344846
Q9NQU5	PAK6	H215R	Q9NQU5/H215R	PAK6/H215R	VARIANT	H -> R (in dbSNP:rs3743135)	ECO:0000269|PubMed:17344846	17344846
Q9NQU5	PAK6	P337L	Q9NQU5/P337L	PAK6/P337L	VARIANT	P -> L (in dbSNP:rs3743137)	ECO:0000269|PubMed:17344846	17344846
Q9NQU5	PAK6	A376V	Q9NQU5/A376V	PAK6/A376V	VARIANT	A -> V (in dbSNP:rs55806501)	ECO:0000269|PubMed:17344846	17344846
Q9NQU5	PAK6	E475K	Q9NQU5/E475K	PAK6/E475K	VARIANT	E -> K (in dbSNP:rs34445577)		
Q9NQU5	PAK6	L514R	Q9NQU5/L514R	PAK6/L514R	VARIANT	L -> R (in a lung small cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NQU5	PAK6	S165A	Q9NQU5/S165A	PAK6/S165A	MUTAGEN	S->A: Almost complete loss of PAK6 activation by MAP2K6/MAPKK6; when associated with F-566.	ECO:0000269|PubMed:15550393	15550393
Q9NQU5	PAK6	S560A	Q9NQU5/S560A	PAK6/S560A	MUTAGEN	S->A: Complete loss of PAK6 activation by MAP2K6/MAPKK6; when associated with A-165.	ECO:0000269|PubMed:15550393	15550393
Q9NQU5	PAK6	Y566F	Q9NQU5/Y566F	PAK6/Y566F	MUTAGEN	Y->F: Complete loss of PAK6 activation by MAP2K6/MAPKK6; when associated with A-165.	ECO:0000269|PubMed:15550393	15550393

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NR20	DYRK4	A61T	Q9NR20/A61T	DYRK4/A61T	VARIANT	A -> T (in dbSNP:rs12306130)		
Q9NR20	DYRK4	A70S	Q9NR20/A70S	DYRK4/A70S	VARIANT	A -> S	ECO:0000269|PubMed:17344846	17344846
Q9NR20	DYRK4	V95I	Q9NR20/V95I	DYRK4/V95I	VARIANT	V -> I (in dbSNP:rs746486416)	ECO:0000269|PubMed:11062477	11062477
Q9NR20	DYRK4	N189S	Q9NR20/N189S	DYRK4/N189S	VARIANT	N -> S (in dbSNP:rs3741927)	ECO:0000269|PubMed:11062477	11062477
Q9NR20	DYRK4	D454V	Q9NR20/D454V	DYRK4/D454V	VARIANT	D -> V (in dbSNP:rs1801016)		
Q9NR20	DYRK4	K133R	Q9NR20/K133R	DYRK4/K133R	MUTAGEN	K->R: Loss of kinase activity.	ECO:0000269|PubMed:17292540	17292540
Q9NR20	DYRK4	Y264F	Q9NR20/Y264F	DYRK4/Y264F	MUTAGEN	Y->F: Abolishes kinase activity.	ECO:0000269|PubMed:21127067	21127067

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NRH2	SNRK	L260S	Q9NRH2/L260S	SNRK/L260S	VARIANT	L -> S (in dbSNP:rs35624204)	ECO:0000269|PubMed:17344846	17344846
Q9NRH2	SNRK	P391S	Q9NRH2/P391S	SNRK/P391S	VARIANT	P -> S (in dbSNP:rs56104180)	ECO:0000269|PubMed:17344846	17344846
Q9NRH2	SNRK	G611S	Q9NRH2/G611S	SNRK/G611S	VARIANT	G -> S (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs368877591)	ECO:0000269|PubMed:17344846	17344846
Q9NRH2	SNRK	P748L	Q9NRH2/P748L	SNRK/P748L	VARIANT	P -> L (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NRH2	SNRK	I765M	Q9NRH2/I765M	SNRK/I765M	VARIANT	I -> M (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NRH2	SNRK	T173A	Q9NRH2/T173A	SNRK/T173A	MUTAGEN			
Q9NRH2	SNRK	T173E	Q9NRH2/T173E	SNRK/T173E	MUTAGEN			

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NRL2	BAZ1A	D344E	Q9NRL2/D344E	BAZ1A/D344E	VARIANT	D -> E (in dbSNP:rs1133285)		
Q9NRL2	BAZ1A	N1366K	Q9NRL2/N1366K	BAZ1A/N1366K	VARIANT	N -> K (in dbSNP:rs1044140)	ECO:0000269|PubMed:10880450, ECO:0000269|PubMed:17974005	10880450,17974005

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NRM7	LATS2	G40E	Q9NRM7/G40E	LATS2/G40E	VARIANT	G -> E (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NRM7	LATS2	S91L	Q9NRM7/S91L	LATS2/S91L	VARIANT	S -> L (in dbSNP:rs55842804)	ECO:0000269|PubMed:17344846	17344846
Q9NRM7	LATS2	A324V	Q9NRM7/A324V	LATS2/A324V	VARIANT	A -> V (in dbSNP:rs558614)	ECO:0000269|PubMed:10673337	10673337
Q9NRM7	LATS2	G363S	Q9NRM7/G363S	LATS2/G363S	VARIANT	G -> S (in dbSNP:rs2770928)		
Q9NRM7	LATS2	I799V	Q9NRM7/I799V	LATS2/I799V	VARIANT	I -> V (in dbSNP:rs35368391)	ECO:0000269|PubMed:17344846	17344846
Q9NRM7	LATS2	A1014G	Q9NRM7/A1014G	LATS2/A1014G	VARIANT	A -> G (in dbSNP:rs45523141)	ECO:0000269|PubMed:17344846	17344846
Q9NRM7	LATS2	L1025P	Q9NRM7/L1025P	LATS2/L1025P	VARIANT	L -> P (in dbSNP:rs56116059)	ECO:0000269|PubMed:17344846	17344846
Q9NRM7	LATS2	S83C	Q9NRM7/S83C	LATS2/S83C	MUTAGEN	S->C: Fails to localize at the centromere during interphase.	ECO:0000269|PubMed:15147269	15147269
Q9NRM7	LATS2	S83E	Q9NRM7/S83E	LATS2/S83E	MUTAGEN	S->E: Fails to localize at the centromere during interphase.	ECO:0000269|PubMed:15147269	15147269
Q9NRM7	LATS2	K697A	Q9NRM7/K697A	LATS2/K697A	MUTAGEN	K->A: Loss of kinase activity, autophosphorylation and tumor suppressor activity.	ECO:0000269|PubMed:10871863, ECO:0000269|PubMed:12853976	10871863,12853976
Q9NRM7	LATS2	S872A	Q9NRM7/S872A	LATS2/S872A	MUTAGEN	S->A: Loss of tumor suppressor activity.	ECO:0000269|PubMed:12853976	12853976

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NRP7	STK36	I90M	Q9NRP7/I90M	STK36/I90M	VARIANT	I -> M (in dbSNP:rs55706732)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	R240W	Q9NRP7/R240W	STK36/R240W	VARIANT	R -> W (in dbSNP:rs35038757)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	K295R	Q9NRP7/K295R	STK36/K295R	VARIANT	K -> R (in dbSNP:rs1863703)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	D329N	Q9NRP7/D329N	STK36/D329N	VARIANT	D -> N (in dbSNP:rs34027859)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	L462V	Q9NRP7/L462V	STK36/L462V	VARIANT	L -> V (in dbSNP:rs45586733)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	K463N	Q9NRP7/K463N	STK36/K463N	VARIANT	K -> N (in dbSNP:rs17856747)	ECO:0000269|PubMed:15489334	15489334
Q9NRP7	STK36	F476S	Q9NRP7/F476S	STK36/F476S	VARIANT	F -> S (in dbSNP:rs34128793)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	R477W	Q9NRP7/R477W	STK36/R477W	VARIANT	R -> W (in dbSNP:rs16859180)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	R583Q	Q9NRP7/R583Q	STK36/R583Q	VARIANT	R -> Q (in dbSNP:rs1344642)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	Q638P	Q9NRP7/Q638P	STK36/Q638P	VARIANT	Q -> P (in dbSNP:rs6709303)		
Q9NRP7	STK36	S660C	Q9NRP7/S660C	STK36/S660C	VARIANT	S -> C (in a breast pleomorphic lobular carcinoma sample; somatic mutation; dbSNP:rs1244829273)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	L672P	Q9NRP7/L672P	STK36/L672P	VARIANT	L -> P (in dbSNP:rs35448374)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	S767T	Q9NRP7/S767T	STK36/S767T	VARIANT	S -> T (in dbSNP:rs17856748)	ECO:0000269|PubMed:15489334	15489334
Q9NRP7	STK36	S767Y	Q9NRP7/S767Y	STK36/S767Y	VARIANT	S -> Y (in an ovarian papillary serous adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	T816A	Q9NRP7/T816A	STK36/T816A	VARIANT	T -> A (in dbSNP:rs34271431)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	R839Q	Q9NRP7/R839Q	STK36/R839Q	VARIANT	R -> Q (in dbSNP:rs13023540)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	L840V	Q9NRP7/L840V	STK36/L840V	VARIANT	L -> V (in dbSNP:rs36099639)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	G1003D	Q9NRP7/G1003D	STK36/G1003D	VARIANT	G -> D (in dbSNP:rs1863704)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q9NRP7	STK36	V1004I	Q9NRP7/V1004I	STK36/V1004I	VARIANT	V -> I (in dbSNP:rs55633575)		
Q9NRP7	STK36	Y1111C	Q9NRP7/Y1111C	STK36/Y1111C	VARIANT	Y -> C (in dbSNP:rs56278660)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	R1112Q	Q9NRP7/R1112Q	STK36/R1112Q	VARIANT	R -> Q (in dbSNP:rs12993599)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	Q1138K	Q9NRP7/Q1138K	STK36/Q1138K	VARIANT	Q -> K (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	P1185S	Q9NRP7/P1185S	STK36/P1185S	VARIANT	P -> S (in an ovarian endometrioid sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	H1313P	Q9NRP7/H1313P	STK36/H1313P	VARIANT	H -> P	ECO:0000269|PubMed:17344846	17344846
Q9NRP7	STK36	K33R	Q9NRP7/K33R	STK36/K33R	MUTAGEN	K->R: No effect on nuclear localization of GLI1 or GLI2 or on GLI-mediated transcription.	ECO:0000269|PubMed:10806483	10806483

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NSY1	BMP2K	V68M	Q9NSY1/V68M	BMP2K/V68M	VARIANT	V -> M (in a lung squamous cell carcinoma sample; somatic mutation; dbSNP:rs770167074)	ECO:0000269|PubMed:17344846	17344846
Q9NSY1	BMP2K	D212V	Q9NSY1/D212V	BMP2K/D212V	VARIANT	D -> V (in dbSNP:rs56143363)	ECO:0000269|PubMed:17344846	17344846
Q9NSY1	BMP2K	R288H	Q9NSY1/R288H	BMP2K/R288H	VARIANT	R -> H (in dbSNP:rs55782848)	ECO:0000269|PubMed:17344846	17344846
Q9NSY1	BMP2K	G405S	Q9NSY1/G405S	BMP2K/G405S	VARIANT	G -> S (in dbSNP:rs2288255)	ECO:0000269|PubMed:15489334	15489334
Q9NSY1	BMP2K	Q486H	Q9NSY1/Q486H	BMP2K/Q486H	VARIANT	Q -> H (in dbSNP:rs2114202)		
Q9NSY1	BMP2K	T1002S	Q9NSY1/T1002S	BMP2K/T1002S	VARIANT	T -> S (in dbSNP:rs12507099)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NWZ3	IRAK4	I5V	Q9NWZ3/I5V	IRAK4/I5V	VARIANT	I -> V (no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs56312115)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:24316379	17344846,24316379
Q9NWZ3	IRAK4	R12C	Q9NWZ3/R12C	IRAK4/R12C	VARIANT	R -> C (in IMD67; no effect on inhibition of NF-kappa-B complex activation; loss of interaction with MYD88; decreases protein stability; dbSNP:rs377584435)	ECO:0000269|PubMed:17878374, ECO:0000269|PubMed:24316379	17878374,24316379
Q9NWZ3	IRAK4	R20W	Q9NWZ3/R20W	IRAK4/R20W	VARIANT	R -> W (increases inhibition of NF-kappa-B complex activation; decreases interaction with MYD88; decreases protein stability; dbSNP:rs143625818)	ECO:0000269|PubMed:24316379	24316379
Q9NWZ3	IRAK4	I26T	Q9NWZ3/I26T	IRAK4/I26T	VARIANT	I -> T (no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs138116867)	ECO:0000269|PubMed:24316379	24316379
Q9NWZ3	IRAK4	I39V	Q9NWZ3/I39V	IRAK4/I39V	VARIANT	I -> V (no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs113588409)	ECO:0000269|PubMed:24316379	24316379
Q9NWZ3	IRAK4	S98R	Q9NWZ3/S98R	IRAK4/S98R	VARIANT	S -> R (no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs4251469)	ECO:0000269|PubMed:24316379, ECO:0000269|Ref.5	24316379
Q9NWZ3	IRAK4	G298D	Q9NWZ3/G298D	IRAK4/G298D	VARIANT	G -> D (in IMD67; decreases inhibition of NF-kappa-B complex activation; impairs neutrophil migration and phagocytosis; dbSNP:rs568782766)	ECO:0000269|PubMed:19663824, ECO:0000269|PubMed:21057262, ECO:0000269|PubMed:24316379	19663824,21057262,24316379
Q9NWZ3	IRAK4	M355V	Q9NWZ3/M355V	IRAK4/M355V	VARIANT	M -> V (in dbSNP:rs142376871)	ECO:0000269|PubMed:17344846	17344846
Q9NWZ3	IRAK4	H390R	Q9NWZ3/H390R	IRAK4/H390R	VARIANT	H -> R (in dbSNP:rs4251583)	ECO:0000269|Ref.5	
Q9NWZ3	IRAK4	R391H	Q9NWZ3/R391H	IRAK4/R391H	VARIANT	R -> H (in dbSNP:rs55944915)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17878374	17344846,17878374
Q9NWZ3	IRAK4	A428T	Q9NWZ3/A428T	IRAK4/A428T	VARIANT	A -> T (in dbSNP:rs4251545)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5	17344846
Q9NWZ3	IRAK4	K213A	Q9NWZ3/K213A	IRAK4/K213A	MUTAGEN	K->A: Loss of kinase activity.	ECO:0000269|PubMed:15084582	15084582

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NY57	STK32B	G35E	Q9NY57/G35E	STK32B/G35E	VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NY57	STK32B	R198G	Q9NY57/R198G	STK32B/R198G	VARIANT	R -> G (in dbSNP:rs3733182)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
Q9NY57	STK32B	R244H	Q9NY57/R244H	STK32B/R244H	VARIANT	R -> H (in dbSNP:rs35207488)	ECO:0000269|PubMed:17344846	17344846
Q9NY57	STK32B	D310V	Q9NY57/D310V	STK32B/D310V	VARIANT	D -> V (in dbSNP:rs56259884)	ECO:0000269|PubMed:17344846	17344846
Q9NY57	STK32B	K342T	Q9NY57/K342T	STK32B/K342T	VARIANT	K -> T (in dbSNP:rs55961955)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NYL2	MAP3K20	R250W	Q9NYL2/R250W	MAP3K20/R250W	VARIANT	R -> W (in CNM6; unknown pathological significance; dbSNP:rs763481300)	ECO:0000269|PubMed:30237576	30237576
Q9NYL2	MAP3K20	T267M	Q9NYL2/T267M	MAP3K20/T267M	VARIANT	T -> M (in dbSNP:rs6758025)	ECO:0000269|PubMed:17344846	17344846
Q9NYL2	MAP3K20	A281T	Q9NYL2/A281T	MAP3K20/A281T	VARIANT	A -> T (in an ovarian endometrioid sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NYL2	MAP3K20	A281V	Q9NYL2/A281V	MAP3K20/A281V	VARIANT	A -> V (in dbSNP:rs34683477)	ECO:0000269|PubMed:17344846	17344846
Q9NYL2	MAP3K20	F368C	Q9NYL2/F368C	MAP3K20/F368C	VARIANT	F -> C (in SFMMP; produces protein aggregation; dbSNP:rs863225437)	ECO:0000269|PubMed:26755636	26755636
Q9NYL2	MAP3K20	A505S	Q9NYL2/A505S	MAP3K20/A505S	VARIANT	A -> S (in SFMMP; mild destabilization of the protein)	ECO:0000269|PubMed:32266845	32266845
Q9NYL2	MAP3K20	S531L	Q9NYL2/S531L	MAP3K20/S531L	VARIANT	S -> L (in dbSNP:rs3769148)	ECO:0000269|PubMed:10924358, ECO:0000269|PubMed:11042189, ECO:0000269|PubMed:11836244, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.6	10924358,11042189,11836244,17344846
Q9NYL2	MAP3K20	R580W	Q9NYL2/R580W	MAP3K20/R580W	VARIANT	R -> W (in dbSNP:rs7593622)	ECO:0000269|PubMed:17344846	17344846
Q9NYL2	MAP3K20	P740T	Q9NYL2/P740T	MAP3K20/P740T	VARIANT	P -> T (in dbSNP:rs56202258)	ECO:0000269|PubMed:17344846	17344846
Q9NYL2	MAP3K20	Y773H	Q9NYL2/Y773H	MAP3K20/Y773H	VARIANT	Y -> H (in dbSNP:rs35608243)	ECO:0000269|PubMed:17344846	17344846
Q9NYL2	MAP3K20	K784T	Q9NYL2/K784T	MAP3K20/K784T	VARIANT	K -> T (in dbSNP:rs55830025)	ECO:0000269|PubMed:17344846, ECO:0000269|Ref.9	17344846
Q9NYL2	MAP3K20	K45M	Q9NYL2/K45M	MAP3K20/K45M	MUTAGEN	K->M: Loss of kinase activity. Does not affect ability to activate EIF2AK4/GCN2 in response to mild ribosome collision.	ECO:0000269|PubMed:11836244, ECO:0000269|PubMed:32610081, ECO:0000269|PubMed:35857590	11836244,32610081,35857590
Q9NYL2	MAP3K20	T161A	Q9NYL2/T161A	MAP3K20/T161A	MUTAGEN	T->A: Loss of autophosphorylation activity.	ECO:0000269|PubMed:15342622	15342622
Q9NYL2	MAP3K20	T162A	Q9NYL2/T162A	MAP3K20/T162A	MUTAGEN	T->A: Slight loss of autophosphorylation activity.	ECO:0000269|PubMed:15342622	15342622
Q9NYL2	MAP3K20	S165A	Q9NYL2/S165A	MAP3K20/S165A	MUTAGEN	S->A: Loss of autophosphorylation activity.	ECO:0000269|PubMed:15342622	15342622
Q9NYL2	MAP3K20	S657A	Q9NYL2/S657A	MAP3K20/S657A	MUTAGEN	S->A: Abolished association with BTRC without affecting protein stability.	ECO:0000269|PubMed:32289254	32289254

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NYV4	CDK12	P530A	Q9NYV4/P530A	CDK12/P530A	VARIANT	P -> A (in dbSNP:rs56121596)	ECO:0000269|PubMed:17344846	17344846
Q9NYV4	CDK12	R912H	Q9NYV4/R912H	CDK12/R912H	VARIANT	R -> H (in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NYV4	CDK12	L1189Q	Q9NYV4/L1189Q	CDK12/L1189Q	VARIANT	L -> Q (in dbSNP:rs56362165)	ECO:0000269|PubMed:17344846	17344846
Q9NYV4	CDK12	P1275L	Q9NYV4/P1275L	CDK12/P1275L	VARIANT	P -> L (in dbSNP:rs34070318)	ECO:0000269|PubMed:17344846	17344846
Q9NYV4	CDK12	D877N	Q9NYV4/D877N	CDK12/D877N	MUTAGEN	D->N: Abolishes kinase activity.	ECO:0000269|PubMed:24662513	24662513

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NYY3	PLK2	S14T	Q9NYY3/S14T	PLK2/S14T	VARIANT	S -> T (in an ovarian Endometrioid carcinoma sample; somatic mutation; dbSNP:rs1404394734)	ECO:0000269|PubMed:17344846	17344846
Q9NYY3	PLK2	G92S	Q9NYY3/G92S	PLK2/G92S	VARIANT	G -> S (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9NYY3	PLK2	E436K	Q9NYY3/E436K	PLK2/E436K	VARIANT	E -> K (in dbSNP:rs55768901)	ECO:0000269|PubMed:17344846	17344846
Q9NYY3	PLK2	P487L	Q9NYY3/P487L	PLK2/P487L	VARIANT	P -> L (in dbSNP:rs55645589)	ECO:0000269|PubMed:17344846	17344846
Q9NYY3	PLK2	N210A	Q9NYY3/N210A	PLK2/N210A	MUTAGEN	N->A: Loss of kinase activity.	ECO:0000269|PubMed:19001868	19001868
Q9NYY3	PLK2	W503F	Q9NYY3/W503F	PLK2/W503F	MUTAGEN	W->F: Impairs localization to the centrosome and centriole duplication; when associated with A-629 and M-631.	ECO:0000269|PubMed:19001868	19001868
Q9NYY3	PLK2	H629A	Q9NYY3/H629A	PLK2/H629A	MUTAGEN	H->A: Impairs localization to the centrosome and centriole duplication; when associated with F-503 and M-631.	ECO:0000269|PubMed:19001868	19001868
Q9NYY3	PLK2	K631M	Q9NYY3/K631M	PLK2/K631M	MUTAGEN	K->M: Impairs localization to the centrosome and centriole duplication; when associated with F-503 and A-631.	ECO:0000269|PubMed:19001868	19001868

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9NZJ5	EIF2AK3	S136C	Q9NZJ5/S136C	EIF2AK3/S136C	VARIANT	S -> C (in dbSNP:rs867529)	ECO:0000269|PubMed:10932183, ECO:0000269|PubMed:17344846	10932183,17344846
Q9NZJ5	EIF2AK3	Q166R	Q9NZJ5/Q166R	EIF2AK3/Q166R	VARIANT	Q -> R (in dbSNP:rs13045)	ECO:0000269|PubMed:10026192, ECO:0000269|PubMed:10677345, ECO:0000269|PubMed:15489334	10026192,10677345,15489334
Q9NZJ5	EIF2AK3	D566V	Q9NZJ5/D566V	EIF2AK3/D566V	VARIANT	D -> V (in dbSNP:rs55791823)	ECO:0000269|PubMed:17344846	17344846
Q9NZJ5	EIF2AK3	R588Q	Q9NZJ5/R588Q	EIF2AK3/R588Q	VARIANT	R -> Q (in WRS; dbSNP:rs121908569)	ECO:0000269|PubMed:10932183	10932183
Q9NZJ5	EIF2AK3	A704S	Q9NZJ5/A704S	EIF2AK3/A704S	VARIANT	A -> S (in dbSNP:rs1805165)	ECO:0000269|PubMed:10026192, ECO:0000269|PubMed:10677345, ECO:0000269|PubMed:15489334	10026192,10677345,15489334
Q9NZJ5	EIF2AK3	P716L	Q9NZJ5/P716L	EIF2AK3/P716L	VARIANT	P -> L (in dbSNP:rs55861585)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9P0L2	MARK1	Y233C	Q9P0L2/Y233C	MARK1/Y233C	VARIANT	Y -> C (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9P0L2	MARK1	N355T	Q9P0L2/N355T	MARK1/N355T	VARIANT	N -> T (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9P0L2	MARK1	V530M	Q9P0L2/V530M	MARK1/V530M	VARIANT	V -> M (in dbSNP:rs56212551)	ECO:0000269|PubMed:17344846	17344846
Q9P0L2	MARK1	P578L	Q9P0L2/P578L	MARK1/P578L	VARIANT	P -> L (in dbSNP:rs55691439)	ECO:0000269|PubMed:17344846	17344846
Q9P0L2	MARK1	R645G	Q9P0L2/R645G	MARK1/R645G	VARIANT	R -> G (in dbSNP:rs12123778)		
Q9P0L2	MARK1	E691G	Q9P0L2/E691G	MARK1/E691G	VARIANT	E -> G (in dbSNP:rs55688276)	ECO:0000269|PubMed:17344846	17344846
Q9P0L2	MARK1	T215A	Q9P0L2/T215A	MARK1/T215A	MUTAGEN			
Q9P0L2	MARK1	T215E	Q9P0L2/T215E	MARK1/T215E	MUTAGEN	T->E: Constitutively active.	ECO:0000269|PubMed:14976552	14976552
Q9P0L2	MARK1	R698S	Q9P0L2/R698S	MARK1/R698S	MUTAGEN	R->S: Impairs phospholipid-binding, targeting to membrane and vesicle-binding; when associated with S-701.	ECO:0000269|PubMed:21145462	21145462
Q9P0L2	MARK1	R701S	Q9P0L2/R701S	MARK1/R701S	MUTAGEN	R->S: Impairs phospholipid-binding, targeting to membrane and vesicle-binding; when associated with S-698.	ECO:0000269|PubMed:21145462	21145462

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9P1W9	PIM2	G138D	Q9P1W9/G138D	PIM2/G138D	VARIANT	G -> D (in dbSNP:rs35044770)	ECO:0000269|PubMed:17344846	17344846
Q9P1W9	PIM2	I280V	Q9P1W9/I280V	PIM2/I280V	VARIANT	I -> V (in dbSNP:rs35208542)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9P286	PAK5	G118D	Q9P286/G118D	PAK5/G118D	VARIANT	G -> D (in dbSNP:rs55923311)	ECO:0000269|PubMed:17344846	17344846
Q9P286	PAK5	P187A	Q9P286/P187A	PAK5/P187A	VARIANT	P -> A (in dbSNP:rs34280805)	ECO:0000269|PubMed:17344846	17344846
Q9P286	PAK5	S312P	Q9P286/S312P	PAK5/S312P	VARIANT	S -> P (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs952665081)	ECO:0000269|PubMed:17344846	17344846
Q9P286	PAK5	R335P	Q9P286/R335P	PAK5/R335P	VARIANT	R -> P (in dbSNP:rs11700112)	ECO:0000269|PubMed:17344846	17344846
Q9P286	PAK5	S511N	Q9P286/S511N	PAK5/S511N	VARIANT	S -> N (in dbSNP:rs2297345)	ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846	14702039,17344846
Q9P286	PAK5	T538N	Q9P286/T538N	PAK5/T538N	VARIANT	T -> N (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9P286	PAK5	A555S	Q9P286/A555S	PAK5/A555S	VARIANT	A -> S (in dbSNP:rs34102290)	ECO:0000269|PubMed:17344846	17344846
Q9P286	PAK5	V604I	Q9P286/V604I	PAK5/V604I	VARIANT	V -> I (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9P286	PAK5	G704S	Q9P286/G704S	PAK5/G704S	VARIANT	G -> S (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1484691555)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9P289	STK26	Q9R	Q9P289/Q9R	STK26/Q9R	VARIANT	Q -> R (in dbSNP:rs56035648)	ECO:0000269|PubMed:17344846	17344846
Q9P289	STK26	G36W	Q9P289/G36W	STK26/G36W	VARIANT	G -> W (in a gastric adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9P289	STK26	R45C	Q9P289/R45C	STK26/R45C	VARIANT	R -> C (in dbSNP:rs56044451)	ECO:0000269|PubMed:17344846	17344846
Q9P289	STK26	K53E	Q9P289/K53E	STK26/K53E	MUTAGEN	K->E: Abolished serine/threonine-protein kinase activity.	ECO:0000269|PubMed:29232556	29232556

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9P2K8	EIF2AK4	H137R	Q9P2K8/H137R	EIF2AK4/H137R	VARIANT	H -> R (in dbSNP:rs35509999)	ECO:0000269|PubMed:17344846	17344846
Q9P2K8	EIF2AK4	R166W	Q9P2K8/R166W	EIF2AK4/R166W	VARIANT	R -> W (in dbSNP:rs34439704)	ECO:0000269|PubMed:17344846	17344846
Q9P2K8	EIF2AK4	I441L	Q9P2K8/I441L	EIF2AK4/I441L	VARIANT	I -> L (in dbSNP:rs2291627)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17974005	17344846,17974005
Q9P2K8	EIF2AK4	R585Q	Q9P2K8/R585Q	EIF2AK4/R585Q	VARIANT	R -> Q (in PVOD2; dbSNP:rs587777106)	ECO:0000269|PubMed:24292273	24292273
Q9P2K8	EIF2AK4	L643R	Q9P2K8/L643R	EIF2AK4/L643R	VARIANT	L -> R (in PVOD2; dbSNP:rs757852728)	ECO:0000269|PubMed:24292273	24292273
Q9P2K8	EIF2AK4	D872V	Q9P2K8/D872V	EIF2AK4/D872V	VARIANT	D -> V (in dbSNP:rs34665481)	ECO:0000269|PubMed:17344846	17344846
Q9P2K8	EIF2AK4	H939Y	Q9P2K8/H939Y	EIF2AK4/H939Y	VARIANT	H -> Y (in a lung neuroendocrine carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9P2K8	EIF2AK4	T1060R	Q9P2K8/T1060R	EIF2AK4/T1060R	VARIANT	T -> R (in dbSNP:rs55781333)	ECO:0000269|PubMed:17344846	17344846
Q9P2K8	EIF2AK4	G1306C	Q9P2K8/G1306C	EIF2AK4/G1306C	VARIANT	G -> C (in dbSNP:rs35602605)	ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	15489334,17344846
Q9P2K8	EIF2AK4	K1336R	Q9P2K8/K1336R	EIF2AK4/K1336R	VARIANT	K -> R (in dbSNP:rs35480871)	ECO:0000269|PubMed:17344846	17344846
Q9P2K8	EIF2AK4	Q1406H	Q9P2K8/Q1406H	EIF2AK4/Q1406H	VARIANT	Q -> H (in dbSNP:rs55721315)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UBE8	NLK	V177A	Q9UBE8/V177A	NLK/V177A	VARIANT	V -> A (in dbSNP:rs11871287)		
Q9UBE8	NLK	A343T	Q9UBE8/A343T	NLK/A343T	VARIANT	A -> T (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UBE8	NLK	K167N	Q9UBE8/K167N	NLK/K167N	MUTAGEN	K->N: Abrogates kinase activity.	ECO:0000269|PubMed:20061393	20061393

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UBS0	RPS6KB2	P267L	Q9UBS0/P267L	RPS6KB2/P267L	VARIANT	P -> L (in dbSNP:rs55987642)	ECO:0000269|PubMed:17344846	17344846
Q9UBS0	RPS6KB2	V368M	Q9UBS0/V368M	RPS6KB2/V368M	VARIANT	V -> M (in dbSNP:rs55642995)	ECO:0000269|PubMed:17344846	17344846
Q9UBS0	RPS6KB2	A420V	Q9UBS0/A420V	RPS6KB2/A420V	VARIANT	A -> V (in dbSNP:rs13859)	ECO:0000269|PubMed:10490847, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9804755, ECO:0000269|PubMed:9878560, ECO:0007744|PubMed:23186163	10490847,15489334,17344846,9804755,9878560,23186163
Q9UBS0	RPS6KB2	T443M	Q9UBS0/T443M	RPS6KB2/T443M	VARIANT	T -> M (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs374535834)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UEE5	STK17A	E126D	Q9UEE5/E126D	STK17A/E126D	VARIANT	E -> D (in dbSNP:rs56286238)	ECO:0000269|PubMed:17344846	17344846
Q9UEE5	STK17A	M167T	Q9UEE5/M167T	STK17A/M167T	VARIANT	M -> T (in dbSNP:rs35940029)	ECO:0000269|PubMed:17344846	17344846
Q9UEE5	STK17A	E286Q	Q9UEE5/E286Q	STK17A/E286Q	VARIANT	E -> Q (in dbSNP:rs3779062)	ECO:0000269|PubMed:17344846	17344846
Q9UEE5	STK17A	K362E	Q9UEE5/K362E	STK17A/K362E	VARIANT	K -> E (in dbSNP:rs1044141)	ECO:0000269|PubMed:12690205, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9786912, ECO:0000269|Ref.4	12690205,15489334,17344846,9786912
Q9UEE5	STK17A	K90A	Q9UEE5/K90A	STK17A/K90A	MUTAGEN	K->A: Loss of activity and of apoptotic function.	ECO:0000269|PubMed:9786912	9786912

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UF33	EPHA6	F704S	Q9UF33/F704S	EPHA6/F704S	VARIANT	F -> S	ECO:0000269|PubMed:17344846	17344846
Q9UF33	EPHA6	A711V	Q9UF33/A711V	EPHA6/A711V	VARIANT	A -> V (in dbSNP:rs4857276)		

Error: Q9UHD2 TBK1 'NoneType' object has no attribute 'group' FT                   /note="Missing (in FTDALS4)"

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UHD2	TBK1	F24S	Q9UHD2/F24S	TBK1/F24S	VARIANT	F -> S (loss of IFNB induction)	ECO:0000269|PubMed:32972995	32972995
Q9UHD2	TBK1	R47H	Q9UHD2/R47H	TBK1/R47H	VARIANT	R -> H (in FTDALS4; loss of kinase activity)	ECO:0000269|PubMed:25803835	25803835
Q9UHD2	TBK1	D50A	Q9UHD2/D50A	TBK1/D50A	VARIANT	D -> A (in IIAE8; decreased expression levels; dbSNP:rs1010930015)	ECO:0000269|PubMed:22851595	22851595
Q9UHD2	TBK1	Y105C	Q9UHD2/Y105C	TBK1/Y105C	VARIANT	Y -> C (in FTDALS4; dbSNP:rs1366668789)	ECO:0000269|PubMed:25803835	25803835
Q9UHD2	TBK1	S151F	Q9UHD2/S151F	TBK1/S151F	VARIANT	S -> F (in dbSNP:rs55824172)	ECO:0000269|PubMed:21447600	21447600
Q9UHD2	TBK1	V152L	Q9UHD2/V152L	TBK1/V152L	VARIANT	V -> L (no effect on IFNB induction)	ECO:0000269|PubMed:32972995	32972995
Q9UHD2	TBK1	G159A	Q9UHD2/G159A	TBK1/G159A	VARIANT	G -> A (in IIAE8; loss of kinase activity; loss of autophosphorylation at S-172; loss of IFNB induction; dbSNP:rs1555202947)	ECO:0000269|PubMed:22851595, ECO:0000269|PubMed:32972995	22851595,32972995
Q9UHD2	TBK1	I207V	Q9UHD2/I207V	TBK1/I207V	VARIANT	I -> V (in IIAE8; unknown pathological significance; dbSNP:rs1555203557)	ECO:0000269|PubMed:26513235	26513235
Q9UHD2	TBK1	R271Q	Q9UHD2/R271Q	TBK1/R271Q	VARIANT	R -> Q (in dbSNP:rs56196591)	ECO:0000269|PubMed:17344846	17344846
Q9UHD2	TBK1	K291E	Q9UHD2/K291E	TBK1/K291E	VARIANT	K -> E (in dbSNP:rs34774243)	ECO:0000269|PubMed:17344846	17344846
Q9UHD2	TBK1	D296H	Q9UHD2/D296H	TBK1/D296H	VARIANT	D -> H (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UHD2	TBK1	I305T	Q9UHD2/I305T	TBK1/I305T	VARIANT	I -> T (in FTDALS4; dbSNP:rs770942184)	ECO:0000269|PubMed:25803835	25803835
Q9UHD2	TBK1	L306I	Q9UHD2/L306I	TBK1/L306I	VARIANT	L -> I (in FTDALS4; unknown pathological significance; dbSNP:rs201970436)	ECO:0000269|PubMed:21447600, ECO:0000269|PubMed:25943890	21447600,25943890
Q9UHD2	TBK1	R308Q	Q9UHD2/R308Q	TBK1/R308Q	VARIANT	R -> Q (in FTDALS4; reduced kinase activity)	ECO:0000269|PubMed:25803835	25803835
Q9UHD2	TBK1	R357Q	Q9UHD2/R357Q	TBK1/R357Q	VARIANT	R -> Q (in FTDALS4; reduced kinase activity; dbSNP:rs758357594)	ECO:0000269|PubMed:25803835	25803835
Q9UHD2	TBK1	R384Q	Q9UHD2/R384Q	TBK1/R384Q	VARIANT	R -> Q (no effect on IFNB induction)	ECO:0000269|PubMed:32972995	32972995
Q9UHD2	TBK1	N388D	Q9UHD2/N388D	TBK1/N388D	VARIANT	N -> D (in dbSNP:rs17857028)	ECO:0000269|PubMed:15489334	15489334
Q9UHD2	TBK1	N388S	Q9UHD2/N388S	TBK1/N388S	VARIANT	N -> S (no effect on IFNB induction)	ECO:0000269|PubMed:32972995	32972995
Q9UHD2	TBK1	I397T	Q9UHD2/I397T	TBK1/I397T	VARIANT	I -> T (no effect on IFNB induction)	ECO:0000269|PubMed:32972995	32972995
Q9UHD2	TBK1	K401E	Q9UHD2/K401E	TBK1/K401E	VARIANT	K -> E (in FTDALS4; dbSNP:rs756751089)	ECO:0000269|PubMed:25943890	25943890
Q9UHD2	TBK1	G410R	Q9UHD2/G410R	TBK1/G410R	VARIANT	G -> R (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs1262765773)	ECO:0000269|PubMed:17344846	17344846
Q9UHD2	TBK1	V464A	Q9UHD2/V464A	TBK1/V464A	VARIANT	V -> A (in dbSNP:rs35635889)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21447600	17344846,21447600
Q9UHD2	TBK1	L508I	Q9UHD2/L508I	TBK1/L508I	VARIANT	L -> I (no effect on IFNB induction)	ECO:0000269|PubMed:32972995	32972995
Q9UHD2	TBK1	I522M	Q9UHD2/I522M	TBK1/I522M	VARIANT	I -> M (no effect on IFNB induction)	ECO:0000269|PubMed:32972995	32972995
Q9UHD2	TBK1	A533T	Q9UHD2/A533T	TBK1/A533T	VARIANT	A -> T (no effect on IFNB induction)	ECO:0000269|PubMed:32972995	32972995
Q9UHD2	TBK1	M559R	Q9UHD2/M559R	TBK1/M559R	VARIANT	M -> R (in FTDALS4; loss of kinase activity)	ECO:0000269|PubMed:25803835	25803835
Q9UHD2	TBK1	K570Q	Q9UHD2/K570Q	TBK1/K570Q	VARIANT	K -> Q (in dbSNP:rs17853341)	ECO:0000269|PubMed:15489334	15489334
Q9UHD2	TBK1	A571V	Q9UHD2/A571V	TBK1/A571V	VARIANT	A -> V (in FTDALS4; dbSNP:rs765035140)	ECO:0000269|PubMed:25803835	25803835
Q9UHD2	TBK1	M598V	Q9UHD2/M598V	TBK1/M598V	VARIANT	M -> V (in FTDALS4; dbSNP:rs899858451)	ECO:0000269|PubMed:25803835	25803835
Q9UHD2	TBK1	E653Q	Q9UHD2/E653Q	TBK1/E653Q	VARIANT	E -> Q (no effect on IFNB induction)	ECO:0000269|PubMed:32972995	32972995
Q9UHD2	TBK1	P659S	Q9UHD2/P659S	TBK1/P659S	VARIANT	P -> S (no effect on IFNB induction)	ECO:0000269|PubMed:32972995	32972995
Q9UHD2	TBK1	E696K	Q9UHD2/E696K	TBK1/E696K	VARIANT	E -> K (in FTDALS4; loss of kinase activity; impairs binding to OPTN; dbSNP:rs748112833)	ECO:0000269|PubMed:25803835, ECO:0000269|PubMed:25943890	25803835,25943890
Q9UHD2	TBK1	K30R	Q9UHD2/K30R	TBK1/K30R	MUTAGEN	K->R: Decreases ubiquitination. Abolishes ubiquitination, phosphorylation and kinase activity; when associated with R-401.	ECO:0000269|PubMed:23453971	23453971
Q9UHD2	TBK1	D33A	Q9UHD2/D33A	TBK1/D33A	MUTAGEN	D->A: Decreases phosphorylation and kinase activity.	ECO:0000269|PubMed:23453971	23453971
Q9UHD2	TBK1	K38A	Q9UHD2/K38A	TBK1/K38A	MUTAGEN	K->A: Loss of kinase activity.	ECO:0000269|PubMed:10581243, ECO:0000269|PubMed:22851595, ECO:0000269|PubMed:23453971, ECO:0000269|PubMed:23453972, ECO:0000269|PubMed:31709703	10581243,22851595,23453971,23453972,31709703
Q9UHD2	TBK1	D135N	Q9UHD2/D135N	TBK1/D135N	MUTAGEN	D->N: Loss of kinase activity.	ECO:0000269|PubMed:21931631, ECO:0000269|PubMed:23453971, ECO:0000269|PubMed:23453972, ECO:0000269|PubMed:30842653	21931631,23453971,23453972,30842653
Q9UHD2	TBK1	S172A	Q9UHD2/S172A	TBK1/S172A	MUTAGEN	S->A: Loss of kinase activity. No effect on dimerization. Loss of localization to cytoplasmic spherical structures.	ECO:0000269|PubMed:11839743, ECO:0000269|PubMed:23453972, ECO:0000269|PubMed:36640307	11839743,23453972,36640307
Q9UHD2	TBK1	S172E	Q9UHD2/S172E	TBK1/S172E	MUTAGEN	S->E: Decreased kinase activity.	ECO:0000269|PubMed:11839743, ECO:0000269|PubMed:23453972	11839743,23453972
Q9UHD2	TBK1	Y179A	Q9UHD2/Y179A	TBK1/Y179A	MUTAGEN	Y->A: Loss of localization to cytoplasmic spherical structures.	ECO:0000269|PubMed:36640307	36640307
Q9UHD2	TBK1	L316E	Q9UHD2/L316E	TBK1/L316E	MUTAGEN	L->E: Decreases kinase activity. No effect on phosphorylation.	ECO:0000269|PubMed:23453972	23453972
Q9UHD2	TBK1	Y325E	Q9UHD2/Y325E	TBK1/Y325E	MUTAGEN	Y->E: Abolishes phosphorylation and kinase activity.	ECO:0000269|PubMed:23453972	23453972
Q9UHD2	TBK1	E355R	Q9UHD2/E355R	TBK1/E355R	MUTAGEN	E->R: Decreases phosphorylation and kinase activity. Abolishes dimerization; when associated with A-357 or R-448.	ECO:0000269|PubMed:23453971, ECO:0000269|PubMed:23453972	23453971,23453972
Q9UHD2	TBK1	R357A	Q9UHD2/R357A	TBK1/R357A	MUTAGEN	R->A: Decreases phosphorylation and kinase activity. Abolishes dimerization; when associated with R-355.	ECO:0000269|PubMed:23453971	23453971
Q9UHD2	TBK1	K401R	Q9UHD2/K401R	TBK1/K401R	MUTAGEN	K->R: Decreases ubiquitination. Abolishes ubiquitination, phosphorylation and kinase activity; when associated with R-30.	ECO:0000269|PubMed:23453971	23453971
Q9UHD2	TBK1	E448R	Q9UHD2/E448R	TBK1/E448R	MUTAGEN	E->R: Decreases phosphorylation and kinase activity. Abolishes dimerization; when associated with R-355.	ECO:0000269|PubMed:23453972	23453972
Q9UHD2	TBK1	H459E	Q9UHD2/H459E	TBK1/H459E	MUTAGEN	H->E: Abolishes dimerization and decreases kinase activity but no effect on phosphorylation; when associated with E-466 and E-470.	ECO:0000269|PubMed:23453972	23453972
Q9UHD2	TBK1	I466E	Q9UHD2/I466E	TBK1/I466E	MUTAGEN	I->E: Abolishes dimerization and decreases kinase activity but no effect on phosphorylation; when associated with E-459 and E-470.	ECO:0000269|PubMed:23453972	23453972
Q9UHD2	TBK1	F470E	Q9UHD2/F470E	TBK1/F470E	MUTAGEN	F->E: Abolishes dimerization and decreases kinase activity but no effect on phosphorylation; when associated with E-459 and E-466.	ECO:0000269|PubMed:23453972	23453972
Q9UHD2	TBK1	R547D	Q9UHD2/R547D	TBK1/R547D	MUTAGEN	R->D: Decreases phosphorylation and kinase activity. Abolishes dimerization.	ECO:0000269|PubMed:23453971	23453971
Q9UHD2	TBK1	Y577A	Q9UHD2/Y577A	TBK1/Y577A	MUTAGEN	Y->A: Decreases kinase activity. Reduced phosphorylation of STING1.	ECO:0000269|PubMed:23453971, ECO:0000269|PubMed:30842653	23453971,30842653
Q9UHD2	TBK1	N578A	Q9UHD2/N578A	TBK1/N578A	MUTAGEN	N->A: Reduced phosphorylation of STING1.	ECO:0000269|PubMed:30842653	30842653
Q9UHD2	TBK1	E580A	Q9UHD2/E580A	TBK1/E580A	MUTAGEN	E->A: Decreases kinase activity.	ECO:0000269|PubMed:23453971	23453971
Q9UHD2	TBK1	Q581A	Q9UHD2/Q581A	TBK1/Q581A	MUTAGEN	Q->A: Reduced phosphorylation of STING1.	ECO:0000269|PubMed:30842653	30842653
Q9UHD2	TBK1	I582A	Q9UHD2/I582A	TBK1/I582A	MUTAGEN	I->A: Decreases kinase activity.	ECO:0000269|PubMed:23453971	23453971
Q9UHD2	TBK1	K589D	Q9UHD2/K589D	TBK1/K589D	MUTAGEN	K->D: Decreases phosphorylation and kinase activity.	ECO:0000269|PubMed:23453971	23453971
Q9UHD2	TBK1	M690A	Q9UHD2/M690A	TBK1/M690A	MUTAGEN	M->A: Decreases interaction with TANK.	ECO:0000269|PubMed:21931631	21931631
Q9UHD2	TBK1	L693A	Q9UHD2/L693A	TBK1/L693A	MUTAGEN	L->A: Almost abolishes interaction with TANK.	ECO:0000269|PubMed:21931631	21931631
Q9UHD2	TBK1	K694E	Q9UHD2/K694E	TBK1/K694E	MUTAGEN	K->E: Strongly decreases interaction with TANK and TBKBP1. No effect on phosphorylation.	ECO:0000269|PubMed:21931631	21931631
Q9UHD2	TBK1	L704A	Q9UHD2/L704A	TBK1/L704A	MUTAGEN	L->A: Strongly decreases interaction with AZI2, TANK and TBKBP1. No effect on phosphorylation.	ECO:0000269|PubMed:21931631	21931631
Q9UHD2	TBK1	N708A	Q9UHD2/N708A	TBK1/N708A	MUTAGEN	N->A: Decreases interaction with TANK.	ECO:0000269|PubMed:21931631	21931631
Q9UHD2	TBK1	L711A	Q9UHD2/L711A	TBK1/L711A	MUTAGEN	L->A: Almost abolishes interaction with TANK.	ECO:0000269|PubMed:21931631	21931631

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UHY1	NRBP1	V365I	Q9UHY1/V365I	NRBP1/V365I	VARIANT	V -> I (in dbSNP:rs56004639)	ECO:0000269|PubMed:17344846	17344846
Q9UHY1	NRBP1	P432L	Q9UHY1/P432L	NRBP1/P432L	VARIANT	P -> L (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs753734841)	ECO:0000269|PubMed:17344846	17344846
Q9UHY1	NRBP1	H460R	Q9UHY1/H460R	NRBP1/H460R	VARIANT	H -> R (in dbSNP:rs34260196)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UIG0	BAZ1B	C338A	Q9UIG0/C338A	BAZ1B/C338A	MUTAGEN	C->A: Loss of tyrosine-protein kinase activity.	ECO:0000269|PubMed:19092802	19092802

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UIK4	DAPK2	R60W	Q9UIK4/R60W	DAPK2/R60W	VARIANT	R -> W (in dbSNP:rs56047843)	ECO:0000269|PubMed:17344846	17344846
Q9UIK4	DAPK2	R271W	Q9UIK4/R271W	DAPK2/R271W	VARIANT	R -> W (in dbSNP:rs34270163)	ECO:0000269|PubMed:17344846	17344846
Q9UIK4	DAPK2	K52A	Q9UIK4/K52A	DAPK2/K52A	MUTAGEN	K->A: Loss of activity, apoptotic function and of autophosphorylation.	ECO:0000269|PubMed:10376525, ECO:0000269|PubMed:10629061, ECO:0000269|PubMed:11230133	10376525,10629061,11230133
Q9UIK4	DAPK2	S299A	Q9UIK4/S299A	DAPK2/S299A	MUTAGEN	S->A: No effect on Ca(2+)-calmodulin independent phosphorylation or apoptotic activity.	ECO:0000269|PubMed:11230133	11230133
Q9UIK4	DAPK2	S318A	Q9UIK4/S318A	DAPK2/S318A	MUTAGEN	S->A: Loss of Ca(2+)-calmodulin independent phosphorylation, increase in apoptotic activity.	ECO:0000269|PubMed:11230133	11230133
Q9UIK4	DAPK2	S318D	Q9UIK4/S318D	DAPK2/S318D	MUTAGEN	S->D: Abolishes apoptotic activity.	ECO:0000269|PubMed:11230133	11230133
Q9UIK4	DAPK2	S320A	Q9UIK4/S320A	DAPK2/S320A	MUTAGEN	S->A: No effect on Ca(2+)-calmodulin independent phosphorylation or apoptotic activity.	ECO:0000269|PubMed:11230133	11230133
Q9UIK4	DAPK2	S323A	Q9UIK4/S323A	DAPK2/S323A	MUTAGEN	S->A: No effect on Ca(2+)-calmodulin independent phosphorylation or apoptotic activity.	ECO:0000269|PubMed:11230133	11230133
Q9UIK4	DAPK2	T329A	Q9UIK4/T329A	DAPK2/T329A	MUTAGEN	T->A: No effect on Ca(2+)-calmodulin independent phosphorylation or apoptotic activity.	ECO:0000269|PubMed:11230133	11230133
Q9UIK4	DAPK2	S367A	Q9UIK4/S367A	DAPK2/S367A	MUTAGEN	S->A: No effect on interaction with YWHAE.	ECO:0000269|PubMed:26047703	26047703
Q9UIK4	DAPK2	S368A	Q9UIK4/S368A	DAPK2/S368A	MUTAGEN	S->A: No effect on interaction with YWHAE.	ECO:0000269|PubMed:26047703	26047703
Q9UIK4	DAPK2	T369A	Q9UIK4/T369A	DAPK2/T369A	MUTAGEN	T->A: Interaction with YWHAE is reduced.	ECO:0000269|PubMed:26047703	26047703
Q9UIK4	DAPK2	S370A	Q9UIK4/S370A	DAPK2/S370A	MUTAGEN	S->A: Interaction with YWHAE is increased.	ECO:0000269|PubMed:26047703	26047703

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UK32	RPS6KA6	Y140C	Q9UK32/Y140C	RPS6KA6/Y140C	VARIANT	Y -> C (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UK32	RPS6KA6	S258T	Q9UK32/S258T	RPS6KA6/S258T	VARIANT	S -> T (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UK32	RPS6KA6	D692N	Q9UK32/D692N	RPS6KA6/D692N	VARIANT	D -> N (in dbSNP:rs6616890)	ECO:0000269|PubMed:17344846	17344846
Q9UK32	RPS6KA6	S372A	Q9UK32/S372A	RPS6KA6/S372A	MUTAGEN	S->A: No effect on activity.	ECO:0000269|PubMed:15632195	15632195
Q9UK32	RPS6KA6	S389A	Q9UK32/S389A	RPS6KA6/S389A	MUTAGEN	S->A: Strongly decreases activity.	ECO:0000269|PubMed:15632195	15632195
Q9UK32	RPS6KA6	T581A	Q9UK32/T581A	RPS6KA6/T581A	MUTAGEN	T->A: No effect on activity.	ECO:0000269|PubMed:15632195	15632195

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UKE5	TNIK	K778E	Q9UKE5/K778E	TNIK/K778E	VARIANT	K -> E (in dbSNP:rs55778284)	ECO:0000269|PubMed:17344846	17344846
Q9UKE5	TNIK	G910E	Q9UKE5/G910E	TNIK/G910E	VARIANT	G -> E (in dbSNP:rs35090763)	ECO:0000269|PubMed:17344846	17344846
Q9UKE5	TNIK	A999T	Q9UKE5/A999T	TNIK/A999T	VARIANT	A -> T (in dbSNP:rs17857452)	ECO:0000269|PubMed:17344846	17344846
Q9UKE5	TNIK	K54A	Q9UKE5/K54A	TNIK/K54A	MUTAGEN	K->A: Kinase dead. Loss of autophosphorylation and loss of function in cytoskeleton regulation.	ECO:0000269|PubMed:15342639, ECO:0000269|PubMed:19816403	15342639,19816403

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UKI8	TLK1	R121C	Q9UKI8/R121C	TLK1/R121C	VARIANT	R -> C	ECO:0000269|PubMed:17344846	17344846
Q9UKI8	TLK1	D607A	Q9UKI8/D607A	TLK1/D607A	MUTAGEN	D->A: Loss of kinase activity.	ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:11470414	10523312,11470414
Q9UKI8	TLK1	S743A	Q9UKI8/S743A	TLK1/S743A	MUTAGEN	S->A: Loss of kinase inhibition in response to DNA damage.	ECO:0000269|PubMed:12660173	12660173
Q9UKI8	TLK1	S743D	Q9UKI8/S743D	TLK1/S743D	MUTAGEN	S->D: Loss of kinase inhibition in response to DNA damage.	ECO:0000269|PubMed:12660173	12660173
Q9UKI8	TLK1	S743E	Q9UKI8/S743E	TLK1/S743E	MUTAGEN	S->E: Loss of kinase inhibition in response to DNA damage.	ECO:0000269|PubMed:12660173	12660173

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UL54	TAOK2	K57A	Q9UL54/K57A	TAOK2/K57A	MUTAGEN	K->A: Loss of kinase activity. In isoform 1, excluded from the nucleus. No effect on microtubule-binding.	ECO:0000269|PubMed:10660600, ECO:0000269|PubMed:12639963, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:17158878	10660600,12639963,16893890,17158878
Q9UL54	TAOK2	D169A	Q9UL54/D169A	TAOK2/D169A	MUTAGEN	D->A: Loss of kinase activity; No effect on MAP3K7-mediated activation of NF-kappa-B.	ECO:0000269|PubMed:16893890	16893890
Q9UL54	TAOK2	D919N	Q9UL54/D919N	TAOK2/D919N	MUTAGEN	D->N: No effect on kinase activity, nor on JNK activation, but severe reduction in nuclear localization and apoptotic membrane blebbing.	ECO:0000269|PubMed:17158878	17158878

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UM73	ALK	S90L	Q9UM73/S90L	ALK/S90L	VARIANT	S -> L (in dbSNP:rs34617074)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	V163L	Q9UM73/V163L	ALK/V163L	VARIANT	V -> L (in dbSNP:rs55697431)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	E296Q	Q9UM73/E296Q	ALK/E296Q	VARIANT	E -> Q (in dbSNP:rs56077855)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	V476A	Q9UM73/V476A	ALK/V476A	VARIANT	V -> A (in dbSNP:rs35093491)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	L560F	Q9UM73/L560F	ALK/L560F	VARIANT	L -> F (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	T680I	Q9UM73/T680I	ALK/T680I	VARIANT	T -> I (in dbSNP:rs35228363)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	A704T	Q9UM73/A704T	ALK/A704T	VARIANT	A -> T (in dbSNP:rs34829159)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	L868Q	Q9UM73/L868Q	ALK/L868Q	VARIANT	L -> Q (in dbSNP:rs55941323)		
Q9UM73	ALK	A877S	Q9UM73/A877S	ALK/A877S	VARIANT	A -> S (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs746442213)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	T1012M	Q9UM73/T1012M	ALK/T1012M	VARIANT	T -> M (in dbSNP:rs35073634)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	D1091N	Q9UM73/D1091N	ALK/D1091N	VARIANT	D -> N (in NBLST3; somatic mutation; dbSNP:rs864309584)	ECO:0000269|PubMed:18724359	18724359
Q9UM73	ALK	G1121D	Q9UM73/G1121D	ALK/G1121D	VARIANT	G -> D (in dbSNP:rs55760835)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	G1128A	Q9UM73/G1128A	ALK/G1128A	VARIANT	G -> A (in NBLST3; dbSNP:rs113994088)	ECO:0000269|PubMed:18724359	18724359
Q9UM73	ALK	T1151M	Q9UM73/T1151M	ALK/T1151M	VARIANT	T -> M (in NBLST3; dbSNP:rs113994091)	ECO:0000269|PubMed:18923525	18923525
Q9UM73	ALK	M1166R	Q9UM73/M1166R	ALK/M1166R	VARIANT	M -> R (in NBLST3; somatic mutation; dbSNP:rs1057520019)	ECO:0000269|PubMed:18724359	18724359
Q9UM73	ALK	I1171N	Q9UM73/I1171N	ALK/I1171N	VARIANT	I -> N (in NBLST3; somatic mutation; dbSNP:rs1057519698)	ECO:0000269|PubMed:18724359	18724359
Q9UM73	ALK	F1174C	Q9UM73/F1174C	ALK/F1174C	VARIANT	F -> C (in NBLST3; dbSNP:rs1057519697)	ECO:0000269|PubMed:18923523	18923523
Q9UM73	ALK	F1174I	Q9UM73/F1174I	ALK/F1174I	VARIANT	F -> I (in NBLST3; somatic mutation; dbSNP:rs281864719)	ECO:0000269|PubMed:18724359	18724359
Q9UM73	ALK	F1174L	Q9UM73/F1174L	ALK/F1174L	VARIANT	F -> L (in NBLST3; somatic mutation; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs863225281)	ECO:0000269|PubMed:18923523, ECO:0000269|PubMed:18923525, ECO:0000269|PubMed:21242967	18923523,18923525,21242967
Q9UM73	ALK	F1174V	Q9UM73/F1174V	ALK/F1174V	VARIANT	F -> V (in NBLST3; somatic mutation; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs281864719)	ECO:0000269|PubMed:18923523, ECO:0000269|PubMed:21242967	18923523,21242967
Q9UM73	ALK	R1192P	Q9UM73/R1192P	ALK/R1192P	VARIANT	R -> P (in NBLST3; dbSNP:rs113994089)	ECO:0000269|PubMed:18724359, ECO:0000269|PubMed:18923523	18724359,18923523
Q9UM73	ALK	A1234T	Q9UM73/A1234T	ALK/A1234T	VARIANT	A -> T (in NBLST3; somatic mutation)	ECO:0000269|PubMed:18923525	18923525
Q9UM73	ALK	F1245C	Q9UM73/F1245C	ALK/F1245C	VARIANT	F -> C (in NBLST3; somatic mutation; dbSNP:rs863225283)	ECO:0000269|PubMed:18724359, ECO:0000269|PubMed:18923525	18724359,18923525
Q9UM73	ALK	F1245V	Q9UM73/F1245V	ALK/F1245V	VARIANT	F -> V (in NBLST3; somatic mutation; dbSNP:rs281864720)		
Q9UM73	ALK	I1250T	Q9UM73/I1250T	ALK/I1250T	VARIANT	I -> T (in NBLST3; somatic mutation; dbSNP:rs113994092)	ECO:0000269|PubMed:18724359	18724359
Q9UM73	ALK	A1274T	Q9UM73/A1274T	ALK/A1274T	VARIANT	A -> T (in dbSNP:rs45502292)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	R1275L	Q9UM73/R1275L	ALK/R1275L	VARIANT	R -> L (observed in neuroblastoma; dbSNP:rs113994087)	ECO:0000269|PubMed:18923523	18923523
Q9UM73	ALK	R1275Q	Q9UM73/R1275Q	ALK/R1275Q	VARIANT	R -> Q (in NBLST3; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs113994087)	ECO:0000269|PubMed:18724359, ECO:0000269|PubMed:18923523, ECO:0000269|PubMed:18923525, ECO:0000269|PubMed:21242967, ECO:0000269|PubMed:22932897	18724359,18923523,18923525,21242967,22932897
Q9UM73	ALK	Y1278S	Q9UM73/Y1278S	ALK/Y1278S	VARIANT	Y -> S (in NBLST3; somatic mutation; dbSNP:rs863225285)	ECO:0000269|PubMed:18923523	18923523
Q9UM73	ALK	M1328L	Q9UM73/M1328L	ALK/M1328L	VARIANT	M -> L (in dbSNP:rs56160491)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	F1376S	Q9UM73/F1376S	ALK/F1376S	VARIANT	F -> S (in dbSNP:rs17694720)		
Q9UM73	ALK	K1416N	Q9UM73/K1416N	ALK/K1416N	VARIANT	K -> N (in dbSNP:rs55782189)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	E1419K	Q9UM73/E1419K	ALK/E1419K	VARIANT	E -> K (in dbSNP:rs56181542)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	Q1429R	Q9UM73/Q1429R	ALK/Q1429R	VARIANT	Q -> R (in dbSNP:rs55906201)	ECO:0000269|PubMed:17344846	17344846
Q9UM73	ALK	I1461V	Q9UM73/I1461V	ALK/I1461V	VARIANT	I -> V (in dbSNP:rs1670283)	ECO:0000269|PubMed:17625570, ECO:0000269|PubMed:8122112, ECO:0000269|PubMed:9053841, ECO:0000269|PubMed:9174053, ECO:0000269|Ref.4	17625570,8122112,9053841,9174053
Q9UM73	ALK	K1491R	Q9UM73/K1491R	ALK/K1491R	VARIANT	K -> R (in dbSNP:rs1881420)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17625570, ECO:0000269|PubMed:9053841, ECO:0000269|Ref.4	17344846,17625570,9053841
Q9UM73	ALK	D1529E	Q9UM73/D1529E	ALK/D1529E	VARIANT	D -> E (in dbSNP:rs1881421)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:17625570, ECO:0000269|PubMed:9053841, ECO:0000269|Ref.4	17344846,17625570,9053841
Q9UM73	ALK	P1599H	Q9UM73/P1599H	ALK/P1599H	VARIANT	P -> H (in dbSNP:rs1881423)		
Q9UM73	ALK	E859A	Q9UM73/E859A	ALK/E859A	MUTAGEN	E->A: Slightly decreased autophosphorylation. Decreased autophosphorylation and subsequent activation; when associated with A-974.	ECO:0000269|PubMed:34819673	34819673
Q9UM73	ALK	Y966A	Q9UM73/Y966A	ALK/Y966A	MUTAGEN	Y->A: Slightly decreased autophosphorylation. Strongly reduced autophosphorylation and subsequent activation; when associated with A-994.	ECO:0000269|PubMed:34819673	34819673
Q9UM73	ALK	E974A	Q9UM73/E974A	ALK/E974A	MUTAGEN	E->A: Slightly decreased autophosphorylation. Decreased autophosphorylation and subsequent activation; when associated with A-859.	ECO:0000269|PubMed:34819673	34819673
Q9UM73	ALK	E994A	Q9UM73/E994A	ALK/E994A	MUTAGEN	E->A: SlStrongly reduced autophosphorylation and subsequent activation; when associated with A-966.	ECO:0000269|PubMed:34819673	34819673
Q9UM73	ALK	Y1507F	Q9UM73/Y1507F	ALK/Y1507F	MUTAGEN	Y->F: Impairs interaction with SHC1.	ECO:0000269|PubMed:17274988	17274988

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UPE1	SRPK3	R101C	Q9UPE1/R101C	SRPK3/R101C	VARIANT	R -> C (in dbSNP:rs55910507)	ECO:0000269|PubMed:17344846	17344846
Q9UPE1	SRPK3	G114E	Q9UPE1/G114E	SRPK3/G114E	VARIANT	G -> E (in dbSNP:rs35865042)	ECO:0000269|PubMed:17344846	17344846
Q9UPE1	SRPK3	E233K	Q9UPE1/E233K	SRPK3/E233K	VARIANT	E -> K (in dbSNP:rs34497419)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UPN9	TRIM33	V67A	Q9UPN9/V67A	TRIM33/V67A	VARIANT	V -> A (in dbSNP:rs6691166)		
Q9UPN9	TRIM33	M580I	Q9UPN9/M580I	TRIM33/M580I	VARIANT	M -> I (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UPN9	TRIM33	L696S	Q9UPN9/L696S	TRIM33/L696S	VARIANT	L -> S (in dbSNP:rs56151583)	ECO:0000269|PubMed:17344846	17344846
Q9UPN9	TRIM33	E811K	Q9UPN9/E811K	TRIM33/E811K	VARIANT	E -> K (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UPN9	TRIM33	I840T	Q9UPN9/I840T	TRIM33/I840T	VARIANT	I -> T (in dbSNP:rs6537825)	ECO:0000269|PubMed:10022127, ECO:0000269|PubMed:10439047, ECO:0000269|PubMed:10470851, ECO:0000269|PubMed:11331580	10022127,10439047,10470851,11331580
Q9UPN9	TRIM33	P885S	Q9UPN9/P885S	TRIM33/P885S	VARIANT	P -> S (in a glioblastoma multiforme sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UPN9	TRIM33	V961M	Q9UPN9/V961M	TRIM33/V961M	VARIANT	V -> M (in dbSNP:rs55688622)	ECO:0000269|PubMed:17344846	17344846
Q9UPN9	TRIM33	P1090T	Q9UPN9/P1090T	TRIM33/P1090T	VARIANT	P -> T (in dbSNP:rs55784699)	ECO:0000269|PubMed:17344846	17344846
Q9UPN9	TRIM33	C125A	Q9UPN9/C125A	TRIM33/C125A	MUTAGEN	C->A: Abolishes E3 activity but does not affect interaction with SMAD4; when associated with A-128.	ECO:0000269|PubMed:15820681	15820681
Q9UPN9	TRIM33	C128A	Q9UPN9/C128A	TRIM33/C128A	MUTAGEN	C->A: Abolishes E3 activity but does not affect interaction with SMAD4; when associated with A-125.	ECO:0000269|PubMed:15820681	15820681

Error: Q9UPZ9 CILK1 'NoneType' object has no attribute 'group' FT                   /note="Missing (in EJM10; impairs mitosis, cell-cycle exit

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UPZ9	CILK1	P98L	Q9UPZ9/P98L	CILK1/P98L	VARIANT	P -> L (in dbSNP:rs1493105)		
Q9UPZ9	CILK1	I102L	Q9UPZ9/I102L	CILK1/I102L	VARIANT	I -> L (in EJM10; unknown pathological significance; dbSNP:rs748539319)	ECO:0000269|PubMed:29539279	29539279
Q9UPZ9	CILK1	F115Y	Q9UPZ9/F115Y	CILK1/F115Y	VARIANT	F -> Y (in a renal clear cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UPZ9	CILK1	K220E	Q9UPZ9/K220E	CILK1/K220E	VARIANT	K -> E (in EJM10; impairs mitosis, cell-cycle exit and radial neuroblast migration, while promoting apoptosis, when tested in a heterologous system)	ECO:0000269|PubMed:29539279	29539279
Q9UPZ9	CILK1	R272Q	Q9UPZ9/R272Q	CILK1/R272Q	VARIANT	R -> Q (in ECO; significantly impairs kinase activity; decreased localization at the ciliary tips; impaired ciliogenesis; results in abnormally elongated cilia; impairs mitosis, cell-cycle exit and radial neuroblast migration, while promoting apoptosis, when tested in a heterologous system; loss of nuclear localization; dbSNP:rs118203918)	ECO:0000269|PubMed:19185282, ECO:0000269|PubMed:24797473, ECO:0000269|PubMed:24853502, ECO:0000269|PubMed:29539279	19185282,24797473,24853502,29539279
Q9UPZ9	CILK1	K305T	Q9UPZ9/K305T	CILK1/K305T	VARIANT	K -> T (in EJM10; impairs mitosis, cell-cycle exit and radial neuroblast migration, while promoting apoptosis, when tested in a heterologous system; dbSNP:rs765078446)	ECO:0000269|PubMed:29539279	29539279
Q9UPZ9	CILK1	V320I	Q9UPZ9/V320I	CILK1/V320I	VARIANT	V -> I (in dbSNP:rs33936662)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:29539279	17344846,29539279
Q9UPZ9	CILK1	T471K	Q9UPZ9/T471K	CILK1/T471K	VARIANT	T -> K (in dbSNP:rs56164633)	ECO:0000269|PubMed:17344846	17344846
Q9UPZ9	CILK1	R476Q	Q9UPZ9/R476Q	CILK1/R476Q	VARIANT	R -> Q (in dbSNP:rs55895113)	ECO:0000269|PubMed:17344846	17344846
Q9UPZ9	CILK1	A615T	Q9UPZ9/A615T	CILK1/A615T	VARIANT	A -> T (in EJM10; unknown pathological significance; impairs mitosis, cell-cycle exit and radial neuroblast migration, while promoting apoptosis, when tested in a heterologous system; dbSNP:rs55932059)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:29539279	17344846,29539279
Q9UPZ9	CILK1	K33R	Q9UPZ9/K33R	CILK1/K33R	MUTAGEN	K->R: Loss of activity and autophosphorylation; when associated with R-34; R-36 and R-38.	ECO:0000269|PubMed:10699974	10699974
Q9UPZ9	CILK1	K34R	Q9UPZ9/K34R	CILK1/K34R	MUTAGEN	K->R: Loss of activity and autophosphorylation; when associated with R-33; R-36 and R-38.	ECO:0000269|PubMed:10699974	10699974
Q9UPZ9	CILK1	K36R	Q9UPZ9/K36R	CILK1/K36R	MUTAGEN	K->R: Loss of activity and autophosphorylation; when associated with R-33; R-34 and R-38.	ECO:0000269|PubMed:10699974	10699974
Q9UPZ9	CILK1	K38R	Q9UPZ9/K38R	CILK1/K38R	MUTAGEN	K->R: Loss of activity and autophosphorylation; when associated with R-33; R-34 and R-36.	ECO:0000269|PubMed:10699974	10699974
Q9UPZ9	CILK1	T157A	Q9UPZ9/T157A	CILK1/T157A	MUTAGEN	T->A: Reduction of activity and loss of autophosphorylation. Loss of activity and autophosphorylation; when associated with F-159.	ECO:0000269|PubMed:10699974	10699974
Q9UPZ9	CILK1	Y159F	Q9UPZ9/Y159F	CILK1/Y159F	MUTAGEN	Y->F: Reduction of activity and loss of autophosphorylation. Loss of activity and autophosphorylation; when associated with A-157.	ECO:0000269|PubMed:10699974	10699974

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UQ07	MOK	R38H	Q9UQ07/R38H	MOK/R38H	VARIANT	R -> H (in dbSNP:rs34114580)	ECO:0000269|PubMed:17344846	17344846
Q9UQ07	MOK	D86N	Q9UQ07/D86N	MOK/D86N	VARIANT	D -> N (in dbSNP:rs34084056)	ECO:0000269|PubMed:17344846	17344846
Q9UQ07	MOK	V217I	Q9UQ07/V217I	MOK/V217I	VARIANT	V -> I (in dbSNP:rs148360666)	ECO:0000269|PubMed:14702039	14702039
Q9UQ07	MOK	K230R	Q9UQ07/K230R	MOK/K230R	VARIANT	K -> R (in dbSNP:rs34965156)	ECO:0000269|PubMed:17344846	17344846
Q9UQ07	MOK	P248S	Q9UQ07/P248S	MOK/P248S	VARIANT	P -> S (in dbSNP:rs34299975)	ECO:0000269|PubMed:17344846	17344846
Q9UQ07	MOK	E272D	Q9UQ07/E272D	MOK/E272D	VARIANT	E -> D (in a breast pleomorphic lobular carcinoma sample; somatic mutation; dbSNP:rs1567133856)	ECO:0000269|PubMed:17344846	17344846
Q9UQ07	MOK	Q398R	Q9UQ07/Q398R	MOK/Q398R	VARIANT	Q -> R (in dbSNP:rs2236493)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UQB9	AURKC	G52E	Q9UQB9/G52E	AURKC/G52E	VARIANT	G -> E (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UQB9	AURKC	E148Q	Q9UQB9/E148Q	AURKC/E148Q	VARIANT	E -> Q (in a lung squamous cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UQB9	AURKC	H244Q	Q9UQB9/H244Q	AURKC/H244Q	VARIANT	H -> Q (in a lung adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9UQB9	AURKC	K72R	Q9UQB9/K72R	AURKC/K72R	MUTAGEN	K->R: Impairs kinase activity.	ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:15499654	15316025,15499654
Q9UQB9	AURKC	D166Y	Q9UQB9/D166Y	AURKC/D166Y	MUTAGEN	D->Y: Impairs kinase activity, and keeps AURKC with the chromosomes until the end of mitosis.	ECO:0000269|PubMed:15938719	15938719
Q9UQB9	AURKC	T198A	Q9UQB9/T198A	AURKC/T198A	MUTAGEN	T->A: Impairs kinase activity.	ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:15670791	15316025,15670791

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9UQM7	CAMK2A	F98S	Q9UQM7/F98S	CAMK2A/F98S	VARIANT	F -> S (in MRD53; no effect on protein abundance; decreased autophosphorylation; decreased neuronal migration; dbSNP:rs1554122526)	ECO:0000269|PubMed:29100089	29100089
Q9UQM7	CAMK2A	E109D	Q9UQM7/E109D	CAMK2A/E109D	VARIANT	E -> D (in MRD53; no effect on protein abundance; increased autophosphorylation; decreased neuronal migration)	ECO:0000269|PubMed:29100089	29100089
Q9UQM7	CAMK2A	A112V	Q9UQM7/A112V	CAMK2A/A112V	VARIANT	A -> V (in MRD53; unknown pathological significance)	ECO:0000269|PubMed:29100089	29100089
Q9UQM7	CAMK2A	P138A	Q9UQM7/P138A	CAMK2A/P138A	VARIANT	P -> A (in MRD53; unknown pathological significance; no effect on protein abundance; no effect on autophosphorylation; no effect on neuronal migration)	ECO:0000269|PubMed:25533962, ECO:0000269|PubMed:29100089	25533962,29100089
Q9UQM7	CAMK2A	E183V	Q9UQM7/E183V	CAMK2A/E183V	VARIANT	E -> V (in MRD53; increased ubiquitin-mediated proteasomal degradation with a dominant negative effect on wild-type protein; decreased localization to dendritic spines; no effect on holoenzyme assembly; loss of interaction with SHANK3; loss of interaction with GRIN2B; loss of interaction with CACNB2; loss of interaction with LRRC7; loss of interaction with GRM5; decreased protein serine/threonine kinase activity with a dominant negative effect on wild-type protein; decreased autophosphorylation; changed dendritic spine development; decreased neuronal migration; dbSNP:rs1554122129)	ECO:0000269|PubMed:28130356, ECO:0000269|PubMed:29100089	28130356,29100089
Q9UQM7	CAMK2A	P212L	Q9UQM7/P212L	CAMK2A/P212L	VARIANT	P -> L (in MRD53; unknown pathological significance; no effect on protein abundance; no effect on autophosphorylation; no effect on neuronal migration; dbSNP:rs926027867)	ECO:0000269|PubMed:29100089	29100089
Q9UQM7	CAMK2A	P212Q	Q9UQM7/P212Q	CAMK2A/P212Q	VARIANT	P -> Q (in MRD53; increased basal autophosphorylation)	ECO:0000269|PubMed:29560374	29560374
Q9UQM7	CAMK2A	P235L	Q9UQM7/P235L	CAMK2A/P235L	VARIANT	P -> L (in MRD53; unknown pathological significance; no effect on protein abundance; no effect on autophosphorylation; no effect on neuronal migration; dbSNP:rs864309606)	ECO:0000269|PubMed:29100089, ECO:0000269|PubMed:29560374	29100089,29560374
Q9UQM7	CAMK2A	H282R	Q9UQM7/H282R	CAMK2A/H282R	VARIANT	H -> R (in MRD53; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554121875)	ECO:0000269|PubMed:29100089	29100089
Q9UQM7	CAMK2A	T286P	Q9UQM7/T286P	CAMK2A/T286P	VARIANT	T->P: No effect on neuronal migration; when associated with R-42.	ECO:0000269|PubMed:29100089	29100089
Q9UQM7	CAMK2A	H466Y	Q9UQM7/H466Y	CAMK2A/H466Y	VARIANT	H -> Y (in MRT63; decreased oligomerization; dbSNP:rs1554119274)	ECO:0000269|PubMed:29784083	29784083
Q9UQM7	CAMK2A	K42R	Q9UQM7/K42R	CAMK2A/K42R	MUTAGEN	K->R: No effect on protein stability or degradation. No effect on neuronal migration; when associated with P-286.	ECO:0000269|PubMed:29100089	29100089
Q9UQM7	CAMK2A	T286A	Q9UQM7/T286A	CAMK2A/T286A	MUTAGEN	T->A: No effect on neuronal migration.	ECO:0000269|PubMed:29100089	29100089
Q9UQM7	CAMK2A	T286D	Q9UQM7/T286D	CAMK2A/T286D	MUTAGEN	T->D: Loss of neuronal migration.	ECO:0000269|PubMed:29100089	29100089

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y243	AKT3	E17K	Q9Y243/E17K	AKT3/E17K	VARIANT	E -> K (in MPPH2 and melanoma; results in activation of AKT; dbSNP:rs397514606)	ECO:0000269|PubMed:18813315, ECO:0000269|PubMed:22500628, ECO:0000269|PubMed:22729223	18813315,22500628,22729223
Q9Y243	AKT3	G171R	Q9Y243/G171R	AKT3/G171R	VARIANT	G -> R (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs1402272180)	ECO:0000269|PubMed:17344846	17344846
Q9Y243	AKT3	N229S	Q9Y243/N229S	AKT3/N229S	VARIANT	N -> S (in MPPH2; dbSNP:rs397514605)	ECO:0000269|PubMed:22729224, ECO:0000269|PubMed:23745724	22729224,23745724
Q9Y243	AKT3	R465W	Q9Y243/R465W	AKT3/R465W	VARIANT	R -> W (in MPPH2; disease phenotype overlaps with megalencephaly-capillary malformation syndrome; dbSNP:rs587776935)	ECO:0000269|PubMed:22729224	22729224
Q9Y243	AKT3	T305A	Q9Y243/T305A	AKT3/T305A	MUTAGEN	T->A: No activation after pervanadate treatment.	ECO:0000269|PubMed:11387345	11387345
Q9Y243	AKT3	T305D	Q9Y243/T305D	AKT3/T305D	MUTAGEN	T->D: 2-fold increase of phosphorylation steady state level, no activation after pervanadate treatment.	ECO:0000269|PubMed:11387345	11387345
Q9Y243	AKT3	T447A	Q9Y243/T447A	AKT3/T447A	MUTAGEN	T->A: No effect.	ECO:0000269|PubMed:11387345	11387345
Q9Y243	AKT3	T447D	Q9Y243/T447D	AKT3/T447D	MUTAGEN	T->D: No effect.	ECO:0000269|PubMed:11387345	11387345
Q9Y243	AKT3	S472A	Q9Y243/S472A	AKT3/S472A	MUTAGEN	S->A: 67% decrease of activity after pervanadate treatment.	ECO:0000269|PubMed:10092583	10092583
Q9Y243	AKT3	S472D	Q9Y243/S472D	AKT3/S472D	MUTAGEN	S->D: 1.4-fold increase of phosphorylation steady state level, 50% decrease of activity after pervanadate treatment.	ECO:0000269|PubMed:10092583	10092583

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y2H1	STK38L	G99A	Q9Y2H1/G99A	STK38L/G99A	VARIANT	G -> A (in a aLLTEL/AML1+ sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9Y2H1	STK38L	T75A	Q9Y2H1/T75A	STK38L/T75A	MUTAGEN	T->A: Decreased kinase activity. Reduced binding of S100B.	ECO:0000269|PubMed:15037617	15037617
Q9Y2H1	STK38L	K119A	Q9Y2H1/K119A	STK38L/K119A	MUTAGEN	K->A: Loss of autophosphorylation and kinase activity.	ECO:0000269|PubMed:15037617	15037617
Q9Y2H1	STK38L	S282A	Q9Y2H1/S282A	STK38L/S282A	MUTAGEN	S->A: Loss of autophosphorylation and kinase activity.	ECO:0000269|PubMed:15037617	15037617
Q9Y2H1	STK38L	T442A	Q9Y2H1/T442A	STK38L/T442A	MUTAGEN	T->A: Decreased kinase activity.	ECO:0000269|PubMed:15037617	15037617

Error: Q9Y2H9 MAST1 'NoneType' object has no attribute 'group' FT                   /note="Missing (in MCCCHCM; unknown pathological

Error: Q9Y2H9 MAST1 'NoneType' object has no attribute 'group' FT                   /note="Missing (in MCCCHCM; dbSNP:rs1568409494)"

Error: Q9Y2H9 MAST1 'NoneType' object has no attribute 'group' FT                   /note="Missing (in MCCCHCM; expression of this variant in

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y2H9	MAST1	S93L	Q9Y2H9/S93L	MAST1/S93L	VARIANT	S -> L (in a patient with neurodevelopmental abnormalities; de novo variant; unknown pathological significance; dbSNP:rs878853165)	ECO:0000269|PubMed:30449657	30449657
Q9Y2H9	MAST1	G98V	Q9Y2H9/G98V	MAST1/G98V	VARIANT	G -> V (in a patient with neurodevelopmental abnormalities; de novo variant; unknown pathological significance)	ECO:0000269|PubMed:30449657	30449657
Q9Y2H9	MAST1	A269T	Q9Y2H9/A269T	MAST1/A269T	VARIANT	A -> T (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9Y2H9	MAST1	G517S	Q9Y2H9/G517S	MAST1/G517S	VARIANT	G -> S (in MCCCHCM; dbSNP:rs1568413207)	ECO:0000269|PubMed:30449657	30449657
Q9Y2H9	MAST1	A915T	Q9Y2H9/A915T	MAST1/A915T	VARIANT	A -> T (in a patient with neurodevelopmental abnormalities; de novo variant; unknown pathological significance)	ECO:0000269|PubMed:30449657	30449657
Q9Y2H9	MAST1	A1048S	Q9Y2H9/A1048S	MAST1/A1048S	VARIANT	A -> S (in dbSNP:rs35052801)		
Q9Y2H9	MAST1	P1177R	Q9Y2H9/P1177R	MAST1/P1177R	VARIANT	P -> R (in a patient with neurodevelopmental abnormalities; de novo variant; unknown pathological significance)	ECO:0000269|PubMed:30449657	30449657
Q9Y2H9	MAST1	H1240Y	Q9Y2H9/H1240Y	MAST1/H1240Y	VARIANT	H -> Y (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs1411105125)	ECO:0000269|PubMed:17344846	17344846
Q9Y2H9	MAST1	P1292S	Q9Y2H9/P1292S	MAST1/P1292S	VARIANT	P -> S (in dbSNP:rs35071862)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y2K2	SIK3	R187C	Q9Y2K2/R187C	SIK3/R187C	VARIANT	R -> C (in SEMDK; decreased protein expression; decreased kinase activity; no effect on the interaction with DEPTOR, MLST8/GbetaL, RICTOR and RPTOR; dbSNP:rs1565460853)	ECO:0000269|PubMed:30232230	30232230
Q9Y2K2	SIK3	H389L	Q9Y2K2/H389L	SIK3/H389L	VARIANT	H -> L (in a breast cancer sample; somatic mutation; dbSNP:rs376144593)	ECO:0000269|PubMed:16959974	16959974
Q9Y2K2	SIK3	D1098E	Q9Y2K2/D1098E	SIK3/D1098E	VARIANT	D -> E (in dbSNP:rs11216163)		
Q9Y2K2	SIK3	P1136R	Q9Y2K2/P1136R	SIK3/P1136R	VARIANT	P -> R (in dbSNP:rs12225230)	ECO:0000269|Ref.6	
Q9Y2K2	SIK3	A1161V	Q9Y2K2/A1161V	SIK3/A1161V	VARIANT	A -> V (in a breast cancer sample; somatic mutation)	ECO:0000269|PubMed:16959974	16959974
Q9Y2K2	SIK3	T221A	Q9Y2K2/T221A	SIK3/T221A	MUTAGEN			
Q9Y2K2	SIK3	T469A	Q9Y2K2/T469A	SIK3/T469A	MUTAGEN	T->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	ECO:0000269|PubMed:29211348	29211348
Q9Y2K2	SIK3	T469E	Q9Y2K2/T469E	SIK3/T469E	MUTAGEN	T->E: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	ECO:0000269|PubMed:29211348	29211348
Q9Y2K2	SIK3	S551A	Q9Y2K2/S551A	SIK3/S551A	MUTAGEN	S->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	ECO:0000269|PubMed:29211348	29211348
Q9Y2K2	SIK3	S551E	Q9Y2K2/S551E	SIK3/S551E	MUTAGEN	S->E: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	ECO:0000269|PubMed:29211348	29211348
Q9Y2K2	SIK3	S626A	Q9Y2K2/S626A	SIK3/S626A	MUTAGEN	S->A: No effect on interaction with 14-3-3 proteins, nor on cAMP signaling.	ECO:0000269|PubMed:29211348	29211348
Q9Y2K2	SIK3	S626E	Q9Y2K2/S626E	SIK3/S626E	MUTAGEN	S->E: No effect on cAMP signaling.	ECO:0000269|PubMed:29211348	29211348

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y2U5	MAP3K2	I110V	Q9Y2U5/I110V	MAP3K2/I110V	VARIANT	I -> V (in dbSNP:rs55767983)	ECO:0000269|PubMed:17344846	17344846
Q9Y2U5	MAP3K2	M112I	Q9Y2U5/M112I	MAP3K2/M112I	VARIANT	M -> I (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9Y2U5	MAP3K2	D140G	Q9Y2U5/D140G	MAP3K2/D140G	VARIANT	D -> G (in dbSNP:rs56307783)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y3S1	WNK2	V828M	Q9Y3S1/V828M	WNK2/V828M	VARIANT	V -> M (in dbSNP:rs10761203)		
Q9Y3S1	WNK2	R974L	Q9Y3S1/R974L	WNK2/R974L	VARIANT	R -> L (in dbSNP:rs10114908)		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y463	DYRK1B	L28P	Q9Y463/L28P	DYRK1B/L28P	VARIANT	L -> P (in dbSNP:rs34587974)	ECO:0000269|PubMed:17344846	17344846
Q9Y463	DYRK1B	H90P	Q9Y463/H90P	DYRK1B/H90P	VARIANT	H -> P (in AOMS3; expression of glucose-6-phosphatase is significantly higher than wild-type; dbSNP:rs587777380)	ECO:0000269|PubMed:24827035	24827035
Q9Y463	DYRK1B	R102C	Q9Y463/R102C	DYRK1B/R102C	VARIANT	R -> C (in AOMS3; accumulation of intracellular lipid is significantly greater than with wild-type protein; cells expressing the variant are able to transform into mature adipocytes without requiring adipogenic medium; expression levels of CEBPA, PPARG forms 1 and 2 and PPARGC1A are higher and those of GLI1 and CDKN1B are lower in cells transfected with the mutant protein compared to wild-type; WNT1 signaling activity is lower in mutant cells compared to wild-type; dbSNP:rs367643250)	ECO:0000269|PubMed:24827035	24827035
Q9Y463	DYRK1B	R102H	Q9Y463/R102H	DYRK1B/R102H	VARIANT	R -> H (in dbSNP:rs55687541)	ECO:0000269|PubMed:17344846	17344846
Q9Y463	DYRK1B	S234G	Q9Y463/S234G	DYRK1B/S234G	VARIANT	S -> G (in dbSNP:rs35858874)	ECO:0000269|PubMed:17344846	17344846
Q9Y463	DYRK1B	Q275R	Q9Y463/Q275R	DYRK1B/Q275R	VARIANT	Q -> R (in a metastatic melanoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9Y463	DYRK1B	K140R	Q9Y463/K140R	DYRK1B/K140R	MUTAGEN	K->R: Abolishes kinase activity.	ECO:0000269|PubMed:10910078	10910078
Q9Y463	DYRK1B	D239A	Q9Y463/D239A	DYRK1B/D239A	MUTAGEN	D->A: Abolishes kinase activity.	ECO:0000269|PubMed:32611815	32611815
Q9Y463	DYRK1B	Y271F	Q9Y463/Y271F	DYRK1B/Y271F	MUTAGEN	Y->F: Abolishes kinase activity; when associated with F-273.	ECO:0000269|PubMed:10910078	10910078
Q9Y463	DYRK1B	Y273F	Q9Y463/Y273F	DYRK1B/Y273F	MUTAGEN	Y->F: Abolishes kinase activity; when associated with F-271.	ECO:0000269|PubMed:10910078	10910078

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y4A5	TRRAP	R171C	Q9Y4A5/R171C	TRRAP/R171C	VARIANT	R -> C (in DFNA75; unknown pathological significance; dbSNP:rs200157211)	ECO:0000269|PubMed:31231791	31231791
Q9Y4A5	TRRAP	D394N	Q9Y4A5/D394N	TRRAP/D394N	VARIANT	D -> N (in DFNA75; unknown pathological significance; dbSNP:rs1554407965)	ECO:0000269|PubMed:31231791	31231791
Q9Y4A5	TRRAP	S722F	Q9Y4A5/S722F	TRRAP/S722F	VARIANT	S -> F (found in a cutaneous malignant melanoma sample; somatic mutation; induces cell transformation and confers resistance to apoptosis; dbSNP:rs147405090)	ECO:0000269|PubMed:21499247	21499247
Q9Y4A5	TRRAP	L805F	Q9Y4A5/L805F	TRRAP/L805F	VARIANT	L -> F (in DEDDFA; unknown pathological significance; dbSNP:rs1562940289)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	F860L	Q9Y4A5/F860L	TRRAP/F860L	VARIANT	F -> L (in DEDDFA; unknown pathological significance)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	R878L	Q9Y4A5/R878L	TRRAP/R878L	VARIANT	R -> L (in dbSNP:rs17161510)		
Q9Y4A5	TRRAP	R893C	Q9Y4A5/R893C	TRRAP/R893C	VARIANT	R -> C (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	R893L	Q9Y4A5/R893L	TRRAP/R893L	VARIANT	R -> L (in DEDDFA; unknown pathological significance)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	I1031M	Q9Y4A5/I1031M	TRRAP/I1031M	VARIANT	I -> M (in DEDDFA)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	R1035Q	Q9Y4A5/R1035Q	TRRAP/R1035Q	VARIANT	R -> Q (in DEDDFA; unknown pathological significance)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	S1037R	Q9Y4A5/S1037R	TRRAP/S1037R	VARIANT	S -> R (in DEDDFA; unknown pathological significance)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	A1043T	Q9Y4A5/A1043T	TRRAP/A1043T	VARIANT	A -> T (in DEDDFA; dbSNP:rs1562945106)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	S1070G	Q9Y4A5/S1070G	TRRAP/S1070G	VARIANT	S -> G (in dbSNP:rs55920979)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	E1104G	Q9Y4A5/E1104G	TRRAP/E1104G	VARIANT	E -> G (in DEDDFA; dbSNP:rs1790257064)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	E1106K	Q9Y4A5/E1106K	TRRAP/E1106K	VARIANT	E -> K (in DEDDFA; dbSNP:rs1584324956)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	G1111W	Q9Y4A5/G1111W	TRRAP/G1111W	VARIANT	G -> W (in DEDDFA; unknown pathological significance)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	G1159R	Q9Y4A5/G1159R	TRRAP/G1159R	VARIANT	G -> R (in DEDDFA; dbSNP:rs1790288810)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	R1669H	Q9Y4A5/R1669H	TRRAP/R1669H	VARIANT	R -> H (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs373632999)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	R1724H	Q9Y4A5/R1724H	TRRAP/R1724H	VARIANT	R -> H (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs782203759)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	R1859C	Q9Y4A5/R1859C	TRRAP/R1859C	VARIANT	R -> C (in DEDDFA; dbSNP:rs1791432323)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	W1866C	Q9Y4A5/W1866C	TRRAP/W1866C	VARIANT	W -> C (in DEDDFA; unknown pathological significance; dbSNP:rs1562957576)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	W1866R	Q9Y4A5/W1866R	TRRAP/W1866R	VARIANT	W -> R (in DEDDFA; dbSNP:rs1562957569)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	G1883R	Q9Y4A5/G1883R	TRRAP/G1883R	VARIANT	G -> R (in DEDDFA)	ECO:0000269|PubMed:30827496	30827496
Q9Y4A5	TRRAP	A1925V	Q9Y4A5/A1925V	TRRAP/A1925V	VARIANT	A -> V (in dbSNP:rs56197298)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	P1932L	Q9Y4A5/P1932L	TRRAP/P1932L	VARIANT	P -> L (in DEDDFA; unknown pathological significance; also found in a colorectal adenocarcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:30827496	17344846,30827496
Q9Y4A5	TRRAP	R1947L	Q9Y4A5/R1947L	TRRAP/R1947L	VARIANT	R -> L (in an ovarian mucinous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	R2004Q	Q9Y4A5/R2004Q	TRRAP/R2004Q	VARIANT	R -> Q (in DEDDFA; unknown pathological significance; dbSNP:rs1562959030)	ECO:0000269|PubMed:30424743	30424743
Q9Y4A5	TRRAP	W2139G	Q9Y4A5/W2139G	TRRAP/W2139G	VARIANT	W -> G (in dbSNP:rs34185633)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	R2302W	Q9Y4A5/R2302W	TRRAP/R2302W	VARIANT	R -> W (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs528967912)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	S2433G	Q9Y4A5/S2433G	TRRAP/S2433G	VARIANT	S -> G (in dbSNP:rs35634065)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	P2690L	Q9Y4A5/P2690L	TRRAP/P2690L	VARIANT	P -> L (in a lung large cell carcinoma sample; somatic mutation; dbSNP:rs753661271)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	E2750D	Q9Y4A5/E2750D	TRRAP/E2750D	VARIANT	E -> D (in dbSNP:rs55755466)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:31231791	17344846,31231791
Q9Y4A5	TRRAP	K2801E	Q9Y4A5/K2801E	TRRAP/K2801E	VARIANT	K -> E (in dbSNP:rs56341061)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	T2931M	Q9Y4A5/T2931M	TRRAP/T2931M	VARIANT	T -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs1294404368)	ECO:0000269|PubMed:17344846	17344846
Q9Y4A5	TRRAP	R3757Q	Q9Y4A5/R3757Q	TRRAP/R3757Q	VARIANT	R -> Q (in DEDDFA; unknown pathological significance; dbSNP:rs987263983)	ECO:0000269|PubMed:30827496	30827496

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y4K4	MAP4K5	H41Y	Q9Y4K4/H41Y	MAP4K5/H41Y	VARIANT	H -> Y (in dbSNP:rs34726242)		
Q9Y4K4	MAP4K5	A334T	Q9Y4K4/A334T	MAP4K5/A334T	VARIANT	A -> T (in dbSNP:rs12881869)	ECO:0000269|PubMed:17344846	17344846
Q9Y4K4	MAP4K5	P407L	Q9Y4K4/P407L	MAP4K5/P407L	VARIANT	P -> L (in dbSNP:rs34818002)	ECO:0000269|PubMed:17344846	17344846
Q9Y4K4	MAP4K5	I446V	Q9Y4K4/I446V	MAP4K5/I446V	VARIANT	I -> V (in dbSNP:rs55815015)	ECO:0000269|PubMed:17344846	17344846
Q9Y4K4	MAP4K5	K473N	Q9Y4K4/K473N	MAP4K5/K473N	VARIANT	K -> N (in dbSNP:rs35768475)	ECO:0000269|PubMed:9038372	9038372
Q9Y4K4	MAP4K5	R552Q	Q9Y4K4/R552Q	MAP4K5/R552Q	VARIANT	R -> Q (in dbSNP:rs55997280)	ECO:0000269|PubMed:17344846	17344846
Q9Y4K4	MAP4K5	T633M	Q9Y4K4/T633M	MAP4K5/T633M	VARIANT	T -> M (in dbSNP:rs17780143)	ECO:0000269|PubMed:17344846	17344846
Q9Y4K4	MAP4K5	K49R	Q9Y4K4/K49R	MAP4K5/K49R	MUTAGEN	K->R: Loss of kinase activity and ability to activate JNK family.	ECO:0000269|PubMed:9038372	9038372

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y572	RIPK3	E260V	Q9Y572/E260V	RIPK3/E260V	VARIANT	E -> V (in dbSNP:rs7153640)		
Q9Y572	RIPK3	T300M	Q9Y572/T300M	RIPK3/T300M	VARIANT	T -> M (in dbSNP:rs34106261)	ECO:0000269|PubMed:17344846	17344846
Q9Y572	RIPK3	P492Q	Q9Y572/P492Q	RIPK3/P492Q	VARIANT	P -> Q (in dbSNP:rs3212254)	ECO:0000269|PubMed:17344846	17344846
Q9Y572	RIPK3	K50A	Q9Y572/K50A	RIPK3/K50A	MUTAGEN	K->A: Abolishes kinase activity. Loss of PGAM5- and MLKL-binding. No effect on RIPK1-binding. Loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of STUB1-mediated ubiquitination.	ECO:0000269|PubMed:10339433, ECO:0000269|PubMed:10358032, ECO:0000269|PubMed:22265414, ECO:0000269|PubMed:29883609	10339433,10358032,22265414,29883609
Q9Y572	RIPK3	K50D	Q9Y572/K50D	RIPK3/K50D	MUTAGEN	K->D: Abolishes kinase activity.	ECO:0000269|PubMed:10339433, ECO:0000269|PubMed:10358032, ECO:0000269|PubMed:22265414	10339433,10358032,22265414
Q9Y572	RIPK3	D142N	Q9Y572/D142N	RIPK3/D142N	MUTAGEN	D->N: Abolishes kinase activity and ability to mediate necroptosis.	ECO:0000269|PubMed:22265413	22265413
Q9Y572	RIPK3	T182A	Q9Y572/T182A	RIPK3/T182A	MUTAGEN	T->A: Abolishes kinase activity. Loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of interaction with STUB1 and STUB1-mediated ubiquitination. No loss of interaction with RIPK1. Loss of ability to mediate TNF-induced necroptosis. Loss of autophosphorylation at Ser-227.	ECO:0000269|PubMed:29883609	29883609
Q9Y572	RIPK3	T182S	Q9Y572/T182S	RIPK3/T182S	MUTAGEN	T->S: No loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of interaction with RIPK1 and MLKL.	ECO:0000269|PubMed:29883609	29883609
Q9Y572	RIPK3	Y185A	Q9Y572/Y185A	RIPK3/Y185A	MUTAGEN			
Q9Y572	RIPK3	Y185F	Q9Y572/Y185F	RIPK3/Y185F	MUTAGEN	Y->A,F: Loss of interaction with PELI1 and PELI1-mediated ubiquitination.	ECO:0000269|PubMed:29883609	29883609
Q9Y572	RIPK3	S227A	Q9Y572/S227A	RIPK3/S227A	MUTAGEN	S->A: Abolishes ability to mediate necroptosis. Partial loss of kinase activity. No loss of PELI1-mediated degradation.	ECO:0000269|PubMed:22265413, ECO:0000269|PubMed:29883609	22265413,29883609
Q9Y572	RIPK3	S227D	Q9Y572/S227D	RIPK3/S227D	MUTAGEN	S->D: No loss of PELI1-mediated degradation.	ECO:0000269|PubMed:29883609	29883609
Q9Y572	RIPK3	K363R	Q9Y572/K363R	RIPK3/K363R	MUTAGEN	K->R: Loss of PELI1-mediated ubiquitination. No loss of interaction with PELI1.	ECO:0000269|PubMed:29883609	29883609

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y5P4	CERT1	S132L	Q9Y5P4/S132L	CERT1/S132L	VARIANT	S -> L (in MRD34; dbSNP:rs1064794019)	ECO:0000269|PubMed:25533962	25533962
Q9Y5P4	CERT1	S138C	Q9Y5P4/S138C	CERT1/S138C	VARIANT	S -> C (found in a patient with intellectual disability)	ECO:0000269|PubMed:23033978	23033978
Q9Y5P4	CERT1	G243R	Q9Y5P4/G243R	CERT1/G243R	VARIANT	G -> R (in MRD34; associated with authism and epilepsy)	ECO:0000269|PubMed:25356899	25356899
Q9Y5P4	CERT1	K599R	Q9Y5P4/K599R	CERT1/K599R	VARIANT	K -> R (in dbSNP:rs55882089)		
Q9Y5P4	CERT1	S132A	Q9Y5P4/S132A	CERT1/S132A	MUTAGEN	S->A: Abolishes the phosphorylation. Strongly reduces the interaction with phosphatidylinositol 4-phosphate. Increases the ceramide transfer activity.	ECO:0000269|PubMed:17591919	17591919
Q9Y5P4	CERT1	D324A	Q9Y5P4/D324A	CERT1/D324A	MUTAGEN	D->A: Impairs the endoplasmic reticulum-to-Golgi ceramide trafficking and abolishes the interaction with VAPA and MOSPD2.	ECO:0000269|PubMed:16895911, ECO:0000269|PubMed:29858488	16895911,29858488
Q9Y5P4	CERT1	E472A	Q9Y5P4/E472A	CERT1/E472A	MUTAGEN	E->A: Reduces ceramide transfer.	ECO:0000269|PubMed:18184806	18184806
Q9Y5P4	CERT1	Q493A	Q9Y5P4/Q493A	CERT1/Q493A	MUTAGEN	Q->A: No effect on ceramide transfer activity.	ECO:0000269|PubMed:18184806	18184806
Q9Y5P4	CERT1	W499A	Q9Y5P4/W499A	CERT1/W499A	MUTAGEN	W->A: Reduces affinity for membranes. Abolishes ceramide transfer; when associated with A-588.	ECO:0000269|PubMed:20036255	20036255
Q9Y5P4	CERT1	N530A	Q9Y5P4/N530A	CERT1/N530A	MUTAGEN	N->A: Reduces ceramide transfer.	ECO:0000269|PubMed:18184806	18184806
Q9Y5P4	CERT1	W588A	Q9Y5P4/W588A	CERT1/W588A	MUTAGEN	W->A: Abolishes ceramide transfer; when associated with A-499.		

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y5S2	CDC42BPB	A142T	Q9Y5S2/A142T	CDC42BPB/A142T	VARIANT	A -> T (in CHOCNS; unknown pathological significance)	ECO:0000269|PubMed:32031333	32031333
Q9Y5S2	CDC42BPB	D175Y	Q9Y5S2/D175Y	CDC42BPB/D175Y	VARIANT	D -> Y (in CHOCNS; unknown pathological significance)	ECO:0000269|PubMed:32031333	32031333
Q9Y5S2	CDC42BPB	I293M	Q9Y5S2/I293M	CDC42BPB/I293M	VARIANT	I -> M (in CHOCNS; unknown pathological significance)	ECO:0000269|PubMed:32031333	32031333
Q9Y5S2	CDC42BPB	K500E	Q9Y5S2/K500E	CDC42BPB/K500E	VARIANT	K -> E (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1158962067)	ECO:0000269|PubMed:17344846	17344846
Q9Y5S2	CDC42BPB	R555Q	Q9Y5S2/R555Q	CDC42BPB/R555Q	VARIANT	R -> Q (in dbSNP:rs36001612)	ECO:0000269|PubMed:17344846	17344846
Q9Y5S2	CDC42BPB	R671Q	Q9Y5S2/R671Q	CDC42BPB/R671Q	VARIANT	R -> Q (in dbSNP:rs55948035)	ECO:0000269|PubMed:17344846	17344846
Q9Y5S2	CDC42BPB	R867C	Q9Y5S2/R867C	CDC42BPB/R867C	VARIANT	R -> C (in CHOCNS)	ECO:0000269|PubMed:32031333	32031333
Q9Y5S2	CDC42BPB	L871P	Q9Y5S2/L871P	CDC42BPB/L871P	VARIANT	L -> P (in CHOCNS; unknown pathological significance)	ECO:0000269|PubMed:32031333	32031333
Q9Y5S2	CDC42BPB	R876P	Q9Y5S2/R876P	CDC42BPB/R876P	VARIANT	R -> P (in CHOCNS)	ECO:0000269|PubMed:32031333	32031333
Q9Y5S2	CDC42BPB	R876W	Q9Y5S2/R876W	CDC42BPB/R876W	VARIANT	R -> W (in a colorectal adenocarcinoma sample and CHOCNS; somatic mutation; dbSNP:rs1595472741)	ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:32031333	17344846,32031333
Q9Y5S2	CDC42BPB	I1077V	Q9Y5S2/I1077V	CDC42BPB/I1077V	VARIANT	I -> V (in dbSNP:rs34822377)	ECO:0000269|Ref.4	
Q9Y5S2	CDC42BPB	R1203K	Q9Y5S2/R1203K	CDC42BPB/R1203K	VARIANT	R -> K (in dbSNP:rs146298297)	ECO:0000269|PubMed:10574461, ECO:0000269|PubMed:15489334	10574461,15489334
Q9Y5S2	CDC42BPB	R1299Q	Q9Y5S2/R1299Q	CDC42BPB/R1299Q	VARIANT	R -> Q (in CHOCNS; unknown pathological significance)	ECO:0000269|PubMed:32031333	32031333
Q9Y5S2	CDC42BPB	E1315K	Q9Y5S2/E1315K	CDC42BPB/E1315K	VARIANT	E -> K (in a lung large cell carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9Y5S2	CDC42BPB	R1350P	Q9Y5S2/R1350P	CDC42BPB/R1350P	VARIANT	R -> P (in CHOCNS; unknown pathological significance)	ECO:0000269|PubMed:32031333	32031333
Q9Y5S2	CDC42BPB	S1633Y	Q9Y5S2/S1633Y	CDC42BPB/S1633Y	VARIANT	S -> Y (in dbSNP:rs56412851)	ECO:0000269|PubMed:17344846	17344846

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y616	IRAK3	P22L	Q9Y616/P22L	IRAK3/P22L	VARIANT	P -> L (may be associated with ASRT5; dbSNP:rs536546109)	ECO:0000269|PubMed:17503328	17503328
Q9Y616	IRAK3	H57R	Q9Y616/H57R	IRAK3/H57R	VARIANT	H -> R (in dbSNP:rs35239505)	ECO:0000269|PubMed:17344846	17344846
Q9Y616	IRAK3	G84S	Q9Y616/G84S	IRAK3/G84S	VARIANT	G -> S (in dbSNP:rs34443407)	ECO:0000269|PubMed:17344846	17344846
Q9Y616	IRAK3	P111A	Q9Y616/P111A	IRAK3/P111A	VARIANT	P -> A (may be associated with ASRT5; abolishes phosphorylation of Ser-110; abolishes interaction with PIN1; no effect on cytoplasmic localization; reduces protein stability; dbSNP:rs373806603)	ECO:0000269|PubMed:17503328, ECO:0000269|PubMed:29686383	17503328,29686383
Q9Y616	IRAK3	V134M	Q9Y616/V134M	IRAK3/V134M	VARIANT	V -> M (may be associated with ASRT5; dbSNP:rs138559915)	ECO:0000269|PubMed:17503328	17503328
Q9Y616	IRAK3	I147V	Q9Y616/I147V	IRAK3/I147V	VARIANT	I -> V (in dbSNP:rs1152888)	ECO:0000269|PubMed:10383454, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846	10383454,14702039,15489334,17344846
Q9Y616	IRAK3	I171V	Q9Y616/I171V	IRAK3/I171V	VARIANT	I -> V (in dbSNP:rs34682166)	ECO:0000269|PubMed:17344846	17344846
Q9Y616	IRAK3	G269S	Q9Y616/G269S	IRAK3/G269S	VARIANT	G -> S (in dbSNP:rs35823766)		
Q9Y616	IRAK3	I270V	Q9Y616/I270V	IRAK3/I270V	VARIANT	I -> V (in dbSNP:rs11465972)		
Q9Y616	IRAK3	S288L	Q9Y616/S288L	IRAK3/S288L	VARIANT	S -> L (in dbSNP:rs35574245)	ECO:0000269|PubMed:17344846	17344846
Q9Y616	IRAK3	R384Q	Q9Y616/R384Q	IRAK3/R384Q	VARIANT	R -> Q (in dbSNP:rs34272472)	ECO:0000269|PubMed:17344846	17344846
Q9Y616	IRAK3	M391T	Q9Y616/M391T	IRAK3/M391T	VARIANT	M -> T (in dbSNP:rs35737689)	ECO:0000269|PubMed:17344846	17344846
Q9Y616	IRAK3	L400V	Q9Y616/L400V	IRAK3/L400V	VARIANT	L -> V (may be associated with ASRT5; dbSNP:rs146120640)	ECO:0000269|PubMed:17503328	17503328
Q9Y616	IRAK3	R429Q	Q9Y616/R429Q	IRAK3/R429Q	VARIANT	R -> Q (may be associated with ASRT5; dbSNP:rs140671957)	ECO:0000269|PubMed:17503328	17503328
Q9Y616	IRAK3	D482N	Q9Y616/D482N	IRAK3/D482N	VARIANT	D -> N (in dbSNP:rs35756811)	ECO:0000269|PubMed:17344846	17344846
Q9Y616	IRAK3	S110A	Q9Y616/S110A	IRAK3/S110A	MUTAGEN	S->A: Abolishes phosphorylation. Abolishes interaction with PIN1. Reduces protein stability.	ECO:0000269|PubMed:29686383	29686383
Q9Y616	IRAK3	S110E	Q9Y616/S110E	IRAK3/S110E	MUTAGEN	S->E: Phosphomimic. Slight decrease in the interaction with PIN1. Weak interaction with PIN1 in absence of IL33-mediated dendritic cell stimulation. Increases resistant to degradation. Localizes to the nucleus in absence of stimulus. Does not affect isomerization of Pro-111 peptide bond.	ECO:0000269|PubMed:29686383	29686383
Q9Y616	IRAK3	L210E	Q9Y616/L210E	IRAK3/L210E	MUTAGEN	L->E: Abolishes dimerization.	ECO:0000269|PubMed:33238146	33238146
Q9Y616	IRAK3	E214L	Q9Y616/E214L	IRAK3/E214L	MUTAGEN	E->L: Enhances dimerization.	ECO:0000269|PubMed:33238146	33238146
Q9Y616	IRAK3	S467A	Q9Y616/S467A	IRAK3/S467A	MUTAGEN	S->A: No effect on the interaction with PIN1.	ECO:0000269|PubMed:29686383	29686383

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y6E0	STK24	A414V	Q9Y6E0/A414V	STK24/A414V	VARIANT	A -> V (in dbSNP:rs55953606)	ECO:0000269|PubMed:10644707, ECO:0000269|PubMed:17344846	10644707,17344846
Q9Y6E0	STK24	L426I	Q9Y6E0/L426I	STK24/L426I	VARIANT	L -> I (in dbSNP:rs55897869)	ECO:0000269|PubMed:17344846	17344846
Q9Y6E0	STK24	T18A	Q9Y6E0/T18A	STK24/T18A	MUTAGEN	T->A: Loss of phosphorylation by PKA.	ECO:0000269|PubMed:10644707	10644707
Q9Y6E0	STK24	K65A	Q9Y6E0/K65A	STK24/K65A	MUTAGEN	K->A: Loss of activity and autophosphorylation.	ECO:0000269|PubMed:12107159	12107159
Q9Y6E0	STK24	T190A	Q9Y6E0/T190A	STK24/T190A	MUTAGEN	T->A: Loss of activity and autophosphorylation.	ECO:0000269|PubMed:17046825	17046825
Q9Y6E0	STK24	D321N	Q9Y6E0/D321N	STK24/D321N	MUTAGEN	D->N: Loss of proteolytic cleavage by caspases.	ECO:0000269|PubMed:12107159	12107159

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y6R4	MAP3K4	R157H	Q9Y6R4/R157H	MAP3K4/R157H	VARIANT	R -> H (in dbSNP:rs4559074)	ECO:0000269|PubMed:15489334	15489334
Q9Y6R4	MAP3K4	I294T	Q9Y6R4/I294T	MAP3K4/I294T	VARIANT	I -> T (in dbSNP:rs35842248)	ECO:0000269|PubMed:17344846	17344846
Q9Y6R4	MAP3K4	V335I	Q9Y6R4/V335I	MAP3K4/V335I	VARIANT	V -> I (in dbSNP:rs35730939)	ECO:0000269|PubMed:17344846	17344846
Q9Y6R4	MAP3K4	R566H	Q9Y6R4/R566H	MAP3K4/R566H	VARIANT	R -> H (in dbSNP:rs55765351)	ECO:0000269|PubMed:17344846	17344846
Q9Y6R4	MAP3K4	Q584H	Q9Y6R4/Q584H	MAP3K4/Q584H	VARIANT	Q -> H (in dbSNP:rs34018542)	ECO:0000269|PubMed:17344846	17344846
Q9Y6R4	MAP3K4	H906P	Q9Y6R4/H906P	MAP3K4/H906P	VARIANT	H -> P (in dbSNP:rs35533223)	ECO:0000269|PubMed:17344846	17344846
Q9Y6R4	MAP3K4	E1413Q	Q9Y6R4/E1413Q	MAP3K4/E1413Q	VARIANT	E -> Q (in an ovarian serous carcinoma sample; somatic mutation)	ECO:0000269|PubMed:17344846	17344846
Q9Y6R4	MAP3K4	A1492V	Q9Y6R4/A1492V	MAP3K4/A1492V	VARIANT	A -> V (in dbSNP:rs41267837)	ECO:0000269|PubMed:17344846	17344846
Q9Y6R4	MAP3K4	K1372R	Q9Y6R4/K1372R	MAP3K4/K1372R	MUTAGEN	K->R: Loss of activity.	ECO:0000269|PubMed:12052864, ECO:0000269|PubMed:9305639	12052864,9305639

UniProt	Gene	Mutation	UniProt/Mutation	Gene/Mutation	Type	Note	Evidence	Pubmed
Q9Y6S9	RPS6KL1	R21Q	Q9Y6S9/R21Q	RPS6KL1/R21Q	VARIANT	R -> Q (in dbSNP:rs7156590)	ECO:0000269|PubMed:17344846	17344846
Q9Y6S9	RPS6KL1	P121L	Q9Y6S9/P121L	RPS6KL1/P121L	VARIANT	P -> L (in dbSNP:rs2286913)	ECO:0000269|PubMed:17344846	17344846
Q9Y6S9	RPS6KL1	R332W	Q9Y6S9/R332W	RPS6KL1/R332W	VARIANT	R -> W (in dbSNP:rs55871101)	ECO:0000269|PubMed:17344846	17344846

